U.S. patent application number 10/831997 was filed with the patent office on 2005-11-03 for single nucleotide polymorphisms in genes.
This patent application is currently assigned to Whitehead Institute for Biomedical Research. Invention is credited to Bolk, Stacey, Cargill, Michele, Daley, George Q., Ireland, James S., Lander, Eric S., McCarthy, Jeanette J..
Application Number | 20050244834 10/831997 |
Document ID | / |
Family ID | 32111002 |
Filed Date | 2005-11-03 |
United States Patent
Application |
20050244834 |
Kind Code |
A1 |
Lander, Eric S. ; et
al. |
November 3, 2005 |
Single nucleotide polymorphisms in genes
Abstract
The invention provides nucleic acid segments of the human
genome, particularly nucleic acid segments from a gene, including
polymorphic sites. Allele-specific primers and probes hybridizing
to regions flanking or containing these sites are also provided.
The nucleic acids, primers and probes are used in applications such
as phenotype correlations, forensics, paternity testing, medicine
and genetic analysis. A role for the thrombospondin gene(s) in
vascular disease is also disclosed. Use of single nucleotide
polymorphisms in the thrombospondin gene(s) for diagnosis,
prediction of clinical course and treatment response, development
of therapeutics and development of cell-culture-based and animal
models for research and treatment are disclosed.
Inventors: |
Lander, Eric S.; (Cambridge,
MA) ; Cargill, Michele; (Gaithersburg, MD) ;
Ireland, James S.; (Gaithersburg, MD) ; Bolk,
Stacey; (West Roxbury, MA) ; Daley, George Q.;
(Weston, MA) ; McCarthy, Jeanette J.; (San Diego,
CA) |
Correspondence
Address: |
ROPES & GRAY LLP
ONE INTERNATIONAL PLACE
BOSTON
MA
02110-2624
US
|
Assignee: |
Whitehead Institute for Biomedical
Research
Cambridge
MA
Millennium Pharmaceuticals, Inc.
Cambridge
MA
|
Family ID: |
32111002 |
Appl. No.: |
10/831997 |
Filed: |
April 26, 2004 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10831997 |
Apr 26, 2004 |
|
|
|
09657472 |
Sep 7, 2000 |
|
|
|
6727063 |
|
|
|
|
60220947 |
Jul 26, 2000 |
|
|
|
60153357 |
Sep 10, 1999 |
|
|
|
60225724 |
Aug 16, 2000 |
|
|
|
Current U.S.
Class: |
435/6.11 |
Current CPC
Class: |
C12Q 1/6883 20130101;
C07K 14/78 20130101; C12Q 2600/156 20130101 |
Class at
Publication: |
435/006 |
International
Class: |
C12Q 001/68 |
Claims
We claim:
1. A method of diagnosing or aiding in the diagnosis of a vascular
disease in an individual comprising a) obtaining a nucleic acid
sample from the individual; and b) determining the nucleotide
present at nucleotide position 2210 of the thrombospondin-1 gene,
wherein presence of a G at nucleotide position 2210 is indicative
of increased likelihood of a vascular disease in the individual as
compared with an individual having an A at nucleotide position
2210, and wherein presence of an A at nucleotide position 2210 is
indicative of decreased likelihood of a vascular disease in the
individual as compared with an individual having a G at nucleotide
position 2210.
2. The method of claim 1, wherein the thrombospondin-1 gene has the
nucleotide sequence of SEQ ID NO: 1.
3. The method of claim 1, wherein the vascular disease is selected
from the group consisting of atherosclerosis, coronary heart
disease, myocardial infarction, stroke, peripheral vascular
diseases, venous thromboembolism and pulmonary embolism.
4. A method for predicting the likelihood that an individual will
have a vascular disease, comprising the steps of: a) obtaining a
DNA sample from an individual to be assessed; and b) determining
the nucleotide present at nucleotide position 2210 of the
thrombospondin-1 gene, wherein presence of a G at nucleotide
position 2210 is indicative of increased likelihood of a vascular
disease in the individual as compared with an individual having an
A at nucleotide position 2210.
5. The method according to claim 4, wherein the thrombospondin-I
gene has the nucleotide sequence of SEQ ID NO: 1.
6. The method according to claim 4, wherein the individual is an
individual at risk for development of a vascular disease.
7. The method according to claim 4, wherein the vascular disease is
selected from the group consisting of atherosclerosis, coronary
heart disease, myocardial infarction, stroke, peripheral vascular
diseases, venous thromboembolism and pulmonary embolism.
8. A nucleic acid molecule comprising all or a portion of the
nucleic acid sequence of SEQ ID NO: 1 wherein said nucleic acid
molecule is at least 10 nucleotides in length and wherein the
nucleic acid sequence comprises a polymorphic site at nucleotide
position 2210 of SEQ ID NO: 1.
9. The nucleic acid molecule according to claim 8, wherein the
nucleotide at the polymorphic site is different from a nucleotide
at the polymorphic site in a corresponding reference allele.
10. An allele-specific oligonucleotide that hybridizes to the
nucleic acid molecule of claim 8.
11. A peptide of SEQ ID NO: 2 which is at least ten contiguous
amino acids, wherein the peptide comprises the serine at amino acid
position 700 of SEQ ID NO: 2.
12. A method of diagnosing or aiding in the diagnosis of a vascular
disease in an individual comprising a) obtaining a biological
sample comprising thrombospondin-1 protein or relevant portion
thereof from the individual; and b) determining the amino acid
present at amino acid position 700 of the thrombospondin-1 protein,
wherein presence of an asparagine at amino acid position 700 is
indicative of increased likelihood of a vascular disease in the
individual as compared with an individual having a serine at amino
acid position 700, and wherein presence of a serine at amino acid
position 700 is indicative of reduced likelihood of a vascular
disease in the individual as compared with an individual having an
asparagine at amino acid position 700.
13. The method of claim 12, wherein the thrombospondin-1 protein
has the amino acid sequence of SEQ ID NO: 2.
14. The method of claim 12, wherein the vascular disease is
selected from the group consisting of atherosclerosis, coronary
heart disease, myocardial infarction, stroke, peripheral vascular
diseases, venous thromboembolism and pulmonary embolism.
15. A nucleic acid molecule comprising all or a portion of the
nucleic acid sequence of SEQ ID NO: 3 wherein said nucleic acid
molecule is at least 10 nucleotides in length and wherein the
nucleic acid sequence comprises a polymorphic site at nucleotide
position 1186 of SEQ ID NO: 3.
16. The nucleic acid molecule according to claim 15, wherein the
nucleotide at the polymorphic site is different from a nucleotide
at the polymorphic site in a corresponding reference allele.
17. An allele-specific oligonucleotide that hybridizes to the
nucleic acid molecule of claim 15.
18. A peptide of SEQ ID NO: 4 which is at least ten contiguous
amino acids, wherein the peptide comprises the proline at amino
acid position 387 of SEQ ID NO: 4.
19. A method of diagnosing or aiding in the diagnosis of a vascular
disease in an individual comprising a) obtaining a biological
sample comprising thrombospondin-4 protein or relevant portion
thereof from the individual; and b) determining the amino acid
present at amino acid position 387 of the thrombospondin-4 protein,
wherein presence of an alanine at amino acid position 387 is
indicative of increased likelihood of a vascular disease in the
individual as compared with an individual having a proline at amino
acid position 387, and wherein presence of a proline at amino acid
position 387 is indicative of reduced likelihood of a vascular
disease in the individual as compared with an individual having an
alanine at amino acid position 387.
20. The method of claim 19, wherein the thrombospondin-4 protein
has the amino acid sequence of SEQ ID NO: 4.
21. The method of claim 19, wherein the vascular disease is
selected from the group consisting of atherosclerosis, coronary
heart disease, myocardial infarction, stroke, peripheral vascular
diseases, venous thromboembolism and pulmonary embolism.
22. A nucleic acid molecule selected from the group consisting of
the genes listed in the Table, wherein said nucleic acid molecule
is at least 10 nucleotides in length and comprises a polymorphic
site identified in the Table, wherein a nucleotide at the
polymorphic site is different from a nucleotide at the polymorphic
site in a corresponding reference allele.
23. A nucleic acid molecule according to claim 22, wherein said
nucleic acid molecule is at least 15 nucleotides in length.
24. A nucleic acid molecule according to claim 22, wherein said
nucleic acid molecule is at least 20 nucleotides in length.
25. A nucleic acid molecule according to claim 22, wherein the
nucleotide at the polymorphic site is the variant nucleotide for
the gene listed in the Table.
26. An allele-specific oligonucleotide that hybridizes to a portion
of a gene selected from the group consisting of the genes listed in
the Table, wherein said portion is at least 10 nucleotides in
length and comprises a polymorphic site identified in the Table,
wherein a nucleotide at the polymorphic site is different from a
nucleotide at the polymorphic site in a corresponding reference
allele.
27. An allele-specific oligonucleotide according to claim 26 that
is a probe.
28. An allele-specific oligonucleotide according to claim 26,
wherein a central position of the probe aligns with the polymorphic
site of the portion.
29. An allele-specific oligonucleotide according to claim 26 that
is a primer.
30. An allele-specific oligonucleotide according to claim 29,
wherein the 3' end of the primer aligns with the polymorphic site
of the portion.
31. An isolated gene product encoded by a nucleic acid molecule
according to claim 22.
32. A method of analyzing a nucleic acid sample, comprising
obtaining the nucleic acid sample from an individual; and
determining a base occupying any one of the polymorphic sites shown
in the Table.
33. A method according to claim 32, wherein the nucleic acid sample
is obtained from a plurality of individuals, and a base occupying
one of the polymorphic positions is determined in each of the
individuals, and wherein the method further comprising testing each
individual for the presence of a disease phenotype, and correlating
the presence of the disease phenotype with the base.
Description
RELATED APPLICATIONS
[0001] This application is a divisional of U.S. application Ser.
No. 09/657,472, filed Sep. 7, 2000, which claims the benefit of
U.S. Provisional Application Serial No. 60/153,357, filed Sep. 10,
1999, U.S. Provisional Application Serial No. 60/220,947, filed
Jul. 26, 2000, and U.S. Provisional Application Serial No.
60/225,724, filed Aug. 16, 2000, the entire teachings of all of
which are incorporated herein by reference.
BACKGROUND OF THE INVENTION
[0002] The genomes of all organisms undergo spontaneous mutation in
the course of their continuing evolution, generating variant forms
of progenitor nucleic acid sequences (Gusella, Ann. Rev. Biochem.
55, 831-854 (1986)). The variant form may confer an evolutionary
advantage or disadvantage relative to a progenitor form, or may be
neutral. In some instances, a variant form confers a lethal
disadvantage and is not transmitted to subsequent generations of
the organism. In other instances, a variant form confers an
evolutionary advantage to the species and is eventually
incorporated into the DNA of many or most members of the species
and effectively becomes the progenitor form. In many instances,
both progenitor and variant form(s) survive and co-exist in a
species population. The coexistence of multiple forms of a sequence
gives rise to polymorphisms.
[0003] Several different types of polymorphism have been reported.
A restriction fragment length polymorphism (RFLP) is a variation in
DNA sequence that alters the length of a restriction fragment
(Botstein et al., Am. J. Hum. Genet. 32, 314-331 (1980)). The
restriction fragment length polymorphism may create or delete a
restriction site, thus changing the length of the restriction
fragment. RFLPs have been widely used in human and animal genetic
analyses (see WO 90/13668; W090/11369; Donis-Keller, Cell 51,
319-337 (1987); Lander et al., Genetics 121, 85-99 (1989)). When a
heritable trait can be linked to a particular RFLP, the presence of
the RFLP in an individual can be used to predict the likelihood
that the animal will also exhibit the trait.
[0004] Other polymorphisms take the form of short tandem repeats
(STRs) that include tandem di-, tri- and tetra-nucleotide repeated
motifs. These tandem repeats are also referred to as variable
number tandem repeat (VNTR) polymorphisms. VNTRs have been used in
identity and paternity analysis (U.S. Pat. No. 5,075,217; Armour et
al., FEBS Lett. 307, 113-115 (1992); Horn et al., WO 91/14003;
Jeffreys, EP 370,719), and in a large number of genetic mapping
studies.
[0005] Other polymorphisms take the form of single nucleotide
variations between individuals of the same species. Such
polymorphisms are far more frequent than RFLPs, STRs and VNTRs.
Some single nucleotide polymorphisms (SNP) occur in protein-coding
nucleic acid sequences (coding sequence SNP (cSNP)), in which case,
one of the polymorphic forms may give rise to the expression of a
defective or otherwise variant protein and, potentially, a genetic
disease. Examples of genes in which polymorphisms within coding
sequences give rise to genetic disease include .beta.-globin
(sickle cell anemia), apoE4 (Alzheimer's Disease), Factor V Leiden
(thrombosis), and CFTR (cystic fibrosis). cSNPs can alter the codon
sequence of the gene and therefore specify an alternative amino
acid. Such changes are called "missense" when another amino acid is
substituted, and "nonsense" when the alternative codon specifies a
stop signal in protein translation. When the cSNP does not alter
the amino acid specified the cSNP is called "silent".
[0006] Other single nucleotide polymorphisms occur in noncoding
regions. Some of these polymorphisms may also result in defective
protein expression (e.g., as a result of defective splicing). Other
single nucleotide polymorphisms have no phenotypic effects.
[0007] Single nucleotide polymorphisms can be used in the same
manner as RFLPs and VNTRs, but offer several advantages. Single
nucleotide polymorphisms occur with greater frequency and are
spaced more uniformly throughout the genome than other forms of
polymorphism. The greater frequency and uniformity of single
nucleotide polymorphisms means that there is a greater probability
that such a polymorphism will be found in close proximity to a
genetic locus of interest than would be the case for other
polymorphisms. The different forms of characterized single
nucleotide polymorphisms are often easier to distinguish than other
types of polymorphism (e.g., by use of assays employing
allele-specific hybridization probes or primers).
[0008] Only a small percentage of the total repository of
polymorphisms in humans and other organisms has been identified.
The limited number of polymorphisms identified to date is due to
the large amount of work required for their detection by
conventional methods. For example, a conventional approach to
identifying polymorphisms might be to sequence the same stretch of
DNA in a population of individuals by dideoxy sequencing. In this
type of approach, the amount of work increases in proportion to
both the length of sequence and the number of individuals in a
population and becomes impractical for large stretches of DNA or
large numbers of persons.
SUMMARY OF THE INVENTION
[0009] Work described herein pertains to the identification of
polymorphisms which can predispose individuals to disease, by
resequencing large numbers of genes in a large number of
individuals. Various genes from a number of individuals have been
resequenced as described herein, and SNPs in these genes have been
discovered (see the Table and FIG. 3). Some of these SNPs are cSNPs
which specify a different amino acid sequence, some of the SNPs are
silent cSNPs and some of these cSNPs specify a stop signal in
protein translation. Some of the identified SNPs were located in
non-coding regions.
[0010] The invention relates to a gene which comprises a single
nucleotide polymorphism at a specific location. In a particular
embodiment the invention relates to the variant allele of a gene
having a single nucleotide polymorphism, which variant allele
differs from a reference allele by one nucleotide at the site(s)
identified in the Table and FIG. 3. Complements of these nucleic
acid sequences are also included. The nucleic acid molecules can be
DNA or RNA, and can be double- or single-stranded. Nucleic acid
molecules can be, for example, 5-10, 5-15, 10-20, 5-25, 10-30,
10-50 or 10-100 bases long.
[0011] The invention further provides allele-specific
oligonucleotides that hybridize to the reference or variant allele
of a gene comprising a single nucleotide polymorphism or to the
complement thereof. These oligonucleotides can be probes or
primers.
[0012] The invention further provides a method of analyzing a
nucleic acid from an individual. The method determines which base
is present at any one of the polymorphic sites shown in the Table
and/or FIG. 3. Optionally, a set of bases occupying a set of the
polymorphic sites shown in the Table and/or FIG. 3 is determined.
This type of analysis can be performed on a number of individuals,
who are tested for the presence of a disease phenotype. The
presence or absence of disease phenotype is then correlated with a
base or set of bases present at the polymorphic site or sites in
the individuals tested.
[0013] Thus, the invention further relates to a method of
predicting the presence, absence, likelihood of the presence or
absence, or severity of a particular phenotype or disorder
associated with a particular genotype. The method comprises
obtaining a nucleic acid sample from an individual and determining
the identity of one or more bases (nucleotides) at polymorphic
sites of genes described herein, wherein the presence of a
particular base is correlated with a specified phenotype or
disorder, thereby predicting the presence, absence, likelihood of
the presence or absence, or severity of the phenotype or disorder
in the individual.
[0014] The thrombospondins are a family of extracellular matrix
(ECM) glycoproteins that modulate many cell behaviors including
adhesion, migration, and proliferation. Thrombospondins (also known
as thrombin sensitive proteins or TSPs) are large molecular weight
glycoproteins composed of three identical disulfide-linked
polypeptide chains. The results described herein also reveal an
important association between alterations, particularly SNPs, in
TSP genes, particularly TSP-1 and TSP-4, and vascular disease. In
particular, SNPs in these genes which are associated with premature
coronary artery disease (CAD)(or coronary heart disease) and
myocardial infarction (MI) have been identified and represent a
potentially vital marker of upstream biology influencing the
complex process of atherosclerotic plaque generation and
vulnerability.
[0015] Thus, the invention relates to the TSP gene SNPs identified
as described herein, both singly and in combination, as well as to
the use of these SNPs, and others in TSP genes, particularly those
nearby in linkage disequilibrium with these SNPs, for diagnosis,
prediction of clinical course and treatment response for vascular
disease, development of new treatments for vascular disease based
upon comparison of the variant and normal versions of the gene or
gene product, and development of cell-culture based and animal
models for research and treatment of vascular disease. The
invention further relates to novel compounds and pharmaceutical
compositions for use in the diagnosis and treatment of such
disorders. In preferred embodiments, the vascular disease is CAD or
MI.
[0016] The invention relates to isolated nucleic acid molecules
comprising all or a portion of the variant allele of TSP-1 (e.g.,
as exemplified by SEQ ID NO: 1), and to isolated nucleic acid
molecules comprising all or a portion of the variant allele of
TSP-4 (e.g., as exemplified by SEQ ID NO: 3). Preferred portions
are at least 10 contiguous nucleotides and comprise the polymorphic
site, e.g., a portion of SEQ ID NO: 1 which is at least 10
contiguous nucleotides and comprises the "G" at position 2210, or a
portion of SEQ ID NO: 3 which is at least 10 contiguous nucleotides
and comprises the "C" at position 1186. The invention further
relates to isolated gene products, e.g., polypeptides or proteins,
which are encoded by a nucleic acid molecule comprising all or a
portion of the variant allele of TSP-1 or TSP-4 (e.g., SEQ ID NO: 1
or SEQ ID NO: 3, respectively). The invention also relates to
nucleic acid molecules which hybridize to and/or share identity
with the variant alleles identified herein (or their complements)
and which also comprise the variant nucleotide at the SNP site.
[0017] The invention further relates to isolated proteins or
polypeptides comprising all or a portion of the variant amino acid
sequence of TSP-1 (e.g., as exemplified by SEQ ID NO: 2), and to
isolated proteins or polypeptides comprising all or a portion of
the variant amino acid sequence of TSP-4 (e.g., as exemplified by
SEQ ID NO: 4). Preferred polypeptides are at least 10 contiguous
amino acids and comprise the polymorphic amino acid, e.g., a
portion of SEQ ID NO: 2 which is at least 10 contiguous amino acids
and comprises the serine at residue 700, or a portion of SEQ ID NO:
4 which is at least 10 contiguous amino acids and comprises the
proline at residue 387. The invention further relates to isolated
nucleic acid molecules encoding such proteins and polypeptides, as
well as to antibodies which bind, e.g., specifically, to such
proteins and polypeptides.
[0018] The invention further relates to a method of diagnosing or
aiding in the diagnosis of a disorder associated with the presence
of one or more of (a) a G at nucleotide position 2210 of SEQ ID NO:
1; or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 in an
individual. The method comprises obtaining a nucleic acid sample
from the individual and determining the nucleotide present at one
or more of the indicated nucleotide positions, wherein presence of
one or more of (a) a G at nucleotide position 2210 of SEQ ID NO: 1;
or (b) a C at nucleotide position 1186 of SEQ ID NO: 3 is
indicative of increased likelihood of said disorder in the
individual as compared with an appropriate control, e.g., an
individual having the reference nucleotide at one or more of said
positions. In a particular embodiment the disorder is a vascular
disease selected from the group consisting of atherosclerosis,
coronary heart or artery disease, MI, stroke, peripheral vascular
diseases, venous thromboembolism and pulmonary embolism. In a
preferred embodiment, the vascular disease is selected from the
group consisting of CAD and MI.
[0019] The invention further relates to a method of diagnosing or
aiding in the diagnosis of a disorder associated with one or more
of (a) a G at nucleotide position 2210 of SEQ ID NO: 1; or (b) a C
at nucleotide position 1186 of SEQ ID NO: 3 in an individual. The
method comprises obtaining a nucleic acid sample from the
individual and determining the nucleotide present at one or more of
the indicated nucleotide positions, wherein presence of one or more
of (a) an A at nucleotide position 2210 of SEQ ID NO: 1; or (b) a G
at nucleotide position 1186 of SEQ ID NO: 3 is indicative of
decreased likelihood of said disorder in the individual as compared
with an appropriate control, e.g., an individual having the variant
nucleotide at said position. In a particular embodiment the
disorder is a vascular disease selected from the group consisting
of atherosclerosis, coronary heart or artery disease, MI, stroke,
peripheral vascular diseases, venous thromboembolism and pulmonary
embolism. In a preferred embodiment, the vascular disease is
selected from the group consisting of CAD and MI.
[0020] In one embodiment, the invention relates to a method for
predicting the likelihood that an individual will have a vascular
disease (or aiding in the diagnosis of a vascular disease),
comprising the steps of obtaining a DNA sample from an individual
to be assessed and determining the nucleotide present at one or
more of nucleotide positions 2210 of SEQ ID NO: 1 or 1186 of SEQ ID
NO: 3. The presence of the reference nucleotide at one or more of
these positions indicates that the individual has a lower
likelihood of having a vascular disease than an individual having
the variant nucleotide at one or more of these positions, or a
lower likelihood of having severe symptomology. In a particular
embodiment, the individual is an individual at risk for development
of a vascular disease.
[0021] The invention further relates to a method of diagnosing or
aiding in the diagnosis of a disorder associated with the presence
of one or more of (a) a serine at amino acid position 700 of SEQ ID
NO: 2; or (b) a proline at amino acid position 387 of SEQ ID NO: 4
in an individual. The method comprises obtaining a biological
sample containing the TSP-1 and/or TSP-4 protein or relevant
portion thereof from the individual and determining the amino acid
present at one or more of the indicated amino acid positions,
wherein presence of one or more of (a) a serine at amino acid
position 700 of SEQ ID NO: 2; or (b) a proline at amino acid
position 387 of SEQ ID NO: 4 is indicative of increased likelihood
of said disorder in the individual as compared with an appropriate
control, e.g., an individual having the reference amino acid at one
or more of said positions.
[0022] The invention further relates to a method of diagnosing or
aiding in the diagnosis of a disorder associated with one or more
of (a) a serine at amino acid position 700 of SEQ ID NO: 2; or (b)
a proline at amino acid position 387 of SEQ ID NO: 4 in an
individual. The method comprises obtaining a biological sample
containing the TSP-1 and/or TSP-4 protein or relevant portion
thereof from the individual and determining the amino acid present
at one or more of the indicated amino acid positions, wherein
presence of one or more of (a) an asparagine at amino acid position
700 of SEQ ID NO: 2; or (b) an alanine at amino acid position 387
of SEQ ID NO: 4 is indicative of decreased likelihood of said
disorder in the individual as compared with an appropriate control,
e.g., an individual having the variant amino acid at one or more of
said positions.
[0023] In one embodiment, the invention relates to a method for
predicting the likelihood that an individual will have a vascular
disease (or aiding in the diagnosis of a vascular disease),
comprising the steps of obtaining a biological sample comprising
the TSP-1 and/or TSP-4 protein or relevant portion thereof from an
individual to be assessed and determining the amino acid present at
one or more of amino acid positions 700 of SEQ ID NO: 2 or 387 of
SEQ ID NO: 4. The presence of the reference amino acid at one or
more of these positions indicates that the individual has a lower
likelihood of having a vascular disease than an individual having
the variant amino acid at one or more of these positions, or a
lower likelihood of having severe symptomology. In a particular
embodiment, the individual is an individual at risk for development
of a vascular disease.
[0024] In another embodiment, the invention relates to
pharmaceutical compositions comprising a reference TSP-1 and/or
TSP-4 gene or gene product, or active portion thereof, for use in
the treatment of vascular diseases. The invention further relates
to the use of agonists and antagonists of TSP-1 and TSP-4 activity
for use in the treatment of vascular diseases. In a particular
embodiment the vascular disease is selected from the group
consisting of atherosclerosis, coronary heart or artery disease,
MI, stroke, peripheral vascular diseases, venous thromboembolism
and pulmonary embolism. In a preferred embodiment, the vascular
disease is selected from the group consisting of CAD and MI.
BRIEF DESCRIPTION OF THE DRAWINGS
[0025] FIGS. 1A-1D show the reference nucleotide (SEQ ID NO: 1) and
amino acid (SEQ ID NO: 2) sequences for TSP-1.
[0026] FIGS. 2A-2C show the reference nucleotide (SEQ ID NO: 3) and
amino acid (SEQ ID NO: 4) sequences for TSP-4.
[0027] FIG. 3 shows a table providing detailed information about
the SNPs identified herein. Column one shows the internal
polymorphism identifier. Column two shows the accession number for
the reference sequence in the TIGR database which can be found on
the world wide web at tigr.org/tdb/hgi/searching/hgigreports.html.
Column three shows the nucleotide position for the SNP site. Column
four shows the gene in which the polymorphism was identified.
Column five shows the polymorphic site and additional flanking
sequence on each side of the polymorphism. Column six shows the
type of mutation produced by the polymorphism. Columns seven and
eight show the reference and alternate (variant) nucleotides,
respectively, for the SNP. Columns nine and ten show the reference
and alternate (variant) amino acids, respectively, encoded by the
alleles of the gene.
DETAILED DESCRIPTION OF THE INVENTION
[0028] The present invention relates to a gene which comprises a
single nucleotide polymorphism (SNP) at a specific location. The
gene which includes the SNP has at least two alleles, referred to
herein as the reference allele and the variant allele. The
reference allele (prototypical or wild type allele) has been
designated arbitrarily and typically corresponds to the nucleotide
sequence of the gene which has been deposited with GenBank or TIGR
under a given Accession number. The variant allele differs from the
reference allele by one nucleotide at the site(s) identified in the
Table. The present invention also relates to variant alleles of the
described genes and to complements of the variant alleles. The
invention also relates to nucleic acid molecules which hybridize to
and/or share identity with the variant alleles identified herein
(or their complements) and which also comprise the variant
nucleotide at the SNP site.
[0029] The invention further relates to portions of the variant
alleles and portions of complements of the variant alleles which
comprise (encompass) the site of the SNP and are at least 5
nucleotides in length. Portions can be, for example, 5-10, 5-15,
10-20, 5-25, 10-30, 10-50 or 10-100 bases long. For example, a
portion of a variant allele which is 21 nucleotides in length
includes the single nucleotide polymorphism (the nucleotide which
differs from the reference allele at that site) and twenty
additional nucleotides which flank the site in the variant allele.
These nucleotides can be on one or both sides of the polymorphism.
Polymorphisms which are the subject of this invention are defined
in the Table with respect to the reference sequence deposited in
GenBank or TIGR under the Accession number indicated. For example,
the invention relates to a portion of a gene (e.g., AT3) having a
nucleotide sequence as deposited in GenBank (e.g., U11270)
comprising a single nucleotide polymorphism at a specific position
(e.g., nucleotide 11918). The reference nucleotide for AT3 is shown
in column 8, and the variant nucleotide is shown in column 9 of the
Table. The nucleotide sequences of the invention can be double- or
single-stranded.
[0030] The invention further provides allele-specific
oligonucleotides that hybridize to the reference or variant allele
of a gene comprising a single nucleotide polymorphism or to the
complement thereof. These oligonucleotides can be probes or
primers.
[0031] The invention further provides a method of analyzing a
nucleic acid from an individual. The method determines which base
is present at any one of the polymorphic sites shown in the Table
and/or FIG. 3. Optionally, a set of bases occupying a set of the
polymorphic sites shown in the Table and/or FIG. 3 is determined.
This type of analysis can be performed on a number of individuals,
who are tested for the presence of a disease phenotype. The
presence or absence of disease phenotype is then correlated with a
base or set of bases present at the polymorphic site or sites in
the individuals tested.
[0032] Thus, the invention further relates to a method of
predicting the presence, absence, likelihood of the presence or
absence, or severity of a particular phenotype or disorder
associated with a particular genotype. The method comprises
obtaining a nucleic acid sample from an individual and determining
the identity of one or more bases (nucleotides) at polymorphic
sites of genes described herein, wherein the presence of a
particular base is correlated with a specified phenotype or
disorder, thereby predicting the presence, absence, likelihood of
the presence or absence, or severity of the phenotype or disorder
in the individual.
[0033] Definitions
[0034] A nucleic acid molecule or oligonucleotide can be DNA or
RNA, and single- or double-stranded. Nucleic acid molecules and
oligonucleotides can be naturally occurring or synthetic, but are
typically prepared by synthetic means. Preferred nucleic acid
molecules and oligonucleotides of the invention include segments of
DNA, or their complements, which include any one of the polymorphic
sites shown in the Table. The segments can be between 5 and 250
bases, and, in specific embodiments, are between 5-10, 5-20, 10-20,
10-50, 20-50 or 10-100 bases. For example, the segment can be 21
bases. The polymorphic site can occur within any position of the
segment. The segments can be from any of the allelic forms of DNA
shown in the Table.
[0035] As used herein, the terms "nucleotide", "base" and "nucleic
acid" are intended to be equivalent. The terms "nucleotide
sequence", "nucleic acid sequence", "nucleic acid molecule" and
"segment" are intended to be equivalent.
[0036] Hybridization probes are oligonucleotides which bind in a
base-specific manner to a complementary strand of nucleic acid.
Such probes include peptide nucleic acids, as described in Nielsen
et al., Science 254, 1497-1500 (1991). Probes can be any length
suitable for specific hybridization to the target nucleic acid
sequence. The most appropriate length of the probe may vary
depending upon the hybridization method in which it is being used;
for example, particular lengths may be more appropriate for use in
microfabricated arrays, while other lengths may be more suitable
for use in classical hybridization methods. Such optimizations are
known to the skilled artisan. Suitable probes and primers can range
from about 5 nucleotides to about 30 nucleotides in length. For
example, probes and primers can be 5, 6, 8, 10, 12, 14, 16, 18, 20,
22, 24, 25, 26, 28 or 30 nucleotides in length. The probe or primer
preferably overlaps at least one polymorphic site occupied by any
of the possible variant nucleotides. The nucleotide sequence can
correspond to the coding sequence of the allele or to the
complement of the coding sequence of the allele.
[0037] As used herein, the term "primer" refers to a
single-stranded oligonucleotide which acts as a point of initiation
of template-directed DNA synthesis under appropriate conditions
(e.g., in the presence of four different nucleoside triphosphates
and an agent for polymerization, such as DNA or RNA polymerase or
reverse transcriptase) in an appropriate buffer and at a suitable
temperature. The appropriate length of a primer depends on the
intended use of the primer, but typically ranges from 15 to 30
nucleotides. Short primer molecules generally require cooler
temperatures to form sufficiently stable hybrid complexes with the
template. A primer need not reflect the exact sequence of the
template, but must be sufficiently complementary to hybridize with
a template. The term primer site refers to the area of the target
DNA to which a primer hybridizes. The term primer pair refers to a
set of primers including a 5' (upstream) primer that hybridizes
with the 5' end of the DNA sequence to be amplified and a 3'
(downstream) primer that hybridizes with the complement of the 3'
end of the sequence to be amplified.
[0038] As used herein, linkage describes the tendency of genes,
alleles, loci or genetic markers to be inherited together as a
result of their location on the same chromosome. It can be measured
by percent recombination between the two genes, alleles, loci or
genetic markers.
[0039] As used herein, polymorphism refers to the occurrence of two
or more genetically determined alternative sequences or alleles in
a population. A polymorphic marker or site is the locus at which
divergence occurs. Preferred markers have at least two alleles,
each occurring at frequency of greater than 1%, and more preferably
greater than 10% or 20% of a selected population. A polymorphic
locus may be as small as one base pair. Polymorphic markers include
restriction fragment length polymorphisms, variable number of
tandem repeats (VNTR's), hypervariable regions, minisatellites,
dinucleotide repeats, trinucleotide repeats, tetranucleotide
repeats, simple sequence repeats, and insertion elements such as
Alu. The first identified allelic form is arbitrarily designated as
the reference form and other allelic forms are designated as
alternative or variant alleles. The allelic form occurring most
frequently in a selected population is sometimes referred to as the
wildtype form. Diploid organisms may be homozygous or heterozygous
for allelic forms. A diallelic or biallelic polymorphism has two
forms. A triallelic polymorphism has three forms.
[0040] Work described herein pertains to the resequencing of large
numbers of genes in a large number of individuals to identify
polymorphisms which can predispose individuals to disease. For
example, polymorphisms in genes which are expressed in liver may
predispose individuals to disorders of the liver. By altering amino
acid sequence, SNPs may alter the function of the encoded proteins.
The discovery of the SNP facilitates biochemical analysis of the
variants and the development of assays to characterize the variants
and to screen for pharmaceutical that would interact directly with
on or another form of the protein. SNPs (including silent SNPs)
also enable the development of specific DNA, RNA, or protein-based
diagnostics that detect the presence or absence of the polymorphism
in particular conditions.
[0041] A single nucleotide polymorphism occurs at a polymorphic
site occupied by a single nucleotide, which is the site of
variation between allelic sequences. The site is usually preceded
by and followed by highly conserved sequences of the allele (e.g.,
sequences that vary in less than {fraction (1/100)} or {fraction
(1/1000)} members of the populations).
[0042] A single nucleotide polymorphism usually arises due to
substitution of one nucleotide for another at the polymorphic site.
A transition is the replacement of one purine by another purine or
one pyrimidine by another pyrimidine. A transversion is the
replacement of a purine by a pyrimidine or vice versa. Single
nucleotide polymorphisms can also arise from a deletion of a
nucleotide or an insertion of a nucleotide relative to a reference
allele. Typically the polymorphic site is occupied by a base other
than the reference base. For example, where the reference allele
contains the base "T" at the polymorphic site, the altered allele
can contain a "C", "G" or "A" at the polymorphic site.
[0043] The invention also relates to nucleic acid molecules which
hybridize to the variant alleles identified herein (or their
complements) and which also comprise the variant nucleotide at the
SNP site. Hybridizations are usually performed under stringent
conditions, for example, at a salt concentration of no more than 1
M and a temperature of at least 25.degree. C. For example,
conditions of 5.times.SSPE (750 mM NaCl, 50 mM NaPhosphate, 5 mM
EDTA, pH 7.4) and a temperature of 25-30.degree. C., or equivalent
conditions, are suitable for allele-specific probe hybridizations.
Equivalent conditions can be determined by varying one or more of
the parameters given as an example, as known in the art, while
maintaining a similar degree of identity or similarity between the
target nucleotide sequence and the primer or probe used.
[0044] The invention also relates to nucleic acid molecules which
share substantial sequence identity to the variant alleles
identified herein (or their complements) and which also comprise
the variant nucleotide at the SNP site. Particularly preferred are
nucleic acid molecules and fragments which have at least about 60%,
preferably at least about 70, 80 or 85%, more preferably at least
about 90%, even more preferably at least about 95%, and most
preferably at least about 98% identity with nucleic acid molecules
described herein. The percent identity of two nucleotide or amino
acid sequences can be determined by aligning the sequences for
optimal comparison purposes (e.g., gaps can be introduced in the
sequence of a first sequence). The nucleotides or amino acids at
corresponding positions are then compared, and the percent identity
between the two sequences is a function of the number of identical
positions shared by the sequences (i.e., % identity=# of identical
positions/total # of positions.times.100). In certain embodiments,
the length of a sequence aligned for comparison purposes is at
least 30%, preferably at least 40%, more preferably at least 60%,
and even more preferably at least 70%, 80% or 90% of the length of
the reference sequence. The actual comparison of the two sequences
can be accomplished by well-known methods, for example, using a
mathematical algorithm. A preferred, non-limiting example of such a
mathematical algorithm is described in Karlin et al., Proc. Natl.
Acad. Sci. USA, 90:5873-5877 (1993). Such an algorithm is
incorporated into the NBLAST and XBLAST programs (version 2.0) as
described in Altschul et al., Nucleic Acids Res., 25:389-3402
(1997). When utilizing BLAST and Gapped BLAST programs, the default
parameters of the respective programs (e.g., NBLAST) can be used.
See the world wide web at ncbi.nlm.nih.gov. In one embodiment,
parameters for sequence comparison can be set at score=100,
wordlength=12, or can be varied (e.g., W=5 or W=20).
[0045] The term "isolated" is used herein to indicate that the
material in question exists in a physical milieu distinct from that
in which it occurs in nature. For example, an isolated nucleic acid
of the invention may be substantially isolated with respect to the
complex cellular milieu in which it naturally occurs. In some
instances, the isolated material will form part of a composition
(for example, a crude extract containing other substances), buffer
system or reagent mix. In other circumstance, the material may be
purified to essential homogeneity, for example as determined by
PAGE or column chromatography such as HPLC. Preferably, an isolated
nucleic acid comprises at least about 50, 80 or 90 percent (on a
molar basis) of all macromolecular species present.
[0046] I. Novel Polymorphisms of the Invention
[0047] Some of the novel polymorphisms of the invention are shown
in the Table. Columns one and two show designations for the
indicated polymorphism. Column three shows the Genbank or TIGR
Accession number for the wild type (or reference) allele. Column
four shows the location of the polymorphic site in the nucleic acid
sequence with reference to the Genbank or TIGR sequence shown in
column three. Column five shows common names for the gene in which
the polymorphism is located. Column six shows the polymorphism and
a portion of the 3' and 5' flanking sequence of the gene. Column
seven shows the type of mutation; N, non-sense, S, silent, M,
missense. Columns eight and nine show the reference and alternate
nucleotides, respectively, at the polymorphic site. Columns ten and
eleven show the reference and alternate amino acids, respectively,
encoded by the reference and variant, respectively, alleles. Other
novel polymorphisms of the invention are shown in FIG. 3.
[0048] II. Analysis of Polymorphisms
[0049] A. Preparation of Samples
[0050] Polymorphisms are detected in a target nucleic acid from an
individual being analyzed. For assay of genomic DNA, virtually any
biological sample (other than pure red blood cells) is suitable.
For example, convenient tissue samples include whole blood, semen,
saliva, tears, urine, fecal material, sweat, buccal, skin and hair.
For assay of cDNA or mRNA, the tissue sample must be obtained from
an organ in which the target nucleic acid is expressed. For
example, if the target nucleic acid is a cytochrome P450, the liver
is a suitable source.
[0051] Many of the methods described below require amplification of
DNA from target samples. This can be accomplished by e.g., PCR. See
generally PCR Technology: Principles and Applications for DNA
Amplification (ed. H. A. Erlich, Freeman Press, NY, N.Y., 1992);
PCR Protocols: A Guide to Methods and Applications (eds. Innis, et
al., Academic Press, San Diego, Calif., 1990); Mattila et al.,
Nucleic Acids Res. 19, 4967 (1991); Eckert et al., PCR Methods and
Applications 1, 17 (1991); PCR (eds. McPherson et al., IRL Press,
Oxford); and U.S. Pat. No. 4,683,202.
[0052] Other suitable amplification methods include the ligase
chain reaction (LCR) (see Wu and Wallace, Genomics 4, 560 (1989),
Landegren et al., Science 241, 1077 (1988), transcription
amplification (Kwoh et al., Proc. Natl. Acad. Sci. USA 86, 1173
(1989)), and self-sustained sequence replication (Guatelli et al.,
Proc. Nat. Acad. Sci. USA, 87, 1874 (1990)) and nucleic acid based
sequence amplification (NASBA). The latter two amplification
methods involve isothermal reactions based on isothermal
transcription, which produce both single stranded RNA (ssRNA) and
double stranded DNA (dsDNA) as the amplification products in a
ratio of about 30 or 100 to 1, respectively.
[0053] B. Detection of Polymorphisms in Target DNA
[0054] There are two distinct types of analysis of target DNA for
detecting polymorphisms. The first type of analysis, sometimes
referred to as de novo characterization, is carried out to identify
polymorphic sites not previously characterized (i.e., to identify
new polymorphisms). This analysis compares target sequences in
different individuals to identify points of variation, i.e.,
polymorphic sites. By analyzing groups of individuals representing
the greatest ethnic diversity among humans and greatest breed and
species variety in plants and animals, patterns characteristic of
the most common alleles/haplotypes of the locus can be identified,
and the frequencies of such alleles/haplotypes in the population
can be determined. Additional allelic frequencies can be determined
for subpopulations characterized by criteria such as geography,
race, or gender. The de novo identification of polymorphisms of the
invention is described in the Examples section. The second type of
analysis determines which form(s) of a characterized (known)
polymorphism are present in individuals under test. There are a
variety of suitable procedures, which are discussed in turn.
[0055] 1. Allele-Specific Probes
[0056] The design and use of allele-specific probes for analyzing
polymorphisms is described by e.g., Saiki et al., Nature 324,
163-166 (1986); Dattagupta, EP 235,726, Saiki, WO 89/11548.
Allele-specific probes can be designed that hybridize to a segment
of target DNA from one individual but do not hybridize to the
corresponding segment from another individual due to the presence
of different polymorphic forms in the respective segments from the
two individuals. Hybridization conditions should be sufficiently
stringent that there is a significant difference in hybridization
intensity between alleles, and preferably an essentially binary
response, whereby a probe hybridizes to only one of the alleles.
Some probes are designed to hybridize to a segment of target DNA
such that the polymorphic site aligns with a central position
(e.g., in a 15-mer at the 7 position; in a 16-mer, at either the 8
or 9 position) of the probe. This design of probe achieves good
discrimination in hybridization between different allelic
forms.
[0057] Allele-specific probes are often used in pairs, one member
of a pair showing a perfect match to a reference form of a target
sequence and the other member showing a perfect match to a variant
form. Several pairs of probes can then be immobilized on the same
support for simultaneous analysis of multiple polymorphisms within
the same target sequence.
[0058] 2. Tiling Arrays
[0059] The polymorphisms can also be identified by hybridization to
nucleic acid arrays, some examples of which are described in WO
95/11995. One form of such arrays is described in the Examples
section in connection with de novo identification of polymorphisms.
The same array or a different array can be used for analysis of
characterized polymorphisms. WO 95/11995 also describes subarrays
that are optimized for detection of a variant form of a
precharacterized polymorphism. Such a subarray contains probes
designed to be complementary to a second reference sequence, which
is an allelic variant of the first reference sequence. The second
group of probes is designed by the same principles as described in
the Examples, except that the probes exhibit complementarity to the
second reference sequence. The inclusion of a second group (or
further groups) can be particularly useful for analyzing short
subsequences of the primary reference sequence in which multiple
mutations are expected to occur within a short distance
commensurate with the length of the probes (e.g., two or more
mutations within 9 to 21 bases).
[0060] 3. Allele-Specific Primers
[0061] An allele-specific primer hybridizes to a site on target DNA
overlapping a polymorphism and only primes amplification of an
allelic form to which the primer exhibits perfect complementarity.
See Gibbs, Nucleic Acid Res. 17, 2427-2448 (1989). This primer is
used in conjunction with a second primer which hybridizes at a
distal site. Amplification proceeds from the two primers, resulting
in a detectable product which indicates the particular allelic form
is present. A control is usually performed with a second pair of
primers, one of which shows a single base mismatch at the
polymorphic site and the other of which exhibits perfect
complementarity to a distal site. The single-base mismatch prevents
amplification and no detectable product is formed. The method works
best when the mismatch is included in the 3'-most position of the
oligonucleotide aligned with the polymorphism because this position
is most destabilizing to elongation from the primer (see, e.g., WO
93/22456).
[0062] 4. Direct-Sequencing
[0063] The direct analysis of the sequence of polymorphisms of the
present invention can be accomplished using either the dideoxy
chain termination method or the Maxam-Gilbert method (see Sambrook
et al., Molecular Cloning, A Laboratory Manual (2nd Ed., CSHP, New
York 1989); Zyskind et al., Recombinant DNA Laboratory Manual,
(Acad. Press, 1988)).
[0064] 5. Denaturing Gradient Gel Electrophoresis
[0065] Amplification products generated using the polymerase chain
reaction can be analyzed by the use of denaturing gradient gel
electrophoresis. Different alleles can be identified based on the
different sequence-dependent melting properties and electrophoretic
migration of DNA in solution. Erlich, ed., PCR Technology,
Principles and Applications for DNA Amplification, (W. H. Freeman
and Co, New York, 1992), Chapter 7.
[0066] 6. Single-Strand Conformation Polymorphism Analysis
[0067] Alleles of target sequences can be differentiated using
single-strand conformation polymorphism analysis, which identifies
base differences by alteration in electrophoretic migration of
single stranded PCR products, as described in Orita et al., Proc.
Nat. Acad. Sci. 86, 2766-2770 (1989). Amplified PCR products can be
generated as described above, and heated or otherwise denatured, to
form single stranded amplification products. Single-stranded
nucleic acids may refold or form secondary structures which are
partially dependent on the base sequence. The different
electrophoretic mobilities of single-stranded amplification
products can be related to base-sequence differences between
alleles of target sequences.
[0068] 7. Single-Base Extension
[0069] An alternative method for identifying and analyzing
polymorphisms is based on single-base extension (SBE) of a
fluorescently-labeled primer coupled with fluorescence resonance
energy transfer (FRET) between the label of the added base and the
label of the primer. Typically, the method, such as that described
by Chen et al., (PNAS 94:10756-61 (1997), incorporated herein by
reference) uses a locus-specific oligonucleotide primer labeled on
the 5' terminus with 5-carboxyfluorescein (FAM). This labeled
primer is designed so that the 3' end is immediately adjacent to
the polymorphic site of interest. The labeled primer is hybridized
to the locus, and single base extension of the labeled primer is
performed with fluorescently labeled dideoxyribonucleotides
(ddNTPs) in dye-terminator sequencing fashion, except that no
deoxyribonucleotides are present. An increase in fluorescence of
the added ddNTP in response to excitation at the wavelength of the
labeled primer is used to infer the identity of the added
nucleotide.
[0070] III. Methods of Use
[0071] After determining polymorphic form(s) present in an
individual at one or more polymorphic sites, this information can
be used in a number of methods.
[0072] A. Forensics
[0073] Determination of which polymorphic forms occupy a set of
polymorphic sites in an individual identifies a set of polymorphic
forms that distinguishes the individual. See generally National
Research Council, The Evaluation of Forensic DNA Evidence (Eds.
Pollard et al., National Academy Press, DC, 1996). The more sites
that are analyzed, the lower the probability that the set of
polymorphic forms in one individual is the same as that in an
unrelated individual. Preferably, if multiple sites are analyzed,
the sites are unlinked. Thus, polymorphisms of the invention are
often used in conjunction with polymorphisms in distal genes.
Preferred polymorphisms for use in forensics are biallelic because
the population frequencies of two polymorphic forms can usually be
determined with greater accuracy than those of multiple polymorphic
forms at multi-allelic loci.
[0074] The capacity to identify a distinguishing or unique set of
forensic markers in an individual is useful for forensic analysis.
For example, one can determine whether a blood sample from a
suspect matches a blood or other tissue sample from a crime scene
by determining whether the set of polymorphic forms occupying
selected polymorphic sites is the same in the suspect and the
sample. If the set of polymorphic markers does not match between a
suspect and a sample, it can be concluded (barring experimental
error) that the suspect was not the source of the sample. If the
set of markers does match, one can conclude that the DNA from the
suspect is consistent with that found at the crime scene. If
frequencies of the polymorphic forms at the loci tested have been
determined (e.g., by analysis of a suitable population of
individuals), one can perform a statistical analysis to determine
the probability that a match of suspect and crime scene sample
would occur by chance.
[0075] p(ID) is the probability that two random individuals have
the same polymorphic or allelic form at a given polymorphic site.
In biallelic loci, four genotypes are possible: AA, AB, BA, and BB.
If alleles A and B occur in a haploid genome of the organism with
frequencies x and y, the probability of each genotype in a diploid
organism is (see WO 95/12607):
[0076] Homozygote: p(AA)=x.sup.2
[0077] Homozygote: p(BB)=y.sup.2=(1-x).sup.2
[0078] Single Heterozygote: p(AB)=p(BA)=xy=x(1-x)
[0079] Both Heterozygotes: p(AB+BA)=2xy=2x(1-x)
[0080] The probability of identity at one locus (i.e, the
probability that two individuals, picked at random from a
population will have identical polymorphic forms at a given locus)
is given by the equation:
p(ID)=(x.sup.2).sup.2+(2xy).sup.2+(y.sup.2).sup.2.
[0081] These calculations can be extended for any number of
polymnorphic forms at a given locus. For example, the probability
of identity p(ID) for a 3-allele system where the alleles have the
frequencies in the population of x, y and z, respectively, is equal
to the sum of the squares of the genotype frequencies:
p(ID)=x.sup.4+(2xy).sup.2+(2yz).sup.2+(2xz).sup.2+z.sup.4+y.sup.4
[0082] In a locus of n alleles, the appropriate binomial expansion
is used to calculate p(ID) and p(exc).
[0083] The cumulative probability of identity (cum p(ID)) for each
of multiple unlinked loci is determined by multiplying the
probabilities provided by each locus.
cum p(ID)=p(ID1)p(ID2)p(ID3) . . . p(IDn)
[0084] The cumulative probability of non-identity for n loci (i.e.
the probability that two random individuals will be different at 1
or more loci) is given by the equation:
cump(nonID)=1-cump(ID).
[0085] If several polymorphic loci are tested, the cumulative
probability of non-identity for random individuals becomes very
high (e.g., one billion to one). Such probabilities can be taken
into account together with other evidence in determining the guilt
or innocence of the suspect.
[0086] B. Paternity Testing
[0087] The object of paternity testing is usually to determine
whether a male is the father of a child. In most cases, the mother
of the child is known and thus, the mother's contribution to the
child's genotype can be traced. Paternity testing investigates
whether the part of the child's genotype not attributable to the
mother is consistent with that of the putative father. Paternity
testing can be performed by analyzing sets of polymorphisms in the
putative father and the child.
[0088] If the set of polymorphisms in the child attributable to the
father does not match the set of polymorphisms of the putative
father, it can be concluded, barring experimental error, that the
putative father is not the real father. If the set of polymorphisms
in the child attributable to the father does match the set of
polymorphisms of the putative father, a statistical calculation can
be performed to determine the probability of coincidental
match.
[0089] The probability of parentage exclusion (representing the
probability that a random male will have a polymorphic form at a
given polymorphic site that makes him incompatible as the father)
is given by the equation (see WO 95/12607):
p(exc)=xy(1-xy)
[0090] where x and y are the population frequencies of alleles A
and B of a biallelic polymorphic site.
[0091] (At a triallelic site
p(exc)=xy(1-xy)+yz(1-yz)+xz(1-xz)+3xyz(1-xyz)- )), where x, y and z
and the respective population frequencies of alleles A, B and
C).
[0092] The probability of non-exclusion is
p(non-exc)=1-p(exc)
[0093] The cumulative probability of non-exclusion (representing
the value obtained when n loci are used) is thus:
cump(non-exc)=p(non-exc1)p(non-exc2)p(non-exc3) . . .
p(non-excn)
[0094] The cumulative probability of exclusion for n loci
(representing the probability that a random male will be
excluded)
cump(exc)=1-cump(non-exc).
[0095] If several polymorphic loci are included in the analysis,
the cumulative probability of exclusion of a random male is very
high. This probability can be taken into account in assessing the
liability of a putative father whose polymorphic marker set matches
the child's polymorphic marker set attributable to his/her
father.
[0096] C. Correlation of Polymorphisms with Phenotypic Traits
[0097] The polymorphisms of the invention may contribute to the
phenotype of an organism in different ways. Some polymorphisms
occur within a protein coding sequence and contribute to phenotype
by affecting protein structure. The effect may be neutral,
beneficial or detrimental, or both beneficial and detrimental,
depending on the circumstances. For example, a heterozygous sickle
cell mutationi confers resistance to malaria, but a homozygous
sickle cell mutation is usually lethal. Other polymorphisms occur
in noncoding regions but may exert phenotypic effects indirectly
via influence on replication, transcription, and translation. A
single polymorphism may affect more than one phenotypic trait.
Likewise, a single phenotypic trait may be affected by
polymorphisms in different genes. Further, some polymorphisms
predispose an individual to a distinct mutation that is causally
related to a certain phenotype.
[0098] Phenotypic traits include diseases that have known but
hitherto unmapped genetic components (e.g., agammaglobulimenia,
diabetes insipidus, Lesch-Nyhan syndrome, muscular dystrophy,
Wiskott-Aldrich syndrome, Fabry's disease, familial
hypercholesterolemia, polycystic kidney disease, hereditary
spherocytosis, von Willebrand's disease, tuberous sclerosis,
hereditary hemorrhagic telangiectasia, familial colonic polyposis,
Ehlers-Danlos syndrome, osteogenesis imperfecta, and acute
intermittent porphyria). Phenotypic traits also include symptoms
of, or susceptibility to, multifactorial diseases of which a
component is or may be genetic, such as autoimmune diseases,
inflammation, cancer, diseases of the nervous system, and infection
by pathogenic microorganisms. Some examples of autoimmune diseases
include rheumatoid arthritis, multiple sclerosis, diabetes
(insulin-dependent and non-independent), systemic lupus
erythematosus and Graves disease. Some examples of cancers include
cancers of the bladder, brain, breast, colon, esophagus, kidney,
leukemia, liver, lung, oral cavity, ovary, pancreas, prostate,
skin, stomach and uterus. Phenotypic traits also include
characteristics such as longevity, appearance (e.g., baldness,
obesity), strength, speed, endurance, fertility, and susceptibility
or receptivity to particular drugs or therapeutic treatments.
[0099] The correlation of one or more polymorphisms with phenotypic
traits can be facilitated by knowledge of the gene product of the
wild type (reference) gene. The genes in which cSNPs of the present
invention have been identified are genes which have been previously
sequenced and characterized in one of their allelic forms.
[0100] Correlation is performed for a population of individuals who
have been tested for the presence or absence of a phenotypic trait
of interest and for polymorphic markers sets. To perform such
analysis, the presence or absence of a set of polymorphisms (i.e. a
polymorphic set) is determined for a set of the individuals, some
of whom exhibit a particular trait, and some of which exhibit lack
of the trait. The alleles of each polymorphism of the set are then
reviewed to determine whether the presence or absence of a
particular allele is associated with the trait of interest.
Correlation can be performed by standard statistical methods such
as a .kappa.-squared test and statistically significant
correlations between polymorphic form(s) and phenotypic
characteristics are noted. For example, it might be found that the
presence of allele A1 at polymorphism A correlates with heart
disease. As a further example, it might be found that the combined
presence of allele A1 at polymorphism A and allele B1 at
polymorphism B correlates with increased milk production of a farm
animal.
[0101] Such correlations can be exploited in several ways. In the
case of a strong correlation between a set of one or more
polymorphic forms and a disease for which treatment is available,
detection of the polymorphic form set in a human or animal patient
may justify immediate administration of treatment, or at least the
institution of regular monitoring of the patient. Detection of a
polymorphic form correlated with serious disease in a couple
contemplating a family may also be valuable to the couple in their
reproductive decisions. For example, the female partner might elect
to undergo in vitro fertilization to avoid the possibility of
transmitting such a polymorphism from her husband to her offspring.
In the case of a weaker, but still statistically significant
correlation between a polymorphic set and human disease, immediate
therapeutic intervention or monitoring may not be justified.
Nevertheless, the patient can be motivated to begin simple
life-style changes (e.g., diet, exercise) that can be accomplished
at little cost to the patient but confer potential benefits in
reducing the risk of conditions to which the patient may have
increased susceptibility by virtue of variant alleles.
Identification of a polymorphic set in a patient correlated with
enhanced receptiveness to one of several treatment regimes for a
disease indicates that this treatment regime should be
followed.
[0102] For animals and plants, correlations between characteristics
and phenotype are useful for breeding for desired characteristics.
For example, Beitz et al., U.S. Pat. No. 5,292,639 discuss use of
bovine mitochondrial polymorphisms in a breeding program to improve
milk production in cows. To evaluate the effect of mtDNA D-loop
sequence polymorphism on milk production, each cow was assigned a
value of 1 if variant or 0 if wildtype with respect to a
prototypical mitochondrial DNA sequence at each of 17 locations
considered. Each production trait was analyzed individually with
the following animal model:
Y.sub.ijkpn=.mu.+YS.sub.i+P.sub.j+X.sub.k+.beta..sub.1+ . . .
.beta..sub.17+PE.sub.n+a.sub.n+e.sub.p
[0103] where Y.sub.ijknp is the milk, fat, fat percentage, SNF, SNF
percentage, energy concentration, or lactation energy record; .mu.
is an overall mean; YS.sub.i is the effect common to all cows
calving in year-season; X.sub.k is the effect common to cows in
either the high or average selection line; .beta..sub.1 to
.beta..sub.17 are the binomial regressions of production record on
mtDNA D-loop sequence polymorphisms; PE.sub.n is permanent
environmental effect common to all records of cow n; a.sub.n is
effect of animal n and is composed of the additive genetic
contribution of sire and dam breeding values and a Mendelian
sampling effect; and e.sub.p is a random residual. It was found
that eleven of seventeen polymorphisms tested influenced at least
one production trait. Bovines having the best polymorphic forms for
milk production at these eleven loci are used as parents for
breeding the next generation of the herd.
[0104] D. Genetic Mapping of Phenotypic Traits
[0105] The previous section concerns identifying correlations
between phenotypic traits and polymorphisms that directly or
indirectly contribute to those traits. The present section
describes identification of a physical linkage between a genetic
locus associated with a trait of interest and polymorphic markers
that are not associated with the trait, but are in physical
proximity with the genetic locus responsible for the trait and
co-segregate with it. Such analysis is useful for mapping a genetic
locus associated with a phenotypic trait to a chromosomal position,
and thereby cloning gene(s) responsible for the trait. See Lander
et al., Proc. Natl. Acad. Sci. (USA) 83, 7353-7357 (1986); Lander
et al., Proc. Natl. Acad. Sci. (USA) 84, 2363-2367 (1987);
Donis-Keller et al., Cell 51, 319-337 (1987); Lander et al.,
Genetics 121, 185-199 (1989)). Genes localized by linkage can be
cloned by a process known as directional cloning. See Wainwright,
Med. J. Australia 159, 170-174 (1993); Collins, Nature Genetics 1,
3-6 (1992).
[0106] Linkage studies are typically performed on members of a
family. Available members of the family are characterized for the
presence or absence of a phenotypic trait and for a set of
polymorphic markers. The distribution of polymorphic markers in an
informative meiosis is then analyzed to determine which polymorphic
markers co-segregate with a phenotypic trait. See, e.g., Kerem et
al., Science 245, 1073-1080 (1989); Monaco et al., Nature 316, 842
(1985); Yamoka et al., Neurology 40, 222-226 (1990); Rossiter et
al., FASEB Journal 5, 21-27 (1991).
[0107] Linkage is analyzed by calculation of LOD (log of the odds)
values. A lod value is the relative likelihood of obtaining
observed segregation data for a marker and a genetic locus when the
two are located at a recombination fraction .theta., versus the
situation in which the two are not linked, and thus segregating
independently (Thompson & Thompson, Genetics in Medicine (5th
ed, W. B. Saunders Company, Philadelphia, 1991); Strachan, "Mapping
the human genome" in The Human Genome (BIOS Scientific Publishers
Ltd, Oxford), Chapter 4). A series of likelihood ratios are
calculated at various recombination fractions (.theta.), ranging
from .theta.=0.0 (coincident loci) to .theta.=0.50 (unlinked).
Thus, the likelihood at a given value of .theta. is: probability of
data if loci linked at .theta. to probability of data if loci
unlinked. The computed likelihoods are usually expressed as the
log.sub.10 of this ratio (i.e., a lod score). For example, a lod
score of 3 indicates 1000:1 odds against an apparent observed
linkage being a coincidence. The use of logarithms allows data
collected from different families to be combined by simple
addition. Computer programs are available for the calculation of
lod scores for differing values of .theta. (e.g., LIPED, MLINK
(Lathrop, Proc. Nat. Acad. Sci. (USA) 81, 3443-3446 (1984)). For
any particular lod score, a recombination fraction may be
determined from mathematical tables. See Smith et al., Mathematical
tables for research workers in human genetics (Churchill, London,
1961); Smith, Ann. Hum. Genet. 32, 127-150 (1968). The value of
.theta. at which the lod score is the highest is considered to be
the best estimate of the recombination fraction.
[0108] Positive lod score values suggest that the two loci are
linked, whereas negative values suggest that linkage is less likely
(at that value of .theta.) than the possibility that the two loci
are unlinked. By convention, a combined lod score of +3 or greater
(equivalent to greater than 1000:1 odds in favor of linkage) is
considered definitive evidence that two loci are linked. Similarly,
by convention, a negative lod score of -2 or less is taken as
definitive evidence against linkage of the two loci being compared.
Negative linkage data are useful in excluding a chromosome or a
segment thereof from consideration. The search focuses on the
remaining non-excluded chromosomal locations.
[0109] IV. Modified Polypeptides and Gene Sequences
[0110] The invention further provides variant forms of nucleic
acids and corresponding proteins. The nucleic acids comprise one of
the sequences described in the Table, column 5, in which the
polymorphic position is occupied by one of the alternative bases
for that position. Some nucleic acids encode full-length variant
forms of proteins. Similarly, variant proteins have the
prototypical amino acid sequences encoded by nucleic acid sequences
shown in the Table, column 5, (read so as to be in-frame with the
full-length coding sequence of which it is a component) except at
an amino acid encoded by a codon including one of the polymorphic
positions shown in the Table. That position is occupied by the
amino acid coded by the corresponding codon in any of the
alternative forms shown in the Table.
[0111] Variant genes can be expressed in an expression vector in
which a variant gene is operably linked to a native or other
promoter. Usually, the promoter is a eukaryotic promoter for
expression in a mammalian cell. The transcription regulation
sequences typically include a heterologous promoter and optionally
an enhancer which is recognized by the host. The selection of an
appropriate promoter, for example trp, lac, phage promoters,
glycolytic enzyme promoters and tRNA promoters, depends on the host
selected. Commercially available expression vectors can be used.
Vectors can include host-recognized replication systems,
amplifiable genes, selectable markers, host sequences useful for
insertion into the host genome, and the like.
[0112] The means of introducing the expression construct into a
host cell varies depending upon the particular construction and the
target host. Suitable means include fusion, conjugation,
transfection, transduction, electroporation or injection, as
described in Sambrook, supra. A wide variety of host cells can be
employed for expression of the variant gene, both prokaryotic and
eukaryotic. Suitable host cells include bacteria such as E. coli,
yeast, filamentous fuigi, insect cells, mammalian cells, typically
immortalized, e.g., mouse, CHO, human and monkey cell lines and
derivatives thereof. Preferred host cells are able to process the
variant gene product to produce an appropriate mature polypeptide.
Processing includes glycosylation, ubiquitination, disulfide bond
formation, general post-translational modification, and the like.
As used herein, "gene product" includes mRNA, peptide and protein
products.
[0113] The protein may be isolated by conventional means of protein
biochemistry and purification to obtain a substantially pure
product, i.e., 80, 95 or 99% free of cell component contaminants,
as described in Jacoby, Methods in Enzymology Volume 104, Academic
Press, New York (1984); Scopes, Protein Purification, Principles
and Practice, 2nd Edition, Springer-Verlag, New York (1987); and
Deutscher (ed), Guide to Protein Purification, Methods in
Enzymology, Vol. 182 (1990). If the protein is secreted, it can be
isolated from the supernatant in which the host cell is grown. If
not secreted, the protein can be isolated from a lysate of the host
cells.
[0114] The invention further provides transgenic nonhuman animals
capable of expressing an exogenous variant gene and/or having one
or both alleles of an endogenous variant gene inactivated.
Expression of an exogenous variant gene is usually achieved by
operably linking the gene to a promoter and optionally an enhancer,
and microinjecting the construct into a zygote. See Hogan et al.,
"Manipulating the Mouse Embryo, A Laboratory Manual," Cold Spring
Harbor Laboratory. Inactivation of endogenous variant genes can be
achieved by forming a transgene in which a cloned variant gene is
inactivated by insertion of a positive selection marker. See
Capecchi, Science 244, 1288-1292 (1989). The transgene is then
introduced into an embryonic stem cell, where it undergoes
homologous recombination with an endogenous variant gene. Mice and
other rodents are preferred animals. Such animals provide useful
drug screening systems.
[0115] In addition to substantially full-length polypeptides
expressed by variant genes, the present invention includes
biologically active fragments of the polypeptides, or analogs
thereof, including organic molecules which simulate the
interactions of the peptides. Biologically active fragments include
any portion of the full-length polypeptide which confers a
biological function on the variant gene product, including ligand
binding, and antibody binding. Ligand binding includes binding by
nucleic acids, proteins or polypeptides, small biologically active
molecules, or large cellular structures.
[0116] Polyclonal and/or monoclonal antibodies that specifically
bind to variant gene products but not to corresponding prototypical
gene products are also provided. Antibodies can be made by
injecting mice or other animals with the variant gene product or
synthetic peptide fragments thereof. Monoclonal antibodies are
screened as are described, for example, in Harlow & Lane,
Antibodies, A Laboratory Manual, Cold Spring Harbor Press, New York
(1988); Goding, Monoclonal antibodies, Principles and Practice (2d
ed.) Academic Press, New York (1986). Monoclonal antibodies are
tested for specific immunoreactivity with a variant gene product
and lack of immunoreactivity to the corresponding prototypical gene
product. These antibodies are useful in diagnostic assays for
detection of the variant form, or as an active ingredient in a
pharmaceutical composition.
[0117] V. Kits
[0118] The invention further provides kits comprising at least one
allele-specific oligonucleotide as described herein. Often, the
kits contain one or more pairs of allele-specific oligonucleotides
hybridizing to different forms of a polymorphism. In some kits, the
allele-specific oligonucleotides are provided immobilized to a
substrate. For example, the same substrate can comprise
allele-specific oligonucleotide probes for detecting at least 10,
100 or all of the polymorphisms shown in the Table. Optional
additional components of the kit include, for example, restriction
enzymes, reverse-transcriptase or polymerase, the substrate
nucleoside triphosphates, means used to label (for example, an
avidin-enzyme conjugate and enzyme substrate and chromogen if the
label is biotin), and the appropriate buffers for reverse
transcription, PCR, or hybridization reactions. Usually, the kit
also contains instructions for carrying out the methods.
[0119] The thrombospondins are a family of extracellular matrix
(ECM) glycoproteins that modulate many cell behaviors including
adhesion, migration, and proliferation. Thrombospondins (also known
as thrombin sensitive proteins or TSPs) are large molecular weight
glycoproteins composed of three identical disulfide-linked
polypeptide chains. TSPs are stored in the alpha-granules of
platelets and secreted by a variety of mesenchymal and epithelial
cells (Majack et al., Cell Membrane 3:57-77 (1987)). Platelets
secrete TSPs when activated in the blood by such physiological
agonists such as thrombin. TSPs have lectin properties and a broad
function in the regulation of fibrinolysis and as a component of
the ECM, and are one of a group of ECM proteins which have adhesive
properties. TSPs bind to fibronectin and fibrinogen (Lahav et al.,
Eur J Biochem 145:151-6 (1984)), and these proteins are known to be
involved in platelet adhesion to substratum and platelet
aggregation (Leung, J Clin Invest 74:1764-1772 (1986)).
[0120] Recent work has implicated TSPs in response of cells to
growth factors. Submitogenic doses of PDGF induce a rapid but
transitory, increase in TSP synthesis and secretion by rat aortic
smooth muscle cells (Majack et al., J Biol Chem 101: 1059-70
(1985)). PDGF responsiveness to TSP synthesis in glial cells has
also been shown (Asch et al., Proc Natl Acad Sci 83:2904-8 (1986)).
TSP mRNA levels rise rapidly in response to PDGF (Majack et al., J.
Biol Chem 262:8821-5 (1987)). TSPs act synergistically with
epidermal growth factor to increase DNA synthesis in smooth muscle
cells (Majack et al., Proc Natl Acad Sci 83:9050-4 (1986)), and
monoclonal antibodies to TSPs inhibit smooth muscle cell
proliferation (Majack et al., J Biol Chem 106:415-22 (1988)). TSPs
modulate local adhesions in endothelial cells, and TSPs,
particularly TSP-1 primarily derived from platelet granules, are
known to be an important activator of transforming growth factor
beta-1 (TGFB-1) (Crawford et al., Cell 93:1159 (1998)) and appear
to be a potential link between platelet-thrombosis and development
of atherosclerosis.
[0121] To determine pivotal genes associated with premature
coronary artery disease, we analyzed DNA from 347 patients with MI
or coronary revascularization before age 40 (men) or 45 (women) and
422 general population controls. Cases were drawn (one per family)
from a retrospective collection of sibling pairs with premature
CAD. Controls were ascertained through random-digit dialing. Both
cases and controls were Caucasian. A complete database of
phenotypic and laboratory variables for the affected patients
afforded logistic regression to control for age, diabetes, body
mass index, gender.
[0122] Thrombospondin (TSP) 4 and 1 emerged as important SNPs
associated with premature CAD and MI. For CAD, 148 of 347 patients
carried at least one copy of the TSP-4 variant compared with 142 of
422 control subjects; adjusted odds ratio 1.47, p=0.01. For
premature MI, the association was even stronger: 91 of 187 cases
vs. 142 of 422 controls had the variant; adjusted odds ratio 2.08,
p=0.0003. The TSP-1 SNP was rare. Nonetheless, homozygosity for the
variant allele gave an adjusted odds ratio of 9.5, p=0.04.
[0123] Specific reference nucleotide (SEQ ID NO: 1) and amino acid
(SEQ ID NO: 2) sequences for TSP-1 are shown in FIGS. 1A-1D.
Specific reference nucleotide (SEQ ID NO: 3) and amino acid (SEQ ID
NO: 4) sequences for TSP-4 are shown in FIGS. 2A-2C. It is
understood that the invention is not limited by these exemplified
reference sequences, as variants of these sequences which differ at
locations other than the SNP sites identified herein can also be
utilized. The skilled artisan can readily determine the SNP sites
in these other reference sequences which correspond to the SNP
sites identified herein by aligning the sequence of interest with
the reference sequences specifically disclosed herein, and programs
for performing such alignments are commercially available. For
example, the ALIGN program in the GCG software package can be used,
utilizing a PAM120 weight residue table, a gap length penalty of 12
and a gap penalty of 4, for example.
[0124] Two SNPs have been specifically studied as described herein.
The first (G334u4) is a change from A (reference nucleotide) to G
(alternate or variant nucleotide) at nucleotide position 2210 of
the nucleic acid sequence of TSP--I (FIGS. 1A-1D), resulting in a
missense amino acid mutation from asparagine (reference) to serine
(alternate) at amino acid 700. The second SNP (G355u2) is a change
from G (reference) to C (alternate) at nucleotide position 1186 of
the nucleic acid sequence of TSP-4 (FIGS. 2A-2C), resulting in a
missense amino acid alteration from alanine (reference) to proline
(alternate) at amino acid 387. With respect to the G355u2 SNP,
individuals with CAD carried at least one copy of the variant "C"
allele more frequently than control individuals (43% as compared
with 34%). With respect to the G355u2 SNP, individuals with MI
carried at least one copy of the variant "C" allele more frequently
than control individuals (49% as compared with 34%). With respect
to the G334u4 SNP, individuals with CAD carried two copies of the
variant "G" allele more frequently than control individuals (1.7%
as compared with 0.2%). With respect to the G334u4 SNP, individuals
with MI carried two copies of the variant "G" allele more
frequently than control individuals (2% as compared with 0.2%).
[0125] As used herein, the term "polymorphism" refers to the
occurrence of two or more genetically determined alternative
sequences or alleles in a population. A polymorphic marker or site
is the locus at which divergence occurs. Preferred markers have at
least two alleles, each occurring at frequency of greater than 1%,
and more preferably greater than 10% or 20% of a selected
population. A polymorphic locus may be as small as one base pair,
in which case it is referred to as a single nucleotide polymorphism
(SNP).
[0126] Thus, the invention relates to a method for predicting the
likelihood that an individual will have a vascular disease, or for
aiding in the diagnosis of a vascular disease, or predicting the
likelihood of having altered symptomology associated with a
vascular disease, comprising the steps of obtaining a DNA sample
from an individual to be assessed and determining the nucleotide
present at one or more of nucleotide positions 2210 of the TSP-1
gene or 1186 of the TSP-4 gene. In a preferred embodiment, the
nucleotides present at both of these nucleotide positions are
determined. In one embodiment the TSP-1 gene has the nucleotide
sequence of SEQ ID NO: 1 and the TSP-4 gene has the nucleotide
sequence of SEQ ID NO: 3. The presence of one or more of a G (the
variant nucleotide) at position 2210 of SEQ ID NO: 1 or a C (the
variant nucleotide) at position 1186 of SEQ ID NO: 1186 indicates
that the individual has a greater likelihood of having a vascular
disease, or a greater likelihood of having severe symptomology
associated with a vascular disease, than if that individual had the
reference nucleotide at one or more of these positions. Conversely,
the presence of one or more of an A (the reference nucleotide) at
position 2210 of SEQ ID NO: 1 or a G (the reference nucleotide) at
position 1186 of SEQ ID NO: 3 indicates that the individual has a
reduced likelihood of having a vascular disease or a likelihood of
having reduced symptomology associated with a vascular disease than
if that individual had the variant nucleotide at one or more of
these positions.
[0127] In a particular embodiment, the individual is an individual
at risk for development of a vascular disease. In another
embodiment the individual exhibits clinical symptomology associated
with a vascular disease. In one embodiment, the individual has been
clinically diagnosed as having a vascular disease. Vascular
diseases include, but are not limited to, atherosclerosis, coronary
heart disease, myocardial infarction (MI), stroke, peripheral
vascular diseases, venous thromboembolism and puhnonary embolism.
In preferred embodiments, the vascular disease is CAD or MI.
[0128] The genetic material to be assessed can be obtained from any
nucleated cell from the individual. For assay of genomic DNA,
virtually any biological sample (other than pure red blood cells)
is suitable. For example, convenient tissue samples include whole
blood, semen, saliva, tears, urine, fecal material, sweat, skin and
hair. For assay of cDNA or mRNA, the tissue sample must be obtained
from a tissue or organ in which the target nucleic acid is
expressed.
[0129] Many of the methods described herein require amplification
of DNA from target samples. This can be accomplished by e.g., PCR.
See generally PCR Technology: Principles and Applications for DNA
Amplification (ed. H. A. Erlich, Freeman Press, NY, N.Y., 1992);
PCR Protocols: A Guide to Methods and Applications (eds. Innis, et
al., Academic Press, San Diego, Calif., 1990); Mattila et al.,
Nucleic Acids Res. 19, 4967 (1991); Eckert et al., PCR Methods and
Applications 1, 17 (1991); PCR (eds. McPherson et al., IRL Press,
Oxford); and U.S. Pat. No. 4,683,202.
[0130] Other suitable amplification methods include the ligase
chain reaction (LCR) (see Wu and Wallace, Genomics 4, 560 (1989),
Landegren et al., Science 241, 1077 (1988), transcription
amplification (Kwoh et al., Proc. Natl. Acad. Sci. USA 86, 1173
(1989)), and self-sustained sequence replication (Guatelli et al.,
Proc. Nat. Acad. Sci. USA, 87, 1874 (1990)) and nucleic acid based
sequence amplification (NASBA). The latter two amplification
methods involve isothermal reactions based on isothermal
transcription, which produce both single stranded RNA (ssRNA) and
double stranded DNA (dsDNA) as the amplification products in a
ratio of about 30 or 100 to 1, respectively.
[0131] The nucleotide which occupies the polymorphic site of
interest (e.g., nucleotide position 2210 in TSP-1 and/or nucleotide
position 1186 in TSP-4) can be identified by a variety of methods,
such as Southern analysis of genomic DNA; direct mutation analysis
by restriction enzyme digestion; Northern analysis of RNA;
denaturing high pressure liquid chromatography (DHPLC); gene
isolation and sequencing; hybridization of an allele-specific
oligonucleotide with amplified gene products; single base extension
(SBE). In a preferred embodiment, determination of the allelic form
of TSP is carried out using SBE-FRET methods as described herein,
or using chip-based oligonucleotide arrays as described herein.
[0132] The invention also relates to a method for predicting the
likelihood that an individual will have a vascular disease, or for
aiding in the diagnosis of a vascular disease, or predicting the
likelihood of having altered symptomology associated with a
vascular disease, comprising the steps of obtaining a biological
sample comprising TSP-1 and/or TSP-4 protein or relevant portion
thereof from an individual to be assessed and determining the amino
acid present at one or more of amino acid positions 700 of the
TSP-1 gene product (e.g., as exemplified by SEQ ID NO: 2) or 387 of
the TSP-4 gene product (e.g., as exemplified by SEQ ID NO: 4). In a
preferred embodiment, the amino acids present at both of these
amino acid positions are determined. As used herein, the term
"relevant portion" of the TSP-1 and TSP-4 proteins is intended to
encompass any portion of the protein which comprises the
polymorphic amino acid positions. The presence of one or more of a
serine (the variant amino acid) at position 700 of SEQ ID NO: 2, or
a proline (the variant amino acid) at position 387 of SEQ ID NO: 4
indicates that the individual has a greater likelihood of having a
vascular disease, or a greater likelihood of having severe
symptomology associated with a vascular disease, than if that
individual had the reference amino acid at one or more of these
positions. Conversely, the presence of one or more of an asparagine
(the reference amino acid) at position 700 of SEQ ID NO: 2, or an
alanine (the reference amino acid) at position 387 of SEQ ID NO: 4
indicates that the individual has a reduced likelihood of having a
vascular disease or a likelihood of having reduced symptomology
associated with a vascular disease, than if that individual had the
varaint amino acid at one or more of these positions.
[0133] In a particular embodiment, the individual is an individual
at risk for development of a vascular disease. In another
embodiment the individual exhibits clinical symptomology associated
with a vascular disease. In one embodiment, the individual has been
clinically diagnosed as having a vascular disease.
[0134] In this embodiment of the invention, the biological sample
contains protein molecules from the test subject. In vitro
techniques for detection of protein include enzyme linked
immunosorbent assays (ELISAs), Western blots, immunoprecipitations
and immunofluorescence. Furthermore, in vivo techniques for
detection of protein include introducing into a subject a labeled
anti-protein antibody. For example, the antibody can be labeled
with a radioactive marker whose presence and location in a subject
can be detected by standard imaging techniques. Polyclonal and/or
monoclonal antibodies that specifically bind to variant gene
products but not to corresponding reference gene products, and vice
versa, are also provided. Antibodies can be made by injecting mice
or other animals with the variant gene product or synthetic peptide
fragments thereof comprising the variant portion. Monoclonal
antibodies are screened as are described, for example, in Harlow
& Lane, Antibodies, A Laboratory Manual, Cold Spring Harbor
Press, New York (1988); Goding, Monoclonal antibodies, Principles
and Practice (2d ed.) Academic Press, New York (1986). Monoclonal
antibodies are tested for specific immunoreactivity with a variant
gene product and lack of immunoreactivity to the corresponding
prototypical gene product. These antibodies are useful in
diagnostic assays for detection of the variant form, or as an
active ingredient in a pharmaceutical composition.
[0135] The polymorphisms of the invention may be associated with
vascular disease in different ways. The polymorphisms may exert
phenotypic effects indirectly via influence on replication,
transcription, and translation. Additionally, the described
polymorphisms may predispose an individual to a distinct mutation
that is causally related to a certain phenotype, such as
susceptibility or resistance to vascular disease and related
disorders. The discovery of the polymorphisms and their correlation
with CAD and MI facilitates biochemical analysis of the variant and
reference forms and the development of assays to characterize the
variant and reference forms and to screen for pharmaceutical agents
that interact directly with one or another form of the protein.
[0136] Alternatively, these particular polymorphisms may belong to
a group of two or more polymorphisms in the TSP gene(s) which
contributes to the presence, absence or severity of vascular
disease. An assessment of other polymorphisms within the TSP
gene(s) can be undertaken, and the separate and combined effects of
these polymorphisms, as well as alternations in other, distinct
genes, on the vascular disease phenotype can be assessed.
[0137] Correlation between a particular phenotype, e.g., the CAD or
MI phenotype, and the presence or absence of a particular allele is
performed for a population of individuals who have been tested for
the presence or absence of the phenotype. Correlation can be
performed by standard statistical methods such as a Chi-squared
test and statistically significant correlations between polymorphic
form(s) and phenotypic characteristics are noted. This correlation
can be exploited in several ways. In the case of a strong
correlation between a particular polymorphic form, e.g., the
variant allele for TSP-1 and/or TSP-4, and a disease for which
treatment is available, detection of the polymorphic form in an
individual may justify immediate administration of treatment, or at
least the institution of regular monitoring of the individual.
Detection of a polymorphic form correlated with a disorder in a
couple contemplating a family may also be valuable to the couple in
their reproductive decisions. For example, the female partner might
elect to undergo in vitro fertilization to avoid the possibility of
transmitting such a polymorphism from her husband to her offspring.
In the case of a weaker, but still statistically significant
correlation between a polymorphic form and a particular disorder,
immediate therapeutic intervention or monitoring may not be
justified. Nevertheless, the individual can be motivated to begin
simple life-style changes (e.g., diet modification, therapy or
counseling) that can be accomplished at little cost to the
individual but confer potential benefits in reducing the risk of
conditions to which the individual may have increased
susceptibility by virtue of the particular allele. Furthermore,
identification of a polymorphic form correlated with enhanced
receptiveness to one of several treatment regimes for a disorder
indicates that this treatment regimen should be followed for the
individual in question.
[0138] Furthermore, it may be possible to identify a physical
linkage between a genetic locus associated with a trait of interest
(e.g., CAD or MI) and polymorphic markers that are or are not
associated with the trait, but are in physical proximity with the
genetic locus responsible for the trait and co-segregate with it.
Such analysis is useful for mapping a genetic locus associated with
a phenotypic trait to a chromosomal position, and thereby cloning
gene(s) responsible for the trait. See Lander et al., Proc. Natl.
Acad. Sci. (USA) 83, 7353-7357 (1986); Lander et al., Proc. Natl.
Acad. Sci. (USA) 84, 2363-2367 (1987); Donis-Keller et al., Cell
51, 319-337 (1987); Lander et al., Genetics 121, 185-199 (1989)).
Genes localized by linkage can be cloned by a process known as
directional cloning. See Wainwright, Med. J Australia 159, 170-174
(1993); Collins, Nature Genetics 1, 3-6 (1992). Linkage studies are
discussed in more detail above.
[0139] In another embodiment, the invention relates to
pharmaceutical compositions comprising a reference TSP-1 and/or
TSP-4 gene or gene product for use in the treatment of vascular
disease, e.g., CAD and MI. As used herein, a reference TSP gene
product is intended to mean gene products which are encoded by the
reference allele of the TSP gene. In addition to substantially
full-length polypeptides expressed by the genes, the present
invention includes biologically active fragments of the
polypeptides, or analogs thereof, including organic molecules which
simulate the interactions of the peptides. Biologically active
fragments include any portion of the full-length polypeptide which
confers a biological function on the variant gene product,
including ligand binding, and antibody binding. Ligand binding
includes binding by nucleic acids, proteins or polypeptides, small
biologically active molecules, or large cellular structures.
[0140] For instance, the polypeptide or protein, or fragment
thereof, of the present invention can be formulated with a
physiologically acceptable medium to prepare a pharmaceutical
composition. The particular physiological medium may include, but
is not limited to, water, buffered saline, polyols (e.g., glycerol,
propylene glycol, liquid polyethylene glycol) and dextrose
solutions. The optimum concentration of the active ingredient(s) in
the chosen medium can be determined empirically, according to
procedures well known to medicinal chemists, and will depend on the
ultimate pharmaceutical formulation desired. Methods of
introduction of exogenous peptides at the site of treatment
include, but are not limited to, intradernal, intramuscular,
intraperitoneal, intravenous, subcutaneous, oral and intranasal.
Other suitable methods of introduction can also include
rechargeable or biodegradable devices and slow release polymeric
devices. The pharmaceutical compositions of this invention can also
be administered as part of a combinatorial therapy with other
agents and treatment regimens.
[0141] The invention further pertains to compositions, e.g.,
vectors, comprising a nucleotide sequence encoding reference or
variant TSP-1 and/or TSP-4 gene products. For example, reference
genes can be expressed in an expression vector in which a reference
gene is operably linked to a native or other promoter. Usually, the
promoter is a eukaryotic promoter for expression in a mammalian
cell. The transcription regulation sequences typically include a
heterologous promoter and optionally an enhancer which is
recognized by the host. The selection of an appropriate promoter,
for example trp, lac, phage promoters, glycolytic enzyme promoters
and tRNA promoters, depends on the host selected. Commercially
available expression vectors can be used. Vectors can include
host-recognized replication systems, amplifiable genes, selectable
markers, host sequences useful for insertion into the host genome,
and the like.
[0142] The means of introducing the expression construct into a
host cell varies depending upon the particular construction and the
target host. Suitable means include fusion, conjugation,
transfection, transduction, electroporation or injection, as
described in Sambrook, supra. A wide variety of host cells can be
employed for expression of the variant gene, both prokaryotic and
eukaryotic. Suitable host cells include bacteria such as E. coli,
yeast, filamentous fungi, insect cells, mammalian cells, typically
immortalized, e.g., mouse, CHO, human and monkey cell lines and
derivatives thereof. Preferred host cells are able to process the
variant gene product to produce an appropriate mature polypeptide.
Processing includes glycosylation, ubiquitination, disulfide bond
formation, general post-translational modification, and the
like.
[0143] It is also contemplated that cells can be engineered to
express the reference allele of the invention by gene therapy
methods. For example, DNA encoding the reference TSP gene product,
or an active fragment or derivative thereof, can be introduced into
an expression vector, such as a viral vector, and the vector can be
introduced into appropriate cells in an animal. In such a method,
the cell population can be engineered to inducibly or
constitutively express active reference TSP gene product. In a
preferred embodiment, the vector is delivered to the bone marrow,
for example as described in Corey et al. (Science 244:1275-1281
(1989)).
[0144] The invention further relates to the use of compositions
(i.e., agonists) which enhance or increase the activity of the
reference (or variant) TSP (e.g., TSP-1 or TSP-4) gene product, or
a functional portion thereof, for use in the treatment of vascular
disease. The invention also relates to the use of compositions
(i.e., antagonists) which reduce or decrease the activity of the
variant (or reference) TSP (e.g., TSP-1 or TSP-4) gene product, or
a functional portion thereof, for use in the treatment of vascular
disease.
[0145] The invention also relates to constructs which comprise a
vector into which a sequence of the invention has been inserted in
a sense or antisense orientation. For example, a vector comprising
a nucleotide sequence which is antisense to the variant TSP-1 or
TSP-4 allele may be used as an antagonist of the activity of the
TSP-1 or TSP-4 variant allele. Alternatively, a vector comprising a
nucleotide sequence of the TSP-1 or TSP-4 reference allele may be
used therapeutically to treat vascular diseases. As used herein,
the term "vector" refers to a nucleic acid molecule capable of
transporting another nucleic acid to which it has been linked. One
type of vector is a "plasmid", which refers to a circular double
stranded DNA loop into which additional DNA segments can be
ligated. Another type of vector is a viral vector, wherein
additional DNA segments can be ligated into the viral genome.
Certain vectors are capable of autonomous replication in a host
cell into which they are introduced (e.g., bacterial vectors having
a bacterial origin of replication and episomal mammalian vectors).
Other vectors (e.g., non-episomal mammalian vectors) are integrated
into the genome of a host cell upon introduction into the host
cell, and thereby are replicated along with the host genome.
Moreover, certain vectors, expression vectors, are capable of
directing the expression of genes to which they are operably
linked. In general, expression vectors of utility in recombinant
DNA techniques are often in the form of plasmids (vectors).
However, the invention is intended to include such other forms of
expression vectors, such as viral vectors (e.g., replication
defective retroviruses, adenoviruses and adeno-associated viruses)
that serve equivalent functions.
[0146] Preferred recombinant expression vectors of the invention
comprise a nucleic acid of the invention in a form suitable for
expression of the nucleic acid in a host cell. This means that the
recombinant expression vectors include one or more regulatory
sequences, selected on the basis of the host cells to be used for
expression, which is operably linked to the nucleic acid sequence
to be expressed. Within a recombinant expression vector, "operably
linked" is intended to mean that the nucleotide sequence of
interest is linked to the regulatory sequence(s) in a manner which
allows for expression of the nucleotide sequence (e.g., in an in
vitro transcription/translation system or in a host cell when the
vector is introduced into the host cell). The term "regulatory
sequence" is intended to include promoters, enhancers and other
expression control elements (e.g., polyadenylation signals). Such
regulatory sequences are described, for example, in Goeddel, Gene
Expression Technology: Methods in Enzymology 185, Academic Press,
San Diego, Calif. (1990). Regulatory sequences include those which
direct constitutive expression of a nucleotide sequence in many
types of host cell and those which direct expression of the
nucleotide sequence only in certain host cells (e.g.,
tissue-specific regulatory sequences). It will be appreciated by
those skilled in the art that the design of the expression vector
can depend on such factors as the choice of the host cell to be
transformed, the level of expression of protein desired, etc.
[0147] The expression vectors of the invention can be introduced
into host cells to thereby produce proteins or peptides, including
fusion proteins or peptides, encoded by nucleic acids as described
herein. The recombinant expression vectors of the invention can be
designed for expression of a polypeptide of the invention in
prokaryotic or eukaryotic cells, e.g., bacterial cells such as E.
coli, insect cells (using baculovirus expression vectors), yeast
cells or mammalian cells. Suitable host cells are discussed further
in Goeddel, supra. Alternatively, the recombinant expression vector
can be transcribed and translated in vitro, for example using T7
promoter regulatory sequences and T7 polymerase.
[0148] Another aspect of the invention pertains to host cells into
which a recombinant expression vector of the invention has been
introduced. The terms "host cell" and "recombinant host cell" are
used interchangeably herein. It is understood that such terms refer
not only to the particular subject cell but also to the progeny or
potential progeny of such a cell. Because certain modifications may
occur in succeeding generations due to either mutation or
environmental influences, such progeny may not, in fact, be
identical to the parent cell, but are still included within the
scope of the term as used herein. A host cell can be any
prokaryotic or eukaryotic cell. For example, a nucleic acid of the
invention can be expressed in bacterial cells (e.g., E. coli),
insect cells, yeast or mammalian cells (such as Chinese hamster
ovary cells (CHO) or COS cells). Other suitable host cells are
known to those skilled in the art.
[0149] Vector DNA can be introduced into prokaryotic or eukaryotic
cells via conventional transformation or transfection techniques.
As used herein, the terms "transformation" and "transfection" are
intended to refer to a variety of art-recognized techniques for
introducing foreign nucleic acid (e.g., DNA) into a host cell,
including calcium phosphate or calcium chloride co-precipitation,
DEAE-dextran-mediated transfection, lipofection, or
electroporation. Suitable methods for transforming or transfecting
host cells can be found in Sambrook, et al. (supra), and other
laboratory manuals.
[0150] A host cell of the invention, such as a prokaryotic or
eukaryotic host cell in culture, can be used to produce (i.e.,
express) a polypeptide of the invention. Accordingly, the invention
further provides methods for producing a polypeptide using the host
cells of the invention. In one embodiment, the method comprises
culturing the host cell of the invention (into which a recombinant
expression vector encoding a polypeptide of the invention has been
introduced) in a suitable medium such that the polypeptide is
produced. In another embodiment, the method further comprises
isolating the polypeptide from the medium or the host cell.
[0151] The host cells of the invention can also be used to produce
nonhuman transgenic animals. For example, in one embodiment, a host
cell of the invention is a fertilized oocyte or an embryonic stem
cell into which a nucleic acid of the invention has been
introduced. Such host cells can then be used to create non-human
transgenic animals in which exogenous nucleotide sequences have
been introduced into their genome or homologous recombinant animals
in which endogenous nucleotide sequences have been altered. Such
animals are useful for studying the function and/or activity of the
nucleotide sequence and polypeptide encoded by the sequence and for
identifying and/or evaluating modulators of their activity. As used
herein, a "transgenic animal" is a non-human animal, preferably a
mammal, more preferably a rodent such as a rat or mouse, in which
one or more of the cells of the animal includes a transgene. Other
examples of transgenic animals include non-human primates, sheep,
dogs, cows, goats, chickens, amphibians, etc. A transgene is
exogenous DNA which is integrated into the genome of a cell from
which a transgenic animal develops and which remains in the genome
of the mature animal, thereby directing the expression of an
encoded gene product in one or more cell types or tissues of the
transgenic animal. As used herein, an "homologous recombinant
animal" is a non-human animal, preferably a mammal, more preferably
a mouse, in which an endogenous gene has been altered by homologous
recombination between the endogenous gene and an exogenous DNA
molecule introduced into a cell of the animal, e.g., an embryonic
cell of the animal, prior to development of the animal.
[0152] A transgenic animal of the invention can be created by
introducing a nucleic acid of the invention into the male pronuclei
of a fertilized oocyte, e.g., by microinjection, retroviral
infection, and allowing the oocyte to develop in a pseudopregnant
female foster animal. The sequence can be introduced as a transgene
into the genome of a non-human animal. Intronic sequences and
polyadenylation signals can also be included in the transgene to
increase the efficiency of expression of the transgene. A
tissue-specific regulatory sequence(s) can be operably linked to
the transgene to direct expression of a polypeptide in particular
cells. Methods for generating transgenic animals via embryo
manipulation and microinjection, particularly animals such as mice,
have become conventional in the art and are described, for example,
in U.S. Pat. Nos. 4,736,866 and 4,870,009, U.S. Pat. No. 4,873,191
and in Hogan, Manipulating the Mouse Embryo (Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, N.Y., 1986). Similar methods
are used for production of other transgenic animals. A transgenic
founder animal can be identified based upon the presence of the
transgene in its genome and/or expression of mRNA in tissues or
cells of the animals. A transgenic founder animal can then be used
to breed additional animals carrying the transgene. Moreover,
transgenic animals carrying a transgene encoding the transgene can
further be bred to other transgenic animals carrying other
transgenes.
[0153] The invention also relates to the use of the variant and
reference gene products to guide efforts to identify the causative
mutation for vascular diseases or to identify or synthesize agents
useful in the treatment of vascular diseases, e.g., CAD and MI.
Amino acids that are essential for function can be identified by
methods known in the art, such as site-directed mutagenesis or
alanine-scanning mutagenesis (Cunningham et al., Science,
244:1081-1085 (1989)). The latter procedure introduces single
alanine mutations at every residue in the molecule. The resulting
mutant molecules are then tested for biological activity in vitro,
or in vitro activity. Sites that are critical for polypeptide
activity can also be determined by structural analysis such as
crystallization, nuclear magnetic resonance or photoaffinity
labeling (Smith et al., J. Mol. Biol., 224:899-904 (1992); de Vos
et al. Science, 255:306-312 (1992)).
[0154] Another aspect of the invention pertains to monitoring the
influence of agents (e.g., drugs, compounds) on the expression or
activity of proteins of the invention in clinical trials. An
exemplary method for detecting the presence or absence of proteins
or nucleic acids of the invention in a biological sample involves
obtaining a biological sample from a test subject and contacting
the biological sample with a compound or an agent capable of
detecting the protein, or nucleic acid (e.g., mRNA, genomic DNA)
that encodes the protein, such that the presence of the protein or
nucleic acid is detected in the biological sample. A preferred
agent for detecting mRNA or genomic DNA is a labeled nucleic acid
probe capable of hybridizing to mRNA or genomic DNA sequences
described herein, preferably in an allele-specific manner. The
nucleic acid probe can be, for example, a full-length nucleic acid,
or a portion thereof, such as an oligonucleotide of at least 15,
30, 50, 100, 250 or 500 nucleotides in length and sufficient to
specifically hybridize under stringent conditions to appropriate
mRNA or genomic DNA. Other suitable probes for use in the
diagnostic assays of the invention are described herein.
[0155] The invention also encompasses kits for detecting the
presence of proteins or nucleic acid molecules of the invention in
a biological sample. For example, the kit can comprise a labeled
compound or agent (e.g., nucleic acid probe) capable of detecting
protein or mRNA in a biological sample; means for determining the
amount of protein or mRNA in the sample; and means for comparing
the amount of protein or mRNA in the sample with a standard. The
compound or agent can be packaged in a suitable container. The kit
can further comprise instructions for using the kit to detect
protein or nucleic acid.
[0156] The following Examples are offered for the purpose of
illustrating the present invention and are not to be construed to
limit the scope of this invention. The teachings of all references
cited herein are hereby incorporated herein by reference.
EXAMPLES
[0157] Identification of Single Nucleotide Polymorphisms
[0158] The polymorphisms shown in the Table were identified by
resequencing of target sequences from individuals of diverse ethnic
and geographic backgrounds by hybridization to probes immobilized
to microfabricated arrays. The strategy and principles for design
and use of such arrays are generally described in WO 95/11995.
[0159] A typical probe array used in this analysis has two groups
of four sets of probes that respectively tile both strands of a
reference sequence. A first probe set comprises a plurality of
probes exhibiting perfect complementarily with one of the reference
sequences. Each probe in the first probe set has an interrogation
position that corresponds to a nucleotide in the reference
sequence. That is, the interrogation position is aligned with the
corresponding nucleotide in the reference sequence, when the probe
and reference sequence are aligned to maximize complementarily
between the two. For each probe in the first set, there are three
corresponding probes from three additional probe sets. Thus, there
are four probes corresponding to each nucleotide in the reference
sequence. The probes from the three additional probe sets are
identical to the corresponding probe from the first probe set
except at the interrogation position, which occurs in the same
position in each of the four corresponding probes from the four
probe sets, and is occupied by a different nucleotide in the four
probe sets. In the present analysis, probes were 25 nucleotides
long. Arrays tiled for multiple different references sequences were
included on the same substrate.
[0160] Publicly available sequences for a given gene were assembled
into Gap4, which can be found on the world wide web at
biozentrum.unibas.ch/bi- ocomp/staden/Overview.html. PCR primers
covering each exon were designed using Primer 3, which can be found
on the world wide web at
genome.wi.mit.edu/cgi-bin/primer/primer3.cgi. Primers were not
designed in regions where there were sequence discrepancies between
reads. Genomic DNA was amplified in at least 50 individuals using
2.5 pmol each primer, 1.5 mM MgCl.sub.2, 100 .mu.M dNTPs, 0.75
.mu.M AmpliTaq GOLD polymerase, and 19 ng DNA in a 15 .mu.l
reaction. Reactions were assembled using a PACKARD MultiPROBE
robotic pipetting station and then put in MJ 96-well tetrad
thermocyclers (96.degree. C. for 10 minutes, followed by 35 cycles
of 96.degree. C. for 30 seconds, 59.degree. C. for 2 minutes, and
72.degree. C. for 2 minutes). A subset of the PCR assays for each
individual were run on 3% NuSieve gels in 0.5.times.TBE to confirm
that the reaction worked.
[0161] For a given DNA, 5 .mu.L (about 50 ng) of each PCR or RT-PCR
product were pooled (Final volume=150-200 .mu.l). The products were
purified using QiaQuick PCR purification from Qiagen. The samples
were eluted once in 35 .mu.l sterile water and 4 .mu.l 10.times.
One-Phor-All buffer (Pharmacia). The pooled samples were digested
with 0.2.mu. DNaseI (Promega) for 10 minutes at 37.degree. C. and
then labeled with 0.5 mmols biotin-N-6-ddATP and 15.mu. Terminal
Transferase (GibcoBRL Life Technology) for 60 minutes at 37.degree.
C. Both fragmentation and labeling reactions were terminated by
incubating the pooled sample for 15 minutes at 100.degree. C.
[0162] Low-density DNA chips (Affymetrix, Calif.) were hybridized
following the manufacturer's instructions. Briefly, the
hybridization cocktail consisted of 3M TMACl, 10 mM Tris pH 7.8,
0.01% Triton X-100, 100 mg/ml herring sperm DNA (Gibco BRL), 200 pM
control biotin-labeled oligo. The processed PCR products were
denatured for 7 minutes at 100.degree. C. and then added to
prewarmed (37.degree. C.) hybridization solution. The chips were
hybridized overnight at 44.degree. C. Chips were washed in
1.times.SSPET and 6.times.SSPET followed by staining with 2
.mu.g/ml SARPE and 0.5 mg/ml acetylated BSA in 200 .mu.l of
6.times.SSPET for 8 minutes at room temperature. Chips were scanned
using a Molecular Dynamics scanner.
[0163] Chip image files were analyzed using Ulysses (Affymetrix,
Calif.) which uses four algorithms to identify potential
polymorphisms. Candidate polymorphisms were visually inspected and
assigned a confidence value: high confidence candidates displayed
all three genotypes, while likely candidates showed only two
genotypes (homozygous for reference sequence and heterozygous for
reference and variant). Some of the candidate polymorphisms were
confirmed by ABI sequencing. Identified polymorphisms were compared
to several databases to determine if they were novel. Results are
shown in the Table.
[0164] Association of Thrombospondin Gene Polymorphisms with
Vascular Disease
[0165] To determine pivotal genes associated with premature
coronary artery disease, we analyzed DNA from 347 patients with MI
or coronary revascularization before age 40 (men) or 45 (women) and
422 general population controls. Cases were drawn (one per family)
from a retrospective collection of sibling pairs with premature
CAD. Controls were ascertained through random-digit dialing. Both
cases and controls were Caucasian. A complete database of
phenotypic and laboratory variables for the affected patients
afforded logistic regression to control for age, diabetes, body
mass index, gender.
[0166] Thrombospondin (TSP) 4 and 1 emerged as important SNPs
associated with premature CAD and MI. For CAD, 148 of 347 patients
carried at least one copy of the TSP-4 variant compared with 142 of
422 control subjects; adjusted odds ratio 1.47, p=0.01. For
premature MI, the association was even stronger: 91 of 187 cases
vs. 142 of 422 controls had the variant; adjusted odds ratio 2.08,
p=0.0003. The TSP-1 SNP was rare. Nonetheless, homozygosity for the
variant allele gave an adjusted odds ratio of 9.5, p=0.04.
1 Genbank or TIGR Position Muta- Poly WIAF Accession in Gene
Flanking tion Ref Alt Ref Alt ID ID Number Sequence Description Seq
Type NT NT AA AA AT3a7 WIAF-13246 U11270 11918 AT3,
CTGCAGGAGT[G/A]GCTGGATGAA N G A W * antithrombin III DRD5u22
WIAF-12913 M67439 310 DRD1, CATCTGGACC[C/T]TGCTGGGCAA S C T L L
dopamine receptor D1 DRD5u23 WIAF-12914 M67439 332 DRD1,
GTGCTGGTGT[G/C]CGCAGCCATC M G C C S dopamine receptor D1 DRD5u24
WIAF-12915 M67439 369 DRD1, TGCGCGCCAA[C/G]ATGACCAACG M C G N K
dopamine receptor D1 DRD5u25 WIAF-12916 M67439 522 DRD1,
TGTGCTCCAC[T/C]GCCTCCATCC S T C T T dopamine receptor D1 DRD5u26
WIAF-12917 M67439 953 DRD1, GCAGAGCACG[C/T]GCAGAGCTGC M C T A V
dopamine receptor D1 DRD5u27 WIAF-12918 M67439 635 DRD1,
ATGGTCGGCC[T/C]GGCATGGACC M T C L P dopamine receptor D1 DRD5u2B
WIAF-129l9 M67439 606 DRD1, GCAAGATGAC[T/C]CAGCGCATGG S T C T T
dopamine receptor D1 DRD5u29 WIAF-12920 M67439 845 DRD1,
TCGCTCATCA[G/A]CTTCTACATC M G A S N dopamine receptor D1 DRD5u30
WIAF-12921 M67439 720 DRD1, CGGGCCGGCT[G/T]GACCTGCCAA S G T L L
dopamine receptor D1 DRD5u31 WIAF-12922 M67439 1044 DRD1,
AGACCCTGTC[G/A]GTGATCATGG S G A S S dopamine receptor D1 DRD5u32
WIAF-12923 M67439 766 DRD1, GGAGGAGGAC[T/G]TTTGGGAGCC M T G F V
dopamine receptor D1 DRD5u33 WIAF-12924 N67439 777 DRD1,
TTTCCGAOCC[C/T]GACCTCAATG S C T P P dopamine receptor D1 DRD5u34
WIAF-12925 M67439 786 DRD1, CCGACGTGAA[T/C]GCACACAACT M T G N K
dopamine receptor D1 DRD5u35 WIAF-12926 M67439 881 DRD1,
ACCTACACGC[G/A]CATCTACCGC M G A R H dopamine receptor D1 DRD5u36
WIAF-12927 M67439 1279 DRD1, GTGCACCCAC[T/G]TCTGCTCCCG M T G F V
dopamine receptor D1 DRD5u37 WIAF-12928 M67439 1370 DRD1,
GAAATCGCAG[C/T]TGCCTACATC M C T A V dopamine receptor D1 DRD5u38
WIAF-12929 M67439 1500 DRD1, ACCCTGTTGC[T/A]GAGTCTGTCT S T A A A
dopamine receptor D1 DRD5u39 WIAF-12930 M67439 1338 DRD1,
TCTCCTACAA[C/T]CAAGACATCG S C T N N dopamine receptor D1 DRD5u40
WIAF-12931 M67439 1215 DRD1, CACTCAACCC[C/A]CTCATCTATG S C A P P
dopamine receptor D1 DRD5u41 WIAF-12932 M67439 1242 DRD1,
ACGCCGACTT[T/C]CAGAAGGTGT S T C P F dopamine receptor D1 DRD5u42
WIAF-12933 M67439 1441 DRD1, CGAGGAGGAC[G/A]GTCCTTTCGA M G A G S
dopamine receptor D1 DRD5u43 WIAF-12934 M67439 1460 DRD1,
GATCGCATGT[T/C]CCAGATCTAT M T C F S dopamine receptor D1 DRD5u44
WIAF-12960 M67439 399 DRD1, TGTCTCTGGC[C/T]GTGTCTGACC S C T A A
dopamine receptor D1 DRD5u45 WIAF-12961 M46743 9162 DRD1,
TGCCGCCAGC[C/G]AGcAAcOCCA S C G G G dopamine receptor D1 DRD5u46
WIAF-12962 M67439 195 DRD1, GGCAGTTCGC[T/G]CTATACCAGC S T G A A
dopamine receptor D1 DRD5u47 WIAF-12963 M67439 264 DRD1,
TGGGGCCCTC[A/C]CAGCTCCTCA S A G S S dopamine receptor D1 DRD5u48
WIAF-12964 M61439 465 DRD1, TGGCCGGTTA[C/T]TGCCCCTTTC S C T Y Y
dopamine receptor D1 DRD5u49 WIAF-12965 M67439 511 DRD1,
CTTCGACATC[A/T]TGTGCTCCAC M A T M L dopamine receptor D1 DRD5u50
WIAF-12966 M67439 557 DRD1, ATCAGCGTGG[A/C]CCCCTACTGG M A G D G
dopamine receptor D1 DRD5u51 WIAF-12967 M67439 476 DRD1,
TGGCCCTTTG[C/A]AGCGTTCTGC M G A G E dopamine receptor D1 DRD5u52
WIAF-12968 M67439 1004 DRD1, AGCCTGCGCG[C/T]TTCCATCAAC M C T A V
dopamine receptor D1 DRD5u53 WIAF-12969 M67439 1036 DRD1,
GGTTCTCAAG[A/C]CCCTGTCGGT M A C T P dopamine receptor D1 DRD5u54
WIAF-12970 M67439 859 DRD1, CTACATCCCC[G/A]TTGCCATCAT M G A V I
dopamine receptor D1 DRD5u55 WIAF-12971 M67439 931 DRD1,
GATTTCCTCC[C/T]TGGAGAGGGC S C T L L dopamine receptor D1 G10u1
WIAF-10234 J04111 1308 JUN, v-jun avian CCCTCAACGC[C/T]TCGTTCCTCC S
C T A A sarcoma virus 17 oncogene homolog G10u2 WIAF-10235 J04111
1471 JUN, v-jun avian GCTGCTCAAG[C/T]TGGCGTCGCC S C T L L sarcoma
virus 17 oncogene homolog G10u3 WIAF-10253 J04111 2010 JUN, v-jun
avian TGGAGTCCCA[G/A]GAGCCGATCA S G A Q Q sarcoma virus 17 oncogene
homolog G1001u1 WIAF-13746 D26135 993 DGKG, diacyl-
CCCCAGTCGT[C/A]TACCTGAAGG S G A V V glycerol kinase, gamma (90 kD)
G1001u2 WIAF-13764 D26135 2313 DGKG, diacyl-
ATGTGATGAG[A/T]GAGAAACATC M A T R S glycerol kinase, gamma (90 kD)
G1002u1 WIAF-13918 X57206 334 ITPKB, inositol
CCCCAACATC[A/C]GGACAAGCCT M A C Q P 1,4,5-trisphosphate 3-kinase B
G1002u2 WIAF-13925 X57206 575 ITPKB, inositol
CCAACTCAGC[T/C]TTCCTGCATA S T C A A 1,4,5-trisphosphate 3-kinase B
G1004u1 WIAF-13567 L36151 1854 PIK4CA, phospha-
GCCGCTCAGA[C/T]TCCGAGGATG S C T D D tidylinositol 4- kinase,
catalytic, alpha polypeptide G1006u1 WIAF-12375 HT2690 858 PRKCA,
protein GGTACAAGTT[G/A]CTTAACCAAG S G A L L kinase C, alpha G1008u1
WIAF-12397 HT2136 300 PRKCZ, protein CTGGCCTGCC[A/C]TCTCCCCGAC S A
G P P kinase C, zeta C1008u2 WIAF-12398 HT2136 246 PRKCZ, protein
AGTGCAGGGA[T/C]GAAGGCCTCA S T C D D kinase C, zeta G1008u3
WIAF-12399 HT2136 504 PRKCZ, protein GCTCCCACCC[C/T]CTCGTCCCC- C S
C T G G kinase C, zeta G1008u4 WIAF-12403 HT2136 807 PRKCZ, protein
AGAAGAATGA[C/T]CAAATTTACG S C T D D kinase C, zeta G1008u5
WIAF-12404 HT2136 1514 PRKCZ, protein GGATTTTCTG[A/T]CATCAACTCC M A
T D V kinase C, zeta G1008u6 WIAF-12412 HT2136 166 PRKCZ, protein
CAAGTGGGTC[C/A]ACACCGAAGG M G A D N kinase C, zeta C1008u7
WIAF-12418 HT2136 560 PRKCZ, protein TCCCAACAGC[C/T]TCCACTACA- C M
C T P L kinase C, zeta C1009u1 WIAF-12396 L05186 2495 PTK2, PTK2
protein TCATCAACAA[G/A]ATGAAACTCG S G A K K tyrosine kinase 2
G1011u1 WIAF-11988 X07876 1250 WNT2, wingless-type
TCCCATCTCA[C/A]CCGCATGACC M C A T N MMTV integration site family
member 2 G1011u2 WIAF-11997 X07876 788 WNT2, wingless-type
CACTATGGGA[T/C]CAAATTTG- CC M T C I T MMTV integration site family
member 2 G1011u3 WIAF-12014 X07876 1338 WNT2, wingless-type
TGCACACATG[C/A]AAGGCCCCCA N C A C * MMTV integration site family
member 2 C1011u4 WIAF-13475 X07876 856 WNT2, wingless-type
CCTGATGAAT[C/T]TTCACAAC- AA M C T L F MMTV integration site family
member 2 C1011u5 WIAF-13476 X07876 958 WNT2, wingless-type
GACATGCTGG[C/T]TGGCCATGGC S C T L L MMTV integration site family
member 2 G1011u6 WIAF-13477 X07876 789 WNT2, wingless-type
ACTATCCGAT[C/T]AAATTTCC- CC S C T I I MMTV integration site family
member 2 G1011u7 WIAF-13478 X07876 823 WNT2, wingless-type
TGCAAAGGAA[A/C]GCAAACCAAA M A G R G MMTV integration site family
member 2 G1012u1 WIAF-12408 HT48910 1574 WNT2B, wingless-type
ATACTTGCAA[A/C]GCCCCCAAGA S A G K K MMTV integration site family,
member 2B G1016a1 WIAF-12125 Z22534 793 ACVR1, activin A
CCCAAGCCGA[A/C]AATGTTCCCG S A G E E receptor, type I G1016u2
WIAF-12392 Z22534 373 ACVR1, activin A CTGGCCAACC[T/C]GTGGACTGCT S
T C A A receptor, type I G1018u1 WIAF-12413 X74210 1150 ADCY2,
adenylate CAAATTCCGA[C/T]TGCGTATTAA M G T V L cyclase 2 (brain)
G1019u1 WIAF-12394 U83867 5475 SPTAN1, spectrin,
GCGACCTAAC[T/C]CGCCTCCACA S T C T T alpha, nonerythro- cytic 1
(alpha- fodrin) G1019u2 WIAF-12406 U83867 1223 SPTAN1, spectrin,
GCCCTCATCA[A/G]TGCACATCAC M A G N S alpha, nonerythro- cytic 1
(alpha- fodrin) G1019u3 WIAF-12409 U83867 3555 SPTAN1, spectrin,
CTCAAGCTCT[T/C]ATCCCACACC S T C L L alpha, nonerythro- cytic 1
(alpha- fodrin) G1019u4 WIAF-12415 U83867 3369 SPTAN1, spectrin,
TCCCTCAACC[C/A]AATGAACTAC S G A A A alpha, nonerythro- cytic 1
(alpha- fodrin) C1019u5 WIAF-12417 U83867 5839 SPTAN1, spectrin,
TCACACACAC[T/A]TCACCCTCCA M T A F I alpha, nonerythro- cytic 1
(alpha- fodrin) G1022u1 WIAF-12393 U45945 631 ATP1B2, ATPase,
CATCAATCTT[A/C]CCTCTCCTCC M A G T A Na+/K+ transporting, beta 2
polypeptide G1022u2 WIAF-12400 U45945 432 ATP1B2, ATPase,
GCCGCCCTGG[G/A]CGCTATTA- CG S G A G G Na+/K+ transporting, beta 2
polypeptide G1023u1 WIAF-12401 D89722 395 ARNTL, aryl hydro-
AACATTAAGA[C/C]GTGCCACCAA M G C G R carbon receptor nuclear
translocator-like G1023u2 WIAF-12407 D89722 681 ARNTL, aryl hydro-
CTCATAGATC[C/T]AAAAACTGGA M C T A V carbon receptor nuclear
translocator-like G1024u1 WIAF-12410 U85946 731 Homo sapiens brain
CATACATTTT[C/T]ACAACTTAAA M C T S L secretory protein hSec10p
(HSEC10) mRNA, complete cds. G1027u1 WIAF-12402 L47647 1135 CKB,
creatine TCGAGATGGA[A/G]CAGCGGCTGG S A G E E kinase, brain G1027u2
WIAF-12405 L47647 499 CKB, creatine CCGAGCCCCG[A/C]GCCATCGACA S A C
R R kinase, brain G103u1 WIAF-10427 HT2269 335 ERCC5, excision
GGGATCCCCA[T/C]CCGAACTCAA S T C H H repair cross- complementing
rodent repair deficiency, complementation group 5 (xeroderma
pigmentosum, complementation group G (Cockayne syndrome)) G103u2
WIAF-10429 HT2269 1221 ERCC5, excision CCCTCCTTCT[C/T]CAAGAACTTT M
C T P S repair cross- complementing rodent repair deficiency,
complementation group 5 (xeroderma pigmentosum, complementation
group G (Cockayne syndrome)) G103u3 WIAF-10431 HT2269 1783 ERCC5,
excision TCTCCAACTT[C/C]TACAAATTCT M G C C S repair cross-
complementing rodent repair deficiency, complementation group 5
(xeroderma pigmentosum, complenientation group G (Cockayne
syndrome)) G103u4 WIAF-10432 HT2269 2077 ERCC5, excision
ACTGAATCTG[C/A]AGGCCAGGAT M C A A E repair cross- complementing
rodent repair deficiency, complementation group 5 (xeroderma
pigmentosum, complementation group G (Cockayne syndrome)) G103u5
WIAF-10446 HT2269 3338 ERCC5, excision AATTTGAGCT[A/T]CTTGATAAGG S
A T L L repair cross- complementing rodent repair deficiency,
complementation group 5 (xeroderma pigmentosum, complementation
group G (Cockayne syndrome)) G103u6 WIAF-10447 HT2269 3487 ERCC5,
excision TCAGAATCAT[C/T]TGATGGATCT M C T S F repair cross-
complementing rodent repair deficiency, complementation group 5
(xeroderma pigmentosum, complementation group G (Cockayne
syndrome)) G103u7 WIAF-10448 HT2269 3507 ERCC5, excision
TTCAAGTGAA[C/G]ATGCTGAAAG M C G H D repair cross- complementing
rodent repair deficiency, complementation group 5 (xeroderma
pigmentosum, complementation group G (Cockayne syndrome)) G103u8
WIAF-10457 HT2269 1388 ERCC5, excision CTCTTCACGAE[T/G]CACCAAGATC M
T G D E repair cross- complementing rodent repair deficiency,
complementation group 5 (xeroderma- pigmentosum, complementation
group G (Cockayne syndrome)) G103u9 WIAF-10458 HT2269 1362 ERCC5,
excision CCGGACTCTT[T/C]CAGCCATTAA M T C S P repair cross-
complementing rodent repair deficiency, complementation group 5
(xeroderma pigmentosum, complementation group G (Cockayne
syndrome)) G103u10 WIAF-10459 HT2269 2357 ERCC5, excision
CTGAGAAAGA[T/C]GCCGAACATT S T C D D repair cross- complementing
rodent repair deficiency, complementation group 5 (xeroderma
pigmentosum, complementation group G (Cockayne syndrome)) G103u11
WIAF-10462 HT2269 3109 ERCC5, excision TGGAACAGAA[C/T]GAAGACAGAT M
C T T M repair cross- complementing rodent repair deficiency,
complementation group 5 (xeroderma pigmentosum, complementation
group G (Cockayne syndrome)) G103u12 WIAF-10463 HT2269 3138 ERCC5,
excision GTTTCCTGTA[T/C]TAAAGCAACT S T C L L repair cross-
complementing rodent repair deficiency, complementation group 5
(xeroderma pigmentosum, complementation group G (Cockayne
syndrome)) G103u14 WIAF-10484 HT2269 3553 ERCC5, excision
AGAACAGCTG[C/T]GAAAGAGCCA M C T A V repair cross- complementing
rodent repair deficiency, complementation group 5 (xeroderma
pigmentosum, complementation group G (Cockayne syndrome)) G103u15
WIAF-10485 HT2269 1429 ERCC5, excision CATCTCCACA[C/T]CCGACCGCCA M
C T T M repair cross- complementing rodent repair deficiency,
complementation group 5 (xeroderma pigmentosum, complementation
group G (Cockayne syndrome)) G103a16 WIAF-12097 HT2269 3335 ERCC5,
excision AACAATTTGA[G/T]CTACTTCATA M G T E D repair cross-
complementing rodent repair deficiency, complementation group 5
(xeroderma pigmentosum, complementation group G (Cockayne
syndrome)) G1030u1 WIAF-12411 U07358 203 ZPK, zipper
ACACTTCTGA[C/T]TGCACTCCCG S C T D D (leucine) protein kinase
G1030u2 WIAF-12416 U07358 1806 ZPK, zipper
GCCACCCCAT[G/T]AACCTGGACG N G T E * (leucine) protein kinase
G1031a1 WIAF-12124 U87460 2825 GPR37, G protein-
GAGTCACCAC[C/T]TTCACCTTAT S C T T T coupled receptor 37 (endothelin
receptor type B-like) G1032u1 WIAF-12381 U57911 926 C110RF8,
chromosome ACGTACATCA[A/C]TGCCTCGACG M A C N T 11 open reading
frame 8 G1033u1 WIAF-12437 M65188 431 GJA1, gap junction
TCTGTACCCA[C/T]ACTCTTCTAC M C T T I protein, alpha 1, 43 kD
(connexin 43) G1033u2 WIAF-12438 M65188 169 GJA1, gap junction
ACGCAACATG[G/C]GTGACTGGAG M G C G R protein, alpha 1, 43 kD
(connexin 43) G1033u3 WIAF-12439 M65188 467 GJA1, gap junction
TATCTCATGC[C/A]AAAGGAACAG M G A R Q protein, alpha 1, 43 kD
(connexin 43) G1033u4 WIAF-12440 M65188 263 GJA1, gap junction
TTCATTTTCC[C/A]AATCCTGCTG M C A R Q protein, alpha 1, 43 kD
(connexin 43) G1033u5 WIAF-12441 M65188 218 GJA1, gap junction
CAAGCCTACT[C/T]AACTGCTCGA M C T S L protein, alpha 1, 43 kD
(connexin 43) G1033u6 WIAF-12442 M65188 498 GJA1, gap junction
AGAAAGAGGA[A/G]GAACTCAAGC S A G E E protein, alpha 1, 43 kD
(connexin 43) G1033u7 WIAF-12465 M65188 550 GJA1, gap junction
GCACTTGAAG[C/A]AGATTGAGAT M C A Q K protein, alpha 1, 43 kD
(connexin 43) G1033u8 WIAF-12466 M65188 548 GJA1, gap junction
ATGCACTTGA[A/G]GCACATTGAC M A G K R protein, alpha 1, 43 kD
(connexin 43) G1033u9 WIAF-12486 M65188 933 GJA1, gap junction
CCCTGAGCCC[T/C]GCCAAACACT S T C P P protein, alpha 1, 43 kD
(connexin 43) G1033u10 WIAF-12487 M65188 990 GJA1, gap junction
CCTCACCAAC[C/T]GCTCCCCTCT S C T T T protein, alpha 1, 43 kD
(connexin 43) G1033u11 WIAF-12488 M65188 1034 GJA1, gap junction
AACCTGCTTA[C/A]TCGCGACAGA M C A T N protein, alpha 1, 43 kD
(connexin 43) G1033u12 WIAF-12489 M65188 1158 GJA1, gap junction
CTAACTCCCA[T/C]CCACAGCCTT S T C H H protein, alpha 1, 43 kD
(connexin 43) G1033u13 WIAF-12490 M65188 1222 GJA1, gap junction
TGGACATGAA[T/C]TACAGCCACT S T C L L protein, alpha 1, 43 kD
(connexin 43) G1033u14 WIAF-12491 M65188 1069 GJA1, gap junction
CCGCAATTAC[A/C]ACAAGCAAGC M A G N D protein, alpha 1, 43 kD
(connexin 43) G1033u15 WIAF-12492 M65188 1250 GJA1, gap junction
CTCCACCACC[G/A]ACCTTCAAGC M G A R Q protein, alpha 1, 43 kD
(connexin 43) G1033u16 WIAF-12496 M65188 423 GJA1, gap junction
TATTTCTCTC[T/C]GTACCCACAC S T C S S protein, alpha 1, 43 kD
(connexin 43) G1033u17 WIAF-12503 M65188 880 GJA1, gap junction
CCTTAAGGAT[C/T]GGGTTAACCG M C T R W protein, alpha 1, 43 kD
(connexin 43) G1033u18 WIAF-12504 M65188 855 GJA1, gap junction
AACTCTTCTA[T/C]GTTTTCTTCA S T C Y Y protein, alpha 1, 43 kD
(connexin 43) G1033u19 WIAF-12505 M65188 576 GJA1, gap junction
AGTTCAAGTA[C/T]GGTATTGAAG S C T Y Y protein, alpha 1, 43 kD
(connexin 43) G1033u20 WIAF-12512 M65188 1255 GJA1, gap junction
CCACCCACCT[T/G]CAACCACACC M T G S A protein, alpha 1, 43 kD
(connexin 43) G1033u21 WIAF-12513 M65188 1078 GJA1, gap junction
CAACAAGCAA[C/A]CAAGTGACCA M G A A T protein, alpha 1, 43 kD
(connexin 43) G1033u22 WIAF-12514 M65188 1097 GJA1, gap junction
CAAAACTCCG[C/G]TAATTACACT M C G A G protein, alpha 1, 43 kD
(connexin 43) G1034u1 WIAF-12443 J03544 1201 PYGB, phosphory-
AGACCTGTGC[A/G]TACACCAACC S A G A A lase, glycogen; brain G1034u2
WIAF-12469 J03544 771 PYGB, phosphory- GACACCCCAG[T/C]CCCCGGCTAC M
T C V A lase, glycogen; brain G1034u3 WIAF-12470 J03544 1465 PYGB,
phosphory- TCCACTCCGA[C/C]ATCGTCAAAC M G C E D lase, glycogen;
brain G1034u4 WIAF-12471 J03544 1583 PYGB, phosphory-
CCCGCTCCCC[G/A]ATACCATCCT M G A D N lase, glycogen; brain G1034u5
WIAF-12472 J03544 1774 PYGB, phosphory- CCATGTTCGA[T/C]GTGCATGTGA S
T C D D lase, glycogen; brain G1034u6 WIAF-12474 J03544 2449 PYGB,
phosphory- AGGTGGACCA[G/A]CTGTACCGGA S G A Q Q lase, glycogen;
brain G1034u7 WIAF-12508 J03544 718 PYGB, phosphory-
CCCCCGACGG[C/T]GTGAAGTGGC S C T G G lase, glycogen; brain G1035u1
WIAF-12484 U97105 1962 DPYSL2, dihydro- GCAGAGGAGC[A/G]GCAGACGATC M
A G Q R pyrimidinase-like 2 G1035u2 WIAF-12485 U97105 2842 DPYSL2,
dihydro- ATGACGGACC[T/C]GTGTGTGAAG S T C P P pyrimidinase-like 2
G1035u3 WIAF-12511 U97105 2062 DPYSL2, dihydro-
CCATCACCAT[C/T]GCCAACCAGA S C T I I pyrimidinase-like 2 G1036u1
WIAF-12444 D88460 311 WASL, Wiskott- ACGTGGGGTC[C/T]CTGTTGCTCA S C
T S S Aldrich syndrome like G1038u1 WIAF-12445 HT2746 994 PCTK2,
PCTAIRE TAGAAGAAAG[C/A]TATTGCATCG M G A V I protein kinase 2
G1039u1 WIAF-12429 HT2747 955 serine/threonine
ATCCAAGAGT[C/T]GCATGTCAGC M C T R C kinase, PCTAIRE-3 G1039u2
WIAF-12458 HT2747 808 serine/threonine CACAGAAGAG[A/T]CGTGGCCCGG M
A T T S kinase, PCTAIRE-3 G1041u1 WIAF-12459 X72886 544 H.sapiens
TYRO3 CAAGTGGCTG[G/C]CCCTGGAGAG M G C A P mRNA. G1041u2 WIAF-12460
X72886 693 H.sapiens TYRO3 TTGGCGGGAA[C/T]CGCCTGAAAC S C T N N
mRNA. G1041u3 WIAF-12502 X72886 561 H.sapiens TYRO3
AGAGCCTGGC[C/T]GACAACCTGT S C T A A mRNA. G1043u1 WIAF-12448 M94055
5481 Human voltage-gated CTCTGAGTGA[G/A]GATGACTTTG S G A E E sodium
channel mRNA, complete cds. G1043u2 WIAF-12449 M94055 5205 Human
voltage-gated TTGACACCTT[T/C]GGCAACAGCA S T C F F sodium channel
mRNA, complete cds. G1043u3 WIAF-12450 M94055 5224 Human
voltage-gated CATGATCTGC[C/T]TGTTCCAAAT S C T L L sodium channel
mRNA, complete cds. G1043u4 WIAF-12451 M94055 5514 Human
voltage-gated AGGTTTGGGA[C/A]AACTTTCATC S C A E E sodium channel
mRNA, complete cds. G1043u5 WIAF-12452 M94055 5217 Human
voltage-gated CCAACAGCAT[G/C]ATCTCCCTGT M G C M I sodium channel
mRNA, complete cds. G1043u6 WIAF-12453 M94055 5334 Human
voltage-gated CCTCACTTAA[A/G]CCAGACTCTG S A G K K sodium channel
mRNA, complete cds. G1043u7 WIAF-12454 M54055 5424 Human
voltage-gated TGTACATCGC[G/C]GTCATCCTGG S G C A A sodium channel
mRNA, complete cds. G1043u8 WIAF-12455 M94055 5322 Human
voltage-gated ATCACCCTGG[A/C]AGCTCAGTTA S A C G G sodium channel
mRNA, complete cds. G1043u9 WIAF-12456 M94055 1200 Human
voltage-gated ATGGCTACAC[G/A]AGCTTTGACA S G A T T sodium channel
mRNA, complete cds. G1043u10 WIAF-12499 M94055 1170 Human
voltage-gated TCTGTGTGAA[G/T]GCTCGTAGAA M G T K N sodium channel
mRNA, complete cds. G1046a1 WIAF-13187 U50352 267 ACCN1, amiloride-
TCCCACCTGT[C/A]ACCCTCTCTA S G A V V sensitive cation channel 1,
neuronal (degenerin) G1046a2 WIAF-13188 U50352 282 ACCN1,
amiloride- TCTGTAACCT[C/g]AATGGCTTCC S C g L L sensitive cation
channel 1, neuronal (degenerin) G1046a3 WIAF-13189 U50352 315
ACCN1, amiloride- TCACCACCAA[C/t]CACCTGTACC S C t N N sensitive
cation channel 1, neuronal (degenerin) G1046a4 WIAF-13190 U50352
386 ACCN1, amiloride- CCCCATCTGG[C/a]TGACCCCTCC M C a A D sensitive
cation channel 1, neuronal (degenerin) G1046a5 WIAF-13191 U50352
417 ACCN1, amiloride- CCCTCCGGCA[C/A]AACCCCAACT S G A Q Q sensitive
cation channel 1, neuronal (degenerin) G1048u1 WIAF-12641 HT5174S
3214 REST, RE1-silencing CAGTCAAACC[G/A]CCTAAGGCAC S G A A A
transcription factor G1048u2 WIAF-12642 HT5174S 3199 REST,
RE1-silencing CAAAGGAAGC[C/G]TTGGCAGTCA S C G A A transcription
factor G1048u3 WIAF-12657 HT5174S 2125 REST, RE1-silencing
CTCCCATCGA[C/T]ACTCCTCAGA M G T E D transcription factor G1048u4
WIAF-12660 HT5174S 2333 REST, RE1-silencing
CGAACCTCTT[A/C]ACATACACCT M A C K Q transcription factor G1051u1
WIAF-12431 HT28321 658 SCNN1G, sodium ATGACACCTC[C/T]GACTGTGCCA S C
T S S channel, non- voltage gated 1, gamma G1051u2 WIAF-12434
HT28321 1735 SCNN1G, sodium AAGCCAAGGA[G/A]TGGTCCGCCT S C A E E
channel, non- voltage gated 1, gamma G1051u3 WIAF-12473 HT28321 409
SCNN1G, sodium AGTCCCTGTA[T/C]GCCTTTCCAC S T C Y Y channel, non-
voltage gated 1, gamma G1051u4 WIAF-12475 HT28321 953 SCNN1G,
sodium AGTCATTTTG[T/C]ACATAAACGA M T C Y H channel, non- voltage
gated 1, gamma G1051u5 WIAF-12476 HT28321 975 SCNN1G, sodium
GAGCAATACA[A/C]CCCATTCCTC M A G N S channel, non- voltage gated 1,
gamma G1051u6 WIAF-12477 HT28321 1192 SCNN1G, sodium
CTGCCTACTC[C/A]CTCCAGATCT S G A S S channel, non- voltage gated 1,
gamma G1053a1 WIAF-13192 HT2201 4085 SCN5A, sodium
CGTCCTCTGA[C/A]AGCTCTCTCA M G A R K channel, voltage- gated, type
V, alpha polypeptide (long (electro- cardiographic) QT syndrome 3)
G1053a2 WIAF-13193 HT2201 5607 SCN5A, sodium
ACTTTCCCCA[C/T]CCCCTGTCTG S C T D D channel, voltage- gated, type
V, alpha polypeptide (long (electro- cardiographic) QT syndrome 3)
G1053a3 WIAF-13194 HT2201 5828 SCN5A, sodium
GACCCCATCA[C/T]CACCACACTC M C T T I channel, voltage- gated, type
V, alpha polypeptide (long (electro- cardiographic) QT syndrome 3)
G1053a4 WIAF-13202 HT2201 713 SCN5A, sodium
GCGTTCACTT[T/A]CCTTCCGGAC M T A F Y channel, voltage- gated, type
V, alpha polypeptide (long (electro- cardiographic) QT syndrome 3)
G1053a5 WIAF-13203 HT2201 6148 SCN5A, sodium
CCACACTGAA[G/T]ATCTCGCCGA M G T D Y channel, voltage- gated, type
V, alpha polypeptide (long (electro- cardiographic) QT syndrome 3)
G1053a6 WIAF-13204 HT2201 6217 SCN5A, sodium
GCCCTCGCTC[C/T]CCACGACACA -- G T -- -- channel, voltage- gated,
type V, alpha polypeptide (long (electro- cardiographic) QT
syndrome 3) G1053a7 WIAF-13205 HT2201 6324 SCN5A, sodium
AATCCCCCTC[G/A]CCCCCGCCC- A -- G A -- -- channel, voltage- gated,
type V, alpha polypeptide (long (electro- cardiographic) QT
syndrome 3) G1054u1 WIAF-12419 HT2202 2252 SCN4A, sodium
TTGGCAAGAG[C/T]TACAAGGAGT S C T S S channel, voltage- gated, type
IV, alpha polypeptide G1054u2 WIAF-12423 HT2202 4559 SCN4A, sodium
TGGTCATGTT[C/T]ATCTACTCCA S C T F F channel, voltage- gated, type
IV, alpha polypeptide G1054u3 WIAF-12424 HT2202 4856 SCN4A, sodium
TCAACATGTA[C/G]ATCGCCATCA N C G Y * channel, voltage- gated, type
IV, alpha polypeptide G1054u4 WIAF-12425 HT2202 4777 SCN4A, sodium
GTCAAGGCTC[A/G]CTGCGGCAAC M A G D G channel, voltage- gated, type
IV, alpha polypeptide G1054u5 WIAF-12426 HT2202 4863 SCN4A, sodium
GTACATCGCC[A/G]TCATCCTGGA M A G I V channel, voltage- gated, type
IV, alpha polypeptide G1054u6 WIAF-12427 HT2202 4566 SCN4A, sodium
GTTCATCTAC[T/G]CCATCTTCGG M T G S A channel, voltage- gated, type
IV, alpha polypeptide G1054u7 WIAF-12428 HT2202 4923 SCN4A, sodium
TGGTGAAGAT[G/T]ACTTTGAGAT M G T D Y channel, voltage- gated, type
IV, alpha polypeptide G1054u8 WIAF-12446 HT2202 3595 SCN4A, sodium
TTCTGGCTGA[T/C]CTTCAGCATC M T C I T channel, voltage- gated, type
IV, alpha polypeptide G1054u9 WIAF-12447 HT2202 4203 SCN4A, sodium
GGAGACAGAC[G/A]ACCAGAGCCA M G A D N channel, voltage- gated, type
IV, alpha polypeptide G1054u10 WIAF-12495 HT2202 4811 SCN4A, sodium
TCTGCTTCTT[C/A]TGCAGCTATA M C A F L channel, voltage- gated, type
IV, alpha polypeptide G1054u11 WIAF-12497 HT2202 5555 SCN4A, sodium
CAGGGCAGAC[T/G]GTGCGCCCAG S T G T T channel, voltage- gated, type
IV, alpha polypeptide G1054u12 WIAF-12498 HT2202 5480 SCN4A, sodium
CACGGGACGC[C/T]GGACCCACTA S C T A A channel, voltage- gated, type
IV, alpha polypeptide G1059u1 WIAF-12432 HT33704 112 APLP1, amyloid
beta CGCTGCTGCT[G/A]CCACTATTGC S G A L L (A4) precursor-like
protein 1 G1059u2 WIAF-12433 HT33704 140 APLP1, amyloid beta
TCTGCGCGCG[C/T]AGCCCGCCAT N C T Q * (A4) precursor-like protein 1
G1059u3 WIAF-12435 HT33704 1344 APLP1, amyloid beta
CACCATGTGG[C/T]CGCCCTGGAT M C T A V (A4) precursor-like protein 1
G1059u4 WIAF-12457 HT33704 1687 APLP1, amyloid beta
ATCACCGAAA[C/A]CTGAATGCGT S C A K K (A4) precursor-like protein 1
G1059u5 WIAF-12500 HT33704 976 APLP1, amyloid beta
CGTTCCTGAG[A/C]GCCAAGATGG S A G R R (A4) precursor-like protein 1
G1059u6 WIAF-12501 HT33704 1786 APLP1, amyloid beta
GTCAGGCTCT[A/G]TCGGGTCTGC S A G V V (A4) precursor-like protein 1
G1060u1 WIAF-12436 HT1418 1744 APLP2, amyloid beta
CCAAGAAATT[C/C]AAGAGGAAAT M C G Q E (A4) precursor-like protein 2
G1060u2 WIAF-12467 HT1418 2213 APLP2, amyloid beta
ATCACCCTGC[T/C]GATGCTGACC M T G V G (A4) precursor-like protein 2
G1060u3 WIAF-12468 HT1418 2256 APLP2, amyloid beta
GCCACGGGAT[C/T]CTGGAGGTTG S C T I I (A4) precursor-like protein 2
G1066a1 WIAF-13195 HT3538 566 CCKBR, cholecysto-
CTTTGGCACC[G/A]TCATCTGCA- A M G A V I kinin B receptor G1066a2
WIAF-13196 HT3538 607 CCKBR, cholecysto- GGGTGTCTGT[G/A]AGTGTGTCCA
S G A V V kinin B receptor G1066a3 WIAF-13206 HT3538 864 CCKBR,
cholecysto- CTGCTGCTTC[T/A]GCTCTTGTTC M T A L Q kinin B receptor
G1067u1 WIAF-12478 HT0830 684 KCNA1, potassium
AAACGCTGTG[C/T]ATCATCTGGT S C T C C voltage-gated channel, shaker-
related subfamily, member 1 (episodic ataxia with myokymia) G1067u2
WIAF-12479 HT0830 722 KCNA1, potassium GTGCGCTTCT[T/C]CGCCTGCCCC M
T C F S voltage-gated channel, shaker- related subfamily, member 1
(episodic ataxia with myo- kymia) G1067u3 WIAF-12480 HT0830 804
KCNA1, potassium ATTTCATCAC[C/C]CTCGCCACCG S C G T T voltage-gated
channel, shaker- related subfamily, member 1 (episodic ataxia with
myo- kymia) G1067u4 WIAF-12509 HT0830 690 KCNA1, potassium
TGTGCATCAT[C/T]TGGTTCTCCT S C T I I voltage-gated channel, shaker-
related subfamily, member 1 (episodic ataxia with myo- kymia)
G1068u1 WIAF-12493 HT0831 774 KCNA2, potassium
TGAACATCAT[T/A]GACATTGTGG S T A I I voltage-gated channel, shaker-
related subfamily, member 2 G1070a1 WIAF-13197 HT27728 522 KCNJ6,
potassium CACAGTGACC[T/C]GGCTCTTTTT M T C W R inwardly-rectifying
channel, subfamily J, member 6 G1070a2 WIAF-13201 HT27728 1244
KCNJ6, potassium CCCTGGAGGA[T/C]GGGTTCTACG S T C D D
inwardly-rectifying channel, subfamily J, member 6 G1070a3
WIAF-13207 HT27728 707 KCNJ6, potassium ATAAATGCCC[C/A]GACCGAATTA S
G A P P inwardly-rectifying channel, subfamily J, member 6 G1071u1
WIAF-12422 HT48672 1534 KCNJ3, potassium TTCCGGGCAA[C/T]TCAGAACAAA
S C T N N inwardly-rectifying channel, subfamily J, member 3
G1073u1 WIAF-12461 HT4556 1127 KCNJ1, potassium
CACTGTGCCA[T/C]GTGCCTTTAT M T C M T inwardly-rectifying channel,
subfamily J, member 1 G1074u1 WIAF-12462 HT27804 289 KCNAB2,
potassium ACCTCTTCGA[T/C]ACACCAGAAG S T C D D voltage-gated
channel, shaker- related subfamily, beta member 2 G1079u1
WIAF-12463 HT27383 1130 potassium channel,
ACCTGGCCGA[T/A]GAGATCCTGT M T
A D E inwardly rectifing (GB:D50582) G1079u2 WIAF-12464 HT27383
1192 potassium channel, CCTTACTCTG[T/G]GGACTACTCC M T G V G
inwardly rectifing (GB:D50582) G1079u3 WIAF-12481 HT27383 708
potassium channel, CCTTCCCTCC[A/G]TCTTCATCAA M A G I V inwardly
rectifing (GB:D50582) G1079u4 WIAF-12482 HT27383 779 potassium
channel, CGGTCATCGC[T/C]CTCCCCCACG S T C A A inwardly rectifing
(GB:D50582) G1079u5 WIAF-12483 HT27383 276 potassium channel,
GCACCCTGCC[C/A]ACCCCACCTA M G A E K inwardly rectifing (GB:D50582)
G1079u6 WIAF-12510 HT27383 489 potassium channel,
CTGCCTCATC[C/A]CCTTCCCC- CA M G A A T inwardly rectifing
(GB:D50582) G1080u1 WIAF-12536 HT4412 1099 KCNJ4, potassium
TCGACTACTC[A/G]CGTTTTCACA S A G S S inwardly rectifying channel,
subfamily J, member 4 G1080u2 WIAF-12537 HT4412 1050 KCNJ4,
potassium GGCCACCGCT[T/A]TGAGCCTGTG M T A F Y inwardly-rectifying
channel, subfamily J, member 4 G1081u1 WIAF-12538 HT27724 1090
KCNJ2, potassium GGCCACCGCT[A/T]TGAGCCTGTG M A T Y F
inwardly-rectifying channel, subfamily J, member 2 G1082u1
WIAF-12662 HT28319 768 potassium channel, CGCGGGTCAC[C/T]GACGAGGGCG
S C T T T inwardly rectify- ing, high conductance, alpha subunit
G1082u2 WIAF-12663 HT28319 854 potassium channel,
CTGGTGTCGC[C/T]CATCACCATC M C T P L inwardly rectify- ing, high
conductance, alpha subunit G1082u3 WIAF-12679 HT28319 471 potassium
channel, TCTCCATCGA[G/C]ACGCAGACCA M G C E D inwardly rectify- ing,
high conductance, alpha subunit G1084a1 WIAF-13198 HT0383 2028
KCNB1, potassium CACTCCCCAG[C/A]AAGACTCCGG M C A S R voltage-gated
channel, Shab- related subfamily, member 1 G1084a2 WIAF-13199
HT0383 2033 KCNB1, potassium CCCAGCAAGA[C/G]TGGGCGCAGC M C G T S
voltage-gated channel, Shab- related subfamily, member 1 G1084a3
WIAF-13200 HT0383 2321 KCNB1, potassium GAGTGTGCCA[C/A]GCTTTTGGAC M
C A T K voltage-gated channel, Shab- related subfamily, member 1
G1084a4 WIAF-13208 HT0383 870 KCNB1, potassium
ACAACCCCCA[G/A]CTGGCCCACG S C A Q Q voltage-gated channel, Shab-
related subfamily, member 1 G1088u1 WIAF-12516 HT0522 1503 KCNA5,
potassium TCCTGGGCAA[G/A]ACCTTCCAGC S G A K K voltage-gated
channel, shaker- related subfamily, member 5 G1088u2 WIAF-12519
HT0522 1249 KCNA5, potassium CGAGCTGCTC[G/A]TGCGCTTCTT M G A V M
voltage-gated channel, shaker- related subfamily, member 5 G1088u3
WIAF-12520 HT0522 973 KCNA5, potassium CTCTGGGTCC[G/A]CGCGGGCCAT M
G A A T voltage-gated channel, shaker- related subfamily, member 5
G1088u4 WIAF-12521 HT0522 1013 KCNA5, potassium
GTTATCCTCA[T/C]CTCCATCATC M T C I T voltage-gated channel, shaker-
related subfamily, member 5 G1090u1 WIAF-12651 HT1497 1836 KCNA5,
potassium CAACCAGCCA[G/A]TGGAGGAGGC M G A S N voltage-gated
channel, shaker- related subfamily, member 6 G1091u1 WIAF-12714
HT0222 843 KCNA3, potassium CATCATCTGG[T/C]TCTCCTTCGA M T C F L
voltage-gated channel, shaker- related subfamily, member 3 G1094a1
WIAF-13218 HT27381 1280 KCNJ8, potassium GTGTATTCTG[T/A]GGATTACTCC
M T a V E inwardly-rectifying channel, subfamily J, member 8
G1095u1 WIAF-12532 HT2629 765 KCNMA1, potassium
TTCTCTACTT[C/T]GGCTTGCGGT S C T F F large conductance
calcium-activated channel, subfamily M, alpha member 1 G1095u2
WIAF-12533 HT2629 2441 KCNMA1, potassium GTGGTCTGCA[T/C]CTTTGCCCAC
M T C I T large conductance calcium-activated channel, subfamily M,
alpha member 1 G1095u3 WIAF-12534 HT2629 2714 KCNMA1, potassium
GATGATACTT[C/C]GCTCCACCAC M C G S W large conductance
calcium-activated channel, subfamily M, alpha member 1 G1095u4
WIAF-12535 HT2629 2439 KCNMA1, potassium TCGTGGTCTG[C/T]ATCTTTGGCG
S C T C C large conductance calcium-activated channel, subfamily M,
alpha member 1 G1095u5 WIAF-12539 HT2629 3048 KCNMA1, potassium
CACTCATGAG[C/T]GCGACGTA- CT S C T S S large conductance
calcium-activated channel, subfamily M, alpha member 1 G1095u6
WIAF-12544 HT2629 2352 KCNMA1, potassium GGATGTTTCA[C/T]TGGTGTGCA-
C S C T H H large conductance calcium-activated channel, subfamily
M, alpha member 1 G1095u7 WIAF-12545 HT2629 2392 KCNMA1, potassium
CATCCTGACT[C/T]GAAGTGAAG- C N C T R * large conductance
calcium-activated channel, subfamily M, alpha member 1 G1095u8
WIAF-12546 HT2629 2295 KCNMA1, potassium CTGGCAATGA[T/C]CAGATTGAC-
A S T C D D large conductance calcium-activated channel, subfamily
M, alpha member 1 G1095u9 WIAF-12548 HT2629 2949 KCNMA1, potassium
AGTTTTTGGA[C/T]CAAGACGAT- G S C T D D large conductance
calcium-activated channel, subfamily M, alpha member 1 G1095u10
WIAF-12549 HT2629 2865 KCNMA1, potassium TGCACGGCAT[G/A]TTACGTCA-
AC M C A M I large conductance calcium-activated channel, subfamily
M, alpha member 1 G1095u1 WIAF-12547 L26318 930 PRKMB, protein
TGCTGGTAAT[A/T]CATCCATCTA S A T I I kinase mitogen activated 8 (MAP
kinase) G1098u1 WIAF-12515 L19711 2650 DAG1, dystroglycan
TCTACCTGCA[C/T]ACAGTCATTC S C T H H 1 (dystrophin- associated
glycoprotein 1) G110u1 WIAF-10385 HT27392 230 meiosis-specific
CAAAGGTATA[C/T]AGATGACAAC N C T Q * recA homolog, HsLim15 G110u2
WIAF-10397 HT27392 1050 meiosis-specific CCTGAAAATG[A/G]AGCCACCTTC
M A G E G recA homolog, HsLim15 G110u3 WIAF-10399 HT27392 674
meiosis-specific TGAACATCAG[A/G]TGGACCTACT M A G M V recA homolog,
HsLim15 G1106u1 WIAF-12647 HT5073 5781 MAP1B, microtubule-
ACTATGAGAA[G/A]ATAGACAGAA S C A K K associated protein 1B G1106u2
WIAF-12648 HT5073 5916 MAP1B, microtubule-
CTGAACAGCG[C/T]GGGTACTCAT S C T G G associated protein 1B G1106u3
WIAF-12650 HT5073 1837 MAP1B, microtubule-
AGACAAGCCA[G/A]TAAAAACAGA M G A V I associated protein 1B G1105u4
WIAF-12653 HT5073 2476 MAP1B, microtubule-
CACCACACCA[G/A]CTGTCATGGC M G A A T associated protein 1B G1106u5
WIAF-12656 HT5073 3913 MAP1B, microtubule-
GCCCAATGAG[A/C]TTAAACTCTC M A G I V associated protein 1B G1106u6
WIAF-12667 HT5073 559 MAP1B, microtubule- GATTTTCACC[G/A]ATCAAGAGAT
M G A D N associated protein 1B G1106u7 WIAF-12668 HT5073 570
MAP1B, microtubule- ATCAAGAGAT[C/T]CCGGAGTTAC S C T I I associated
protein 1B G1106u8 WIAF-12669 HT5073 6175 MAP1B, microtubule-
TACTTCCACA[T/C]ACTCTTACCA M T C Y H associated protein 1B G1106u9
WIAF-12670 HT5073 1215 MAP1B, microtubule-
TCACTCTCCA[C/C]TACCTAAACA M G C Q H associated protein 1B G1106u10
WIAF-12672 HT5073 1821 MAP1B, microtubule-
AGGTAATGGT[G/A]AAAAAAGACA S G A V V associated protein 1B G1106u11
WIAF-12673 HT5073 2727 MAP1B, microtubule-
CTCCTGCCGA[G/T]TCCCCTGATG M G T E D associated protein 1B G1106u12
WIAF-12674 HT5073 2739 MAP1B, microtubule-
CCCCTCATGA[G/A]GGAATCACTA S G A E E associated protein 1B G1106u13
WIAF-12676 HT5073 3643 MAP1B, microtubule-
ACATGCCACT[C/A]ATCCCAAGCA M G A D N associated protein 1B G1106u14
WIAF-12677 HT5073 3609 MAP1B, microtubule-
CACCCCTCAA[C/T]CCATTTTCTG S C T N N associated protein 1B G1106u15
WIAF-12682 HT5073 4752 MAP1B, microtubule-
TTCCACACCC[A/T]ACAACAGATG S A T p p associated protein 1B G1110u1
WIAF-12517 HT1096 1527 myelin associated GCCCCCTCGT[G/C]CTCACCAGCA
S G C V V glycoprotein G1110u2 WIAF-12518 HT1096 1678 myelin
associated TGTGCGCCCC[G/T]TGGTCGCCTT M G T V L glycoprotein G1110u3
WIAF-12522 HT1096 1271 myelin associated GCCGTGTCAC[C/T]CCACGATGAT
M C T P L glycoprotein G1113u1 WIAF-12523 HT2242 353 myelin
transcrip- AATTCCGATC[C/T]GATCCTCA- CC M C T R L tion factor 1
G1116a1 WIAF-13217 HT28451 417 myelin oligodendro-
CAACCTTATC[G/A]ACACCCTCTC S G A S S cyte glycoprotein (MOG) G1116a2
WIAF-13219 HT28451 913 myelin oligodendro-
GCAGATCACT[C/G]TTGGCCTCGT M C G L V cyte glycoprotein (MOG) G1116a3
WIAF-132201 HT28451 922 myelin oligodendro-
TCTTGGCCTC[G/A]TCTTCCTCTG M G A V I cyte glycoprotein (MOG) G1120u1
WIAF-12525 HT3695 1200 neurofilament, TAGAGATAGC[T/C]GCTTACAGAA S T
C A A subunit H G1123u1 WIAF-12542 HT2569 2269 OMG, oligodendro-
CAGCTGCAAC[T/C]CTAACTATT- C S T C T T cyte myelin glycoprotein
G1126u1 WIAF-12526 HT28354 626 PSEN2, presenilin 2
GAGCGAAGCA[T/C]GTGATCATGC S T C H H (Alzheimer disease 4) G1126u2
WIAF-12527 HT28354 494 PSEN2, presenilin 2
ATGGAGAGAA[T/C]ACTGCCCAGT S T C N N (Alzheimer disease 4) G1126u3
WIAF-12528 HT28354 434 PSEN2, presenilin 2
TAATGTCGGC[C/T]GAGAGCCCCA S C T A A (Alzheimer disease 4) G1126u4
WIAF-12543 HT28354 550 PSEN2, presenilin 2
GACCCTGACC[G/A]CTATGTCTGT M G A R H (Alzheimer disease 4) G117u1
WIAF-10391 HT27765 156 GTBP, G/T mismatch-
ACTTCTCACC[A/G]GGAGATTTGG S A G P P binding protein G117u2
WIAF-10392 HT27765 420 GTBP, G/T mismatch-
AACGTGCAGA[T/C]GAAGCCTTAA S T C S S binding protein G117u3
WIAF-10407 HT27765 939 GTBP, G/T mismatch-
CCCACGTTAG[T/C]GGAGGTGGTG S T C S S binding protein G117u4
WIAF-10411 HT27765 1622 GTBP, G/T mismatch- binding protein
CATTGTTCGA[G/A]ATTTAGGACT M G A R K G117u5 WIAF-10412 HT27765 2405
GTBP, G/T mismatch- GACAGCAGGG[C/T]TATAATGTAT M C T A V binding
protein G117u6 WIAF-10413 HT27765 2387 GTBP, G/T mismatch-
AAGAGTCAGA[A/T]CCACCCAGAC M A T N I binding protein G125u1
WIAF-10371 HT28632 1999 ATM, ataxia CAGTAATTTT[C/T]CTCATCTTGT M C T
P S telangiectasia mutated (includes complementation groups A, C
and D) G125u2 WIAF-10372 HT28632 2631 ATM, ataxia
TAATGAATGA[C/A]ATTGCAGATA M C A D E telangiectasia mutated
(includes complementation groups A, C and D) G125u3 WIAF-10373
HT28632 3084 ATM, ataxia CAATGGAAGA[T/G]GTTCTTGAAC M T G D E
telangiectasia mutated (includes complementation groups A, C and D)
G125Su5 WIAF-10375 HT28632 4767 ATM, ataxia
CACTTATACC[C/T]CTTGTGTATG S C T P P telangiectasia mutated
(includes complementation groups A, C and D) G125u6 WIAF-10383
HT28632 8713 ATM, ataxia ATTCTTGGAT[C/T]CAGCTATTTG M C T P S
telangiectasia mutated (includes complementation groups A, C and D)
G125u7 WIAF-10396 HT28632 1825 ATM, ataxia
CACTTTGGCA[C/G]TGACCACCAG M C G L V telangiectasia mutated
(includes complementation groups A, C and D) G125u8 WIAF-10398
HT28632 2924 ATM, ataxia ACTACTGCTC[A/G]GACCAATACT M A G Q R
telangiectasia mutated (includes complementation groups A, C and D)
G125u9 WIAF-10405 HT28632 8967 ATM, ataxia
TTCAACGTGT[C/T]TTCACAAGAT S C T V V telangiectasia mutated
(includes complementation groups A, C and D) G125u10 WIAF-10408
HT28632 6954 ATM, ataxia CCAAACACCT[T/C]GTACAACTCT S T C L L
telangiectasia mutated (includes complementation groups A, C and D)
G125u11 WIAF-10409 HT28632 6855 ATM, ataxia
TTCACCACCC[T/C]ATCATCGCTC S T C P P telangiectasia mutated
(includes complementation groups A, C and D) G125u12 WIAF-10410
HT28632 6801 ATM, ataxia TATATATTAA[G/T]TGGCAGAAAC M G T K N
telangiectasia mutated (includes complementation groups A, C and D)
G125u13 WIAF-10421 HT28632 335 ATM, ataxia
CATTCAGATT[C/C]CAAACAAGCA M C G S C telangiectasia mutated
(includes complementation groups A, C and D) G125u14 WIAF-11607
HT28632 3966 ATM, ataxia TTCCACATCT[C/A]GTCATTAGAA S G A L L
telangiectasia mutated (includes complementation groups A, C and D)
G125a15 WIAF-13130 HT28632 8642 ATM, ataxia
CAGAAATATC[A/C]ACTCTTCATG M A C E A telangiectasia mutated
(includes complementation groups A, C and D) G136u1 WIAF-10388
HT3337 535 MLH1, mutL AGGAGAAAAG[C/T]TTTAAAAAAT M C T A V (E. coli)
homolog 1 (colon cancer, non- polyposis type 2) G136u2 WIAF-10389
HT3337 769 MLH1, mutL TTCAAAATGA[A/G]TGGTTACATA M A G N S (E. coli)
homolog 1 (colon cancer, non- polyposis type 2) G144u1 WIAF-11638
HT3625 1129 FOS, v-fos FBJ CCTCTGCACT[C/T]CGGTCGTCAC M C T P S
murine osteo- sarcoma viral oncogene homolog G1461u1 WIAF-12562
HT0329 684 pRB-binding protein TTGCCAAGAA[C/A]TCCAAGAACC S G A K K
G1466u1 WIAF-12571 HT27849 2128 API2, apoptosis
ATGATCCATG[G/C]GTAGAACATG M G C W C inhibitor 2 G1468u1 WIAF-12563
HT4986 1928 apoptosis CCACCAGACC[A/T]GACGAGGGGC S A T P P
inhibitor, neuronal G1468u2 WIAF-12564 HT4986 3057 apoptosis
TTTGCAATTC[C/C]TTCAAGGGAG M C G L V inhibitor, neuronal G1472u1
WIAF-12565 HT28478 242 BAK1, BCL2- GGCACCAGTC[C/T]GGAGAGCCTG S C T
C C antagonist/killer 1 G1472u2 WIAF-12572 HT28478 509 BAK1, BCL2-
TGCACCCCAC[G/A]GCAGAGAATG S G A T T antagonist/killer 1 G1473u1
WIAF-12568 HT28606 394 CASP6, caspase 6, GGTGTCAACT[G/C]TTAGCCACGC
M G C V L apoptosis-related cysteine protease G1473u2 WIAF-12576
HT28606 411 CASP6, caspase 6, ACGCAGATGC[C/T]GATTGCTTTG S C T A A
apoptosis related cysteine protease G1479u1 WIAF-12550 Y09077 711
ATR, ataxia ACTTTATTAA[T/C]GGTTCTTACT M T C M T telangiectasis and
Rad3 related G1479u2 WIAF-12551 Y09077 4303 ATR, ataxia
TTGCGTATGC[T/C]GATAATAGCC S T C A A telangiectasia and Rad3 related
G1479u3 WIAF-12552 Y09077 1894 ATR, ataxia
ATTCTGATGA[T/C]CCCTGTTTAA S T C D D telangiectasia and Rad3 related
G1479u4 WIAF-12553 Y09077 1855 ATR, ataxia
ATTTATGTGG[T/A]ATGCTCTCAC S T A G G telangiectasia and Rad3 related
G1479u5 WIAF-12558 Y09077 5287 ATR, ataxia
TCATTCATTA[T/C]CATGGTCTAG S T C Y Y telangiectasia and Rad3 related
G1479u6 WIAF-12559 Y09077 5539 ATR, ataxia CAGCTTTTTA[T/C]GACTCACT-
GA S T C Y Y telangiectasia and Rad3 related G1479u7 WIAF-12569
Y09077 1540 ATR, ataxia ATCCTGTTAT[T/C]GAGATGTTAG S T C I I
telangiectasia and Rad3 related G1479u8 WIAF-12570 Y09077 2521 ATR,
ataxia ATTTAATGGA[A/C]GATCCAGACA S A G E E telangiectasia and
Rad3 related G1482u1 WIAF-12560 HT27870 3176 BLM, Bloom syndrome
AAAATATAAC[G/A]GAATCCAGGA S G A T T G1482u2 WIAF-12561 HT27870 3605
BLM, Bloom syndrome GAAATAAAGC[C/A]CAAACTGTAC S C A A A G1482u3
WIAF-12573 HT27870 2677 BLM, Bloom syndrome
TATCTATTAC[C/T]GAAAAACCCT M C T P L G1483u1 WIAF-12597 HT1470 1910
MYBL2, v-myb avian GGATGAGGAT[C/A]TGAAGCTGAT M G A V M
myeloblastosis viral oncogene homolog-like 2 G14B3u2 WIAF-12610
HT1470 244 MYBL2, v-myb avian ATGAGGAGGA[C/T]GAGCAGCTGA S C T D D
myeloblastosis viral oncogene homolog-like 2 G1483u3 WIAF-12611
HT1470 1406 MYBL2, v-myb avian CACTCAGAAT[A/G]GCACCAGTCT M A G S G
myeloblastosis viral oncogene homolog-like 2 G1485u1 WIAF-12581
HT1432 1941 BCR, breakpoint TGGAGATGAG[A/G]AAATGGGTCC S A G R R
cluster region G1485u2 WIAF-12582 HT1432 3144 BCR, breakpoint
TGACCATCAA[T/C]AAGGAAGATG S T C N N cluster region G1485u3
WIAF-12583 HT1432 3777 BCR, breakpoint ATAACAAGGA[T/C]GTGTCGGTGA S
T C D D cluster region G1485u4 WIAF-12603 HT1432 2831 BCR,
breakpoint CAGATCAAGA[C/A]TGACATCCAG M G A S N cluster region
G1485u5 WIAF-12608 HT1432 4217 BCR, breakpoint
ATCCCTGCCC[C/T]GGACAGCAAG M C T P L cluster region G1486u1
WIAF-12578 HT33770 1909 BRCA2, breast ATTGATAATG[G/A]AAGCTGGC- CA M
G A G E cancer 2, early onset G1486u2 WIAF-12579 HT33770 3623
BRCA2, breast AGTTTAGAAA[A/G]CCAAGCTACA S A G K K cancer 2, early
onset G1486u3 WIAF-12586 HT33770 1341 BRCA2, breast
AAATGTAGCA[A/C]ATCAGAAGCC M A C N H cancer 2, early onset G1486u4
WIAF-12594 HT33770 446 BRCA2, breast CTTATAATCA[G/A]CTGGCTTCAA S G
A Q Q cancer 2, early onset G1486u5 WIAF-12598 HT33770 3013 BRCA2,
breast ACCATGGTTT[T/C]ATATGGAGAC M T C L S cancer 2, early onset
G1486u6 WIAF-12599 HT33770 3187 BRCA2, breast
GAAAAAAATA[A/T]TGATTACATG M A T N I cancer 2, early onset G1486u7
WIAF-12604 HT33770 4971 BRCA2, breast AGCATGTGAG[A/C]CCATTGAGAT M A
C T P cancer 2, early onset G1486u8 WIAF-12607 HT33770 4034 BRCA2,
breast ATGATTCTGT[C/T]GTTTCAATGT S C T V V cancer 2, early onset
G1487u1 WIAF-12584 HT27632 2536 BRCA1, breast
AGTCAGTGTG[C/G]AGCATTTGAA M C G A G cancer 1, early onset G1487u2
WIAF-12587 HT27632 4697 BRCA1, breast CATCTCAAGA[G/C]GAGCTCATTA M G
C E D cancer 1, early onset G1487u3 WIAF-12595 HT27632 469 BRCA1,
breast TCTCCTGAAC[A/G]TCTAAAAGAT M A G H R cancer 1, early onset
G1487u4 WIAF-12600 HT27632 3667 BRCA1, breast
AGCGTCCAGA[A/G]AGGAGAGCTT M A G K R cancer 1, early onset G1487u5
WIAF-12601 HT27632 3537 BRCA1, breast TATGGGAAGT[A/G]GTCATGCATC M A
G S G cancer 1, early onset G1487u6 WIAF-12602 HT27632 4956 BRCA1,
breast ATCTGCCCAG[A/G]GTCCAGCTGC M A G S G cancer 1, early onset
G1487u7 WIAF-12605 HT27632 2090 BRCA1,breast
AGTACAACCA[A/G]ATGCCAGTCA S A G Q Q cancer 1, early onset G1487u8
WIAF-12614 HT27632 233 BRCA1,breast TCTCCACAAA[G/A]TGTGACCACA S G A
K K cancer 1, early onset G1492u1 WIAF-12585 HT3506 3912 cell
death- TCCAGGTCCG[T/C]GGCCTGGAGA S T C R R associated kinase
G1492u2 WIAF-12593 HT3506 4352 cell death-
TACAACACCA[A/G]TAACGGGGCT M A G N S associated kinase G1492u3
WIAF-12606 HT3506 2127 cell death- GCAATTTGGA[C/T]ATCTCCAACA S C T
D D associated kinase G1492u4 WIAF-12612 HT3506 1605 cell death-
TCAAATTTCT[C/T]ACTGACAA- CA S C T L L associated kinase G1494u1
WIAF-12589 HT28507 366 cell death-inducing
TTCACCACAC[T/C]TAAGGAGAAC M T C L P protein Bik G1495u1 WIAF-12580
HT27803 759 CSE1L, chromosome TTTCTTCCCT[G/C]ATCCTGATCT S G C L L
segregation 1 (yeast homolog)- like G1501u1 WIAF-13502 HT1949 1181
MCC, mutated in CAGCAATGAC[A/C]TTCCCATCGC M A C I L colorectal
cancers G1501u2 WIAF-13503 HT1949 1753 MCC, mutated in
CAGCTGAGAA[C/T]GCTGCCAAGG S C T N N colorectal cancers G1501u3
WIAF-13504 HT1949 2344 MCC, mutated in TGTCCCTAGC[T/C]GAACTCAGGA S
T C A A colorectal cancers G1501u4 WIAF-13521 HT1949 445 MCC,
mutated in AGCGAACGAC[G/A]CTTCGCTATG S G A T T colorectal cancers
G1501u5 WIAF-13522 HT1949 1504 MCC, mutated in
AAAGCAATGC[T/C]GAGAGGATGA S T C A A colorectal cancers G1501u6
WIAF-13527 HT1949 2511 MCC, mutated in TTCGTGAATG[A/G]TCTAAAGCGG M
A G D G colorectal cancers G1502u1 WIAF-12633 HT1547 870 CCND1,
cyclin D1 AGTGTGACCC[A/G]GACTGCCTCC S A G P P (PRAD1: para- thyroid
adeno- matosis 1) G1503u1 WIAF-13741 U37022 1151 CDK4, cyclin-
CATGCCAATT[G/A]CATCGTTCAC M G A C Y dependent kinase 4 G1503u2
WIAF-13742 U37022 1410 CDK4, cyclin- CTGAAGCCCA[C/T]CAGTTGGGCA S C
T D D dependent kinase 4 G1503u3 WIAF-13743 U37022 1328 CDK4,
cyclin- TATGCAACAC[C/T]TGTGGACATG M C T P L dependent kinase 4
G1503u4 WIAF-13780 U37022 1194 CDK4, cyclin-
TTCTGGTCAC[A/G]AGTGGTCCAA S A G T T dependent kinase 4 G1503u5
WIAF-13781 U37022 1443 CDK4, cyclin- TGATTGGGCT[G/A]CCTCCAGAGG S G
A L L dependent kinase 4 G1503u6 WIAF-13787 U37022 1633 CDK4,
cyclin- CTCTTATCTA[C/T]ATAAGGATGA M C T H Y dependent kinase 4
G1517u1 WIAF-12618 HT1132 3894 ERBB3, v-erb-b2
CAGACCTCAG[T/C]GCCTCTCTGG S T C S S avian erythro- blastic leukemia
viral oncogene homolog 3 G152u1 WIAF-11608 HT3854 1673 HSPA1L, heat
shock GTGAGTGATG[A/C]AGGTTTCAAG M A C E A 70 kD protein like 1
G152u2 WIAF-11629 HT3854 1683 HSPA1L, heat shock
AAGGTTTGAA[G/A]GGCAAGATTA S G A K K 70 kD protein like 1 G152u3
WIAF-11609 HT3854 1478 HSPA1L, heat shock GTCACAGCCA[C/T]GGACAAGAGC
M C T T M 70 kD protein like 1 G152u4 WIAF-11610 HT3854 1443
HSPA1L, heat shock TGACGTTTCA[C/T]ATTGATGCCA S C T D D 70 kD
protein like 1 G1520u1 WIAF-12162 HT1175 2211 DNA excision repair
TGACCGTGGA[C/T]GAGGGTGTCC S C T D D protein ERCC2, 5' end G1520u2
WIAF-12166 HT1175 546 DNA excision repair CCCACTGCCG[A/C]TTCTATGAGG
S A C R R protein ERCC2, 5' end G1527u1 WIAF-12168 HT0086 577
GSTM2, glutathione TCATCTCCCG[A/C]TTTGAGGGCT S A C R R
S-transferase M2 (muscle) G1527u2 WIAF-12169 HT0086 644 GSTM2,
glutathione ACCTGTGTTC[A/T]CAAAGATGGC M A T T S S-transferase M2
(muscle) G1527u3 WIAF-12171 HT0086 100 GSTM2, glutathione
ACTCAAGCTA[C/T]GAGGAAAAGA S C T Y Y S-transferase M2 (muscle)
G1527u4 WIAF-12172 HT0086 41 GSTM2, glutathione
GGGGTACTGG[A/G]ACATCCGCGG M A G N D S-transferase M2 (muscle)
G1527u5 WIAF-12173 HT0086 215 GSTM2, glutathione
GATTGATGGG[A/G]CTCACAAGAT M A G T A S-transferase M2 (muscle)
G1527u6 WIAF-12194 HT0086 238 GSTM2, glutathione
CCCAGAGCAA[T/C]GCCATCCTGC S T C N N S-transferase M2 (muscle)
G1528u1 WIAF-11950 HT1811 529 GSTM3, glutathione
GTATATTTGA[C/G]CCCAAGTGC- C M C G D E S-transferase M3 (brain)
G1528u2 WIAF-11951 HT1811 674 GSTM3, glutathione
CAACAAGCCT[C/A]TATGCTGAG- C M G A V I S-transferase M3 (brain)
G1528u3 WIAF-11989 HT1811 572 GSTM3, glutathione
GGCTTTCATG[T/C]GCCGTTTTG- A M T G C G S-transferase M3 (brain)
G1528u4 WIAF-13470 HT1811 240 GSTM3, glutathione
CAGAGCAATG[C/A]CATCTTGCG- C M C A A D S-transferase M3 (brain)
G1529u1 WIAF-14146 HT2006 797 GSTM4, glutathione
TGGACGCCTT[C/T]CCAAATCTG- A S C T F F S-transferase M4 G153u1
WIAF-12163 HT3856 1212 HSPA1B, heat shock TGGGGCTGGA[G/A]ACGGCCGGAG
S G A E E 70 kD protein 1 G153u2 WIAF-12182 HT3856 676 HSPA1B, heat
shock GGCCGGGGAC[A/G]CCCACCTGGG M A G T A 70 kD protein 1 G153u3
WIAF-12183 HT3856 1695 HSPA1B, heat shock TCAGCGAGGC[C/G]GACAAGAAGA
S C G A A 70 kD protein 1 G153u4 WIAF-12189 HT3856 330 HSPA1B, heat
shock ACAAGGGGGA[G/C]ACCAAGGCAT M G C E D 70 kD protein 1 G153u5
WIAF-12190 HT3856 1053 HSPA1B, heat shock AGCTGCTGCA[A/G]GACTTCTTCA
S A G Q Q 70 kD protein 1 G1530u1 WIAF-11964 HT3010 673 GSTM5,
glutathione ATTCCTCCGA[G/A]GTCTTTTGTT M G A G S S-transferase M5
G1530u2 WIAF-11995 HT3010 593 GSTM5, glutathione
GACGCCTTCC[T/C]AAACTTGAAG M T C L P S-transferase M5 G1530u3
WIAF-13473 HT3010 693 GSTM5, glutathione TTGGAAAGTC[A/G]GCTACATGGA
S A G S S S-transferase M5 G1533u1 WIAF-13458 HT27460 543 GSTT2,
glutathione CTCTCGGCTA[C/T]GAACTGTTTG S C T Y Y S-transferase theta
2 G1533u2 WIAF-13460 HT27460 417 GSTT2, glutathione
GGACTGCCAT[G/A]GACCAGGCCC M G A M I S-transferase theta 2 G1533u3
WIAF-13461 HT27460 359 GSTT2, glutathione CAGGTGTTGG[G/A]GCCACTCATT
M G A G E S-transferase theta 2 G1533u4 WIAF-13462 HT27460 363
GSTT2, glutathione TGTTGGGGCC[A/C]CTCATTGGGG S A C P P
S-transferase theta 2 G1533u5 WIAF-13463 HT27460 385 GSTT2,
glutathione CCAGGTGCCC[G/A]AGGAGAAGGT M G A E K S-transferase theta
2 G1535u1 WIAF-11952 HT0436 517 HCK, hemopoietic
CCGCGTTGAC[T/C]CTCTGGACAC M T C S P cells kinase G1535u2 WIAF-12013
HT0436 783 HCK, hemopoietic TGGACCACTA[C/T]AAGAAGGGG- A S C T Y Y
cells kinase G1535u3 WIAF-13464 HT0436 357 HCK, hemopoietic
TCATCGTGGT[T/C]GCCCTGTATG S T C V V cells kinase G1535u4 WIAF-13465
HT0436 387 HCK, hemopoietic CCATTCACCA[C/T]GAAGACCTCA S C T H H
cells kinase G1535u5 WIAF-13466 HT0436 471 HCK, hemopoietic
CCCTGGCCAC[C/G]CGGAAGGACG S C G T T cells kinase G1535u6 WIAF-13467
HT0436 240 HCK, hemopoietic CCAGCGCCAG[C/T]CCACACTCT- C S C T S S
cells kinase G1535u7 WIAF-13468 HT0436 394 HCK, hemopoietic
CCACGAAGAC[C/T]TCAGCTTCCA M C T L F cells kinase G1537u1 WIAF-12020
U04045 1514 MSH2, mutS GTGAATTAAG[A/C]GAAATAATCA S A G R R (E.
coli) homolog 2 (colon cancer, non- polyposis type 1) G1537u2
WIAF-12044 U04045 599 MSH2, mutS GACTGTGTGA[A/T]TTCCCTGATA M A T E
D (E. coli) homolog 2 (colon cancer, non- polyposis type 1) G1537u3
WIAF-12045 U04045 1452 MSH2, mutS AGATATGGAT[C/T]AGGTGGAAAA N C T Q
* (E. coli) homolog 2 (colon cancer, non- polyposis type 1) G1537u4
WIAF-12076 U04045 938 MSH2, mutS GACACTTTGA[A/T]CTGACTACTT M A T E
D (E. coli) homolog 2 (colon cancer, non- polyposis type 1) G1537u5
WIAF-12077 U04045 1878 MSH2, mutS TCAGCTAGAT[G/A]CTGTTGTCAG M G A A
T (E. coli) homolog 2 (colon cancer, non- polyposis type 1) G1543u1
WIAF-13856 J00119 553 MOS, v-mos Moloney GAGTTTCTGG[G/T]CTGAGCTCA-
A M G T A S murine sarcoma viral oncogene homolog G1543u2
WIAF-13857 J00119 621 MOS, v-mos Moloney GCACGCGCAC[G/A]CCCGCAGGGT
S G A T T murine sarcoma viral oncogene homolog G1544u1 WIAF-12018
U59464 3821 PTCH, patched CATCCCGAAT[C/T]CAGGCATCAC M C T S F
(Drosophila) homolog G1544u2 WIAF-12019 U59464 3618 PTCH, patched
GCGTGGTCCG[C/T]TTCGCCATGC S C T R R (Drosophila) homolog G1544u3
WIAF-12027 U59464 1761 PTCH, patched ATTTTGCCAT[G/T]GTTCTGCTCA M G
T M I (Drosophila) homolog G1544u4 WIAF-12029 U59464 4074 PTCH,
patched CTGCCATGGG[C/T]AGCTCCGTGC S C T G G (Drosophila) homolog
G1544u5 WIAF-12043 U59464 3845 PTCH, patched
CCCTCGAACC[C/T]GAGACAGCAG M C T P L (Drosophila) homolog G1544u6
WIAF-12056 U59464 1433 PTCH, patched CTGCTGGTTG[C/T]ACTGTCAGTG M C
T A V (Drosophila) homolog G1544u7 WIAF-12058 U59464 3298 PTCH,
patched CACCGTTCAC[G/C]TTGCTTTGGC M G C V L (Drosophila) homolog
G1544u8 WIAF-12062 U59464 3986 PTCH, patched
TCTACTGAAG[G/A]GCATTCTGGC M G A G E (Drosophila) homolog G1544u9
WIAF-13489 U59464 1665 PTCH, patched CCATCAGCAA[T/C]GTCACAGCCT S T
C N N (Drosophila) homolog G1544u10 WIAF-13490 U59464 2396 PTCH,
patched AAATACTTTT[C/T]TTTCTACAAC M C T S F (Drosophila) homolog
G1544u11 WIAF-13491 U59464 2199 PTCH, patched
GGACACTCTC[A/G]TCTTTTGCTG S A G S S (Drosophila) homolog G1544u12
WIAF-13492 U59464 2222 PTCH, patched AAGCACTATG[C/T]TCCTTTCCTC M C
T A V (Drosophila) homolog G1544u13 WIAF-13500 U59464 1686 PTCH,
patched TCTTCATGGC[C/T]GCGTTAATCC S C T A A (Drosophila) homolog
G1545u1 WIAF-12032 HT0473 1835 RAG1, recombina-
GGACATGGAA[G/A]AAGACATCTT M G A E K tion activating gene 1 G1545u2
WIAF-12035 HT0473 2519 RAG1, recombina- TGACATTGGC[A/G]ATGCAGCTGA M
A G N D tion activating gene 1 G1545u3 WIAF-12046 HT0473 3045 RAG1,
recombina- CGGAAAATGA[A/G]TGCCAGGCAG M A G N S tion activating gene
1 G1545u4 WIAF-12047 HT0473 3146 RAG1, recombina-
TCATAATGCA[T/C]TAAAAACCTC S T C L L tion activating gene 1 G1545u5
WIAF-12075 HT0473 2513 RAG1, recombina- CCACTGTGAC[A/T]TTGGCAATGC M
A T I F tion activating gene 1 G1545u6 WIAF-13484 HT0473 1322 RAG1,
recombina- GTCGCTGACT[C/T]GGAGAGCTCA M C T R W tion activating gene
1 G1545u7 WIAF-13494 HT0473 2571 RAG1, recombina-
GAAGTGTATA[A/C]GAATCCCAAT M A G K R tion activating gene 1 G1545u8
WIAF-13498 HT0473 1018 RAG1, recombina- TTCTGGCTGA[C/A]CCTGTGGAGA M
C A D E tion activating gene 1 G1545u9 WIAF-13499 HT0473 2782 RAG1,
recombina- ATCTTTACCT[G/C]AAGATGAAAC S G C L L tion activating gene
1 G1548u1 WIAF-12015 HT4999 133 IF127, interferon,
CTCTGCCGTA[G/A]TTTTGCCCCT M G A V I alpha-inducible protein 27
G1548u2 WIAF-13482 HT4999 380 IFI27, interferon,
ATCCTGGGCT[C/T]CATTGGGTCT M C T S F alpha-inducible protein 27
G1548u3 WIAF-13483 HT4999 135 IF127, interferon,
CTGCCGTAGT[T/C]TTGCCCCTGG S T C V V alpha-inducible protein 27
G155u1 WIAF-11634 HT3962 991 CHCl, chromosome
AGCTGGATGT[G/A]CCTGTGGTAA S G A V V condensation 1 G155u2
WIAF-11635 HT3962 1271 CHCl, chromosome CGGCTTCGGC[C/T]TCTCCAACTA M
C T L F condensation 1 G155u3 WIAF-11636 HT3962 1192 CHCl,
chromosome GCCGGGGCCA[C/T]GTGAGATTCC S C T H H condensation 1
G155u4 WIAF-11637 HT3962 1267 CHCl, chromosome
TGTACGGCTT[C/T]GGCCTCTCCA S C T F F condensation 1 G155u5
WIAF-11649 HT3962 1657 CHCl, chromosome TGATGGGCAA[A/G]CAGCTGGAGA S
A G K K condensation 1 G1550u1 WIAF-12057 M16038 611 LYN, v-yes-1
Yama- GCAAAGTCCC[T/G]TTTAACAAAA M T G L R guchi sarcoma viral
related oncogene homolog G1550u2 WIAF-12061 M16038 1371 LYN,
v-yes-1 Yama- TGGCATACAT[C/T]GAGCGGAAGA S C T I I guchi sarcoma
viral related oncogene homolog G1550u3 WIAF-12080 M16038 1059 LYN,
v-yes-1 Yama- AAAGGCTTGG[C/T]GCTGGGCAGT S C T G G guchi sarcoma
viral related oncogene homolog G1550u4 WIAF-12081 M16038 996 LYN,
v-yes-1 Yama- AGCCACAGAA[G/A]CCATGGGATA S G A
K K guchi sarcoma viral related oncogene homolog G1552u1 WIAF-12030
HT4578 2355 PMS1, postmeiotic CCTGCTATTT[A/T]AAAGACTTCT N A T K *
segregation increased (S. cerevisiae) 1 G1552u2 WIAF-12031 HT4578
2231 PMS1, postmeiotic segregation ACAAAGTTGA[C/T]TTAGAAGAGA S C T
D D increased (S. cerevisiae) 1 G1552u3 WIAF-12040 HT4578 617 PMS1,
postmeiotic TCATGAGCTT[T/C]GGTATCCTTA S T C F F segregation
increased (S. cerevisiae) 1 G1552u4 WIAF-12063 HT4578 1723 PMS1,
postmeiotic TCATGTAACA[A/C]AAAATCAAAT M A G K R segregation
increased (S. cerevisiae) 1 G1552u5 WIAF-12064 HT4578 1732 PMS1,
postmeiotic AAAAAATCAA[A/G]TGTAATAGAT M A G N S segregation
increased (S. cerevisiae) 1 G1552u6 WIAF-12065 HT4578 1660 PMS1,
postmeiotic TTACCATGTA[A/G]AGTAAGTAAT M A G K R segregation
increased (S. cerevisiae) 1 G1552u7 WIAF-12066 HT4578 1975 PMS1,
postmeiotic GAACGATACA[A/G]TAGTCAAATG M A G N S segregation
increased (S. cerevisiae) 1 G1552u8 WIAF-12067 HT4578 1881 PMS1,
postmeiotic TTTAGAGGAT[G/T]CAACACTACA M G T A S segregation
increased (S. cerevisiae) 1 G1552u9 WIAF-12068 HT4578 2454 PMS1,
postmeiotic TTTAGACGTT[T/A]TATATAAAAT M T A L I segregation
increased (S. cerevisiae) 1 G1552u10 WIAF-12069 HT4578 2457 PMS1,
postmeiotic AGACGTTTTA[T/C]ATAAAATGAC M T C Y H segregation
increased (S. cerevisise) 1 G1552u11 WIAF-12082 HT4578 2557 PMS1,
postmeiotic ATACCAGGAC[T/C]TTCAATTACT M T C V A segregation
increased (S. cerevisiae) 1 G1552u12 WIAF-12083 HT4578 971 PMS1,
postmeiotic segregation TTTTCTTTCT[G/T]AAAATCGATG S G T L L
increased (S. cerevisiae) 1 G1554u1 WIAF-12028 HT4161 1500 ELK3,
ELK3, ETS- CTCAGAAATC[C/T]TGATGACCTC S C T S S domain protein (SRF
accessory protein 2) NOTE: Symbol and name provisional. G1554u2
WIAF-12059 HT4161 1380 ELK3, ELK3, ETS- CTGCCAGGCT[G/A]CAAGGGCCAA S
G A L L domain protein (SRF accessory protein 2) NOTE: Symbol and
name provisional. G1554u3 WIAF-12060 HT4161 1436 ELK3, ELK3, ETS-
CACATGCCAG[T/C]GCCAATCCCC M T C V A domain protein (SRF accessory
protein 2) NOTE: Symbol and name provisional. G1562u1 WIAF-12024
HT28220 804 PDCD1, programmed GGGGCTCAGC[T/C]GACGGCCCT- C S T C A A
cell death 1 G1562u2 WIAF-13488 HT28220 644 PDCD1, programmed
GACCCCTCAG[C/T]CGTGCCTCTG M C T A V cell death 1 G1563u1 WIAF-13493
HT1187 1748 EGFR, epidermal CCGGAGCCCA[G/A]GGACTGCGTC M G A R K
growth factor receptor (avian erythroblastic leukemia viral
(v-erb-b) oncogene homolog) G1563u2 WIAF-13497 HT1187 2073 EGFR,
epidermal ACGGATGCAC[T/A]GGGCCAGGTC S T A T T growth factor
receptor (avian erythroblastic leukemia viral (v-erb-b) oncogene
homolog) G1566u1 WIAF-12016 HT27594 235 PDCD2, programmed
GCGCCGCTGC[C/G]TGGCCGCCCG M C G P R cell death 2 G1566u2 WIAF-12033
HT27594 904 PDCD2, programmed TTGGAATTCC[A/G]GGTCATGCCT M A G Q R
cell death 2 G1566u3 WIAF-12041 HT27594 331 PDCD2, programmed
AATCAACTAC[C/T]CAGGAAAAAC M C T P L cell death 2 G1566u4 WIAF-12071
HT27594 649 PDCD2, programmed CCTGAGGTTG[T/C]GGAAAAGGAA M T C V A
cell death 2 G1566u5 WIAF-12072 HT27594 633 PDCD2,programmed
AGAAGATGAG[A/T]TTATGCCT- GA M A T I F cell death 2 G1567u1
WIAF-12042 M95936 293 AKT2, v-akt murine GAGAGGCCGC[G/A]ACCCAACACC
M G A R Q thymoma viral oncogene homolog 2 G1572u1 WIAF-12212
HT3998 1894 proto-oncogene c- TGTTCCAGGA[A/G]TCCAGTATCT S A G E E
abl, tyrosine protein kinase, alt. transcript 2 G1572u2 WIAF-12233
HT3998 3694 proto-oncogene c- AGCTTCAGAT[C/T]TGCCCGGCGA S C T I I
abl, tyrosine protein kinase, alt. transcript 2 G1572u3 WIAF-12234
HT3998 3721 proto-oncogene c- GCAGTGGTCC[G/A]GCGGCCACTC S G A P P
abl, tyrosine protein kinase, alt. transcript 2 G1573u1 WIAF-12021
HT0642 343 CBL, Cas-Br-M TCATGGACAA[G/C]CTGGTGCGGT M G C K N
(murine) ecotropic retroviral transforming sequence G1573u2
WIAF-12022 HT0642 363 CBL, Cas-Br-M TTGTGTCAGA[A/T]CCCAAAGCTG M A T
N I (murine) ecotropic retroviral transforming sequence G1573u3
WIAF-12034 HT0642 2364 CBL, Cas-Br-M AATATTCAGT[C/T]CCAGGCGCCA M C
T S P (murine) ecotropic retroviral transforming sequence G1573u4
WIAF-12049 HT0642 387 CBL, Cas-Br-M CTAAAGAATA[G/A]CCCACCTTAT M G A
S N (murine) ecotropic retroviral transforming sequence G1573u5
WIAF-12050 HT0642 947 CBL, Cas-Br-M AACTCATCCT[G/A]GCTACATGGC M G A
G S (murine) ecotropic retroviral transforming sequence G1573u6
WIAF-12070 HT0642 2740 CBL, Cas-Br-M TCGAGAACCT[C/T]ATGAGTCAGG S C
T L L (murine) ecotropic retroviral transforming sequence G1573u7
WIAF-12073 HT0642 661 CBL, Cas-Br-M TCTTTCCAAG[T/C]GGACTCTTTC S T C
S S (murine) ecotropic retroviral transforming sequence G1573u8
WIAF-12074 HT0642 2569 CBL, Cas-Br-M CTCTGGATGG[T/C]GATCCTACAA S T
C G G (murine) ecotropic retroviral transforming sequence G1573u9
WIAF-13486 HT0642 2006 CBL, Cas-Br-M CCGGCACTCA[C/T]TTCCATTTTC M C
T L F (murine) ecotropic retroviral transforming sequence G1574u1
WIAF-12037 HT1508 2493 FES, feline sarcoma (Snyder-Theilen)
AGCGGCCCAG[C/T]TTCAGCACCA S C T S S viral (v-fes)/ Fujinami avian
sarcoma (PRCII) viral (v- fps) oncogene homolog G1574u2 WIAF-12051
HT1508 189 FES, feline sarcoma (Snyder-Theilen)
CCCAGCGGGT[C/T]AAGAGTGACA S C T V V viral (v-fes)/ Fujinami avian
sarcoma (pRCII) viral (v- fps) oncogene homolog G1574u3 WIAF-12052
HT1508 1441 FES, feline sarcoma GAAGCCCCTG[C/T]ATGAGCAGCT M C T H Y
(Snyder-Theilen) viral (v-fes)/ Fujinami avian sarcoma (PRCII)
viral (v- fps) oncogene homolog G1574u4 WIAF-12053 HT1508 2202 FES,
feline sarcoma GAGAGGAAGC[C/T]GATGGGGTCT S C T A A (Snyder-Theilen)
viral (v-fes)/ Fujinami avian sarcoma (PRCII) viral (v-fps)
oncogene homolog G1574u5 WIAF-12054 HT1508 2088 FES, feline sarcoma
CTGCTGGCAT[G/T]GAGTACCTGG M G T M I (Snyder-Theilen) viral (v-fes)/
Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog
G1574u6 WIAF-12078 HT1508 1577 FES, feline sarcoma
GATGGTCTGC[C/T]CCGGCACTTC M C T P L (Snyder-Theilen) viral (v-fes)/
Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog
G1574u7 WIAF-13495 HT1508 579 FES, feline sarcoma
GTGACAAGGC[T/C]AAGGACAAGT S T C A A (Snyder-Theilen) viral (v-fes)/
Fujinami avian sarcoma (PRCII) viral (v-fps) oncogene homolog
G1575u1 WIAF-12079 HT1052 963 FGR, Gardner-
TGGGCACCGG[C/T]TGCTTCGGGG S C T G G Rasheed feline sarcoma viral
(v-fgr) oncogene homolog G1575u2 WIAF-13487 HT1052 232 FGR,
Gardner- CAGAAGCTAC[G/A]GGGCAGCAGA M G A G R Rasheed feline sarcoma
viral (v-fgr) oncogene homolog G1585u1 WIAF-12017 HT1675 996 CRK,
v-crk avian TGGATCAACA[G/A]AATCCCGATG S G A Q Q sarcoma virus CT10
oncogene homolog G1585u2 WIAF-12036 HT1675 446 CRK, v-crk avian
ACTACAACGT[T/C]GATAGAACCA M T C L S sarcoma virus CT10 oncogene
homolog G1587u1 WIAF-12023 HT0590 1473 proto-oncogene dbl
GGCCAATCCA[A/G]TTTGTGGTAC S A G Q Q G1587u2 WIAF-12025 HT0590 2549
proto-oncogene dbl GTCCAGGCTT[C/T]TAATGTAGAT M C T S F G1587u3
WIAF-12026 HT0590 2828 proto-oncogene dbl GCATCACAAT[C/T]TGCAGAAATC
M C T S F G1587u4 WIAF-12038 HT0590 982 proto-oncogene dbl
AAATTCTCAG[G/C]AGCTATTATC M G C E Q G1587u5 WIAF-12039 HT0590 2343
proto-oncogene dbl AACCAATGCA[G/T]CGACACCTTT M G T Q H G1587u6
WIAF-12048 HT0590 683 proto-oncogene dbl GACACTGAAG[G/A]AGCTGTCAGT
M G A G E G1587u7 WIAF-12055 HT0590 2686 proto-oncogene dbl
TTCTCTTCAG[C/T]AGAATGATGA N C T Q * G1587u8 WIAF-13485 HT0590 2136
proto-oncogene dbl ACTGTGAAGG[T/A]TCTGCTCTGT S T A G G G1587u9
WIAF-13496 HT0590 1566 proto-oncogene dbl AAAATCAGAG[C/T]AACTTAAAAA
S C T S S G159u1 WIAF-11616 HT4209 1059 RAD23B, RAD23
AGTACTGGGG[C/T]TCCTCAGTCT M C T A V (S. cerevisiae) homolog B
G1590u1 WIAF-13897 HT2455 1257 ETS2, v-ets avian
GCCAGTCTCT[C/G]TGCCTCAATA S C G L L erythroblastosis virus E26
oncogene homolog 2 G1590u2 WIAF-13913 HT2455 1107 ETS2, v-ets avian
ATTCTGGGAC[T/G]CCCAAAGACC S T G T T erythroblastosis virus E26
oncogene homolog 2 G1590u3 WIAF-13914 HT2455 1314 ETS2, v-ets avian
GGAGTGACCC[A/G]GTGGAGCAAG S A G P P erythroblastosis virus E26
oncogene homolog 2 G1591u1 WIAF-13924 HT2333 417 HRAS, v-Ha-ras
TCCAGAACCA[T/C]TTTGTGGACG S T C H H Harvey rat sarcoma viral
oncogene homolog G1595u1 WIAF-12262 HT33778 1302 proto-oncogene
GCATACCTCA[G/C]TGGCTACTAA M G C S T 1-myc, alt. transcript 1
G1597u1 WIAF-12243 HT0410 900 MAS1, MAS1 oncogene
CCATCTTGGT[C/T]GTGAAGATCC S C T V V G150u1 WIAF-11630 HT4247 690
RAD23A, RAD23 AGAGCCAGGT[A/G]TCGGAGCAGC S A G V V (S. cerevisiae)
homolog G1602u1 WIAF-14180 HT1903 1321 proto-oncogene
GTCGCCGGGG[C/A]CCAGCAAATA M C A P T pim-1 G1604u1 WIAF-12319 HT2788
1182 REL, v-rel avian CCTCCCAAAG[T/C]GCTGGGATTA S T C S S
reticuloendo- theliosis viral oncogene homolog G1609u1 WIAF-12358
HT33646 348 RIPK1, receptor GACGCACGGT[C/T]TCCCATGACC S C T V V
(TNFRSF) interact- ing serine- threonine kinase 1 G161u1 WIAF-11654
HT4251 1522 DNA repair and TATGATCCAT[C/T]TTAACTGAGG M C T S F
recombination homolog RAD52 G1610a1 WIAF-12101 HT27727 501
replication TGCAACTCCT[G/A]CTATTAAGAC M G A A T protein Rpa4, 30
kDa G1610a2 WIAF-12102 HT27727 554 replication
TACCGTGTAA[C/T]GTGAACCAGC S C T N N protein Rpa4, 30 kDa G1610u3
WIAF-12307 HT27727 450 replication TTCTGCTGCT[G/A]ATGGAGCGAG M G A
D N protein Rpa4, 30 kDa G1610u4 WIAF-12320 HT27727 1037
replication TGATTCATGA[G/C]TGTCCTCATC M G C E D protein Rpa4, 30
kDa G1610u5 WIAF-12321 HT27727 857 replication
TAGAGGACAT[G/A]AACGAGTTCA M G A M I protein Rpa4, 30 kDa G1610u6
WIAF-12343 HT27727 539 replication GAATTCAGGA[C/T]GTTGTACCGT S C T
D D protein Rpa4, 30 kDa G1630u1 WIAF-12302 HT3563 4312 DCC,
deleted in ACTCATGAAG[C/T]AGCTTAATGC N C T Q * colorectal carcinoma
G1632u1 WIAF-13572 HT27355 742 tumor suppressor,
TTTATGACAT[G/C]AAGCGGGGCT M G C M I PDGF receptor beta-like G1632u2
WIAF-13584 HT27355 1102 tumor suppressor, TGGAAGACTT[C/T]GAGACGATTG
S C T F F PDGF receptor beta-like G1632u3 WIAF-13601 HT27355 258
tumor suppressor, AAGACGCAGT[C/T]TATCATGATG M C T S F PDGF receptor
beta-like G1633u1 WIAF-13957 HT1778 1263 FER, fer (fps/
TTCAGGCAAA[T/C]GAGATCATGT S T C N N fes related) tyrosine kinase
(phosphoprotein NCP94) G1633u2 WIAF-13958 HT1778 2407 F2R, fer
(fps/ TATGTTGTAT[C/T]TCGAGAGTAA M C T L F fes related) tyrosine
kinase (phosphoprotein NCP94) G1634u1 WIAF-13505 HT3216 1569 ELK1,
ELK1, member TCTCGACCCC[C/T]GTGGTGCTCT S C T P P of ETS oncogene
family G1634u2 WIAF-13858 HT3216 456 ELK1, ELK1, member
GGCTGTGGGG[A/G]CTACGCAAGA S A G G G oncogene family G1634u3
WIAF-13859 HT3216 745 ELK1, ELK1, member AGGCCCAGGC[G/A]GTTTGGCACG
M G A G S of ETS oncogene family G1638u1 WIAF-14172 HT1224 98
uracil-DNA GCTGGGACCT[G/C]TTCCACAAAT -- G C -- -- glycosylase
G1643u1 WIAF-13517 HT3751 629 DXS648E, DNA seg-
TACATCCCCA[G/A]TCGTGGCCCT M G A S N ment on chromosome X (unique)
648 expressed sequence G1645u1 WIAF-14087 D21089 363 XPC, xeroderma
AAAACCTCAA[G/A]GTTATAAAGG S G A K K pigmentosum, com- plementation
group C G1645u2 WIAF-14088 D21089 2166 XPC, xeroderma
TGCATTCCAG[G/A]CACACGTGGC S G A R R pigmentosum, com- plementation
group C G1645u3 WIAF-14089 D21089 1580 XPC, xeroderma
GGGAGCCATC[G/A]TAAGGACCCA M G A R H pigmentosum, com- plementation
group C G1645u4 WIAF-14090 D21089 1601 XPC, xeroderma
AGCTTGCCAG[T/C]GGCATCCTC- A M T C V A pigmentosum, com-
plementation group C G1645u5 WIAF-14091 D21089 2920 XPC, xeroderma
CCCATTTGAG[A/C]AGCTGTGAGC M A C K Q pigmentosum, com- plementation
group C G1645u6 WIAF-14103 D21089 405 XPC, xeroderma
ATGACCTCAG[G/A]GACTTTCCAA S G A R R pigmentosum, com- plementation
group C G1645u7 WIAF-14104 D21089 151 XPC, xeroderma
GGGACGCGAA[C/G]TGCGCAGCCA M C G L V pigmentosum, com- plementation
group C G1645u8 WIAF-14105 D21089 2133 XPC, xeroderma
AAGCGGTCTA[C/T]TCCAGGGATT S C T Y Y pigmentosum, com- plementation
group C G167u1 WIAF-11632 HT4579 83 PMS2L8, postmeiotic
CCTATTCATC[G/A]GAAGTCAGTC M G A R Q segregation increased 2-like 8
G167u2 WIAF-11633 HT4579 219 PMS2L8, postmeiotic
GAGTGGATCT[T/C]ATTGAAGTTT S T C L L segregation increased 2-like 8
G167u3 WIAF-11644 HT4579 768 PMS2L8, postmeiotic
TGCCCCCTAG[T/C]GACTCCGTG- T S T C S S segregation increased 2-like
8 G161u4 WIAF-11622 HT4579 1645 PMS2L8, postmeiotic
GAAAGCGCCT[G/A]AAACTGACGA M G A E K segregation increased 2-like 8
G167u5 WIAF-11645 HT4579 1512 PMS2L8, postmeiotic
ACTCGGGGCA[C/T]GGCAGCACTT S C T H H segregation increased 2-like 8
G167u6 WIAF-11646 HT4579 1619 PMS2L8, postmeiotic
TCGCAGGAAC[A/C]TGTGGACTCT M A G H R segregation increased 2-like 8
G167u7 WIAF-11647 HT4579 1432 PMS2L8, postmeiotic
CGTCCTGAGA[C/T]CTCAGAAAGA M C T P S segregation increased 2-like 8
G167u8 WIAF-11625 HT4579 2490 PMS2L8, postmeiotic
GGACTGCTCT[T/C]AACACAAGCG S T C L L segregation increased 2-like 8
G167u9 WIAF-11619 HT4579 804 PMS2L8, postmeiotic
TGAGCTGTTC[G/C]GATGCTCTGC S G C S S segregation increased 2-like 8
G167u10 WIAF-11623 HT4579 1555 PMS2L8, postmeiotic
CATCCCAGAC[A/G]CGGGCAGTCA M A G T A segregation increased 2-like 8
G167u11 WIAF-11624 HT4575 2364 PMS2L8, postmeiotic
CCTTCGGACC[C/T]CAGGACGTCG S C T P P segregation increased 2-like
8
G167u12 WIAF-11626 HT4579 2348 PMS2L8, postmeiotic
ACTAGTAAAA[A/G]CTGGACCTTC M A G N S segregation increased 2-like 8
G181u1 WIAF-11697 HT48793 311 ERCC4, excision
ATATTTGCGA[C/T]AAGTAGGATA M C T T I repair cross- complementing
rodent repair deficiency, complementation group 4 G181u2 WIAF-11698
HT48793 295 ERCC4, excision CACACAAGGT[G/C]GTGTTATATT M G C G R
repair cross- complementing rodent repair deficiency,
complementation group 4 G181u3 WIAF-11699 HT48793 234 ERCC4,
excision TTGAACACCT[C/T]CCTCCCCCTC S C T L L repair cross-
complementing rodent repair deficiency, complementation group 4
G181u4 WIAF-11704 HT48793 808 ERCC4, excision
TTTGTGGCAC[C/T]AGCTTGGAGC N C T Q * repair cross- complementing
rodent repair deficiency, complementation group 4 G181u5 WIAF-11705
HT48793 640 ERCC4, excision TTCTATGACA[C/T]CTACCATGCT M C T P S
repair cross- complementing rodent repair deficiency,
complementation group 4 G181u6 WIAF-11670 HT48793 1117 ERCC4,
excision AGAAAGCAAC[C/T]CAAAGTGGGA M C T P S repair cross-
complementing rodent repair deficiency, complementation group 4
G185u1 WIAF-11668 HT5122 319 ACVR2B, activin A
TCTGCAACGA[G/A]CGCTTCACTC S G A E E receptor, type IIB G185u2
WIAF-11707 HT5122 70 ACVR2B, activin A AGACACGGGA[G/C]TGCATCTACT M
G C E D receptor, type IIB G185u3 WIAF-11672 HT5122 812 ACVR2B,
activin A CCTCACGGAT[T/C]ACCTCAAGGG M T C Y H receptor, type IIB
G185u4 WIAF-13542 X77533 1109 ACVR2B, activin A
GGCTCCTGAG[G/A]TGCTCGAGGG M G A V M receptor, type IIB G185u5
WIAF-13558 X77533 997 ACVR2B, activin A TGCTGAAGAG[C/T]GACCTCACAG S
C T S S receptor, type IIB G187u1 WIAF-11669 HT97400 183 androgen
CCAGAGACAG[C/T]GCGACCCGGA M C T R C G191u1 WIAF-10176 AF025375 414
CXCR4, chemokine ACCTGGCCAT[C/T]GTCCACGCCA S C T I I (C-X-C motif),
receptor 4 (fusin) G193u1 WIAF-10178 D29984 231 CCR2, chemokine
AGTGCTTGAC[T/A]GACATTTACC S T A T T (C-C motif) receptor 2 G193u2
WIAF-10179 D29984 190 CCR2, chemokine CATGCTGGTC[G/A]TCCTCATCTT M G
A V I (C-C motif) receptor 2 G194u1 WIAF-10211 D43767 121 SCYA17,
small ACATCCACCC[A/C]GCTCGAGGGA S A C A A inducible cytokine
subfamily A (Cys-Cys), member 17 G197u1 WIAF-10167 D50403 1515
NRAMP1, natural GGTGCTAGTC[T/C]GCGCCATCAA M T C C R resistance-
associated macrophage protein 1 (might include Leishmaniasis)
G197u2 WIAF-10173 D50403 1629 NRAMP1, natural
CACCTACCTG[G/C]TCTGGACCTG M G C V L resistance- associated
macrophage protein 1 (might include Leishmaniasis) G20u1 WIAF-10249
U14722 896 ACVR1B, activin A CGGTACACAG[T/C]GACAATTGAG M T C V A
receptor, type IB G20u2 WIAF-10250 U14722 866 ACVR1B, activin A
GAGCACGGGT[C/T]CCTGTTTGAT M C T S F receptor, type IB G20u3
WIAF-10251 U14722 1391 ACVR1B, activin A CAGAGTTATG[A/T]GGCACTGCGG
M A T E V receptor, type IB G20u4 WIAF-10252 U14722 1236 ACVR1B,
activin A TATATTGGGA[G/C]ATTGCTCGAA M G C E D receptor, type IB
G20u5 WIAF-10261 U14722 518 ACVR1B, activin A
GAGATGTGTC[T/C]CTCCAAAGAC M T C L P receptor, type IB G207a1
WIAF-10516 L25259 866 Human CTLA4 AGCTGTACTT[C/T]CAACAGTTAT M C T P
S counter-receptor (B7-2) mRNA, complete cds. G208u1 WIAF-10204
L31581 85 CCR7, chemokine GGGGAAACCA[A/G]TGAAAAGCGT M A G M V (C-C
motif) receptor 7 G211u1 WIAF-10213 M24545 174 SCYA2, small,
TCACCTGCTG[T/C]TATAACTTCA S T C C C inducible cytokine A2 (monocyte
chemotactic protein 1, homologous to mouse Sig-je) G214u1
WIAF-10191 M27533 452 CD80, CD80 antigen TGAAAGAAGT[G/A]GCAACGCTGT
S G A V V (CD28 antigen ligand 1, B7-1 antigen) G215u1 WIAF-11659
M28393 822 PRF1, perforin 1 GCATCTCTGC[C/T]GAAGCCAAGG S C T A A
(preforming protein) G215u2 WIAF-11723 M28393 159 PRF1, perform 1
TGACCAGCCT[C/T]CGCCGCTCGG S C T L L (preforming protein) G215u3
WIAF-11724 M28393 96 PRF1, perform 1 CAGAGTGCAA[G/A]CGCAGCCACA S G
A K K (preforming protein) G215u4 WIAF-11725 M28393 1377 PRF1,
perform 1 ATAACAACCC[C/T]ATCTGGTCAG S C T P P (preforming protein)
G215u5 WIAF-11726 M28393 1326 PRF1, perform 1
TGAAGCTCTT[C/T]TTTGGTGGCC S C T F F (preforming protein) G215u6
WIAF-11727 M28393 1076 PRF1, perform 1 CGGCGGGAGG[C/T]ACTGAGGAGG M
C T A V (preforming protein) G217u1 WIAF-11691 M31932 649 FCGR2B,
Fc fragment GCAGCTCTTC[A/C]CCAATGGGGA S A G S S of IgG, low
affinity IIb, receptor for (CD32) G217u2 WIAF-11692 M31932 625
FCGR2B, Fc fragment TCACTGTCCA[A/G]GTGCCCAGCA S A G Q Q of IgG, low
affinity IIb, receptor for (CD32) G217u3 WIAF-11712 M31932 332
FCGR2B, Fc fragment GACTGGCCAG[A/C]CCAGCCTCAG M A C T P of IgG, low
affinity IIb, receptor for (CD32) G217u4 WIAF-11713 M31932 101
FCGR2B, Fc fragment GGCTTCTGCA[G/T]ACAGTCAAGC M G T D Y of IgG, low
affinity IIb, receptor for (CD32) G218u1 WIAF-10184 M36712 677
CD8B1, CD8 antigen, TTTTACAAAT[A/G]AGCAGAGAAT N A G * * beta
polypeptide 1 (p37) G218u2 WIAF-10188 M36712 326 CD8B1, CD8
antigen, GCTGTGTTTC[G/C]GGATGCAAGC M G C R P beta polypeptide 1
(p37) G218u3 WIAF-10189 M36712 196 CD8B1, CD8 antigen,
CAGTAACATG[C/T]GCATCTACTG M C T R C beta polypeptide 1 (p37) G218u4
WIAF-10190 M36712 225 CD8B1, CD8 antigen, AGCGCCAGGC[A/C]CCGAGCAGTG
S A C A A beta polypeptide 1 (p37) G218u5 WIAF-10194 M36712 583
CD8B1, CD8 antigen, GGTGGCTGGC[G/A]TCCTGGTTCT M G A V I beta
polypeptide 1 (p37) G218u6 WIAF-10208 M36712 372 CD8B1, CD8
antigen, TGAAGCCGGA[A/G]GACAGTGGCA S A G E E beta polypeptide 1
(p37) G218u7 WIAF-10209 M36712 400 CD8B1, CD8 antigen,
CTGCATGATC[G/T]TCGGGAGCCC M G T V F beta polypeptide 1 (p37) G218u8
WIAF-10210 M36712 270 CD8B1, CD8 antigen, TCTGGGATTC[C/T]GCAAAAGGGA
S C T S S beta polypeptide 1 (p37) G218a9 WIAF-10518 M36712 618
CD8B1, CD8 antigen, GAGTGGCCAT[C/G]CACCTGTGCT M C G I M beta
polypeptide 1 (p37) G218a10 WIAF-13223 M36712 556 CD8B1, CD8
antigen, TTGTAGCCCC[A/G]TCACCCTT- GG M A G I V beta polypeptide 1
(p37) G218a11 WIAF-13224 M36712 836 CD8B1, CD8 antigen,
CTGTGTGTGA[T/C]GTGCATGGGA -- T C -- -- beta polypeptide 1 (p37)
G22u1 WIAF-10301 U86136 6719 Human telomerase-
GGTGGTAACC[G/A]TCGGGCTAGA M G A V I associated protein TP-1 mRNA,
complete cds. G22u2 WIAF-10302 U86136 7537 Human telomerase-
CTGATGGGAT[C/G]CTATGGAACC M C G I M associated protein TP-1 mRNA,
complete cds. G22u3 WIAF-10311 U86136 1798 Human telomerase-
ATGATGCCAT[T/C]GATGCCCTCG S T C I I associated protein TP-1 mRNA,
complete cds. G22u4 WIAF-10312 U86136 2397 Human telomerase-
CTGTCTCTGG[C/T]TGGCCAAAGG M C T A V associated protein TP-1 mRNA,
complete cds. G22u5 WIAF-10313 U86136 3289 Human telomerase-
AGAAAGGGAT[A/C]ACCTGCCGCA S A C I I associated protein TP-1 mRNA,
complete cds. G22u6 WIAF-10314 U86136 3242 Human telomerase-
AGAGGCCGCA[T/C]GTCGGATCTC M T C C R associated protein TP-1 mRNA,
complete cds. G22u7 WIAF-10315 U86136 4482 Human telomerase-
CCGTTTGCCT[G/A]CCTCGTCCAG M G A C Y associated protein TP-1 mRNA,
complete cds. G22u8 WIAF-10316 U86136 4363 Human telomerase-
GTTTGACTGT[G/A]GACCAGCTGC S G A V V associated protein TP-1 mRNA,
complete cds. G22u9 WIAF-10317 U86136 4230 Human telomerase-
GTGTCTGAGA[G/A]ACTCCGGACC M G A R K associated protein TP-1 mRNA,
complete cds. G22u10 WIAF-10318 U86136 4419 Human telomerase-
GGGACTAAGA[G/C]CTGGGAAGAA M G C S T associated protein TP-1 mRNA,
complete cds. G22u11 WIAF-10319 U86136 5269 Human telomerase-
TCTCCGATGA[T/C]ACACTCTTTC S T C D D associated protein TP-1 mRNA,
complete cds. G22u12 WIAF-10320 U86136 5015 Human telomerase-
GCTGCTCTCC[C/T]GGAGATGGCA M C T R W associated protein TP-1 mRNA,
complete cds. G22u13 WIAF-10321 U86136 5133 Human telomerase-
GTGGCCTTCT[C/T]CACCAATGGG M C T S F associated protein TP-1 mRNA,
complete cds. G22u14 WIAF-10322 U86136 7764 Human telomerase-
ACAGCCCTCC[A/G]TGTCCTACCT M A G H R associated protein TP-1 mRNA,
complete cds. G22u15 WIAF-10323 U86136 7884 Human telomerase-
TGCCTGGAAC[C/T]TTGCCTGGGC M C T P L associated protein TP-1 mRNA,
complete cds. G22u16 WIAF-10324 U86136 7744 Human telomerase-
AGATTCACTC[C/A]GCCTCTGTCA S G A S S associated protein TP-1 mRNA,
complete cds. G22u17 WIAF-10337 U86136 1018 Human telomerase-
CCATTGCTGC[T/C]TTCTTGCCGG S T C A A associated protein TP-1 mRNA,
complete cds. G22u18 WIAF-10338 U86136 1000 Human telomerase-
TGGCCAATAA[C/A]ATCTTGGCCA M C A N K associated protein TP-1 mRNA,
complete cds. G22u19 WIAF-10339 U86136 1182 Human telomerase-
ATGACGGACA[A/G]ATTTGCCCAG M A G K R associated protein TP-1 mRNA,
complete cds. G22u20 WIAF-10340 U86136 1939 Human telomerase-
AGCAGCTTCG[T/G]ATGGCAATGA S T G R R associated protein TP-1 mRNA,
complete cds. G22u21 WIAF-10341 U86136 2227 Human telomerase-
TCACGAGGGC[G/A]GAGCAGGTGG S G A A A associated protein TP-1 mRNA,
complete cds. G22u22 WIAF-10342 U86136 2776 Human telomerase-
GGCGCAGCAT[C/T]CGGCTTTTCA S C T I I associated protein TP-1 mRNA,
complete cds. G22u23 WIAF-10343 U86136 2877 Human telomerase-
GCCCCTCACC[C/A]TATCAGCCTT M G A R H associated protein TP-1 mRNA,
complete cds. G22u24 WIAF-10344 U86136 3087 Human telomerase-
TCAGGGCGCT[C/T]TGTGACAGAG M C T S F associated protein TP-1 mRNA,
complete cds. G22u25 WIAF-10345 U86136 3662 Human telomerase-
CAAGGTGGCA[C/T]CATTAGTCTT M C T P S associated protein TP-1 mRNA,
complete cds. G22u26 WIAF-10346 U86136 4762 Human telomerase-
TTTCGAAGTT[C/T]CTTACCAACC S C T F F associated protein TP-1 mRNA,
complete cds. G22u27 WIAF-10351 U86136 1737 Human telomerase-
CTCCAGCATG[G/C]GAAGTCGGTG M G C G A associated protein TP-1 mRNA,
complete cds. G22u28 WIAF-10352 U86136 3543 Human telomerase-
ACAGTGCAAC[A/G]GCTGATGCTG M A G Q R associated protein TP-1 mRNA,
complete cds. G22u29 WIAF-10353 U86136 4232 Human telomerase-
GTCTGAGAGA[C/T]TCCGGACCCT M C T L F associated protein TP-1 mRNA,
complete cds. G22u30 WIAF-10354 U86136 4523 Human telomerase-
GGAGGGCCCT[C/T]TGGAGCGCCC S C T L L associated protein TP-1 mRNA,
complete cds. G22u31 WIAF-10355 U86136 5333 Human telomerase-
TGGTTGTCGG[G/T]TGCTGCAGAC M G T V L associated protein TP-1 mRNA,
complete cds. G22u32 WIAF-10356 U86136 6208 Human telomerase-
AGCTGCTGAC[G/A]CGGCCACACA S G A T T associated protein TP-1 mRNA,
complete cds. G22u33 WIAF-10357 U86136 7703 Human telomerase-
TAGTCAGCCA[A/G]CACCACATCT M A G T a associated protein TP-1 mRNA,
complete cds. G22u34 WIAF-10360 U86136 3881 Human telomerase-
CATCGATGGG[G/A]CTGATAGGTT M G A A T associated protein TP-1 mRNA,
complete cds. G222u1 WIAF-11700 M57230 697 IL6ST, interleukin
TGAGTGGGAT[G/C]GTGGAAGGGA M G C G R 6 signal transducer (gp130,
oncostatin M receptor) G222u2 WIAF-11701 M57230 708 IL6ST,
interleukin GTGGAAGGGA[A/G]ACACACTTGG S A G E E 6 signal transducer
(gp130, oncostatin M receptor) G222u3 WIAF-11702 M57230 677 IL6ST,
interleukin GAGGGGAACA[A/G]AATGAGGTGT M A G K R 6 signal transducer
(gp130, oncostatin M receptor) G222u4 WIAF-11706 M57230 1616 IL6ST,
interleukin AAGAAATATA[T/C]ACTTGAGTGG M T C I T 6 signal transducer
(gp130, oncostatin M receptor) G222u5 WIAF-11667 M57230 1444 IL6ST,
interleukin TGATCGCTAT[C/G]TAGCAACCCT M C G L V 6 signal transducer
(gp130, oncostatin M receptor) G222u6 WIAF-11708 M57230 981 IL6ST,
interleukin TCTTAAAATT[G/C]ACATGGACCA M G C L F 6 signal transducer
(gp130, oncostatin M receptor) G226u1 WIAF-11714 M85079 869 TGFBR2,
transform- CACTGGGAGT[T/C]GCCATATCTG S T C V V ing growth factor,
beta receptor II (70-80 kD) G226u2 WIAF-11715 H85079 1749 TGFBR2,
transform- ACATTATCAC[C/T]CTCCATTTC- C M C T P S ing growth factor,
beta receptor II (70-80 kD) G226u3 WIAF-11716 M85079 1601 TGFBR2,
transform- TCCCAACTCC[A/C]ACATACATCC S A G A A ing growth factor,
beta receptor II (70-80 kD) G226u4 WIAF-11721 H85079 1256 TGFBR2,
transform- TACTCCACTT[C/C]CTCACCCCT- C M C G F L ing growth factor,
beta receptor II (70-80 kD) G226u5 WIAF-11722 M85079 1502 TGFBR2,
transform- TCCTCAACAA[C/T]CACCTAACCT S C T N N ing growth factor,
beta receptor II (70-80 kD) G226u6 WIAF-11671 M85079 888 TGFBR2,
transform- TCTCATCATC[A/C]TCTTCTACTC M A C I L ing growth factor,
beta receptor II (70-80 kD) G226u7 WIAF-11674 M85079 1425 TGFBR2,
transform- CCTCCACAGT[G/A]ATCACACTCC M G A D N ing growth factor,
beta receptor II (70-80 kD) G227u1 WIAF-10197 M86511 685 CD14, CD14
antigen CCTGTCTGAC[A/G]ATCCTGGACT M A G N D G227u2 WIAF-10212
M86511 497 CD14, CD14 antigen GAAGCCACAG[G/A]ACTTGCACTT M G A G E
G2278u1 WIAF-14117 AF034611 959 CUBN, cubilin
ACATAAATAA[T/C]CGCCCCTGTT S T C N N (intrinsic factor- cobalamn
receptor) G2278u2 WIAF-14118 AF034611 781 CUBN, cubilin
CCGTGGATGT[C/T]TTCACCCAAC M C T S F (intrinsic factor- cobalain
receptor) G2278u3 WIAF-14119 AF034611 641 CUBN, cubilin
CTCAGACGTA[C/T]CCACCCCAGT S C T Y Y (intrinsic factor- cobalamin
receptor) G2278u4 WIAF-14121 AF034611 1185 CUBN, cubilin
TCCTTATCCG[C/A]CAAATGCATG M C A P T (intrinsic factor- cobalamin
receptor) G2278u5 WIAF-14133 AF034611 1532 CUBN, cubilin
TCTGCGTTAT[C/G]AAAACTGAAA M C G I M (intrinsic factor cobalamin
receptor) G2278u6 WIAF-14134 AF034611 2208 CUBN, cubilin
GCCTTTCACT[C/T]ACACCAGGCA M C T H Y (intrinsic factor cobalamin
receptor) G228u1 WIAF-10199 U00672 586 IL10RA, interleukin
CCAACGTCCC[G/A]CCAAACTTCA S G A P P 10 receptor, alpha G228u2
WIAF-10200 U00672 731 IL10RA, interleukin AGAGCAGTGC[A/G]TCTCCCTCAC
M A G I V 10 receptor, alpha G2280u1 WIAF-13970 AJ001515 1747
RYR3, ryanodine CAGGTATCTT[G/A]GAAGTTTTGC S G A L L receptor 3
G2280u2 WIAF-13974 AJ001515 8593 RYR3, ryanodine
TAGAAGCCAT[T/C]GTCAGCAGTG S T C I I receptor 3 G2282u1 WIAF-12694
D00726 263 FECH, ACATGGGAGG[C/T]CCTGAAACTG S C T G G ferrochelatase
(protoporphyria) G2282u2 WIAF-12695 D00726 514 FECH,
TACTATATTG[G/A]ATTTCGGTAC M G A G E ferrochelatase (protoporphyria)
G2285u1 WIAF-12688 D16611 673 CPO, copropor-
AGAAGACGCT[G/A]TCCATTTTCA M G A V I phyrinogen oxidase
(coproporphyria, harderoporphyria) G2285u2 WIAF-12689 D16611 783
CPO, copropor- ATCGTGGAGA[G/A]CGGCGGGGCA S G A E E phyrinogen
oxidase (coproporphyria, harderoporphyria) G2287u1 WIAF-12687
D28472 502 PTGER4, prosta- GGGCCTCACG[C/T]TCTTTGCAGT M C T L F
glandin E receptor 4 (subtype EP4) G2287u2 WIAF-12691 D28472 1309
PTGER4, prosta- TGAAAATGGC[C/T]TTGGAGGCAG M C T L F glandin E
receptor 4 (subtype EP4) G2287u3 WIAF-12707 D28472 243 PTGER4,
prosta- AGGAGACGAC[C/T]TTCTACACGC S C T T T glandin E receptor 4
(subtype EP4) G2287u4 WIAF-12710 D28472 1342 PTGER4, prosta-
GGTGTGCCTG[G/A]CATGGGCCTG M G A G D glandin E receptor 4 (subtype
EP4) G229u1 WIAF-10185 U16752 202 SDF1, stromal cell-
CATGTTGCCA[G/A]AGCCAACCTC M G A R K derived factor 1 G2295u1
WIAF-12727 D89079 613 LTB4R, leukotriene CTATGTCTGC[G/C]GAGTCAGCAT
M G C G R b4 receptor (chemo- kine receptor-like 1) G2295u2
WIAF-1272B D89079 1248 LTB4R, leukotriene AGGGCACGGG[T/C]TCCGAGGCGT
S T C G G b4 receptor (chemo- kine receptor-like 1) G2295u3
WIAF-12753 D89079 1348 LTB4R, leukotriene CCTCACTGCC[T/G]CCAGCCCTCT
M T G S A b4 receptor (chemo- kine receptor-like 1) G230u1
WIAF-10201 U31628 627 IL15RA, interleukin ACAGCCAAGA[A/C]CTGGGAACTC
M A C N T 15 receptor, alpha alpha G2300u1 WIAF-12735 J02959 102
LTA4H, leukotriene ACCTGCACCT[C/T]CGCTGCACGC S G T L L A4 hydrolase
G2300u2 WIAF-12738 J02959 1380 LTA4H, leukotriene
CCTGGCTCTA[C/T]TCTCCTGGAC S C T Y Y A4 hydrolase G2302u1 WIAF-12741
J03037 627 CA2, carbonic TCCTGAATCC[C/T]TGGATTACTG S C T L L
anhydrase II G2302u2 WIAF-12742 J03037 819 CA2, carbonic
GCCACTGAAG[A/G]ACAGGCAAAT M A G N D anhydrase II G2303u1 WIAF-12751
J03571 304 ALOX5, arachidonate CGCTGAAGAC[G/A]CCCCACGGGG S G A T T
5-lipoxygenase G2303u2 WIAF-12752 J03571 794 ALOX5, arachidonate
AGAGCTGCCC[G/A]AGAAGCTCCC M G A E K 5-lipoxygenase G2304u1
WIAF-12772 J03575 840 PDHA1, pyruvate TCCGAGAGGC[A/C]ACAAGGTTTG S A
G A A dehydrogenase (lipoamide) alpha 1 G2304u2 WIAF-12779 J03575
1044 PDHA1, pyruvate CCAGTGTGGA[A/C]GAACTAAAGG M A C E D
dehydrogenase (lipoamide) alpha 1 G2305u1 WIAF-12763 J03576 456
PDHB, pyruvate TCTTCAGGGG[A/G]CCCAATGGTG S A G G G debydrogenase
(lipoamide) beta G2305u2 WIAF-12764 J03576 650 PDHB, pyruvate
GTTCCTTTTG[A/C]ATTTCTCCCG M A C E A dehydrogenase (lipoamide) beta
G231u1 WIAF-10202 U32324 734 IL11RA, interleukin
CCAGGGCCTG[C/T]GGGTAGAGTC M C T R W 11 receptor, alpha G2312u1
WIAF-12762 J05096 3726 ATP1A2, ATPase, TCAAGAACCA[C/T]ACAGAGATCG S
C T H H Na+/K+ transporting, alpha 2 (+) polypeptide G2313u1
WIAF-12760 J05200 6141 RYR1, ryanodine TGCAATTCAA[A/G]GATGGTACA- G
S A G K K receptor 1 (skeletal) G2313u2 WIAF-12767 J05200 3048
RYR1, ryanodine CGGCGCAGAC[A/G]ACACTGGTGG S A G T T receptor 1
(skeletal) G2313u3 WIAF-12768 J05200 3084 RYR1, ryanodine
ATGGCCACAA[C/T]GTGTGGGCCC S C T N N receptor 1 (skeletal) G2313u4
WIAF-12777 J05200 5667 RYR1, ryanodine GCATCTTTGG[C/T]GATGAGGATG S
C T G G receptor 1 (skeletal) G2313u5 WIAF-12780 J05200 6600 RYR1,
ryanodine GCTCGCTGCT[C/T]ATCGTGCAGA S C T L L receptor 1 (skeletal)
G2313u6 WIAF-12781 J05200 7191 RYR1, ryanodine
AGCCTGAGTG[C/T]TTCGHACCCG S C T C C receptor 1 (skeletal) G2313u7
WIAF-12782 J05200 7602 RYR1, ryanodine ACCACAAGGC[G/A]TCCATGGTGC S
G A A A receptor 1 (skeletal) G2313u8 WIAF-12784 J05200 9288 RYR1,
ryanodine CAGACGCCCC[A/G]GCTCTGGTCA S A G P P receptor 1 (skeletal)
G2313u9 WIAF-12786 J05200 13690 RYR1, ryanodine
TCCAAAGAAG[G/A]AGGAAGCTGG M G A E K receptor 1 (skeletal) G2313u10
WIAF-12789 J05200 3147 RYR1, ryanodine ACATCCCAGC[G/A]CGCCCAAACC S
G A A A receptor 1 (skeletal) G23144u1 WIAF-12771 J05272 1920
IMPDH1, IMP TGAAGATCGC[A/G]CAGGGTGTCT S A G A A (inosine mono-
phosphate) dehydrogenase 1 G2319u1 WIAF-12814 K03191 651 CYP1A1,
cytochrome CCCCTACAGG[T/C]ATGTGGTGGT M T C Y H P450, subfamily I
(aromatic compound inducible), poly- peptide 1 G232u1 WIAF-11657
U58917 1490 Homo sapiens IL,-17 TGAACATGAT[C/T]CTCCCGGACT S C T I I
receptor mRNA, complete cds. G232u2 WIAF-11677 U58917 1293 Homo
sapiens IL-17 GCAGGCCATC[T/C]CGGAGGCAGG M T C S P receptor mRNA,
complete cds. G232u3 WIAF-11658 U58917 1132 Homo sapiens IL-17
GGCCTGCCTG[C/T]GGCTCACCTG M C T A V receptor mRNA, complete cds.
G232u4 WIAF-11679 U58917 905 Homo sapiens IL-17
GCAGCTGCCT[C/T]AATGACTGCC S C T L L receptor mRNA, complete cds.
G232u5 WIAF-11682 U58917 1794 Homo sapiens IL-17
GTTCGAATGTE[G/T]AGAACCTCTA N G T E * receptor mRNA, complete cds.
G232u7 WIAF-11660 U58917 743 Homo sapiens IL-17
TGACCAGTTT[T/C]CCGCACATGG S T C F F receptor mRNA, complete cds.
G2322u1 WIAF-12853 L01406 1316 GHRHR, growth
CTGACATCTA[T/C]GTGCTAGGCT M T C M T hormone releasing hormone
receptor G2328u1 WIAF-12845 L20316 1285 GCGR, glucagon
TGCGGGCACG[G/C]CAGATGCACC S G C R R receptor G2329u1 WIAF-12850
L22214 713 ADORA1, adenosine TGCTGGCAAT[T/C]GCTGTGGACC S T C I I A1
receptor G2329u2 WIAF-12851 L22214 716 ADORA1, adenosine
TGGCAATTGC[T/G]GTGGACCGCT S T G A A A1 receptor G2335a1 WIAF-12136
L32961 265 ABAT, 4-amino- CCTAGATCTC[A/G]GGAGTTAATG M A G Q R
butyrate amino- transferase G2335a2 WIAF-12137 L32961 407 ABAT,
4-amino- TCTCCTCTGT[T/C]CCCATAGGTT S T C V V butyrate amino-
transferase G2335u3 WIAF-12838 L32961 365 ABAT, 4-amino-
TTGATGTGGA[C/T]GGCAACCGAA S C T D D butyrate amino- transferase
G2335u4 WIAF-12839 L32961 583 ABAT, 4-amino-
ATCACCATGG[C/T]CTGCGGCTCC M C T A V butyrate amino- transferase
G2335u5 WIAF-12841 L32961 1082 ABAT, 4-amino-
TGGACGAGGT[C/A]CAGACCGGAG S C A V V butyrate amino- transferase
G2335u6 WIAF-12852 L32961 227 ABAT, 4-amino-
ATTATGATGG[C/A]CCTCTGATGA S G A G G butyrate amino- transferase
G2337u1 WIAF-13577 L34820 149 ALDH5A1, aldehyde
TGTTCTCGAA[A/C]GAATGCCAAG M A G K R dehydrogenase 5 family, member
A1 (succinate-semi- aldehyde dehydrogenase) G2342a1 WIAF-12138
M12530 1602 TF, transferrin GCCTAAACCT[G/C]TGTGAACCCA S G C L L
G2342a2 WIAF-12139 M12530 1795 TF, transferrin
TACCAGGAAA[C/T]CTGTGGAGGA M C T P S G2346u1 WIAF-12829 M13928 234
ALAD, aminolevuli- TGGCCAGGTA[T/C]GGTGTGAAGC S T C Y Y nate,
delta-, dehydratase G2346u2 WIAF-12830 M13928 529 ALAD,
aminolevuli- TGAGGTGGCA[T/C]TGGCGTATGC S T C L L nate, delta-,
dehydratase G2346u3 WIAF-12843 M13928 480 ALAD, aminolevuli-
TGAGTGAAAA[C/T]GGAGCATTC- C S C T N N nate, delta-, dehydratase
G2348u1 WIAF-12835 M14016 621 UROD, uroporphyrino-
CTCTGGTCCC[A/G]TATCTGGTAG S A G P P gen decarboxylase G235u1
WIAF-11678 U83171 100 SCYA22, small CAGGCCCCTA[C/T]GGCGCCAA- CA S C
T Y Y inducible cytokine subfamily A (Cys- Cys), member 22 G2363a1
WIAF-10519 M37435 596 CSF1, colony GACAAGGACT[G/T]GAATATTTTC M G T
W L stimulating factor 1 (macrophage) G2363a2 WIAF-13225 M37435 498
CSF1, colony AAGAGCATGA[C/T]AAGGCCTGCG S C T D D stimulating factor
1 (macrophage) G2363a3 WIAF-13226 M37435 712 CSF1, colony
CAGTGACCCG[G/T]CCTCTGTCTC M G T A S stimulating factor 1
(macrophage) G2369u1 WIAF-12854 M30773 857 PPP3R1, protein
TTGATTTGCA[C/T]AATTCTCGTT S C T D D phosphatase 3 (formerly 2B),
regulatory subunit B (19 kD), alpha isoform (calcineurin B, type I)
G2369u2 WIAF-12855 M30773 1274 PPP3R1, protein
ATGTGTGACT[C/T]TTATCAGAGA - C T - - phosphatase 3 (formerly 25),
regulatory subunit B (19 kD), alpha isoform (calcineurin B, type I)
G237u1 WIAF-11662 U86358 311 SCYA25, small
CACCACAACA[T/C]GCAGACCTTC M T C M T inducible cytokine subfamily A
(Cys- Cys), member 25 G237u2 WIAF-11680 U86358 134 SCYA25, small
GTGCTCCGGC[G/A]CGCCTGGACT M G A R H inducible cytokine subfamily A
(Cys- Cys), member 25 G237u3 WIAF-11681 U86358 133 SCYA25, small
TGTGCTCCGG[C/T]GCGCCTGGAC M C T R C inducible cytokine subfamily A
(Cys- Cys), member 25 G237u5 WIAF-11661 U86358 302 SCYA25, small
GCAAAGCTCC[A/G]CCACAACATG M A G H R inducible cytokine subfamily A
(Cys- Cys), member 25 G237u6 WIAF-11663 U86358 378 SCYA25, small
AGTTATCATC[A/C]TCCAAGTTTA S A G S S inducible cytokine subfamily A
(Cys- Cys), member 25 G2373u1 WIAF-12870 M36035 500 BZRP, benzo-
GCTGGCCTTC[G/A]CGACCACACT M G A A T diazapine receptor (peripheral)
G2376u1 WIAF-13025 M57414 979 TACR2, tachykinin
CTGCTGCCCA[T/C]GGGTCACA- CC M T C W R receptor 2 G238u1 WIAF-10177
X01394 239 TNF, tumor necrosis GCTCCAGGCG[G/T]TGCTTGTTCC S G T R R
factor (TNF super- family, member 2) G2381u1 WIAF-12894 M59941 730
CSF2RB, colony CAGAGGTTTG[C/T]TGGGACTCCC S C T C C stimulating
factor 2 receptor, beta, low-affinity (granulocyte- macrophage)
G2381u2 WIAF-12896 M59941 1306 CSF2RB, colony
GGATCTGGAG[C/T]GAGTGGAGTG S C T S S stimulating factor 2 receptor,
beta, low-affinity (granulocyte- macrophage) G2381u3 WIAF-12900
M59941 1972 CSF2RB, colony CGATGGGACCC[G/A]GGACAGGCCG S G A P P
stimulating factor 2 receptor, beta, low-affinity (granulocyte-
macrophage) G2381u4 WIAF-12901 M59941 1982 CSF2RB, colony
GGGACAGGCC[G/A]TGGAACTGGA M G A V M stimulating factor 2 receptor,
beta, low-affinity (granulocyte- macrophage) G2381u5 WIAF-12942
M59941 773 CSF2RB, colony CCAGAACCTG[G/C]AGTGCTTCTT M G C E Q
stimulating factor 2 receptor, beta, low-affinity (granulocyte-
macrophage) G2381u6 WIAF-12946 M59941 2458 CSF2RB, colony
CCCCACAGCC[C/A]GAGGGCCTC- C S C A P P stimulating factor 2
receptor, beta, low-affinity (granulocyte- macrophage) G2384u1
WIAF-12908 M61831 1000 AHCY, S-adenosyl- GCCGTGGAGA[A/C]GGTGAACATC
M A C K T homocysteine hydrolase G2387u1 WIAF-12910 M63967 2585
ALDH5, aldehyde CTGCTGAACC[T/G]CCTGGCAGAC M T G L R dehydrogenase 5
G2387u2 WIAF-12911 M63967 2996 ALDH5, aldehyde
TATGGCCCAA[C/G]AGCAGGTGCG M C G T R dehydrogenase 5 G2387u3
WIAF-12954 M63967 2522 ALDH5, aldehyde GCCCGGGAAG[C/T]CTTCCGCCTG M
C T A V dehydrogenase 5 G2387u4 WIAF-12955 M63967 2448 ALDH5,
aldehyde ACCCTACCAC[C/T]GGGGAGGTCA S C T T T dehydrogenase 5
G2387u5 WIAF-12956 M63967 2460 ALDH5, aldehyde
GGGAGGTCAT[C/T]GGGCACGTGG S C T I I dehydrogenase 5 G2387u6
WIAF-12957 M63967 2991 ALDH5, aldehyde CGGGGTATGG[C/T]CCAACAGCAG S
C T G G dehydrogenase 5 G2387u7 WIAF-12958 M63967 3022 ALDH5,
aldehyde CGCCCAGCAC[A/G]TGGATGTTGA M A G M V dehydrogenase 5
G2387u8 WIAF-12959 M63967 2943 ALDH5, aldehyde
CCCTCATCAA[G/C]GAGGCAGGCT M G C K N dehydrogenase 5 G2388u1
WIAF-12888 M64590 588 GLDC, glycine TGCCACAGAC[G/A]ATTTTGCCG- A S C
A T T dehydrogenase (decarboxylating; glycine decarboxyl- ase,
glycine cleav- age system protein P) G2388u2 WIAF-12889 M64590 651
GLDC, glycine ACCAGCCTGA[G/A]GTGTCTCAGG S G A E E dehydrogenase
(decarboxylating; glycine decarboxyl- ase, glycine cleav- age
system protein P) G2388u3 WIAF-12890 M64590 698 GLDC, glycine
CAGACCATGG[T/C]GTGTGACATC M T C V A dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u4 WIAF-12891 M64590 557 GLDC, glycine
TATATTGGCA[T/C]GGGCTATTAT M T C M T dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u5 WIAF-12938 M64590 587 GLDC, glycine
GTGCCACAGA[C/G]GATTTTGCGG M C G T R dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u6 WIAF-12939 M64590 518 GLDC, glycine
CTGCATGCCA[T/C]TTCAAGCAAA M T C I T dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u7 WIAF-12940 M64590 810 GLDC, glycine
GGAAATTTCT[C/T]GTTGATCCCC S C T L L dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u8 WIAF-12941 M64590 1481 GLDC, glycine
CATTGTGGCT[G/A]CTCAGTGAAG M G A C Y dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u9 WIAF-12947 M64590 1841 GLDC, glycine
AAACTGAACA[C/A]TTCGTCTGAA M G A S N dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav age system protein P)
G2388u10 WIAF-12948 M64590 2325 GLDC, glycine
GACAGGTCTA[C/T]CTACACCGGG S C T Y Y dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u11 WIAF-12949 M64590 2362 GLDC, glycine
GGTGGGAATC[T/A]GTCCCCCTGG M T A C S dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2388u12 WIAF-12950 M64590 3220 GLDC, glycine
TTAGTCCTCT[C/G]TCCCTAAGTT - C G - - dehydrogenase (decarboxylating;
glycine decarboxyl- ase, glycine cleav- age system protein P)
G2391u1 WIAF-12998 M69238 623 ARNT, aryl hydro-
TGGTGTATGT[G/C]TCTGACTCCG S G C V V carbon receptor nuclear
translocator G2391u2 WIAF-13002 M69238 1072 ARNT, aryl hydro-
TGCCTAGTGG[C/T]CATTGGCAGA M C T A V carbon receptor nuclear
translocator G2391u3 WIAF-13021 M69238 966 ARNT, aryl hydro-
ACCTCACTTC[G/A]TGGTGGTCC- A M G A V M carbon receptor nuclear
translocator G2394u1 WIAF-13003 M73747 2061 TSHR, thyroid
TTGCTCGTAC[T/A]CTTCTATCCA M T A L H stimulating hormone receptor
G2394u2 WIAF-13004 M73747 2248 TSHR, thyroid
TTACCCACGA[C/G]ATGAGGCAGG M C G D E stimulating hormone receptor
G2396u1 WIAF-12995 M74542 1027 ALDH3, aldehyde
CCCCCAGTCC[C/G]CGGTGATGCA M C G P A dehydrogenase 3 G2396u2
WIAF-13019 M74542 1295 ALDH3, aldehyde GGCAACAACA[G/A]CTTCGAGACT M
G A S N dehydrogenase 3 G2403u1 WIAF-13583 M83670 280 CA4, carbonic
TACGATAAGA[A/T]GCAAACGTG- G M A T K M anhydrase IV G2409u1
WIAF-10010 HT2156 1268 AGTR1, angiotensin CCACTCAAAC[C/T9
TTTCAACAAA M C T L F receptor 1 G2411u1 WIAF-13541 M97759 210
ADORA2B, adenosine TGGCGGGCAA[C/T]GTGCTGGTGT S C T N N A2b receptor
G2422u1 WIAF-14077 S90469 375 POR, P450 GCAGCCTGCC[A/G]GAGATCGACA S
A G P P (cytochrome) oxidoreductase G2422u2 WIAF-14078 S90469 852
POR, P450 TCCTGGCTGC[A/G]GTCACCACCA S A G A A (cytochrome)
oxidoreductase G2422u3 WIAF-14082 S90469 1496 POR, P450
AAGGAGCCTG[T/C]CGCCGAGAAC M T C V A (cytochrome) oxidoreductase
G2422u4 WIAF-14099 S90469 1443 POR, P450 AGACCAAGGC[C/T]GGCCGCATCA
S C T A A (cytochrome) oxidoreductase G2422u5 WIAF-14100 S90469
1704 POR, P450 GCCGCCGCTC[G/A]GATGAGGACT S G A S S (cytochrome)
oxidoreductase G2427u1 WIAF-14079 U07919 1369 ALDH6, aldehyde
ACTATGGACT[C/T]ACAGCAGCCG S C T L L dehydrogenase 6 G2427u2
WIAF-14096 U07919 1347 ALDH6, aldehyde ATAAAAAGAG[C/T]GAATACCACC M
C T A V dehydrogenase 6 G243u1 WIAF-11684 X57522 926 TAP1,
transporter ATAGCCAGTG[C/G]AGTGCTGGAG M C G A G 1, ABC (ATP binding
cassette) G243u2 WIAF-11685 X57522 627 TAP1, transporter
ACCCTACCGC[C/T]TTCGTTGTCA S C T A A 1, ABC (ATP binding cassette)
G243u3 WIAF-11686 X57522 538 TAP1, transporter
CCTGCCGGGA[C/G]TTCCCTTGTT M C G L V 1, ABC (ATP binding cassette)
G243u4 WIAF-11687 X57522 798 TAP1, transporter
TGGTGGTCCT[C/G]TCCTCTCTTG S C G L L 1, ABC (ATP binding cassette)
G243u5 WIAF-11689 X57522 1465 TAP1, transporter
TAGTATTTCA[G/T]GTATCCTGCT M G T G C 1, ABC (ATP binding cassette)
G243u6 WIAF-11690 X57522 177 TAP1, transporter
AGAGTCCCAG[A/G]CCCGGCCGGG S A G R R 1, ABC (ATP binding cassette)
G243u7 WIAF-11693 X57522 1067 TAP1, transporter
AACATCATGT[C/T]TCGGGTAACA M C T S F 1, ABC (ATP binding cassette)
G243u8 WIAF-11665 X57522 1207 TAP1, transporter
GGTCACCCTG[A/G]TCACCCTGCC M A G I V 1, ABC (ATP binding cassette)
G243u9 WIAF-11664 X57522 1757 TAP1, transporter
CCAAACCCCC[C/T]ACATGTCTTA N C T P L 1, ABC (ATP binding cassette)
G244u1 WIAF-10174 X60592 239 TNFRSF5, tumor
CTTGCGGTCA[A/C]AGCGAATTCC S A G E E necrosis factor receptor super-
family, member 5 G2441u1 WIAF-13682 U30246 1355 SLC12A2, solute
TGCTTAAGGA[A/G]CATTCCATAC S A G E E carrier family 12
(sodium/potassium/ chloride trans- porters), member 2 G2441u2
WIAF-13714 U30246 2691 SLC12A2, solute AGCCAAATAT[C/G]AGCCATGGCT M
C G Q E carrier family 12 (sodium/potassium/ chloride trans-
porters), member 2 G2443u1 WIAF-14004 U37143 1456 CYP2J2,
cytochrome CTGAAGTTTA[G/A]AATGGGTATC M G A R K P450, subfamily IIJ
(arachidonic acid epoxygenase) polypeptide 2 G2443u2 WIAF-14032
U37143 376 CYP2J2, cytochrome TTTAAGAAAA[A/G]TGGATTGATT M A G N S
P450, subfamily IIJ (arachidonic acid epoxygenase) polypeptide 2
G2443u3 WIAF-14033 U37143 1502 CYP2J2, cytochrone
TCTGCGCTGT[T/A]CCTCAGGTGT S T A V V P450, subfamily IIJ
(arachidonic acid epoxygenase) polypeptide 2 G2444u1 WIAF-14065
U37519 771 ALDH3, aldehyde CCCGCACGGA[A/G]TTGCCTCGTG M A G N S
dehydrogenase 3 G2444u2 WIAF-14066 U37519 1698 ALDH3, aldehyde
AAGGAGATCC[G/A]CTACCCACCC M G A R H dehydrogenase 3 G2445u1
WIAF-14114 U38178 236 CNP, 2',3'-cyclic TGCCGGGCGC[C/A]CCTCTCGCTG M
G A R H nucleotide 3' phosphodiesterase G2445u2 WIAF-14115 U38175
849 CNP, 2',3'-cyclic GTGCCGCCGA[A/G]GAAAAAGTGC S A G G E
nucleotide 3' phosphodiesterase G2445u3 WIAF-14122 U38178 1655 CNP,
2',3'-cyclic GTTATCTTGC[A/T]GAGATCTCTG M A T Q L nucleotide 3'
phosphodiesterase G2445u4 WIAF-14241 X95520 941 CNP, 2',3'-cyclic
TGCAAAATAT[T/C]CAGGAGACCG ? T C ? ? nucleotide 3' phosphodiesterase
G2445u5 WIAF-14242 X95520 1057 CNP, 2',3'-cyclic
TCGAGTTGAT[C/T]TTTCAGTGC- T ? C T ? ? nucleotide 3'
phosphodiesterase G2445u6 WIAF-14243 X95520 1583 CNP, 2',3'-cyclic
TCTACTGGCT[C/G]TCTAACTAAT ? C G ? ? nucleotide 3' phosphodiesterase
G2448u1 WIAF-13973 U46689 1895 ALDH10, aldehyde
TTGTCAAGGC[A/T]GAATATTACT S A T A A dehydrogenase 10 (fatty
aldehyde dehydrogenase) G2457u1 WIAF-13898 U90277 1304 GRIN2A,
glutamate GGTCCCGATG[C/T]ACACCTTGC- A M C T H Y receptor, iono-
tropic, N-methyl D-aspartate 2A G2457u2 WIAF-13899 U90277 1934
GRIN2A, glutamate AAGAAGTAAT[G/T]GCACCGTCTC M G T G C receptor,
iono- tropic, N-methyl D-aspartate 2A G2457u3 WIAF-13900 U90277
2230 GRIN2A, glutamate TCGCTGTCAT[A/G]TTCCTGGCT- A M A G I M
receptor, iono- tropic, N-methyl D-aspartate 2A G2457u4 WIAF-13902
U90277 2916 GRIN2A, glutamate GGCATCTACA[G/A]CTGCATTCAT M G A S N
receptor, iono- tropic, N-methyl D-aspartate 2A G2457u5 WIAF-13903
U90277 3251 GRIN2A, glutamate CTATGTATTC[C/T]AGGCACAAC- A N C T Q *
receptor, iono- tropic, N-methyl D-aspartate 2A G2457u6 WIAF-13917
U90277 2756 GRIN2A, glutamate GGACATTGAC[A/C]ACATCCCGGG M A G N D
receptor, iono- tropiC, N-methyl D-aspartate 2A G2468u1 WIAF-13642
X04011 1017 CYBB, cytochrome AGGTGTCCAA[G/A]CTGGAGTGGC S G A K K
b-245, beta poly- peptide (chronic granulomatous disease) G2473u1
WIAF-13670 X06990 1417 ICAM1, inter- GGTCACCCGC[G/A]AGGTGACCGT M G
A E K cellular adhesion molecule 1 (CD54), human rhinovirus
receptor G2473u2 WIAF-13695 X06990 179 ICAM1, inter-
GACCAGCCCA[A/T]GTTGTTGGGC M A T K M cellular adhesion molecule 1
(CD54), human rhinovirus receptor G2480u1 WIAF-14148 X55330 800
AGA, aspartylgluco- TTGGCATGGT[T/G]GTAATCCATA S T G V V saminidase
G2480u2 WIAF-14149 X55330 852 AGA, aspartylgluco-
AAATGGTATA[A/T]AATTCAAAAT M A T K * saminidase G2480u3 WIAF-14158
X55330 616 AGA, aspartylgluco- TTATCTACCA[G/C]TGCTTCTC- AA M G C S
T saminidase G2485u1 WIAF-13612 X59543 2301 RRM1, ribo-
ATTGATCAAA[C/A]CCAATCTTTG M G A S N nucleotide reductase M1
polypeptide G2485u2 WIAF-43613 X59543 2410 RRM1, ribo-
ATTTAAGGAC[G/A]AGACCAGCAG S G A T T nucleotide reductase M1
polypeptide G2485u3 WIAF-13651 X59543 548 RRM1, ribo-
CAAGTCAACA[T/C]TGGATATTGT S T C L L nucleotide reductase M1
polypeptide G2485u4 WIAF-13652 X59543 199 RRM1, ribo-
TGCATGTGAT[C/T]AAGCGAGATG S C T I I nucleotide reductase M1
polypeptide G2485u5 WIAF-13653 X59543 1037 RRM1, ribo-
CAACACAGCT[C/A]GATATGTGGA S C A R R nucleotide reductase M1
polypeptide G2485u6 WIAF-13660 X59543 1955 RRM1, ribo-
GAAGATTGCA[A/C]ADTATGGTAT M A C K Q nucleotide reductase M1
polypeptide G2485u7 WIAF-13877 X59543 860 RRM1, ribo-
GAGTATGAAA[G/C]ATGACAGCAT M G C E Q nucleotide reductase M1
polypeptide G2486u1 WIAF-14075 X59618 543 RRM2, ribo-
TCAGCACTGG[G/C]AATCCCTGAA M G C E Q nucleotide reductase M2
polypeptide G2486u2 WIAF-14076 X59618 189 RRM2, ribo-
TCGCTGCGCC[T/G]CCACTATGCT - T G - - nucleotide reductase M2
polypeptide G2486u3 WIAF-14092 X59618 524 RRM2, ribo-
TTGACCTCTC[C/G]AACGACATTC S C G S S nucleotide reductase M2
polypeptide G2488u1 WIAF-13585 X63563 1633 POLR2B, polymerase
CCTTGATGGC[C/A]TATATTTC- AG S G A A A (RNA) II (DNA directed) poly-
peptide B (140 kD) G2488u2 WIAF-13586 X63563 2452 POLR2B,
polymerase CTGTAGACCG[C/T]GGCTTCTTCA S C T R R (RNA) II (DNA
directed) poly- peptide B (140 kD) G2488u3 WIAF-13587 X63563 2740
POLR2B, polymerase TCAGAACTAG[T/C]GAGACCGGCA S T C S S (RNA) II
(DNA directed) poly- peptide B (140 kD) G2488u4 WIAF-13602 X63563
1411 POLR2B, polymerase GGGGTGATCA[A/G]AAGAAAGCTC S A G Q Q (RNA)
II (DNA directed) poly- peptide B (140 kD) G2488u5 WIAF-13603
X63563 2386 POLR2B, polymerase CAATTGTGGC[C/T]ATTGCATCAT S C T A A
(RNA) II (DNA directed) poly- peptide B (140 kD) G2489u1 WIAF-14181
X63564 1346 POLR2A, polymerase TGGTGGACAA[T/C]GAGCTGCC- TG S T C N
N (RNA) II (DNA directed) poly- peptide A (220 kD) G2489u2
WIAF-14236 X63564 1647 POLR2A, polymerase TGAATCTTAG[C/T]GTGACAACTC
? C T ? ? (RNA) II (DNA directed) poly- peptide A (220 kD) G2489u3
WIAF-14237 X63564 2678 POLR2A, polymerase CTGAATACAA[C/T]AACTTCAAGT
? C T ? ? (RNA) II (DNA directed) poly- peptide A (220 kD) G2489u4
WIAF-14238 X63564 3059 POLR2A, polymerase AGCTGCGCTA[C/T]GGCGAACACG
? C T ? ? (RNA) II (DNA directed) poly- peptide A (220 kD) G2489u5
WIAF-14239 X63564 3827 POLR2A, polymerase TGGGCCAGTC[C/T]GCTCGAGATG
? C T ? ? (RNA) II (DNA directed) poly- peptide A (220 kD) G2489u6
WIAF-14240 X63564 3992 POLR2A, polymerase TGCCTGACTT[T/C]GATGTGGC-
CC ? T C ? ? (RNA) II (DNA directed) poly- peptide A (220 kD)
G2489u7 WIAF-14245 X63564 3938 POLR2A, polymerase
CCCAGAGCAC[G/A]GTGGTGGCAG ? G A ? ? (RNA) II (DNA directed) poly-
peptide A (220 kD) G250u1 WIAF-11696 HT0155 1113 IL3RA, interleukin
CTGTGTCTTC[G/C]TGATCTGCAG M G C V L 3 receptor, alpha (low
affinity) G251u1 WIAF-11666 HT0240 179 interleukin 1
TGGATAAGAC[C/T]CGAGCTTTGA S C T T T beta convertase G251u2
WIAF-11694 HT0240 973 interleukin 1 GATGCTATTA[A/G]GAAAGCCC- AC M A
G K R beta convertase G251u3 WIAF-11695 HT0240 783 interleukin 1
CCCAGATATA[C/T]TACAACTCAA S C T L L beta convertase G2513u1
WIAF-13736 HT27365 1721 PLCB3, phospho- AACTATCTAT[G/A]AAAAGCCAAA M
G A M I lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u2
WIAF-13737 HT27365 1741 PLCB3, phospho- AACTATTGGG[A/T]AATCTGTTCA M
A T E V lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u3
WIAF-13738 HT27365 1697 PLCB3, phospho- AATCTGTTCA[A/G]TACACGGATT S
A G Q Q lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u4
WIAF-13739 HT27365 1908 PLCB3, phospho- CTGTCAGATT[C/A]TAGCAATGAA M
G A V I lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u5
WIAF-13740 HT27365 2172 PLCB3, phospho- TATACAGATA[C/T]ACGGAATTCC M
C T H Y lipase C, beta 3 (phosphotidylino- sitol-specific) G2513u6
WIAF-13744 HT27365 3019 PLCB3, phospho- TTGAAGGGCC[A/C]AGGAGATCTG M
A G Q R lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u7
WIAF-13745 HT27365 3024 PLCB3, phospho- GGGCCAAGCA[G/A]ATCTGTTGAA M
G A D N lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u8
WIAF-13771 HT27365 1079 PLCB3, phospho- ACATTTTTGA[T/C]CCTGAGCAAA S
T C D D lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u9
WIAF-13772 HT27365 1546 PLCB3, phospho- AAGTTGCCTT[C/T]TGATCCAGAT M
C T S F lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u10
WIAF-13773 HT27365 1514 PLCB3, phospho- AATTAAAAAG[A/T]ATGATCATTG M
A T R S lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u11
WIAF-13774 HT27365 1445 PLCB3, phospho- AGGTCTTTGG[C/T]AATAAACTCT S
C T G G lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u12
WIAF-13778 HT27365 2087 PLCB3, phospho- TTCATATCAA[G/A]ATCATCAGT- G
S G A K K lipase C, beta 3 (phosphotidylino- sitol-specific)
G2513u13 WIAF-13779 HT27365 2367 PLCB3, phospho-
TGAATGTTTG[C/T]ACCCTGGATA N C T Q * lipase C, beta 3
(phosphatidylino- sitol-specific) G2513u14 WIAF-13782 HT27365 2719
PLCB3, phospho- CTCATCACCA[G/A]TGACAATACT M G A S N lipase C, beta
3 (phosphatidylino- sitol-specific) G2513u15 WIAF-13783 HT27365
2567 PLCB3, phospho- TTGATGACAT[C/T]TTTAAAATAG S C T I I lipase C,
beta 3 (phosphatidylino- sitol-specific) G2513u16 WIAF-13784
HT27365 2864 PLCB3, phospho- TAGAAATGGC[G/A]GACACACTCC S G A A A
lipase C, beta 3 (phosphatidylino- sitol-specific) G2513u17
WIAF-13785 HT27365 2571 PLCB3, phospho- TGACATCTTT[A/T]AAATAGCGG- T
N A T K * lipase C, beta 3 (phosphatidylino- sitol-specific)
G2513u18 WIAF-13786 HT27365 2706 PLCB3, phospho-
TCTGTCATCT[C/T]GCCTCATCAC M C T R W lipase C, beta 3
(phosphatidylino- sitol-specific) G252u1 WIAF-10195 HT0425 397
FCER2, Fc fragment GAGGGCTGCC[C/T]GGAACGTCTC M C T R W of IgE, low
affinity II, receptor for (CD23A) G252u2 WIAF-10206 HT0425 930
FCER2, Fc fragment ATGGGAGCCA[T/C]GTGGACTACA S T C H H of IgE, low
affinity II, receptor for (CD23A) G253u1 WIAF-10175 HT0573 228
IFNB1, interferon, GGCTTGAATA[C/T]TGCCTCAACG S C T Y Y beta 1,
fibroblast G254u1 WIAF-10196 HT0611 466 IL4R, interleukin
TCAGTGCGGA[T/C]AACTATACAC S T C D D 4 receptor G254u2 WIAF-10198
HT0611 1474 IL4R, interleukin CATGCCTTCT[T/C]CCACCTTCGG S T C L L 4
receptor G254u3 WIAF-10207 HT0611 1902 IL4R, interleukin
AGTGGCTATC[A/G]GGAGTTTGTA M A G Q R 4 receptor G260u1 WIAF-10186
HT1090 453 IL4R, interleukin TGTTATAATC[C/G]ACAACCCATA M C G A G 1
receptor, type I G261u1 WIAF-10187 HT1101 434 IL7R, interleukin
CCTCACTGTC[A/G]TCTATCCCCA M A G I V 7 receptor G261u2 WIAF-10203
HT1101 517 IL7R, interleukin TTTTAATCCA[T/C]CATCTAGCTT S T C H H 7
receptor G267u1 WIAF-11735 HT1877 881 IL2RB, interleukin
TCCTCGTGGG[C/T]CTCAGCGGGG S C T G G 2 receptor, beta G267u2
WIAF-11759 HT1877 379 IL2RB, interleukin AGTCAAGCAT[C/T]CTGCGCCTGC
M G T S F 2 receptor, beta G268u1 WIAF-11758 HT1985 568 CD19
antigen GCCTCCGTGT[G/C]TCCCACCGAG M G C V L G268u2 WIAF-11734
HT1985 783 CD19 antigen ACGATCGCCC[G/T]GCCAGAGATA S G T P P G270u1
WIAF-11736 HT2415 530 IL6R, interleukin AGGAGGTGGC[A/G]AGAGCCGTGC S
A G A A 6 receptor G270u2 WIAF-11760 HT2415 1590 IL6R, interleukin
CATTGCCATT[G/A]TTCTGAGGTT M G A V I 6 receptor G270u3 WIAF-11737
HT2415 1510 IL6R, interleukin CCAGTGCAAG[A/C]TTCTTCTTCA M A C D A 6
receptor G270u4 WIAF-11761 HT2415 1451 IL6R, interleukin
CTACTAATAA[A/T]GACGATGATA M A T K N 6 receptor G270u5 WIAF-11766
HT2415 1843 IL6R, interleukin TTCCCCAGAT[A/C]CCTGGCTGGG N A G * W 6
receptor G270u6 WIAF-11767 HT2415 1829 IL6R, interleukin
ATACAGACTA[C/T]TTCTTCCCCA S C T Y Y 6 receptor G271u1 WIAF-11762
HT2531 577 CD2, CD2 antigen TCAGAGGCTC[A/G]TCACACACAA M A G I V
(p50), sheep red blood cell receptor G271u2 WIAF-11739 HT2531 861
CD2, CD2 antigen GGAAGCCCCA[A/C]CAAATTCCAG M A C X H (p50), sheep
red blood cell receptor G271u3 WIAF-11768 HT2531 818 CD2, CD2
antigen CTGGAGACAA[G/A]AGCCCACAGA M G A R K (p50), sheep red blood
cell receptor G271u4 WIAF-11738 HT2531 736 CD2, CD2 antigen
CCTCTTGATG[G/A]TCTTTGTGGC M G A V I (p50), sheep red blood cell
receptor G273u1 WIAF-11763 HT3139 667 IL2RA, interleukin
ATCATCGTGC[C/T]TGGCTGCCAG M C T P L 2 receptor, alpha G273u2
WIAF-11764 HT3139 956 IL2RA, interleukin AAACTCCAAT[G/C]CACCCACTGC
M G C M I 2 receptor, alpha G273u3 WIAF-11765 HT3139 701 IL2RA,
interleukin ACGATGACCC[G/A]CCAGAGATCC S G A P P 2 receptor, alpha
G273u4 WIAF-11740 HT3139 1133 IL2RA, interleukin
AAATGACCCA[C/T]GGGAAGACAA S C T H H 2 receptor, alpha G273u5
WIAF-11769 HT3139 1163 IL2RA, interleukin AGCCCCAGCT[C/A]ATATGCACAG
S C A L L 2 receptor, alpha G276u1 WIAF-10192 HT3670 644 CD4
antigen CTCCTAGTAG[C/G]CCCTCAGTGC M C G S R G276u2 WIAF-10193
HT3670 1535 CD4 antigen CCTGCCAGTG[T/C]CCTCACCGCT S T C C C G276u3
WIAF-10205 HT3670 1217 CD4 antigen TGATCCTGAC[T/C]TTCAAACTCG S T C
S S G277u1 WIAF-10007 D10232 851 RENBP, renin-
CACGTGATTG[A/G]CAAGTTCCTA M A G D G binding protein G277u2
WIAF-10032 D10232 842 RENBP, renin- CTTCGAGCCC[A/G]CGTGATTGAC M A G
H R binding protein G277u3 WIAF-10042 D10232 634 RENBP, renin-
CCTGGCGGCC[A/G]AATACGCAGA M A G K E binding protein G279u1
WIAF-10047 K01740 1658 F8C, coagulation ACTGATGTCC[G/A]TCCTTTGTAT M
G A R H factor VIIIc, procoagulant component (hemophilia A) G279u2
WIAF-10049 K01740 2328 F8C, coagulation CCTTACTGAA[G/A]GTTTCTAGT- T
S G A K K factor VIIIc, procoagulant component (hemophilia A)
G279u3 WIAF-10050 K01740 4650 F8C, coagulation
CTGTTCTCCC[G/A]AAACCAGACT S G A P P factor VIIIc, procoagulant
component (hemophilia A) G279u4 WIAF-10050 K01740 6919 F8C,
coagulation CCAGAAGACA[A/C]TGAAAGTCAC M A G M V factor VIIIc,
procoagulant component (hemophilia A) G279u5 WIAF-10080 K01740 480
F8C, coagulation TTAAGAACAT[G/A]GCTTCCCATC M G A M I factor VIIIc,
procoagulant component (hemophilia A) G279u6 WIAF-10082 K01740 2129
F8C, coagulation TACATTCTAA[G/A]CATTGGAGC- A M G A S N factor
VIIIc, procoagulant component (hemophilia A) G279u7 WIAF-10084
K01740 2533 F8C, coagulation GTTTGCACAC[A/G]CAACACCTAT M A G R G
factor VIIIc, procoagulant component (hemophilia A) G279u8
WIAF-10086 K01740 6639 F8C, coagulation ACCCTCCAAT[T/C]ATTGCTCGAT S
T C I I factor VIIIc, procoagulant component (hemophilia A) G279u9
WIAF-10087 K01740 5957 F8C, coagulation GAGAATTATC[G/A]CTTCCATGCA M
G A R H factor VIIIc, procoagulant component (hemophilia A) G279a10
WIAF-10495 K01740 5829 F8C, coagulation TGACAGTACA[G/A]GAATTTGC- TC
S G A Q Q factor VIIIc, procoagulant component (hemophilia A)
G279a11 WIAF-10496 K01740 5852 F8C, coagulation
TTTTTCACCA[T/G]CTTTCATGAG M T G I S factor VIIIc, procoagulant
component (hemophilia A) G279a12 WIAF-10502 K01740 2492 F8C,
coagulation ACCACAATTC[C/T]AGAAAATGAC M C T P L factor VIIIc,
procoagulant component (hemophilia A) G279a13 WIAF-10503 K01740
6906 F8C, coagulation TGCAAGTGGA[C/T]TTCCAGAAGA S C T D D factor
VIIIc, procoagulant component (hemophilia A) G279a14 WIAF-13120
K01740 1980 F8C, coagulation CAGAGAATAT[A/C]CAACGCTT- TC S A c I I
factor VIIIc, procoagulant component (hemophilia A) G279a15
WIAF-13121 K01740 1982 F8C, coagulation GAGAATATAC[A/C]ACGCTTTCTC M
A c Q P factor VIIIc, procoagulant component (hemophilia A) G282u1
WIAF-10067 L25615 976 AVPR1A, arginine CGCCTTTCTT[C/A]ATCATCCAGA M
C A F F vasopressin receptor 1A G282u2 WIAF-10070 L25615 460
AVPR1A, arginine TCGGCATGTT[T/C]GCGTCGGCCT S T C F F vasopressin
receptor 1A G282u3 WIAF-10071 L25615 343 AVPR1A, arginine
GCCTGGCCGA[C/T]CTGGCCGTGG S C T D D vasopression receptor 1A G282u4
WIAF-10072 L25615 68 AVPR1A, arginine TCTCTCCGCC[G/A]GTCCCGACGC M G
A G S vasopression receptor 1A G282u5 WIAF-10073 L25615 535 AVPR1A,
arginine AGACTCTGCA[A/G]CAGCCCGCGC S A G Q Q vasopressin receptor
1A G282u6 WIAF-10092 L25615 1075 AVPR1A, arginine
CCTTGAATAG[C/A]TGCTGTAATC M C A S R vasopressin receptor 1A G282a7
WIAF-10499 L25615 1089 AVPR1A, arginine TGTAATCCCT[G/A]GATATACATG N
G A W * vasopressin receptor 1A G284u1 WIAF-10182 M16827 1179
ACADM, acyl- AATATCCTGT[A/G]GAAAAACTAA S A G V V Coenzyme A
dehydrogenase, C-4 to C-12 straight chain G284a2 WIAF-10515 M16827
696 ACADM, acyl- TTGTGGAACC[A/G]GATACCCCA- G S A G A A Coenzyme A
dehydrogenase, C-4 to C-12 straight chain G285u1 WIAF-10108 M28372
258 ZNF9, zinc finger CTCTTCCAGA[T/C]ATTTGTTATC S T C D D protein 9
(a cellular retroviral nucleic acid binding protein) G289u1
WIAF-10041 M63012 172 PON1, paraoxonase 1 CTCTGAAGAC[A/T]TGGAGATACT
M A T M L G290u1 WIAF-10085 M63959 354 LRPAP1, low density
CTCATACGCA[A/G]CCTCAATGT- C M A G N S lipoprotein-related
protein-associated protein 1 (alpha-2- macroglobulin receptor
associated protein 1) G290a2 WIAF-13122 M63959 223 LRPAP1, low
density AGCGACTGCA[T/A]CTTCCTCCCG M T A H Q lipoprotein-related
protein-associated protein 1 (alpha-2- macroglobulin receptor
associated protein 1) G292u1 WIAF-10180 M74096 1002 ACADL, acyl-
AGTGCAACAT[A/C]AATTAGCAGA M A C K Q Coenzyme A dehydrogenase, long
chain G293u1 WIAF-10068 M74775 723 LIPA, lipase A,
AAGGACTTAT[T/C]TGGACACAAA M T C F S lysosomal acid, cholesterol
esterase (Wolman disease) G293a2 WIAF-10497 M74775 107 LIPA, lipase
A, TGAGGGGTCT[G/A]GAGGGAAACT M G A G R lysosomal acid, cholesterol
esterase (Wolman disease) G293a3 WIAF-10498 M74775 86 LIPA, lipase
A, GGTTCTCTGG[C/A]CCCTGCATTC M C A P T lysosomal acid, cholesterol
esterase (Wolman disease) G295u1 WIAF-10057 U04270 1282 KCNH2,
potassium AAAGGAGCGA[A/T]CCCACAATGT M A T T S voltage-gated
channel, subfamily H, member 2 G295u2 WIAF-10062 U04270 1875 KCNH2,
potassium CGCACTGGCT[A/G]GCCTGCATCT S A G L L voltage-gated
channel, subfamily H, member 2 G295u3 WIAF-10064 U04270 2040 KCNH2,
potassium ACTTCACCTT[C/T]AGCAGCCTCA S C T F F voltage-gated
channel, subfamily H, member 2 G295u4 WIAF-10088 U04270 1650 KCNH2,
potassium CCGGCCGCAT[C/T]GCCCTCCACT S C T I I voltage-gated
channel, subfamily H, member 2 G295u5 WIAF-10090 U04270 2139 KCNH2,
potassium CCCTCATGTA[T/C]GCTAGCATCT S T C Y Y voltage-gated
channel, subfamily H, member 2 G2951u1 WIAF-14147 HT0030 1334
ZNF42, zinc finger CCCTGCTCTG[A/G]TCACCACCCG M A G I V protein 42
(myeloid-specific retinoic acid responsive) G2951u2 WIAF-14157
HT0030 1558 ZNF42, zinc finger ACCAGCTTAC[G/A]CACACCGAGG S G A T T
protein 42 (myeloid-specific retinoic acid responsive) G2959u1
WIAF-13501 HT0134 1014 GRLP1, gluco- GTGGAGAGAC[T/C]CTGCATAGCT S T
C T T corticoid receptor DNA binding factor 1 G2959u2 WIAF-13518
HT0134 1853 GRLF1, gluco- GAGCCATCTT[A/C]CAGCCTGTTT M A C Y S
corticoid receptor DNA binding factor 1 G296a1 WIAF-10514 U12778
961 ACADSB, acyl- TATTCCATAT[A/G]TTAAAGAAAG M A G I V Coenzyme A
dehydrogenase, short/branched chain G2968u1 WIAF-12699 HT0244 1754
SMARCA1, SWI/SNF CAGAACAAAC[C/T]ACTACGTGTA M C T P L related,
matrix associated, actin dependent regulator of chromatin, sub-
family a, member 1 G2968u2 WIAF-12716 HT0244 2624 SMARCA1, SWI/SNF
TGGGAACGTT[G/T]CAATGAATTA M G T C F related, matrix associated,
actinc dependent regulator of chromatin, sub- family a, member 1
G297u1 WIAF-10109 U516660 402 ECH1, enoyl ACATGGCTTC[G/A]GACATCCTCC
S G A S S Coenzyme Ahydratase 1, peroxisomal G297u2 WIAF-10110
U16660 149 ECH1, enoyl GCACAAGAGG[A/C]GGCTTCCGGA M A C E A Coenzyme
A hydratase 1, peroxisomal G2970u1 WIAF-12746 HT0281 682 BR140:
bromodomain- ATGACATGGA[C/T]GAGCAGGACT S C T D D containing
protein, 140 kD (peregrin) G2975U1 WIAF-12729 HT0334 1104
B-cell-specific ACTTTTCCGG[G/A]ACTCCCTACA S G A C G transcription
factor G2975u2 WIAF-12730 HT0334 1185 B-cell-specific
GCTCCCCCTA[C/T]TATTATACCC S C T Y Y transcription factor G2976a1
WIAF-12129 HT0340 1600 SATB1, special GTCCTGCCCC[C/A]CTCATCAGCA S C
A P P AT-rich sequence binding protein 1 (binds to nuclear
matrix/scaf fold- associating DNA's) G2976u2 WIAF-12743 HT0340 2116
SATB1, special AT- TGGCCTCTCC[A/G]GCACAGTCAG S A G P P rich
sequence binding protein 1 (binds to nuclear matrix/scaf fold-
associating DNA's) G2978u1 WIAF-12721 HT0346 1140 MSX1, msh (Droso-
CATAGAGGGT[C/T]CCAGGTCCCC - C T - - phila) homeo box homolog 1
(formerly homeo box 7) G298u1 WIAF-10048 U33837 8995 Human
glycoprotein CCGGACAGGA[G/A]GTGCATTCCC M G A R K receptor gp330
precursor, mRNA, complete cds. G298u2 WIAF-10051 U33837 13217 Human
glycoprotein ATGCAGCCAT[C/T]GAACTGCCTA S C T I I receptor gp330
precursor, mRNA, complete cds. G298u3 WIAF-10077 U33837 6298 Human
glycoprotein AACTCTTTCA[T/C]TGTTGTTTCA M T C I T receptor gp330
precursor, mRNA, complete cds. G298u4 WIAF-10078 U33837 6371 Human
glycoprotein CCATGGTCCC[G/A]GTGGCAGG- CC S G A P P receptor gp330
precursor, mRNA, complete cds. G298u5 WIAF-10079 U33837 6914 Human
glycoprotein ACTCTGAAGT[G/A]ATTCGTTATG S G A V V receptor gp330
precursor, mRNA, complete cds. G298u6 WIAF-10081 U33837 8718 Human
glycoprotein GTTCCAATGC[G/A]CATCTGGG- CG M G A A T receptor gp330
precursor, mRNA, complete cds. G298u7 WIAF-10083 U33837 9088 Human
glycoprotein ACTTGCTCTG[A/G]AAATGAATTC M A G E G receptor gp330
precursor, mRNA, complete cds. G298u8 WIAF-10096 U33837 6949 Human
glycoprotein ACTCCTTATC[G/C]CATCACTC- TT M G C G A receptor gp330
precursor, mRNA, complete cds. G298u9 WIAF-10097 U33837 7149 Human
glycoprotein TTCCTTCCAA[A/C]ACAATCGTGG M A G N D receptor gp330
precursor, mRNA, complete cds. G298u10 WIAF-10100 U33837 8590 Human
glycoprotein TACACAAAAT [C/A]TCATAATTCA M G A C Y receptor gp330
precursor, mRNA, complete cds. G298u11 WIAF-10101 U33837 12948
Human glycoprotein CATCTTTCAA[G/C]ACCACTTATA M G C D H receptor
gp330 precursor, mRNA, complete cds. G2980u1 WIAF-12723 HT0356 437
TLE1, transducin- TCATGGCCAC[G/A]GACCCCCACT M G A G R like enhancer
of split 1, homolog of Drosophila E(sp1) G2980u2 WIAF-12726 HT0356
2044 TLE1, transducin- AGTGGCTGGC[A/G]GTGGGCATGG S A G A A like
enhancer of split 1, homolog of Drosophila E(sp1) G2980u3
WIAF-12747 HT0356 379 TLE1, transducin- CCATGGCAGA[G/A]TTGAATGCCA S
G A E E like enhancer of split 1, homolog of Drosophila E(sp1)
G2980u4 WIAF-12748 HT0356 276 TLE1, transducin-
ATCGCCAAGA[G/A]ATTGAATACG M G A R K like enhancer of split 1,
homolog of Drosophila E(sp1) G2980u5 WIAF-12749 HT0356 1876 TLE1,
transducin- GCCACACAGA[C/T]GGAGCCAGCT S C T D D like enhancer of
split 1, homolog of Drosophila E(sp1) G2980u6 WIAF-12750 HT0356
1759 TLE1, transducin- CCGCCTGCTA[C/T]GCCCTGGCCA S C T Y Y like
enhancer of split 1, homolog of Drosophila E(sp1) G2981u1
WIAF-12720 HT0357 2206 TLE2, transducin- ACAAATACAT[T/C]GTGACAGSCT
S T C I I like enhancer of split 2, homolog of Drosophila E(sp1)
G2981u2 WIAF-12737 HT0357 1036 TLE2, transducin-
CGGACAGCGT[C/T]GCCCTCACCA S C T V V like enhancer of split 2,
homolog of Drosophila E(sp1) G2981u3 WIAF-12740 HT0357 2181 TLE2,
transducin- CTGAGTTGTG[A/T]CATCTCCAGA M A T D V like enhancer of
split 2, homolog of Drosophila E(sp1) G2983u1 WIAF-12833 HT0360 636
TLE3, transducin- TGTCACCCTC[G/C]GAAAGCCTCC S G C S S like enhancer
of split 3, homolog of Drosophila E(sp1) G2983u2 WIAF-12834 HT0360
1944 TLE3, transducin- TGGACAACAC[G/A]GTGCGCTCCT S G A T T like
enhancer of split 3, homolog of Drosophila E(sp1) G2983u3
WIAF-12848 HT0360 1710 TLE3, transducin- ACCTGGCCTC[C/A]CCCACGCCCC
S G A S S like enhancer of split 3, homolog of Drosophila E(sp1)
G2985u1 WIAF-12724 HT0421 995 homeotic protein D3
CGCTTCGCCA[G/A]CGCCAACCTC M G A S N G2985u2 WIAF-12725 HT0421 1003
homeotic protein D3 CACCGCCAAC[C/T]TGCAGGCCAC S C T L L G2986u1
WIAF-14124 HT0468 1197 CSDA, cold shock GCCGTGGATA[C/T]CGGCCTCCCT S
C T Y Y domain protein A G2987u1 WIAF-12758 HT0474 2068 ZNF7, zinc
AGTGCTTTTA[C/T]GAATATGCG- A S C T Y Y finger protein 7 (KOX 4,
clone HF.16) G2987u2 WIAF-12773 HT0474 985 ZNF7, zinc
GAGAGAAGCC[G/C]TACGAATGTG S G C P P finger protein 7 (KOX 4, clone
HF.16) G2987u3 WIAF-12775 HT0474 1278 ZNF7, zinc
AGCCAGCAGT[C/T]GCAGCTGGTT M C T S L finger protein 7 (KOX 4, clone
HF.16) G3005a1 WIAF-12133 HT0735 1441 homeotic protein
GAGGCAGCGG[C/T]CCCGGGCC- TG S C T G G 5.1 G3008a1 WIAF-12134 HT0753
1850 ATF4, activating TAAAAGAGAG[C/A]GCGGATTCCC S G A R R
transcription factor 4 (tax- responsive enhancer element B67)
G3008u2 WIAF-12798 HT0753 946 ATF4, activating
CCCTTCGACC[C/A]GTCGGGTTTG M C A P Q transcription factor 4 (tax-
responsive enhancer element B67) G3008u3 WIAF-12812 HT0753 1482
ATF4, activating CACTGCTTAC[G/A]TTGCCATGAT M G A V I transcription
factor 4 (tax- responsive enhancer element B67) G3008u4 WIAF-12813
HT0753 1847 ATF4, activating CTCTAAAAGA[G/C]AGGGCGGATT M G C E D
transcription
factor 4 (tax- responsive enhancer element B67) G301u1 WIAF-10127
U71285 3639 MTR, 5-methyltetra- TGTGGAGACT[C/T]GCAGACATCG S C T L L
hydrofolate- homocysteine methyltransferase G3012u1 WIAF-12794
HT0873 402 MAD, MAX TGGTGCCACT[C/T]GGACCCGAAT S G T L L
dimerization protein G3014u1 WIAF-14183 HT0899 274 homeotic protein
2, AAAAGACTCA[G/A]TACTTGGCCT S G A Q Q distal-less G3020u1
WIAF-12797 HT0956 852 MLLT3, myeloid/ GTGCCTTCAA[A/G]GAACCTTCCA S A
G K K lymphoid or mixed- lineage leukemia (trithorax (Drosophila)
homolog); translocated to, 3 G3023u1 WIAF-13724 HT0966 381 zinc
finger, X- GCTGCAGCAA[G/A]CAATATGACA S G A K K linked, duplicated A
G3023u2 WIAF-13725 HT0966 220 zinc finger, X-
GGCCAAACTC[G/A]GCGCCCACCA M G A G S linked, duplicated A G3023u3
WIAF-13726 HT0966 69 zinc finger, X- AGTCGCACGA[T/C]AAACTGCGGC S T
C D D linked, duplicated A G3023u4 WIAF-13727 HT0966 249 zinc
finger, X- ACTTCGAACC[C/T]CACACCCCTT S C T P P linked, duplicated A
G3023u5 WIAF-13765 HT0966 661 zinc finger, X-
CAGGTTCTCT[G/A]CTCGCAGTAG M G A A T linked, duplicated A G3023u6
WIAF-13766 HT0966 1302 zinc finger, X- TGACTCCTTC[C/T]AGCACCCTTT S
G T S S linked, duplicated A G3027u1 WIAF-12800 HT1035 124 HOXB7,
homeo box B7 TTATGCGAAT[G/A]CTTTATTTTC M G A A T G3027u2 WIAF-12816
HT1035 450 HOXB7, homeo box B7 GCCACTCGCA[C/T]TTCGCGCCCC S C T D D
G3028u1 WIAF-12806 HT1037 701 homeotic protein C8
AGACCCTCGA[A/G]CTCCAGAACC S A G E E G3029u1 WIAF-14153 HT1100 441
zinc finger TCAGACTCAG[G/A]CAAAACTCCG S G A R R protein 8 G3029u2
WIAF-14155 HT1100 1416 zinc finger GCCGTCAACA[A/G]TCCTCGACCA S A G
Q Q protein 8 G303u1 WIAF-10000 X13916 4110 LRP1, low density
ATGGAGCTGG[C/A]GCCCGACAAC M G A G E lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u2 WIAF-10001 X13916 4012
LRP1, low density GCGAGCTCTG[C/T]GACCACTGCT S C T C C lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G303u3
WIAF-10002 X13916 4702 LRP1, low density GCCTGCCCCG[C/T]ATTGAGGCAG
S C T R R lipoprotein- related protein 1 (alpha-2-macro- globulin
receptor) G303u4 WIAF-10003 X13916 6395 LRP1, low density
CTGGATCGCA[G/A]GCAACATCTA M G A G S lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u5 WIAF-10004 X13916 6937
LRP1, low density AAGGCACCAA[C/T]GTGTGCGCGG S C T N N lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G303u6
WIAF-10005 X13916 9391 LRP1, low density GGCTGAAGGA[T/C]GACGGCCGCA
S T C D D lipoprotein- related protein 1 (alpha-2-macro- globulin
receptor) G303u7 WIAF-10011 X13916 766 LRP1, low density
ACTGCATCGA[C/T]GGCTCAGATG S C T D D lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u8 WIAF-10015 X13916 9040
LRP1, low density ACCCGACCTG[C/T]GGCCCCAGTG S C T C C lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G303u9
WIAF-10019 X13916 11749 LRP1, low density CCCTGCGCTG[C/T]AACATGTTCG
S C T C C lipoprotein- related protein 1 (alpha-2-macro- globulin
receptor) G303u10 WIAF-10020 X13916 1917 LRP1, low density
GACCAGTATG[G/A]GAAGCCGGGT M G A G E lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u11 WIAF-10021 X13916 4810
LRP1, low density AGAAGCGCAT[C/T]CTTTGGATTG S C T I I lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G303u12
WIAF-10022 X13916 6367 LRP1, low density TTGGCCGTGT[G/C]GAGGGCATTG
S G C V V lipoprotein- related protein 1 (alpha-2-macro- globulin
receptor) G303u13 WIAF-10023 X13916 6247 LRP1, low density
CTGTCCGCAT[C/T]GACTTCCACG S C T I I lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u14 WIAF-10024 X13916 8371
LRP1, low density ACGCCTCAGA[T/C]GAGATGAACT S T C D D lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G303u15
WIAF-10030 X13916 11395 LRP1, low density ACGGCAGCGA[C/T]GAGGAGGCCT
S C T D D lipoprotein- related protein 1 (alpha-2-macro- globulin
receptor) G303u16 WIAF-10031 X13916 12763 LRP1, low density
ACGTCTTTGA[G/A]GATTACATCT S G A E E lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u17 WIAF-10035 X13916 640
LRP1, low density ACGGATCTGA[C/T]GAGGCCCCTG S C T D D lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G303u18
WIAF-10037 X13916 1609 LRP1, low density GCCGCCTTGT[C/T]TACTGGGCAG
S C T V V lipoprotein- related protein 1 (alpha-2-macro- globulin
receptor) G303u19 WIAF-10038 X13916 1629 LRP1, low density
GATGCCTATC[T/G]GGACTATATT M T G L R lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u20 WIAF-10039 X13916 2210
LRP1, low density CACCAGCTAC[C/T]TCATTGGCCG M C T L F lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G303u21
WIAF-10043 X13916 7287 LRP1, low density GATGGCTCCA[G/A]GAGGATCACC
M G A R K lipoprotein- related protein 1 (alpha-2-macro- globulin
receptor) G303u22 WIAF-10044 X13916 8258 LRP1, low density
CTCTGACGAC[A/G]TCCCTTGCAA M A G I V lipoprotein- related protein 1
(alpha-2-macro- globulin receptor) G303u23 WIAF-10045 X13916 11871
LRP1, low density GTGCGCACCG[A/G]GAAAGCCGCC M A G E G lipoprotein-
related protein 1 (alpha-2-macro- globulin receptor) G3031u1
WIAF-14097 HT1128 611 PSMC3, proteasome TGGGGATCCA[A/C]CCTCCAAAAG S
A G Q Q (prosome, macro- pain) 26S subunit, ATPase, 3 G3034u2
WIAF-12837 HT1182 421 TCF12, tran- ATCTTCAATT[A/C]TGGGTTCCTT M A G
M V scription factor 12 (HTF4, helix-loop- helix transcription
factors 4) G3038u1 WIAF-12864 HT1373 1700 NFKB1, nuclear
AGAGAAGGCT[A/G]TGCAGCTTGC M A G M V factor of kappa light
polypeptide gene enhancer in B-cells 1 (p105) G3038u2 WIAF-12881
HT1373 1936 NFKB1, nuclear TGTACCAGAC[G/A]CCCTTGCACT S G A T T
factor of kappa light polypeptide gene enhancer in B-cells 1 (p105)
G3038u3 WIAF-12882 HT1373 2641 NFKB1, nuclear
AGCTGCACCT[G/C]TATAAGTTAC S G C L L factor of kappa light
polypeptide gene enhancer in B-cells 1 (p105) G3039u1 WIAF-13027
HT1375 3761 GLI3, GLI-Kruppel AACAGCCCCG[G/T]AACTCCCACC M G T G V
family member GLI3 (Greig cephalopoly- syndactyly syndrome) G3039u2
WIAF-13028 HT1375 3963 GLI3, CLI-Kruppel CGCCAAATGA[G/T]TCAGCTGGCA
M G T E D family member GLI3 (Greig cephalopoly- syndactyly
syndrome) G304u1 WIAF-12242 HT637 158 FABP3, fatty acid
CTCACCCTAA[A/C]AACACACAGC M A G K R binding protein 3, muscle and
heart (mammary derived growth inhibitor) G3043u1 WIAF-12867 HT1486
842 IRF2, interferon GTGCCGAGGG[G/A]CGGCCACACT S G A G G regulatory
factor 2 G3047u1 WIAF-12875 HT1518 1233 transcription
TCCGTTTCCT[C/T]GAGAGCCTGC S C T L L factor 1, nucleolar G3047u2
WIAF-12876 HT1518 1746 transcription GGATTAAGAA[G/A]GCACCCGAAG S G
A K K factor 1, nucleolar G3047u3 WIAF-12877 HT1518 1829
transcription TCCAAGAAGA[T/C]GAAATTCCAG M T C M T factor 1,
nucleolar G3048u1 WIAF-12884 HT1530 628 transcription
AGTGGAGCGT[C/T]GCCGCCGAGA M C T R C factor USF G305u1 WIAF-10150
HT0034 777 prolyl 4-hydroxy- CCCTTGTCAT[C/T]GAGTTCACCG S C T I I
lase, beta subunit/ protein disulfide isomerase/thyroid
hormone-binding protein, alt. transcript 1 G305u21 WIAF-10154
HT0034 186 prolyl 4-hydroxy- TGGCCGCCCA[C/A]AAGTACCTCC M C A H Q
lase, beta subunit/ protein disulfide isomerase/thyroid
hormone-binding protein, alt. transcript 1 G305u3 WIAF-10155 HT0034
1428 prolyl 4-hydroxy- GGACGGTCAT[T/C]GATTACAACG S T C I I lase,
beta subunit/ protein disulfide isomerase/thyroid hormone-binding
protein, alt, transcript 1 G3050u1 WIAF-12860 HT1558 2098 PSRG1:
female AACATTGCAA[T/C]GGCATTTTGA S T C N N sterile homeotic related
gene 1 (mouse homolog) G3050u2 WIAF-12861 HT1558 2845 FSRG1: female
TAGGCCCTTC[T/C]GGCTTTGGAC S T C S S sterile homeotic related gene 1
(mouse homolog) G3050u3 WIAF-12862 HT1558 3409 FSRG1: female
CCTCGTCGTC[G/A]TCTTCAGACA S G A S S sterile homeotic related gene 1
(mouse homolog) G3050u4 WIAF-12874 HT1558 1699 FSRG1: female
TCTCTTCTGT[G/C]TCACACACAG S G C V V sterile homeotic related gene 1
(mouse homolog) G3050u5 WIAF-12878 HT1558 2093 FSRG1: female
GTTAAAACAT[T/G]GCAATGGCAT M T G C G sterile homeotic related gene 1
(mouse homolog) G3050u6 WIAF-12879 HT1558 2746 FSRG1: female
CTGGGGCCGA[C/T]GAAGATGACA S C T D D sterile homeotic related gene 1
(mouse homolog) G3051u1 WIAF-12866 HT1569 1423 MEF2B, MADS box
CTTGGCCGAC[G/A]GCTGGCCCCG S G A T T transcription enhancer factor
2, polypeptide B (myocyte enhancer factor 2B) G3051u2 WIAF-13022
HT1569 661 MEF2B, MADS box CAGACTACAG[C/T]GAGCCCCACG S C T S S
transcription enhancer factor 2, polypeptide B (myocyte enhancer
factor 2B) G3057a1 WIAF-12142 HT1669 5565 alpha-fetoprotein
AGACTGCTCT[T/C]GAGGCTCATA S T C L L enhancer-binding protein
G3057a2 WIAF-12143 HT1669 5634 alpha-fetoprotein
CTCTGTCTGC[C/A]ATGCTCTTA- G S G A A A enhancer-binding protein
G3057a3 WIAF-12144 HT1669 5664 alpha-fetoprotein
GGGGACTCCA[G/T]ATGAAAGGA- G M G T Q H enhancer-binding protein
G3057a4 WIAF-12145 HT1669 5703 alpha-fetoprotein
GCTTTTCCCA[C/T]CTACCCCCA- A S C T H H enhancer-binding protein
G3057u5 WIAF-12885 HT1669 2227 alpha-fetoprotein
TCTGGAGATC[C/T]ATATGAGGT- C M C T H Y enhancer-binding protein
G3057u6 WIAF-12892 HT1669 3720 alpha-fetoprotein
AGACCTTGCC[G/A]GCTCAGCTA- C S G A P P enhancer-binding protein
G3057u7 WIAF-12893 HT1669 4137 alpha-fetoprotein
CAAGGTTTAC[G/A]GACTACCAC- C S G A T T enhancer-binding protein
G3057u8 WIAF-12897 HT1669 4783 alpha-fetoprotein
GAAGACCAAC[A/C]CTCCCCAGC- A M A C T P enhancer-binding protein
G3057u9 WIAF-12898 HT1669 5215 alpha-fetoprotein
TCCAACCTCC[A/C]CAATGAACA- C M A C T P enhancer-binding protein
G3057u10 WIAF-12904 HT1669 7266 alpha-fetoprotein CCCTGCAGCC[C/TI
GCGTTGACTT S C T A A enhancer-binding protein G3057u11 WIAF-12907
HT1669 8345 alpha-fetoprotein CCAACACACG[A/C]CTATTCGGAG M A C D A
enhancer-binding protein G3057u12 WIAF-12943 HT1669 4257
alpha-fetoprotein TGGTGTGGTT[T/C]CAGAATGCCC S T C F F
enhancer-binding protein G057u13 WIAF-12951 HT1669 7333
alpha-fetoprotein ACCAGGCTTT[T/A]CTCCTTATTA M T A S T
enhancer-binding protein G3057u14 WIAF-13030 HT1669 303
alpha-fetoprotein GCAHCCTGTC[C/A]GAGGACGAGT S G A S S
enhancer-binding protein G3057u15 WIAF-13031 HT1669 777
alpha-fetoprotein GCCTTCCAGA[G/A]GACGACGAGG S G A E E
enhancer-binding protein G306u1 WIAF-10118 HT0040 1618 CPT2,
carnitine CTCTACTGCC[C/A]TCCACTTTGA M G A V I palmitoyl-
transferase II G307u1 WIAF-10076 HT0114 110 EDN2, endothelin 2
CGTTGCGCTA[G/A]CCCTGCTCGT M G A A T G3070u1 WIAF-12972 HT2085 625
pre-B-cell leukemia AGAAATATGA[A/C]CAGGCATGTA S A G E E
transcription factor 3 G3070u2 WIAF-12973 HT2085 841 pre-B-cell
leukemia GTAACTTCAG[T/C]AAACAGGCCA S T C S S transcription factor 3
G3071u1 WIAF-12886 HT2086 995 AGER, advanced
CCTGCGAGGC[T/C]GTGATGATCC S T C A A glycosylation end
product-specific receptor G3071u2 WIAF-12887 HT2086 1475 AGER,
advanced GAGGCCAGAT[C/G]TACAGCCCAC M C G I M glycosylation end
product-specific receptor G3071u3 WIAF-12935 HT2086 933 AGER,
advanced ACGCATGGTG[A/G]GCATCATCCA M A G S G glycosylation end
product-specific receptor G3071u4 WIAF-12936 HT2086 1052 AGER,
advanced GTAACTTCAC(C/T]AAACAGGCCA S C T S S glycosylation end
product-specific receptor G3071u5 WIAF-12937 HT2086 836 AGER,
advanced AGAAGTATGA[G/A]CAGGCATGTA S G A E E glycosylation end
product-specific receptor G308u1 WIAF-10094 HT0192 484 ANX4,
annexin IV ATGGACGGAG[C/G]CTTGAAGATG M C G S R (placental anti-
coagulant protein II) G308u2 WIAF-10095 HT0192 333 ANX4, annexin IV
GGGATCATGA[C/T]GCCCACGG- TC M C T T M (placental anti- coagulant
protein II) G3081u1 WIAF-12997 HT2188 689 PSMC2, proteasome
GGCATTGAGC[C/T]TCCCAAGGGC M C T P L (prosome, macro- pain) 26S
subunit, ATPase, 2 G3083u1 WIAF-12976 HT2228 106 IGHMBP2, immuno-
TGCTGGAGCT[T/C]GAGAGAGACG S T C L L globulin mu binding protein 2
G3083u2 WIAF-12985 HT2228 2260 IGHMBP2, immuno-
TGGAGTTCAT[G/C]GCCAGCAAGA M G C M I globulin mu binding protein 2
G3083u3 WIAF-12986 HT2228 2060 IGHMBP2, inmuno-
GGGACCTGCT[A/G]CGTCCACCAG M A G T A globulin mu binding protein 2
G3083u4 WIAF-12987 HT2228 2365 IGHMBP2, immuno-
ACGACAGTTC[C/T]GGGGAAGGGA S C T S S globulin mu binding protein 2
G3083u5 WIAF-13005 HT2228 411 IGHMBP2, immuno-
TTTGATGAGT[C/T]CCACGATTTC M C T S F globulin mu binding protein 2
G3083u6 WIAF-13006 HT2228 272 IGHMBP2, immuno-
ATACGGGTCC[G/A]CGGCAGCTCT M G A A T globulin mu binding protein 2
G3083u7 WIAF-13010 HT2228 2581 IGHMBP2, immuno-
TCAGGAGCGC[G/A]CAGGGGCAGC S G A A A globulin mu binding protein 2
G3083u8 WIAF-13011 HT2228 2594 IGHMBP2, immuno-
GGGGCAGCCC[G/A]CCAGCAAGGA M G A A T globulin mu binding protein 2
G3088u1 WIAF-12984 HT2318 884 HIVEP1, human
TGTGGCACTA[C/T]GTCCCCCTCC M C T T M immunodeficiency virus type I
enhancer-binding protein 1 G3088u2 WIAF-12988 HT2318 2469 HIVEP1,
human TCTTGTCACC[A/G]CGTCAACACC S A G P P immunodeficiency virus
type I enhancer-binding protein G3088u3 WIAF-12989 HT2318 3066
HIVEP1, human TTCTTGGTAC[T/C]GGACAGTCCC S T C T T immunodeficiency
virus type I enhancer-binding protein 1 G3088u4 WIAF-12991 HT2318
4008 HIVEP1, human TTATCCGGCA[G/T]CACAACATCC M G T Q H
immunodeficiency
virus type I enhancer-binding protein 1 G3088u5 WIAF-12992 HT2318
4880 HIVEP1, human CAAATCCATG[C/G]ACCGCCTA- GC M C G A G
immunodeficiency virus type I enhancer-binding protein 1 G3088u6
WIAF-12993 HT2318 5148 HIVEP1, human TTGACAGCAT[G/A]TCTAATTCGC M G
A M I immunodeficiency virus type I enhancer-binding protein 1
G3088u7 WIAF-12999 HT2318 5834 HIVEP1, human
CCAGCTGATA[A/C]TTCATCAACA M A G N S immunodeficiency virus type I
enhancer-binding protein 1 G3088u8 WIAF-13000 HT2318 6065 HIVEP1,
human CAAAGTCAAC[G/A]GCCAGTCACT M G A R Q immunodeficiency virus
type I enhancer-binding protein 1 G3088u9 WIAF-13001 HT2318 7652
HIVEP1, human CATAGGAATA[C/T]GGTCACAC- AA M C T T M
immunodeficiency virus type I enhancer-binding protein 1 G30B8u10
WIAF-13008 HT2318 741 HIVEP1, human TTCTGCAGCA[A/G]CCATCTGAAC S A G
Q Q immunodeficiency virus type I enhancer-binding protein 1
G3088u11 WIAF-13009 HT2318 948 HIVEP1, human
CAGAACTGAG[C/T]ACCTTGTCAC S C T S S immunodeficiency virus type I
enhancer-binding protein 1 G3088u12 WIAF-13012 HT2318 1909 HIVEP1,
human TGAAACTTTA[C/T]TAAAATCAAG S C T L L immunodeficiency virus
type I enhancer-binding protein 1 G3088u13 WIAF-13013 HT2318 2803
HIVEP1, human TCTTCTGTCT[G/A]TACCTTCACT M G A V I immunodeficiency
virus type I enhancer-binding protein 1 G3088u14 WIAF-13015 HT2318
3342 HIVEP1, human GCGGTCTGCA[A/G]CCTCAGATTC S A G Q Q
immunodeficiency virus type I enhancer-binding protein 1 G3088u15
WIAF-13016 HT2318 3542 HIVEP1, human CCTAAACATA[G/A]TGTTACCATA M G
A S N immunodeficiency virus type I enhancer-binding protein 1
G3088u16 WIAF-13017 HT2318 4972 HIVEP1, human
TGGGTCTTCT[A/G]AAAGTGAGGA M A G K E immunodeficiency virus type I
enhancer-binding protein 1 G3095u1 WIAF-12994 HT2435 701 TCF2,
transcription CCGCTCTGTA[C/T]ACCTGGTACG S C T Y Y factor 2,
hepatic; LF-B3; variant hepatic nuclear factor G3095u2 WIAF-13018
HT2435 362 TCF2, transcription GGGCCGAGCC[C/T]GACACCAAGC S C T P P
factor 2, hepatic; LF-B3; variant hepatic nuclear factor G3095u3
WIAF-13020 HT2435 1620 TCF2, transcription
CCAGTTCTCC[C/T]AGCAGCTGCA N C T Q * factor 2, hepatic; LF-B3;
variant hepatic nuclear factor G3100a1 WIAF-12147 HT2483 526
ZNF141, zinc finger GAATGAGTGT[A/G]AGTTGCAGAA M A G K E protein 141
(dione pHZ-44) G3102u1 WIAF-12975 HT2508 259 NRF1, nuclear
CGCCTTCTTC[G/T]CCCGAGGACA S G T S S respiratory factor 1 G3103u1
WIAF-13617 HT2511 1106 E2F2, E2F CCTTGGACCA[G/T]CTCATCCAGA M H T Q
H transcription factor 2 C3103u2 WIAF-13659 HT2511 1154 E2F2, E2F
CTGAGGACAA[G/A]GCCAACAAGA S G A K K transcription factor 2 G311u1
WIAF-10291 HT0402 1339 A2M, alpha-2-macro-
GTCCCTGTTA[C/T]GGCTACCAGT S C T Y Y globulin G311u2 WIAF-10292
HT0402 1201 A2M, alpha-2-macro- TCATATTCAT[C/T]AGAGGAAATG S C T I I
globulin G311u3 WIAF-10293 HT0402 3041 A2M, alpha-2-macro-
TACTCCAGAG[C/A]TCAACTCC- AA M G A V I globulin G311u4 WIAF-10294
HT0402 3676 A2M, alpha-2-macro- TGACATCCTA[T/C]GTGCTCCTCC S T C Y Y
globulin G311u5 WIAF-10296 HT0402 3364 A2M, alpha-2-macro-
ATATCACCAT[C/T]GCCCTTCTGG S C T I I globulin G311u6 WIAF-10297
HT0402 3203 A2M, alpha-2-macro- CCAAGCTCGA[G/T]CCTACATCTT M G T A S
globulin G311a7 WIAF-10494 HT0402 1122 A2M, alpha-2-macro-
TCACACTTTC[G/A]ACAGGGAA- TT M G A R Q globulin G3119u1 WIAF-13947
HT2654 2876 GLI, glioma- TTTCTGGGCG[G/A]TTCCCAGGTT M G A G D
associated oncogene homolog (zinc finger protein) G3119u2
WIAF-13959 HT2654 654 GLI, glioma- AGTGCCGGGA[G/A]GAACCCTTGG S G A
E E associated oncogene homolog (zinc finger protein) G3119u3
WIAF-13965 HT2654 3376 GLI, glioma- TGGGGAAACA[G/C]AATTCCTCAA M G C
E Q associated oncogene homolog (zinc finger protein) G312u1
WIAF-10006 HT0428 898 PLAU, plasminogen CTCACCACAA[C/T]CACATTCCCT S
C T N N activator, urokinase G312u2 WIAF-10029 HT0428 498 PLAU,
plasminogen GGCCTAAACC[C/T]GCTTGTCCAA M C T P L activator,
urokinase G312a3 WIAF-10521 HT0428 767 PLAU, plasminogen
TGATTACCCA[A/C]AGAAGGACGA M A C K Q activator, urokinase G3125u1
WIAF-13675 HT2674 740 GTF2F2, general ACATCACAAA[A/G]CAACCTGTGG S A
G K K transcription factor hF, poly- peptide 2 (30 kD subunit)
G313u1 WIAF-10129 HT0462 3086 platelet-derived
CATGCGTGTG[C/A]ACTCAGACAA M G A D N growth factor, alpha
polypeptide (GB:M21574) G313u2 WIAF-10130 HT0462 1078
platelet-derived ATGAGAAAGG[T/C]TTCATTGAAA S T G G G growth factor,
alpha polypeptide (CB:M21574) G313u3 WIAF-10133 HT0462 1571
platelet-derived GGAGATCCAC[T/C]CCCCAGACAG M T C S P growth factor,
alpha polypeptide (CB:M21574) G313u4 WIAF-10135 HT0462 2611
platelet-derived CTCGCAACGT[C/T]CTCCTGGCA- C S C T V V growth
factor, alpha polypeptide (CB:M21574) C314u1 WIAF-10069 HT0467 1890
ALOX15, TCAGCCAGGA[G/A]CTGGCTGCCC S G A E E arachidonate 15-
lipoxygenase G3141u1 WIAF-13934 HT27498 878 NFATC3, nuclear
CCAGAGGATA[G/A]CTGGCTACTC M G A S N factor of activated T-cells,
cytoplasmic 3 G3141u2 WIAF-13936 HT27498 1189 NFATC3, nuclear
GCCTGCCTCA[T/C]GCAATGGGAA M T C C R factor of activated T-cells,
cytoplasmic 3 G3141u3 WIAF-13938 HT27498 2241 NFATC3, nuclear
CTCTGCGGGG[T/C]TTCCCTTCAG S T C G G factor of activated T-cells,
cytoplasmic 3 C3141u4 WIAF-13944 HT27498 702 NFATC3, nuclear
ATGCCTCTGA[C/T]CACGCAGCCC S C T D D factor of activated T-cells,
cytoplasmic 3 G3159u1 WIAF-13891 HT2757 523 SP4, Sp4 tran-
CTTCAAAAGA[C/A]AATAACGTTT S G A E E scription factor G3159u2
WIAF-13892 HT2757 1514 SP4, Sp4 tran- ACAGAATGTT[C/T]AACTTCAAGC N C
T Q * scription factor G3159u3 WIAF-13893 HT2757 2236 SP4, Sp4
tran- TGTTTTGTGG[C/T]AAAAGATTCA S C T G G scription factor G3165u1
WIAF-13860 HT27636 437 transcription AGCAGCTCAC[A/G]GAGGAACTGA S A
G T T factor B-ATF G3165u2 WIAF-13861 HT27636 512 transcription
CCACCACGCC[C/G]TCGCCCCCCG S C G P P factor B-ATF G3173u1 WIAF-13556
HT2772 1686 ZNF74, zinc finger TGCACAGCGA[G/A]GGGAAGCCCT S G A E E
protein 74 (Cos52) G3175u1 WIAF-13948 HT2776 2037 transcriptional
TGTTCGGACC[A/G]GAAGCACCCA S A G P P regulator, via glucocorticoid
receptor G3182u1 WIAF-14036 HT2783 1614 MHC2TA, MHC class
ATCCTAGACG[C/G]CTTCGAGGAG M C G A G II transactivator G3182u2
WIAF-14037 HT2783 2791 MHC2TA, MHC class TGAGCGACAC[G/A]GTGGCGCTGT
S G A T T II transactivator C3182u3 WIAF-14059 HT2783 1657 MHC2TA,
MHC class TGCACAGCAC[C/A]TGCGGACCGG S G A T T II transactivator
G3182u4 WIAF-14060 HT2783 1606 MHC2TA, MHC class
TTCTGCTCAT[C/T]CTAGACGCCT S C T I I II transactivator G3183u1
WIAF-13950 HT27861 392 zinc finger protein
TACTCTAGAG[G/A]AGCCTGTTGG M G A E K C2H2-150 G3184u1 WIAF-13864
HT27862 271 zinc finger protein GAAACTCCAG[T/G]TCAAAGACTT M T G F V
C2H2-171 G3184u2 WIAF-13865 HT27862 248 zinc finger protein
CTGCTTGAAT[T/C]CATGTATGAR M T C F S C2H2-171 G320u1 WIAF-10136
HT0791 552 ANX7, annexin VII CCAACTTCCA[T/C]GCTATAAGAG S T C D D
(synexin) G320u2 WIAF-10137 HT0791 1350 ANX7, annexin VII
TTGACCTTGT[A/G]CAAATAAAAC S A G V V (synexin) G3208u1 WIAF-14186
HT27930 485 zinc finger GTCACAAGTC[A/C]GCCCTAATTG S A G S S protein
ZNF37A G3218u1 WIAF-13526 HT28104 187 zinc finger
CCCGACAGCT[C/T]ATTAAGAAAG M C T H Y protein ZNF169, Krueppel-type
G323u1 WIAF-10066 HT0915 1361 Homo sapiens
ACTTCTGTGA[C/T]GTCCAGCGCT S C T D D inducible nitric oxide synthase
(NOS) mRNA, complete cds. G325u1 WIAF-10106 HT0962 3817 FBN1,
fibrillin 1 TGTGAATGCC[C/T]GCCTGGCCAT M C T P L (Marfan syndrome)
G325u2 WIAF-10113 HT0962 722 FBN1, fibrillin 1
AGATACCTCC[T/C]TCCTCTGGCT S T G P P (Marfan syndrome) G325u3
WIAF-10114 HT0962 2022 FBN1, fibrillin 1 GATCTGCAAT[A/C]ATGGACGCTG
M A C N H (Marfan syndrome) G325u4 WIAF-10116 HT0962 3603 FBN1,
fibrillin 1 GAACTGCACA[G/C]ACATTGACGA M G C D H (Marfan syndrome)
C325u5 WIAF-10117 HT0962 2270 FBN1, fibrillin 1
TCTGCATCAA[C/T]GGGCGTTGCG S C T N N (Marfan syndrome) G326u1
WIAF-10036 HT1009 1854 KLKB1, kallikreim GCAAACACAA[C/T]GGAATGTGGC
S C T N N B plasma (Fletcher factor) 1 G327u1 WIAF-10052 HT1011
1599 HRG, histidine- AAGCCAGACA[A/T]TCAGCCCTTT M A T N I rich
glycoprotein G327u2 WIAF-10054 HT1011 1083 HRG, histidine-
CCACTATTGC[C/T]CATGTCCTGC M C T P L rich glycoprotein G327u3
WIAF-10055 HT1011 1140 HRG, histidine- GCCCAAAGAC[A/G]TTCTCATAAT M
A G H R rich glycoprotein G328u1 WIAF-10145 HT1087 255 SAA1, serum
amyloid GTGCCTGGGC[T/C]GCAGAAGTGA S T C A A A1 G328a2 WIAF-10511
HT1087 248 SAA1, serum amyloid CCTGGGGGTC[C/T]CTGGGCTGC- A M C T A
V A1 G328a3 WIAF-10512 HT1087 305 SAA1, serum amyloid
TTCTTTGGCC[A/G]TGGTGCGGAC M A G H R A1 G328a4 WIAF-13126 HT1087 295
SAA1, serum amyloid TATCCAGAGA[T/C]TCTTTGGCCA M T C F L A1 G328a5
WIAF-13127 HT1087 82 SAA1, serum amyloid CTTGGTCCTG[C/A]GTGTCAGCAG
M G A G S A1 G329u1 WIAF-10140 HT1141 2514 PLCG1, phospho-
CTGACCTTCA[T/C]CAAGAGCGCC M T C I T lipase C, gamma 1 (formerly
subtype 148) G329u2 WIAF-10162 HT1141 1036 PLCG1, phospho-
TATGCCCGGA[C/A]ACCATGAACA M C A D E lipase C, gamma 1 (formerly
subtype 148) G329u3 WIAF-10163 HT1141 911 PLCG1, phospho-
GTTCATGCTC[A/G]GCTTCCTCCG M A G S G lipase C, gamma 1 (formerly
subtype 148) G3295u1 WIAF-14017 HT3460 1229 FUBP, far upstream
CCATAAAAAG[C/T]ATAACCCAGC S C T S S element binding protein G3296u1
WIAF-14168 HT3466 6289 transcription CAGCCTGGAC[G/A]AGAGCCCCAT M G
A E K factor TFIIIC, RNA polymerase III, alpha subunit G3296u2
WIAF-14179 HT3466 235 transcription GGCCATCAGC[T/A]TCTATGAGGA M T A
F I factor TFIIIC, RNA polymerase III, alpha subunit G3298u1
WIAF-13523 HT3504 1803 DNA-binding protein
ACTTTGCCAA[C/T]GTGCAGGAGC S C T N N HRFX2 G3298u2 WIAF-13524 HT3504
1743 DNA-binding protein GGGCGGTGCT[G/A]CAGAACACGT S G A L L HRFX2
G3298u3 WIAF-13528 HT3504 2002 DNA-binding protein
GTTCTTGCTG[A/G]AATGGTCCTT M A G K E HRFX2 G33u1 WIAF-10254 X82540
1044 INHBC, inhibin, AAGGCCAACA[C/T]AGCTGCAGGC M C T T I beta C
G33u2 WIAF-10255 X82540 1136 INHBC, inhibin,
CAGCAACATT[G/A]TCAAGACTGA M G A V I beta C G33u3 WIAF-10256 X82540
1185 INHBC, inhibin, GGGTGCAGTT[A/G]GTCTATGTGT N A G * W beta C
G33u4 WIAF-10259 X82540 892 INHBC, inhibin,
TTTTTGTGGA[C/T]TTCCGTGAGA S C T D D beta C G3303u1 WIAF-13566
HT3523 981 POU6F1, POU CAGGCCAGGA[G/A]ATCACTGAAA S G A E E domain,
class 6, transcription factor 1 G3304u1 WIAF-13932 HT3544 970 SP2,
Sp2 transcrip- TCAACAACCT[C/T]GTGAACGCCA S C T L L tion factor
G3304u2 WIAF-13935 HT3544 1891 SP2, Sp2 transcrip-
AGAAGCACGT[T/G]TGCCACATCC S T G V V tion factor G3304u3 WIAF-13943
HT3544 920 SP2, Sp2 transcrip- TGTGGTGAAG[T/C]TGACAGGTGG S T C L L
tion factor G3311u1 WIAF-13839 HT3585 757 GATA3, GATA-
CCCACTCCCG[T/C]GGCAGCATGA S T C R R binding protein 3 G3311u2
WIAF-13840 HT3585 901 GATA3, GATA- TCGGATGCAA[G/A]TCCAGGCCCA S G A
K K binding protein 3 G3316u1 WIAF-13818 HT3607 282 zinc finger
AAAGAGTTTC[A/G]GTCACACTTC M A G S G protein HKE-T1, Kruppel-like
G3319u1 WIAF-14214 HT3613 1086 SMARCA3, SWI/SNF
AAACTCTTAC[A/C]GCCATTGCAG S A G T T related, matrix associated,
actin dependent regulator of chromatin, subfamily a, member 3
G3319u2 WIAF-14221 HT3613 1261 SMARCA3, SWI/SNF
TAGATCTAGT[G/C]AACAACCCAG M G C E Q related, matrix associated,
actin dependent regulator of chromatin, subfamily a, member 3
G3320u1 WIAF-13692 HT3622 624 BCL6, B-cell CLL/
ATTTGCGGGA[G/C]GGCAACATCA M G C E D lymphoma 6 (zinc finger protein
51) G3320u2 WIAF-13717 HT3622 1062 BCL6, B-cell CLL/
ACAGCCGGCC[C/A]ACTTTGGAGG S G A P P lymphoma 6 (zinc finger protein
51) G3321u1 WIAF-13761 HT3641 235 STAT2, signal
TCTTGGATCA[G/C]CTGAACTATG M G C Q H transducer and activator of
transcription 2, 113 kD G3321u2 WIAF-13762 HT3641 774 STAT2, signal
CAAAAAGCCT[G/C]CATCAGAGCT M G C C S transducer and activator of
transcription 2, 113 kD G3328u1 WIAF-13543 HT3681 1550
transcription CCACAATGGT[A/C]TCAGAGCAGG S A G V V factor znf6
G3328u2 WIAF-13544 HT3681 1389 transcription
AGAGGATTTA[G/C]AGGAAGATGA M G C E Q factor znf6 G3336u1 WIAF-13848
HT3732 216 XBP1, X-box binding ACCTGAGCCC[C/T]GAGGAGAAGG S C T P P
protein 1 G334u1 WIAF-1008 HT1220 893 THBS1, thrombo-
TACATTCGCC[A/C]CAAGACAAAG M A C H P spondin 1 G334u2 WIAF-10009
HT1220 2000 THBS1, thrombo- TCACAGCCCT[T/C]CGGCCAGCCT M T C F S
spondin 1 G334u3 WIAF-10016 HT1220 1521 THBS1, thrombo-
CCCAGATGAA[T/C]GGCAAACCCT S T C N N spondin 1 G334u4 WIAF-10017
HT1220 2210 THBS1, thrombo- GGCTGGCCCA[A/G]TGAGAACCTG M A G N S
spondin 1 G334u5 WIAF-10018 HT1220 2979 THBS1, thrombo-
GTGAGACCGA[T/C]TTCCGCCGAT S T C D D spondin 1 G334u6 WIAF-10033
HT1220 1136 THBS1, thrombo- TGTCACTGTC[A/G]GAACTCACTT M A G Q R
spondin 1 G334u7 WIAF-10034 HT1220 1859 THBS1, thrombo-
AGTGGAAATG[C/A]CATCCAGTGC M G A G D spondin 1 G3343u1 WIAF-13545
HT3770 1104 ZNF76, zinc finger GCACTGCCCA[C/T]GGCGAGCTGG S C T H H
protein 76 (expressed in testis) G3343u2 WIAF-13561 HT3770 425
ZNF76, zinc finger GAGCAGTATG[C/A]CAGCAAGGT- T M C A A D protein 76
(expressed in testis) G3343u3 WIAF-13562 HT3770 143 ZNF76, zinc
finger CACCAGGTGA[C/T]GGTACAGAAA M C T T M protein 76 (expressed in
testis) G3343u4 WIAF-13563 HT3770 646 ZNF76, zinc finger
GAAGACCCAC[G/T]TTCGTACCCA M G T V F protein 76 (expressed in
testis) G3343u5 WIAF-13564 HT3770 611 ZNF76, zinc finger
AGCTGTGGAA[A/G]GGCCTTTGC- C M A G K R protein 76 (expressed in
testis) G3344u1 WIAF-13664 HT3772 925 zinc finger protein
AGCTCTCGCA[C/T]TCGGACGACA S C T H H HAZ G3345u1 WIAF-13508 HT3823
315 TCF6L1, transcrip- TTCGATTTTC[T/C]AAAGAACAA- C S T C S S tion
factor 6- like 1 (mito- chondrial transcription factor 1-like)
G3345u2 WIAF-13509 HT3823 167 TCF6L1, transcrip-
GGCGTGCTGA[G/CITGCCCTGGGA M G C S T tion factor 6- like 1 (mito-
chondrial transcription factor 1-like) G3345u3 WIAF-13531 HT3623
625 TCF6L1, transcrip- TTATAACGTT[T/G]ATGTAGCTGA M T G Y D tion
factor 6- like 1 (mito- chondrial transcription factor 1-like)
G3352u1 WIAF-13589 HT4005 1190 MITF, micro-
CTCGGAACTG[G/A]GACTCAGGCC M G A G E phthalmia-associated
transcription factor G3352u2 WIAF-13604 HT4005 1156 MITF, micro-
TCTCACGGAT[G/A]GCACCATCAC M G A G S phthalmia-associated
transcription factor G3353u1 WIAF-13937 HT4010 360 GTF2H3, general
ATCTAATGAC[C/A]AAAAGTGACA S C A T T transcription factor IIH,
polypeptide 3 (34 kD subunit) G3358u1 WIAF-13671 HT4187 398 ETV5,
ets variant GATGATGAAC[A/C]GTTTGTCCCA M A G Q R gene 5 (ets-related
molecule) G3358u2 WIAF-13672 HT4187 223 ETV5, ets variant
TCAGCAAGTC[C/T]CTTTTATGGT M C T P S gene 5 (ets-related molecule)
G3358u3 WIAF-13673 HT4187 1236 ETV5, ets variant
GACTGGAAGC[C/G]AAAGTCAAAC S C G G G gene 5 (eta-related molecule)
G3358u4 WIAF-13674 HT4187 1678 ETV5, ets variant
TTACCTCCTC[G/A]ACATGGACCG M G A D N gene 5 (ets-related molecule)
G3358u5 WIAF-13706 HT4187 414 ETV5, ets variant
TCCCAGATTT[T/C]CAGTCTGATA S T C F F gene 5 (ets-related molecule)
G3358u6 WIAF-13707 HT4187 1238 ETV5, ets variant
CTGGAAGGCA[A/C]AGTCAAACAG M A G K R gene 5 (ets-related molecule)
G336u1 WIAF-10152 HT1258 566 ACAT1, acetyl-
AGAGCATCTC[C/A]AATGTTCCAT S C A S S Coenzyme A acetyl- transferase
1 (acetoacetyl Coenzyme A thiolase) G3369u1 WIAF-14047 HT4302 614
zinc finger ATCTCAATCG[A/G]CACAAGCTCT S A G R R protein DB1 G337u1
WIAF-10268 HT1259 464 EDNRB, endothelin AAAGCAGACA[G/T]GACGGCAGGA M
G T R M receptor type B G337u2 WIAF-10298 HT1259 1281 EDNRB,
endothelin TGAAGCTCAC[T/A]CTTTATAATC S T A T T receptor type B
G3373u1 WIAF-14203 HT4342 1253 MTF1, metal-
CTCAACAGAC[A/G]GCTTCCTTGA S A G T T regulatory transcription factor
1 G3390u1 WIAF-14182 HT4483 680 ZNF133, zinc finger
AGAGCCAGAG[C/T]TCTACCTCGA M C T L F protein 133 (clone pHZ-13)
G3390u2 WIAF-14184 HT4483 1026 ZNF133, zinc finger
GCTCACACAG[G/A]GAACCCTGAG M G A G E protein 133 (clone pHZ-13)
G3390u3 WIAF-14185 HT4483 1423 ZNF133, zinc finger
AAAAGCCTTA[T/C]GTGTGCCGGG S T C Y Y protein 133 (clone pHZ-13)
G3390u4 WIAF-14197 HT4483 811 ZNF133, zinc finger
CTGGGGATCC[A/G]GGCCCAGGGG S A G P P protein 133 (clone pHZ-13)
G3390u5 WIAF-14198 HT4483 1420 ZNF133, zinc finger
GGGAAAAGCC[T/G]TATGTCTCCC S T G P P protein 133 (clone pHZ-13)
G3390u6 WIAF-14199 HT4483 2143 ZNF133, zinc finger
CAGCTCTAAT[C/T]ACACACAAGC S C T I I protein 133 (clone pHZ-13)
G3391u1 WIAF-13631 HT4484 391 ZNF136, zinc finger
AGCATTGTAT[A/G]TGGAGAAGTC M A G Y C protein 136 (clone pHZ-20)
G3396u1 WIAF-13978 HT4491 1283 ZNF135, zinc finger
CACACCTCCT[C/T]GCTCAGCCAG M C T S L protein 135 (clone pHZ-17)
G3396u2 WIAF-13979 HT4491 1296 ZNF135, zinc finger
TCAGCCAGCA[C/T]GAAAGGACGC S C T H H protein 135 (clone pHZ-17)
G3396u3 WIAF-13980 HT4491 1028 ZNF135, zinc finger
AGTCACAGCT[C/T]CTCCCTCACC M C T S L protein 135 (clone pHZ-17)
G3396u4 WIAF-13981 HT4491 1057 ZNF135, zinc finger
GCGAATCCAC[A/C]CTGGGGAGAA M A G T A protein 135 (clone pHZ-17)
G3396u5 WIAF-13982 HT4491 1152 ZNF135, zinc finger
CAGGAGAGAA[A/G]CCCTATGAAT S A G K K protein 135 (clone pHZ-17)
G3396u6 WIAF-13983 HT4491 1243 ZNF135, zinc finger
AAAGCCGTAT[G/C]GGTGCAATGA M G C G R protein 135 (clone pHZ-17)
G3396u7 WIAF-13984 HT4491 1045 ZNF135, zinc finger
CACCAAACAT[C/T]AGCGAATCCA N C T Q * protein 135 (clone pHZ-17)
G340u1 WIAF-10139 HT1386 459 CYP27A1, cytochrome
CCTATGGGCC[G/A]TTCACCACGG S G A P P P450, subfamily XXVIIA (steroid
27- hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1
G340u2 WIAF-10160 HT1386 801 CYP27A1, cytochrome
TCCCCAAGTG[G/A]ACTCGCCCCG N G A W * P450, subfamily XXVIIA (steroid
27- hydroxylase, cerebrotendinous xanthomatosis), polypeptide 1
G341u1 WIAF-10121 HT1388 912 MUT, methylmalonyl
GAGCTGGCCT[A/G]TACTTTAGCA M A G Y C Coenzyme A mutase G341u2
WIAF-10128 HT1388 2087 MUT, methylmalonyl TGCTCTGGGC[G/A]TAAGCACCCT
M G A V I Coenzyme A mutase G3410u1 WIAF-13749 HT4550 1720 zinc
finger TGAGTCCTCT[G/T]TTTCATCAGC M G T V F homeodomain protein
G3410u2 WIAF-13750 HT4550 2843 zinc finger
AAACATCATT[T/C]GATTGAACAC M T C L S homeodonain protein G3410u3
WIAF-13751 HT4550 2745 zinc finger AGATATTCCA[A/T]AAGAGTAGTT M A T
Q H homeodomain protein G3410u4 WIAF-13775 HT4550 236 zinc finger
AGAGAAGGGA[A/C]TGCTAACAAC M A C N T homeodomain protein G3410u5
WIAF-13776 HT4550 195 zinc finger TGCCAACAGA[C/T]CAGACAGTGT S C T D
D homeodomain protein G3410u6 WIAF-13777 HT4550 606 zinc finger
ATAACTTTAG[T/C]TGCTCCCTGT S T C S S homeodomain protein G3410u7
WIAF-13793 HT4550 2073 zinc finger CAGTTTTACC[A/C]GTGCCATCAA S A G
P P homeodomain protein G343u1 WIAF-10120 HT1552 561 HK1,
hexokinase 1 CTTGCCAACA[A/C]TCCAAAATAG S A G Q Q C343u2 WIAF-10124
HT1552 159 HK1, hexokinase 1 ACAAGTATCT[G/C]TATGCCATCC S G C L L
G348u1 WIAF-10269 HT1906 2212 PECAM1, platelet/
TGACGATGTC[A/G]GAAACCATCC S A G G G endothelial cell adhesion
molecule (CD31 antigen) G348u2 WIAF-10277 HT1906 1656 PECAM1,
platelet/ GCCATTCCCA[C/T]GCCAAAATGT S C T H H endothelial cell
adhesion molecule (CD31 antigen) G348u3 WIAF-10283 HT1906 577
PECAM1, platelet/ AGAGTACCAG[C/G]TGTTGGTGGA S C G V V endothelial
cell adhesion molecule (CD31 antigen) G348a5 WIAF-13119 HT1906 ?
PECAM1, platelet/ ATTCTTCCC[C/G] ? C G endothelial cell adhesion
molecule (CD31 antigen) G351u1 WIAF-10123 HT1990 1047 OSBP,
oxysterol TGCTCGCAGA[C/A]TCAGATGAAT S G A E E binding protein
G351u2 WIAF-10132 HT1990 1023 OSBP, oxysterol
TGGCCAAGGC[C/A]AAAGCTGTGA S C A A A binding protein G355u1
WIAF-10146 HT2143 1670 THBS4, AACTCCCTGA[C/A]TGTCTTAAAT M G A S N
thrombospondin 4 G355u2 WIAF-10165 HT2143 1186 THBS4,
TCGAAATCCA[G/C]CGTGCGTTCC M G C A P thrombospondin 4 G355a3
WIAF-10510 HT2143 1962 THBS4, ACTGCCCCAC[C/G]GTCATTAACA S C G T T
thrombospondin 4 G355a4 WIAF-13125 HT2143 1963 THBS4,
CTGCCCCACC[G/a]TCATTAACAG M C a V I thrombospondin 4 G3552u1
WIAF-12701 HT28101 1006 CLCN2, chloride AAGAGACTAT[T/C]ACAGCCCTCT S
T C I I channel 2 G3552u2 WIAF-12731 HT28101 1823 CLCN2, chloride
CCGCCACCAG[C/T]AGTACCCGGT N C T Q * channel 2 G3552u3 WIAF-12736
HT28101 2254 CLCN2, chloride GGAGCGCAGA[G/C]TCGGCAGGCA M G C E D
channel 2 G3565u1 WIAF-12744 HT2896 334 calcyclin
GCCCTCAAGG[G/A]CTGAAAATAA M G A G D G357u1 WIAF-10267 HT2244 4300
C4B, complement ATGAGTACGA[T/C]GAGCTTCCAG S T C D D component 4B
G357u2 WIAF-10280 HT2244 5095 C4B, complement
TCATGGGTCT[G/A]GATGGGGCCA S G A L L component 4B G357u3 WIAF-10295
HT2244 2996 C4B, complement CTCAGATCCA[T/C]TGGACACTTT S T C L L
component 4B G359u1 WIAF-10026 HT2411 936 PLAT, plasminogen
CGCAGGCTCA[A/C]GTGGGAGTAC M A G T M activator, tissue G359a2
WIAF-10520 HT2411 1444 PLAT, plasminogen AGGCCTTGTC[T/C]CCTTTCTATT
S T C S S activator, tissue G3592u1 WIAF-12759 HT4214 743 CLCN4,
chloride CTTCTAACGA[C/A]ACCACTTTTG S G A E E channel 4 G3592u2
WIAF-12761 HT4214 835 CLCN4, chloride GCTTACATTC[T/G]GAATTACTTA M T
G L R channel 4 G361u1 WIAF-10053 HT2479 857 cystathionine beta
TGGCTCACTA[C/T]GACACCACCG S C T Y Y synthase, alt. transcript 1
G361u2 WIAF-10056 HT2479 1097 cystathionine beta
TCATCCCCAC[G/A]GTGCTGGACA S G A T T synthase, alt. transcript 1
G362u1 WIAF-10058 HT2638 223 ADRB2, adrenergic,
GGCACCCAAT[G/A]GAACCCATCC M G A G R beta-2-, receptor, surface
G362u2 WIAF-10059 HT2638 429 ADRS2, adrenergic,
TCATGGGCCT[G/A]CCAGTGGTGC S G A L L beta-2-, receptor, surface
G362u3 WIAF-10060 HT2638 256 ADRB2, adrenergic,
CGTCACGCAG[G/C]AAAGGGACC- A M G C E Q beta-2-, receptor, surface
G362u4 WIAF-10093 HT2638 1230 ADRB2, adrenergic,
AGGCCTATGG[G/C]AATGGCTACT S G C G G beta-2-, receptor, surface
G3620u1 WIAF-12808 HT97200 458 ACATN, acetyl-
CACTCTCTGG[A/G]TATGAAGAGC M A G D G Coenzyme A transporter G3627u1
WIAF-12820 HT97387 347 NAPG, N-ethyl- GCACAAACTA[C/T]CAGAGGCCGT M C
T P S maleimide-sensitive factor attachment protein, gamma G366u1
WIAF-10046 HT2764 987 BDKRB2, bradykinin GCCTCCTTCA[T/C]CGCCTACAGC
M T C M T receptor B2 G366a2 WIAF-10500 HT2764 820 BDKRB2,
bradykinin AGATCCAGAC[C/A]GAGAGGAGGG S G A T T receptor B2 G366a3
WIAF-10501 HT2764 961 BDKRB2, bradykinin GCATCATCGA[T/C]GTAATCACAC
S T C D D receptor B2 G367u1 WIAF-10156 HT27685 6965 ACACA, acetyl-
ATCATCCATA[T/C]GACGCAGCAC N T C * C Coenzyme A carboxylase alpha
G370u1 WIAF-10281 HT27888 3250 LEPR, leptin
AAAATTCTCC[G/A]TTGAAGGATT S G A P P receptor G370u2 WIAF-10282
HT27888 3229 LEPR, leptin TCACCAAGTG[C/T]TTCTCTAGC- A S C T C C
receptor G370u3 WIAF-10284 HT27888 1005 LEPR, leptin
CAATATCAAG[T/C]GAAATATTCA M T C V A receptor G370u4 WIAF-10285
HT27888 1894 LEPR, leptin CAGAGAATAA[C/TI CTTCAATTCC S C T N N
receptor G370u5 WIAF-10299 HT27888 1222 LEPR, leptin
TTCTGACAAG[T/C]GTTGGGTCTA S T C S S receptor G370u6 WIAF-10300
HT27888 2161 LEPR, leptin CTATGAAAAA[G/C]GAGAAAAATG M G C K N
receptor G371u1 WIAF-10107 HT27943 349 CRAT, carnitine
TCATCTACTC[G/C]AGCCCAGGCG S G C S S acetyltransferase G371a2
WIAF-12093 HT27943 287 CRAT, carnitine GGAGAACTGG[C/T]TGTCTGAGTG S
C T L L acetyltransferase G372a1 WIAF-10506 HT28247 1099 HADHA,
hydroxyacyl- TGGAGCTCCA[C/A]AGAAGGATGT M C A Q K Coenzyme A
dehydro- genase dehydro- genase/3-ketoacyl- Coenzyme A
thiolase/enoyl- Coenzyme A hydratase (tri- functional protein),
alpha subunit G374u1 WIAF-10103 HT28496 4435 FASN, fatty acid
CACCTCCCAC[G/A]TCCCGGAGGT M G A V I synthase G374u2 WIAF-10104
HT28496 5996 FASN, fatty acid CTGGACAGGG[T/C]GACCCGAGAG M T C V A
synthase G374u3 WIAF-10105 HT28496 5644 FASN, fatty acid
CAAGAGCTAC[A/G]TCATCGCTGG M A G I V synthase G374u4 WIAF-10115
HT28496 6387 FASN, fatty acid TGGCACACAT[C/T]CTGGGCATCC S C T I I
synthase G374u5 WIAF-10119 HT28496 567 FASN, fatty acid
GGGGCATCAA[C/T]GTCCTGCTGA S C T N N synthase G374a6 WIAF-12094
HT28496 5520 FASN, fatty acid ACATGGCCCA[A/G]GGGAAGCACA S A G Q Q
synthase G377u1 WIAF-10142 HT2996 929 PCCB, propionyl
GGACCCGGCT[T/C]CCGTCCGTGA M T C S P Coenzyme A carboxylase, beta
polypeptide G377u2 WIAF-10143 HT2996 1416 PCCB, propionyl
CACCTTTGTG[G/A]TGATACCAAC N G A G D Coenzyme A carboxylase, beta
polypeptide G380u1 WIAF-10122 HT3159 831 INSR, insulin
TCTACCTCCA[C/T]GGCAGGTGTG S C T D D receptor G380u2 WIAF-10126
HT3159 1698 INSR, insulin GGCAGGATCC[A/G]TGTGGTTCCA S A G A A
receptor G380u4 WIAF-11605 HT3159 2382 INSR, insulin
GCGTGCCCAC[G/A]AGTCCGGAGG S G A T T receptor G383u1 WIAF-10125
HT33546 3633 phospholipase C, AGCAGCGGGC[G/A]AGGCTCCCCC M G A R Q
beta 3, alt. transcript 2 G385u1 WIAF-10141 HT3383 1505 PRCP,
ATGACAGTGC[A/G]GGAAAGCAGC S A G A A prolylcarboxy- peptidase
(angiotensinase C) G385u2 WIAF-10157 HT3383 1360 PRCP,
ATCACAGACA[C/G]TCTGGTTGCA M C G T S prolylcarboxy- peptidase
(angiotensinase C) G387u1 WIAF-11729 HT3439 2697 SREBF2, sterol
CACTCTCCAG[G/C]AGCTCCGTGC M G C R S regulatory element binding
tran- scription factor 2 G387u2 WIAF-11770 HT3439 1901 SREBF2,
sterol GCTGCTGCCC[C/G]CAACCTACAA M C G A G regulatory element
binding tran- scription factor 2 G388u1 WIAF-10270 HT3440 245
SELPLG, selectin CTCCAGAAAT[G/A]CTGAGGAACA M G A M I P ligand
G390u1 WIAF-10276 HT3568 2049 NOS3, nitric oxide
TTGCTCGTGC[C/G]GTGGACACAC S C G A A synthase 3 (endothelial cell)
G391u1 WIAF-10013 HT3630 6205 VWF, von Willebrand
AGCACCTGCA[G/C]GTGATTCTCC M G C E D factor G391u2 WIAF-10265 HT3630
4554 VWF, von Hillebrand GCCCCTCACA[A/C]CAACGCCTTC M A G N S factor
G391u3 WIAF-10266 HT3630 7489 VWF, von Willebrand
TGGCCTCAAC[C/T]GCCACCAA- TC S C T T T factor C391u4 HIAF-10272
HT3630 2470 VWF, von Willebrand ACTGTACCAT[G/A]AGTGCAGTCC M G A M I
factor G391u5 WIAF-10273 HT3630 2615 VWF, von Willebrand
GCTCGAGTGT[A/G]CCAAAACGTG M A G T A factor G391u6 WIAF-10274 HT3630
2635 VWF, von Willebrand GCCAGAACTA[T/C]GACCTGGA- CT S T C Y Y
factor G391u7 WIAF-10275 HT3630 4045 VWF, von Willebrand
TCTCGGAACC[G/A]CCGTTGCACG S G A P P factor G391u8 WIAF-10278 HT3630
4446 VWF, von Willebrand AACTTTGTCC[C/A]CTACGTCCAG M G A R H factor
G391u9 WIAF-10279 HT3630 5152 VWF, von Willebrand
GCCCTAATGC[C/T]AACGTGCA- CG S C T A A factor G391u10 WIAF-10286
HT3630 3448 VWF, von Willebrand TTACCAGTGA[C/T]GTCTTCCAGG S C T D D
factor G391u11 WIAF-10287 HT3630 4891 VWF, von Willebrand
ACATGGTCAC[C/T]GTGGAGTACC S C T T T factor G391u12 WIAF-10288
HT3630 4805 VWF, von Willebrand CAGGAGCAAG[G/A]AGTTCATGGA M G A E K
factor G391u13 WIAF-10289 HT3630 4943 VWF, von Willebrand
CCTGCAGCCC[G/T]TGCGAGAGAT M G T V L factor G391u14 WIAF-10290
HT3630 4915 VWF, von Willebrand TCAGCGAGGC[A/C]CAGTCCAAAG S A C A A
factor G391a15 WIAF-10517 HT3630 6194 VWF, von Willebrand
AAACAAGGAG[C/T]AGGACCTGGA N C T Q * factor G391a16 WIAF-13222
HT3630 6419 VWF, von Willebrand TCACCTTGGT[C/T]ACATCTTCAC M C T H Y
factor G3941u1 WIAF-14123 HT3464 1265 mannosidase, alpha,
CACGTCTGCA[A/G]CCAGCTGGAG M A G N S lysosomal G3941u2 WIAF-14135
HT3464 965 mannosidase, alpha, ACCAACCACA[C/T]TGTGATGA-
CC M C T T I lysosomal G395u1 WIAF-10271 HT4158 1627 ECE1,
endothelin TCACTGCCGA[T/C]CAGCTCAGGA S T C D D converting enzyme 1
G395a2 WIAF-13110 HT4158 1493 ECE1, endothelin
CATCTACAAC[A/T]TGATAGGATA M A T M L converting enzyme 1 G3959u1
WIAF-13634 HT4490 250 ADTB1, adaptin, TGAAGAAGCT[G/A]GTATACCTCT S G
A L L beta 1 (beta prime) G3959u2 WIAF-13640 HT4490 2029 ADTB1,
adaptin, TTCTTGGCGG[T/C]GCCCTTGACA S T C G G beta 1 (beta prime)
G3959u3 WIAF-13641 HT4490 2395 ADTB1, adaptin,
AGGTCCACGC[C/A]CCACTCACCC S G A A A beta 1 (beta prime) G3967u1
WIAF-13997 HT2958 918 ACTC, actin, GAGGCACCAC[T/C]ATGTACCCTG S T C
T T alpha, cardiac muscle G3968u1 WIAF-14159 HT1986 1747 ACTN3,
actinin, CGAGGCTGAC[C/T]GAGAGCGAGG N C T R * alpha 3 G3968u2
WIAF-14164 HT1986 1900 ACTN3, actinin, GGTGCCCAGC[C/T]GTGACCAGAC M
C T R C alpha 3 G3968u3 WIAF-14165 HT1986 2184 ACTN3, actinin,
ACACCGTCTA[C/T]AGCATGGAGC S C T Y Y alpha 3 G3968u4 WIAF-14167
HT1986 2557 ACTN3, actinin, GATCTTGCCA[G/A]GAGACAAGAA M G A G R
alpha 3 G3968u5 WIAF-14175 HT1986 1212 ACTN3, actinin,
GGCTGCTCTC[G/A]GAGATCCGGC S G A S S alpha 3 G3979u1 WIAF-13884
HT0623 776 GPC1, glypican 1 TGCTGCTGCC[T/G]GATCACTACC S T G P P
G3979u2 WIAF-13885 HT0623 680 GPC1, glypican 1 TCTACTACCC[C/TI
GCTGCCAACC S C T R R G3979u3 WIAF-13886 HT0623 1361 GPC1, glypican
1 AGCTGCTCTC[T/C]GAACCCAAGG S T C S S G3979u4 WIAF-13887 HT0623
1163 GPC1, glypican 1 ACAGTCTCAT[C/T]GGCAGCGTCC S C T I I G3979u5
WIAF-13888 HT0623 1670 GPC1, glypican 1 ACGCCAGTGA[C/T]GACGGCACCG S
C T D D G3979u6 WIAF-13905 HT0623 1069 GPC1, glypican 1
CTTCCCAACC[A/T]CGCCGACCTG M A T Q L G3979u7 WIAF-13906 HT0623 1514
GPC1, glypican 1 TCATCCCTCA[C/T]GCCCTCCCCA S C T D D G3979u8
WIAF-13907 HT0623 1720 GPC1, glypican 1 GACCTCTCCC[G/C]CCCCAAGGTC M
G C G A G3979u9 WIAF-13908 HT0623 1676 GPC1, glypican 1
CTCACCACGG[C/T]AGCGGCTCGG S C T G G G3979u10 WIAF-13909 HT0623 1719
GPC1, glypican 1 TGACCTCTCC[G/A]GCCGCAACGT M G A G S G399u1
WIAF-10102 HT48511 450 AQP3, aquaporin 3 TCTGGCACTT[T/C]GCCCACAACC
S T C A A G399u2 WIAF-10111 HT48511 192 AQP3, aquaporin 3
CCTCCCTCCC[C/T]CAGGTTGTGC S C T A A G399u3 WIAF-10112 HT48511 165
AQP3, aquaporin 3 CCCTCATCCT[C/G]GTGATGTTTG S C G L L G3997u1
WIAF-13649 HT27682 473 MFAP2, micro- TGTGTGCCCA[C/T]GAGGAGCTCC S C
T H H fibrillar- associated protein 2 G3997u2 WIAF-13650 HT27682
377 MFAP2, micro- CCATACACAG[G/T]CCTTCCAAAC M G T R S fibrillar-
associated protein 2 G3997u3 WIAF-13876 HT27682 453 MFAP2, micro-
GGAGATCTGT[G/T]TTCGTACAGT M G T V F fibrillar- associated protein 2
G4022u1 WIAF-14020 HT2426 240 TGM1, trans-
TGGCTGCTGT[T/C]CATGCCGAAA M T C S P glutaminase 1 (K polypeptide
epi- dermal type I, protein-glutamine- gamma glutamyl- transferase)
G4022u2 WIAF-14021 HT2426 371 TGM1, trans- CCCGGGGCAG[C/TI
GGTGTCAATG S C T S S glutaminase 1 (K polypeptide epi- dermal type
I, protein-glutamine- gamma-glutamyl- transferase) G4022u3
WIAF-14022 HT2426 506 TGM1, trans- ACGAGCTGAT[A/GIGTGCGCCGCG M A G
I M glutaminase 1 (K polypeptide epi- dermal type I,
protein-glutamine- gamma-glutamyl- transferase) G4022u4 WIAF-14031
HT2426 2491 TGM1, trans- GGTGGAGGTG[A/T]CAGTCACTTA M A T D V
glutaminase 1 (K polypeptide epi- dermal type I, protein-glutamine-
gamma-glutamyl- transferase) G4038u1 WIAF-13998 HT4211 411 LAMB3,
laminin, GGTGGCAGTC[C/A]CAGAATGATG S C A S S beta 3 (nicein (125
kD), kalinin (140 kD), BM600 (125 kD)) G4038u2 WIAF-13999 HT4211
258 LAMB3, laminin, CTTCATCTAC[C/T]TGTGGACTGA S C T T T beta 3
(nicein (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u3
WIAF-14002 HT4211 1830 LAMB3, laminin, GAGGCTACTG[C/T]AATCGCTACC S
C T C C beta 3 (nicein (125 kD), kalinin (140 kD), BM600 (125 kD))
G4038u4 WIAF-14003 HT4211 2668 LAMB3, laminin,
GACCACGCAG[A/T]TGATTAGGCC M A T M L beta 3 (nicein (125 kD),
kalinin (140 kD), BM600 (125 kD)) G4038u5 WIAF-14018 HT4211 248
LAMB3, laminin, TTTCTCCGAG[C/T]TTCATCTACC M C T A V beta 3 (nicein
(125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u6 WIAF-14019
HT4211 887 LAMB3, laminin, CACGGCCATG[C/T]TGATCGCTGC M C T A V beta
3 (nicein (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u7
WIAF-14023 HT4211 1266 LAMB3, laminin, AGTGTGATCC[G/A]GATGGGGCAG S
G A P P beta 3 (nicein (125 kD), kalinin (140 kD), BM600 (125 kD))
G4038u8 WIAF-14025 HT4211 1693 LAMB3, laminin,
CTATGGAGAC[G/A]TGGCCACAGG M G A V M beta 3 (nicein (125 kD),
kalinin (140 kD), BM600 (125 kD)) G4038u9 WIAF-14026 HT4211 1553
LAMB3, laminin, GGCTGTGAAC[C/T]GTGTGCCTGC M C T P L beta 3 (nicein
(125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u10 WIAF-14029
HT4211 3562 LANB3, laminin, CCTGACAGGA[C/T]TGGAGAAGCG S C T L L
beta 3 (nicein (125 kD), kalinin (140 kD), BM600 (125 kD)) G4038u11
WIAF-14030 HT4211 3546 LAMB3, laminin, TGCTGCGCTC[A/G]GCGGACCTGA S
A G S S beta 3 (nicein (125 kD), kalinin (140 kD), BM600 (125 kD))
G4045u1 WIAF-13571 HT0652 1266 adducin, beta sub-
TGGAGCAGGA[G/T]AAGCACCGGC M G T E D unit G4050u1 WIAF-14106 HT1466
1366 villin CGTTTGCCAG[G/A]GCAGCCAGGC M G A G S G4050u2 WIAF-14107
HT1466 1468 villin GGTCCCAATG[G/A]GCAAGGAGCC M G A G S G4050u3
WIAF-14108 HT1466 1932 villin CCACAGAGAT[C/T]CCTGACTTCA S C T I I
G4050u4 WIAF-14110 HT1466 2438 villin TTTGGGATGA[C/T]TCCACCTGCC M C
T T I G4057u1 WIAF-13648 HT33633 371 CNN3, calponin 3,
TTCAGGCTTA[T/C]GGTATGAAGC S T C Y Y acidic G4066u1 WIAF-13676
HT4301 654 troponin T, beta, AGATTGACAA[G/A]TTCGACTTTG S G A K K
skeletal G4066u2 WIAF-13677 HT4301 774 troponin T, beta,
GCAAAGTCGG[C/T]GCGCGCTGGA S C T G G skeletal G4066u3 WIAF-13708
HT4301 625 troponin T, beta, GGAGCTCTGG[G/C]AGACCCTGCA M G C E Q
skeletal G4080u1 WIAF-14142 HT1396 13130 HSPG2, heparan
GATTCTCCTC[G/A]GCCATCACAC S G A S S sulfate proteo- glycan 2
(perlecan) G4080u2 WIAF-14150 HT1396 10340 HSPG2, heparan
TTGAGTTCCA[C/T]TGTCCTCTGC S C T H H sulfate proteo- glycan 2
(perlecan) G4080u3 WIAF-14151 HT1396 12392 HSPG2, heparan
AATGCTATGA[T/C]AGCTCCCCAT S T C D D sulfate proteo- glycan 2
(perlecan) G4080u4 WIAF-14152 HT1396 3416 HSPG2, heparan TCCCTCTGCC
[C/T]GAGCAAACCG S C T P P sulfate proteo- glycan 2 (perlecan)
G4080u5 WIAF-14154 HT1396 4588 HSPG2, heparan
GTGCCGCTGG[T/C]GGCCAGCATC M T C V A sulfate proteo- glycan 2
(perlecan) G4080u6 WIAF-14156 HT1396 9582 HSPG2, heparan
GCACAGCCAC[C/A]CCGTGCTGCA M G A A T sulfate proteo- glycan 2
(perlecan) G4096u1 WIAF-13890 HT4237 394 motor protein
CAAAGAAATC[G/A]ATTCAGTCGC S G A S S G4096u2 WIAF-13910 HT4237 455
motor protein ATCTAAACAC[C/T]CTGCCTCACA M C T P S G4096u3
WIAF-13911 HT4237 1150 motor protein CTAACCTTGT[A/G]TCTCAGTATC S A
G V V G4109u1 WIAF-14034 HT28223 1238 phosphoglucomutase-
TACACCGTCC[C/T]GAAGACGCAT M C T A V related protein G4109u2
WIAF-14035 HT28223 1043 phosphoglucomutase-
ATTATTCCTG[C/A]CCGGAACCAG M C A A D related protein G4112u1
WIAF-13615 HT4401 374 KIF5A, kinesin AGATGTCCTT[G/A]CTCGCTACAA M G
A A T family member 5A G4112u2 WIAF-13623 HT4401 2767 KIF5A,
kinesin AGAGAGTTAA[G/T]GCCCTCCACC M G T K N family member 5A
G4114u1 WIAF-14113 HT4160 830 fibrinogen-like
AACTTCACCA[G/A]AACATGGCAA M G A R K protein pT49 G4118u1 WIAF-14010
HT0841 564 MYL5, myosin, TCGATGTGGC[G/A]GGCAACCTGG S G A A A light
polypeptide 5, regulatory G4118u2 WIAF-14011 HT0841 368 MYL5,
myosin, TTCACCATGT[T/C]TCTGAACCTG M T C F S light polypeptide 5,
regulatory G4118u3 WIAF-14012 HT0841 533 MYL5, myosin,
GAGGTGGACC[A/G]GATGTTCCAG M A G Q R light polypeptide 5, regulatory
G4122u1 WIAF-13955 HT97538 161 myosin-I TCGAGAACCT[A/G]CGCCCCCGAT S
A G L L G4124u1 WIAF-13895 HT0925 1517 TCM3, transgluta-
TCGCTCGCAT[G/A]CTGGCACTAG M G A M I minase 3 (E poly- peptide,
protein- glutamine gamma- glutamyl- transferase) G4124u2 WIAF-13896
HT0925 1433 TCM3, transgluta- AACCCAACAC[G/A]CCATTTGCC- C S G A T T
minase 3 (E poly- peptide, protein- glutamine-gamma- glutamyl-
transferase) G4126u1 WIAF-13830 HT2465 1035 myosin binding
ACTCGTACTC[C/G]TTCCGGCTCT S C G S S protein H G4126u2 WIAF-13853
HT2465 369 myosin binding AGAGAGGCAC[G/C]CTCGGAGTGG M G C G A
protein H G4130u1 WIAF-13614 HT1657 198 CFL1, cofilin 1
CTGTCCACGA[T/C]CCCTACGCCA S T C D D (non-muscle) G4138u1 WIAF-13598
HT33664 601 MAGP2: Microfibril- GAAAGATGAG[C/T]TTTCCCGTCA M C T L F
associated glyco- protein-2 G4138u2 WIAF-13599 HT33664 405 MAGP2:
Microfibril- ATGACTTGGC[C/T]TCCCTCAGTC S C T A A associated glyco-
protein-2 G4138u3 WIAF-13600 HT33664 327 MAGP2: Microfibril-
AAGATCCTAA[T/C]CTGCTGAATG S T C N N associated glyco- protein-2
G4159u1 WIAF-14048 HT3443 1119 SNL, singed
GCTGCTACTT[T/C]GACATCGACT S T C F F (Drosophila)-like (sea urchin
fascin homolog like) G4170u1 WIAF-13580 HT5069 1131 Golgi protein,
GAAATATACC[A/G]TAAGTATCGA M A G I V peripheral, brefeldin A-
sensitive G4170u2 WIAF-13581 HT5069 930 Golgi protein,
GTATAATAAA[C/T]TCCTGGACTT M C T L F peripheral, brefeldin A-
sensitive G4170u3 WIAF-13582 HT5069 2312 Golgi protein,
AGCAGCCTTA[A/G]GCATCTTGGA N A G * * peripheral, brefeldin A-
sensitive G4170u4 WIAF-13596 HT5069 359 Golgi protein,
TCAACCACGT[T/G]TCTGTGCCTT S T G L L peripheral, brefeldin A-
sensitive G4170u5 WIAF-13597 HT5069 1007 Golgi protein,
AAAAAGCCAA[T/A]ACTGTTCCTG M T A N K peripheral, brefeldin A-
sensitive G4171u1 WIAF-13688 HT1587 667 KIF5B, kinesin
TTTTTAATTA[T/C]ATTTACTCCA S T C Y Y family member 5B G4171u2
WIAF-13689 HT1587 1036 KIF5B, kinesin TTAGTAAAAC[T/C]GGAGCTGAAG S T
C T T family member SB G4176u1 WIAF-14204 HT33754 130 TNR, tenascin
R GCTCATTGGC[G/A]TCAACCTGAT M G A V I (restrictin, janusin) G4176u2
WIAF-14205 HT33754 463 TNR, tenascin R CTGTCCATGT[G/T]CCAGTTCAGC M
G T A S (restrictin, janusin) G4176u3 WIAF-14206 HT33754 249 TNR,
tenascin R ACTACAACAC[G/A]TCCAGCAAAC S G A T T (restrictin,
janusin) G4176u4 WIAF-14208 HT33754 2009 TNR, tenascin R
CTGGTCCCCA[G/A]CGCCATTGGT M G A R K (restrictin, janusin) G4176u5
WIAF-14209 HT33754 2175 TNR, tenascin R CAGCCTCCTC[G/A]GAGACCTCCA S
G A S S (restrictin, janusin) G4176u6 WIAF-14210 HT33754 3318 TNR,
tenascin R AATCCACCGA[C/T]GGAAGCCGCA S C T D D (restrictin,
janusin) G4176u7 WIAF-14211 HT33754 3221 TNR, tenascin R
CCGGCAAACC[T/C]GACAGCCAGT M T C L P (restrictin, janusin) G4176u8
WIAF-14217 HT33754 1635 TNR, tenascim R TCTCGGACAC[C/TI GTGGCTTTTG
S C T T T (restrictin, janusin) G4178u1 WIAF-14138 HT0224 2827
ACTN2, actinin, GCTGCGTTCT[C/T]TTCCGCACTC M C T S F alpha 2 G4178u2
WIAF-14139 HT0224 2818 ACTN2, actinin, CTGGATTACG[C/T]TGCGTTCTCT M
C T A V alpha 2 G418u1 WIAF-11750 L07594 2370 TGFBR3, trans-
GAGTGCACTT[C/T]CCTATCCCGC S C T F F forming growth factor, beta
receptor III (betaglycan, 300 kD) G418u2 WIAF-11751 L07594 2586
TGFBR3, trans- AGAAGACGTT[C/T]ACCAACCCCC S C T F F forming growth
factor, beta receptor III (betaglycan, 300 kD) G418u3 WIAF-11752
L07594 2671 TGFBR3, trans- AATTTCTCCA[C/T]CAATTTTCCA M C T P S
forming growth factor, beta receptor III (betaglycan, 300 kD)
G418u4 WIAF-11771 L07594 438 TGFBR3, trans-
TGTCTGAACT[C/T]TCACCTCTCA S G T L L forming growth factor, beta
receptor III (betaglycan, 300 kD) G418u5 WIAF-11744 L07594 392
TGFBR3, trans- CTGATCAGCT[T/C]CTGTTTAGCC M T C F S forming growth
factor, beta receptor III (betaglycan, 300 kD) G418u6 WIAF-11772
L07594 1470 TGFBR3, trans- AGCTACGGAT[C/T]CTGCTGGACC S C T I I
forming growth factor, beta receptor III (betaglycan, 300 kD)
G418u7 WIAF-11773 L07594 1170 TGFBR3, trans-
TCTTGAAGTG[C/A]AAAAACTCTG N C A C * forming growth factor, beta
receptor III (betaglycan, 300 kD) G418u8 WIAF-11745 L07594 1463
TGFBR3, trans- CCTCCTGAGC[T/C]ACGGATCCTC M T C L P forming growth
factor, beta receptor III (betaglycan, 300 kD) G418u9 WIAF-11746
L07594 2211 TGFBR3, trans- ATGTTGAGGT[A/G]TCTGTTACTA S A G V V
forming growth factor, beta receptor III (betaglycan, 300 kD)
G4181u1 WIAF-14207 HT2008 425 SPTBN1, spectrin,
CTCTGCGCGG[C/T]TTTTTCAGCG M C T L F beta, non- erythrocytic 1
G4181u2 WIAF-14213 HT2008 3565 SPTBN1, spectrin,
ACACAGCGAT[C/T]GCCTCGGAGG S C T I I beta, non- erythrocytic 1
G4181u3 WIAF-14218 HT2008 1258 SPTBN1, spectrin,
ACCTTCTGGA[A/G]TGCATTGAAC S A G E E beta, non- erythrocytic 1
G4181u4 WIAF-14219 HT2008 1780 SPTBN1, spectrin,
AGCTCGAGGC[C/T]GAGAATTACC S C T A A beta, non- erythrocytic 1
G4181u5 WIAF-14220 HT2006 3637 SPTBN1, spectrin,
ACATCAAGAA[T/C]GAGATCGACA S T C N N beta, non- erythrocytic 1
G4183u1 WIAF-13976 HT2640 404 TPM4, tropomyosin 4
CCAAGCACAT[T/C]GCGGAAGAGG S T C I I G4185u1 WIAF-13554 HT3451 257
MFAP1, micro- AAGGCCAGAC[T/C]ATGCCCCTAT M T G Y D fibrillar-
associated protein 1 G4185u2 WIAF-13555 HT3451 1108 MFAP1, micro-
CCAACAAAGC[T/C]GTTAAGGGCA S T G A A fibrillar- associated protein 1
G4185u3 WIAF-13570 HT3451 274 MFAP1, micro-
CTATGCAGTC[C/T]TCAGATCACG S C T S S fibrillar- associated protein 1
G4196u1 WIAF-13665 HT97558 941 NUP88, nucleoporin
GGGTCCATTG[C/A]CCATGCATCT M C A A D 88 kD G4196u2 WIAF-13666
HT97558 1092 NUP8B, nucleoporin ATGACCACAC[G/A]TCAGAAAACT S G A T T
88 kD G4196u3 WIAF-13667 HT97558 1551 NUP88, nucleoporin
TCCATCCAGC[C/A]TCTCCTCCCC S G A A A 88 kD G4196u4 WIAF-13668
HT97558 2220 NUP88, nucleoporin AGGGTGAACA[T/C]ATAAGCCAAA S T C H H
88 kD
G4196u5 WIAF-13669 HT97558 2205 NUP88, nucleoporin
CCATCCTGAA[A/G]GAGGAGGGTG S A G K K 88 kD G4208u1 WIAF-13921 HT1122
1329 VCL, vinculin TCATCCTAAA[G/C]AAAGAGATCA M G C E Q G4208u2
WIAF-13922 HT1122 2438 VCL, vinculin CCATCTCCCC[A/G]ATGGTGATGC S A
G P P G4208u3 WIAF-13941 HT1122 818 VCL, vinculin
GCCATCAAGA[T/C]GCCTGCGCCA S T C D D G4208u4 WIAF-13942 HT1122 1556
VCL, vinculin AACCACAGCG[C/A]TCGATTGATA S G A R R G4213u1
WIAF-13605 HT2813 163 NUP153, nucleoporin GCCAGGCTCC[T/C]TACAAAGATA
S T C L L 153 kD G4213u2 WIAF-13606 HT2813 742 NUP153, nucleoporin
GAATTCTTCA[A/C]TCCTTAAAAC M A G I V 153 kD G4213u3 WIAF-13609
HT2813 1800 NUP153, nucleoporin TTACACCTGC[A/C]GAAATCCTCA S A C A A
153 kD G4213u4 WIAF-13627 HT2813 1829 NUP153,nucleoporin
AGTGTTCTAG[A/C]TATTCTCA- AA M A C D A 153 kD G4213u5 WIAF-13632
HT2813 3258 NUP153, nucleoporin CTTTTCCCAA[C/T]GTGGAGCCTC S C T N N
153 kD G4213u6 WIAF-13635 HT2813 4162 NUP153, nucleoporin
CTCTGCAACA[A/C]CTCCTAATTC M A G T A 153 kD G4218u1 WIAF-13854
HT1681 1122 phosphatidyl- AACCTTATTA[T/C]TTTATCTCAC M T C I T
inositol glycan, class A G4223u1 WIAF-14160 HT1684 1434 CD36L2,
CD36 ATTAGATGAC[T/C]TTGTTGAAAC M T C F L antigen (collagen type I
receptor, thrombospondin receptor)-like 2 (lysosomal integral
membrane protein II) G4223u2 WIAF-14173 HT1684 696 CD36L2, CD36
GTGGTCCCAC[G/A]TGCACTTCCT M G A V M antigen (collagen type I
receptor, thrombospondin receptor)-like 2 (lysosomal integral
membrane protein II) G4223u3 WIAF-14174 HT1684 986 CD36L2, CD36
CAGACAAGTC[C/T]AATATCATTA S C T C C antigen (collagen type I
receptor, thrombospondin receptor)-like 2 (lysosomal integral
membrane protein II) G4223u4 WIAF-14176 HT1684 1437 CD36L2, CD36
AGATGACTTT[G/A]TTGAAACGCG M G A V I antigen (collagen type I
receptor, thrombospondin receptor)-like 2 (lysosomal integral
membrane protein II) G4227u1 WIAF-14056 HT1929 912 proteoglycan 2
ATCCCTCCAA[C/A]AAACATCCCC S C A K K G4227u2 WIAF-14057 HT1929 1254
proteoglycan 2 CGAACTTTCC[C/A]TACTCCCCTC S C A A A G4227u3
WIAF-14058 HT1929 1321 proteoglycan 2 CCCAGCACCC[T/C]ACTCCCCTCC M T
C Y H G4229u1 WIAF-13961 HT1689 74 SDC4, syndecan 4
CCTGCTCCTC[T/C]TCTTCCTACC M T C F L (amphiglycan, ryudocan) G4230u1
WIAF-13525 HT4995 602 TRAM protein CCATAACCTC[A/C]TGACATTTCA M A C
M L G4243u1 WIAF-14169 HT2901 406 KRT17, keratin 17
ACCTCCACCT[C/A]AACATCCCTC S G A V V G4243u2 WIAF-14170 HT2901 478
KRT17, keratin 17 ACACCACAAT[T/C]CACCACCTCC S T C I I G4243u3
WIAF-14171 HT2901 389 KRT17, keratin 17 GGAGGAGGCC[A/C]ACACTGAGCT M
A G N D G4243u4 WIAF-14178 HT2901 564 KRT17, keratin 17
CTGGCTGCTC[A/C]TGACTTCCGC M A C D A G4244u1 WIAF-14086 HT1056 386
clathrin, light ATCGATTGCA[G/C]TCAGAGCCTG M G C Q H polypeptide a
G4246u1 WIAF-14044 HT97492 259 SLN, sarcolipin
GTCCTATCAC[T/C]ACTGAGAGGC M T C Y H G4246u2 WIAF-14045 HT97492 189
SLN, sarcolipin ACACCCGGGA[G/A]CTGTTTCTCA S G A E E G4254u1
WIAF-13546 HT3393 86 TNNI2, troponin I, ACCTGAAGAG[C/T]CTGATCCTGC S
C T S S skeletal, fast G4254u2 WIAF-13553 HT3393 530 TNNI2,
troponin I, skeletal, fast TCGAGGAGAA[G/C]TCTGGCATGG M G C K N
G4255u1 WIAF-13644 HT2907 562 CRYAB, crystallin,
AGTTCCACAG[G/A]AAATACCGGA S G A R R alpha B G4255u2 WIAF-13645
HT2907 367 CRYAB, crystallin, CCTCCTTCCT[G/A]CGGCCACCCA S G A L L
alpha B G4255u3 WIAF-13872 HT2907 271 CRYAB, crystallin,
CCAGCCGCCT[C/T]TTTGACCAGT S C T L L alpha B G4255u4 WIAF-13873
HT2907 580 CRYAB, crystallin, GGATCCCAGC[T/C]GATGTAGAC- C S T C A A
alpha B G4257u1 WIAF-14052 HT1694 394 PIGF,
TAGAGTTGGC[A/G]TTGGAAACAT S A G A A phosphatidylinositol glycan,
class F G4257u2 WIAF-14053 HT1694 252 PIGF,
TATTTAGTAG[T/C]GAAACCAAAT M T C V A phosphatidylinositol glycan,
class F G4257u3 WIAF-14069 HT1694 291 PIGF,
TCATTATCAC[A/G]CAAGGTAACT M A G H R phosphatidylinositol glycan,
class F G4264u1 WIAF-13519 HT0968 1720 TJP1, tight
CGGTCAGTGG[C/T]TTCCAGCCAG M C T A V junction protein 1 (zona
occludens 1) G4264u2 WIAF-13520 HT0968 2272 TJP1, tight
CATGCTGATG[A/C]TCACACACCT M A G D G junction protein 1 (zona
occludens 1) G4264u3 WIAF-13529 HT0968 5408 TJP1, tight
AGCCTCCTGA[A/T]GCTGATGGTG M A T E D junction protein 1 (zona
occiudens 1) G434u1 WIAF-11748 M21121 286 SCYA5, small
TACATCAACT[C/T]TTTGGAGATG M C T S F inducible cytokine A5 (RANTES)
G434u2 WIAF-11749 M21121 137 SCYA5, small GCTTTGCCTA[C/T]ATTGCCCGCC
S C T Y Y inducible cytokine A5 (RANTES) G435u1 WIAF-11741 M31933
754 FCGR2B, Fc fragment GTCACTGGGA[T/C]TGCTGTAGCC M T C I T of IgG,
low affinity IIb, receptor for (CD32) G435u2 WIAF-11743 M31933 395
FCGR2B, Fc fragment GGGAGTACAC[G/A]TGCCAGACT- G S G A T T of IgG,
low affinity IIb, receptor for (CD32) G435u3 WIAF-11742 M31933 673
FCGR2B, Fc fragment TACACGCTGT[T/A]CTCATCCAAG M T A F Y of IgG, low
affinity IIb, receptor for (CD32) G4369u1 WIAF-13728 HT0900 1176
GBE1, glucan TTACGTCCAT[G/A]CTTTATCATC M G A M I (1,4-alpha-),
branching enzyme 1 (glycogen branching enzyme, Andersen disease,
glycogen storage disease type IV) G4369u2 WIAF-13729 HT0900 1609
GBE1, glucan GAGTGTCCTG[A/G]CTCCTTTTAC M A G T A (1,4-alpha-),
branching enzyme 1 (glycogen branching enzyme, Andersen disease,
glycogen storage disease type IV) G4373u1 WIAF-13559 HT0940 1117
HSD17B2, hydroxy- GCCAGCAAGG[A/T]CTTCTCTCC- G M A T D V steroid
(17-beta) dehydrogenase 2 G4373u2 WIAF-13560 HT0940 1195 HSD17B2,
hydroxy- CCAGGGAAAG[G/A]CGCTTACTTG M G A G D steroid (17-beta)
dehydrogenase 2 G438u1 WIAF-11830 M63121 583 TNFRSF1A, tumor
ACCGTGTGTG[G/A]CTGCAGGAAG M G A G D necrosis factor receptor super-
family, member 1A G438u2 WIAF-11790 M63121 618 TNFRSF1A, tumor
TTATTGGACT[G/A]AAAACCTTTT M G A E K necrosis factor receptor super-
family, member 1A G440u1 WIAF-11806 M74447 261 TAP2, transporter
TGCTAAAGCT[A/G]AGAGGGCTGC S A G L L 2, ABC (ATP binding cassette)
G440u2 WIAF-11807 M74447 2089 TAP2, transporter
CAGGCTGCAG[G/A]CAGTTCAGCG M G A A T 2, ABC (ATP binding cassette)
G440u3 WIAF-11808 M74447 2155 TAP2, transporter
TGCCCAGCTC[C/T]AGGAGGGACA N C T Q * 2, ABC (ATP binding cassette)
G440u4 WIAF-11818 M74447 1789 TAP2, transporter
GAACAACATT[G/A]CTTATGGGCT M G A A T 2, ABC (ATP binding cassette)
G440u5 WIAF-11819 M74447 1565 TAP2, transporter
AAGGGGCTGA[C/T]GTTTACCCTA M C T T M 2, ABC (ATP binding cassette)
G440u6 WIAF-11820 M74447 1254 TAP2, transporter
TGCACTTGGG[G/T[GTCCACATCC S C T G G 2, ABC (ATP binding cassette)
G440u7 WIAF-11788 M74447 1231 TAP2, transporter
GTACCTGCTC[A/C]TAACCAGGCT M A G I V 2, ABC (ATP binding cassette)
G440u8 WIAF-11821 M74447 1404 TAP2, transporter
TGCTCAGCAA[C/T]GTGGGAGCTC S C T N N 2, ABC (ATP binding cassette)
G440u9 WIAF-11783 M74447 2187 TAP2, transporter
CCCGCCTGGT[T/C]CAGCACCGGC S T G V V 2, ABC (ATP binding cassette)
G440u10 WIAF-11786 M74447 1825 TAP2, transporter
TGATAAGGTG[A/G]TGGCGGCTGC M A G M V 2, ABC (ATP binding cassette)
G4400u1 WIAF-14007 HT97396 839 A33 GCCAATCAAA[G/T]GACGGCTCAC M G T
K N G4404u1 WIAF-14013 HT1215 109 ACP2, acid
CCGCCCACCC[G/A]GGCCCGGAGT M G A R Q phosphatase 2, lysosomal
G4404u2 WIAF-14016 HT1215 1271 ACP2, acid ACCGCCACGT[C/T]GCAGATGGGG
S C T V V phosphatase 2, lysosomal G4406u1 WIAF-13661 HT3564 872
ACPP, acid ACAAAAAACT[T/C]ATCATGTATT S T C L L phosphatase,
prostate G4406u2 WIAF-13662 HT3564 839 ACPP, acid
ATCACATGAA[G/A]AGAGCAACTC S G A K K phosphatase, prostate G4406u3
WIAF-13881 HT3564 741 ACPP, acid AGAATTGTCA[G/T]AATTGTCCCT N G T E
* phosphatase, prostate G441u1 WIAF-10166 M77349 698 TGFBI,
transforming GTGCCCGGCT[C/G]CTGAAAGCCG S C G L L growth factor,
beta-induced, 68 kD G441u2 WIAF-10168 M77349 1028 TGFBI,
transforming GCCTCTCTGT[A/G]CAGACCCTGG S A G V V growth factor,
beta-induced, 68 kD G441u3 WIAF-10169 M77349 1667 TGFBI,
transforming ACACAGTCTT[T/C]GCTCCCACAA S T C F F growth factor,
beta-induced, 68 kD G441u4 WIAF-10171 M77349 1463 TGFBI,
transforming GTAATAGCCT[C/T]TGCATTGAGA S C T L L growth factor,
beta-induced, 68 kD G4411u1 WIAF-14005 HT97468 492 acyl-CoA
GCTCACCAAT[A/G]AGGCCACCCT M A G K E G4411u2 WIAF-14008 HT97468 1076
acyl-CoA TGCCCCACAC[C/T]GAGGACGAGA S C T T T G4412u1 WIAF-13576
HT1882 657 ACADS, acyl- GCAAAACAAG[G/A]GCATCAGTGC M G A G S
Coenzyne A dehydrogenase, C-2 to C-3 short chain G4412u2 WIAF-13579
HT1882 1022 ACADS, acyl- TGACCTGGCC[C/T]GCTGCCATGC S C T R R
Coenzyme A dehydrogenase, C-2 to C-3 short chain G4415u1 WIAF-14080
HT2503 2170 acyl-Coenzyme A: TCATTATATT[C/T]GAGCAGATTC S C T F F
cholesterol acyltransferase G4415u2 WIAF-14081 HT2503 1993
acyl-Coenzyme A: TTTCAGTTCC[C/T]TATTTTCTGT S C T P P cholesterol
acyltransferase G4415u3 WIAF-14098 HT2503 2006 acyl-Coenzyme A:
TTTTCTGTTT[C/G]AACATTGGCG M C G Q E cholesterol acyltransferase
G4415u4 WIAF-14101 HT2503 2365 acyl-Coenzyme A:
GGGGTTATGT[C/T]GCTATGAAGT S C T V V cholesterol acyltransferase
G4417u1 WIAF-13819 HT0542 356 AOAH, acyloxyacyl
TCCAGCCAAC[G/A]ATGACCAGTC M G A D N hydrolase (neutro- phil)
G4417u2 WIAF-13820 HT0542 340 AOAH, acyloxyacyl
TTCAGTCCTC[G/A]GCCTCTCCAG S G A S S hydrolase (neutrophil) G4417u3
WIAF-13824 HT0542 1595 AOAH, acyloxyacyl GCTAAATAAA[G/A]ACATGACCT-
A M G A D N hydrolase (neutrophil) G4417u4 WIAF-13841 HT0542 382
AOAH, acyloxyacyl CCAGCCTCTC[G/A]AATGGGCACA S G A S S hydrolase
(neutrophil) G4417u5 WIAF-13842 HT0542 458 AOAH, acyloxyacyl
CAACTCGACG[G/A]TCCAGGCCTC M G A V I hydrolase (neutrophil) G4417u6
WIAF-13843 HT0542 1201 AOAH, acyloxyacyl GATTTCTGGA[C/T]TCCACTGTT-
G S C T D D hydrolase (neutrophil) G4417u7 WIAF-13844 HT0542 1321
AOAH, acyloxyacyl ACCTGAAGAA[A/G]TTTATAGAA- A S A G K K hydrolase
(neutrophil) G4417u8 WIAF-13845 HT0542 1404 AOAH, acyloxyacyl
GATGTCTCCA[G/A]TCGGAACAG- T M G A S N hydrolase (neutrophil)
G4417u9 WIAF-13846 HT0542 1759 AOAH, acyloxyacyl
AATTTACAAA[C/T]TTCAATCTT- T S C T N N hydrolase (neutrophil)
G4417u10 WIAF-13847 HT0542 1644 AOAH, acyloxyacyl
CTCCAGGTCA[G/A]CCCCTGCC- AC M G A S N hydrolase (neutrophil) G442u1
WIAF-11828 M94582 933 IL8RA, interleukin CACATCGACC[G/A]GGCTCTCGAT
M G A R Q 8 receptor, alpha G442u2 WIAF-11829 M94582 721 IL8RA,
interleukin TCATCGTGCC[A/G]CTGCTGATCA S A G P P 8 receptor, alpha
G442u3 WIAF-11780 M94582 1027 IL8RA, interleukin
GCCATGGACT[C/T]CTCAAGATTC S C T L L 8 receptor, alpha G442u4
WIAF-11792 M94582 78 IL8RA, interleukin ATGGACAGTC[A/C]CAGCTTTGAA M
A G D G 8 receptor, alpha G4423u1 WIAF-13752 HT2216 71 ADSL,
GCTATGCCAG[C/T]CCGGAGATGT S C T S S adenylosuccinate lyase G4423u2
WIAF-13794 HT2216 126 ADSL, ATGGCGCCAG[C/T]TGTGGCTGTG S C T L L
adenylosuccinate lyase G4423u3 WIAF-13795 HT2216 674 ADSL,
AGCTTGACAA[G/A]ATGGTCACAG S G A K K adenylosuccinate lyase G4428u1
WIAF-13954 HT97524 57 ADFP, adipose TGGTCAACCT[C/A]CCCTTGGTGA S G A
L L differentiation related protein; adipophilin G4434u1 WIAF-13506
HT0863 551 ARF3, ADP- TCTGGAGACA[C/T]TACTTCCAGA S C T H H
ribosylation factor 3 G444u1 WIAF-10172 U28694 398 CCR3, chemokine
CGACATCTTT[T/G]TCATAATCCT M T G F V (C-C motif) receptor 3 G444u2
WIAF-10181 U28694 214 CCR3, chemokine TCCTCATAAA[A/C]TACAGGAGGC S A
G K K (C-C motif) receptor 3 G4440u1 WIAF-14054 HT1392 136 ADRBK1,
adrenergic, GCAAGAAGAT[A/C]CTGCTGCCCG S A G I I beta, receptor
kinase 1 G445u1 WIAF-10183 U40373 319 Human cell
TAGAAGGCCA[C/T]CTGGTGATTC S C T H H surface glyco- protein CD44
mRNA, complete cds. G4456u1 WIAF-13629 HT0626 796 ALDOC, aldolase
C, CCCTGCTCAA[G/A]CCCAACATCC S G A K K fructose- bisphosphate
G446u1 WIAF-11832 U64198 754 IL12RB2, inter-
TGAACCCTTC[C/G]CATGTAATTT S C G S S leukin 12 receptor, beta 2
G446u2 WIAF-11795 U64198 2569 IL12RB2, inter-
TTTTCTCAAC[G/A]CATTACTTCC S G A T T leukin 12 receptor, beta 2
G446u3 WIAF-11833 U64198 2500 IL12RB2, inter-
TGCAACGTAA[A/C]CCCAATTGCA S A G K K leukin 12 receptor, beta 2
G446u4 WIAF-11835 U64198 1918 IL12RB2, inter-
CTCCTCGCCA[G/C]CTCTCTGCAA M G C Q H leukin 12 receptor, beta 2
G446u5 WIAF-11793 U64198 991 IL12RB2, inter-
GTGGAGCAGA[C/A]ATCTTCGTTC S G A E E leukin 12 receptor, beta 2
G446u6 WIAF-11794 U64198 2469 IL12RB2, inter-
AGTTCCCACC[G/C]AAATGAGAGG M G C G A leukin 12 receptor, beta 2
G446a7 WIAF-13128 U64198 1964 IL12RB2, inter-
GGTGACTTGG[C/g]AGCCTCCCAG M C g Q E leukin 12 receptor, beta 2
G446a8 WIAF-13129 U64198 2060 IL12RB2, inter-
TCTAAACTGG[C/G]TACCCACTCG M C G L V leukin 12 receptor, beta 2
G447u1 WIAF-11796 X03663 384 CSF1R, colony
CCAGTGTCCC[C/T]GAGCTGGTCG S C T P P stimulating factor 1 receptor,
formerly McDonough feline sarcoma viral (v-fms) oncogene homolog
G447u2 WIAF-11836 X03663 1026 CSF1R, colony
ACAACAACAC[T/C]AAGCTGCCAA S T C T T stimulating factor 1 receptor,
formerly McDonough feline sarcoma viral (v-fms) oncogene homolog
G447u3 WIAF-11837 X03663 886 CSF1R, colony
CCTCAAAGTG[C/A]ACAAACTCAT M C A Q K stimulating factor 1 receptor,
formerly McDonough feline sarcoma viral (v-fms) oncogene homolog
G447u4 WIAF-11797 X03663 2425 CSF1R, colony
GAAGAAATAT[G/A]TCCGCAGGGA M G A V I stimulating factor 1 receptor,
formerly McDonough feline sarcoma viral (v-fms) oncogene homolog
G4473u1 WIAF-13904 HT1352 860 FUCA1, TTCAAGCCAC[A/G]GAGCTTGCCA M A
G Q R fucosidase, alpha-L- 1, tissue G4473u2 WIAF-13916 HT1352 440
FUCA1, ACAAACTGGC[C/T]GAGTCCTGTG M C T P L fucosidase, alpha-L- 1,
tissue G4479u1 WIAF-13637 HT1995 2465 AMPD2, adenosine
GCCTCAATGA[G/T]CCTGGTCCAT -- G T -- -- monophosphate deaminase 2
(isoform L) G4479u2 WIAF-13866 HT1995 1258 AMPD2, adenosine
TGGATGTGCA[T/C]GCGGACAGGA S T C H H monophosphate
deaminase 2 (isoform L) G4479u3 WIAF-13867 HT1995 1280 AMPD2,
adenosine CACTTTCCAT[C/T]CCTTTGACAA M C T R C monophosphate
deaminase 2 (isoform L) G4479u4 WIAF-13868 HT1995 1201 AMPD2,
adenosine TGCGGGAGGT[C/T]TTTGAGAGCA S C T V V monophosphate
deaminase 2 (isoform L) G4479u5 WIAF-13869 HT1995 1579 AMPD2,
adenosine GTACCAAGGG[C/T]CAGCTGGCCA S C T G G monophosphate
deaminase 2 (isoform L) G4492u1 WIAF-14084 HT3390 866 ANX11,
annexin CCTGGGGAGT[C/T]GCTCCAACA- A M C T R C XI (56 kD
autoantigen) G4492u2 WIAF-14085 HT3390 850 ANX11, annexin
AGGCCATCAT[T/C]GACTGCCTGG S T C I I XI (56 kD autoantigen) G450u1
WIAF-10170 X85740 1196 CCR4, chemokine TCCAAATTTA[C/T]TCTGCTGACA S
C T Y Y (C-C motif) receptor 4 G4502u1 WIAF-13510 HT4840 165 ASS,
AAGCCTATGA[C/T]GTCATTGCCT S C T D D argininosuccinate synthetase
G4502u2 WIAF-13511 HT4840 369 ASS, GGCCCTGCAT[C/T]GCCCGCAAAC S C T
I I argininosuccinate synthetase G4502u3 WIAF-13512 HT4840 73 ASS,
AATCCCAGAC[G/A]CTATGTCCAC -- G A -- -- argininosuccinate synthetase
G4502u4 WIAF-13513 HT4840 129 ASS, TGGACACCTC[G/C]TGCATCCTCG S G C
S S argininosuccinate synthetase G4502u5 WIAF-13514 HT4840 285 ASS,
AGTTTGTGGA[G/A]GAGTTCATCT S G A E E argininosuccinate synthetase
G4502u6 WIAF-13515 HT4840 234 ASS, AGGCACTGAA[C/A]CTTGGGGCCA S G A
K K argininosuccinate synthetase G4502u7 WIAF-13516 HT4840 316 ASS,
CCAGTCCAGC[G/A]CACTGTATGA N G A A T argininosuccinate synthetase
G4502u8 WIAF-13537 HT4840 426 ASS, TGTCCCACGG[C/T]GCCACAGGAA S C T
G G argininosuccinate synthetase G4502u9 WIAF-13538 HT4840 530 ASS,
GAATTCTACA[A/C]CCGGTTCAAG M A G N S argininosuccinate synthetase
G4502u10 WIAF-13539 HT4840 750 ASS, TTCTCGACAT[C/T]GAGTTCAAAA S C T
I I argininosuccinate synthetase G4502u11 WIAF-13540 HT4840 960
ASS, ATGCTCATTT[A/G]GACATCGAGG S A G L L argininosuccinate
synthetase G4508u1 WIAF-13663 HT28557 1767 ARSD,
CAGTTTTCCA[T/C]GAGCAACATC M T C M T arylsulfatase D G4508u2
WIAF-13693 HT28557 433 ARSD, TTCAGTGGAA[C/T]GCAGGCTCAG S C T N N
arylsulfatase D G4508u3 WIAF-13694 HT28557 747 ARSD,
GGTTTCTTCT[C/G]TGTCTCCGCG M C G S C arylsulfatase D G4508u4
WIAF-13696 HT28557 1012 ARSD, CCAGCACTGC[A/C]TTCCTGGGGA S A G A A
arylsulfatase D G4508u5 WIAF-13697 HT28557 1302 ARSD,
CGAGTGATTG[G/A]AGAGCCCACG M G A G E arylsulfatase D G4508u6
WIAF-13698 HT28557 1285 ARSD, GGGTGCTCCC[G/A]GCCCGCCGAG S G A P P
arylsulfatase D G4508u7 WIAF-13699 HT28557 1807 ARSD,
AGCCGTGCTG[C/T]GGACATTTCC S C T C C arylsulfatase D G4508u8
WIAF-13718 HT28557 483 ARSD, GCAAGAATCT[T/C]GCAGCAGCAT M T C L S
arylsulfatase D G4518u1 WIAF-13809 HT3430 515 ASPA,
ACAACACCAC[C/T]TCTAACATGG S C T T T aspartoacylase (aminoacylase 2,
Canavan disease) G4518u2 WIAF-13810 HT3430 851 ASPA,
AACTTCATTA[C/T]CCCCGGGATC S C T Y Y aspartoacylase (aminoacylase 2,
Canavan disease) G4518u3 WIAF-13811 HT3430 787 ASPA,
CATCATTTCA[A/G]TGAAGGAAAA M A G N S aspartoacylase (aminoacylase 2,
Canavan disease) G4518u4 WIAF-13837 HT3430 618 ASPA,
ACCCTGCTAC[G/A]TTTATCTG- AT M G A V I aspartoacylase (aminoacylase
2, Canavan disease) G452a1 WIAF-10509 HT0695 553 APOA4,
ACCCAGGTCA[A/C]CACGCAGGCC M A G N S apolipoprotein A-IV G452a2
WIAF-13124 HT0695 563 APOA4, ACACGCAGGC[C/T]GAGCAGCTGC S C T A A
apolipoprotein A-IV G4524u1 WIAF-14120 HT1541 726 ATP5A1, ATP
CTCAATTGCT[A/G]TTGACACAAT M A G I V synthase, H+ transporting,
mito- chondrial F1 complex, alpha subunit, isoform 1, cardiac
muscle G4524u2 WIAF-14131 HT1541 153 ATP5A1, ATP
ATCTTTCATT[G/T]CTGCAAGGAA M G T A S synthase, H+ transporting,
mito- chondrial F1 complex, alpha subunit, isoform 1, cardiac
muscle G4526u1 WIAF-14130 HT4994 400 ATP5D, ATP
TCCATCGCAG[T/C]GAACGGCGAC M T C V A synthase, H+ transporting,
mito- chondrial F1 complex, delta subunit G453u1 WIAF-10138 HT0768
1747 PDGFRB, platelet- CTGCCGCCCA[C/T]GCTGCTGGGG M C T T M derived
growth factor receptor, beta polypeptide G453u2 WIAF-10147 HT0768
2957 PDGFRB, platelet- TTTTGCCTTT[A/G]AAGTGGATGG S A G L L derived
growth factor receptor, beta polypeptide G453u3 WIAF-10148 HT0768
3608 PDGFRB, platelet- AGCCGGAGCC[A/G]GAGCTGGAAC S A G P P derived
growth factor receptor, beta polypeptide G453u4 WIAF-10149 HT0768
457 PDGFRB, platelet- CAGGGCCTGG[T/G]CGTCACACCC M T G V G derived
growth factor receptor, beta polypeptide G453u5 WIAF-10151 HT0768
1505 PDGFRB, platelet- AGCTGACACT[G/C]GTTCGCGTGA S G C L L derived
growth factor receptor, beta polypeptide G453u6 WIAF-10153 HT0768
3446 PDGFRB, platelet- ACCCCAAACC[C/T]GAGCTTGCTG S C T P P derived
growth factor receptor, beta polypeptide G453u7 WIAF-10161 HT0768
2030 PDGFRB, platelet- TTTGGCAGAA[G/A]AAGCCACGTT S G A K K derived
growth factor receptor, beta polypeptide G4533u1 WIAF-13616 HT1618
343 ATP synthase, H+ GTTACATGAT[C/T]GACAACGTGA S C T I I
transporting, subunit D, vacuolar G4534u1 WIAF-13569 HT3556 654
ATP6E, ATPase, H+ TAAAGGTTTC[C/T]AACACCCTGG S C T S S transporting,
lysosomal (vacuolar proton pump) 31 kD G4535u1 WIAF-13747 HT27972
357 ATP50, ATP TCACTACCAA[C/T]CTGATCAATT S C T N N synthase, H+
transporting, mitochondrial F1 complex, O subunit (oligomycin
sensitivity conferring protein) G4535u2 WIAF-13748 HT27972 144
ATP50, ATP AGGTATACGG[T/C]ATTGAAGGTC S T C G G synthase, H+
transporting, mitochondrial F1 complex, O subunit (oligomycin
sensitivity conferring protein) G4535u3 WIAF-13792 HT27972 329
ATP50, ATP ATCACAGCAA[A/G]AGAGAGGTTC M A G K R synthase, H+
transporting, mitochondrial F1 complex, O subunit (oligomycin
sensitivity conferring protein) G45439u1 WIAF-13711 HT48520 288
ATPase, 14 kDa TGCCCTGGAC[G/A]CCCACCAGCA M G A A T subunit,
vacuolar G4548u1 WIAF-14127 HT1574 3138 ATPase, Ca2+ trans-
CGCAATGTCT[T/C]TGACGGCATC M T C F S porting membrane, isoform 2
G4548u2 WIAF-14137 HT1574 2089 ATPase, Ca2+ trans-
GCACTATCTG[C/T]GTGGCCTACC S C T C C porting membrane, isoform 2
G4548u3 WIAF-14140 HT1574 2924 ATPase, Ca2+ trans-
CAGGACCATG[A/T]TGAAGAACAT M A T M L porting membrane, isoform 2
G4549u1 WIAF-14161 HT1346 524 ATP2B4, ATPase,
TGCACTGACC[C/T]AGATTAATGT N C T Q * Ca++ transporting, plasma
membrane 4 G4549u2 WIAF-14162 HT1346 715 ATP2B4, ATPase,
ATGTCACGCT[C/T]ATCATCCTGC S C T L L Ca++ transporting, plasma
membrane 4 G4549u3 WIAF-14163 HT1346 508 ATP2B4, ATPase,
AGCTGCGTTC[G/A]ACGGATOCAC S G A S S Ca++transporting, plasma
membrane 4 G4549u4 WIAF-14166 HT1346 1084 ATP2B4, ATPase,
TGATCCAACG[G/A]AATGATCTCA S G A G G Ca++ transporting, plasma
membrane 4 G4552u1 WIAF-13630 HT0867 710 ATP7A, ATPase,
TACTAGCACT[A/G]TTGAAGGAAA M A G I V Cu++ transporting, alpha
polypeptide (Menkes syndrome) G456u1 WIAF-100741 HT2834 408 EDN1,
endothelin 1 CCTGGCGGCT[T/G]CGCCGGTCCA S T G L L G456u2 WIAF-10075
HT2834 585 EDN1, endothelin 1 CAGACCGTGA[A/G]AATAGATGCC S A G E E
G456a3 WIAF-10507 HT2834 861 EDN1, endothelin 1
TGAAAGGCAA[T/G]CCCTCCAGAG M T G K N G4565u1 WIAF-14041 HT28561 320
ATP1G1, ATPase, CGAGGCTGCT[G/A]TTACGGCTCA S G A L L Na+/K+
transporting, gamma 1 polypeptide G4565u2 WIAF-14062 HT28561 216
ATP1G1, ATPase, CAGTGACGGG[G/A]ACAAAGGTCT M G A D N Na+/K+
transporting, gamma 1 polypeptide G4565u3 WIAF-14063 HT28561 315
ATP1G1, ATPase, ACCGCCGAGG[C/A]TGCTGTTACG M C A L M Na+/K+
transporting, gamma 1 polypeptide G4565u4 WIAF-14064 HT28561 531
ATP1G1, ATPase, TTTCCCCAGG[T/C]GAATGGGCTG N T C * R Na+/K+
transporting, gamma 1 polypeptide G4568u1 WIAF-14212 HT0082 717
AMFR, autocrine TGCCTCATGC[A/G]TACGTCCCAC M A G I V motility factor
receptor G457a1 WIAF-10489 HT2903 321 SELL, selectin L
ACAAATCTCT[C/T]ACTGAAGAAG S C T L L (lymphocyte adhesion molecule
1) G457a2 WIAF-10490 HT2903 577 SELL, selectin L
CCAGTGTCAG[T/C]TTGTGATTCA M T C F L (lymphocyte adhesion molecule
1) G457a3 WIAF-10491 HT2903 601 SELL, selectin L
TGAGCCTTTG[G/C]AGGCCCCAGA M G C E Q (lymphocyte adhesion molecule
1) G457a4 WIAF-10492 HT2903 637 SELL, selectin L
CTGTACTCAC[C/T]CTTTGGGAAA M C T P S (lymphocyte adhesion molecule
1) G4573u1 WIAF-13568 HT28320 943 NCAT2, mannosyl
CGGACAACCT[G/T]ACCCTGCGCT S G T L L (alpha-1,6-)- glycoprotein
beta- 1,2-N-acetylgluco- saminyltransferase G4574u1 WIAF-13805
HT0198 163 beta-1,4 N- CGGCCTCCGG[C/G]TACCTCTTGC M C G L V
acetylgalacto- saminyltransferase G4574u2 WIAF-13806 HT0198 415
beta-1,4 N- TGCCACAAGA[G/A]AGCAGGAGTT M G A E K acetylgalacto-
saminyltransferase G4574u3 WIAF-13807 HT0196 726 beta-1,4 N-
AACTACAACT[G/T]GTCACTTACA S G T L L acetylgalacto-
saminyltransferase G4574u4 WIAF-13836 HT0198 559 beta-1,4 N-
AGGGCTGAGC[C/A]TTCAGGCAGC M C A L I acetylgalacto-
saminyltransferase G4575u1 WIAF-13626 HT0341 1251 GCNT1,
glucosaminyl AGTATGATCT[A/G]TCTGACATGC S A G L L (N-acetyl)
transferase 1, core 2 (beta-1,6-N- acetylgluco- saminyltransferase)
G4577u1 WIAF-13971 HT1495 1268 SIAT1, sialyl-
ATTTCTTTAA[C/T]AACTACAAGA S C T N N transferase 1 (beta-galactoside
alpha-2, 6- sialytransferase) G458u1 WIAF-10063 HT2968 1464 ALB,
albumin GTGCAGAAGA[C/A]TATCTATCCG M C A D E G458u2 WIAF-10089
HT2968 1470 ALB, albumin AAGACTATCT[A/C]TCCGTGGTCC S A C L L G458u3
WIAF-10091 HT2968 1707 ALB, albumin TTGTTGAGCT[C/T]GTGAAACACA S C T
L L G458a4 WIAF-10504 HT2968 889 ALB, albumin
CAGGGCGGAC[C/T]TTGCCAAGTA M C T L F G458a5 WIAF-10508 HT2968 1475
ALB, albumin TATCTATCCG[T/A]GGTCCTGAAC M T A V E G458a6 WIAF-12091
HT2968 1330 ALB, albumin CCAGAATGCG[C/T]TATTAGTTCG S C T L L G458a7
WIAF-12092 HT2968 1408 ALB, albumin CCTAGGAAAA[G/a]TGGGCAGCAA M G a
V M G4592u1 WIAF-14126 HT2128 985 branched-chain keto
ACCAGCCCTT[T/C]CTCATCGAGG S T C F F acid dehydrogenase E1, alpha
poly- peptide G4593u1 WIAF-13574 HT97373 1743 BARD1, ERCA1
GCTAGCCACT[G/C]CTCAGTAATG M G C C S associated RING domain 1
G4593u2 WIAF-13592 HT97373 1167 BARD1, ERCA1
TGTTCTTCAC[C/T]ACCTTCATGC M C T P L associated RING domain 1
G4593u3 WIAF-13593 HT97373 1591 BARD1, ERCA1 AGAATGGGCA[C/TI
GTGGATATAG S C T H H associated RING domain 1 G4593u4 WIAF-13594
HT97373 2030 BARD1, ERCA1 AAAGTATGAA[A/G]TTCCTGAAGG M A G I V
associated RING domain 1 G4593u5 WIAF-13595 HT97373 2006 BARD1,
ERCA1 AAGAAAAGTA[T/C]GTGAACAGGA M T C C R associated RING domain 1
G4599u1 WIAF-13920 HT4273 1803 CDH13, cadherin 13,
TCGTACCCGA[C/T]GTCTCCTACG S C T D D H-cadherin (heart) G4614u1
WIAF-13733 HT4835 91 S100A3, S100 AGGATGGCCA[G/A]GCCTCTGGAG M G A R
K calcium-binding protein A3 G4614u2 WIAF-13734 HT4835 203 S100A3,
S100 TGCTGCAGAA[G/A]GAGCTGGCCA S G A K K calcium-binding protein A3
G4614u3 WIAF-13769 HT4835 344 S100A3, S100
TCTACTGCCA[C/T]GAGTACTTCA S C T H H calcium-binding protein A3
G462u1 WIAF-10134 HT4753 600 PDGFA, platelet-
ACGGGGTCCA[C/T]GCCACTAAGC S C T H H derived growth factor alpha
polypeptide G4627u1 WIAF-14042 HT0771 186 ANX6, annexin VI
GGAGGCCATA[C/T]TGGACATAAT S C T L L (p68) G4627u2 WIAF-14043 HT0771
1664 ANX6, annexin VI CAGACACACC[T/C]AGTGGAGACA S T C P P (p68)
G4627u3 WIAF-14067 HT0771 1498 ANX6, annexin VI
AAGGAGCACT[A/G]TCACAAGTCC M A G Y C (p68) G4644u1 WIAF-13801 HT1736
1990 CPS1, carbamoyl- TGGTGGAGAA[G/A]TCAGTGACAG S G A K K phosphate
synthetase 1, mitochondrial G4644u2 WIAF-13802 HT1736 1866 CPS1,
carbamoyl- ATTGGCTACC[C/T]AGTGATGATC M C T P L phosphate synthetase
1, mitochondrial G4644u3 WIAF-13803 HT1736 1993 CPS1, carbamoyl-
TGGAGAAGTC[A/C]GTGACAGGTT S A C S S phosphate synthetase 1,
mitochondrial G4644u4 WIAF-13804 HT1736 1860 CPS1, carbamoyl-
GACACCATTG[G/A]CTACCCAGTG M G A G D phosphate synthetase 1,
mitochondrial G4644u5 WIAF-13831 HT1736 1087 CPS1, carbamoyl-
AGCCTGTTTT[C/T]AATATCACAA M G T L F phosphate synthetase 1,
mitochondrial G4644u6 WIAF-13835 HT1736 1958 CPS1, carbamoyl-
CACAAAGGCC[T/C]TTGCTATGAC M T C F L phosphate synthetase 1,
mitochondrial G4644u7 WIAF-13855 HT1736 1332 CPS1, carbamoyl-
AAAGCTACCA[C/A]CATTACATCA M C A T N phosphate synthetase 1,
mitochondrial G4659u1 WIAF-14143 HT1183 1830 catenin, alpha
GTGCCAACGT[T/C]CCTCAACCGT S T C V V G466u1 WIAF-10164 U00968 2403
SREBF1, sterol AGCAGTGCCC[C/A]CCAGGCCT- GC M G A R H regulatory
element binding transcrip- tion factor 1 G4662u1 WIAF-13710 HT2142
2183 CTNNB1, catenin TTTTGTTCCG[A/C]ATGTCTGAGG S A C R R (cadherin
associated protein), beta 1 (88 kD) G467a1 WIAF-13304 X72861 827
ADRB3, adrenergic, GGCCATCGCC[T/C]GGACTCCGAG M T C W R beta-3-,
receptor G467a2 WIAF-13305 X72861 832 ADRB3, adrenergic,
TCGCCTGGAC[T/A]CCGAGACTCC S T A T T beta-3-, receptor G467a3
WIAF-13306 X72861 870 ADRB3, adrenergic, TTCGTCACTT[C/T]CCTGGCCGCA
M C T S L beta-3-, receptor G467a4 WIAF-13307 X72861 1761 ADRB3,
adrenergic, TGCGCCGCCG[C/T]CCGCCCCGCC M C T A V beta-3-, receptor
G467a5 WIAF-13305 X72861 1899 ADRB3, adrenergic,
TCTGTTGATC[A/C]GAACCTGTCG -- A C -- -- beta-3-, receptor G4671u1
WIAF-13956 HT1925 161 NDUFB7, NADH TGGTGGCCAC[A/C]CAGCAGGACA S A G
T T dehydrogenase (ubiquinone) 1 beta subcomplex, 7 (18 kD, B18)
G4673u1 WIAF-13889 HT0191 1349 CDC25A, cell
TCTCGGGCCA[G/C]CCCCAAAGAC M G C S T division cycle 25A G4674u1
WIAF-13821 HT1393 261 CDC25B, cell ACCACCTCCC[C/T]GGGCTCGGCA S C T
A A division cycle 25B G4674u2 WIAF-13822 HT1393 1297 CDC25B, cell
GATGGTCCCC[C/T]TATTCACGGG S C T L L division cycle 25B
G4674u3 WIAF-13823 HT1393 1083 CDC25B, cell
ATAACCCCAG[C/A]CGGAGCCTGA S G A R R division cycle 25B G4674u4
WIAF-13827 HT1393 1446 CDC25B, cell AGAGCCCCAT[C/T]CCCCCCTGTA S C T
I I division cycle 25B G468a1 WIAF-13309 L37019 192 ASIP, agouti
AAATCCAAAC[C/A]CATCGGCA- CA M C A P Q (mouse)-signaling protein
G4691u1 WIAF-13753 HT97602 179 CMKBR9, chemokine
TATAGCCTGA[T/A]TTTTGTGTTG M T A I N (C-C motif) receptor 9 G4691u2
WIAF-13754 HT97602 134 CMKBR9, chemokine AAGGATGCAG[T/C]GGTCTCCTTT
M T C V A (C-C motif) receptor 9 G4691u3 WIAF-13755 HT97602 193
CMKBR9, chemokine TGTGTTGGGC[C/T]TCAGCGGGAA M C T L F (C-C motif)
receptor 9 G4691u4 WIAF-13756 HT97602 770 CMKBR9, chemokine
AAAATAGCTC[C/T]AGCCTTGGTG M C T A V (C-C motif) receptor 9 G4691u5
WIAF-13759 HT97602 1130 CMKBR9, chemokine TCTCAGAACT[A/C]CCCTAACAAG
M A C Y S (C-C motif) receptor 9 G4691u6 WIAF-13796 HT97602 482
CMKBR9, chemokine AGGCTGAGGA[C/A]CCCGGCCAAG M C A T N (C-C motif)
receptor 9 G4691u7 WIAF-13797 HT97602 259 CMKBR9, chemokine
GATGGTTGAG[A/G]TCTATCTGCT M A G I V (C-C motif) receptor 9 G4691u8
WIAF-13798 HT97602 434 CMKBR9, chemokine ATGACCCTGG[A/G]CAAGTACCTG
M A G D G (C-C motif) receptor 9 G4691u9 WIAF-13799 HT97602 755
CMKBR9, chemokine CAGGGCCGGG[C/T]TTTAAAAATA M C T A V (C-C motif)
receptor 9 G4699u1 WIAF-14040 HT4277 1426 BAAT, bile acid
TTCCAGATGT[C/T]ACCAGTCAAC S G T V V Coenzyme A: amino acid N-acyl-
transferase (glycine N- choloyltransferase) G4726u1 WIAF-14128
HT48614 1606 AOC3, amine TCCACCCCAG[T/C]GGGGCCATAG S T C S S
oxidase, copper containing 3 (vascular adhesion protein 1) G4726u2
WIAF-14129 HT48614 2242 AOC3, amine TTCCTAACAC[A/G]GTGACTGTGG S A G
T T oxidase, copper containing 3 (vascular adhesion. protein 1)
G4726u3 WIAF-14141 HT48614 659 AOC3, amine
CCTGCCCTAT[C/T]ACCGACGCCC M C T H Y oxidase, copper containing 3
(vascular adhesion protein 1) G4744u1 WIAF-13683 HT2599 564 CTH,
cystathionase ATATTGTCCA[T/C]AAGCATGGAG S T C H H (cystathionine
gamma-lyase) G4748u1 WIAF-14144 HT1061 242 CYBA, cytochrome
GGGACAGAAG[C/T]ACATGACCGC M C T H Y b-245, alpha polypeptide
G4748u2 WIAF-14145 HT1061 265 CYBA, cytochrome
TGGTGAAGCT[G/C]TTCGGGCCCT S G C L L b-245, alpha polypeptide
G4750u1 WIAF-14116 HT48417 156 CYB5, cytochrome
TGAAGTACTA[C/T]ACCCTAGAGG S C T Y Y b-5 G4751u1 WIAF-13770 HT1285
495 UQCRC2, ubiquinol- AGAATTTCGT[C/A]GTTGGGAAGT M C A R S
cytochrome c reductase core protein II G4788u1 WIAF-13931 HT28249
1864 DSC3, desmocollin 3 CTGTTGATCC[T/C]GATGAACCTG S T C P P
G4788u2 WIAF-13933 HT28249 2000 DSC3, desmocollin 3
TGGATTTCAA[G/T]AATATACCAT N G T E * G4788u3 WIAF-13945 HT28249 2524
DSC3, desmocollin 3 ACACTTACTC[G/A]GAGTGGCACA S G A S S G479u1
WIAF-12567 U36310 894 GPD2, glycerol-3- GGGAAAGTCC[A/G]TGTGACCGGC M
A G H R phosphate dehydrogenase 2 (mitochondrial) G479u2 WIAF-12574
U36310 1657 GPD2, glycerol-3- CTGGCAAAAG[G/T]TGGCCTATTG M G T R S
phosphate dehydrogenase 2 (mitochondrial) G479u3 WIAF-12575 U36310
1131 GPD2, glycerol-3- GTTATTTTCT[T/C]CTTACCCTGG M T C F S
phosphate dehydrogenase 2 (mitochondrial) G480u1 WIAF-12175 HT336
250 GRB2, growth AATGAAACCA[C/A]ATCCGTGGTT M C A H N factor
receptor- hound protein 2 G4819u1 WIAF-13985 HT97576 1804 EYA1,
eyes absent CCCTGCACCA[T/C]GCCTTGGA- AC S T C H H (Drosophila)
homolog 1 G482u1 WIAF-12181 J04501 1186 GYS1, glycogen
CTGACGTCTT[T/C]CTGGAGGCAT S T C F F synthase 1 (muscle) G482u2
WIAF-12195 J04501 1406 GYS1, glycogen CCTTCCCGAC[A/G]TGAACAAGAT M A
G M V synthase 1 (muscle) G4827u1 WIAF-14177 HT97477 68 elongation
CGAGCTGGCC[A/G]TCATGGTCAT M A G H R G483a1 WIAF-12113 HT4341 1850
GSY2 TTACCAGCAT[C/T]CCAGACACCT M G T A S G483u2 WIAF-12148 HT4341
1130 GSY2 GTTTTTCATT[A/C]TCCCTGCCAA M A C M L G483u3 WIAF-12149
HT4341 880 GSY2 CCTTCAATGT[T/C]AAGAAATTTT S T G V V G483u4
WIAF-12150 HT4341 1115 GSY2 CATCACACTC[C/A]TGGTGTTTTT M G A V M
G483u5 WIAF-12156 HT4341 1230 GSY2 GAAAACTTTG[C/A]AAAAAAACTC M G A
G E G483u6 WIAF-12159 HT4341 2033 GSY2 TCACAGATAC[G/A]ATGACGAACA M
G A D N G483u7 WIAF-12160 HT4341 1836 GSY2
TACTTACGCA[G/C]ATATTACCAC M G C R T G483u8 WIAF-12161 HT4341 1678
GSY2 CTTACGGTAT[T/C]TACATCGTTG S T C I I G483u9 WIAF-12177 HT4341
790 GSY2 GCGCTCACGT[G/C]TTCACCACGG S G C V V G483u10 WIAF-12188
HT4341 1728 GSY2 TCCAATCACC[T/C]GACTAAGTTT M T C L P G484u1
WIAF-12151 HT5111 487 GSY3 CATCAAAGTG[A/G]TTGGCAATGG M A G I V
G484u2 WIAF-12187 HT5111 1141 GSY3 AACCCCGCAA[C/T]AAATCCCAGA N C T
Q * G489u1 WIAF-12152 HT2607 1181 IRS1, insulin
AAGAAGTGGC[G/A]GCACAAGTCG M G A R Q receptor substrate 1 G489u2
WIAF-12184 HT2607 1031 IRS1, insulin ATGGCCAGCC[C/T]TCCGGAGAGC M C
T P L receptor substrate 1 G492a1 WIAF-13345 L08603 307 MC4R,
melanocortin AGAAACCATT[A/C]TCATCACCCT M A G I V 4 receptor G493u1
WIAF-12154 X67594 346 MC1R, melanocortin CGCGCTGGTG[G/T]TGGCCACCAT
M G T V L 1 receptor (alpha melanocyte stimulating hormone
receptor) G493u2 WIAF-12167 X67594 646 MC1R, melanocortin
GACCCTGCCG[C/T]GGGCGCGGCA M C T R W 1 receptor (alpha melanocyte
stimulating hormone receptor) G493u3 WIAF-12170 X67594 1110 MC1R,
melanocortin AGGTCCTGAC[A/G]TGCTCCTGGT S A G T T 1 receptor (alpha
melanocyte stimulating hormone receptor) G493u4 WIAF-12186 X67594
442 MC1R, melanocortin CGGGAGCAAC[C/T]TGCTCGAGAC M G T V L 1
receptor (alpha melanocyte stimulating hormone receptor) G498u1
WIAF-11809 J04127 1305 CYP19, cytochrome CTTATAGGTA[C/T]TTTCAGCCAT
S C T Y Y P450, subfamily XIX (aromatization of androgens) G498u2
WIAF-11810 J04127 1377 CYP19, cytochrome TGAAAGCCAT[C/T]CTCGTTACAC
S C T I I P450, subfamily XIX (aromatization of androgens) G498u3
WIAF-11811 J04127 1406 CYP19, cytochrome CGATTCCACG[T/C]GAAGACATTG
M T C V A P450, subfamily XIX (aromatization of androgens) G498u4
WIAF-11838 J04127 1055 CYP19, cytochrome ATTGCTGACA[G/A]AGACATAAAG
M G A R K P450, subfamily XIX (aromatization of androgens) G498u5
WIAF-11800 J04127 1001 CYP19, cytochrome ATTGCAAAGC[A/C]CCCTAATGTT
M A G H R P450, subfamily XIX (aromatization of androgens) G499u1
WIAF-11785 HT1439 2142 ESR1, estrogen TCCCTGCCAC[A/G]GTCTGAGAGC S A
G T T receptor 1 G499u2 WIAF-11801 HT1439 443 ESR1, estrogen
CCCCTGAACC[G/A]TCCGCAGCTC M G A R H receptor 1 G500u1 WIAF-11803
X99101 793 ESR1, estrogen CATGATCAGC]T/C]GGGCCAAGAA M T C W R
receptor 1 G500u2 WIAF-11816 X99101 489 ESR1, estrogen
GGAAGTGTTA[C/T]GAAGTGGGAA S C T Y Y receptor 1 G500u3 WIAF-11817
X99101 474 ESR1, estrogen AGGCCTGCCG[A/G]CTTCGGAAGT S A G R R
receptor 1 G505u1 WIAF-11824 HT1113 1063 PRLR, prolactin
GCTTTCAAGC[C/A]CTATAGCATC M G A G D receptor G505u2 WIAF-11827
HT1113 2083 PRLR, prolactin GCAACATCAA[C/A]CAAGTCCAGG M G A S N
receptor G505u3 WIAF-11787 HT1113 582 PRLR, prolactin
GAGGACATAC[A/G]TCATGATGGT M A G I V receptor G505u4 WIAF-11802
HT1113 792 PRLR, prolactin CCTGTATGAA[A/C]TTCGATTAAA M A C I L
receptor G509u1 WIAF-11789 M32313 378 SRD5A1, steroid-S-
CACTGTTCGC[A/G]TGTACAATGG S A G A A alpha-reductase, alpha
polypeptide 1 (3-oxo-5 alpha- steroid delta 4- dehydrogenase alpha
1) G510a1 WIAF-13348 U17280 582 STAR, steroidogenic
CCAATGTCAA[C/A]GAGATCAAGG S G A K K acute regulatory protein G52u1
WIAF-10224 HT0488 1139 inhibin, beta B CCAACATGAT[T/C]GTGGAGGAGT S
T C I I G520u1 WIAF-13507 D31770 517 ACVR2, activin A
CTTATTTTCC[G/A]GAGATGGAAG S G A P P receptor, type II G520u2
WIAF-13532 D31770 1177 ACVR2, activin A CAGCTTGCAT[T/G]GCTGACTTTG M
T G I M receptor, type II G520u3 WIAF-13533 D31770 1189 ACVR2,
activin A CTGACTTTGG[G/C]TTGGCCTTAA S G C G G receptor, type II
G520u4 WIAF-13534 D31770 1024 ACVR2, activin A
TCTCTTCGAA[T/C]GAACTGTGTC S T C N N receptor, type II G523u1
WIAF-12155 HT4996 538 OXTR, oxytocin TGACGGGGAA[C/T]GCGTGTGTGC S C
T N N receptor G523u2 WIAF-12180 HT4996 1057 OXTR, oxytocin
TCTGGCAGAA[C/T]TTGCGGCTCA S C T N N receptor G524a1 WIAF-13349
L05144 190 PCK1, phosphoenol- TGGACAGCCT[G/A]CCCCAGGCAG S G A L L
pyruvate carboxy- kinase 1 (soluble) G528u1 WIAF-11831 V00572 988
PGK1, phospho- AAGCCACTGT[G/C]GCTTCTGGCA S G C V V glycerate kinase
1 G53u1 WIAF-10307 HT0508 723 DNA repair protein
CCAGCGACCC[G/A]GCAGGACCTA S G A P P XRCC1 G53u2 WIAF-10308 HT0508
746 DNA repair protein TATGCAGCTG[C/T[TACCCTCCAG M C T A V XRCC1
G53u3 WIAF-10309 HT0508 1884 DNA repair protein
GGGATCCCAG[C/T]TTTGAGGAGG S C T S S XRCC1 G53u4 WIAF-10362 HT0508
425 DNA repair protein AACCCCAACC[G/A]CGTTCGCATG M G A R H XRCC1
G534a1 WIAF-13311 U28281 1284 SCTR, secretin
GCTTCCTCAA[T/C]GGGGAGGTGC S T C N N receptor G534a2 WIAF-13311
U28281 1404 SCTR, secretin AGCACAGCCA[G/A]GGCACCTGCA S G A Q Q
receptor G535u1 WIAF-12157 HT5001 1158 SHC1
ATGCTCTTCG[G/C]GTGCCTCCAC S G C R R G535u2 WIAF-12196 HT5001 774
SHC1 ATGAGGAGGA[G/A]GAAGAGCCAC S G A E E G536u1 WIAF-13923 M20747
535 SLC2A4, solute GCCTGCCCAA[C/T]GCTGCTGCC- T S C T N N carrier
family 2 (facilitated glucose transporter), member 4 G538u1
WIAF-11812 M55531 438 SLC2A5, solute GCAGCAGAGT[C/T]GCCACATCAT S C
T V V carrier family 2 (facilitated glucose transporter), member 5
G538u2 WIAF-11813 M55531 124 SLC2A5, solute
GACGCTTGTG[C/T]TTGCCCTGGC M C T L F carrier family 2 (facilitated
glucose transporter) member 5 G538u3 WIAF-11791 M55531 816 SLC2A5,
solute ACAGGGAGGT[C/A]GCCGAGATCC S G A V V carrier family 2
(facilitated glucose transporter), member 5 G539u1 WIAF-12158
K03195 224 Human (HepG2) glu- TCATGCTGCC[T/C]GTCCGAGGAC S T C A A
cose transporter gene mRNA, complete cds. G539u2 WIAF-12191 K03195
1244 Human (HepG2) glu- CCATCGCGCT[A/C]CCACTCCTGG S A G L L cose
transporter gene mRNA, complete cds. G540a1 WIAF-12114 HT960 1100
SOS1 AGTGAAGATC[A/C]ACAACACAAG M A C Q P G540u2 WIAF-12165 HT950
933 SOS1 ATGATCGTTT[C/T]CTTAGTCAGT S C T F F G540u3 WIAF-12178
HT960 399 SOS1 TACTACCAGT[C/T]TTACAATAC- A S C T V V G540u4
WIAF-12193 HT960 195 SOS1 CTCAGCCCCG[A/C]AGTCCTTCAG S A C R R
G540u5 WIAF-12197 HT960 1329 SOS1 GTTGTAATCA[A/C]TTTATAATCC S A G E
E G540u6 WIAF-12198 HT960 1339 SOS1 ATTTATAATC[C/A]AACCAACTCT M G A
E K G543a1 WIAF-13312 J00306 1373 SST, somatostatin
AACCAGGAAC[T/C]CCCCAACTAC M T C L P G543a2 WIAF-13313 J00306 1603
SST, somatostatin ACTATTGTCC[A/G]TATCACACCT -- A G -- -- G544u1
WIAF-12174 HT27489 982 SUR, sulfonylurea CCATTGACAT[G/C]GCCACGGAAA
M G C M I receptor (hyperinsulinemia) G546u1 WIAF-13618 HT225 426
TKT, transketolase GCTACATTGC[C/T]CAGCAGAACA S C T A A (Wernicke
Korsakoff syndrome) G551u1 WIAF-11709 HT1118 257 TNFRSF1B, tumor
GCTGCAGCAA[A/G]TGCTCGCCGG S A G K K necrosis factor receptor super-
family, member 1B G551u2 WIAF-11710 HT1118 449 TNFRSF1B, tumor
TCTGCACCTG[C/T]AGGCCCGGCT S C T C C necrosis factor receptor super-
family, member 1B G551u3 WIAF-11719 HT1118 648 TNFRSF1B, tumor
GATCTGTAAC[G/A]TGGTGGCCAT M G A V M necrosis factor receptor super-
family, member 1B G551u4 WIAF-11673 HT1118 676 TNFRSF1B, tumor
AATGCAACCA[T/C]CCATGCAGTC M T G M R necrosis factor receptor super-
family, member 1B G551u5 WIAF-11720 HT1118 808 TNFRSF1B, tumor
CCAAGCACCT[C/T]CTTCCTGCTC M C T S F necrosis factor receptor super-
family, member 1B G552u1 WIAF-12229 HT5108 384 TRAP3
GCCGCTGCCC[G/AICTCATGCTGA S G A P P G555u1 WIAF-12211 U94592 478
UCP2, uncoupling CGCGCTACAG[T/C]CAGCGCCCAG M T C V A protein 2
(mitochondrial, proton carrier) G556u1 WIAF-11804 AF001787 480
UCP2, uncoupling TCGGCCTCTA[T/C]GACTCCCTCA S T C Y Y protein 2
(mitochondrial, proton carrier) G556u2 WIAF-11805 AF001787 563
UCP2, uncoupling TGCACCACAG[G/A]AGCCATGGCG M G A G E protein 2
(mitochondrial, proton carrier) G556u3 WIAF-11823 AF001787 1113
UCP2, uncoupling TACGCCAATC[A/C]CCCTTTTGAA S A G S S protein 2
(mitochondrial, proton carrier) G556u4 WIAF-11782 AF001787 386
UCP2, uncoupling ATCCTGACCA[T/C]GGTGCGGACT M T C M T protein 2
(mitochondrial, proton carrier) G561a1 WIAF-12111 HT1176 2430 IDE,
insulin- ACTCTGGCAT[C/A]GAGATATACT S C A I I degrading enzyme
G561u2 WIAF-12222 HT1176 3099 IDE, insulin-
ATATTAACTT[C/G]ATGGCTGCAA M C G F L degrading enzyme GSG2u1
WIAF-12223 HT27503 680 tumor necrosis CCTGTAGTGA[A/C]TCGGCCGCTG M A
C N T factor receptor type 1 associated protein G562u2 WIAF-12224
HT27503 900 tumor necrosis CGCTCCAGCG[C/A]CTGGTGGAGG S C A R R
factor receptor type 1 associated protein G573u1 WIAF-12199 HT28094
469 SSTR1, somatostatin GGACCGCTAC[G/C]TGGCCGTGGT M G C V L
receptor 1 G573u2 WIAF-12208 HT28094 480 SSTR1, somatostatin
TGGCCCTGGT[G/A]CATCCCAT- CA S G A V V receptor 1 G573u3 WIAF-12209
HT28094 879 SSTR1, somatostatin TGCAGCTGGT[T/C]AACGTGTTTG S T C V V
receptor 1 G574u1 WIAF-11822 HT4058 1054 SSTR5, somatostatin
GCCACGGAGC[C/T]GCGTCCAGAC M C T P L receptor 5 G575u1 WIAF-12200
HT28095 99 SSTR3, somatostatin ACGTGTCGGC[C/A]GGCCCAAGCC S G A A A
receptor 3 G575u2 WIAF-12217 HT28095 453 SSTR3, somatostatin
CCACCCGGTC[G/A]GCCCGCTG- GC S G A S S receptor 3 G585u1 WIAF-12204
HT1022 1133 PYGL, AGCTGAATGA[T/C]ACTCACCCTC S T C D D
phosphorylase, glycogen; liver (Hers disease, glycogen storage
disease type VI) G585u2 WIAF-12205 HT1022 1988 PYGL,
AGCTGATCAC[T/C[TCAGTGGCAG S T C T T phosphorylase, glycogen; liver
(Hers disease, glycogen storage disease type VI) G585u3 WIAF-12225
HT1022 1883 PYGL, TGTACAACCC[C/T]ATTAAGAAAG S C T R R
phosphorylase, glycogen; liver (Hers disease, glycogen
storage disease type VI) G585u4 WIAF-12226 HT1022 2037 PYGL,
AAGCAAGTTG[A/G]AAGTCATCTT M A G K E phosphorylase, glycogen; liver
(Hers disease, glycogen storage disease type VI) G585u5 WIAF-12231
HT1022 1387 PYGL, GATGTGGACC[C/G]TCTGAGAAGG M C G P R
phosphorylase, glycogen; liver (Hers disease, glycogen storage
disease type VI) G586a1 WIAF-12112 HT1878 2410 PFKM,
CCGGGGAAGC[T/G]GCCGTCTAAA S T G A A phosphofructo- kinase, muscle
G586u2 WIAF-12206 HT1878 375 PFKM, GGACCACTCC[G/A]AGCTCCCTAC M G A
R Q phosphofructo- kinase, muscle G586u3 WIAF-12207 HT1878 322
PFKM, TGCGAGGCAC[C/A]GTGATTGGAA S G A T T phosphofructo- kinase,
muscle G586u4 WIAF-12227 HT1878 334 PFKM, TGATTGGAAG[T/C]GCCCGGTGCA
S T C S S phosphofructo- kinase, muscle G586u5 WIAF-12228 HT1878
408 PFKM, CGTCGGATCA[C/G]CAATCTCTGT M C G T S phosphofructo-
kinase, muscle G586u6 WIAF-12235 HT1878 717 PFKM,
CACTGTGGAT[A/G]CCTGGCCCTT M A G Y C phosphofructo- kinase, muscle
G587u1 WIAF-12615 HT3847 366 phosphofructo-
ATGCCAGCCT[T/C]ACAGGTGCCA S T C L L kinase, liver G589u1 WIAF-12210
L39211 1327 CPT1A, carnitine CAGCGTTCTT[C/T]GTGACGTTAG S C T F F
palmitoyl- transferase I, liver G589u2 WIAF-12215 L39211 2080
CPT1A, carnitine AATATCTCGC[T/C]GTGGAGTCCC S T C A A palmitoyl-
transferase I, liver G589u3 WIAF-12216 L39211 679 CPT1A, carnitine
ACTTCAAACG[C/T]ATGACAGCAC S G T R R palmitoyl- transferase I, liver
G589u4 WIAF-12218 L39211 1844 CPT1A, carnitine
CCTCACATAC[G/C]AGGCCTCCAT M G C E Q palmitoyl- transferase I, liver
G592u1 WIAF-11814 X96586 1089 NSMAF, neutral
TCCGGGATCT[C/T]AGTAAGCCAG S C T L L sphingomyelinase (N-SMase)
activation associated factor G592u2 WIAF-11815 X96586 2020 NSMAF,
neutral AAGTATATCA[T/G]TTTCAAATAT M T G F V sphingomyelinase
(N-SMase) activation associated factor G592u3 WIAF-11834 X96586
1673 NSMAF, neutral GTAGCCATGC[T/C]TACGCAAATC M T C L P
sphingomyelinase (N-SMase) activation associated factor G592u4
WIAF-11784 X96586 1889 NSMAF, neutral CACGAGCACT[A/G]TAAAATCCAC M A
C Y C sphingomyelinase (N-SMase) activation associated factor
G592u5 WIAF-11798 X96586 1677 NSMAF, neutral
CCATGCTTAC[G/A]CAAATCTTGG S G A T T sphingomyelinase (N-SMase)
activation associated factor G592u6 WIAF-11799 X96586 2429 NSMAF,
neutral TGCCATTCAG[G/C]GATTCTATGT M G C G A sphingomyelinase
(N-SMase) activation associated factor G592a7 WIAF-13156 X96586
2205 NSMAF, neutral ATTCTGCATC[G/A]TGGGACTCTA S G A S S
sphingomyelinase (N-SMase) activation associated factor GS94u1
WIAF-10065 HT3921 1153 annexin V, alt. TTGTGAAATC[T/A]ATTCGAAGTA S
T A S S transcript 2 G594u2 WIAF-10098 HT3921 567 annexin V, alt.
CGAAGTAATG[C/T]TCACCGCCAG M C T A V transcript 2 G594u3 WIAF-10099
HT3921 774 annexin V, alt. ATTGCTTCAA[G/C]CACACCTCAA M G C R T
transcript 2 G594a4 WIAF-10505 HT3921 424 annexin V, alt.
GAGTAGTCGC[C/T]ATGCCACACG -- C T -- -- transcript 2 G594a5
WIAF-13123 HT3921 571 annexin V, alt. GTAATGCTCA[G/C]CGCCAGGAAA M G
C Q H transcript 2 G595u1 WIAF-12203 HT27983 1008 NRIP1, nuclear
TGCAACATTA[C/T]AGGCTGTTGC N C T Q * receptor interacting protein 1
G595u2 WIAF-12220 HT27983 785 NRIP1, nuclear
CCCTCAGTCA[T/C]GATTCTTTAA S T C H H receptor interacting protein 1
G595u3 WIAF-12232 HT27983 1231 NRP1, nuclear
GTTGGCAGTT[A/T]CCAGCTCCCA M A T Y F receptor interacting protein 1
G595u4 WIAF-12261 HT27983 2048 NRIP1, nuclear
GCAGTACTCA[G/A]TCTCAAAACC S G A Q Q receptor interacting protein 1
C595u5 WIAF-12274 HT27983 2376 NRIP1, nuclear
TCCTCAACCA[G/T]GGCTTTCTGG M G T G W receptor interacting protein 1
G595u6 WIAF-12275 HT27983 3498 NRIP1, nuclear
ACTATATTAC[A/G]TGCTTCAAAA M A G M V receptor interacting protein 1
G595u7 WIAF-12276 HT27983 3671 NRIP1, nuclear
ACAATAGCCA[T/C]ATGGGAAATA S T C H H receptor interacting protein 1
G595u8 WIAF-12294 HT27983 2020 NRIP1, nuclear
ATCAAATGGA[A/G]TTCCCCACCA M A G N S receptor interacting protein 1
G595u9 WIAF-12295 HT27983 3140 NRIP1, nuclear
ATTTGTCCCC[G/A]CACAGAAGTA S G A P P receptor interacting protein 1
G596u1 WIAF-10144 HT3537 3299 PC, pyruvate
TGCGGTCCAT[C/T]TTGGTCAAGG S C T I I carboxylase G596u2 WIAF-10158
HT3537 2662 PC, pyruvate ACCAACCTCC[A/C]CTTCCAGGCC M A C H P
carboxylase G596u3 WIAF-10159 HT3537 2156 PC, pyruvate
CCATCTCATA[C/A]ACGGGCGACG N C A Y * carboxylase G598a1 WIAF-12118
HT48666 5585 HERC1, hect GGGACCTATG[C/T]TGATAAACTG M C T A V
(homologous to the E6 AP (UBE3A) carboxyl terminus) domain and RCC1
(CHC1)-like domain (RLD) 1 G598u2 WIAF-12236 HT48666 4456 HERC1,
hect CCTGTTAATA[T/C]TAGGAGTAAG S T C L L (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u3 WIAF-12237 HT48665 6356 HERC1, hect
GGTAATGAAG[G/T]CACGTGTGTT M G T G V (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u4 WIAF-12240 HT48666 12219 HERC1, hect
GTACCTTTGT[C/T]ATCCAGGCCA S C T V V (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u5 WIAF-12241 HT48666 12480 HERC1, hect
CCAGGCAGAT[C/G]GAGGCCTTAC M C G I M (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u6 WIAF-12244 HT48666 12975 HERC1, hect
GAGTAATCAT[T/A]GAAGATGTGG S T A I I (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u7 WIAF-12245 HT48666 1424 HERC1, hect
TCCAATAATC[A/T]GTCAACTTTA M A T Q L (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u8 WIAF-12250 HT48666 5854 HERC1, hect
TTCAAAAGCA[A/T]TTCAATCAAA M A T I F (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u9 WIAF-12251 HT48666 6754 HERC1, hect
TATTCAGCTC[G/A]TCCGTATCCT M G A V I (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u10 WIAF-12252 HT48666 7535 HERC1, hect
ATCTTTACCT[C/T]GGTCCTATGA S C T L L (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u11 WIAF-12254 HT48666 9189 HERC1, hect
GTGGAAATCC[A/G]TACTACCTGT S A G P P (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u12 WIAF-12255 HT48666 10119 HERC1, hect
TTGTGGCATT[G/C]CTAGCAGACA M G C L F (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u13 WIAF-12257 HT48666 11109 HERC1, hect
ATCCATCTAT[T/C]GTAAATGGCA S T C I I (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u14 WIAF-12258 HT48666 13513 HERC1, hect
CTATGGACCT[C/T]AGATAACTGT N C T Q * (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G5958u15 WIAF-12259 HT48666 13697 HERC1, hect
ACCATCACAG[A/C]GATGTGCCAG M A G E G (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u16 WIAF-12255 HT48666 1098 HERC1, hect
CCCTTTACGA[G/A]GCAGCATTAT S G A E E (homologous to the E6 AP
(UDE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u17 WIAF-12272 HT48666 6079 HERC1, hect
TATGTGGGAG[A/G]CACCCATTGC M A G T A (homologous to the E6 AP
(UHE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u18 WIAF-12273 HT48666 9551 HERC1, hect
AAGAGCTCCT[C/T]TGGGAGAATA M C T S F (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u19 WIAF-12277 HT48666 666 HERC1, hect
GTCTTTGCAA[C/T]GATGTCATTC S C T N N (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u20 WIAF-12278 HT48666 882 HERC1, hect
GCTCATTGCG[A/G]TATCTTCTTG S A G R R (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u21 WIAF-12279 HT48666 893 HERC1, hect
TATCTTCTTC[A/T]ATGGATAGAA M A T E V (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u22 WIAF-12280 HT48666 13276 HERC1, hect
AGAACTCAGC[A/C]TTCACACGGT M A G I V (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u23 WIAF-12283 HT48666 6519 HERC1, hect
CCTGTCTGTT[A/T]GACATGGAAC M A T L F (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u24 WIAF-12284 HT48666 8386 HERC1, hect
GGGGTTCTCT[C/T]TTCGGCAGAT M C T L F (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u25 WIAF-12286 HT48666 10266 HERC1, hect
CAGCTCAGCA[A/T]CTCGTGCGCA M A T Q H (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u26 WIAF-12287 HT48666 10099 HERC1, hect
CTTTGTTGTA[A/G]CACAGGCCCT M A G T A (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u27 WIAF-12289 HT48666 11835 HERC1, hect
AGAACTGTCT[G/C]CCTGACCCTG S G C L L (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u28 WIAF-12290 HT48666 12689 HERC1, hect
TTAAACCACA[C/T]TTTGGCAGTG M C T T I (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u29 WIAF-12291 HT48666 14655 HERC1, hect
ACGTGGACAA[C/T]GCCGAGGGCT S C T N N (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u30 WIAF-12296 HT48666 393 HERC1, hect
ATTCCCCATT[T/C]GCCGGGGCAC S T C F F (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u31 WIAF-12297 HT48666 479 HERC1, hect
GGCAAGGTGA[A/G]GCAGCAGCAG M A G K R (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u32 WIAF-12298 HT48666 1197 HERC1, hect
ATGCTCCCAT[T/C]GTCTCCGAAA S T C I I (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u33 WIAF-12300 HT48666 3595 HERC1, hect
TCCAGAGGAA[C/T]AGCACACTGC N C T Q * (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G598u34 WIAF-12301 HT48666 3661 HERC1, hect
CACTCCTCAA[T/C]TGGATAAATG S T C L L (homologous to the E6 AP
(UBE3A) carboxyl terminus) domain and RCC1 (CHC1)-like domain (RLD)
1 G601u1 WIAF-12246 HT27734 106 PRKMK5, protein
TGGAGAACCA[G/A]GTGCTGGTAA S G A Q Q kinase, mitogen- activated,
kinase 5 (MAP kinase kinase 5) G601u2 WIAF-12247 HT27734 351
PRKMK5, protein GTAAATGGAC[A/G]GTTAATAGAG M A G Q R kinase,
mitogen- activated, kinase 5 (MAP kinase kinase 5) G601u3
WIAF-12292 HT27734 617 PRKMK5, protein AGCATATCAT[G/C]TCCCGAGTGG M
G C V L kinase, mitogen- activated, kinase 5 (MAP kinase kinase 5)
G603u1 WIAF-12248 HT4291 1336 mitogen-activated
AGTCATCAGC[T/C]TTGTGCCACC M T C F L protein (MAP) kinase p38 G603u2
WIAF-12281 HT4291 1230 mitogen-activated CTCAGTACCA[C/T]GATCCTGATG
S C T H H protein (MAP) kinase p38 G610u1 WIAF-12249 HT48690 1012
protein kinase, CCGAGCCATA[T/C]GATGAGAGCG S T C V Y
mitogen-activated, p38Beta (MAP kinase p38Beta) G610u2 WIAF-12263
HT48690 799 protein kinase, AAATCTCCTC[G/A]GAACACGCCC S G A S S
mitogem-activated, p38Beta (MAP kinase p38Beta) GS10u3 WIAF-12264
HT48690 848 protein kinase, GCCCCAGAAG[G/A]ACCTGAGCAG M G A D N
mitogen-activated, p38Beta (MAP kinase p38Beta) G610u4 WIAF-12282
HT48690 439 protein kinase, TCCTGGTTTA[C/T]CAGCTCCTGC S C T Y Y
mitogen-activated, p38Beta (MAP kinase p38Beta) G612u1 WIAF-12344
HT1436 1513 RAF1, v-raf-1 TTTGCATGCA[A/G]AGAACATCAT M A G K E
murine leukemia viral oncogene homolog 1 G614u1 WIAF-12267 HT321
603 BRAF, v-raf murine GACAGTCTAA[A/G]GAAAGCACTG M A G K R sarcoma
viral oncogene homolog 51 G614u2 WIAF-12268 HT321 2282 BRAF, v-raf
murine CCAAACAGAG[G/A]ATTTTAGTCT M G A D N sarcoma viral oncogene
homolog 51 G614u3 WIAF-12299 HT321 973 BRAF, v-raf murine
AGGAAGAGGC[G/A]TCCTTAGCAC S G A A A sarcoma viral oncogene homolog
51 G616u1 WIAF-12253 HT48746 498 TRAF-interacting
AAGAAGACAA[G/T]AGGTTTCTTC N G T E * protein (I-TRAF) G616u2
WIAF-12269 HT48746 1338 TRAF-interacting GCATATACCT[C/G]GAGTATGTGA
M C G R G protein (I-TRAF) G616u3 WIAF-12285 HT48746 377
TRAF-interacting ATAACAATTA[T/C]GGCTGTGTCC S T C Y Y protein
(I-TRAF) G616u4 WIAF-12288 HT48746 1032 TRAF-interacting
TGAAATTCAG[G/A]GAATTGACCC M G A G R protein (I-TRAF) G617u1
WIAF-12256 HT1614 52 PPP1CA, protein GAAGCTCAAC[C/T]TGGACTCGAT S C
T L L phosphatase 1, catalytic subunit, alpha isoform G617u2
WIAF-12270 HT1614 792 PPP1CA, protein AAGACGGCTA[C/T]GAGTTCTTTG S C
T Y Y
phosphatase 1, catalytic subunit, alpha isoform G618u1 WIAF-12238
HT27508 1598 protein CATTGAACCA[A/C]CACAGTTCAA M A C T P
phosphatase, 2A B56-alpha subunit G618u2 WIAF-12271 HT27508 1135
protein ATCAGAAATT[C/T]GTACAACAGC S C T F F phosphatase, 2A
B56-alpha subunit G62u1 WIAF-10369 HT0855 214 ERCC6, excision
AGGAGTACCT[G/C]TCCTTTCGTT S G C L L repair cross- complementing
rodent repair deficiency, complementation group 6 G62u2 WIAF-10370
HT0855 926 ERCC6, excision AAAACTGTCT[T/C]TTGAAAGGAA M T C F L
repair cross- complementing rodent repair deficiency,
complementation group 6 G62u3 WIAF-10428 HT0855 2904 ERCC6,
excision AGCACGGACA[C/T]GCAGGCCCGG M C T T M repair cross-
complementing rodent repair deficiency, complementation group 6
G62u4 WIAF-10430 HT0855 3368 ERCC6, excision
TGACCCTCAC[A/G]TGAGTAGTAA M A G M V repair cross- complementing
rodent repair deficiency, complementation group 6 G62u5 WIAF-10451
HT0855 1376 ERCC6, excision TTCTGGGGAA[G/A]AAGCTGAAGC M G A E K
repair cross- complementing rodent repair deficiency,
complementation group 6 G62u6 WIAF-10452 HT0855 3716 ERCC6,
excision TAAGCATTGC[A/G]GACACGCCAA M A G R G repair cross-
complementing rodent repair deficiency, complementation group 6
G62u7 WIAF-10453 HT0855 3967 ERCC6, excision
CCCTGAAAGC[A/C]CTGAGGCTCT S A C A A repair cross- complementing
rodent repair deficiency, complementation group 6 G62u8 WIAF-10454
HT0855 4016 ERCC6, excision TGGTGTTCCC[A/G]CCTGGACTGG M A G T A
repair cross- complementing rodent repair deficiency,
complementation group 6 G62u9 WIAF-10455 HT0855 3979 ERCC6,
excision TGAGGCTCTC[T/C]CGTCAGCGGT S T C S S repair cross-
complementing rodent repair deficiency, complementation group 6
G62u10 WIAF-10456 HT0855 3729 ERCC6, excision
GACCCCAAGT[T/C]TGAAGGAACT M T G F C repair cross- complementing
rodent repair deficiency, complementation group 6 G62u11 WIAF-10476
HT0855 1275 ERCC6, excision TCTGGAGATG[G/A]TACTGACTAT M G A G D
repair cross- complementing rodent repair deficiency,
complementation group 6 G62u12 WIAF-10477 HT0855 2017 ERCC6,
excision TGATCTTGGA[C/T]GAAGGACACA S C T D D repair cross-
complementing rodent repair deficiency, complementation group 6
G62u13 WIAF-10479 HT0855 3265 ERCC6, excision
CTAACATATC[T/C]CTAAATCATG S T C S S repair cross- complementing
rodent repair deficiency, complementation group 6 G62u14 WIAF-10481
HT0855 4317 ERCC6, excision GGGCACCTGC[A/G]GGAAGCTTCT M A G Q R
repair cross- complementing rodent repair deficiency,
complementation group 6 G620a1 WIAF-12116 HT1943 1256 PPP2CB,
protein TATCATGGAA[T/A]TAGATGACAC M T A L I phosphatase 2 (formerly
2A), catalytic subunit, beta isoform G620a2 WIAF-12117 HT1943 1326
PPP2CB, protein CCTCATGTTA[C/G]ACGGCGCACC M C G T R phosphatase 2
(formerly 2A), catalytic subunit, beta isoform G620u3 WIAF-12239
HT1943 819 PPP2CB, protein TTTTATGATG[A/G]ATGTCTGCGA M A G E G
phosphatase 2 (formerly 2A), catalytic subunit, beta isoform G623u1
WIAF-12260 HT3979 459 PPP1CB, protein TTCATCGACA[A/G]TATACACATT S A
G Q Q phosphatase 1, catalytic subunit, beta isoform G625u1
WIAF-12266 HT1951 2279 PPP2R2A, protein CATTCTGGAG[A/G]ATTACTAGCA M
A G E G phosphatase 2 (formerly 2A), regulatory subunit (PR 52),
alpha isoform G628a1 WIAF-12104 HT2780 1104 PPP1CC, protein
AGGGGTATGA[T/A]CACAAAGCAA M T A I N phosphatase 1, catalytic
subunit, gamma isoform G628a2 WIAF-12105 HT2780 973 PPP1CC, protein
CCAATTATTG[C/T]GGACAGTTTG S C T C C phosphatase 1, catalytic
subunit, gamma isoform G628u3 WIAF-12311 HT2780 888 PPP1CC, protein
GATCTTATAT[G/T]TAGAGCCCAT M A T C P phosphatase 1, catalytic
subunit, gamma isoforn G630a1 WIAF-12103 HT5086 704 protein
phosphatase AAAGATGCAG[A/G]TCTGAACTCT M A G D G 2A, 130 kDa
regulatory subunit G630a2 WIAF-12106 HT5086 1015 protein
phosphatase CGATGGGAAC[G/T]CCCCATCC- TT M G T A S 2A, 130 kDa
regulatory subunit G630a3 WIAF-12107 HT5086 1024 protein
phosphatase CGCCCCATCC[T/c]TTGGTTTACT M T c F L 2A, 130 kDa
regulatory subunit G630a4 WIAF-12108 HT5086 837 protein phosphatase
ACTTAAAGGA[T/C]ATTGCAGGAG S T C D D 2A, 130 kDa regulatory subunit
G630u5 WIAF-12325 HT5086 1200 protein phosphatase
TAAAGATGTG[C/T]TTGGACATCT S C T C C 2A, 130 kDa regulatory subunit
G630u6 WIAF-12326 HT5086 2810 protein phosphatase
ATGTTCAGGG[C/TITGCAGGGGGA M C T A V 2A, 130 kDa regulatory subunit
G630u7 WIAF-12351 HT5086 512 protein phosphatase ATTATGGCAG
[C/T]AACTTACAGA M C T A V 2A, 130 kDa regulatory subunit G630u8
WIAF-12352 HT5086 703 protein phosphatase CAAACATGCA[G/A]ATCTGAAC-
TC M G A D N 2A, 130 kDa regulatory subunit G630u9 WIAF-12353
HT5086 1069 protein phosphatasa ACCTTTGTCT[C/T]ATAGAAACTC M C T H Y
2A, 130 kDa regulatory subunit G634u1 WIAF-11825 X04434 2283 IGF1R,
insulin- TGCAAGTGGC[C/T]AACACCACCA S C T A A like growth factor 1
receptor G634u2 WIAF-11826 X04434 2279 IGF1R, insulin-
GTCATGCAAG[T/C]GGCCAACACC M T C V A like growth factor 1 receptor
G634u3 WIAF-11781 X04434 1731 IGF1R, insulin-
ACAAGGACGT[G/AIGAGCCCGGCA S G A V V like growth factor 1 receptor
G634a4 WIAF-13106 X04434 948 IGF1R, insulin-
TCCACGACGG[C/A]GAGTGCATGC S C A G G like growth factor 1 receptor
G634a5 WIAF-13107 X04434 1089 IGF1R, insulin-
CTTCTGCTCA[G/C]ATGCTCCAAG M G C Q H like growth factor 1 receptor
G634a6 WIAF-13108 X04434 2539 IGF1R, insulin-
AGAAGGAGCA[G/A]ATGACATTCC M G A D N like growth factor 1 receptor
G634a7 WIAF-13109 X04434 2606 IGF1R, insulin-
AAGTGGCCGG[A/C]ACCTGACA- AT M A C E A like growth factor 1 receptor
G634a8 WIAF-13111 X04434 1543 IGF1R, insulin-
CTCCACCACC[A/T]CGTCGAAGAA M A T T S like growth factor 1 receptor
G634a9 WIAF-13112 X04434 1549 IGF1R, insulin-
CACCACGTCG[A/G]AGAATCGCAT M A G K E like growth factor 1 receptor
G634a10 WIAF-13113 X04434 1596 IGF1R, insulin-
CCCCTGACTA[C/T]AGGGATCTCA S C T Y Y like growth factor 1 receptor
G645u1 WIAF-12332 HT5191 1127 retinoic acid-
TCTGCAGACT[C/T]TTCAGGAGAG M C T L F binding protein II G645u2
WIAF-12333 HT5191 1048 retinoic acid- AAGCATTAGA[G/A]GCCTTACAGA S G
A E E binding protein II G646u1 WIAF-12303 X81479 1204 EMR1,
egf-like CAAATATCCA[T/C]GTGGACTAAA M T C M T module containing,
mucin-like, hormone receptor- like sequence 1 G646u2 WIAF-12304
X81419 1919 EMR1, egf-like TTCTGCTGTG[T/G]CGCTCCATCC M T G C W
module containing, mucin-like, hormone receptor- like sequence 1
G646u3 WIAF-12316 X81479 590 EMR1, egf-like
CTTGCCCAGA[G/T]CATGCAACTT M G T E D module containing, mucin-like,
hormone receptor- like sequence 1 G646u4 WIAF-12317 X81479 799
EMR1, egf-like GCACCAAGCA[G/A]TGGACAGTTG M G A S N module
containing, mucin-like, hormone receptor- like sequence 1 G646u5
WIAF-12318 X81479 558 EMR1, egf-like TGAAGACGTG[A/G]ATGAATGTGC M A
G N D module containing, mucin-like, hormone receptor- like
sequence 1 G646u6 WIAF-12334 X81479 207 EMR1, egf-like
TTACTATTGC[A/G]CTTGCAAACA M A G T A module containing, mucin-like,
hormone receptor- like sequence 1 G646u7 WIAF-12335 X81479 458
EMR1, egf-like TCACCAGCAG[G/C]GTCTGCCCTG M G C R S module
containing, mucin-like, hormone receptor- like sequence 1 G646u8
WIAF-12336 X81479 1308 EMR1, egf-like CTCAGCAAAT[G/A]TCACTCCGGC M G
A V I module containing, mucin-like, hormone receptor- like
sequence 1 G646u9 WIAF-12337 X81479 1285 EMR1, egf-like
ACACTGGCAT[C/T]TTTTTGGAAA M C T S F module containing, mucin-like,
hormone receptor- like sequence 1 G646u10 WIAF-12338 X81479 2026
EMR1, egf-like GACAACAAGA[C/T]GGGCTGCGCC M C T T M module
containing, mucin-like, hormone receptor- like sequence 1 G647u1
WIAF-12339 HT5190 174 RARA, retinoic acid TGCCTCCCTA[C/T]GCCTTCTTCT
S C T Y Y receptor, alpha G648a1 WIAF-13332 HT0070 469 retinoic
acid AACCTGAGCC[A/G]CGACCAGCGT -- A G -- -- receptor, beta G648a2
WIAF-13333 HT0070 532 retinoic acid ATTGTTTTTA[A/G]GGTGAGAAAT -- A
G -- -- receptor, beta G6S0u1 WIAF-12323 X52773 862 RXRA, retinoid
X CTCGCCGAAC[G/A]ACCCTGTCAC M G A D N receptor, alpha G650u2
WIAF-12341 X5277 3102 RXRA, retinoid X TCCTGCCGCT[C/T]GATTTCTCCA S
C T L L receptor, alpha G650u3 WIAF-12348 X5277 3673 RXRA, retinoid
X GGCCATCGGC[A/C]TGAAGCGGCA M A G M V receptor, alpha G650u4
WIAF-12349 X52773 902 RXRA, retinoid X GACAAACACC[T/C]TTTCACCCTC M
T C L P receptor, alpha G653a1 WIAF-13326 HT1458 439 RARB, retinoic
AGGACAAAGC[T/C]CTCAAAGCA- T S T C A A acid receptor, beta G655a1
WIAF-13327 J05252 1158 PCSK2, proprotein CCTTCACGAA[C/T]GGGAGGAAAA
S C T N N convertase subtilisin/kexin type 2 G655a2 WIAF-13334
J05252 678 PCSK2, proprotein CCTATCCTTA[C/A]CCTCCCTACA N C A Y *
convertase subtilisin/kexin type 2 G655a3 WIAF-13335 J05252 744
PCSK2, proprotein TTTCTGCTCC[C/T]GCCAACAACA S C T A A convertase
subtilisin/kexin type 2 G658u1 WIAF-11856 J02943 971 CBG,
corticosteroid TCTATGACCT[T/C]CGAGATGT- CC S T C L L binding
globulin G658u2 WIAF-13407 J02943 771 CBG, corticosteroid
CCTTCATGAC[T/C]CACAGCTCCC M T G S A binding globulin G658u3
WIAF-13408 J02943 773 CBG, corticosteroid TTCATCACTC[A/G]GAGCTCCCCT
S A G S S binding globulin G658u4 WIAF-13409 J02943 1046 CBG,
corticosteroid TCACCCAGGA[C/T]GCCCAGCTCA S C T D D binding globulin
G663u1 WIAF-13400 HT3157 1202 TPO, thyroid
CGCCACGCGC[G/A]CCTGCGGCCT S G A A A peroxidase G663u2 WIAF-13401
HT3157 1282 TPO, thyroid GGCCGCGCCA[G/C]CGAGGTCCCC M G C S T
peroxidase G668a1 WIAF-13350 U53506 350 DI02, deiodinase,
TCGATGCCTA[C/A]AAACAGGTGA N C A Y * iodothyronine, type II G668a2
WIAF-13351 U53506 354 DI02, deiodinase, TGCCTACAAA[C/A]AGGTGAAATT M
C A Q K iodothyronine, type II G668a3 WIAF-13352 U53506 408 DI02,
deiodinase, TGTCTCGACT[A/G]CAGAAGGAGG M A G T A iodothyronine, type
II G673a1 WIAF-13328 M57464 1723 Human ret proto-
CGAGCCTGGC[C/A]AGCCCCGGGG M G A E K oncogene mRNA for tyrosine
kinase. G673a2 WIAF-13338 M57464 1186 Human ret proto-
GGCTCGCCCA[T/A[TTGCCCAGAT M T A F I oncogene mRNA for tyrosine
kinase. G673a3 WIAF-13337 M57464 1227 Hunan ret proto-
ACTGCCAGGC[G/A]TTCACTCGGA S G A A A oncogene mRNA for tyrosine
kinase. G673a4 WIAF-13338 M57464 2118 Human ret proto-
TTGGAAAAAC[T/A]CTAGGAGAAG S T A T T oncogene mRNA for tyrosine
kinase. G673a5 WIAF-13339 M57464 2238 Human ret proto-
CGAGTGAGCT[T/C]CGAGACCTGC S T G L L oncogene mRNA for tyrosine
kinase. G678a1 WIAF-13353 D49492 1439 GDF10, growth
TCGGCTGGAA[T/A]GAATGCATAA M T A N K differentiation factor 10 G55u1
WIAF-10434 HT1115 1214 ERCC3, excision CTGTGGAGCA[G/A]TGGAAAGCCC S
G A Q Q repair cross- complementing rodent repair deficiency,
complementation group 3 (xeroderma pigmentosum group B
complementing) G68u2 WIAF-10435 HT1115 1155 ERCC3, excision
TGTGACTGCT[G/C]CATGCACTGT M G C A P repair cross- complementing
rodent repair deficiency, complementation group 3 (xeroderma
pigmentosum group B complementing) G68u3 WIAF-10436 HT1115 1327
ERCC3, excision AGCACCTACT[C/T]CATCCTGGGC M C T S F repair cross-
complementing rodent repair deficiency, complementation group 3
(xeroderma pigmentosum group B complementing) G68u4 WIAF-10461
HT1115 926 ERCC3, excision AGGAAATCAT[T/C]CACGAACTCC S T C I I
repair cross- complementing rodent repair deficiency,
complementation group 3 (xeroderma pigmentosum group B
complementing) G68u5 WIAF-10464 HT1115 1430 ERCC3, excision
AAGTGCACAC[C/T]ATACCAGCCA S C T T T repair cross- complementing
rodent repair deficiency, complementation group 3 (xeroderma
pigmentosum group B complementing) G684a1 WIAF-13359 X51801 712
BMP7, bone morpho- GTTTATCACG[T/G]GCTCCACCAG M T G V G genetic
protein 7 (osteogenic protein 1) G684a2 WIAF-13360 X51801 719 BMP7,
bone morpho- AGGTCCTCCA[G/A]GAGCACTTGG S G A Q Q genetic protein 7
(osteogenic protein 1) G684a3 WIAF-13361 X51801 796 BMP7, bone
morpho- GGCTGGCTGG[T/G]GTTTCACATC M T G V G genetic protein 7
(osteogenic protein 1) G684a4 WIAF-13362 X51803 862 BMP7, bone
morpho- GGCCTGCAGC[T/G]CTCGGTGGAG M T G L R genetic protein 7
(osteogenic protein 1) G684a5 WIAF-13363 X51801 658 BMP7, bone
morpho- ATCTACAAGG[A/G]CTACATCCGC M A G D G genetic protein 7
(osteogenic protein 1) G684u6 WIAF-13834 X51801 1421 BMP7, bone
morpho- GCCACTAGCT[C/T]CTCCCAGAAT -- C T -- -- genetic protein 7
(osteogenic protein 1) G685a1 WIAF-13329 D89675 882 BMPR1B, bone
GTTCCCTTTA[T/G]GATTATCTGA N T G Y * morphogenetic protein receptor,
type IB G685a2 WIAF-13330 D89675 920 BMPR1B, bone
GCTAAATCAA[T/C]GCTGAAGTTA M T C M T morphogenetic protein receptor,
type IB G685a3 WIAF-13331 D89675 770 BMPR1B, bone
TATCACACAG[T/C]GTTCATGAGG M T G V G morphogenetic protein receptor,
type IB G685a4 WIAF-13340 D89675 1303 BMPR1B, bone
TCCTTATCAT[C/A]ACCTACTGCC M G A D N morphogenetic protein receptor,
type IB G685a5 WIAF-13341 D89675 1372 BMPR1B, bone
GTTACCCCCC[T/G]CATTCCCAAA M T G S A morphogenetic protein receptor,
type IB G685a6 WIAF-13342 D89675 1173 BMPR1B, bone
TGTTGGACGA[C/A]AGCTTGAACA S G A E E morphogenetic
protein receptor, type IB G686u1 WIAF-13816 Z48923 2705 BMPR2, bone
AAATTTGGCA[G/A]CAAGCACAAA M G A S N morphogenetic protein receptor,
type II (serine/ threonine kinase) G686u2 WIAF-13817 Z48923 2749
BMPR2, bone TGGAGTTGCC[A/T]AGATGAATAC N A T K * morphogenetic
protein receptor, type II (serine/threonine kinase) G687a1
WIAF-13343 HT1455 626 CALB1, calbindin 1, ATGATCACGA[C/T]GGCAATCCAT
S C T D D (28 kD) G696u1 WIAF-11839 HT27700 1075 calcium-sensing
GCCCACAATT[G/C]CACCTGATGA M G C A P receptor G696u2 WIAF-11840
HT27700 1551 calcium-sensing TACCTGTGGA[C/T]ACCTTTCTGA S C T D D
receptor G696u3 WIAF-11841 HT27700 1688 calcium-sensing
TTACGGATAT[C/T]CTACAATGTG M C T S F receptor G696u4 WIAF-11842
HT27700 1698 calcium-sensing CCTACAATGT [G/T]TACTTACCAG S G T V V
receptor G696u5 WIAF-11858 HT27700 1767 calcium-sensing
GGAGAGGGCT[C/T]TTCACCAATG S C T L L receptor G696u6 WIAF-118S9
HT27700 1689 calcium-sensing TACGCATATC[C/T]TACAATGTGT S C T S S
receptor G696u7 WIAF-11860 HT27700 2541 calcium-sensing
TCGTCCTCTG[C/T]ATCTCATCCA S C T C C receptor G696u8 WIAF-11861
HT27700 2581 calcium-sensing TGTCCTCCTG[G/A]TGTTTGAGGC M G A V M
receptor G696u9 WIAF-11863 HT27700 3159 calcium-sensing
TCTCCCGCAA[G/C]CGGTCCAGCA M G C K N receptor G696u10 WIAF-11872
HT27700 562 calcium-sensing TCCTATTCAT[T/AJTTCGAGTACC M T A F I
receptor G696u11 WIAF-11878 HT27700 2941 calcium-sensing
CATTCCAGCC[T/G]ATGCCAGCAC M T G Y D receptor G696u12 WIAF-13386
HT27700 1145 calcium-sensing AGGGATATCT[G/A]CATCGACTTC M G A C Y
receptor G696u13 WIAF-13395 HT27700 670 calcium-sensing
CATATTTGCC[A/GJTAGAGGACAT M A G I V receptor G696u14 WIAF-13396
HT27700 2243 calcium-sensing TTCTGGTCCA[A/G]TGAGAACCAC M A G N S
receptor G696u15 WIAF-13397 HT27700 2742 calcium-sensing
AGCTGGAGGA[T/C]GAGATCATCT S T C D D receptor G698u1 WIAF-13547
X61598 393 CBP1, collagen- TCAGCAACTC[G/C]ACGGCGCGCA S G C S S
binding protein 1 G698u2 WIAF-13549 X61598 628 CBP1, collagen-
CGGCGCCCTG[C/T]TAGTCAACGC S C T L L binding protein 1 G698u3
WIAF-13550 X61598 1230 CBP1, collagen- GCGGCTCCCT[G/A]CTATTCATTG S
G A L L binding protein 1 G701u1 WIAF-12382 HT27657 706 CGRP type I
AACGATGTTG[C/A]AGCAGGAAC- T M C A A E receptor G701u2 WIAF-12391
HT27657 841 CGRP type I TGGACAAATT[A/T]TACCCAGTGT M A T Y F
receptor G704u1 WIAF-14046 X60382 1396 COL10A1, collagen,
AGGCATTCCA[G/A]GATTCCCTGG M G A G R type X, alpha 1 (Schmid meta-
physeal chondro- dysplasia) G704u2 WIAF-14070 X60382 1648 COL10A1,
collagen, TGCCAACCAG[G/C]CGGTAACAGC M G C G R type X, alpha 1
(Schmid meta- physeal chondro- dysplasia) G704u3 WIAF-14071 X60382
1824 COL10A1, collagen, CATACCACGT[G/C]CATCTGAAAG S G C V V type X,
alpha 1 (Schmid meta- physeal chondro- dysplasia) G704u4 WIAF-14072
X60382 1582 COL10A1, collagen, AGTCATCCCT[C/C]ACGGTTTTAT M G C E Q
type X, alpha 1 (Schmid meta- physeal chondro- dysplasia) G705a1
WIAF-13228 J04177 686 COL11A1, collagen, ACAACAAAAC[T/A]GTCACAATCA
S T A T T type XI, alpha 1 G705a2 WIAF-13229 J04177 698 COL11A1,
collagen, TGACAATCAT[T/A]GTTGATTGTA S T A I I type XI, alpha 1
G705a3 WIAF-13230 J04177 8881 COL11A1, collagen,
TACTCCACAC[T/A]CTGACTCTTC M T A C S type XI, alpha 1 G705a4
WIAF-13231 J04177 894 COL11A1, collagen, AGACTGTGAC[T/A]CTTCAGCACC
M T A S T type XI, alpha 1 G705a5 WIAF-13232 J04177 651 COL11A1,
collagen, TGACCGCAAG[T/A]CCCATCCCCT M T A W R type XI, alpha 1
G705a6 WIAF-13233 J04177 661 COL11A1, collagen,
TGGCATCGGG[T/A]AGCAATCAGC M T A V E type XI, alpha 1 G705a7
WIAF-13234 J04177 1597 COL11A1, collagen, CGTCCTGGCT[T/C]ACCAGGGGCT
M T C L S type XI, alpha 1 G705a8 WIAF-13235 J04177 2745 COL11A1,
collagen, TGGGTTTCCA[C/A]GTGCCAATGG M G A G S type XI, alpha 1
G705a9 WIAF-13236 J04177 4385 COL11A1, collagen,
GTCCAGAAGG[T/A]CTTCGGGGCA S T A G G type XI, alpha 1 G705a10
WIAF-13237 J04177 4576 COL11A1, collagen, GAAAAAGGTG[A/T]CCGAGGGGTC
M A T D V type XI, alpha 1 G705a11 WIAF-13238 J04177 4306 COL11A1,
collagen, GCTAAGGGGG[A/C]AGCAGGTCCA M A C E A type XI, alpha 1
G705a12 WIAF-13239 J04177 4837 COL11A1, collagen,
AGACATACTG[A/G]AGGCATGCAA M A G E G type XI, alpha 1 G705a13
WIAF-13240 J04177 4931 COL11A1, collagen, AACAAGACAT[C/T]CACCATATGA
S C T I I type XI, alpha 1 G705a14 WIAF-13346 J04177 299 COL11A1,
collagen, AAGCACTAGA[T/G]TTTCACAATT M T G D E type XI, alpha 1
G705a15 WIAF-13347 J04177 2225 COL11A1, collagen,
GGGAGCCTGG[G/C]CCTCCAGGTC S G C G G type XI, alpha 1 G705u16
WIAF-13679 J04177 5493 COL11A1, collagen, AATTCATCAA[G/A]TACCTATTGT
M G A V I type XI, alpha 1 G705u17 WIAF-13700 J04177 3484 COL11A1,
collagen, GGACTTCAAG[G/A]TCCTGTTGGT M G A G D type XI, alpha 1
G705u18 WIAF-13709 J04177 5392 COL11A1, collagen,
GACATGTCCT[A/T]TGACAATAAT M A T Y F type XI, alpha 1 G707u1
WIAF-12363 U32169 4996 COL11A2, collagen, TCCCCTGAGA[C/T]TCCGTGGGGC
M C T L F type XI, alpha 2 G707u2 WIAF-12374 U32169 3580 COL11A2,
collagen, CAATGGCCCT[C/A]ATGGCCCACA M G A D N type XI, alpha 2
G707u3 WIAF-12385 U32169 2059 COL11A2, collagen,
GCCTGGCTCA[C/A]ACGGACCCCC M G A D N type XI, alpha 2 G708a1
WIAF-13354 U73778 1885 COL12A1, collagen, GCCTCTCCTC[C/T]TCCACAGACC
M C T P L type XII, alpha 1 G708a2 WIAF-13355 U73778 3630 COL12A1,
collagen, TGTTGGACAA[C/A]AAATGACAAC M G A E K type XII, alpha 1
G708a3 WIAF-13356 U73778 3905 COL12A1, collagen,
GCTTCTTGCA[A/T]GCTCTGGCAA M A T Q H type XII, alpha 1 G708a4
WIAF-13357 U73778 7051 COL12A1, collagen, ATTCCACCAG[C/A]CCGGGATGTA
M C A A D type XII, alpha 1 G708a5 WIAF-13358 U73778 8036 COL12A1,
collagen, AAGAAGTAAA[C/A]ACATTATTTT S G A K K type XII, alpha 1
G708a6 WIAF-13364 U73778 1461 COL12A1, collagen,
TGGCTCCTAT[A/T]GCATTGGGAT M A T S C type XII, alpha 1 G708a7
WIAF-13365 U73778 2344 COL12A1, collagen, ATTACTTGGA[C/T]TCAAGCTCCA
M C T T I type XII, alpha 1 G708a8 WIAF-13366 U73778 5207 COL12A1,
collagen, CAGATAAGAT[C/A]GAGACCATCT M G A M I type XII, alpha 1
G708a9 WIAF-13367 U73778 6592 COL12A1, collagen,
GAGCCCATGG[A/T]AGCCTTTGTT M A T E V type XII, alpha 1 G708a10
WIAF-13368 U73778 7434 COL12A1, collagen, CCAGGATGAG[G/A]TCAACAAGGC
M G A V I type XII, alpha 1 G708a11 WIAF-13369 U73778 9108 COL12A1,
collagen, ACCTCGGGGG[C/G]TGCCTGGGCC M C G L V type XII, alpha 1
G708a12 WIAF-13370 U73778 9111 COL12A1, collagen,
TCGGGGGCTG[C/T]CTGGGCCCCC M C T P S type XII, alpha 1 G708a13
WIAF-13371 U73778 9196 COL12A1, collagen, CCCCCTGGCC[G/A]TCCTGGAAAC
M G A R H type XII, alpha 1 G708u14 WIAF-13972 U73778 3044 COL12A1,
collagen, CAGTATTTGC[C/A]ACTTACAGCA S C A A A type XII, alpha 1
G708u15 WIAF-13977 U73778 5853 COL12A1, collagen,
TCTGACTCTA[G/C]TTCCCGTTTA M G C V L type XII, alpha 1 G710u1
WIAF-12371 D38163 3082 COL19A1, collagen, AGGAAACAAG[C/T]GCTCCATGGG
M G T G C type XIX, alpha 1 G710u2 WIAF-12388 D38163 2089 COL19A1,
collagen, TCCAGGGACT[C/T]CAGGCAATGA M C T P S type XIX, alpha l
C711u1 WIAF-12360 L25286 1449 COL15A1, collagen,
TGTGGGTCCA[A/C]GCACTCAACA M A G S G type XV, alpha 1 C711u2
WIAF-12372 L25286 4001 COL15A1, collagen, ATATTCCAAT[A/C]TACTCCTTTC
M A G I M type XV, alpha 1 G711u3 WIAF-12373 L25286 3867 COL15A1,
collagen, CCATTTGCAA[G/T]ATCTGTCCAC M G T D Y type XV, alpha 1
C711a4 WIAF-13372 L25286 395 COL15A1, collagen,
CCACCAGCAC[C/T]CGTGCTGCCG S C T T T type XV, alpha 1 C711a5
WIAF-13373 L25286 3101 COL15A1, collagen, AAGGCGACCA[G/A]GGACCCCAGG
S G A Q Q type XV, alpha 1 G712u1 WIAF-13619 M92642 3608 COL16A1,
collagen, GGCGACCAGG[C/A]ATTTCAAGGC M G A G E type XVI, alpha 1
G712u2 WIAF-13620 M92642 4944 COL16A1, collagen,
CCATGAAAAC[C/T]ATGAAGGGGC S C T T T type XVI, alpha 1 G712u3
WIAF-13621 M92642 4707 COL16A1, collagen, CCAAACGTCA[A/C]AAAGGGGACA
M A C E D type XVI, alpha 1 G712u4 WIAF-13654 M92642 421 COL16A1,
collagen, GCCCACGCCA[C/A]GAGTATTCCC S C A R R type XVI, alpha 1
G712u5 WIAF-13655 M92642 444 COL16A1, collagen,
GGGGTCTCCC[G/A]GAGGAGTTTG S G A P P type XVI, alpha 1 G712u6
WIAF-13656 M92642 338 COL16A1, collagen, CTCATGAAGA[A/C]GTCTGCCATC
M A C K T type XVI, alpha 1 G712u7 WIAF-13862 M92642 3227 COL16A1,
collagen, CCTGGTCCTC[C/T]GGGATTCCCA M C T P L type XVI, alpha 1
G712u8 WIAF-13863 M92642 3199 COL16A1, collagen,
TCCTGGCTGT[G/T]TTGGGAGCCC M G T V F type XVI, alpha 1 G712u9
WIAF-13878 M92642 318 COL16A1, collagen, ACCTCATCCA[C/T]CGACTCAGCC
S C T H H type XVI, alpha 1 G712u10 WIAF-13882 M92642 1346 COL16A1,
collagen, ACAGGCGAGA[A/G]GGGCCAGAAA M A G K R type XVI, alpha 1
G712u11 WIAF-13883 M92642 1309 COL16A1, collagen,
GTCACGACCT[C/T]TGGGACCCTC S C T L L type XVI, alpha 1 G715a1
WIAF-13344 Z74615 3504 COL1A1, collagen, TCCTGGTGAA[C/G]AAGGTCCCTC
M C G Q E type I, alpha 1 G717u1 WIAF-12639 Z74616 3988 COL1A2,
collagen, ATGAGGAGAC[T/C]GGCAACCTGA S T C T T type I, alpha 2
G720u1 WIAF-12367 X14420 3494 COL3A1, collagen,
GGTGCAATCG[G/A]CAGTCCAGGA M G A G D type III, alpha 1
(Ehlers-Danlos syndrome type IV, autosomal dominant) G720u2
WIAF-12383 X14420 3035 COL3A1, collagen, GGTGTCAAGG[G/A]TGAAAGTGGG
M G A G D type III, alpha 1 (Ehlers-Danlos syndrome type IV,
autosomal dominant) G720a3 WIAF-13374 X14420 214 COL3A1, collagen,
TCTTGGTCAG[T/C]CCTATGCGGA M T C S P type III, alpha 1
(Ehlers-Danlos syndrome type IV, autosomal dominant) G720a4
WIAF-13375 X14420 1953 COL3A1, collagen, CTGGACCTCA[A/G]GGACCCCCAG
S A G Q Q type III, alpha 1 (Ehlers-Danlos syndrome type IV,
autosomal dominant) G720a5 WIAF-13376 X14420 2194 COL3A1, collagen,
TAGAGGTGGA[G/A]CTGGTCCCCC M G A A T type III, alpha 1
(Ehlers-Danlos syndrome type IV, autosomal dominant) G720a6
WIAF-13377 X14420 3731 COL3A1, collagen, GGGATTGGAG[G/A]TGAAAAAGCT
M G A G D type III, alpha 1 (Ehlers-Danlos syndrome type IV,
autosomal dominant) G722u1 WIAF-14132 HT3162 140 COL4A2, collagen,
GAGATTGGCG[C/T]GACTGGTGAT M C T A V type IV, alpha 2 G724a1
WIAF-12120 X81053 3892 COL4A4, collagen, CTCGTGGAAA[G/A]AAAGGTCCCC
S G A K K type IV, alpha 4 G724a2 WIAF-12121 X81053 4187 COL4A4,
collagen, GAAAGGACCA[A/G]TGGGATTCCC M A G H V type IV, alpha 4
G724a3 WIAF-12122 X81053 3802 COL4A4, collagen,
ATGATGTGGG[G/A]CCACCTGGTC S G A G G type IV, alpha 4 G724a4
WIAF-12123 X81053 1838 COL4A4, collagen, ACCAGGAAAG[C/A]ATGGTGCCTC
M C A H N type IV, alpha 4 G724u5 WIAF-12364 X81053 376 COL4A4,
collagen, CTGTTTGCCA[C/T[TGTCTTCCTG S C T H H type IV, alpha 4
G724u6 WIAF-12365 X81053 2018 COL4A4, collagen,
TCCAGGGGAT[C/G]ATGAACATGC M C G H D type IV, alpha 4 G724u7
WIAF-12366 X81053 4756 COL4A4, collagen, GCCTTCCCCT[A/G]TTTACCACGC
S A G V V type IV, alpha 4 G724u8 WIAF-12377 X81053 3595 COL4A4,
collagen, CTGGACCACC[A/G]GGGTGCCCAG S A G P P type IV, alpha 4
G724u9 WIAF-12378 X81053 3516 COL4A4, collagen,
GGAGCATCCG[C/C]ACACCAGGGC M G C G A type IV, alpha 4 G724u10
WIAF-12379 X81053 4288 COL4A4, collagen, CTGGTCTTCC[A/G]GCTCCCAGAG
S A G P P type IV, alpha 4 G724u11 WIAF-12380 X81053 5140 COL4A4,
collagen, GCCACTTTTT[C/A]GCAAATAAGT M C A F L type IV, alpha 4
G724u12 WIAF-12387 X81053 207 COL4A4, collagen,
GACTTCCCTG[C/T]GATGTGGTCT -- C T -- -- type IV, alpha 4 G727u1
WIAF-12362 D90279 5135 COL5A1, collagen, TTCAACGTTT[A/T]CTGCAACTTC
M A T Y F type V, alpha 1 G727u2 WIAF-12369 D90279 4686 COL5A1,
collagen, AACAGGGTAT[C/T]ACTGCTCCTT S C T I I type V, alpha 1
G727u3 WIAF-12370 D90279 4608 COL5A1, collagen,
TCGGTCCTCC[G/C]GCTGAACAGG S G C P P type V, alpha 1 G727a4
WIAF-13300 D90279 2034 COL5A1, collagen, ACGGCCTGGC[T/A]GGGTTGCCAG
S T A A A type V, alpha 1 G727a5 WIAF-13301 D90279 2073 COL5A1,
collagen, GTGACCCTGG[T/C]CCTTCCGGCC S T C G G type V, alpha 1
G727a6 WIAF-13302 D90279 3763 COL5A1, collagen,
CGGGCACAAA[G/A]GTGATGAAGG M G A G S type V, alpha 1 G729u1
WIAF-11844 L02870 2345 COL7A1, collagen, ATGGACTGGA[G/A]CCAGATACTG
S G A E E type VII, alpha 1 (epidermolysis bullosa, dys- trophic,
dominant and recessive) G729u2 WIAF-11845 L02870 3083 COL7A1,
collagen, TATCCTGGCG[G/A]CCACTCAGAG S G A R R type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u3 WIAF-11846 L02810 3031 COL7A1, collagen,
GACTCGGTGA[C/T]TTTGGCCTGG M C T T I type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u4 WIAF-11851 L02870 1289 COL7A1, collagen,
CGGACTATGA[G/T]GTGACCGTGA M G T E D type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u5 WIAF-11852 L02870 1032 COL7A1, collagen,
CCAAGTGACT[G/T]TGATTGCCCT M G T V L type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u6 WIAF-11853 L02870 1897 COL7A1, collagen,
CGCCGGGAGC[C/T]GGAAACTCCA M C T P L type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u7 WIAF-11854 L02870 1827 COL7A1, collagen,
GCTTAGCTAC[A/T]CTGTGCGGGT M A T T S type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u8 WIAF-11855 L02870 1893 COL7A1, collagen,
TGTCCGCCGG[G/A]AGCCCGAAAC M G A E K type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u9 WIAF-11864 L02870 2142 COL7A1, collagen,
GGGCCCTGCT[G/A]CAGTCATCGT M G A A T type VII, alpha 1
(epidermolysis
bullosa, dys- trophic, dominant and recessive) G729u10 WIAF-11865
L02870 2353 COL7A1, collagen, GAGCCAGATA(C/T]TGAGTATACG M C T T I
type VII, alpha 1 (epidermolysis bullosa, dys- trophic, dominant
and recessive) G729u11 WIAF-11866 L02870 2221 COL7A1, collagen,
TCATCTGTCA[C/T]CATTACCTGG M C T T I type VII, alpha (epidermolysis
bullosa, dys- trophic, dominant and recessive) G729u12 WIAF-11869
L02870 6585 COL7A1, collagen, ACCAGGAGAG[C/T]GTGGTATGGC M C T R C
type VII, alpha 1 (epidermolysis bullosa, dys- trophic, dominant
and recessive) G729u13 WIAF-11870 L02870 8169 COL7A1, collagen,
GGGTGACCGA[G/T]GCTTTGACGG M G T G C type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u14 WIAF-11877 L02870 438 COL7A1, collagen,
CGCCATCCGT[G/A]AGCTTAGCTA M G A E K type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u15 WIAF-11882 L02870 3481 COL7A1, collagen,
AGGATCCGTG[A/T]CATGCCCTAC M A T D V type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u16 WIAF-11883 L02870 5654 COL7A1, collagen,
ACGGAGAACC[T/C]GGGGACCCTG S T C P P type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u17 WIAF-11884 L02870 7124 COL7A1, collagen,
TGCCAGGGCC[G/C]CGAGGCCAGA S G C P P type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u18 WIAF-11885 L02870 7757 COL7A1, collagen,
CCTTGGATGG[T/C]GACAAAGGAC S T C G C type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u19 WIAF-13389 L02870 1615 COL7A1, collagen,
ACCGTGGTTC[C/T]CACTGGACCA M C T P L type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u20 WIAF-13390 L02870 2930 COL7A1, collagen,
TCCTAGGGCC[G/A]GCTGGAGAAG S G A P P type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u21 WIAF-13399 L02870 5145 COL7A1, collagen,
CCAGCGACAT[C/T]CTGGACAGGA M C T P S type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G729u22 WIAF-13411 L02870 3472 COL7A1, collagen,
ATCTTGCAAA[G/A]GATCCCTGAC M G A R K type VII, alpha 1
(epidermolysis bullosa, dys- trophic, dominant and recessive)
G730a1 WIAF-13303 X57527 305 COL8A1, collagen,
ATGGGCAAGG[A/G]AGCCGTTCCC M A G E G type VIII, alpha 1 G732u1
WIAF-l26l6 M95610 936 COL9A2, collagen, CACGGGCCAC[A/G]GCCCGGAACT S
A G T T type IX, alpha 2 G732u2 WIAF-12617 M95610 696 COL9A2,
collagen, AAGGGAGAGA[C/T]GGGCCCTCAT S C T D D type IX, alpha 2
G732u3 WIAF-12619 M95610 1288 COL9A2, collagen,
AACTCGGTCA[C/T]CCAGCGCTCG H C T P S type IX, alpha 2 G732u4
WIAF-12620 M95610 962 COL9A2, collagen, CCACCAGCCC[C/G]TAGCGCCTCT M
C G P R type IX, alpha 2 G737u1 WIAF-13394 M13436 ? INHBA, inhibin,
TGCTCCCTG[G/T] ? G T beta A (activin A, activin AB alpha
polypeptide) G738a1 WIAF-13383 M58549 183 MGP, matrix Gla
ATGGAGAGCT[A/G]AAGTCCAAGA M A G K E protein G738a2 WIAF-13384
M58549 330 MGP, matrix Gla GCGCCGAGGG[A/G]CCAAATGAGA M A G T A
protein G739u1 WIAF-11867 U94332 862 TNFRSF11B, tumor
TGCTGAAGTT[A/G]TGGAAACATC S A G L L necrosis factor receptor super-
family, member 11b (osteoprotegerin) G739u2 WIAF-11874 U94332 1244
TNFRSP11B, tumor GTATCACAAG[T/C]TATTTTTAGA S T C L L necrosis
factor receptor-super- family, member 11b (osteoprotegerin) G743u1
WIAF-13402 HT847 1669 PTHR1, parathyroid CCCTGGAGAC[C/A]CTCGAGACCA
S C A T T hormone receptor 1 G747u1 WIAF-12414 J03040 123 SPARC,
secreted CTCAGCAAGA[A/G]GCCCTGCCTG S A G E E protein, acidic,
cysteine-rich (osteonectin) G748u1 WIAF-12628 HT0157 117 VDR,
vitamin D CCTTCAGGGA[T/C]GGAGGCAATG M T C M T (1,25-dihydroxy-
vitamin D3) receptor G748u2 WIAF-12629 HT0157 1171 VDR, vitamin D
CCGCGCTGAT[T/C]GAGGCCATCC S T C I I (1,25-dihydroxy- vitamin D3)
receptor G748u3 WIAF-12640 HT0157 172 VDR, vitamin D
TTGACCGGAA[C/T]GTGCCCCGGA S C T N N (1,25-dihydroxy- vitamin D3)
receptor G749u1 WIAF-11862 HT3734 679 osteopontin, alt.
ATCACCTCAC[A/T]CATGGAAAGC M A T H L transcript 1 G749u2 WIAF-11875
HT3734 386 osteopontin, alt. AAGATGATGA[A/G]GACCATGTGG S A G D D
transcript 1 G749u3 WIAF-11876 HT3734 419 osteopontin, alt.
CCATTGACTC[C/A]AACCACTCTC S G A S S transcript 1 G749a4 WIAF-12084
HT3734 171 osteopontin, alt. TAAACAGGCT[G/A]ATTCTCGAA- C M G A D N
transcript 1 G749u5 WIAF-13387 HT3734 738 osteopontin, alt.
CCAGGACCTG[A/C]ACGCGCCTTC M A C N H transcript 1 G749u6 WIAF-13388
HT3734 716 osteopontin, alt. CATACAAGGC[C/A]ATCCCCGTTC S C A A A
transcript 1 G751u1 WIAF-12631 HT5036 410 ADM,
GACAGCAGTC[C/G]GGATGCCGCC M C G P R adrenomedullin G752u1
WIAF-11843 HT1782 1405 CHGA, chromogranin CGGCCATTGA[A/G]GCAGAGCTGG
S A G E E A (parathyroid secretory protein 1) G752u2 WIAF-11873
HT1782 1187 CHGA, chromogranin GGACAACCCG[C/A]ACAGTTCCA- T M G A D
N A (parathyroid secretory protein 1) G754a1 WIAF-13382 K02043 663
NPPA, natriuretic GTACAATGCC[C/A]TGTCCAACGC M G A V M peptide
precursor A G756u1 WIAF-12395 HT3508 2086 SCNN1A, sodium
CAGTTCCTCC[A/G]CCTGTCCTCT ? A G T A channel, non- voltage-gated 1
alpha G757u1 WIAF-12420 HT28563 797 SCNN1B, sodium
CCTGCAGGCC[A/C]CCAACATCTT M A C T P channel, non- voltage-gated 1,
beta (Liddle syndrome) G757u2 WIAF-12421 HT28563 1006 SCNN1B,
sodium channel, non- voltage-gated 1, beta (Liddle syndrome) G757u3
WIAF-12430 HT28563 1768 SCNN1B, sodium TCATCGACTT[T/C]GTGTGGATCA S
T C F F channel, non- voltage-gated 1, beta (Liddle syndrome)
G757u4 WIAF-12494 HT28563 662 SCNN1B, sodium
AAGCAGCTCA[G/C]CATCAGAAAA M G C A P channel, non- voltage-gated 1,
beta (Liddle syndrome) G757u5 WIAF-12506 HT28563 1091 SCNN1B,
sodium GATGCTTCAC[G/C]AGCAGAGCTC M G C E Q channel, non-
voltage-gated 1, beta (Liddle syndrome) G757u6 WIAF-12507 HT28563
1452 SCNN1B, sodium ACCTGCATTC[C/T]CATCTGCA- AG M G T G V channel,
non- voltage-gated 1, beta (Liddle syndrome) G758u1 WIAF-12621
HT27856 415 SCNN1D, sodium CGGGAACCCA[C/T]GTCGGCCGAG M C T R C
channel, non- voltage-gated 1, delta G758u2 WIAF-12632 HT27856 325
SCNN1D, sodium CCTCTTTGAG[C/T]GTCACTGCCA M C T R C channel, non-
voltage-gated 1, delta G758u3 WIAF-12634 HT27856 879 SCNN1D, sodium
ATGGCGTCTG[C/A]ACAGCTCAGC N G A W * channel, non- voltage-gated 1,
delta G758u4 WIAF-12635 HT27856 1138 SCNN1D, sodium
CGTGGAGGTG[G/C]AGCTCCTACA M G C E Q channel, non- voltage-gated 1,
delta G762u1 WIAF-12622 HT27531 1850 NPR3, natriuretic
TAGGACCTGG[C/T]TTGCTAATGG S C T G G peptide receptor C/guanylate
cyclase C (atrionatriuretic peptide receptor C) G762u2 WIAF-12623
HT27531 1926 NPR3, natriuretic AGAAGAAAGT[A/G]ACCTTGGAAA M A G N D
peptide receptor C/guanylate cyclase C (atrionatriuretic peptide
receptor C) C) G762u3 WIAF-12624 HT27531 1791 NPR3, natriuretic
CAAATCATCA[G/T]GTGGCCTAGA M G T G C peptide receptor C/guanylate
cyclase C (atrionatriuretic peptide receptor G762u4 WIAF-12636
HT27531 1963 NPR3, natriuretic GAAGATTCCA[T/C]CAGATCCCAT M T C I T
peptide receptor C/guanylate cyclase C (atrionatriuretic peptide
receptor C) G763u1 WIAF-12659 HT3183 1633 NPR2, natriuretic
CTGGGCCCTT[C/T]CCTGATGAAC M C T S F peptide receptor B/guanylate
cyclase B (atrionatriuretic peptide receptor B) G763u2 WIAF-12678
HT3183 668 NPR2, natriuretic TGCCATCACT[T/C]CTGCTGTTGG S T C L L
peptide receptor B/guanylate cyclase B (atrionatriuretic peptide
receptor B) G763u3 WIAF-12684 HT3183 2354 NPR2, natriuretic
TGTTTGAACT[C/T]AAACATATGA S C T L L peptide receptor B/guanylate
cyclase B (atrionatriuretic peptide receptor B) G764u1 WIAF-12698
HT1221 3021 NPR1, natriuretic CCCCGTTACT[C/T]TCTCTTTG- GG M G T C F
peptide receptor A/guanylate cyclase A (atrionatriuretic peptide
receptor A) G764u2 WIAF-12706 HT1221 588 NPR1, natriuretic
GAGCGCCAAG[C/T]GCTCATGCTC M C T A V peptide receptor A/guanylate
cyclase A (atrionatriuretic peptide receptor A) G764u3 WIAF-12709
HT1221 1897 NPR1, natriuretic GTCCCCGTGG[G/A]AGCCTGCAGG S G A G G
peptide receptor A/guanylate cyclase A (atrionatriuretic peptide
receptor A) G765u1 WIAF-10012 HT2456 604 DCP1, dipeptidyl
GCTGGCACAA[A/G]GCTGCGGGCA S A G N N carboxypeptidase 1 (angiotensin
I converting enzyme) G765u2 WIAF-10014 HT2456 2350 DCP1, dipeptidyl
TGATGGCCAC[A/G]TCCCGCAAAT S A G T T carboxypeptidase 1 (angiotensin
I converting enzyme) G765u3 WIAF-10025 HT2456 1688 DCP1, dipeptidyl
CCCACTGCAC[C/A]AGTGTCACAT M C A Q K carboxypeptidase 1 (angiotensin
I converting enzyme) G765u4 WIAF-10027 HT2456 3220 DCP1, dipeptidyl
TCCCCTTCAG[C/T]TACCTCGTCG S C T S S carboxypeptidase 1 (angiotensin
I converting enzyme) G765u5 WIAF-10028 HT2456 3409 DCP1, dipeptidyl
TCAGGTACTT[T/C]GTCAGCTTCA S T C F F carboxypeptidase 1 (angiotensin
I converting enzyme) G765u6 WIAF-10040 HT2456 775 DCP1, dipeptidyl
AGCCCCTCTA[C/T]CTGAACCTCC S C T Y Y carboxypeptidase 1 (angiotensin
I converting enzyme) G772u1 WIAF-12626 HT2121 1064 AVPR2, arginine
TCAGCAGCAC[C/T]GTGTCCTCAG S C T S S vasopressin receptor 2
(nephrogenic diabetes insipidus) G772u2 WIAF-12627 HT2121 998
AVPR2, arginine CCTTTGTGCT[A/G]CTCATGTTGC S A G L L vasopressin
receptor 2 (nephrogenic diabetes insipidus) G773u1 WIAF-12644
HT2141 163 SLC6A6, solute CTAGCAAGAT[C/T]GACTTTGTGC S C T I I
carrier family 6 (neurotransmitter transporter, taurine), member 6
G773u2 WIAF-12645 HT2141 445 SLC6A6, solute
TCGTCATCCT[G/C]GCCTGGGCCA S G C L L carrier family 6
(neurotransmitter transporter, taurine), member 6 G773u3 WIAF-12665
HT2141 289 SLC6A6, solute TCTTTGGGAG[C/T]GGCCTGCCTG S C T S S
carrier family 6 (neurotranemitter transporter, taurine), member 6
G773u4 WIAF-12666 HT2141 382 SLC6A6, solute
CCTTGTTCTC[T/C]GGTATCGGCT S T C S S carrier family 6
(neurotransmitter transporter, taurine), member 6 G776u1 WIAF-11857
U66088 1457 SLC6A6, solute TAGAACACCT[C/T]ATCAAACCTC S C T L L
carrier family 5 (sodium iodide symporter), member 5 G776u2
WIAF-11871 U66088 2039 SLC5A5, solute GATTGTTGTG[G/C]TGGGACCTCG M G
C W C carrier family 5 (sodium iodide symporter), member 5 G776u3
WIAF-13398 U66088 1379 SLC5A5, solute GGCTTTTCCT[G/A]GCCTGTGCTT S G
A L L carrier family 5 (sodium iodide symporter), member 5 G777u1
WIAF-12646 HT27843 4348 SMRT ATACAATATC[A/G]GCCACCCTGG M A G S G
G777u2 WIAF-12654 HT27843 2031 SMRT CTGAGCTGGG[T/C]AACCCGCGCC S T C
G G G777u3 WIAF-12655 HT27643 2052 SMRT ACACCCCCCT[C/A]ACCTATCACC S
G A L L G777u4 WIAF-12675 HT27843 2205 SMRT
CTCGTGACAT[C/T]GCCAAGTC- CC S C T I I G778u1 WIAF-14093 HT1449 8212
TG, thyroglobulin ATCTCCTCTC[T/C]GAACACATCT M T C L P G778u2
WIAF-14111 HT1449 6033 TG, thyroglobulin ATGTCAACGA[C/T]CGTGCGATGC
M C T R W G778u3 WIAF-14112 HT1449 6894 TG, thyroglobulin
GTATCTCAAT[G/T]TGTTCATCCC M G T V L G778u4 WIAF-14125 HT1449 2375
TG, thyroglobulin ATGGCCCTCC[T/C]GAGCACCTCT S T C P P G778u5
WIAF-14136 HT1449 1931 TG, thyroglobulin ACCATCTCCA[A/C]TCCTTTTCCC
S A G Q Q G783u1 WIAF-12649 X97674 4008 H. sapiens mRNA for
CTACTGGTAT[G/C]CCAGCAACTA M G C M I transcriptional intermediary
factor 2. G783u2 WIAF-12658 X97674 2566 H. sapiens mRNA for
GCCTGCCACT[G/A]AGCTGCACAA M G A E K transcriptional intermediary
factor 2. G783u3 WIAF-12671 X97674 3828 H. sapiens mRNA for
CTCTGAGCCC[T/C]GGACTACCAA S T C P P transcriptional intermediary
factor 2. G785u1 WIAF-13385 HT1291 386 TTR, transthyretin
CCAACCACTC[C/T]GCCCCCCGCC S C T S S (prealbumin, amyloidosis type
I) G787u1 WIAF-12652 HT27477 468 TRIP15: thyroid
GAAAATTATA[T/C]TTAGAACGAG S T C Y Y receptor interacting protein 15
G792u1 WIAF-12661 HT27476 265 thyroid receptor
CAGCTGGAAC[G/A]TGAACAGGGC M G A V M interactor 14 G793u1 WIAF-12643
HT5152 458 thyroid receptor GGAACCTTTT[C/G]AAAGAATGTT N C G S *
interactor 8 G794u1 WIAF-12664 HT5136 1110 PSMC5, proteasome
GCGTGTCCAC[G/A]GAACCTGGCA S G A T T (prosome, macro- pain) 26S
subunit, ATPase, 5 G797u1 WIAF-11847 HT3919 140 glutamate receptor
CTCACGGAGG[A/G]TTCCCCAACA S A G G G 3, flip isoform G797u2
WIAF-11848 HT3919 759 glutamate receptor GGTTGTGATC[C/T]TAGGGAAACA
S C T L L 3, flip isoform G797u3 WIAF-11849 HT3919 1253 glutamate
receptor GCTACTCCAA[C/T]GACTATGAAA S C T N N 3, flip isoform G797u4
WIAF-11850 HT3919 1770 glutamate receptor TCTTTTCCTA[C/A]TCAGCACGTT
M G A V I 3, flip isoform G797u5 WIAF-13404 HT3919 2711 glutamate
receptor GCTACAACGT[G/A]TATGGAACAG S G A V V 3, flip isoform G797u6
WIAF-13405 HT3919 2376 glutamate receptor CTCAGCATTA[G/A]GAACGCCTGT
M G A G R 3, flip isoform G798u1 WIAF-11868 X77748 2655 GRM3,
glutamate TGCAGACGAC[A/G]ACCATGTGCA S A G T T receptor, metabo-
tropic 3 G798u2 WIAF-11879 X77748 2771 GRM3, glutamate
CACAGACTCC[A/G]CCTCAACAGG M A G H R receptor, metabotropic 3 G798a3
WIAF-12085 X77748 2699 GRM3, glutamate GTGGTCTTGG[G/C]CTGTTTGTTT M
G C G A receptor, metabotropic 3 G798a4 WIAF-12086 X77748 2738
GRM3, glutamate ATCCTGTTTC[A/G]ACCCCAGAAG M A G Q R receptor,
metabotropic 3 G798a5 WIAF-12087 X77748 2072 GRM3, glutamate
ACACCCTTGG[T/C]CAAAGCATCG M T C V A receptor, metabotropic 3 G798a6
WIAF-12088 X77748 2235 GRM3, glutamate CCCTGCTCAC[C/TI AAGACAAACT S
C T T T receptor,
metabotropic 3 G798u7 WIAF-13391 X77748 1131 GRM3, glutamate
GCGCCAATGC[C/T]TCCTTCACCT S C T A A receptor, metabotropic 3 G799u1
WIAF-11880 M81883 2000 GAD1, glutamate CAACAAATGC[C/T]TGGAACTGGC S
C T L L decarboxylase 1 (brain, 67 kD) G799u2 WIAF-11881 M81883
1822 GAD1, glutamate AGGGTATACT[C/T]CAAGGATCCA S C T L L
decarboxylase 1 (brain, 67 kD) G799u3 WIAF-13392 M81883 661 GAD1,
glutamate GCGTGGCCCA[T/C]GGATGCACCA S T C H H decarboxylase 1
(brain, 67 kD) G799u4 WIAF-13393 M81883 556 GAD1, glutamate
AGCTGATGGC[G/A]TCTTCGACCC S G A A A decarboxylase 1 (brain, 67 kD)
G799u5 WIAF-13410 M81883 1229 GAD1, glutamate
CCTCATGGAA[C/T]AAATAACAC- T N C T Q * decarboxylase 1 (brain, 67
kD) G801u1 WIAF-13403 D49394 1596 HTR3, 5-hydroxy-
TTTACCTGCT[A/G]GCGGTGCTGG S A G L L tryptamine (serotonin) receptor
3 G803a1 WIAF-13118 U66406 1446 EFNB3, ephrin-B3
CTGGGCCTGG[G/A]GGGTGGAGGT M G A G E G804u1 WIAF-11887 Z26653 7237
LAMA2, laminin, TCACTGATGG[G/T]CACATAAAAG S G T G G alpha 2
(merosin, congenital muscular dystrophy) G804u2 WIAF-11901 Z26653
9351 LAMA2, laminin, GCAAGCCACT[G/C]GAGGTTAATT M G C W S alpha 2
(merosin, congenital muscular dystrophy) G804u3 WIAF-11924 Z26653
8740 LAMA2, laminin, ACACTACCCG[A/G]AGAATTGGTC S A G R R alpha 2
(merosin, congenital muscular dystrophy) G804u4 WIAF-11943 Z26653
8577 LAMA2, laminin, ACCAAAATCA[A/G]TGATGGCCAG M A G N S alpha 2
(merosin, congenital muscular dystrophy) G804a5 WIAF-12089 Z26653
3372 LAMA2, laminin, CTCTGTGACT[G/A]CTTCCTCCCT M G A C Y alpha 2
(merosin, congenital muscular dystrophy) G804a6 WIAF-13227 Z26653
7047 LAMA2, laminin, GTCAGTCCTC[A/G]GGTGGAAGAT M A g Q R alpha 2
(nerosin, congenital muscular dystrophy) G804u7 WIAF-13437 Z26653
6791 LAMA2, laminin, TGTGAGAGCC[C/T]TGGATGGACC S C T L L alpha 2
(merosin, congenital muscular dystrophy) G805u1 WIAF-13416 U14755
799 LHX1, LIM AAGTAACAGC[A/G]GTGTTGCCAA M A G S G homeobox protein
1 G805u2 WIAF-13417 U14755 743 LHX1, LIM GGCGAGGAAC[T/C]CTACATCATC
M T C L P homeobox protein 1 G805u3 WIAF-13428 U14755 639 LHX1, LIM
GCCGTCAGGG[C/A]ATCTCCCCTA S C A G G homeobox protein 1 G806u1
WIAF-11886 AF026547 2656 CSPG3, chondroitin
TTGGAGTTCC[A/G]GCCATGTCTA S A G P P sulfate proteo- glycan 3
(neurocan) G606u2 WIAF-11895 AF026547 529 CSPG3, chondroitin
TGACCTTCGC[T/C]GAGGCCCAGG S T C A A sulfate proteo- glycan 3
(neurocan) G806u3 WIAF-11896 AF026547 477 CSPG3, chondroitin
CAGGTGACAG[G/A]TGTTGTGT- TC M G A G D sulfate proteo- glycan 3
(neurocan) G806u4 WIAF-11917 AF026547 89 CSPG3, chondroitin
ACAGGATATC[A/G]CCGATGCCAG M A G T A sulfate proteo- glycan 3
(neurocan) G806u5 WIAF-11918 AF026547 213 CSPG3, chondroitin
AGCGCAGCCC[G/C]AGATCCCCCT M G C R P sulfate proteo- glycan 3
(neurocan) G806u6 WIAF-11929 AF026547 769 CSPG3, chondroitin
GCTTTGCCCG[G/A]GAGCTGGGGG S G A R R sulfate proteo- glycan 3
(neurocan) G806u7 WIAF-11931 AF026547 3148 CSPG3, chondroitin
ACATTGATGA[C/T]TGCCTCTGCA S C T D D sulfate proteo- glycan 3
(neurocan) G806u8 WIAF-11949 AF026547 209 CSPG3, chondroitin
GCCAAGCGCA[G/A]CCCGAGATGC M G A A T sulfate proteo- glycan 3
(neurocan) G806a9 WIAF-13114 AF026547 3430 CSPG3, chondroitin
ATGAAAACAC[G/A]TGGATCGGCC S G A T T sulfate proteo- glycan 3
(neurocan) G806u10 WIAF-13420 AF026547 2113 CSPG3, chondroitin
CCAGGGCAGA[C/G]TTCAGAGAAA M C G D S sulfate proteo- glycan 3
(neurocan) C806u11 WIAF-13431 AF026547 94 CSPG3, chondroitin
ATATCACCGA[T/C]CCCACCCAAA M T C P E sulfate proteo- glycan 3
(neurocan) G806u12 WIAF-13432 AF026547 275 CSPG3, chondroitin
ACAGGACTTC[C/T]CCATCCTGGT M C T P S sulfate proteo- glycan 3
(neurocan) G808a1 WIAF-13117 Y13276 177 TLX, tailless
GCATGAGCAA[G/a]CCAGCCCGAT S G a K K homolog (Drosophila) G810u1
WIAF-11890 X98248 990 SORT1, sortilin 1 ATAACGATAC[C/A]ACAAGAAGGA S
C A T T G810u2 WIAF-11891 X98248 1093 SORT1, sortilin 1
GGCAGCAAAT[G/T]ATGACATCGT M G T D Y G810u3 WIAF-11907 X98248 1683
SORT1, sortilin 1 CAGACGAAGG[T/C]CAATGCTGGC S T G G G G810u4
WIAF-11908 X98248 1433 SORT1, sortilin 1 ATCTCCCAGA[A/C]ACTGAATGTT
M A C K T G810u5 WIAF-11909 X98248 1354 SORT1, sortilin 1
GAAGCCTGAA[A/G]ACAGTGAATG M A G N D G810u6 WIAF-11910 X98248 2180
SORT1, sortilin 1 TACCGGAAAA[T/A]TCCAGGGGAC M T A I N G810u7
WIAF-11911 X98248 2264 SORT1, sortilin 1 AACTTTTTGA[G/A]TCCGGAAAAA
M G A S N G810u8 WIAF-11925 X98248 1993 SORT1, sortilin 1
TCGAGACTAT[G/A]TTGTGACCAA M G A V I G810u9 WIAF-11939 X98248 1351
SORT1, sortilin 1 GAGGAAGCCT[G/C]AAAACAGTGA M G C E Q G810u10
WIAF-11940 X98248 2232 SORT1, sortilin 1 AACTAAAAGA[C/T]TTCAAAAAGA
S C T D D G810a11 WIAF-13115 X98248 1769 SORT1, sortilin 1
TCCATCAATA[T/A]CACCATTTGC M T A I N G810a12 WIAF-13116 X98248 1757
SORT1, sortilin 1 CCTGGAGCTA[G/A]GTCCATGAAT M G A R K G811u1
WIAF-11893 HT3676 900 synapsin I, alt, TGACCAAGAC[G/A]TATGCCACTG S
G A T T transcript 1 G811u2 WIAF-11894 HT3676 758 synapsin I, alt,
ACCTTCTACC[C/T]CAATCACAAA M C T P L transcript 1 G811u3 WIAF-11927
HT3676 996 synapsin I, alt, CGTCAGTGTC[A/T]GGGAACTGGA S A T S S
transcript 1 G811u4 WIAF-11928 HT3676 1054 synapsin I, alt,
CATGTCTCAC[A/G]CATACAAGCT M A G R G transcript 1 G811u5 WIAF-13418
HT3676 249 synapsin I, alt, TGTCCAACGC[G/A[GTCAAGCAGA S G A A A
transcript 1 G811u6 WIAF-13419 HT3676 432 synapsin I, alt,
TTAAAGTAGA[G/A]CAGGCCGAAT S G A E E transcript 1 G812u1 WIAF-11898
HT4564 163 STX1A, syntaxin CCAACCCCCA[T/C]GAGAAGACGA S T C D D 1A
(brain) G812u2 WIAF-11942 HT4564 604 STX1A, syntaxin
TACAGGACAT[C/T]TTCATCGACA M G T M I 1A (brain) G813u1 WIAF-11934
U72508 939 Human B7 mRNA, TATGACACAG[G/A]ACACAGGATG M G A G E
complete cds. G813u2 WIAF-11946 U72508 619 Human B7 mRNA,
GCATCCACAT[G/C]CTCACAGGTC M G C M I complete cds. G816u1 WIAF-11897
HT4230 151 HTR2B, 5-hydroxy- CTAACTGGTC[T/C]GCATTACAGA S T G S S
tryptamine (serotonin) receptor 2B G816u2 WIAF-11930 HT4230 189
HTR2B, 5-hydroxy- GAAATGAAAC[A/G]CATTGTTGAC M A G Q R tryptamine
(serotonin) receptor 2B G818u1 WIAF-11902 HT2694 753 TPH,
tryptophan GAGTTTTTCA[C/T]TCCACTCAAT S C T H H hydroxylase
(tryptophan 5-monooxygenase) G818u2 WIAF-11903 HT2694 775 TPH,
tryptophan TGTGAGACAC[A/G]GTTCACATCC M A G S G hydroxylase
(tryptophan 5-monooxygenase) G818u3 WIAF-11904 HT2694 1211 TPH,
tryptophan TATAATCCAT[A/C]TACACGCAGT M A C Y S hydroxylase
(tryptophan 5-monooxygenase) G818u4 WIAF-11905 HT2694 1081 TPH,
tryptophan GATTACCTGC[A/C]AACAGGAATG M A C K Q hydroxylase
(tryptophan 5-monooxygenase) G818u5 WIAF-11933 HT2694 795 TPH,
tryptophan CCTTCTATAC[C/T]CCAGAGCCAG S C T T T hydroxylase
(tryptophan 5-monooxygenase) G818u6 WIAF-11935 HT2694 1239 TPH,
tryptophan TCCTGAAAGA[C/T]ACCAAGAGCA S C T D D hydroxylase
(tryptophan 5-monooxygenase) G822u1 WIAF-11906 HT0207 936 ASMT,
acetyl- CAGACGGAAA[G/T]TGCTCACA- CC M G T K N serotonin N-
methyltransferase G822u2 WIAF-11919 HT0207 637 ASMT, acetyl-
TGGTGCGACA[C/T]CGATAAAG- CT M C T R W serotonin N-
methyltransferase G822u3 WIAF-11936 HT0207 318 ASMT, acetyl-
GAAAAGCTTT[C/T]TATCGAAA- CA S C T F F serotonin N-
methyltransferase G822u4 WIAF-11937 HT0207 116 ASMT, acetyl-
AATGACTACG[C/T]CAACGGCT- TC M C T A V serotonin N-
methyltransferase G822u5 WIAF-11938 HT0207 930 ASMT, acetyl-
ACTGGGCAGA[C/T]GGAAAGTG- CT S C T D D serotonin N-
methyltransferase G822u6 WIAF-13427 HT0207 120 ASMT, acetyl-
ACTACGCCAA[C/A]GGCTTCAT- GG M C A N K serotonin N-
methyltransferase G825u1 WIAF-11888 HT4974 236 ADAR, adenosine
GCTCAGATAC[C/T]AGCAGCCTGG N C T Q * deaminase, RNA- specific G825u2
WIAF-11900 HT4974 3076 ADAR, adenosine TCTTTGACAA[A/G]TCCTGCAGCG S
A G K K deaminase, RNA specific G825u3 WIAF-11912 HT4974 2537 ADAR,
adenosine CTTGATTGGG[G/C]AGAACGAGAA M G C E Q deaminase, RNA-
specific G825u4 WIAF-11941 HT4974 3558 ADAR, adenosine
GATGGCTATG[A/G]CCTGGAGATC M A G D G deaminase, RNA- specific G825a5
WIAF-12090 HT4974 1305 ADAR, adenosine CCTGAGACCA[A/G]AAGAAACGCA M
A G K R deaminase, RNA- specific G825u6 WIAF-13426 HT4974 3683
ADAR, adenosine CCGCAGGGAT[C/T]TACTGAGACT S C T L L deaminase, RNA-
specific G826u1 WIAF-12554 X99383 2109 ADARB1, adenosine
AGATTACCAA[A/G]CCCAACGTGT S A G K K deaminase, RNA- specific, B1
(homolog of rat RED1) G826u2 WIAF-12566 X99383 1698 ADARB1,
adenosine TGTCCTCCAG[T/G]GACAAGATTG M T G S R deaminase, RNA-
specific, B1 (homolog of rat RED1) G829u1 WIAF-13735 U49262 1404
DVL3, dishevelled 3 GGGTTGGAGG[T/C]CCGTGACTGC M T C V A (homologous
to Drosophila dsh) G83u1 WIAF-10449 HT1576 1338 DNMT1, DNA
ATGATGACCC[G/A]TCTCTTGAAG S G A P P (cytosine-5-)-
methyltransferase 1 G83u2 WIAF-10450 HT1576 1871 DNMT1, DNA
AAGCTGGTCT[A/C]CCAGATCTTC M A G Y C (cytosine-5-)-
methyltransferase 1 G83u3 WIAF-10468 HT1576 928 DNMT1, DNA
AAATCCACAG[A/G]TTTCTGATGA M A G I V (cytosine-5-)-
methyltransferase 1 G83u4 WIAF-10469 HT1576 1562 DNMT1, DNA
AATTCCGACT[C/T]CACCTATGAG M C T S L (cytosine-5-)-
methyltransferase 1 G83u5 WIAF-10471 HT1576 2424 DNMT1, DNA
GGGCCACGTC[G/A]GACCCTCTGC S G A S S (cytosine-5-)-
methyltransferase 1 G83u6 WIAF-10473 HT1576 3790 DNMT1, DNA
GTTCTTCCTC[C/T]TGGACAATGT S C T L L (cytosine-5-)-
methyltransferase 1 G83u7 WIAF-10486 HT1576 1581 DNMT1, DNA
AGGACCTGAT[C/A]AACAAGATCG S C A I I (cytosine-5-)-
methyltransferase 1 G832u1 WIAF-12577 L13387 1129 PAFAH1B1,
platelet- AGACATTCAC[A/T]GGACACAGAG S A T T T activating factor
acetylhydrolase, isoform Ib, alpha subunit (45 kD) G835u1
WIAF-12555 U38276 1311 SEMA3F, sema CCTCTGGCTC[C/A]GTGTTCCGAG S C A
S S domain, immuno- globulin domain (Ig), short basic domain,
secreted, 3F G835u2 WIAF-12556 U38276 1229 SEMA3F, sema
ACTCACTTTG[A/T]TGACCTCCAG M A T D V domain, immuno- globulin domain
(Ig), short basic domain, secreted, 3F G835u3 WIAF-12557 U38276
1473 SEMA3F, sema GAACCTTCAC[G/A]CCATCTATGA S G A T T domain,
immuno- globulin domain (Ig), short basic domain, secreted, 3F
G835a4 WIAF-13138 U38276 1726 SEMA3F, sema
TGACCACCAC[A/T]TCGACCAGCT M A T M L domain, immuno- globulin domain
(Ig), short basic domain, secreted, 3F G836u1 WIAF-12592 U28369
1056 SEMA3B, sema AACGACGTGC[G/A]CGGCCAGCGC M G A G D domain,
immuno- globulin domain (Ig), short basic domain, secreted, 3B
G836u2 WIAF-12609 U28369 1479 SEMA3B, sema
GTCCTCCCCA[C/T]TGGGGGGCGC M C T T I domain, immuno- globulin domain
(Ig), short basic domain, secreted, 3B G838u1 WIAF-12590 U72671
1107 ICAM5, inter- CGCAGCTGGG[A/G]CCCAAGCTCT M A G T A cellular
adhesion molecule 5, telencephalin G838u2 WIAF-12591 U72671 966
ICAM5, inter- CAGGCAGCTG[A/G]TCTGCAACGT M A G I V cellular adhesion
molecule 5, telencephalin G840a1 WIAF-12109 HT961 2232 SOS1, son of
seven- CTCAGGCAAA[T/C]GGACTAAGCC S T C N N less (Drosophila)
homolog 1 G840a2 WIAF-12110 HT961 2404 SOS1, son of seven-
ACCGTCTGAA[C/G]TTGTAGGGAG M C G L V less (Drosophila) homolog 1
G840u3 WIAF-12213 HT961 3813 SOS1, son of seven-
CAAGGGTACC[G/A]CGTCGATGCT S G A P P less (Drosophila) homolog 1
G841u1 WIAF-12153 HT97420 1372 SMOH, smoothened
TTTTGGCTTC[C/G]TGGCCTTTGG M C G L V (Drosophila) homolog G841u2
WIAF-12179 HT97420 858 SMOH, smoothened CCCAGTTCAT[G/T]GATCCTGCCC M
G T M I (Drosophila) homolog G841u3 WIAF-12185 HT97420 1164 SMOH,
smoothened CTCTGAGTGG[G/C]ATTTGTTTTG S C G G G (Drosophila) homolog
G847u1 WIAF-12588 L41939 2019 EPHB2, EphB2
GGTCTGCAGT[G/T]GCCACCTGAA M G T G C G847u2 WIAF-12596 L41939 1806
EPHB2, EphB2 GTGTAACAGA[A/C]GACCGGCCTT S A C R R G847u3 WIAF-12613
L41939 2885 EPHB2, EphB2 AGGCCATCAA[G/C]ATGGGGCAGT M G C K N G848u1
WIAF-12685 L40636 2484 EPHB1, EphB1 GTCAACAGTA[A/C]CCTGGTCTGC M A G
N S G848u2 WIAF-12690 L40636 2020 EPHB1, EphB1
CCTTCACTTA[T/C]GAGGATCCCA S T C Y Y G849u1 WIAF-11920 D83492 1544
EPHB6, EphB6 ACCTGTGTGG[C/T]TCATCCACAC M C T A V G849u2 WIAF-11921
D83492 3301 EPHB6, EphB6 CTTTGGGATA[C/T]TCATGTGGCA M C T L F G849u3
WIAF-13412 D83492 1139 EPHB6, EphB6 GAGACCTTCA[C/T]CCTTTACTAC M C T
T I G849u4 WIAF-13413 D83492 1895 EPHB6, EphH6
TTTGAGGTGC[A/C]AGGCTCAGCA M A C Q P G849u5 WIAF-13414 D83492 2338
EPHB6, EphB6 CTATGACCAG[G/A]CAGAAGACGA M G A A T G849u6 WIAF-13415
D83492 2567 EPHB6, EphB6 GGGGCTTTGG[G/C]CTTCCTCCTG M C G A G G849u7
WIAF-13422 D83492 2860 EPHB6, EphB6 GGCCATCCAG[G/A]CCCTCTGGGC M G A
A T G849u8 WIAF-13423 D83492 2782 EPHB6, EphB6
GGAGGTCATT[G/C]GGACAGGCTC M A C G R G849u9 WIAF-13424 D83492 3038
EPHB6, EphB6 TTCCTCAGGC[A/C]GCGGGAGGGC M A G Q R G849u10 WIAF-13425
D83492 3637 EPHB6, EphB6 AGCCATTGGA[C/T]TGGAGTGCTA S C T L L G856u1
WIAF-12625 D45906 1323 LIMK2, LIM domain AGCTCAACCT[G/C]CTGACAGAGT
S G C L L kinase 2 G858u1 WIAF-12630 U65019 864 MADH2, MAD (mothers
TTTGGTGTTC[G/A]ATAGCATATT S G A S S against decapenta- plegic,
Drosophila) homolog 2 G86u1 WIAF-10437 HT1701 263 RAD51, RAD51
TGAAGCAAAT[G/C]CAGATACTTC M G C A P (S. cerevisiae) homolog (E coli
RecA homolog) G86u2 WIAF-10465 HT1701 861 RAD51, RAD51
GCATCAGCCA[T/C]GATGGTAGAA M T C M T (S. cerevisiae) homolog (E coil
RecA homolog) G86u3 WIAF-10466 HT1701 924 RAD51, RAD51
TACAGAACAC[A/G]CTACTCGGGT M A G D G (S. cerevisiae) homolog (E coli
RecA homolog) G864a1 WIAF-13139 X82324 183 POU3F4, POU domain,
CAGCAATCGG[C/t]ATCCCCTCCG M C t H Y class 3, tran- scription factor
4 G866u1 WIAF-12637 HT0101 2576 glutamate receptor
AAATCCCGTA[G/A]TCAATCCAAG M G A S N (GB:M64752) G866u2 WIAF-12638
HT0101 1131 glutamate receptor TAACAGGAAA[C/T]GTGCAGTTTA S C T N N
(GB:M64752) G869u1 WIAF-13406 HT33620 3627 GRIN2C, glutamate
AGATCAGCAG[G/T]GTACCCCCTC M G T R S receptor, iono- tropic,
N-methyl D-aspartate 2C G870u1
WZAF-11889 HT4468 714 SLC1A1, solute CAGAAGAGTC[C/G]TTCACAGCTG S C
G S S carrier family 1 (neuronal/ epithelial high affinity
glutamate transporter, system Xag), member 1 G870u2 WIAF-11913
HT4468 314 SLC1A1, solute CTACAGAAAT[T/A]CTACTTTGCT M T A F Y
carrier family 1 (neuronal/ epithelial high affinity glutamate
transporter, system Xag), member 1 G870u3 WIAF-11914 HT4468 579
SLC1A1, solute AAGTCAGTAC[G/A]CTCGATGCCA S G A T T carrier family 1
(neuronal/ epithelial high affinity glutamate transporter, system
Xag), member 1 G870u4 WIAF-11922 HT4468 706 SLC1A1, solute
GAACATGACA[G/A]AAGAGTCCTT M G A E K carrier family 1 (neuronal/
epithelial high affinity glutamate transporter, system Xag), member
1 G870u5 WIAF-11923 HT4468 978 SLC1A1, solute
GGAAGATCAT[A/G]GAAGTTGAAG M A G I M carrier family 1 (neuronal/
epithelial high affinity glutamate transporter, system Xag), member
1 G871ul WIAF-11892 HT3187 1004 SLC1A3, solute
TTCTCTTAAC[G/C]AAGCCATCAT M G C E Q carrier family 1 (glial high
affinity glutamate transporter), member 3 G871u2 WIAF-11915 HT3187
1154 SLC1A3, solute TGTTGGCTTA[C/T]TCATTCACGC M C T L F carrier
family 1 (glial high affinity glutamate transporter), member 3
G871u3 WIAF-11926 HT3187 1412 SLC1A3, solute
GGCTGCCATT[T/G]TCATTGCTCA M T G F V carrier family 1 (glial high
affinity glutamate transporter), member 3 G871u4 WIAF-11944 HT3187
1217 SLC1A3, solute AAACCCTTGG[G/A]TTTTTATTCC M G A V I carrier
family 1 (glial high affinity glutamate transporter), member 3
G872u1 WIAF-13433 HT4077 1271 SLC1A2, solute
CTGTTGGAGC[A/C]ACCATTAACA S A C A A carrier family 1 (glial high
affinity glutamate transporter), member 2 G879u1 WIAF-11899 HT28317
1273 GRM2, glutamate GACTTTGTGC[T/C]CAACGTCAAG M T C L P receptor,
metabo- tropic 2 G879u2 WIAF-11932 HT28317 2349 GRM2, glutamate
CTTCTATGTC[A/C]CCTCCAGTGA M A G T A receptor, metabo- tropic 2
G879u3 WIAF-13421 HT28317 2186 GRM2, glutamate
ATGCAAGTAT[G/T]TTGGGCTCGC M G T M I receptor, metabo- tropic 2
G879u4 WIAF-13429 HT28317 2567 GRM2, glutamate
CCCAGTTTGT[C/T]CCCACTGTTT S C T V V receptor, metabo- tropic 2
G879u5 WIAF-13436 HT28317 2046 CRM2, glutamate
ACAGGTGGCC[A/G]TCTGCCTGGC M A G I V receptor, metabo- tropic 2
G879u6 WIAF-13438 HT28317 2425 GRM2, glutamate
GTCCTTGGCT[C/T]CCTCTTTGCG M G T C F receptor, metabo- tropic 2
G879u7 WIAF-13439 HT28317 2463 GRM2, glutamate
CCTCTTCCAG[C/T]CGCAGAAGAA M C T P S receptor, metabo- tropic 2
G880u1 WIAF-12164 HT33719 2117 GRM4, glutamate
AGCCCGACCT[T/G]GGCACCTGCT S T G L L receptor, metabo- tropic 4
G880u2 WIAF-12176 HT33719 2427 GRM4, glutamate
GGACCTGTCG[C/T]TCATCTGCCT M C T L F receptor, metabo- tropic 4
G880u3 WIAF-12192 HT33719 2372 GRM4, glutamate
ACCAGCGGAC[A/G]CTCGACCCCC S A G T T receptor, metabo- tropic 4
G883a1 WIAF-13140 HT48863 1408 GRM7, glutamate
ATCGCAAATC[C/a]ACAGGACAGG N C a C * receptor, metabo- tropic 7
G883a2 WIAF-13141 HT48863 2027 GRM7, glutamate
TCCTGTCTTC[C/t]TGGCAATGTT S C t L L receptor, metabo- tropic 7
G883a3 WIAF-13147 HT48863 1813 GRM7, glutamate
TGTGCACACT[A/g]CCATGTAAGC S A g L L receptor, metabo- tropic 7
G883a4 WIAF-13148 HT48863 1536 GRM7, glutamate
TGTGCTGACT[A/t]CCGGGCTCTC M A t Y F receptor, metabo- tropic 7
G883a5 WIAF-13149 HT48863 2473 GRM7, glutamate
AAGCCAGAGG[G/a]GTTCTCAAGT S G a G G receptor, metabo- tropic 7
G883a6 WIAF-13150 HT48863 2434 GRM7, glutamate
TCATAGACTA[C/t]GATGAACACA S C t Y Y receptor, metabo- tropic 7
G884u1 WIAF-11916 U95025 1052 GRM8, glutamate
CGAACTCTTG[C/A]CAATAATCGA M C A A D receptor, metabotropic 8 G884u2
WIAF-11945 U95025 2016 GRM8, glutamate AAACAAACCG[T/C]ATCCACCGAA S
T C R R receptor, metabo- tropic 8 G884u3 WIAF-11946 U95025 1852
GRM8, glutamate CAGGGCTTCA[G/A]GACGCGAACT M G A G R receptor,
metabo- tropic 8 G884u4 WIAF-11947 U95025 2078 GRM8, glutamate
ATTAGTCCAG[C/G]ATCTCAGCTG M C G A G receptor, metabo- tropic 8
G884u5 WIAF-13430 U95025 1897 GRM8, glutamate
TTTTCTCTGT[T/G]ATTCAATCAC M T G Y D receptor, metabo- tropic 8
G884u6 WIAF-13435 U95025 2364 GRM8, glutamate
TTACCATGTA[T/C]ACCACCTGCA S T C Y Y receptor, metabo- tropic 8
G885u1 WIAF-13434 AF002700 1363 GFRA2, GDNF family
AACTCAGGCC[C/A]CAGCACAGCC M C A P H receptor alpha 2 G886a1
WIAF-13142 U95847 497 GFRA1, GDNF family GAAGTCCCTC[T/a]ACAACTGCCG
M T a Y N receptor alpha 1 G886a2 WIAF-13143 U95847 1385 GFRA1,
GDNF family GTCTGAGAAT[G/a]AAATTCCCAC M G a E K receptor alpha 1
G886a3 WIAF-13151 U95847 781 GFRA1, GDNF family
GCGTGTCCAA[T/C]GATGTCTGCA S T c N N receptor alpha 1 G892u1
WIAF-11956 U12140 798 NTRK2, neuro- TGGGCAATCC[A/C]TTTACATG- CT S A
G P P trophic tyrosine kinase, receptor, type 2 G892u2 WIAF-11957
U12140 834 NTRK2, neuro- GGATCAAGAC[T/A]CTCCAACAGC S T A T T
trophic tyrosine kinase, receptor, type 2 G892u3 WIAF-11958 U12140
956 NTRK2, neuro- GCAAATCTGG[C/T]CGCACCTAAC M C T A V trophic
tyrosine kinase, receptor, type 2 G892u4 WIAF-11960 U12140 1738
NTRK2, neuro- CTCCAAGTTT[G/A]GCATCAAAGG M G A G S trophic tyrosine
kinase, receptor, type 2 G892u5 WIAF-11962 U12140 2486 NTRK2,
neuro- GTCGGTGGCC[A/C]CACAATGCTG M A G H R trophic tyrosine kinase,
receptor, type 2 G892u6 WIAF-11965 U12140 1106 NTRK2, neuro-
TCCTTAAGGA[T/C]AACTAACATT M T C I T trophic tyrosine kinase,
receptor, type 2 G892u7 WIAF-11966 U12140 2085 NTRK2, neuro-
AGGATGCCAG[T/C]GACAATGCAC S T C S S trophic tyrosine kinase,
receptor, type 2 G892u8 WIAF-11967 U12140 2230 NTRK2, neuro-
GGACCTCAAC[A/C]AGTTCCTCAG M A C K Q trophic tyrosine kinase,
receptor, type 2 G892u9 WIAF-11968 U12140 2223 NTRK2, neuro-
AGCATGGGGA[C/T]CTCAACAAGT S C T D D trophic tyrosine kinase,
receptor, type 2 G892u10 WIAF-11992 U12140 1602 NTRK2, neuro-
GTAATCAAAT[C/T]CCTTCCACAG S C T I I trophic tyrosine kinase,
receptor, type 2 G892u11 WIAF-11998 U12140 1354 NTRK2, neuro-
TACTAAAATA[C/T]ATGTTACCAA M C T H Y trophic tyrosine kinase,
receptor, type 2 G892u12 WIAF-11999 U12140 1944 NTRK2, neuro-
CATTTGTTCA[G/C]CACATCAAGC M G C Q H trophic tyrosine kinase,
receptor, type 2 G892u13 WIAF-12000 U12140 2103 NTRK2, neuro-
CACGCAAGGA[C/T]TTCCACCGTG S C T D D trophic tyrosine kinase,
receptor, type 2 G892u14 WIAF-12001 U12140 1860 NTRK2, neuro-
CTGTCATTAT[T/C]GGAATGACCA S T C I I trophic tyrosine kinase,
receptor, type 2 G892a15 WIAF-13144 U12140 1868 NTRK2, neuro-
ATTGGAATGA[C/G]CAAGATCCCT M C G T S trophic tyrosine kinase,
receptor, type 2 G892a16 WIAF-13145 U12140 1903 NTRK2, neuro-
CCAGTACTTT[C/T]GCATCACCAA M G T G C trophic tyrosine kinase,
receptor, type 2 G892a17 WIAF-13146 U12140 1965 NTRK2, neuro-
GACATAACAT[T/G]GTTCTGAAAA M T G I M trophic tyrosine kinase,
receptor, type 2 G892u18 WIAF-13442 U12140 958 NTRK2, neuro-
AAATCTGGCC[G/T]CACCTAACCT M G T A S trophic tyrosine kinase,
receptor, type 2 G892u19 WIAF-13446 U12140 2502 NTRK2, neuro-
TGCTGCCCAT[T/C]CGCTGGATGC S T C I I trophic tyrosine kinase,
receptor, type 2 G892u20 WIAF-13447 U12140 2317 NTRK2, neuro-
GATGCTGCAT[A/T]TAGCCCAGCA M A T I L trophic tyrosine kinase,
receptor, type 2 G892u21 WIAF-13448 U12140 2364 NTRK2, neuro-
CGTCCCAGCA[C/A]TTCGTGCACC M C A H Q trophic tyrosine kinase,
receptor, type 2 G892u22 WIAF-13449 U12140 2507 NTRK2, neuro-
CCCATTCGCT[G/A]GATCCCTCCA N G A W * trophic tyrosine kinase,
receptor, type 2 G892u23 WIAF-13471 U12140 2389 NTRK2, neuro-
TTTGCCCACC[A/C]CGAACTCCCT S A C R R trophic tyrosine kinase,
receptor, type 2 G892u24 WIAF-13472 U12140 2416 NTRK2, neuro-
GGAGAACTTG[C/T]TCGTGAAAAT S C T L L trophic tyrosine kinase,
receptor, type 2 G892u25 WIAF-13474 U12140 359 NTRK2, neuro-
GGGATCTCGT[C/T]CTGGATAAGG M C T S F trophic tyrosine kinase,
receptor, type 2 G892u26 WIAF-13479 U12140 1044 NTRK2, neuro-
TGTATTGGGA[T/C]GTTGGTAACC S T C D D trophic tyrosine kinase,
receptor, type 2 G9u1 WIAF-10222 J03826 1130 FDXR, ferredoxin
GGTATAAGAG[C/T]CGCCCTGTCG S C T S S reductase G9u2 WIAF-10258
J03826 388 FDXR, ferredoxin CCGGAGCTGC[A/C]GGAGGCCTAC M A G Q R
reductase G900u1 WIAF-11970 HT3470 497 STX4A, syntaxin 4A
TGCAATTCAA[T/C]GCACTCCGAA M T C M T (placental) G901u1 WIAF-11969
HT27792 758 STX3A, syntaxin 3A TGCACACAGT[G/A]GACCACGTGG S G A V V
G901u2 WIAF-11971 HT27792 317 STX3A, syntaxin 3A
ACGTCCGGAA[C/A]AAACTGAAGA M C A N K G901u3 WIAF-12002 HT27792 611
STX3A, syntaxin 3A AGCAAGCCCT[C/T]AGTGAGATTG S C T L L G901u4
WIAF-12003 HT27792 909 STX3A, syntaxin 3A CCTCAATTAA[C/A]ACTCCCCTAA
-- G A -- -- G901u5 WIAF-12004 HT27792 163 STX3A, syntaxin 3A
ATTGAGGAAA[C/T]TCGGCTTAAC M C T T I G901a6 WIAF-13152 HT27792 82
STX3A, syntaxin 3A CAGCTGACAC[A/C]GGATGATGAT M A G Q R G901u7
WIAF-13453 HT27192 828 STX3A, syntaxin 3A CCGGAAGAAA[T/C]TGATAATTAT
S T C L L G901u8 WIAF-13455 HT27792 226 STX3A, syntaxin 3A
TACAGTATCA[T/C]TCTCTCTGCA M T C I T G902u1 WIAF-13454 HT27744 848
STX5A, syntaxin 5A ACTTCCAGTC[T/A]GTCACCTCCA S T A S S G902u2
WIAF-13456 HT27744 338 STX5A, syntaxin 5A ATTTCGTGAG[A/G]GCCAAGGGCA
S A G R R G905u1 WIAF-12202 HT27789 487 CREBL1, cAMP
TCCAGATCAA[C/T]GTTATCCCCA S C T N N responsive element binding
protein- like 1 G905u2 WIAF-12219 HT27789 151 CREBL1, cAMP
ATTCTGCCCT[A/T]GATCAAGT- GG S A T L L responsive element binding
protein- like 1 G905u3 WIAF-12230 HT27789 649 CREBL1, cAMP
AGTCCCTGTC[C/G]CCTTCAGGAT S C G S S responsive element binding
protein- like 1 G906u1 WIAF-12214 HT4372 2127 N-ethylmaleimide-
AAGGGAAGAA[G/A]GTCTGGATAG S G A K K sensitive factor G906u2
WIAF-12221 HT4372 514 N-ethylmaleimide- GGGAGAGCCT[G/A]CGACAGGGAA M
G A A T sensitive factor G908u1 WIAF-12201 HT3665 98 RAB5A, RAB5A,
GCCCAAATAC[T/G]GGAAATAAAA S T G T T member RAS oncogene family
G91u1 WIAF-10438 HT1848 496 ERCC1, excision
TCGTGCGCAA[C/T]GTGCCCTGGG S C T N N repair cross- complementing
rodent repair deficiency, com- plementation group 1 (includes over-
lapping antisense sequence) G91u2 WIAF-10439 HT1848 367 ERCC1,
excision CTGGCGCCAC[G/A]TGCCCCACAG S C A T T repair cross-
complementing rodent repair deficiency, complementation group 1
(includes overlapping anti- sense sequence) G914a1 WIAF-13210
HT3672 252 synaptobrevin 1 GCAGTGCTGC[C/A]AAGCTAAAGA S G A A A
G915a1 WIAF-12115 D63506 1390 Homo sapiens mRNA
TTACCTTGGT[G/A]TTCCCATTGT M G A V I for unc- 18homologue, complete
cds. G915u2 WIAF-12293 D63506 685 Homo sapiens mRNA
ACAGCTTGTT[G/A]AAAAAAAGCT M G A E K for unc- 18homologue, complete
cds. G916a1 WIAF-13209 HT28523 308 Huntingtin
GAGCACTTTT[C/T]GGAGGCCAGC M C T S L associated protein 1-like
protein G916a2 WIAF-13211 HT28523 762 Huntingtin
CGGAGGACTT[G/C]GTCCCCCACG M G C L F associated protein 1-like
protein G916a3 WIAF-13212 HT28523 560 Huntingtin
GAGCTCAGAA[C/T]GTCTCTAAGG M C T T N associated protein 1-like
protein G917u1 WIAF-11972 U79734 1075 HIP1, huntingtin
AGAGCCAGCG[G/A]GTTGTGCTGC S G A R R interacting protein 1 G917u2
WIAF-11973 U79734 1005 HIP1, huntingtin GACCACTTAA[T/C]TGAGCGACTA M
T C I T interacting protein 1 G917u3 WIAF-11977 U79734 1539 HIP1,
huntingtin CTGCAAGGCA[G/A]CCTGGAAACT M G A S N interacting protein
1 G917u4 WIAF-12005 U79734 817 HIP1, huntingtin
TGGTGGTGAT[C/T]CCTGCAGAGG S C T I I interacting protein 1 G917u5
WIAF-12006 U79734 1906 HIP1, huntingtin GCTGGAGCCA[G/C]TATCTGGCCT M
G C Q H interacting protein 1 G917a6 WIAF-13157 U79734 993 HIP1,
huntingtin AAGGATGAGA[A/G]GGACCACTTA M A G K R interacting protein
1 G919u1 WIAF-11974 D30742 707 CAMK4, calcium/
ACTGCGCACC[T/C]GAAATTCTTA S T C P P calmodulin dependent protein
kinase IV G919u2 WIAF-11991 D30742 1139 CAMK4, calcium/
AGAGCCACAA[G/A]GCTAGCCGAG S G A K K calmodulin dependent protein
kinase IV G919u3 WIAF-12007 D30742 834 CAMK4, calcium/
CATGTTCAGG[A/T]GAATTCTGA- A N A T R * calmodulin dependent protein
kinase IV G919u4 WIAF-13443 D30742 1088 CAMK4, calcium/
TGGCCTCTTC[C/G]CGCCTGGGAA S C G S S calmodulin- dependent protein
kinase IV G920u1 WIAF-11979 X78520 1952 CLCN3, chloride
ATGACATTCC[T/C]GATCGTCCAG S T C P P channel 3 G920u2 WIAF-11980
X78520 1819 CLCN3, chloride ATAGCCTTCC[C/T]TAATCCATAC M C T P L
channel 3 G920u3 WIAF-11981 X78520 2094 CLCN3, chloride
CATTGGAGCG[A/C]TCGCAGCGAAG M A G I V channel 3 G920u4 WIAF-11983
X78520 2822 CLCN3, chloride ATATTTTCCG[A/G]AAGCTGGGAC S A G R R
channel 3 G920u5 WIAF-11984 X78520 2745 CLCN3, chloride
GCCATTGAAG[C/T]TTCCAAGCAT M C T L F channel 3 G920u6 WIAF-11987
X78520 2499 CLCN3, chloride TCCCTTACCT[C/T]TCCTGACACA M G T V F
channel 3 G920u7 WIAF-12008 X78520 1251 CLCN3, chloride
CATCATCACA[G/A]GTTACTTGGC M G A G S channel 3 G920u8 WIAF-12011
X78520 888 CLCN3, chloride AGTACTAACA[C/T]TAACACGATT S C T L L
channel 3 G920u9 WIAF-13459 X78520 2804 CLCN3, chloride
CAATCGACAT[T/C]GTCCTCCATA S T C I I channel 3 G921u1 WIAF-11954
J02908 931 CLU, clusterin GAGACCTTGA[C/T]CAGGAAATAC M C T T I
(complement lysis inhibitor, SP-40, 40, sulfated glyco- protein 2,
testosterone- repressed prostate message 2, apolipoprotein J)
G921u2 WIAF-11955 J02908 880 CLU, clusterin
CCCTCCCAGG[C/T]TAAGCTCCGG M C T A V (complement lysis inhibitor,
SP-40, 40, sulfated glyco- protein 2, testosterone- repressed
prostate message 2, apolipoprotein J) G921u3 WIAF-11990 J02908 1051
CLU, clusterin CTCACCCAAG[G/C]CGAACACCAG M G C G A (complement
lysis
inhibitor, SP-40, 40, sulfated glyco- protein 2, testosterone-
repressed prostate message 2, apolipoprotein J) G921u4 WIAF-13469
J02908 986 CLU, clusterin TCAACACCTC[C/T]TCCTTCCTGG S C T S S
(complement lysis inhibitor, SP-40, 40, sulfated glyco- protein 2,
testosterone- repressed prostate message 2, apolipoprotein J)
G923u1 WIAF-11993 M19650 1059 Human 2',3'-cyclic
GAGCTAAGCC[G/A]GGGCAAGCTC M G A R Q nucleotide 3'-
phosphodiesterase mRNA, complete cds. G923u2 WIAF-11994 M19650 1062
Human 2',3'-cyclic CTAAGCCGGG[G/T]CAAGCTCTAT M G T G V nucleotide
3'- phosphodiesterase mRNA, complete cds. G923u3 WIAF-13445 M19650
1141 Human 2',3'-cyclic TCTTCACGGG[C/A]TACTACGGGA S G A G G
nucleotide 3'- phosphodiesterase mRNA, complete cds. G925u1
WIAF-11953 L11315 666 CAK, cell adhesion GGGTCATGAG[T/C]GTCTCTCT-
GC S T C S S kinase G925u2 WIAF-11959 L11315 2562 CAK, cell
adhesion TGCTGCCCAT[C/T]CGCTGGATCC S C T I I kinase G925u3
WIAF-11996 L11315 2049 CAK, cell adhesion AAGATCTCCT[T/C]AGTCTTCATT
S T C V V kinase G925u4 WIAF-13440 L11315 1601 CAK, cell adhesion
TACCAGGAGC[C/T]CCGGCCTCG- T M C T P L kinase G925u5 WIAF-13441
L11315 1629 CAK, cell adhesion CGCCCCACTC[C/T]GCTCCCTGTG S C T S S
kinase G925u6 WIAF-13451 L11315 2262 CAK, cell adhesion
TGGACAACGG[C/T]GACCTCAACC S C T G G kinase G926u1 WIAF-11961
AF018956 577 NRP1, neuropilin 1 TGAAAGCTTT[C/T]ACCTGGAC- CC M G T D
Y G926u2 WIAF-11963 AF018956 1683 NRP1, neuropilin 1
CCACCCGATT[G/C]ATCAGGATCT M C G F L G926u3 WIAF-11975 AF018956 2176
NRP1, neuropilin 1 GACCTTCTGG[T/C]ATCACATGTC M T C Y H G926u4
WIAF-11976 AF018956 2092 NRP1, neuropilin 1
TTCCCAAGCT[G/T]ACGAAAATCA M G T D Y G926a5 WIAF-13158 AF018956 747
NRP1, neuropilin 1 TTTTTTACAC[C/T]GACAGCGCGA S C T T T G926a6
WIAF-13159 AF018956 996 NRP1, neuropilin 1
ACTTGGGCCT[T/C]CTGCGCTTTC S T C L L G926u7 WIAF-13444 AF018956 644
NRP1, neuropilin 1 GAAATCTGGG[A/C]TGGATTCCCT M A C D A G926u8
WIAF-13450 AF018956 1738 NRP1, neuropilin 1
CAGAATGGAG[C/G]TGCTCGGCTG M C C L V G926u9 WIAF-13452 AF018956 537
NRP1, neuropilin 1 TTGTCTTTCC[C/A]CCAAAGATGT S C A A A G926u10
WIAF-13457 AF018956 2197 NRP1, neuropilin 1
TGGCTCCCAC[G/A]TCGGCACACT M G A V I G927u1 WIAF-11978 AF022860 870
NRP2, neuropilin 2 GGATTCCTAA[T/C]GAACAGATCA S T C N N G927u2
WIAF-11982 AF022860 1674 NRP2, neuropilin 2
ATCACACCCC[T/G]GACATCCGAA S T G P P G927u3 WIAF-11985 AF022860 1250
NRP2, neuropilin 2 TGGCACTCAG[C/A]TATCGCCCTC M G A G D G927u4
WIAF-11986 AF022860 1071 NRP2, neuropilin 2
ATGGCTACTA[C/T]GTCAAATCCT S C T Y Y G927u5 WIAF-12009 AF022860 726
NRP2, neuropilin 2 GTTCATCCAC[G/A]GCGATCCTCT S G A T T G927u6
WIAF-12010 AF022860 2522 NRP2, neuropilin 2
GCAACCTCAG[G/T]GTCTGGCGCC M G T C V G927u7 WIAF-12012 AF022860 123
NRP2, neuropilin 2 GCTATATCAC[C/T]TCTCCCCGTT S C T T T G927a8
WIAF-13160 AF022860 2427 NRP2, neuropilin 2
CTTTTCCAGT[G/T]CACATCCCAG S C T V V G927a9 WIAF-13161 AF022860 2430
NRP2, neuropilin 2 TTGCAGTGGA[C/G]ATCCCAGAAA M C G D E G927a10
WIAF-13162 AF022860 2463 NRP2, neuropilin 2
AACCATATCA[A/G]GATCAAATTG S A G E E G927a11 WIAF-13163 AF022860
2473 NRP2, neuropilin 2 AGATGAAATT[G/T]ATCATCAATA M G T D Y G927u12
WIAF-13480 AF022860 724 NRP2, neuropilin 2
TCGTTCATCG[A/T]CGGGGATCCT M A T T S G927u13 WIAF-13481 AF022860 767
NRP2, neuropilin 2 ATGCCCGTGC[C/T]CAAGGATGCC M C T A V G930a1
WIAF-13164 HT2608 609 GABRA2, gamma- ACAATGGGAA[G/a]AAATCAGTAG S G
a K K aminobutyric acid (GASA) A receptor, alpha 2 G931a1
WIAF-13153 HT2609 1111 GABRA3, gamma- ACTGGTTCAT[A/g]GCCCTCTGTT M A
g I M aminobutyric acid (GABA) A receptor, alpha 3 G931a2
WIAF-13165 HT2609 1448 GABRA3, gamma- TGTCAGCAAG[G/A]TTCACAAAAT M G
A V I aminobutyric acid (GASA) A receptor, alpha 3 G932a1
WIAF-13154 HT27773 1077 GABRA4, gamma- CAAAAGAAAG[A/G]CATCAAACCC M
A G T A aminobutyric acid (GABA) A receptor, alpha 4 G932a2
WIAF-13155 HT27773 1189 GABRA4, gamma- AGAACAAATG[C/A]TTTGGTTCAC M
C A A D aminobutyric acid (GABA) A receptor, alpha 4 G936u1
WIAF-12308 HT3432 1027 GABRB2, gamma- AATTACGATG[C/T]TTCACCTGCA M C
T A V aminobutyric acid (GABA) A receptor, beta 2 G936u2 WIAF-12327
HT3432 362 GABRB2, gamma- AAGGCTATGA[C/T]ATTCGTCTGA S C T D D
aminobutyric acid (GABA) A receptor, beta 2 G936u3 WIAF-12328
HT3432 571 GABRB2, gamma- CTCTGGGTG[C/T]TGATACCTAT M C T P L
aminobutyric acid (GABA) A receptor, beta 2 G939u1 WIAF-12330
HT2236 1219 GABRR2, gamma- CTGGATGGAA[G/C]CTACAGTGAG M G C S T
aminobutyric acid (GABA) receptor, rho 2 G939u2 WIAF-12355 HT2236
1003 GABRR2, gamma- ACCACCATCA[T/C]CACGGGCGTG M T C I T
aminobutyric acid (GABA) receptor, rho 2 G939u3 WIAF-12356 HT2236
1041 CABRR2, gamma- CGTCTCCTAC[G/A]TCAAGGCC- GT M G A V I
aminobutyric acid (GABA) receptor, rho 2 G950u1 WIAF-13622 U64871
725 Human putative G GTCCTGCTCC[A/C]GTTCACCACT M A C Q P
protein-coupled receptor (GPR19) gene, complete cds. G950u2
WIAF-13624 U64871 443 Human putative G GATAACAGCA[A/C]GCCACATTTG M
A C K T protein-coupled receptor (GPR19) gene, complete cds. G950u3
WIAF-13625 U64871 818 Human putative G CTGGGTAGTG[C/T]AACGTGCAAG M
C T A V protein-coupled receptor (GPR19) gene, complete cds. G955a1
WIAF-13166 HT3860 5110 calcium channel, CTGGCCTCTT[T/c]ACCGTGGAGA S
T c F F voltage-gated, alpha 1 subunit, L type, alt. transcript 1
G955a2 WIAF-13167 HT3860 3842 calcium channel,
CTACCCCAAC[C/a]CAGAAACTAC M C a P T voltage-gated, alpha 1 subunit,
L type, alt. transcript 1 G955a3 WIAF-13168 HT3860 5624 calcium
channel, GTGTGCCCCA[G/a]AGTCCGAGCC M G a E K voltage-gated, alpha 1
subunit, L type, alt. transcript 1 G955a4 WIAF-13169 HT3860 5703
calcium channel, ATCAGCTTCT[A/g]CATGCTCTGT M A g Y C voltage-gated,
alpha 1 subunit, L type, alt. transcript 1 G955a5 WIAF-13170 HT3860
5809 calcium channel, ACCACCTGGA[T/c]GAGTTTAAAA S T c D D
voltage-gated, alpha 1 subunit, L type, alt. transcript 1 G955a6
WIAF-13171 HT3860 6616 calcium channel, CCGGCTCCAA[C/t]GCCAACATCA S
C t N N voltage-gated, alpha 1 subunit, L type, alt. transcript 1
G956u1 WIAF-14187 HT2199 1334 calcium channel,
CTTCACATAG[C/T]CCTTTTGGTA M C T A V voltage-gated, alpha 1D
subunit, DHP-sensitive G956u2 WIAF-14188 HT2199 1452 calcium
channel, AAGAGGACCC[A/T]GCTCCATGTG S A T P P voltage-gated, alpha
1D subunit, DHP-sensitive G956u3 WIAF-14189 HT2199 1614 calcium
channel, GCTGGACAGA[C/T]GTGCTCTACT S C T D D voltage-gated, alpha
1D subunit, DHP-sensitive G956u4 WIAF-14190 HT2199 2540 calcium
channel, GGCAAGTTTA[A/T]TTTTGATGAA M A T N I voltage-gated, alpha
1D subunit, DHP-sensitive. G956u5 WIAF-14191 HT2199 3210 calcium
channel, TGCTGACCAC[T/C]GCTCCCCTGG S T C S S voltage-gatad, alpha
1D subunit, DHP-sensitive G956u6 WIAF-14192 HT2199 3326 calcium
channel, TTGAAGATGA[C/T]AACTTTTGGA M C T T I voltage-gated, alpha
1D subunit, DHP-sensitive G956u7 WIAF-14193 HT2199 3274 calcium
channel, ACTGGGTTAC[T/C]TTGACTATGC M T C F L voltage-gated, alpha
1D subunit, DHP-sensitive G956u8 WIAF-14194 HT2199 5127 calcium
channel, TGCCTCTCAA[C/T)AGTGACGGGA S C T N N voltage-gated, alpha
1D subunit, DHP-sensitive G956u9 WIAF-14195 HT2199 5173 calcium
channel, TGCTTTGGTT[C/T]GAACCGCTCT N C T R * voltage-gated, alpha
1D subunit, DHP-sensitive G956u10 WIAF-14200 HT2199 1437 calcium
channel, CAGATATCGT[A/G]GCTGAAGAGG S A G V V voltage-gated, alpha
1D subunit, DHP-sensitive G956u11 WIAF-14201 HT2199 2567 calcium
channel, ACCAAGCGCA[G/T]CACCTTTGAC M G T S I voltage-gated, alpha
1D subunit, DHP-sensitive G956u12 WIAF-14202 HT2199 4464 calcium
channel, TCACCTTTTT[C/T]CGTCTTTTCC S C T F F voltage-gated, alpha
1D subunit, DHP-sensitive G956u13 WIAF-14215 HT2199 6927 calcium
channel, GCTACAGCGA[C/T]GAAGAGCCAG S C T F F voltage-gated, alpha
1D subunit, DHP-sensitive G956u14 WIAF-14216 HT2199 6858 calcium
channel, CCCGAGCCAA[C/T]GCGGATGTGG S C T N N voltage-gated, alpha
1D subunit, DHP-sensitive G957u1 WIAF-12306 HT4229 915 calcium
channel, TACATCGAGC[G/A]TGCTTCATGA M G A ? R voltage-gated, alpha
1E subunit, alt. transcript 2 G957u2 WIAF-12309 HT4229 3555 calcium
channel, GCCACTACAT[C/T]GTGAACCTGC S C T I I voltage-gated, alpha
1E subunit, alt. transcript 2 G957u3 WIAF-12310 HT4229 4116 calcium
channel, ATGTAGATCA[C/T]GAGAAAAACA S C T H H voltage-gated, alpha
1E subunit, alt. transcript 2 G957u4 WIAF-12313 HT4229 5181 calcium
channel, AGAACGACAA[T/C]GAACGCTGCG S T C N N voltage-gated, alpha
1E subunit, alt. transcript G957u5 WIAF-12314 HT4229 5971 calcium
channel, TATGGACCCC[C/A]CCCATGACGG S G A T T voltage-gated, alpha
1E subunit, alt. transcript 2 G957u6 WIAF-12315 HT4229 5985 calcium
channel, ATGACGGACA[G/T]TTCCAACAAC M G T Q H voltage-gated, alpha
1E subunit, alt. transcript 2 G957u7 WIAF-12329 HT4229 3100 calcium
channel, GCTGGCAGCA[C/A]GCCTTGATGA M G A G S voltage-gated, alpha
1E subunit, alt. transcript 2 G957u8 WIAF-12331 HT4229 6492 calcium
channel, CCCTCCTTTC[C/T]TACAGCTCCC M C T ? R voltage-gated, alpha
1E subunit, alt. transcript 2 G957u9 WIAF-12354 HT4229 3839 calcium
channel, AACGCTTTGC[G/C]AACCAACAAA M G C G A voltage-gated, alpha
1E subunit, alt. transcript 2 G957u10 WIAF-12357 HT4229 4753
calcium channel, TGACTTCATC[A/G]CCCTCATTCG M A G T A voltage-gated,
alpha 1E subunit, alt. transcript 2 G960u1 WIAF-12305 HT3336 1246
CACNB3, calcium TTGATCCCCT[C/T]TCATGAGCCC M C T S F channel,
voltage dependent, beta 3 subunit G960u2 WIAF-12340 HT3336 1288
CACNB3, calcium TGGACAGGAT[C/T]TTCACAGCGT M C T S F channel,
voltage dependent, beta 3 subunit G960u3 WIAF-12345 HT3336 641
CACNB3, calcium AGGCTCTCTT[C/T]CACTTCCTCA S C T F F channel,
voltage dependent, beta 3 subunit G960u4 WIAF-12346 HT3336 576
CACNB3, calcium CATCCCGCCT[G/A]TGGTCCTCCT M G A V M channel,
voltage dependent, beta 3 subunit C961u1 WIAF-12322 U95019 2037
CACNB2, calcium ACTCTCCCTA[C/T]GTAGAGCCAA S C T Y Y channel,
voltage dependent, beta 2 subunit G961u2 WIAF-12347 U95019 2007
CACNB2, calcium CATTTGACTC[G/A]GAAACCCAGG S G A S S channel,
voltage dependent, beta 2 subunit G962u1 WIAF-12324 U95020 1423
CACNB4, calcium CCAATTGAAA[G/A]ACGAAGTCTA M G A R K channel,
voltage dependent, beta 4 subunit G962u2 WIAF-12342 U95020 167
CACNB4, calcium GGACCAGGTT[G/T]AAAAGATCCG M G T L F channel,
voltage dependent, beta 4 subunit G962u3 WIAF-12350 U95020 1571
CACNB4, calcium ACACTTACAA[A/C]CCCCATAGGA S A G K K channel,
voltage dependent, beta 4 subunit G965u1 WIAF-12312 U40583 1276
CHRNA7, cholinergic TCCTGCACGC[T/C]GGCCAACCCC S T C G G receptor,
nicotinic, alpha polypeptide 7 G968a1 WIAF-12119 HT27592 1008
CHRNA1, cholinergic ACACACACCA[C/T]CGCTCACCCA S C T H H receptor,
nicotinic, alpha polypeptide 1 (muscle) G968u2 WIAF-12368 HT27592
1136 CHRNA1, cholinergic AAGATTTTTA[C/T]AGAACACATT M C T T I
receptor, nicotinic, alpha polypeptide 1 (muscle) G973a1 WIAF-13172
HT48774 800 CHRNA2, cholinergic ACACTTCAGA[C/t]GTGGTGATTG S C t D D
receptor, nicotinic, alpha polypeptide 2 (neuronal) G973a2
WIAF-13173 HT48774 927 CHRNA2, cholinergic
CTGGAACCCC[G/a]CTCATTTTGC M G a A T receptor, nicotinic, alpha
polypeptide 2 (neuronal) G977u1 WIAF-13949 Y08419 366 CHRNA5,
cholinergic AACTTATACC[T/C]CTTCCTTCAC S T C R R receptor,
nicotinic, alpha polypeptide 5 G978a1 WIAF-13179 Y08417 1331
CHRNB3, cholinergic CCATTAGATA[C/a]ATTTCCACAC N C a Y * receptor,
nicotinic, beta polypeptide 3 G983a1 WIAF-13214 HT0374 236 NPY,
neuropeptide Y CATACTACTC[C/A]CCCCTCCGAC S G A S S G983a2
WIAF-13215 HT0374 290 NPY, neuropeptide Y CAAAACGATC[C/T]AGCCCAGAGA
S C T S S G983a3 WIAF-13216 HT0374 111 NPY, neuropeptide Y
GCCACTCCCC[C/T]TCTCCGCACT S C T L L G987a1 WIAF-13174 HT27830 159
PPYR1, pancreatic TGGTCTTCAT[C/T]GTCACTTCCT S C T I I polypeptide
receptor 1 G987a2 WIAF-13175 HT27830 222 PPYR1, pancreatic
TGATCTGTGT[G/A]ACTGTGAGGC S G A V V polypeptide receptor 1 G987a3
WIAF-13176 HT27830 322 PPYR1, pancreatic GCCGCTGACC[C/T]CCCTCTACAC
M G T A S polypeptide receptor 1 G987a4 WIAF-13177 HT27830 1074
PPYR1, pancreatic TGGACGACTC[G/A]GACCATCTCC S G A S S polypeptide,
receptor 1 G987a5 WIAF-13178 HT27830 975 PPYR1, pancreatic
CCTCCACCTG[C/T]GTCAACCCAT S C T C C polypeptide receptor 1 G987a6
WIAF-13180 HT27830 615 PPYR1, pancreatic AGTTCCTCCC[A/g]GATAAGCTGC
S A g A A polypeptide receptor 1 G987a7 WIAF-13181 HT27830 718
PPYR1, pancreatic GGGCTTCATC[C/T]TGGTCTGTTA S C T L L polypeptide
receptor 1 G987a8 WIAF-13182 HT27830 745 PPYR1, pancreatic
CATCTACCGG[C/t]GCCTGCAGAG M C t R C polypeptide receptor 1 G987a9
WIAF-13183 HT27830 842 PPYR1, pancreatic GTGATGCTCC[T/A]GGCCTTTGCC
M T A V E polypeptide receptor 1 G987a10 WIAF-13184 HT27830 852
PPYR1, pancreatic TCGCCTTTGC[C/T]GTGCTCTGGC S C T A A polypeptide
receptor 1 G987a11 WIAF-13185 HT27830 889 PPYR1, pancreatic
CAACAGCCTG[G/a]AACACTCGCA M G a E K polypeptide receptor 1 G987a12
WIAF-13186 HT27830 924 PPYR1, pancreatic CCATCTGCCA[C/T]CCGAACCTCA
S C T H H polypeptide receptor 1 G989u1 WIAF-13573 D86519 891
NPY6R, neuro- TGACTCATGC[C/T]TACTGGGCCA S C T A A peptide Y
receptor Y6 G989u2 WIAF-13588 D86519 465 NPY6R, neuro-
ACCACCCAGC[A/C]TCTAATACAA S A G A A peptide Y receptor Y6 G989u3
WIAF-13591 D86519 980 NPY6R, neuro- GAGCCCTTCC[G/A]CAACCTCTCT M G A
R H peptide Y receptor Y6 G991u1 WIAF-12390 HT97376 336 Notch2
AAGCTACTTG[C/T]GTTCAGAAAA S C T C C G993u1
WIAF-12359 U95299 1343 NOTCH4, Notch TCCACACTCT[G/T]CCTGTGTCAG H G
T C F (Drosophila) homolog 4 G993u2 WIAF-12361 U95299 2020 NOTCH4,
Notch TAACCACCAC[A/C]AACACAACCC H A G K E (Drosophila) homolog 4
G993u3 WIAF-12384 U95299 5775 NOTCH4, Notch
CCGCCTATTC[G/T]CATTGCCGGA S C T S S (Drosophila) homolog 4 G996a1
WIAF-13213 HT3329 356 OPRM1, opioid CTTAGATCCC[A/G]ACCTCTCCCA M A G
N D receptor, mu 1 LPLa4 WIAF-13314 HT1320 443 LPL, lipoprotein
ATGTATGACA[C/T]TTGCCTGCCA M C T S I lipase LPLa5 WIAF-13315 HT1320
579 LPL, lipoprotein GACAGCATCT[G/A]GCCCGGTTTA S G A V V lipase
LPLa6 WIAF-13316 HT1320 609 LPL, lipoprotein
TGGACGAGCA[C/A]TTTAACTACC S C A E E lipase LPLa7 WIAF-13317 HT1320
1338 LPL, lipoprotein CAAATAAGAC[C/A]TACTCCTTCC S C A T V lipase
LPLa8 WIAF-13318 HT1320 1117 LPL, lipoprotein
CAATCTGCCC[T/C]ATGAGATCAA M T C Y D lipase LPLa9 WIAF-13319 HT1320
715 LPL, lipoprotein CAGAATTACT[G/A]GCCTCCATCC M C A C S lipase
LPLa10 WIAF-13320 HT1320 834 LPL, lipoprotein
CTGGTCGAAC[C/A]ATTGGAATCC M C A S R lipase LPLa11 WIAF-13321 HT1320
951 LPL, lipoprotein GACTTGCACA[T/A]CTCCACCAGC M T A D E lipase
LPLa12 WIAF-13322 HT1320 1595 LPL, lipoprotein
AATAACAACT[C/C]AGCCTCAAAC N C G S * lipase LPLa13 WIAF-13323 HT1320
1597 LPL, lipoprotein TAAGAAGTCA[G/A]GCTGAAACTG M G A G S lipase
LPLa14 WIAF-13324 HT1320 1606 LPL, lipoprotein
AGGCTGAAAC[T/C]CGGCGAATCT T C -- -- lipase LPLa15 WIAF-13325 HT1320
1611 LPL, lipoprotein GAAACTGGGC[G/A]AATcTACAGA -- G A -- --
lipase
[0167] While this invention has been particularly shown and
described with references to preferred embodiments thereof, it will
be understood by those skilled in the art that various changes in
form and details may be made therein without departing from the
scope of the invention encompassed by the appended claims.
Sequence CWU 1
1
2551 1 5722 DNA Homo sapiens 1 ggacgcacag gcattccccg cgcccctcca
gccctcgccg ccctcgccac cgctcccggc 60 cgccgcgctc cggtacacac
aggatccctg ctgggcacca acagctccac catggggctg 120 gcctggggac
taggcgtcct gttcctgatg catgtgtgtg gcaccaaccg cattccagag 180
tctggcggag acaacagcgt gtttgacatc tttgaactca ccggggccgc ccgcaagggg
240 tctgggcgcc gactggtgaa gggccccgac ccttccagcc cagctttccg
catcgaggat 300 gccaacctga tcccccctgt gcctgatgac aagttccaag
acctggtgga tgctgtgcgg 360 gcagaaaagg gtttcctcct tctggcatcc
ctgaggcaga tgaagaagac ccggggcacg 420 ctgctggccc tggagcggaa
agaccactct ggccaggtct tcagcgtggt gtccaatggc 480 aaggcgggca
ccctggacct cagcctgacc gtccaaggaa agcagcacgt ggtgtctgtg 540
gaagaagctc tcctggcaac cggccagtgg aagagcatca ccctgtttgt gcaggaagac
600 agggcccagc tgtacatcga ctgtgaaaag atggagaatg ctgagttgga
cgtccccatc 660 caaagcgtct tcaccagaga cctggccagc atcgccagac
tccgcatcgc aaaggggggc 720 gtcaatgaca atttccaggg ggtgctgcag
aatgtgaggt ttgtctttgg aaccacacca 780 gaagacatcc tcaggaacaa
aggctgctcc agctctacca gtgtcctcct cacccttgac 840 aacaacgtgg
tgaatggttc cagccctgcc atccgcacta actacattgg ccacaagaca 900
aaggacttgc aagccatctg cggcatctcc tgtgatgagc tgtccagcat ggtcctggaa
960 ctcaggggcc tgcgcaccat tgtgaccacg ctgcaggaca gcatccgcaa
agtgactgaa 1020 gagaacaaag agttggccaa tgagctgagg cggcctcccc
tatgctatca caacggagtt 1080 cagtacagaa ataacgagga atggactgtt
gatagctgca ctgagtgtca ctgtcagaac 1140 tcagttacca tctgcaaaaa
ggtgtcctgc cccatcatgc cctgctccaa tgccacagtt 1200 cctgatggag
aatgctgtcc tcgctgttgg cccagcgact ctgcggacga tggctggtct 1260
ccatggtccg agtggacctc ctgttctacg agctgtggca atggaattca gcagcgcggc
1320 cgctcctgcg atagcctcaa caaccgatgt gagggctcct cggtccagac
acggacctgc 1380 cacattcagg agtgtgacaa aagatttaaa caggatggtg
gctggagcca ctggtccccg 1440 tggtcatctt gttctgtgac atgtggtgat
ggtgtgatca caaggatccg gctctgcaac 1500 tctcccagcc cccagatgaa
tgggaaaccc tgtgaaggcg aagcgcggga gaccaaagcc 1560 tgcaagaaag
acgcctgccc catcaatgga ggctggggtc cttggtcacc atgggacatc 1620
tgttctgtca cctgtggagg aggggtacag aaacgtagtc gtctctgcaa caaccccgca
1680 ccccagtttg gaggcaagga ctgcgttggt gatgtaacag aaaaccagat
ctgcaacaag 1740 caggactgtc caattgatgg atgcctgtcc aatccctgct
ttgccggcgt gaagtgtact 1800 agctaccctg atggcagctg gaaatgtggt
gcttgtcccc ctggttacag tggaaatggc 1860 atccagtgca cagatgttga
tgagtgcaaa gaagtgcctg atgcctgctt caaccacaat 1920 ggagagcacc
ggtgtgagaa cacggacccc ggctacaact gcctgccctg ccccccacgc 1980
ttcaccggct cacagccctt cggccagggt gtcgaacatg ccacggccaa caaacaggtg
2040 tgcaagcccc gtaacccctg cacggatggg acccacgact gcaacaagaa
cgccaagtgc 2100 aactacctgg gccactatag cgaccccatg taccgctgcg
agtgcaagcc tggctacgct 2160 ggcaatggca tcatctgcgg ggaggacaca
gacctggatg gctggcccaa tgagaacctg 2220 gtgtgcgtgg ccaatgcgac
ttaccactgc aaaaaggata attgccccaa ccttcccaac 2280 tcagggcagg
aagactatga caaggatgga attggtgatg cctgtgatga tgacgatgac 2340
aatgataaaa ttccagatga cagggacaac tgtccattcc attacaaccc agctcagtat
2400 gactatgaca gagatgatgt gggagaccgc tgtgacaact gtccctacaa
ccacaaccca 2460 gatcaggcag acacagacaa caatggggaa ggagacgcct
gtgctgcaga cattgatgga 2520 gacggtatcc tcaatgaacg ggacaactgc
cagtacgtct acaatgtgga ccagagagac 2580 actgatatgg atggggttgg
agatcagtgt gacaattgcc ccttggaaca caatccggat 2640 cagctggact
ctgactcaga ccgcattgga gatacctgtg acaacaatca ggatattgat 2700
gaagatggcc accagaacaa tctggacaac tgtccctatg tgcccaatgc caaccaggct
2760 gaccatgaca aagatggcaa gggagatgcc tgtgaccacg atgatgacaa
cgatggcatt 2820 cctgatgaca aggacaactg cagactcgtg cccaatcccg
accagaagga ctctgacggc 2880 gatggtcgag gtgatgcctg caaagatgat
tttgaccatg acagtgtgcc agacatcgat 2940 gacatctgtc ctgagaatgt
tgacatcagt gagaccgatt tccgccgatt ccagatgatt 3000 cctctggacc
ccaaagggac atcccaaaat gaccctaact gggttgtacg ccatcagggt 3060
aaagaactcg tccagactgt caactgtgat cctggactcg ctgtaggtta tgatgagttt
3120 aatgctgtgg acttcagtgg caccttcttc atcaacaccg aaagggacga
tgactatgct 3180 ggatttgtct ttggctacca gtccagcagc cgcttttatg
ttgtgatgtg gaagcaagtc 3240 acccagtcct actgggacac caaccccacg
agggctcagg gatactcggg cctttctgtg 3300 aaagttgtaa actccaccac
agggcctggc gagcacctgc ggaacgccct gtggcacaca 3360 ggaaacaccc
ctggccaggt gcgcaccctg tggcatgacc ctcgtcacat aggctggaaa 3420
gatttcaccg cctacagatg gcgtctcagc cacaggccaa agacgggttt cattagagtg
3480 gtgatgtatg aagggaagaa aatcatggct gactcaggac ccatctatga
taaaacctat 3540 gctggtggta gactagggtt gtttgtcttc tctcaagaaa
tggtgttctt ctctgacctg 3600 aaatacgaat gtagagatcc ctaatcatca
aattgttgat tgaaagactg atcataaacc 3660 aatgctggta ttgcaccttc
tggaactatg ggcttgagaa aacccccagg atcacttctc 3720 cttggcttcc
ttcttttctg tgcttgcatc agtgtggact cctagaacgt gcgacctgcc 3780
tcaagaaaat gcagttttca aaaacagact catcagcatt cagcctccaa tgaataagac
3840 atcttccaag catataaaca attgctttgg tttccttttg aaaaagcatc
tacttgcttc 3900 agttgggaag gtgcccattc cactctgcct ttgtcacaga
gcagggtgct attgtgaggc 3960 catctctgag cagtggactc aaaagcattt
tcaggcatgt cagagaaggg aggactcact 4020 agaattagca aacaaaacca
ccctgacatc ctccttcagg aacacgggga gcagaggcca 4080 aagcactaag
gggagggcgc atacccgaga cgattgtatg aagaaaatat ggaggaactg 4140
ttacatgttc ggtactaagt cattttcagg ggattgaaag actattgctg gatttcatga
4200 tgctgactgg cgttagctga ttaacccatg taaataggca cttaaataga
agcaggaaag 4260 ggagacaaag actggcttct ggacttcctc cctgatcccc
acccttactc atcaccttgc 4320 agtggccaga attagggaat cagaatcaaa
ccagtgtaag gcagtgctgg ctgccattgc 4380 ctggtcacat tgaaattggt
ggcttcattc tagatgtagc ttgtgcagat gtagcaggaa 4440 aataggaaaa
cctaccatct cagtgagcac cagctgcctc ccaaaggagg ggcagccgtg 4500
cttatatttt tatggttaca atggcacaaa attattatca acctaactaa aacattcctt
4560 ttctcttttt tccgtaatta ctaggtagtt ttctaattct ctcttttgga
agtatgattt 4620 ttttaaagtc tttacgatgt aaaatattta ttttttactt
attctggaag atctggctga 4680 aggattattc atggaacagg aagaagcgta
aagactatcc atgtcatctt tgttgagagt 4740 cttcgtgact gtaagattgt
aaatacagat tatttattaa ctctgttctg cctggaaatt 4800 taggcttcat
acggaaagtg tttgagagca agtagttgac atttatcagc aaatctcttg 4860
caagaacagc acaaggaaaa tcagtctaat aagctgctct gccccttgtg ctcagagtgg
4920 atgttatggg attccttttt tctctgtttt atcttttcaa gtggaattag
ttggttatcc 4980 atttgcaaat gttttaaatt gcaaagaaag ccatgaggtc
ttcaatactg ttttacccca 5040 tcccttgtgc atatttccag ggagaaggaa
agcatataca cttttttctt tcatttttcc 5100 aaaagagaaa aaaatgacaa
aaggtgaaac ttacatacaa atattacctc atttgttgtg 5160 tgactgagta
aagaattttt ggatcaagcg gaaagagttt aagtgtctaa caaacttaaa 5220
gctactgtag tacctaaaaa gtcagtgttg tacatagcat aaaaactctg cagagaagta
5280 ttcccaataa ggaaatagca ttgaaatgtt aaatacaatt tctgaaagtt
atgttttttt 5340 tctatcatct ggtataccat tgctttattt ttataaatta
ttttctcatt gccattggaa 5400 tagaatattc agattgtgta gatatgctat
ttaaataatt tatcaggaaa tactgcctgt 5460 agagttagta tttctatttt
tatataatgt ttgcacactg aattgaagaa ttgttggttt 5520 tttctttttt
ttgttttttt tttttttttt tttttttttg cttttgacct cccattttta 5580
ctatttgcca ataccttttt ctaggaatgt gctttttttt gtacacattt ttatccattt
5640 tacattctaa agcagtgtaa gttgtatatt actgtttctt atgtacaagg
aacaacaata 5700 aatcatatgg aaatttatat tt 5722 2 1170 PRT Homo
sapiens 2 Met Gly Leu Ala Trp Gly Leu Gly Val Leu Phe Leu Met His
Val Cys 1 5 10 15 Gly Thr Asn Arg Ile Pro Glu Ser Gly Gly Asp Asn
Ser Val Phe Asp 20 25 30 Ile Phe Glu Leu Thr Gly Ala Ala Arg Lys
Gly Ser Gly Arg Arg Leu 35 40 45 Val Lys Gly Pro Asp Pro Ser Ser
Pro Ala Phe Arg Ile Glu Asp Ala 50 55 60 Asn Leu Ile Pro Pro Val
Pro Asp Asp Lys Phe Gln Asp Leu Val Asp 65 70 75 80 Ala Val Arg Ala
Glu Lys Gly Phe Leu Leu Leu Ala Ser Leu Arg Gln 85 90 95 Met Lys
Lys Thr Arg Gly Thr Leu Leu Ala Leu Glu Arg Lys Asp His 100 105 110
Ser Gly Gln Val Phe Ser Val Val Ser Asn Gly Lys Ala Gly Thr Leu 115
120 125 Asp Leu Ser Leu Thr Val Gln Gly Lys Gln His Val Val Ser Val
Glu 130 135 140 Glu Ala Leu Leu Ala Thr Gly Gln Trp Lys Ser Ile Thr
Leu Phe Val 145 150 155 160 Gln Glu Asp Arg Ala Gln Leu Tyr Ile Asp
Cys Glu Lys Met Glu Asn 165 170 175 Ala Glu Leu Asp Val Pro Ile Gln
Ser Val Phe Thr Arg Asp Leu Ala 180 185 190 Ser Ile Ala Arg Leu Arg
Ile Ala Lys Gly Gly Val Asn Asp Asn Phe 195 200 205 Gln Gly Val Leu
Gln Asn Val Arg Phe Val Phe Gly Thr Thr Pro Glu 210 215 220 Asp Ile
Leu Arg Asn Lys Gly Cys Ser Ser Ser Thr Ser Val Leu Leu 225 230 235
240 Thr Leu Asp Asn Asn Val Val Asn Gly Ser Ser Pro Ala Ile Arg Thr
245 250 255 Asn Tyr Ile Gly His Lys Thr Lys Asp Leu Gln Ala Ile Cys
Gly Ile 260 265 270 Ser Cys Asp Glu Leu Ser Ser Met Val Leu Glu Leu
Arg Gly Leu Arg 275 280 285 Thr Ile Val Thr Thr Leu Gln Asp Ser Ile
Arg Lys Val Thr Glu Glu 290 295 300 Asn Lys Glu Leu Ala Asn Glu Leu
Arg Arg Pro Pro Leu Cys Tyr His 305 310 315 320 Asn Gly Val Gln Tyr
Arg Asn Asn Glu Glu Trp Thr Val Asp Ser Cys 325 330 335 Thr Glu Cys
His Cys Gln Asn Ser Val Thr Ile Cys Lys Lys Val Ser 340 345 350 Cys
Pro Ile Met Pro Cys Ser Asn Ala Thr Val Pro Asp Gly Glu Cys 355 360
365 Cys Pro Arg Cys Trp Pro Ser Asp Ser Ala Asp Asp Gly Trp Ser Pro
370 375 380 Trp Ser Glu Trp Thr Ser Cys Ser Thr Ser Cys Gly Asn Gly
Ile Gln 385 390 395 400 Gln Arg Gly Arg Ser Cys Asp Ser Leu Asn Asn
Arg Cys Glu Gly Ser 405 410 415 Ser Val Gln Thr Arg Thr Cys His Ile
Gln Glu Cys Asp Lys Arg Phe 420 425 430 Lys Gln Asp Gly Gly Trp Ser
His Trp Ser Pro Trp Ser Ser Cys Ser 435 440 445 Val Thr Cys Gly Asp
Gly Val Ile Thr Arg Ile Arg Leu Cys Asn Ser 450 455 460 Pro Ser Pro
Gln Met Asn Gly Lys Pro Cys Glu Gly Glu Ala Arg Glu 465 470 475 480
Thr Lys Ala Cys Lys Lys Asp Ala Cys Pro Ile Asn Gly Gly Trp Gly 485
490 495 Pro Trp Ser Pro Trp Asp Ile Cys Ser Val Thr Cys Gly Gly Gly
Val 500 505 510 Gln Lys Arg Ser Arg Leu Cys Asn Asn Pro Ala Pro Gln
Phe Gly Gly 515 520 525 Lys Asp Cys Val Gly Asp Val Thr Glu Asn Gln
Ile Cys Asn Lys Gln 530 535 540 Asp Cys Pro Ile Asp Gly Cys Leu Ser
Asn Pro Cys Phe Ala Gly Val 545 550 555 560 Lys Cys Thr Ser Tyr Pro
Asp Gly Ser Trp Lys Cys Gly Ala Cys Pro 565 570 575 Pro Gly Tyr Ser
Gly Asn Gly Ile Gln Cys Thr Asp Val Asp Glu Cys 580 585 590 Lys Glu
Val Pro Asp Ala Cys Phe Asn His Asn Gly Glu His Arg Cys 595 600 605
Glu Asn Thr Asp Pro Gly Tyr Asn Cys Leu Pro Cys Pro Pro Arg Phe 610
615 620 Thr Gly Ser Gln Pro Phe Gly Gln Gly Val Glu His Ala Thr Ala
Asn 625 630 635 640 Lys Gln Val Cys Lys Pro Arg Asn Pro Cys Thr Asp
Gly Thr His Asp 645 650 655 Cys Asn Lys Asn Ala Lys Cys Asn Tyr Leu
Gly His Tyr Ser Asp Pro 660 665 670 Met Tyr Arg Cys Glu Cys Lys Pro
Gly Tyr Ala Gly Asn Gly Ile Ile 675 680 685 Cys Gly Glu Asp Thr Asp
Leu Asp Gly Trp Pro Asn Glu Asn Leu Val 690 695 700 Cys Val Ala Asn
Ala Thr Tyr His Cys Lys Lys Asp Asn Cys Pro Asn 705 710 715 720 Leu
Pro Asn Ser Gly Gln Glu Asp Tyr Asp Lys Asp Gly Ile Gly Asp 725 730
735 Ala Cys Asp Asp Asp Asp Asp Asn Asp Lys Ile Pro Asp Asp Arg Asp
740 745 750 Asn Cys Pro Phe His Tyr Asn Pro Ala Gln Tyr Asp Tyr Asp
Arg Asp 755 760 765 Asp Val Gly Asp Arg Cys Asp Asn Cys Pro Tyr Asn
His Asn Pro Asp 770 775 780 Gln Ala Asp Thr Asp Asn Asn Gly Glu Gly
Asp Ala Cys Ala Ala Asp 785 790 795 800 Ile Asp Gly Asp Gly Ile Leu
Asn Glu Arg Asp Asn Cys Gln Tyr Val 805 810 815 Tyr Asn Val Asp Gln
Arg Asp Thr Asp Met Asp Gly Val Gly Asp Gln 820 825 830 Cys Asp Asn
Cys Pro Leu Glu His Asn Pro Asp Gln Leu Asp Ser Asp 835 840 845 Ser
Asp Arg Ile Gly Asp Thr Cys Asp Asn Asn Gln Asp Ile Asp Glu 850 855
860 Asp Gly His Gln Asn Asn Leu Asp Asn Cys Pro Tyr Val Pro Asn Ala
865 870 875 880 Asn Gln Ala Asp His Asp Lys Asp Gly Lys Gly Asp Ala
Cys Asp His 885 890 895 Asp Asp Asp Asn Asp Gly Ile Pro Asp Asp Lys
Asp Asn Cys Arg Leu 900 905 910 Val Pro Asn Pro Asp Gln Lys Asp Ser
Asp Gly Asp Gly Arg Gly Asp 915 920 925 Ala Cys Lys Asp Asp Phe Asp
His Asp Ser Val Pro Asp Ile Asp Asp 930 935 940 Ile Cys Pro Glu Asn
Val Asp Ile Ser Glu Thr Asp Phe Arg Arg Phe 945 950 955 960 Gln Met
Ile Pro Leu Asp Pro Lys Gly Thr Ser Gln Asn Asp Pro Asn 965 970 975
Trp Val Val Arg His Gln Gly Lys Glu Leu Val Gln Thr Val Asn Cys 980
985 990 Asp Pro Gly Leu Ala Val Gly Tyr Asp Glu Phe Asn Ala Val Asp
Phe 995 1000 1005 Ser Gly Thr Phe Phe Ile Asn Thr Glu Arg Asp Asp
Asp Tyr Ala Gly 1010 1015 1020 Phe Val Phe Gly Tyr Gln Ser Ser Ser
Arg Phe Tyr Val Val Met Trp 1025 1030 1035 1040 Lys Gln Val Thr Gln
Ser Tyr Trp Asp Thr Asn Pro Thr Arg Ala Gln 1045 1050 1055 Gly Tyr
Ser Gly Leu Ser Val Lys Val Val Asn Ser Thr Thr Gly Pro 1060 1065
1070 Gly Glu His Leu Arg Asn Ala Leu Trp His Thr Gly Asn Thr Pro
Gly 1075 1080 1085 Gln Val Arg Thr Leu Trp His Asp Pro Arg His Ile
Gly Trp Lys Asp 1090 1095 1100 Phe Thr Ala Tyr Arg Trp Arg Leu Ser
His Arg Pro Lys Thr Gly Phe 1105 1110 1115 1120 Ile Arg Val Val Met
Tyr Glu Gly Lys Lys Ile Met Ala Asp Ser Gly 1125 1130 1135 Pro Ile
Tyr Asp Lys Thr Tyr Ala Gly Gly Arg Leu Gly Leu Phe Val 1140 1145
1150 Phe Ser Gln Glu Met Val Phe Phe Ser Asp Leu Lys Tyr Glu Cys
Arg 1155 1160 1165 Asp Pro 1170 3 3074 DNA Homo sapiens 3
gaattccggg gagcaggaag agccaacatg ctggccccgc gcggagccgc cgtcctcctg
60 ctgcacctgg tcctgcagcg gtggctagcg gcaggcgccc aggccacccc
ccaggtcttt 120 gaccttctcc catcttccag tcagaggcta aacccaggcg
ctctgctgcc agtcctgaca 180 gaccccgccc tgaatgatct ctatgtgatt
tccaccttca agctgcagac taaaagttca 240 gccaccatct tcggtcttta
ctcttcaact gacaacagta aatattttga atttactgtg 300 atgggacgct
taagcaaagc catcctccgt tacctgaaga acgatgggaa ggtgcatttg 360
gtggttttca acaacctgca gctggcagac ggaaggcggc acaggatcct cctgaggctg
420 agcaatttgc agcgaggggc cggctcccta gagctctacc tggactgcat
ccaggtggat 480 tccgttcaca atctccccag ggcctttgct ggcccctccc
agaaacctga gaccattgaa 540 ttgaggactt tccagaggaa gccacaggac
ttcttggaag agctgaagct ggtggtgaga 600 ggctcactgt tccaggtggc
cagcctgcaa gactgcttcc tgcagcagag tgagccactg 660 gctgccacag
gcacagggga ctttaaccgg cagttcttgg gtcaaatgac acaattaaac 720
caactcctgg gagaggtgaa ggaccttctg agacagcagg ttaaggaaac atcatttttg
780 cgaaacacca tagctgaatg ccaggcttgc ggtcctctca agtttcagtc
tccgacccca 840 agcacggtgg tcgccccggc tccccctgca ccgccaacac
gcccacctcg tcggtgtgac 900 tccaacccat gtttccgagg tgtccaatgt
accgacagta gagatggctt ccagtgtggg 960 ccctgccccg agggctacac
aggaaacggg atcacctgta ttgatgttga tgagtgcaaa 1020 taccatccct
gctacccggg cgtgcactgc ataaatttgt ctcctggctt cagatgtgac 1080
gcctgcccag tgggcttcac agggcccatg gtgcagggtg ttgggatcag ttttgccaag
1140 tcaaacaagc aggtctgcac tgacattgat gagtgtcgaa atggagcgtg
cgttcccaac 1200 tcgatctgcg ttaatacttt gggatcttac cgctgtgggc
cttgtaagcc ggggtatact 1260 ggtgatcaga taaggggatg caaagtggaa
agaaactgca gaaacccaga gctgaaccct 1320 tgcagtgtga atgcccagtg
cattgaagag aggcaggggg atgtgacatg tgtgtgtgga 1380 gtcggttggg
ctggagatgg ctatatctgt ggaaaggatg tggacatcga cagttacccc 1440
gacgaagaac tgccatgctc tgccaggaac tgtaaaaagg acaactgcaa atatgtgcca
1500 aattctggcc aagaagatgc agacagagat ggcattggcg acgcttgtga
cgaggatgct 1560 gacggagatg ggatcctgaa tgagcaggat aactgtgtcc
tgattcataa tgtggaccaa 1620 aggaacagcg ataaagatat ctttggggat
gcctgtgata actgcctgag tgtcttaaat 1680 aacgaccaga aagacaccga
tggggatgga agaggagatg cctgtgatga tgacatggat 1740 ggagatggaa
taaaaaacat tctggacaac tgcccaaaat ttcccaatcg tgaccaacgg 1800
gacaaggatg gtgatggtgt gggggatgcc tgtgacagtt gtcctgatgt cagcaaccct
1860 aaccagtctg atgtggataa tgatctggtt ggggactcct gtgacaccaa
tcaggacagt 1920 gatggagatg ggcaccagga cagcacagac aactgcccca
ccgtcattaa cagtgcccag 1980 ctggacaccg ataaggatgg aattggtgac
gagtgtgatg
atgatgatga caatgatggt 2040 atcccagacc tggtgccccc tggaccagac
aactgccggc tggtccccaa cccagcccag 2100 gaggatagca acagcgacgg
agtgggagac atctgtgagt ctgactttga ccaggaccag 2160 gtcatcgatc
ggatcgacgt ctgcccagag aacgcagagg tcaccctgac cgacttcagg 2220
gcttaccaga ccgtgggcct ggatcctgaa ggggatgccc agatcgatcc caactgggtg
2280 gtcctgaacc agggcatgga gattgtacag accatgaaca gtgatcctgg
cctggcagtg 2340 gggtacacag cttttaatgg agttgacttc gaagggacct
tccatgtgaa tacccagaca 2400 gatgatgact atgcaggctt tatctttggc
taccaagata gctccagctt ctacgtggtc 2460 atgtggaagc agacggagca
gacatattgg caagccaccc cattccgagc agttgcagaa 2520 cctggcattc
agctcaaggc tgtgaagtct aagacaggtc caggggagca tctccggaac 2580
tccctgtggc acacggggga caccagtgac caggtcaggc tgctgtggaa ggactccagg
2640 aatgtgggct ggaaggacaa ggtgtcctac cgctggttcc tacagcacag
gccccaggtg 2700 ggctacatca gggtacgatt ttatgaaggc tctgagttgg
tggctgactc tggcgtcacc 2760 atagacacca caatgcgtgg aggccgactt
ggcgttttct gcttctctca agaaaacatc 2820 atctggtcca acctcaagta
tcgctgcaat gacaccatcc ctgaggactt ccaagagttt 2880 caaacccaga
atttcgaccg cttcgataat taaaccaagg aagcaatctg taactgcttt 2940
tcggaacact aaaaccatat atattttaac ttcaattttc tttagctttt accaacccaa
3000 atatatcaaa acgttttatg tgaatgtggc aataaaggag aagagatcat
ttttaaaaaa 3060 aaaaaaaaaa aaaa 3074 4 961 PRT Homo sapiens 4 Met
Leu Ala Pro Arg Gly Ala Ala Val Leu Leu Leu His Leu Val Leu 1 5 10
15 Gln Arg Trp Leu Ala Ala Gly Ala Gln Ala Thr Pro Gln Val Phe Asp
20 25 30 Leu Leu Pro Ser Ser Ser Gln Arg Leu Asn Pro Gly Ala Leu
Leu Pro 35 40 45 Val Leu Thr Asp Pro Ala Leu Asn Asp Leu Tyr Val
Ile Ser Thr Phe 50 55 60 Lys Leu Gln Thr Lys Ser Ser Ala Thr Ile
Phe Gly Leu Tyr Ser Ser 65 70 75 80 Thr Asp Asn Ser Lys Tyr Phe Glu
Phe Thr Val Met Gly Arg Leu Ser 85 90 95 Lys Ala Ile Leu Arg Tyr
Leu Lys Asn Asp Gly Lys Val His Leu Val 100 105 110 Val Phe Asn Asn
Leu Gln Leu Ala Asp Gly Arg Arg His Arg Ile Leu 115 120 125 Leu Arg
Leu Ser Asn Leu Gln Arg Gly Ala Gly Ser Leu Glu Leu Tyr 130 135 140
Leu Asp Cys Ile Gln Val Asp Ser Val His Asn Leu Pro Arg Ala Phe 145
150 155 160 Ala Gly Pro Ser Gln Lys Pro Glu Thr Ile Glu Leu Arg Thr
Phe Gln 165 170 175 Arg Lys Pro Gln Asp Phe Leu Glu Glu Leu Lys Leu
Val Val Arg Gly 180 185 190 Ser Leu Phe Gln Val Ala Ser Leu Gln Asp
Cys Phe Leu Gln Gln Ser 195 200 205 Glu Pro Leu Ala Ala Thr Gly Thr
Gly Asp Phe Asn Arg Gln Phe Leu 210 215 220 Gly Gln Met Thr Gln Leu
Asn Gln Leu Leu Gly Glu Val Lys Asp Leu 225 230 235 240 Leu Arg Gln
Gln Val Lys Glu Thr Ser Phe Leu Arg Asn Thr Ile Ala 245 250 255 Glu
Cys Gln Ala Cys Gly Pro Leu Lys Phe Gln Ser Pro Thr Pro Ser 260 265
270 Thr Val Val Ala Pro Ala Pro Pro Ala Pro Pro Thr Arg Pro Pro Arg
275 280 285 Arg Cys Asp Ser Asn Pro Cys Phe Arg Gly Val Gln Cys Thr
Asp Ser 290 295 300 Arg Asp Gly Phe Gln Cys Gly Pro Cys Pro Glu Gly
Tyr Thr Gly Asn 305 310 315 320 Gly Ile Thr Cys Ile Asp Val Asp Glu
Cys Lys Tyr His Pro Cys Tyr 325 330 335 Pro Gly Val His Cys Ile Asn
Leu Ser Pro Gly Phe Arg Cys Asp Ala 340 345 350 Cys Pro Val Gly Phe
Thr Gly Pro Met Val Gln Gly Val Gly Ile Ser 355 360 365 Phe Ala Lys
Ser Asn Lys Gln Val Cys Thr Asp Ile Asp Glu Cys Arg 370 375 380 Asn
Gly Ala Cys Val Pro Asn Ser Ile Cys Val Asn Thr Leu Gly Ser 385 390
395 400 Tyr Arg Cys Gly Pro Cys Lys Pro Gly Tyr Thr Gly Asp Gln Ile
Arg 405 410 415 Gly Cys Lys Val Glu Arg Asn Cys Arg Asn Pro Glu Leu
Asn Pro Cys 420 425 430 Ser Val Asn Ala Gln Cys Ile Glu Glu Arg Gln
Gly Asp Val Thr Cys 435 440 445 Val Cys Gly Val Gly Trp Ala Gly Asp
Gly Tyr Ile Cys Gly Lys Asp 450 455 460 Val Asp Ile Asp Ser Tyr Pro
Asp Glu Glu Leu Pro Cys Ser Ala Arg 465 470 475 480 Asn Cys Lys Lys
Asp Asn Cys Lys Tyr Val Pro Asn Ser Gly Gln Glu 485 490 495 Asp Ala
Asp Arg Asp Gly Ile Gly Asp Ala Cys Asp Glu Asp Ala Asp 500 505 510
Gly Asp Gly Ile Leu Asn Glu Gln Asp Asn Cys Val Leu Ile His Asn 515
520 525 Val Asp Gln Arg Asn Ser Asp Lys Asp Ile Phe Gly Asp Ala Cys
Asp 530 535 540 Asn Cys Leu Ser Val Leu Asn Asn Asp Gln Lys Asp Thr
Asp Gly Asp 545 550 555 560 Gly Arg Gly Asp Ala Cys Asp Asp Asp Met
Asp Gly Asp Gly Ile Lys 565 570 575 Asn Ile Leu Asp Asn Cys Pro Lys
Phe Pro Asn Arg Asp Gln Arg Asp 580 585 590 Lys Asp Gly Asp Gly Val
Gly Asp Ala Cys Asp Ser Cys Pro Asp Val 595 600 605 Ser Asn Pro Asn
Gln Ser Asp Val Asp Asn Asp Leu Val Gly Asp Ser 610 615 620 Cys Asp
Thr Asn Gln Asp Ser Asp Gly Asp Gly His Gln Asp Ser Thr 625 630 635
640 Asp Asn Cys Pro Thr Val Ile Asn Ser Ala Gln Leu Asp Thr Asp Lys
645 650 655 Asp Gly Ile Gly Asp Glu Cys Asp Asp Asp Asp Asp Asn Asp
Gly Ile 660 665 670 Pro Asp Leu Val Pro Pro Gly Pro Asp Asn Cys Arg
Leu Val Pro Asn 675 680 685 Pro Ala Gln Glu Asp Ser Asn Ser Asp Gly
Val Gly Asp Ile Cys Glu 690 695 700 Ser Asp Phe Asp Gln Asp Gln Val
Ile Asp Arg Ile Asp Val Cys Pro 705 710 715 720 Glu Asn Ala Glu Val
Thr Leu Thr Asp Phe Arg Ala Tyr Gln Thr Val 725 730 735 Gly Leu Asp
Pro Glu Gly Asp Ala Gln Ile Asp Pro Asn Trp Val Val 740 745 750 Leu
Asn Gln Gly Met Glu Ile Val Gln Thr Met Asn Ser Asp Pro Gly 755 760
765 Leu Ala Val Gly Tyr Thr Ala Phe Asn Gly Val Asp Phe Glu Gly Thr
770 775 780 Phe His Val Asn Thr Gln Thr Asp Asp Asp Tyr Ala Gly Phe
Ile Phe 785 790 795 800 Gly Tyr Gln Asp Ser Ser Ser Phe Tyr Val Val
Met Trp Lys Gln Thr 805 810 815 Glu Gln Thr Tyr Trp Gln Ala Thr Pro
Phe Arg Ala Val Ala Glu Pro 820 825 830 Gly Ile Gln Leu Lys Ala Val
Lys Ser Lys Thr Gly Pro Gly Glu His 835 840 845 Leu Arg Asn Ser Leu
Trp His Thr Gly Asp Thr Ser Asp Gln Val Arg 850 855 860 Leu Leu Trp
Lys Asp Ser Arg Asn Val Gly Trp Lys Asp Lys Val Ser 865 870 875 880
Tyr Arg Trp Phe Leu Gln His Arg Pro Gln Val Gly Tyr Ile Arg Val 885
890 895 Arg Phe Tyr Glu Gly Ser Glu Leu Val Ala Asp Ser Gly Val Thr
Ile 900 905 910 Asp Thr Thr Met Arg Gly Gly Arg Leu Gly Val Phe Cys
Phe Ser Gln 915 920 925 Glu Asn Ile Ile Trp Ser Asn Leu Lys Tyr Arg
Cys Asn Asp Thr Ile 930 935 940 Pro Glu Asp Phe Gln Glu Phe Gln Thr
Gln Asn Phe Asp Arg Phe Asp 945 950 955 960 Asn 5 31 DNA Homo
sapiens 5 tggatggctg gcccartgag aacctggtgt g 31 6 31 DNA Homo
sapiens 6 gagtgtcgaa atggascgtg cgttcccaac t 31 7 21 DNA Homo
sapiens 7 ctgcaggagt rgctggatga a 21 8 21 DNA Homo sapiens 8
catctggacc ytgctgggca a 21 9 21 DNA Homo sapiens 9 gtgctggtgt
scgcagccat c 21 10 21 DNA Homo sapiens 10 tgcgcgccaa satgaccaac g
21 11 21 DNA Homo sapiens 11 tgtgctccac ygcctccatc c 21 12 21 DNA
Homo sapiens 12 gcagagcacg ygcagagctg c 21 13 21 DNA Homo sapiens
13 atggtcggcc yggcatggac c 21 14 21 DNA Homo sapiens 14 gcaagatgac
ycagcgcatg g 21 15 21 DNA Homo sapiens 15 tcgctcatca rcttctacat c
21 16 21 DNA Homo sapiens 16 ggggcgggct kgacctgcca a 21 17 21 DNA
Homo sapiens 17 agaccctgtc rgtgatcatg g 21 18 21 DNA Homo sapiens
18 ggaggaggac ktttgggagc c 21 19 21 DNA Homo sapiens 19 tttgggagcc
ygacgtgaat g 21 20 21 DNA Homo sapiens 20 ccgacgtgaa kgcagagaac t
21 21 21 DNA Homo sapiens 21 acctacacgc rcatctaccg c 21 22 21 DNA
Homo sapiens 22 gtgcagccac ktctgctccc g 21 23 21 DNA Homo sapiens
23 gaaatcgcag ytgcctacat c 21 24 21 DNA Homo sapiens 24 accctgttgc
wgagtctgtc t 21 25 21 DNA Homo sapiens 25 tctcctacaa ycaagacatc g
21 26 21 DNA Homo sapiens 26 cactcaaccc mgtcatctat g 21 27 21 DNA
Homo sapiens 27 acgccgactt ycagaaggtg t 21 28 21 DNA Homo sapiens
28 cgaggaggag rgtcctttcg a 21 29 21 DNA Homo sapiens 29 gatcgcatgt
yccagatcta t 21 30 21 DNA Homo sapiens 30 tgtctctggc ygtgtctgac c
21 31 21 DNA Homo sapiens 31 tgccgccagg sagcaacggc a 21 32 21 DNA
Homo sapiens 32 ggcagttcgc kctataccag c 21 33 21 DNA Homo sapiens
33 tggggccctc rcaggtggtc a 21 34 21 DNA Homo sapiens 34 tggccggtta
ytggcccttt g 21 35 21 DNA Homo sapiens 35 cttcgacatc wtgtgctcca c
21 36 21 DNA Homo sapiens 36 atcagcgtgg rccgctactg g 21 37 21 DNA
Homo sapiens 37 tggccctttg ragcgttctg c 21 38 21 DNA Homo sapiens
38 agcctgcgcg yttccatcaa g 21 39 21 DNA Homo sapiens 39 ggttctcaag
mccctgtcgg t 21 40 21 DNA Homo sapiens 40 ctacatcccc rttgccatca t
21 41 21 DNA Homo sapiens 41 gatttcctcc ytggagaggg c 21 42 21 DNA
Homo sapiens 42 ccctcaacgc ytcgttcctc c 21 43 21 DNA Homo sapiens
43 gctgctcaag ytggcgtcgc c 21 44 21 DNA Homo sapiens 44 tggagtccca
rgagcggatc a 21 45 21 DNA Homo sapiens 45 ccccagtggt rtacctgaag g
21 46 21 DNA Homo sapiens 46 atgtgatgag wgagaaacat c 21 47 21 DNA
Homo sapiens 47 ccccaagatc mggacaagcc t 21 48 21 DNA Homo sapiens
48 ccaactcagc yttcctgcat a 21 49 21 DNA Homo sapiens 49 gccgctcaga
ytccgaggat g 21 50 21 DNA Homo sapiens 50 ggtacaagtt rcttaaccaa g
21 51 21 DNA Homo sapiens 51 ctggcctgcc rtgtccggga g 21 52 21 DNA
Homo sapiens 52 agtgcaggga ygaaggcctc a 21 53 21 DNA Homo sapiens
53 gctgccacgg yctcgtcccg c 21 54 21 DNA Homo sapiens 54 agaagaatga
ycaaatttac g 21 55 21 DNA Homo sapiens 55 ggattttctg wcatcaagtc c
21 56 21 DNA Homo sapiens 56 caagtgggtg racagcgaag g 21 57 21 DNA
Homo sapiens 57 tcccaagagc ytccagtaga c 21 58 21 DNA Homo sapiens
58 tcatcaacaa ratgaaactg g 21 59 21 DNA Homo sapiens 59 tcccatgtca
mccggatgac c 21 60 21 DNA Homo sapiens 60 gactatggga ycaaatttgc c
21 61 21 DNA Homo sapiens 61 tgcacacatg maaggccccc a 21 62 21 DNA
Homo sapiens 62 cctgatgaat yttcacaaca a 21 63 21 DNA Homo sapiens
63 gacatgctgg ytggccatgg c 21 64 21 DNA Homo sapiens 64 actatgggat
yaaatttgcc c 21 65 21 DNA Homo sapiens 65 tgcaaaggaa rggaaaggaa a
21 66 21 DNA Homo sapiens 66 atacttgcaa rgcccccaag a 21 67 21 DNA
Homo sapiens 67 ggcaagggga raatgttgcc g 21 68 21 DNA Homo sapiens
68 ctggccaagc ygtggagtgc t 21 69 21 DNA Homo sapiens 69 caaattgcga
ktgggtatta a 21 70 21 DNA Homo sapiens 70 gggacctaac yggcgtgcag a
21 71 21 DNA Homo sapiens 71 gccctcatca rtgcagatga g 21 72 21 DNA
Homo sapiens 72 ctgaaggtct yatggcagag g 21 73 21 DNA Homo sapiens
73 tccgtgaagc raatgaacta c 21 74 21 DNA Homo sapiens 74 tgagacagac
wtcaccgtcc a 21 75 21 DNA Homo sapiens 75 catgaatgtt rcctgtgctg g
21 76 21 DNA Homo sapiens 76 gccgccctgg rcgctattac g 21 77 21 DNA
Homo sapiens 77 aacattaaga sgtgccacca a 21 78 21 DNA Homo sapiens
78 ctcatagatg yaaaaactgg a 21 79 21 DNA Homo sapiens 79 gatagatttt
yagaagttaa a 21 80 21 DNA Homo sapiens 80 tcgagatgga rcagcggctg g
21 81 21 DNA Homo sapiens 81 gggagcgccg mgccatcgag a 21 82 21 DNA
Homo sapiens 82 gggatcgcca ygggaactca a 21 83 21 DNA Homo sapiens
83 ccctccttct ycaagaactt t 21 84 21 DNA Homo sapiens 84 tctccaactt
stacaaattc t 21 85 21 DNA Homo sapiens 85 actgaatctg maggccagga t
21 86 21 DNA Homo sapiens 86 aatttgagct wcttgataag g 21 87 21 DNA
Homo sapiens 87 tcagaatcat ytgatggatc t 21 88 21 DNA Homo sapiens
88 ttcaagtgaa satgctgaaa g 21 89 21 DNA Homo sapiens 89 ctcttgacga
kgacgaagat g 21 90 21 DNA Homo sapiens 90 ccggactctt ycagccatta a
21 91 21 DNA Homo sapiens 91 ctgagaaaga ygcggaagat t 21 92 21 DNA
Homo sapiens 92 tggaacagaa ygaagacaga t 21 93 21 DNA Homo sapiens
93 gtttcctgta ytaaagcaac t 21 94 21 DNA Homo sapiens 94 agaacagctg
ygaaagagcc a 21 95 21 DNA Homo sapiens 95 gatgtgcaga ygggagggcc a
21 96 21 DNA Homo sapiens 96 aagaatttga kctacttgat a 21 97 21 DNA
Homo sapiens 97 acacttctga ytgcactccc g 21 98 21 DNA Homo sapiens
98 gccaccccat kaacctggag g 21 99 21 DNA Homo sapiens 99 gagtcaccac
yttcacctta t 21 100 21 DNA Homo sapiens 100 acgtacatca mtgcctcgac
g
21 101 21 DNA Homo sapiens 101 tctgtaccca yactcttgta c 21 102 21
DNA Homo sapiens 102 aggcaacatg sgtgactgga g 21 103 21 DNA Homo
sapiens 103 tatgtgatgc raaaggaaga g 21 104 21 DNA Homo sapiens 104
ttcattttcc raatcctgct g 21 105 21 DNA Homo sapiens 105 caagcctact
yaactgctgg a 21 106 21 DNA Homo sapiens 106 agaaagagga rgaactcaag g
21 107 21 DNA Homo sapiens 107 gcacttgaag magattgaga t 21 108 21
DNA Homo sapiens 108 atgcacttga rgcagattga g 21 109 21 DNA Homo
sapiens 109 cgctgagccc ygccaaagac t 21 110 21 DNA Homo sapiens 110
cctcaccaac ygctcccctc t 21 111 21 DNA Homo sapiens 111 aagctggtta
mtggcgacag a 21 112 21 DNA Homo sapiens 112 ctaactccca ygcacagcct t
21 113 21 DNA Homo sapiens 113 tggacatgaa ytacagccac t 21 114 21
DNA Homo sapiens 114 ccgcaattac racaagcaag c 21 115 21 DNA Homo
sapiens 115 gtggaccagc raccttcaag c 21 116 21 DNA Homo sapiens 116
tatttgtgtc ygtacccaca c 21 117 21 DNA Homo sapiens 117 cgttaaggat
ygggttaagg g 21 118 21 DNA Homo sapiens 118 aactcttcta ygttttcttc a
21 119 21 DNA Homo sapiens 119 agttcaagta yggtattgaa g 21 120 21
DNA Homo sapiens 120 ccagcgacct kcaagcagag c 21 121 21 DNA Homo
sapiens 121 caacaagcaa rcaagtgagc a 21 122 21 DNA Homo sapiens 122
caaaactggg staattacag t 21 123 21 DNA Homo sapiens 123 agacctgtgc
rtacaccaac c 21 124 21 DNA Homo sapiens 124 gacaccccag ygcccggcta c
21 125 21 DNA Homo sapiens 125 tccactcgga satcgtgaaa c 21 126 21
DNA Homo sapiens 126 ggggctggcc rataccatcg t 21 127 21 DNA Homo
sapiens 127 ccatgttcga ygtgcatgtg a 21 128 21 DNA Homo sapiens 128
aggtggacca rctgtaccgg a 21 129 21 DNA Homo sapiens 129 cccccgacgg
ygtgaagtgg c 21 130 21 DNA Homo sapiens 130 gcagaggagc rgcagaggat c
21 131 21 DNA Homo sapiens 131 atgacggacc ygtgtgtgaa g 21 132 21
DNA Homo sapiens 132 ccatcaccat ygccaaccag a 21 133 21 DNA Homo
sapiens 133 acgtggggtc yctgttgctc a 21 134 21 DNA Homo sapiens 134
tagaagaaag rtattgcatc g 21 135 21 DNA Homo sapiens 135 atccaagagt
ygcatgtcag c 21 136 21 DNA Homo sapiens 136 cacagaagag wcgtggcccg g
21 137 21 DNA Homo sapiens 137 caagtggctg sccctggaga g 21 138 21
DNA Homo sapiens 138 ttggcgggaa ycgcctgaaa c 21 139 21 DNA Homo
sapiens 139 agagcctggc ygacaacctg t 21 140 21 DNA Homo sapiens 140
ctctgagtga rgatgacttt g 21 141 21 DNA Homo sapiens 141 ttgagacctt
yggcaacagc a 21 142 21 DNA Homo sapiens 142 catgatctgc ytgttccaaa t
21 143 21 DNA Homo sapiens 143 aggtttggga raagtttgat c 21 144 21
DNA Homo sapiens 144 gcaacagcat satctgcctg t 21 145 21 DNA Homo
sapiens 145 gctcagttaa rggagactgt g 21 146 21 DNA Homo sapiens 146
tgtacatcgc sgtcatcctg g 21 147 21 DNA Homo sapiens 147 atcaccctgg
magctcagtt a 21 148 21 DNA Homo sapiens 148 atggctacac ragctttgac a
21 149 21 DNA Homo sapiens 149 tctgtgtgaa kgctggtaga a 21 150 21
DNA Homo sapiens 150 tcccagctgt raccctctgt a 21 151 21 DNA Homo
sapiens 151 tctgtaacct saatggcttc c 21 152 21 DNA Homo sapiens 152
tcaccaccaa ygacctgtac c 21 153 21 DNA Homo sapiens 153 ccccatctgg
mtgacccctc c 21 154 21 DNA Homo sapiens 154 ccctgcggca raaggccaac t
21 155 21 DNA Homo sapiens 155 cagtcaaagc rgctaaggga g 21 156 21
DNA Homo sapiens 156 caaaggaagc sttggcagtc a 21 157 21 DNA Homo
sapiens 157 ctcccatgga kactgctcag a 21 158 21 DNA Homo sapiens 158
ggaacctgtt magatagagc t 21 159 21 DNA Homo sapiens 159 atgacacctc
ygactgtgcc a 21 160 21 DNA Homo sapiens 160 aagccaagga rtggtgggcc t
21 161 21 DNA Homo sapiens 161 agtccctgta yggctttcca g 21 162 21
DNA Homo sapiens 162 agtcattttg yacataaacg a 21 163 21 DNA Homo
sapiens 163 gaggaataca rcccattcct c 21 164 21 DNA Homo sapiens 164
ctgcctactc rctccagatc t 21 165 21 DNA Homo sapiens 165 cgtcctctga
ragctctgtc a 21 166 21 DNA Homo sapiens 166 actttgccga ygccctgtct g
21 167 21 DNA Homo sapiens 167 gagcccatca ycaccacact c 21 168 21
DNA Homo sapiens 168 gcgttcactt wccttcggga c 21 169 21 DNA Homo
sapiens 169 ccacagtgaa katctcgccg a 21 170 21 DNA Homo sapiens 170
ggcctggctg kccaggacac a 21 171 21 DNA Homo sapiens 171 aatgggcctc
rgccccgcgg a 21 172 21 DNA Homo sapiens 172 ttggcaagag ytacaaggag t
21 173 21 DNA Homo sapiens 173 tggtcatgtt yatctactcc a 21 174 21
DNA Homo sapiens 174 tcaacatgta satcgccatc a 21 175 21 DNA Homo
sapiens 175 gtcaagggtg rctgcggcaa c 21 176 21 DNA Homo sapiens 176
gtacatcgcc rtcatcctgg a 21 177 21 DNA Homo sapiens 177 gttcatctac
kccatcttcg g 21 178 21 DNA Homo sapiens 178 tggtgaagat kactttgaga t
21 179 21 DNA Homo sapiens 179 ttctggctga ycttcagcat c 21 180 21
DNA Homo sapiens 180 ggagacagac raccagagcc a 21 181 21 DNA Homo
sapiens 181 tctgcttctt mtgcagctat a 21 182 21 DNA Homo sapiens 182
cagggcagac kgtgcgccca g 21 183 21 DNA Homo sapiens 183 caggggacgc
yggacccact a 21 184 21 DNA Homo sapiens 184 cgctgctgct rccactattg c
21 185 21 DNA Homo sapiens 185 tctgcgcgcg yagcccgcca t 21 186 21
DNA Homo sapiens 186 cagcatgtgg ycgccgtgga t 21 187 21 DNA Homo
sapiens 187 atgagcgaaa rgtgaatgcg t 21 188 21 DNA Homo sapiens 188
ggttcctgag rgccaagatg g 21 189 21 DNA Homo sapiens 189 gtgaggctgt
rtcgggtctg c 21 190 21 DNA Homo sapiens 190 ccaagaaatt saagaggaaa t
21 191 21 DNA Homo sapiens 191 atcagcctgg kgatgctgag g 21 192 21
DNA Homo sapiens 192 gccacgggat ygtggaggtt g 21 193 21 DNA Homo
sapiens 193 ctttggcacc rtcatctgca a 21 194 21 DNA Homo sapiens 194
gggtgtctgt ragtgtgtcc a 21 195 21 DNA Homo sapiens 195 ctgctgcttc
wgctcttgtt c 21 196 21 DNA Homo sapiens 196 aaacgctgtg yatcatctgg t
21 197 21 DNA Homo sapiens 197 gtgcgcttct ycgcctgccc c 21 198 21
DNA Homo sapiens 198 atttcatcac sctgggcacc g 21 199 21 DNA Homo
sapiens 199 tgtgcatcat ytggttctcc t 21 200 21 DNA Homo sapiens 200
tgaacatcat wgacattgtg g 21 201 21 DNA Homo sapiens 201 cacagtgacc
yggctctttt t 21 202 21 DNA Homo sapiens 202 ccctggagga ygggttctac g
21 203 21 DNA Homo sapiens 203 ataaatgccc rgagggaatt a 21 204 21
DNA Homo sapiens 204 ttccgggcaa ytcagaagaa a 21 205 21 DNA Homo
sapiens 205 cactgtgcca ygtgccttta t 21 206 21 DNA Homo sapiens 206
acctcttcga yacagcagaa g 21 207 21 DNA Homo sapiens 207 acctggccga
wgagatcctg t 21 208 21 DNA Homo sapiens 208 cgttactctg kggactactc c
21 209 21 DNA Homo sapiens 209 gcttggctgc rtcttcatga a 21 210 21
DNA Homo sapiens 210 cggtgatcgc yctgcgccac g 21 211 21 DNA Homo
sapiens 211 ggaccctgcc ragcccaggt a 21 212 21 DNA Homo sapiens 212
gtggctcatc rccttcgccc a 21 213 21 DNA Homo sapiens 213 tggactactc
rcgttttcac a 21 214 21 DNA Homo sapiens 214 ggccaccgct wtgagcctgt g
21 215 21 DNA Homo sapiens 215 ggccaccgct wtgagcctgt g 21 216 21
DNA Homo sapiens 216 cgcgggtcac ygaggagggc g 21 217 21 DNA Homo
sapiens 217 ctggtgtcgc ycatcaccat c 21 218 21 DNA Homo sapiens 218
tctccatcga sacgcagacc a 21 219 21 DNA Homo sapiens 219 cactccccag
maagactggg g 21 220 21 DNA Homo sapiens 220 cccagcaaga stgggggcag c
21 221 21 DNA Homo sapiens 221 gagtgtgcca mgcttttgga c 21 222 21
DNA Homo sapiens 222 acaaccccca rctggcccac g 21 223 21 DNA Homo
sapiens 223 tcctgggcaa raccttgcag g 21 224 21 DNA Homo sapiens 224
cgagctgctc rtgcgcttct t 21 225 21 DNA Homo sapiens 225 ctctgggtcc
rcgcgggcca t 21 226 21 DNA Homo sapiens 226 gttatcctca yctccatcat c
21 227 21 DNA Homo sapiens 227 caaccagcca rtggaggagg c 21 228 21
DNA Homo sapiens 228 catcatctgg ytctccttcg a 21 229 21 DNA Homo
sapiens 229 gtgtattctg wggattactc c 21 230 21 DNA Homo sapiens 230
ttctctactt yggcttgcgg t 21 231 21 DNA Homo sapiens 231 gtggtctgca
yctttggcga c 21 232 21 DNA Homo sapiens 232 gatgatactt sgctgcagga c
21 233 21 DNA Homo sapiens 233 tcgtggtctg yatctttggc g 21 234 21
DNA Homo sapiens 234 cactcatgag ygcgacgtac t 21 235 21 DNA Homo
sapiens 235 ggatgtttca ytggtgtgca c 21 236 21 DNA Homo sapiens 236
catcctgact ygaagtgaag c 21 237 21 DNA Homo sapiens 237 ctggcaatga
ycagattgac a 21 238 21 DNA Homo sapiens 238 agtttttgga ycaagacgat g
21 239 21 DNA Homo sapiens 239 tgcacgggat rttacgtcaa c 21 240 21
DNA Homo sapiens 240 tgctggtaat wgatgcatct a 21 241 21 DNA Homo
sapiens 241 tctacctgca yacagtcatt c 21 242 21 DNA Homo sapiens 242
caaaggtata yagatgacaa c 21 243 21 DNA Homo sapiens 243 cctgaaaatg
ragccacctt c 21 244 21 DNA Homo sapiens 244 tgaacatcag rtggagctac t
21 245 21 DNA Homo sapiens 245 actatgagaa ratagagaga a 21 246 21
DNA Homo sapiens 246 ctgaagaggg ygggtactca t 21 247 21 DNA Homo
sapiens 247 agacaagcca rtaaaaacag a 21 248 21 DNA Homo sapiens 248
caccacagca rctgtcatgg c 21 249 21 DNA Homo sapiens 249 gcccaatgag
rttaaagtct c 21 250 21 DNA Homo sapiens 250 gattttcacc ratcaagaga t
21 251 21 DNA Homo sapiens 251 atcaagagat yggggagtta c 21 252 21
DNA Homo sapiens 252 tacttccaca yactgttacg a 21 253 21 DNA Homo
sapiens 253 tcactctcca stacctaaac a 21 254 21 DNA Homo sapiens 254
aggtaatggt raaaaaagac a 21 255 21 DNA Homo sapiens 255 gtcctgccga
ktcccctgat g 21 256 21 DNA Homo sapiens 256 cccctgatga rggaatcact a
21 257 21 DNA Homo sapiens 257 agatgccact ratggcaagg a 21 258 21
DNA Homo sapiens 258 caccgctcaa yggattttct g 21 259 21 DNA Homo
sapiens 259 ttccagagcc wacaacagat g 21 260 21 DNA Homo sapiens 260
gcggcctcgt sctcaccagc a 21 261 21 DNA Homo sapiens 261 tgtgggcgcc
ktggtcgcct t 21 262 21 DNA Homo sapiens 262 gccgtgtcac ycgaggatga t
21 263 21 DNA Homo sapiens 263 aattccgatc kgatcctcag g 21 264 21
DNA Homo sapiens 264 caagcttatc ragaccctct c 21 265 21 DNA Homo
sapiens 265 gcagatcact sttggcctcg t 21 266 21 DNA Homo sapiens 266
tcttggcctc rtcttcctct g 21 267 21 DNA Homo sapiens 267 tagagatagc
ygcttacaga a 21 268 21 DNA Homo sapiens 268 cagctgcaac yctaactatt c
21 269 21 DNA Homo sapiens 269 gagcgaagca ygtgatcatg c 21 270 21
DNA Homo sapiens 270 atggagagaa yactgcccag t 21 271 21 DNA Homo
sapiens 271 taatgtcggc ygagagcccc a 21 272 21 DNA Homo sapiens 272
gaccctgacc rctatgtctg t 21 273 21 DNA Homo sapiens 273 acttctcacc
rggagatttg g 21 274 21 DNA Homo sapiens 274 aacgtgcaga ygaagcctta a
21 275 21 DNA Homo sapiens 275 cccacgttag yggaggtggt g 21 276 21
DNA Homo sapiens 276 cattgttcga ratttaggac t 21 277 21 DNA Homo
sapiens 277 gacagcaggg ytataatgta t 21 278 21 DNA Homo sapiens 278
aagagtcaga wccacccaga c 21 279 21 DNA Homo sapiens 279 cagtaatttt
yctcatcttg t 21
280 21 DNA Homo sapiens 280 taatgaatga mattgcagat a 21 281 21 DNA
Homo sapiens 281 caatggaaga kgttcttgaa c 21 282 21 DNA Homo sapiens
282 cacttatacc ycttgtgtat g 21 283 21 DNA Homo sapiens 283
attcttggat ycagctattt g 21 284 21 DNA Homo sapiens 284 gactttggca
stgaccacca g 21 285 21 DNA Homo sapiens 285 actactgctc rgaccaatac t
21 286 21 DNA Homo sapiens 286 ttgaaggtgt yttcagaaga t 21 287 21
DNA Homo sapiens 287 ccaaacacct ygtagaactc t 21 288 21 DNA Homo
sapiens 288 ttcaggagcc yatcatggct c 21 289 21 DNA Homo sapiens 289
tatatattaa ktggcagaaa c 21 290 21 DNA Homo sapiens 290 cattcagatt
scaaacaagg a 21 291 21 DNA Homo sapiens 291 ttccacatct rgtgattaga a
21 292 21 DNA Homo sapiens 292 gagaaatatg magtcttcat g 21 293 21
DNA Homo sapiens 293 aggagaaaag ytttaaaaaa t 21 294 21 DNA Homo
sapiens 294 ttcaaaatga rtggttacat a 21 295 21 DNA Homo sapiens 295
cctgtgcact ycggtggtca c 21 296 21 DNA Homo sapiens 296 ttgccaagaa
rtccaagaac c 21 297 21 DNA Homo sapiens 297 atgatccatg sgtagaacat g
21 298 21 DNA Homo sapiens 298 ccaccagacc wgacgagggg c 21 299 21
DNA Homo sapiens 299 tttgcaattc sttcaaggga g 21 300 21 DNA Homo
sapiens 300 ggcaggagtg yggagagcct g 21 301 21 DNA Homo sapiens 301
tgcagcccac rgcagagaat g 21 302 21 DNA Homo sapiens 302 ggtgtcaact
sttagccacg c 21 303 21 DNA Homo sapiens 303 acgcagatgc ygattgcttt g
21 304 21 DNA Homo sapiens 304 actttattaa yggttcttac t 21 305 21
DNA Homo sapiens 305 ttgcgtatgc ygataatagc c 21 306 21 DNA Homo
sapiens 306 attctgatga yggctgttta a 21 307 21 DNA Homo sapiens 307
atttatgtgg watgctctca c 21 308 21 DNA Homo sapiens 308 tcattcatta
ycatggtgta g 21 309 21 DNA Homo sapiens 309 cagcttttta ygactcactg a
21 310 21 DNA Homo sapiens 310 atcctgttat ygagatgtta g 21 311 21
DNA Homo sapiens 311 atttaatgga rgatccagac a 21 312 21 DNA Homo
sapiens 312 aaaatataac rgaatgcagg a 21 313 21 DNA Homo sapiens 313
gaaataaagc mcaaactgta c 21 314 21 DNA Homo sapiens 314 tatgtattac
ygaaaaagcc t 21 315 21 DNA Homo sapiens 315 ggatgaggat rtgaagctga t
21 316 21 DNA Homo sapiens 316 atgaggagga ygagcagctg a 21 317 21
DNA Homo sapiens 317 cactgagaat rgcaccagtc t 21 318 21 DNA Homo
sapiens 318 tggagatgag raaatgggtc c 21 319 21 DNA Homo sapiens 319
tgaccatcaa yaaggaagat g 21 320 21 DNA Homo sapiens 320 ataacaagga
ygtgtcggtg a 21 321 21 DNA Homo sapiens 321 cagatcaaga rtgacatcca g
21 322 21 DNA Homo sapiens 322 atccctgccc yggacagcaa g 21 323 21
DNA Homo sapiens 323 attgataatg raagctggcc a 21 324 21 DNA Homo
sapiens 324 agtttagaaa rccaagctac a 21 325 21 DNA Homo sapiens 325
aaatgtagca matcagaagc c 21 326 21 DNA Homo sapiens 326 cttataatca
rctggcttca a 21 327 21 DNA Homo sapiens 327 accatggttt yatatggaga c
21 328 21 DNA Homo sapiens 328 gaaaaaaata wtgattacat g 21 329 21
DNA Homo sapiens 329 agcatgtgag mccattgaga t 21 330 21 DNA Homo
sapiens 330 atgattctgt ygtttcaatg t 21 331 21 DNA Homo sapiens 331
agtcagtgtg sagcatttga a 21 332 21 DNA Homo sapiens 332 catctcaaga
sgagctcatt a 21 333 21 DNA Homo sapiens 333 tctcctgaac rtctaaaaga t
21 334 21 DNA Homo sapiens 334 agcgtccaga raggagagct t 21 335 21
DNA Homo sapiens 335 tatgggaagt rgtcatgcat c 21 336 21 DNA Homo
sapiens 336 atctgcccag rgtccagctg c 21 337 21 DNA Homo sapiens 337
agtacaacca ratgccagtc a 21 338 21 DNA Homo sapiens 338 tctccacaaa
rtgtgaccac a 21 339 21 DNA Homo sapiens 339 tccaggtccg yggcctggag a
21 340 21 DNA Homo sapiens 340 tacaacacca rtaacggggc t 21 341 21
DNA Homo sapiens 341 gcaatttgga yatctccaac a 21 342 21 DNA Homo
sapiens 342 tgaaatttct yagtgagaac a 21 343 21 DNA Homo sapiens 343
ttcaccacac ytaaggagaa c 21 344 21 DNA Homo sapiens 344 tttcttccct
satcctgatc t 21 345 21 DNA Homo sapiens 345 cagcaatgac mttcccatcg c
21 346 21 DNA Homo sapiens 346 cagctgagaa ygctgccaag g 21 347 21
DNA Homo sapiens 347 tgtccctagc ygaactcagg a 21 348 21 DNA Homo
sapiens 348 agcgaacgac rcttcgctat g 21 349 21 DNA Homo sapiens 349
aaagcaatgc ygagaggatg a 21 350 21 DNA Homo sapiens 350 ttcgtgaatg
rtctaaagcg g 21 351 21 DNA Homo sapiens 351 agtgtgaccc rgactgcctc c
21 352 21 DNA Homo sapiens 352 catgccaatt rcatcgttca c 21 353 21
DNA Homo sapiens 353 ctgaagccga ycagttgggc a 21 354 21 DNA Homo
sapiens 354 tatgcaacac ytgtggacat g 21 355 21 DNA Homo sapiens 355
ttctggtgac ragtggtgga a 21 356 21 DNA Homo sapiens 356 tgattgggct
rcctccagag g 21 357 21 DNA Homo sapiens 357 ctcttatcta yataaggatg a
21 358 21 DNA Homo sapiens 358 cagacctcag ygcctctctg g 21 359 21
DNA Homo sapiens 359 gtgagtgatg maggtttgaa g 21 360 21 DNA Homo
sapiens 360 aaggtttgaa rggcaagatt a 21 361 21 DNA Homo sapiens 361
gtcacagcca yggacaagag c 21 362 21 DNA Homo sapiens 362 tgacgtttga
yattgatgcc a 21 363 21 DNA Homo sapiens 363 tgaccgtgga ygagggtgtc c
21 364 21 DNA Homo sapiens 364 cccactgccg mttctatgag g 21 365 21
DNA Homo sapiens 365 tcatctcccg mtttgagggc t 21 366 21 DNA Homo
sapiens 366 acctgtgttc wcaaagatgg c 21 367 21 DNA Homo sapiens 367
actcaagcta ygaggaaaag a 21 368 21 DNA Homo sapiens 368 ggggtactgg
racatccgcg g 21 369 21 DNA Homo sapiens 369 gattgatggg rctcacaaga t
21 370 21 DNA Homo sapiens 370 cccagagcaa ygccatcctg c 21 371 21
DNA Homo sapiens 371 gtatatttga scccaagtgc c 21 372 21 DNA Homo
sapiens 372 caacaagcct rtatgctgag c 21 373 21 DNA Homo sapiens 373
ggctttcatg kgccgttttg a 21 374 21 DNA Homo sapiens 374 cagagcaatg
mcatcttgcg c 21 375 21 DNA Homo sapiens 375 tggacgcctt yccaaatctg a
21 376 21 DNA Homo sapiens 376 tggggctgga racggccgga g 21 377 21
DNA Homo sapiens 377 ggccggggac rcccacctgg g 21 378 21 DNA Homo
sapiens 378 tcagcgaggc sgacaagaag a 21 379 21 DNA Homo sapiens 379
acaaggggga saccaaggca t 21 380 21 DNA Homo sapiens 380 agctgctgca
rgacttcttc a 21 381 21 DNA Homo sapiens 381 attcctccga rgtcttttgt t
21 382 21 DNA Homo sapiens 382 gacgccttcc yaaacttgaa g 21 383 21
DNA Homo sapiens 383 ttggaaagtc rgctacatgg a 21 384 21 DNA Homo
sapiens 384 ctctcggcta ygaactgttt g 21 385 21 DNA Homo sapiens 385
ggactgccat rgaccaggcc c 21 386 21 DNA Homo sapiens 386 caggtgttgg
rgccactcat t 21 387 21 DNA Homo sapiens 387 tgttggggcc mctcattggg g
21 388 21 DNA Homo sapiens 388 ccaggtgccc raggagaagg t 21 389 21
DNA Homo sapiens 389 ccgcgttgac yctctggaga c 21 390 21 DNA Homo
sapiens 390 tggaccacta yaagaagggg a 21 391 21 DNA Homo sapiens 391
tcatcgtggt ygccctgtat g 21 392 21 DNA Homo sapiens 392 ccattcacca
ygaagacctc a 21 393 21 DNA Homo sapiens 393 ccctggccac scggaaggag g
21 394 21 DNA Homo sapiens 394 ccagcgccag yccacactgt c 21 395 21
DNA Homo sapiens 395 ccacgaagac ytcagcttcc a 21 396 21 DNA Homo
sapiens 396 gtgaattaag rgaaataatg a 21 397 21 DNA Homo sapiens 397
gactgtgtga wttccctgat a 21 398 21 DNA Homo sapiens 398 agatatggat
yaggtggaaa a 21 399 21 DNA Homo sapiens 399 gacagtttga wctgactact t
21 400 21 DNA Homo sapiens 400 tcagctagat rctgttgtca g 21 401 21
DNA Homo sapiens 401 gagtttctgg kctgagctca a 21 402 21 DNA Homo
sapiens 402 gcacgcgcac rcccgcaggg t 21 403 21 DNA Homo sapiens 403
catcccgaat ycaggcatca c 21 404 21 DNA Homo sapiens 404 gcgtggtccg
yttcgccatg c 21 405 21 DNA Homo sapiens 405 attttgccat kgttctgctc a
21 406 21 DNA Homo sapiens 406 ctgccatggg yagctccgtg c 21 407 21
DNA Homo sapiens 407 ccctcgaacc ygagacagca g 21 408 21 DNA Homo
sapiens 408 ctgctggttg yactgtcagt g 21 409 21 DNA Homo sapiens 409
caccgttcac sttgctttgg c 21 410 21 DNA Homo sapiens 410 tctactgaag
rgcattctgg c 21 411 21 DNA Homo sapiens 411 ccatcagcaa ygtcacagcc t
21 412 21 DNA Homo sapiens 412 aaatactttt ytttctacaa c 21 413 21
DNA Homo sapiens 413 ggacactctc rtcttttgct g 21 414 21 DNA Homo
sapiens 414 aagcactatg ytcctttcct c 21 415 21 DNA Homo sapiens 415
tcttcatggc ygcgttaatc c 21 416 21 DNA Homo sapiens 416 ggacatggaa
raagacatct t 21 417 21 DNA Homo sapiens 417 tgacattggc ratgcagctg a
21 418 21 DNA Homo sapiens 418 cggaaaatga rtgccaggca g 21 419 21
DNA Homo sapiens 419 tcataatgca ytaaaaacct c 21 420 21 DNA Homo
sapiens 420 ccactgtgac wttggcaatg c 21 421 21 DNA Homo sapiens 421
gtcgctgact yggagagctc a 21 422 21 DNA Homo sapiens 422 gaagtgtata
rgaatcccaa t 21 423 21 DNA Homo sapiens 423 ttctggctga mcctgtggag a
21 424 21 DNA Homo sapiens 424 atctttacct saagatgaaa c 21 425 21
DNA Homo sapiens 425 ctctgccgta rttttgcccc t 21 426 21 DNA Homo
sapiens 426 atcctgggct ycattgggtc t 21 427 21 DNA Homo sapiens 427
ctgccgtagt yttgcccctg g 21 428 21 DNA Homo sapiens 428 agctggatgt
rcctgtggta a 21 429 21 DNA Homo sapiens 429 cggcttcggc ytctccaact a
21 430 21 DNA Homo sapiens 430 gccggggcca ygtgagattc c 21 431 21
DNA Homo sapiens 431 tgtacggctt yggcctctcc a 21 432 21 DNA Homo
sapiens 432 tgatgggcaa rcagctggag a 21 433 21 DNA Homo sapiens 433
gcaaagtccc ktttaacaaa a 21 434 21 DNA Homo sapiens 434 tggcatacat
ygagcggaag a 21 435 21 DNA Homo sapiens 435 aaaggcttgg ygctgggcag t
21 436 21 DNA Homo sapiens 436 agccacagaa rccatgggat a 21 437 21
DNA Homo sapiens 437 cctgctattt waaagacttc t 21 438 21 DNA Homo
sapiens 438 acaaagttga yttagaagag a 21 439 21 DNA Homo sapiens 439
tcatgagctt yggtatcctt a 21 440 21 DNA Homo sapiens 440 tcatgtaaca
raaaatcaaa t 21 441 21 DNA Homo sapiens 441 aaaaaatcaa rtgtaataga t
21 442 21 DNA Homo sapiens 442 ttaccatgta ragtaagtaa t 21 443 21
DNA Homo sapiens 443 gaacgataca rtagtcaaat g 21 444 21 DNA Homo
sapiens 444 tttagaggat kcaacactac a 21 445 21 DNA Homo sapiens 445
tttagacgtt wtatataaaa t 21 446 21 DNA Homo sapiens 446 agacgtttta
yataaaatga c 21 447 21 DNA Homo sapiens 447 ataccaggag yttcaattac t
21 448 21 DNA Homo sapiens 448 ttttctttct kaaaatcgat g 21 449 21
DNA Homo sapiens 449 ctcagaaatc ytgatgacgt c 21 450 21 DNA Homo
sapiens 450 ctgccaggct rcaagggcca a 21 451 21 DNA Homo sapiens 451
cacatgccag ygccaatccc c 21 452 21 DNA Homo sapiens 452 ggggctcagc
ygacggccct c 21 453 21 DNA Homo sapiens 453 gacccctcag ycgtgcctgt g
21 454 21 DNA Homo sapiens 454 ccggagccca rggactgcgt c 21 455 21
DNA Homo sapiens 455 acggatgcac wgggccaggt c 21 456 21 DNA Homo
sapiens 456 gcgccgctgc stggccgccc g 21 457 21 DNA Homo sapiens 457
ttggaattcc rggtcatgcc t 21 458 21 DNA Homo sapiens 458 aatcaactac
ycaggaaaaa c 21 459 21 DNA Homo sapiens 459
cctgaggttg yggaaaagga a 21 460 21 DNA Homo sapiens 460 agaagatgag
wttatgcctg a 21 461 21 DNA Homo sapiens 461 gagaggccgc racccaacac c
21 462 21 DNA Homo sapiens 462 tgttccagga rtccagtatc t 21 463 21
DNA Homo sapiens 463 agcttcagat ytgcccggcg a 21 464 21 DNA Homo
sapiens 464 gcagtggtcc rgcggccact c 21 465 21 DNA Homo sapiens 465
tcatggacaa sgtggtgcgg t 21 466 21 DNA Homo sapiens 466 ttgtgtcaga
wcccaaagct g 21 467 21 DNA Homo sapiens 467 aatattcagt yccaggcgcc a
21 468 21 DNA Homo sapiens 468 ctaaagaata rcccacctta t 21 469 21
DNA Homo sapiens 469 aactcatcct rgctacatgg c 21 470 21 DNA Homo
sapiens 470 tcgagaacct yatgagtcag g 21 471 21 DNA Homo sapiens 471
tctttccaag yggactcttt c 21 472 21 DNA Homo sapiens 472 ctctggatgg
ygatcctaca a 21 473 21 DNA Homo sapiens 473 ccggcactca yttccatttt c
21 474 21 DNA Homo sapiens 474 agcggcccag yttcagcacc a 21 475 21
DNA Homo sapiens 475 cccagcgggt yaagagtgac a 21 476 21 DNA Homo
sapiens 476 gaagcccctg yatgagcagc t 21 477 21 DNA Homo sapiens 477
gagaggaagc ygatggggtc t 21 478 21 DNA Homo sapiens 478 ctgctggcat
kgagtacctg g 21 479 21 DNA Homo sapiens 479 gatggtctgc yccggcactt c
21 480 21 DNA Homo sapiens 480 gtgacaaggc yaaggacaag t 21 481 21
DNA Homo sapiens 481 tgggcaccgg ytgcttcggg g 21 482 21 DNA Homo
sapiens 482 cagaagctac rgggcagcag a 21 483 21 DNA Homo sapiens 483
tggatcaaca raatcccgat g 21 484 21 DNA Homo sapiens 484 actacaacgt
ygatagaacc a 21 485 21 DNA Homo sapiens 485 ggccaatcca rtttgtggta c
21 486 21 DNA Homo sapiens 486 gtccaggctt ytaatgtaga t 21 487 21
DNA Homo sapiens 487 gcatcacaat ytgcagaaat c 21 488 21 DNA Homo
sapiens 488 aaattctcag sagctattat c 21 489 21 DNA Homo sapiens 489
aaccaatgca kcgacacctt t 21 490 21 DNA Homo sapiens 490 gacactgaag
ragctgtcag t 21 491 21 DNA Homo sapiens 491 ttctcttcag yagaatgatg a
21 492 21 DNA Homo sapiens 492 actgtgaagg wtctgctctg t 21 493 21
DNA Homo sapiens 493 aaaatcagag yaacttaaaa a 21 494 21 DNA Homo
sapiens 494 agtactgggg ytcctcagtc t 21 495 21 DNA Homo sapiens 495
gccagtctct stgcctcaat a 21 496 21 DNA Homo sapiens 496 attctgggac
kcccaaagac c 21 497 21 DNA Homo sapiens 497 ggagtgaccc rgtggagcaa g
21 498 21 DNA Homo sapiens 498 tccagaacca ytttgtggac g 21 499 21
DNA Homo sapiens 499 gcatacctca stggctacta a 21 500 21 DNA Homo
sapiens 500 ccatcttggt ygtgaagatc c 21 501 21 DNA Homo sapiens 501
agagccaggt rtcggagcag c 21 502 21 DNA Homo sapiens 502 gtcgccgggg
mccagcaaat a 21 503 21 DNA Homo sapiens 503 cctcccaaag ygctgggatt a
21 504 21 DNA Homo sapiens 504 gacgcagggt ytcccatgac c 21 505 21
DNA Homo sapiens 505 tatgatccat yttaactgag g 21 506 21 DNA Homo
sapiens 506 tgcaactcct rctattaaga c 21 507 21 DNA Homo sapiens 507
taccgtgtaa ygtgaaccag c 21 508 21 DNA Homo sapiens 508 ttctgctgct
ratggagcga g 21 509 21 DNA Homo sapiens 509 tgattcatga stgtcctcat c
21 510 21 DNA Homo sapiens 510 tagaggacat raacgagttc a 21 511 21
DNA Homo sapiens 511 gaattcagga ygttgtaccg t 21 512 21 DNA Homo
sapiens 512 actcatgaag yagcttaatg c 21 513 21 DNA Homo sapiens 513
tttatgacat saagcggggc t 21 514 21 DNA Homo sapiens 514 tggaagactt
ygagacgatt g 21 515 21 DNA Homo sapiens 515 aagacgcagt ytatcatgat g
21 516 21 DNA Homo sapiens 516 ttcaggcaaa ygagatcatg t 21 517 21
DNA Homo sapiens 517 tatgttgtat ytcgagagta a 21 518 21 DNA Homo
sapiens 518 tctcgacccc ygtggtgctc t 21 519 21 DNA Homo sapiens 519
ggctgtgggg rctacgcaag a 21 520 21 DNA Homo sapiens 520 aggcccaggc
rgtttggcac g 21 521 21 DNA Homo sapiens 521 gctgggacct sttccacaaa t
21 522 21 DNA Homo sapiens 522 tacatcccca rtcgtggccc t 21 523 21
DNA Homo sapiens 523 aaaacctcaa rgttataaag g 21 524 21 DNA Homo
sapiens 524 tgcattccag rgacacgtgg c 21 525 21 DNA Homo sapiens 525
gggagccatc rtaaggaccc a 21 526 21 DNA Homo sapiens 526 agcttgccag
yggcatcctc a 21 527 21 DNA Homo sapiens 527 cccatttgag magctgtgag c
21 528 21 DNA Homo sapiens 528 atgacctcag rgactttcca a 21 529 21
DNA Homo sapiens 529 gggacgcgaa stgcgcagcc a 21 530 21 DNA Homo
sapiens 530 aagcggtcta ytccagggat t 21 531 21 DNA Homo sapiens 531
cctattgatc rgaagtcagt c 21 532 21 DNA Homo sapiens 532 gagtggatct
yattgaagtt t 21 533 21 DNA Homo sapiens 533 tgccccctag ygactccgtg t
21 534 21 DNA Homo sapiens 534 gaaagcgcct raaactgacg a 21 535 21
DNA Homo sapiens 535 actcggggca yggcagcact t 21 536 21 DNA Homo
sapiens 536 tcgcaggaac rtgtggactc t 21 537 21 DNA Homo sapiens 537
cgtcctgaga yctcagaaag a 21 538 21 DNA Homo sapiens 538 ggactgctct
yaacacaagc g 21 539 21 DNA Homo sapiens 539 tgagctgttc sgatgctctg c
21 540 21 DNA Homo sapiens 540 catcccagac rcgggcagtc a 21 541 21
DNA Homo sapiens 541 ccttcggacc ycaggacgtc g 21 542 21 DNA Homo
sapiens 542 actagtaaaa rctggacctt c 21 543 21 DNA Homo sapiens 543
atatttgcga yaagtaggat a 21 544 21 DNA Homo sapiens 544 cacacaaggt
sgtgttatat t 21 545 21 DNA Homo sapiens 545 ttgaacacct ycctcgccgt g
21 546 21 DNA Homo sapiens 546 tttgtggcac yagcttggag c 21 547 21
DNA Homo sapiens 547 ttctatgaca yctaccatgc t 21 548 21 DNA Homo
sapiens 548 agaaagcaac ycaaagtggg a 21 549 21 DNA Homo sapiens 549
tctgcaacga rcgcttcact c 21 550 21 DNA Homo sapiens 550 agacacggga
stgcatctac t 21 551 21 DNA Homo sapiens 551 cctcacggat yacctcaagg g
21 552 21 DNA Homo sapiens 552 ggctcctgag rtgctcgagg g 21 553 21
DNA Homo sapiens 553 tgctgaagag ygacctcaca g 21 554 21 DNA Homo
sapiens 554 ccagagacag ygcgacccgg a 21 555 21 DNA Homo sapiens 555
acctggccat ygtccacgcc a 21 556 21 DNA Homo sapiens 556 agtgcttgac
wgacatttac c 21 557 21 DNA Homo sapiens 557 catgctggtc rtcctcatct t
21 558 21 DNA Homo sapiens 558 acatccacgc mgctcgaggg a 21 559 21
DNA Homo sapiens 559 ggtgctagtc ygcgccatca a 21 560 21 DNA Homo
sapiens 560 cacctacctg stctggacct g 21 561 21 DNA Homo sapiens 561
cggtacacag ygacaattga g 21 562 21 DNA Homo sapiens 562 gagcacgggt
ycctgtttga t 21 563 21 DNA Homo sapiens 563 cagagttatg wggcactgcg g
21 564 21 DNA Homo sapiens 564 tatattggga sattgctcga a 21 565 21
DNA Homo sapiens 565 gagatgtgtc yctccaaaga c 21 566 21 DNA Homo
sapiens 566 agctgtactt ycaacagtta t 21 567 21 DNA Homo sapiens 567
ggggaaacca rtgaaaagcg t 21 568 21 DNA Homo sapiens 568 tcacctgctg
ytataacttc a 21 569 21 DNA Homo sapiens 569 tgaaagaagt rgcaacgctg t
21 570 21 DNA Homo sapiens 570 gcatctctgc ygaagccaag g 21 571 21
DNA Homo sapiens 571 tgaccagcct ycgccgctcg g 21 572 21 DNA Homo
sapiens 572 cagagtgcaa rcgcagccac a 21 573 21 DNA Homo sapiens 573
ataacaaccc yatctggtca g 21 574 21 DNA Homo sapiens 574 tgaagctctt
ytttggtggc c 21 575 21 DNA Homo sapiens 575 cggcgggagg yactgaggag g
21 576 21 DNA Homo sapiens 576 gcagctcttc rccaatgggg a 21 577 21
DNA Homo sapiens 577 tcactgtcca rgtgcccagc a 21 578 21 DNA Homo
sapiens 578 gactggccag mccagcctca g 21 579 21 DNA Homo sapiens 579
ggcttctgca kacagtcaag c 21 580 21 DNA Homo sapiens 580 ttttacaaat
ragcagagaa t 21 581 21 DNA Homo sapiens 581 gctgtgtttc sggatgcaag c
21 582 21 DNA Homo sapiens 582 cagtaacatg ygcatctact g 21 583 21
DNA Homo sapiens 583 agcgccaggc mccgagcagt g 21 584 21 DNA Homo
sapiens 584 ggtggctggc rtcctggttc t 21 585 21 DNA Homo sapiens 585
tgaagccgga rgacagtggc a 21 586 21 DNA Homo sapiens 586 ctgcatgatc
ktcgggagcc c 21 587 21 DNA Homo sapiens 587 tctgggattc ygcaaaaggg a
21 588 21 DNA Homo sapiens 588 gagtggccat scacctgtgc t 21 589 21
DNA Homo sapiens 589 ttgtagcccc rtcacccttg g 21 590 21 DNA Homo
sapiens 590 ctgtgtgtga ygtgcatggg a 21 591 21 DNA Homo sapiens 591
ggtggtaacc rtcgggctag a 21 592 21 DNA Homo sapiens 592 ctgatgggat
sctatggaac c 21 593 21 DNA Homo sapiens 593 atgatgccat ygatgccctc g
21 594 21 DNA Homo sapiens 594 ctgtctctgg ytggccaaag g 21 595 21
DNA Homo sapiens 595 agaaagggat macctgccgc a 21 596 21 DNA Homo
sapiens 596 agaggccgca ygtcggatct c 21 597 21 DNA Homo sapiens 597
ccgtttgcct rcctcgtcca g 21 598 21 DNA Homo sapiens 598 gtttgactgt
rgaccagctg c 21 599 21 DNA Homo sapiens 599 gtgtctgaga ractccggac c
21 600 21 DNA Homo sapiens 600 gggactaaga sctgggaaga a 21 601 21
DNA Homo sapiens 601 tctccgatga yacactcttt c 21 602 21 DNA Homo
sapiens 602 gctgctctcc yggagatggc a 21 603 21 DNA Homo sapiens 603
gtggccttct ycaccaatgg g 21 604 21 DNA Homo sapiens 604 acagccctcc
rtgtgctacc t 21 605 21 DNA Homo sapiens 605 tgcctggaac yttggctggg c
21 606 21 DNA Homo sapiens 606 agattcactc rggctctgtc a 21 607 21
DNA Homo sapiens 607 ccattgctgc yttcttgccg g 21 608 21 DNA Homo
sapiens 608 tggccaataa matcttggcc a 21 609 21 DNA Homo sapiens 609
atgacggaca ratttgccca g 21 610 21 DNA Homo sapiens 610 agcagcttcg
katggcaatg a 21 611 21 DNA Homo sapiens 611 tcacgagggc rgagcaggtg g
21 612 21 DNA Homo sapiens 612 ggcgcagcat ycggcttttc a 21 613 21
DNA Homo sapiens 613 gcccctcacc rtatcagcct t 21 614 21 DNA Homo
sapiens 614 tcagggcgct ytgtgacaga g 21 615 21 DNA Homo sapiens 615
caaggtggca ycattagtct t 21 616 21 DNA Homo sapiens 616 tttcgaagtt
ycttaccaac c 21 617 21 DNA Homo sapiens 617 ctccagcatg sgaagtcggt g
21 618 21 DNA Homo sapiens 618 acagtgcaac rgctgatgct g 21 619 21
DNA Homo sapiens 619 gtctgagaga ytccggaccc t 21 620 21 DNA Homo
sapiens 620 ggagggccct ytggagcgcc c 21 621 21 DNA Homo sapiens 621
tggttgtcgg ktgctgcaga c 21 622 21 DNA Homo sapiens 622 agctgctgac
rcggccacac a 21 623 21 DNA Homo sapiens 623 tagtgagcca rcaccacatc t
21 624 21 DNA Homo sapiens 624 catcgatggg rctgataggt t 21 625 21
DNA Homo sapiens 625 tgagtgggat sgtggaaggg a 21 626 21 DNA Homo
sapiens 626 gtggaaggga racacacttg g 21 627 21 DNA Homo sapiens 627
gaggggaaga raatgaggtg t 21 628 21 DNA Homo sapiens 628 aagaaatata
yacttgagtg g 21 629 21 DNA Homo sapiens 629 tgatcgctat stagcaaccc t
21 630 21 DNA Homo sapiens 630 tcttaaaatt sacatggacc a 21 631 21
DNA Homo sapiens 631 cactgggagt ygccatatct g 21 632 21 DNA Homo
sapiens 632 agattatgag yctccatttg g 21 633 21 DNA Homo sapiens 633
tgggaactgc ragatacatg g 21 634 21 DNA Homo sapiens 634 tactccagtt
sctgacggct g 21 635 21 DNA Homo sapiens 635 tcgtgaagaa ygacctaacc t
21 636 21 DNA Homo sapiens 636 tgtcatcatc mtcttctact g 21 637 21
DNA Homo sapiens 637 cctccacagt ratcacactc c 21 638 21 DNA Homo
sapiens 638 cctgtctgac ratcctggac t
21 639 21 DNA Homo sapiens 639 gaagccacag racttgcact t 21 640 21
DNA Homo sapiens 640 agataaataa yggcggctgt t 21 641 21 DNA Homo
sapiens 641 gggtggatgt yttcacccaa c 21 642 21 DNA Homo sapiens 642
ctgagacgta yggaccccag t 21 643 21 DNA Homo sapiens 643 tggttatggg
mcaaatggat g 21 644 21 DNA Homo sapiens 644 tctgggttat saaaactgaa a
21 645 21 DNA Homo sapiens 645 gcctttcact yacaccaggc a 21 646 21
DNA Homo sapiens 646 gcaaggtgcc rggaaacttc a 21 647 21 DNA Homo
sapiens 647 agaggagtgc rtctccctca c 21 648 21 DNA Homo sapiens 648
caggtatctt rgaagttttg c 21 649 21 DNA Homo sapiens 649 tagaagccat
ygtcagcagt g 21 650 21 DNA Homo sapiens 650 acatgggagg ycctgaaact c
21 651 21 DNA Homo sapiens 651 tactatattg ratttcggta c 21 652 21
DNA Homo sapiens 652 agaagacgct rtccattttc a 21 653 21 DNA Homo
sapiens 653 atcgtggaga rcggcggggc a 21 654 21 DNA Homo sapiens 654
gggcctcacg ytctttgcag t 21 655 21 DNA Homo sapiens 655 tgaaaatggc
yttggaggca g 21 656 21 DNA Homo sapiens 656 aggagacgac yttctacacg c
21 657 21 DNA Homo sapiens 657 ggtgtgcctg rcatgggcct g 21 658 21
DNA Homo sapiens 658 catgttgcca ragccaacgt c 21 659 21 DNA Homo
sapiens 659 ctatgtctgc sgagtcagca t 21 660 21 DNA Homo sapiens 660
agggcacggg ytccgaggcg t 21 661 21 DNA Homo sapiens 661 cctcactgcc
kccagccctc t 21 662 21 DNA Homo sapiens 662 acagccaaga mctgggaact c
21 663 21 DNA Homo sapiens 663 acctgcacct kcgctgcagc g 21 664 21
DNA Homo sapiens 664 cctggctcta ytctcctgga c 21 665 21 DNA Homo
sapiens 665 tcctgaatcc ytggattact g 21 666 21 DNA Homo sapiens 666
gccactgaag racaggcaaa t 21 667 21 DNA Homo sapiens 667 cgctgaagac
rccccacggg g 21 668 21 DNA Homo sapiens 668 agagctgccc ragaagctcc c
21 669 21 DNA Homo sapiens 669 tccgagaggc racaaggttt g 21 670 21
DNA Homo sapiens 670 ccagtgtgga mgaactaaag g 21 671 21 DNA Homo
sapiens 671 tcttcagggg rcccaatggt g 21 672 21 DNA Homo sapiens 672
gttccttttg matttctccc g 21 673 21 DNA Homo sapiens 673 ccagggcctg
ygggtagagt c 21 674 21 DNA Homo sapiens 674 tcaagaacca yacagagatc g
21 675 21 DNA Homo sapiens 675 tgcaattcaa rgatggtaca g 21 676 21
DNA Homo sapiens 676 cggcgcagac racactggtg g 21 677 21 DNA Homo
sapiens 677 atgggcacaa ygtgtgggcc c 21 678 21 DNA Homo sapiens 678
gcatctttgg ygatgaggat g 21 679 21 DNA Homo sapiens 679 gctcgctgct
yatcgtgcag a 21 680 21 DNA Homo sapiens 680 agcctgagtg yttcggaccc g
21 681 21 DNA Homo sapiens 681 accacaaggc rtccatggtg c 21 682 21
DNA Homo sapiens 682 cagacgcccc rgctgtggtc a 21 683 21 DNA Homo
sapiens 683 tccaaagaag raggaagctg g 21 684 21 DNA Homo sapiens 684
acatcccagc rcgccgaaac c 21 685 21 DNA Homo sapiens 685 tgaagatcgc
rcagggtgtc t 21 686 21 DNA Homo sapiens 686 cccctacagg yatgtggtgg t
21 687 21 DNA Homo sapiens 687 tgaacatgat yctcccggac t 21 688 21
DNA Homo sapiens 688 gcaggccatc ycggaggcag g 21 689 21 DNA Homo
sapiens 689 ggcctgcctg yggctgacct g 21 690 21 DNA Homo sapiens 690
gcagctgcct yaatgactgc c 21 691 21 DNA Homo sapiens 691 gttcgaatgt
kagaacctct a 21 692 21 DNA Homo sapiens 692 tgaccagttt yccgcacatg g
21 693 21 DNA Homo sapiens 693 ctgacatcta ygtgctaggc t 21 694 21
DNA Homo sapiens 694 tgcgggcacg scagatgcac c 21 695 21 DNA Homo
sapiens 695 tgctggcaat ygctgtggac c 21 696 21 DNA Homo sapiens 696
tggcaattgc kgtggaccgc t 21 697 21 DNA Homo sapiens 697 cctagatctc
rggagttaat g 21 698 21 DNA Homo sapiens 698 tctcctctgt ycccataggt t
21 699 21 DNA Homo sapiens 699 ttgatgtgga yggcaaccga a 21 700 21
DNA Homo sapiens 700 atcaccatgg yctgcggctc c 21 701 21 DNA Homo
sapiens 701 tggacgaggt mcagaccgga g 21 702 21 DNA Homo sapiens 702
attatgatgg rcctctgatg a 21 703 21 DNA Homo sapiens 703 tgttctcgaa
rgaatgccaa g 21 704 21 DNA Homo sapiens 704 gcctaaacct stgtgaaccc a
21 705 21 DNA Homo sapiens 705 taccaggaaa yctgtggagg a 21 706 21
DNA Homo sapiens 706 tggccaggta yggtgtgaag c 21 707 21 DNA Homo
sapiens 707 tgaggtggca ytggcgtatg c 21 708 21 DNA Homo sapiens 708
tgagtgaaaa yggagcattc c 21 709 21 DNA Homo sapiens 709 ctctggtccc
rtatctggta g 21 710 21 DNA Homo sapiens 710 caggccccta yggcgccaac a
21 711 21 DNA Homo sapiens 711 gacaaggact kgaatatttt c 21 712 21
DNA Homo sapiens 712 aagagcatga yaaggcctgc g 21 713 21 DNA Homo
sapiens 713 cagtgacccg kcctctgtct c 21 714 21 DNA Homo sapiens 714
ttgatttgga yaattctggt t 21 715 21 DNA Homo sapiens 715 atgtgtgact
yttatcagag a 21 716 21 DNA Homo sapiens 716 caccacaaca ygcagacctt c
21 717 21 DNA Homo sapiens 717 gtgctccggc rcgcctggac t 21 718 21
DNA Homo sapiens 718 tgtgctccgg ygcgcctgga c 21 719 21 DNA Homo
sapiens 719 gcaaagctcc rccacaacat g 21 720 21 DNA Homo sapiens 720
agttatcatc rtccaagttt a 21 721 21 DNA Homo sapiens 721 gctggccttc
rcgaccacac t 21 722 21 DNA Homo sapiens 722 ctgctgccca ygggtcacac c
21 723 21 DNA Homo sapiens 723 gctccaggcg ktgcttgttc c 21 724 21
DNA Homo sapiens 724 cagaggtttg ytgggactcc c 21 725 21 DNA Homo
sapiens 725 ggatctggag ygagtggagt g 21 726 21 DNA Homo sapiens 726
cgatgggacc rggacaggcc g 21 727 21 DNA Homo sapiens 727 gggacaggcc
rtggaagtgg a 21 728 21 DNA Homo sapiens 728 ccagaacctg sagtgcttct t
21 729 21 DNA Homo sapiens 729 ccccacagcc mgagggcctc c 21 730 21
DNA Homo sapiens 730 gccgtggaga mggtgaacat c 21 731 21 DNA Homo
sapiens 731 ctgctgaacc kcctggcaga c 21 732 21 DNA Homo sapiens 732
tatggcccaa sagcaggtgc g 21 733 21 DNA Homo sapiens 733 gcccgggaag
ycttccgcct g 21 734 21 DNA Homo sapiens 734 accctaccac yggggaggtc a
21 735 21 DNA Homo sapiens 735 gggaggtcat ygggcacgtg g 21 736 21
DNA Homo sapiens 736 cggggtatgg yccaacagca g 21 737 21 DNA Homo
sapiens 737 cgcccagcac rtggatgttg a 21 738 21 DNA Homo sapiens 738
ccctcatcaa sgaggcaggc t 21 739 21 DNA Homo sapiens 739 tgccacagac
rattttgcgg a 21 740 21 DNA Homo sapiens 740 accagcctga rgtgtctcag g
21 741 21 DNA Homo sapiens 741 cagaccatgg ygtgtgacat c 21 742 21
DNA Homo sapiens 742 tatattggca ygggctatta t 21 743 21 DNA Homo
sapiens 743 gtgccacaga sgattttgcg g 21 744 21 DNA Homo sapiens 744
ctgcatgcca yttcaagcaa a 21 745 21 DNA Homo sapiens 745 ggaaatttct
ygttgatccc c 21 746 21 DNA Homo sapiens 746 cattgtggct rctcagtgaa g
21 747 21 DNA Homo sapiens 747 aaactgaaca rttcgtctga a 21 748 21
DNA Homo sapiens 748 gacaggtcta yctagacggg g 21 749 21 DNA Homo
sapiens 749 ggtgggaatc wgtcgccctg g 21 750 21 DNA Homo sapiens 750
ttagtcctct stccctaagt t 21 751 21 DNA Homo sapiens 751 tggtgtatgt
stctgactcc g 21 752 21 DNA Homo sapiens 752 tgcctagtgg ycattggcag a
21 753 21 DNA Homo sapiens 753 acctcacttc rtggtggtcc a 21 754 21
DNA Homo sapiens 754 ttgctggtac wcttctatcc a 21 755 21 DNA Homo
sapiens 755 ttacccacga satgaggcag g 21 756 21 DNA Homo sapiens 756
cccccagtcc scggtgatgc a 21 757 21 DNA Homo sapiens 757 ggcaagaaga
rcttcgagac t 21 758 21 DNA Homo sapiens 758 tacgataaga wgcaaacgtg g
21 759 21 DNA Homo sapiens 759 ccactcaaac ytttcaacaa a 21 760 21
DNA Homo sapiens 760 tggcgggcaa ygtgctggtg t 21 761 21 DNA Homo
sapiens 761 gcagcctgcc rgagatcgac a 21 762 21 DNA Homo sapiens 762
tcctggctgc rgtcaccacc a 21 763 21 DNA Homo sapiens 763 aaggagcctg
ycggggagaa c 21 764 21 DNA Homo sapiens 764 agaccaaggc yggccgcatc a
21 765 21 DNA Homo sapiens 765 gccgccgctc rgatgaggac t 21 766 21
DNA Homo sapiens 766 actatggact yacagcagcc g 21 767 21 DNA Homo
sapiens 767 ataaaaagag ygaatagcac c 21 768 21 DNA Homo sapiens 768
atagccagtg sagtgctgga g 21 769 21 DNA Homo sapiens 769 accctaccgc
yttcgttgtc a 21 770 21 DNA Homo sapiens 770 cctgccggga sttgccttgt t
21 771 21 DNA Homo sapiens 771 tggtggtcct stcctctctt g 21 772 21
DNA Homo sapiens 772 tagtatttca kgtatgctgc t 21 773 21 DNA Homo
sapiens 773 agagtcccag rcccggccgg g 21 774 21 DNA Homo sapiens 774
aacatcatgt ytcgggtaac a 21 775 21 DNA Homo sapiens 775 ggtcaccctg
rtcaccctgc c 21 776 21 DNA Homo sapiens 776 ccaaaccgcc yagatgtctt a
21 777 21 DNA Homo sapiens 777 cttgcggtga ragcgaattc c 21 778 21
DNA Homo sapiens 778 tgcttaagga rcattccata c 21 779 21 DNA Homo
sapiens 779 agccaaatat sagcgatggc t 21 780 21 DNA Homo sapiens 780
ctgaagttta raatgggtat c 21 781 21 DNA Homo sapiens 781 tttaagaaaa
rtggattgat t 21 782 21 DNA Homo sapiens 782 tctgcgctgt wcctcaggtg t
21 783 21 DNA Homo sapiens 783 cccgcaggga rttgcgtggt g 21 784 21
DNA Homo sapiens 784 aaggagatcc rctacccacc c 21 785 21 DNA Homo
sapiens 785 tgccgggcgc rcctctcgct g 21 786 21 DNA Homo sapiens 786
gtgccgccga rgaaaaagtg c 21 787 21 DNA Homo sapiens 787 gttatcttgc
wgagatctct g 21 788 21 DNA Homo sapiens 788 tgcaaaatat ycaggagacc g
21 789 21 DNA Homo sapiens 789 tggagttgat ytttcagtgc t 21 790 21
DNA Homo sapiens 790 tctactggct stctaactaa t 21 791 21 DNA Homo
sapiens 791 ttgtcaaggc wgaatattac t 21 792 21 DNA Homo sapiens 792
ggtcccgatg yacaccttgc a 21 793 21 DNA Homo sapiens 793 aagaagtaat
kgcaccgtct c 21 794 21 DNA Homo sapiens 794 tcgctgtcat rttcctggct a
21 795 21 DNA Homo sapiens 795 ggcatctaca rctgcattca t 21 796 21
DNA Homo sapiens 796 ctatgtattc yagggacaac a 21 797 21 DNA Homo
sapiens 797 ggacattgac racatggcgg g 21 798 21 DNA Homo sapiens 798
aggtgtccaa rctggagtgg c 21 799 21 DNA Homo sapiens 799 ggtcacccgc
raggtgaccg t 21 800 21 DNA Homo sapiens 800 gaccagccca wgttgttggg c
21 801 21 DNA Homo sapiens 801 ttggcatggt kgtaatccat a 21 802 21
DNA Homo sapiens 802 aaatggtata waattcaaaa t 21 803 21 DNA Homo
sapiens 803 ttatctacca stgcttctca a 21 804 21 DNA Homo sapiens 804
attgatcaaa rccaatcttt g 21 805 21 DNA Homo sapiens 805 atttaaggac
ragaccagca g 21 806 21 DNA Homo sapiens 806 caagtcaaca ytggatattg t
21 807 21 DNA Homo sapiens 807 tgcatgtgat yaagcgagat g 21 808 21
DNA Homo sapiens 808 caacacagct mgatatgtgg a 21 809 21 DNA Homo
sapiens 809 gaagattgca magtatggta t 21 810 21 DNA Homo sapiens 810
gagtatgaaa satgacagca t 21 811 21 DNA Homo sapiens 811 tcagcactgg
saatccctga a 21 812 21 DNA Homo sapiens 812 tcgctgcgcc kccactatgc t
21 813 21 DNA Homo sapiens 813 ttgacctctc saaggacatt c 21 814 21
DNA Homo sapiens 814 ccttgatggc rtatatttca g 21 815 21 DNA Homo
sapiens 815 ctgtagaccg yggcttcttc a 21 816 21 DNA Homo sapiens 816
tcagaactag ygagacgggc a 21 817 21 DNA Homo sapiens 817 ggggtgatca
raagaaagct c
21 818 21 DNA Homo sapiens 818 caattgtggc yattgcatca t 21 819 21
DNA Homo sapiens 819 tggtggacaa ygagctgcct g 21 820 21 DNA Homo
sapiens 820 tgaatcttag ygtgacaact c 21 821 21 DNA Homo sapiens 821
ctgaatacaa yaacttcaag t 21 822 21 DNA Homo sapiens 822 agctgcgcta
yggcgaagac g 21 823 21 DNA Homo sapiens 823 tgggccagtc ygctcgagat g
21 824 21 DNA Homo sapiens 824 tgcctgactt ygatgtggcc c 21 825 21
DNA Homo sapiens 825 cccagagcac rgtggtggca g 21 826 21 DNA Homo
sapiens 826 ctgtgtcttc stgatctgca g 21 827 21 DNA Homo sapiens 827
tggataagac ycgagctttg a 21 828 21 DNA Homo sapiens 828 gatgctatta
rgaaagccca c 21 829 21 DNA Homo sapiens 829 cccagatata ytacaactca a
21 830 21 DNA Homo sapiens 830 aactatctat raaaagccaa a 21 831 21
DNA Homo sapiens 831 aactattggg waatgtgttc a 21 832 21 DNA Homo
sapiens 832 aatctgttca rtacagggat t 21 833 21 DNA Homo sapiens 833
ctgtcagatt rtagcaatga a 21 834 21 DNA Homo sapiens 834 tatagagata
yacggaattc c 21 835 21 DNA Homo sapiens 835 ttgaagggcc raggagatct g
21 836 21 DNA Homo sapiens 836 gggccaagga ratctgttga a 21 837 21
DNA Homo sapiens 837 acatttttga ycctgagcaa a 21 838 21 DNA Homo
sapiens 838 aagttgcctt ytgatccaga t 21 839 21 DNA Homo sapiens 839
aattaaaaag watgatcatt g 21 840 21 DNA Homo sapiens 840 aggtctttgg
yaataaactc t 21 841 21 DNA Homo sapiens 841 ttcatatcaa ratcatcagt g
21 842 21 DNA Homo sapiens 842 tgaatgtttg yagcctggat a 21 843 21
DNA Homo sapiens 843 ctcatcacca rtgacaatac t 21 844 21 DNA Homo
sapiens 844 ttgatgacat ytttaaaata g 21 845 21 DNA Homo sapiens 845
tagaaatggc rgacacagtc c 21 846 21 DNA Homo sapiens 846 tgacatcttt
waaatagcgg t 21 847 21 DNA Homo sapiens 847 tctgtcatct yggctcatca c
21 848 21 DNA Homo sapiens 848 gagggctgcc yggaacgtct c 21 849 21
DNA Homo sapiens 849 atgggagcca ygtggactac a 21 850 21 DNA Homo
sapiens 850 ggcttgaata ytgcctcaag g 21 851 21 DNA Homo sapiens 851
tcagtgcgga yaactataca c 21 852 21 DNA Homo sapiens 852 catgccttct
yccaccttcg g 21 853 21 DNA Homo sapiens 853 agtggctatc rggagtttgt a
21 854 21 DNA Homo sapiens 854 tgttataatg sacaagccat a 21 855 21
DNA Homo sapiens 855 cctgagtgtc rtctatcggg a 21 856 21 DNA Homo
sapiens 856 ttttaatgca ygatgtagct t 21 857 21 DNA Homo sapiens 857
tcctcgtggg yctcagcggg g 21 858 21 DNA Homo sapiens 858 agtcaagcat
yctgggcctg c 21 859 21 DNA Homo sapiens 859 gcctccgtgt stcccaccga g
21 860 21 DNA Homo sapiens 860 acgatcgccc kgccagagat a 21 861 21
DNA Homo sapiens 861 aggaggtggc ragaggcgtg c 21 862 21 DNA Homo
sapiens 862 cattgccatt rttctgaggt t 21 863 21 DNA Homo sapiens 863
ccagtgcaag mttcttcttc a 21 864 21 DNA Homo sapiens 864 ctactaataa
wgacgatgat a 21 865 21 DNA Homo sapiens 865 ttccccagat rgctggctgg g
21 866 21 DNA Homo sapiens 866 atacagacta yttcttcccc a 21 867 21
DNA Homo sapiens 867 tcagagggtc rtcacacaca a 21 868 21 DNA Homo
sapiens 868 ggaagcccca mcaaattcca g 21 869 21 DNA Homo sapiens 869
ctggagacaa ragcccacag a 21 870 21 DNA Homo sapiens 870 cctcttgatg
rtctttgtgg c 21 871 21 DNA Homo sapiens 871 atcatggtgc ytggctgcca g
21 872 21 DNA Homo sapiens 872 aaagtccaat scagccagtg g 21 873 21
DNA Homo sapiens 873 acgatgaccc rccagagatc c 21 874 21 DNA Homo
sapiens 874 aaatgaccca ygggaagaca a 21 875 21 DNA Homo sapiens 875
agccccagct matatgcaca g 21 876 21 DNA Homo sapiens 876 ctggtagtag
sccctcagtg c 21 877 21 DNA Homo sapiens 877 cctgccagtg ycctcaccgg t
21 878 21 DNA Homo sapiens 878 tgatgctgag yttgaaactg g 21 879 21
DNA Homo sapiens 879 cacgtgattg rcaagttcct a 21 880 21 DNA Homo
sapiens 880 cttcgagccc rcgtgattga c 21 881 21 DNA Homo sapiens 881
gctggcgggc raatacgcag a 21 882 21 DNA Homo sapiens 882 actgatgtcc
rtcctttgta t 21 883 21 DNA Homo sapiens 883 ccttactgaa rgtttctagt t
21 884 21 DNA Homo sapiens 884 ctgttctccc raaaccagac t 21 885 21
DNA Homo sapiens 885 ccagaagaca rtgaaagtca c 21 886 21 DNA Homo
sapiens 886 ttaagaacat rgcttcccat c 21 887 21 DNA Homo sapiens 887
tacattctaa rcattggagc a 21 888 21 DNA Homo sapiens 888 gtttgcacac
rgaacaccta t 21 889 21 DNA Homo sapiens 889 accctccaat yattgctcga t
21 890 21 DNA Homo sapiens 890 gagaattatc rcttccatgc a 21 891 21
DNA Homo sapiens 891 tgacagtaca rgaatttgct c 21 892 21 DNA Homo
sapiens 892 tttttcacca kctttgatga g 21 893 21 DNA Homo sapiens 893
accacaattc yagaaaatga c 21 894 21 DNA Homo sapiens 894 tgcaagtgga
yttccagaag a 21 895 21 DNA Homo sapiens 895 cagagaatat mcaacgcttt c
21 896 21 DNA Homo sapiens 896 gagaatatac macgctttct c 21 897 21
DNA Homo sapiens 897 cgcctttctt matcatccag a 21 898 21 DNA Homo
sapiens 898 tcggcatgtt ygcgtcggcc t 21 899 21 DNA Homo sapiens 899
gcctggccga yctggccgtg g 21 900 21 DNA Homo sapiens 900 tctctccgcc
rgtcccgacg c 21 901 21 DNA Homo sapiens 901 agactctgca rcagcccgcg c
21 902 21 DNA Homo sapiens 902 ccttgaatag mtgctgtaat c 21 903 21
DNA Homo sapiens 903 tgtaatccct rgatatacat g 21 904 21 DNA Homo
sapiens 904 aatatcctgt rgaaaaacta a 21 905 21 DNA Homo sapiens 905
ttgtggaagc rgatacccca g 21 906 21 DNA Homo sapiens 906 ctcttccaga
yatttgttat c 21 907 21 DNA Homo sapiens 907 ctctgaagac wtggagatac t
21 908 21 DNA Homo sapiens 908 ctcatacgca rcctcaatgt c 21 909 21
DNA Homo sapiens 909 agcgactgca wcttcctccc g 21 910 21 DNA Homo
sapiens 910 agtgcaacat maattagcag a 21 911 21 DNA Homo sapiens 911
aaggacttat ytggagacaa a 21 912 21 DNA Homo sapiens 912 tgaggggtct
rgagggaaac t 21 913 21 DNA Homo sapiens 913 ggttctctgg mccctgcatt c
21 914 21 DNA Homo sapiens 914 aaaggagcga wcccacaatg t 21 915 21
DNA Homo sapiens 915 cgcactggct rgcctgcatc t 21 916 21 DNA Homo
sapiens 916 acttcacctt yagcagcctc a 21 917 21 DNA Homo sapiens 917
ccggccgcat ygccgtccac t 21 918 21 DNA Homo sapiens 918 ccctcatgta
ygctagcatc t 21 919 21 DNA Homo sapiens 919 ccctgctctg rtcaccaccc g
21 920 21 DNA Homo sapiens 920 accagcttac rcacaccgag g 21 921 21
DNA Homo sapiens 921 gtggagagac yctgcatagc t 21 922 21 DNA Homo
sapiens 922 gagccatctt mcagcctgtt t 21 923 21 DNA Homo sapiens 923
tattccatat rttaaagaaa g 21 924 21 DNA Homo sapiens 924 cagaagaaac
yagtacgtgt a 21 925 21 DNA Homo sapiens 925 tgggaacgtt kcaatgaatt a
21 926 21 DNA Homo sapiens 926 acatggcttc rgacatcctg c 21 927 21
DNA Homo sapiens 927 gcacaagagg mggcttccgg a 21 928 21 DNA Homo
sapiens 928 atgacatgga ygaggaggac t 21 929 21 DNA Homo sapiens 929
agttttccgg ragtccctac a 21 930 21 DNA Homo sapiens 930 gctcccccta
ytattatagc g 21 931 21 DNA Homo sapiens 931 gtcctgcccc mctcatcagc a
21 932 21 DNA Homo sapiens 932 tggcctctcc rgcagagtca g 21 933 21
DNA Homo sapiens 933 catagagggt yccaggtccc c 21 934 21 DNA Homo
sapiens 934 ccggacagga rgtgcattcc c 21 935 21 DNA Homo sapiens 935
atgcagccat ygaactgcct a 21 936 21 DNA Homo sapiens 936 aactctttca
ytgttgtttc a 21 937 21 DNA Homo sapiens 937 ccatggtgcc rgtggcaggc c
21 938 21 DNA Homo sapiens 938 actctgaagt rattcgttat g 21 939 21
DNA Homo sapiens 939 gttccaatgc rcatctgggc g 21 940 21 DNA Homo
sapiens 940 acttgctctg raaatgaatt c 21 941 21 DNA Homo sapiens 941
actccttatg scatcactgt t 21 942 21 DNA Homo sapiens 942 ttgcttggaa
racaatggtg g 21 943 21 DNA Homo sapiens 943 tacacaaaat rtcataattc a
21 944 21 DNA Homo sapiens 944 catctttgaa saccagttat a 21 945 21
DNA Homo sapiens 945 tcatggccac rgacccccag t 21 946 21 DNA Homo
sapiens 946 agtggctggc rgtgggcatg g 21 947 21 DNA Homo sapiens 947
ccatggcaga rttgaatgcc a 21 948 21 DNA Homo sapiens 948 atcgccaaga
rattgaatac g 21 949 21 DNA Homo sapiens 949 gccacacaga yggagccagc t
21 950 21 DNA Homo sapiens 950 ccgcctgcta ygccctggcc a 21 951 21
DNA Homo sapiens 951 acaaatacat ygtgacaggc t 21 952 21 DNA Homo
sapiens 952 cggacagcgt ygccctgagg a 21 953 21 DNA Homo sapiens 953
ctgagttgtg wcatctccag a 21 954 21 DNA Homo sapiens 954 tgtcaccctc
sgaaagcctc c 21 955 21 DNA Homo sapiens 955 tggacaacac rgtgcgctcc t
21 956 21 DNA Homo sapiens 956 acctggcctc rcccacgccc c 21 957 21
DNA Homo sapiens 957 ggcttcgcca rcgccaacct g 21 958 21 DNA Homo
sapiens 958 cagcgccaac ytgcagggca g 21 959 21 DNA Homo sapiens 959
gccgtggata ycggcgtccc t 21 960 21 DNA Homo sapiens 960 agtggtttta
ygaatatggg a 21 961 21 DNA Homo sapiens 961 gagagaagcc stacgaatgt g
21 962 21 DNA Homo sapiens 962 agccagcagt ygcagctggt t 21 963 21
DNA Homo sapiens 963 gaggcagcgg ycccgggcct g 21 964 21 DNA Homo
sapiens 964 taaaagagag rgcggattcc c 21 965 21 DNA Homo sapiens 965
cccttcgacc mgtcgggttt g 21 966 21 DNA Homo sapiens 966 cactgcttac
rttgccatga t 21 967 21 DNA Homo sapiens 967 ctctaaaaga sagggcggat t
21 968 21 DNA Homo sapiens 968 tgtggagact ygcagacatc g 21 969 21
DNA Homo sapiens 969 tggtgccact kggacccgaa t 21 970 21 DNA Homo
sapiens 970 aaaagactca rtacttggcc t 21 971 21 DNA Homo sapiens 971
gtgccttcaa rgaaccttcc a 21 972 21 DNA Homo sapiens 972 gctgcagcaa
rcaatatgac a 21 973 21 DNA Homo sapiens 973 ggccaaactc rgcgcccacc a
21 974 21 DNA Homo sapiens 974 agtcgcacga yaaactgcgg c 21 975 21
DNA Homo sapiens 975 acttcgaacc ygagaggcct t 21 976 21 DNA Homo
sapiens 976 caggttctct rctcgcagta g 21 977 21 DNA Homo sapiens 977
tgactccttc kagcaccctt t 21 978 21 DNA Homo sapiens 978 ttatgcgaat
rctttatttt c 21 979 21 DNA Homo sapiens 979 gggactcgga yttggcggcc g
21 980 21 DNA Homo sapiens 980 agaccctgga rctggagaag g 21 981 21
DNA Homo sapiens 981 tcagactcag rgaaaactgc g 21 982 21 DNA Homo
sapiens 982 ggcgtgaaca rtcctcgagc a 21 983 21 DNA Homo sapiens 983
atggagctgg rgcccgacaa c 21 984 21 DNA Homo sapiens 984 gcgagctctg
ygaccagtgc t 21 985 21 DNA Homo sapiens 985 gcctgccccg yattgaggca g
21 986 21 DNA Homo sapiens 986 ctggatcgca rgcaacatct a 21 987 21
DNA Homo sapiens 987 aaggcaccaa ygtgtgcgcg g 21 988 21 DNA Homo
sapiens 988 ggctgaagga ygacggccgg a 21 989 21 DNA Homo sapiens 989
actgcatgga yggctcagat g 21 990 21 DNA Homo sapiens 990 acccgacctg
yggccccagt g 21 991 21 DNA Homo sapiens 991 ccctgcgctg yaacatgttc g
21 992 21 DNA Homo sapiens 992 gaccagtatg rgaagccggg t 21 993 21
DNA Homo sapiens 993 agaagcgcat yctttggatt g 21 994 21 DNA Homo
sapiens 994 ttggccgtgt sgagggcatt g 21 995 21 DNA Homo sapiens 995
ctgtcggcat ygacttccac g 21 996 21 DNA Homo sapiens 996 acgcctcaga
ygagatgaac t 21 997 21 DNA
Homo sapiens 997 acggcagcga ygaggaggcc t 21 998 21 DNA Homo sapiens
998 acgtctttga rgattacatc t 21 999 21 DNA Homo sapiens 999
acggatctga ygaggcccct g 21 1000 21 DNA Homo sapiens 1000 gccgccttgt
ytactgggca g 21 1001 21 DNA Homo sapiens 1001 gatgcctatc kggactatat
t 21 1002 21 DNA Homo sapiens 1002 caccagctac ytcattggcc g 21 1003
21 DNA Homo sapiens 1003 gatggctcca rgaggatcac c 21 1004 21 DNA
Homo sapiens 1004 ctctgacgag rtcccttgca a 21 1005 21 DNA Homo
sapiens 1005 gtgcgcaccg rgaaagcggc c 21 1006 21 DNA Homo sapiens
1006 tggggatcca rcctccaaaa g 21 1007 21 DNA Homo sapiens 1007
ataagggagc rtgaggagtc t 21 1008 21 DNA Homo sapiens 1008 atcttcaatt
rtgggttcct t 21 1009 21 DNA Homo sapiens 1009 agagaaggct rtgcagcttg
c 21 1010 21 DNA Homo sapiens 1010 tgtaccagac rcccttgcac t 21 1011
21 DNA Homo sapiens 1011 agctgcagct stataagtta c 21 1012 21 DNA
Homo sapiens 1012 aacagccccg kaagtggcac c 21 1013 21 DNA Homo
sapiens 1013 cgccaaatga ktcagctggc a 21 1014 21 DNA Homo sapiens
1014 ctcaccctaa raacacacag c 21 1015 21 DNA Homo sapiens 1015
gtgccgaggg rcggccacac t 21 1016 21 DNA Homo sapiens 1016 tccgtttcct
ygagagcctg c 21 1017 21 DNA Homo sapiens 1017 ggattaagaa rgcagccgaa
g 21 1018 21 DNA Homo sapiens 1018 tccaagaaga ygaaattcca g 21 1019
21 DNA Homo sapiens 1019 agtggagcgt ygccgccgag a 21 1020 21 DNA
Homo sapiens 1020 cccttgtcat ygagttcacc g 21 1021 21 DNA Homo
sapiens 1021 tggcggccca maagtacctg c 21 1022 21 DNA Homo sapiens
1022 ggacggtcat ygattacaac g 21 1023 21 DNA Homo sapiens 1023
aacattgcaa yggcattttg a 21 1024 21 DNA Homo sapiens 1024 taggcccttc
yggctttgga c 21 1025 21 DNA Homo sapiens 1025 cctcgtcgtc rtcttcagac
a 21 1026 21 DNA Homo sapiens 1026 tctcttctgt stcacacaca g 21 1027
21 DNA Homo sapiens 1027 gttaaaacat kgcaatggca t 21 1028 21 DNA
Homo sapiens 1028 ctggggccga ygaagatgac a 21 1029 21 DNA Homo
sapiens 1029 cttggccgac rgctggcccc g 21 1030 21 DNA Homo sapiens
1030 cagagtacag ygagccccac g 21 1031 21 DNA Homo sapiens 1031
agactgctct ygaggctcat a 21 1032 21 DNA Homo sapiens 1032 ctctgtctgc
ratgctctta g 21 1033 21 DNA Homo sapiens 1033 ggggactcca katgaaagga
g 21 1034 21 DNA Homo sapiens 1034 gcttttccca yctaccccca a 21 1035
21 DNA Homo sapiens 1035 tctggagatc yatatgaggt c 21 1036 21 DNA
Homo sapiens 1036 agaccttgcc rgctcagcta c 21 1037 21 DNA Homo
sapiens 1037 caaggtttac rgactaccag c 21 1038 21 DNA Homo sapiens
1038 gaagaccaac mctccccagc a 21 1039 21 DNA Homo sapiens 1039
tccaacctcc mcaatgaaca c 21 1040 21 DNA Homo sapiens 1040 ccctgcaggc
ygcgttgact t 21 1041 21 DNA Homo sapiens 1041 ccaacagacg mctattcgga
g 21 1042 21 DNA Homo sapiens 1042 tggtgtggtt ycagaatgcc c 21 1043
21 DNA Homo sapiens 1043 accaggcttt wctccttatt a 21 1044 21 DNA
Homo sapiens 1044 gcagcctgtc rgaggacgag t 21 1045 21 DNA Homo
sapiens 1045 gccttccaga rgaggacgag g 21 1046 21 DNA Homo sapiens
1046 ctctactgcc rtccactttg a 21 1047 21 DNA Homo sapiens 1047
cgttgcgcta rccctgctcg t 21 1048 21 DNA Homo sapiens 1048 agaaatatga
rcaggcatgt a 21 1049 21 DNA Homo sapiens 1049 gtaacttcag yaaacaggcc
a 21 1050 21 DNA Homo sapiens 1050 cctgcgaggc ygtgatgatc c 21 1051
21 DNA Homo sapiens 1051 gaggccagat stacagccca c 21 1052 21 DNA
Homo sapiens 1052 acgcatggtg rgcatcatcc a 21 1053 21 DNA Homo
sapiens 1053 gtaacttcag yaaacaggcc a 21 1054 21 DNA Homo sapiens
1054 agaagtatga rcaggcatgt a 21 1055 21 DNA Homo sapiens 1055
atggacggag scttgaagat g 21 1056 21 DNA Homo sapiens 1056 gggatgatga
ygcccacggt g 21 1057 21 DNA Homo sapiens 1057 ggcattgagc ytcccaaggg
c 21 1058 21 DNA Homo sapiens 1058 tgctggagct ygagagagac g 21 1059
21 DNA Homo sapiens 1059 tggagttcat sgccagcaag a 21 1060 21 DNA
Homo sapiens 1060 gggacctgct rcgtccacca g 21 1061 21 DNA Homo
sapiens 1061 acgacagttc yggggaaggg a 21 1062 21 DNA Homo sapiens
1062 tttgatgagt yccacgattt c 21 1063 21 DNA Homo sapiens 1063
atacgggtcc rcggcagctc t 21 1064 21 DNA Homo sapiens 1064 tcaggagcgc
rcaggggcag c 21 1065 21 DNA Homo sapiens 1065 ggggcagccc rccagcaagg
a 21 1066 21 DNA Homo sapiens 1066 tgtggcacta ygtccccctc c 21 1067
21 DNA Homo sapiens 1067 tcttgtcacc rcgtcaacac c 21 1068 21 DNA
Homo sapiens 1068 ttcttggtac yggacagtcc c 21 1069 21 DNA Homo
sapiens 1069 ttatccggca kcacaacatc c 21 1070 21 DNA Homo sapiens
1070 caaatccatg saccgcctag c 21 1071 21 DNA Homo sapiens 1071
ttgacagcat rtctaattcg c 21 1072 21 DNA Homo sapiens 1072 ccagctgata
rttcatcaac a 21 1073 21 DNA Homo sapiens 1073 caaagtcaac rgccagtcac
t 21 1074 21 DNA Homo sapiens 1074 cataggaata yggtcacaga a 21 1075
21 DNA Homo sapiens 1075 ttctgcagca rccatctgaa c 21 1076 21 DNA
Homo sapiens 1076 cagaactgag yaccttgtca c 21 1077 21 DNA Homo
sapiens 1077 tgaaacttta ytaaaatcaa g 21 1078 21 DNA Homo sapiens
1078 tcttctgtct rtaccttcac t 21 1079 21 DNA Homo sapiens 1079
gcggtctgca rcctcagatt c 21 1080 21 DNA Homo sapiens 1080 cctaaacata
rtgttaccat a 21 1081 21 DNA Homo sapiens 1081 tgggtcttct raaagtgagg
a 21 1082 21 DNA Homo sapiens 1082 ccgctctgta yacctggtac g 21 1083
21 DNA Homo sapiens 1083 gggccgagcc ygacaccaag c 21 1084 21 DNA
Homo sapiens 1084 ccagttctcc yagcagctgc a 21 1085 21 DNA Homo
sapiens 1085 gaatgagtgt ragttgcaga a 21 1086 21 DNA Homo sapiens
1086 cgccttcttc kcccgaggac a 21 1087 21 DNA Homo sapiens 1087
ccttggacca kctcatccag a 21 1088 21 DNA Homo sapiens 1088 ctgaggacaa
rgccaacaag a 21 1089 21 DNA Homo sapiens 1089 gtccctgtta yggctaccag
t 21 1090 21 DNA Homo sapiens 1090 tcatattcat yagaggaaat g 21 1091
21 DNA Homo sapiens 1091 tactccagag rtcaagtcca a 21 1092 21 DNA
Homo sapiens 1092 tgacatccta ygtgctcctc g 21 1093 21 DNA Homo
sapiens 1093 atatcaccat ygcccttctg g 21 1094 21 DNA Homo sapiens
1094 ccaagctcga kcctacatct t 21 1095 21 DNA Homo sapiens 1095
tcacactttc racagggaat t 21 1096 21 DNA Homo sapiens 1096 tttctggggg
rttcccaggt t 21 1097 21 DNA Homo sapiens 1097 agtgccggga rgaacccttg
g 21 1098 21 DNA Homo sapiens 1098 tggggaaaca saattcctca a 21 1099
21 DNA Homo sapiens 1099 ctcaccacaa ygacattgcc t 21 1100 21 DNA
Homo sapiens 1100 ggcctaaagc ygcttgtcca a 21 1101 21 DNA Homo
sapiens 1101 tgattaccca magaaggagg a 21 1102 21 DNA Homo sapiens
1102 acatcacaaa rcaacctgtg g 21 1103 21 DNA Homo sapiens 1103
catgcgtgtg ractcagaca a 21 1104 21 DNA Homo sapiens 1104 atgagaaagg
kttcattgaa a 21 1105 21 DNA Homo sapiens 1105 ggagatccac ycccgagaca
g 21 1106 21 DNA Homo sapiens 1106 ctcgcaacgt yctcctggca c 21 1107
21 DNA Homo sapiens 1107 tcagggagga rctggctgcc c 21 1108 21 DNA
Homo sapiens 1108 ccagaggata rctggctact c 21 1109 21 DNA Homo
sapiens 1109 gcctgcctca ygcaatggga a 21 1110 21 DNA Homo sapiens
1110 ctctgcgggg yttcccttca g 21 1111 21 DNA Homo sapiens 1111
atgcctctga ygaggcagcc c 21 1112 21 DNA Homo sapiens 1112 cttcaaaaga
raataacgtt t 21 1113 21 DNA Homo sapiens 1113 acagaatgtt yaacttcaag
c 21 1114 21 DNA Homo sapiens 1114 tgttttgtgg yaaaagattc a 21 1115
21 DNA Homo sapiens 1115 agcagctcac rgaggaactg a 21 1116 21 DNA
Homo sapiens 1116 ccagcacgcc stcgcccccc g 21 1117 21 DNA Homo
sapiens 1117 tgcacagcga rgggaagccc t 21 1118 21 DNA Homo sapiens
1118 tgttcggacc rgaagcaccc a 21 1119 21 DNA Homo sapiens 1119
atcctagacg scttcgagga g 21 1120 21 DNA Homo sapiens 1120 tgagcgacac
rgtggcgctg t 21 1121 21 DNA Homo sapiens 1121 tgcacagcac rtgcggaccg
g 21 1122 21 DNA Homo sapiens 1122 ttctgctcat yctagacgcc t 21 1123
21 DNA Homo sapiens 1123 tactctagag ragcctgttg g 21 1124 21 DNA
Homo sapiens 1124 gaaactccag ktcaaagact t 21 1125 21 DNA Homo
sapiens 1125 ctgcttgaat ycatgtatga r 21 1126 21 DNA Homo sapiens
1126 ccaacttcga ygctataaga g 21 1127 21 DNA Homo sapiens 1127
ttgaccttgt rcaaataaaa c 21 1128 21 DNA Homo sapiens 1128 gtcagaagtc
rgccctaatt g 21 1129 21 DNA Homo sapiens 1129 cccgacagct yattaagaaa
g 21 1130 21 DNA Homo sapiens 1130 acttctgtga ygtccagcgc t 21 1131
21 DNA Homo sapiens 1131 tgtgaatgcc ygcctggcca t 21 1132 21 DNA
Homo sapiens 1132 agatagctcc ktcctgtggc t 21 1133 21 DNA Homo
sapiens 1133 gatctgcaat matggacgct g 21 1134 21 DNA Homo sapiens
1134 gaactgcaca sacattgacg a 21 1135 21 DNA Homo sapiens 1135
tctgcatgaa ygggcgttgc g 21 1136 21 DNA Homo sapiens 1136 gcaaacacaa
yggaatgtgg c 21 1137 21 DNA Homo sapiens 1137 aagccagaca wtcagccctt
t 21 1138 21 DNA Homo sapiens 1138 ccactattgc ycatgtcctg c 21 1139
21 DNA Homo sapiens 1139 gcccaaagac rttctcataa t 21 1140 21 DNA
Homo sapiens 1140 gtgcctgggc ygcagaagtg a 21 1141 21 DNA Homo
sapiens 1141 cctgggggtg yctgggctgc a 21 1142 21 DNA Homo sapiens
1142 ttctttggcc rtggtgcgga g 21 1143 21 DNA Homo sapiens 1143
tatccagaga ytctttggcc a 21 1144 21 DNA Homo sapiens 1144 cttggtcctg
rgtgtcagca g 21 1145 21 DNA Homo sapiens 1145 ctgaccttca ycaagagcgc
c 21 1146 21 DNA Homo sapiens 1146 tatgcccgga maccatgaac a 21 1147
21 DNA Homo sapiens 1147 gttcatgctc rgcttcctcc g 21 1148 21 DNA
Homo sapiens 1148 ccataaaaag yataagccag c 21 1149 21 DNA Homo
sapiens 1149 cagcctggac ragagcccca t 21 1150 21 DNA Homo sapiens
1150 gggcatcagc wtctatgagg a 21 1151 21 DNA Homo sapiens 1151
actttgccaa ygtgcaggag c 21 1152 21 DNA Homo sapiens 1152 gggcggtgct
rcagaacacg t 21 1153 21 DNA Homo sapiens 1153 gttcttgctg raatggtcct
t 21 1154 21 DNA Homo sapiens 1154 aaggccaaca yagctgcagg c 21 1155
21 DNA Homo sapiens 1155 cagcaacatt rtcaagactg a 21 1156 21 DNA
Homo sapiens 1156 gggtgcagtt rgtctatgtg t 21 1157 21 DNA Homo
sapiens 1157 tttttgtgga yttccgtgag a 21 1158 21 DNA Homo sapiens
1158 caggccagga ratcactgaa a 21 1159 21 DNA Homo sapiens 1159
tcaacaacct ygtgaacgcc a 21 1160 21 DNA Homo sapiens 1160 agaagcacgt
ktgccacatc c 21 1161 21 DNA Homo sapiens 1161 tgtggtgaag ytgacaggtg
g 21 1162 21 DNA Homo sapiens 1162 cccactcccg yggcagcatg a 21 1163
21 DNA Homo sapiens 1163 tcggatgcaa rtccaggccc a 21 1164 21 DNA
Homo sapiens 1164 aaagagtttc rgtcagagtt c 21 1165 21 DNA Homo
sapiens 1165 aaactcttac rgccattgca g 21 1166 21 DNA Homo sapiens
1166 tagatgtagt saacaaccca g 21 1167 21 DNA Homo sapiens 1167
atttgcggga sggcaacatc a 21 1168 21 DNA Homo sapiens 1168 acagccggcc
ractttggag g 21 1169 21 DNA Homo sapiens 1169 tcttggatca sctgaactat
g 21 1170 21 DNA Homo sapiens 1170 caaaaagcct scatcagagc t 21 1171
21 DNA Homo sapiens 1171 ccacaatggt rtcagaggag g 21 1172 21 DNA
Homo sapiens 1172 agaggattta saggaagatg a
21 1173 21 DNA Homo sapiens 1173 acctgagccc ygaggagaag g 21 1174 21
DNA Homo sapiens 1174 tacattggcc mcaagacaaa g 21 1175 21 DNA Homo
sapiens 1175 tcacagccct ycggccaggg t 21 1176 21 DNA Homo sapiens
1176 cccagatgaa ygggaaaccc t 21 1177 21 DNA Homo sapiens 1177
ggctggccca rtgagaacct g 21 1178 21 DNA Homo sapiens 1178 gtgagaccga
yttccgccga t 21 1179 21 DNA Homo sapiens 1179 tgtcactgtc rgaactcagt
t 21 1180 21 DNA Homo sapiens 1180 agtggaaatg rcatccagtg c 21 1181
21 DNA Homo sapiens 1181 gcagtgccca yggcgagctg g 21 1182 21 DNA
Homo sapiens 1182 gagcagtatg mcagcaaggt t 21 1183 21 DNA Homo
sapiens 1183 caccaggtga yggtacagaa a 21 1184 21 DNA Homo sapiens
1184 gaagagccac kttcgtaccc a 21 1185 21 DNA Homo sapiens 1185
agctgtggaa rggcctttgc c 21 1186 21 DNA Homo sapiens 1186 agctgtcgca
ytcggacgag a 21 1187 21 DNA Homo sapiens 1187 ttcgattttc yaaagaacaa
c 21 1188 21 DNA Homo sapiens 1188 ggcgtgctga stgccctggg a 21 1189
21 DNA Homo sapiens 1189 ttataacgtt katgtagctg a 21 1190 21 DNA
Homo sapiens 1190 ctcggaactg rgactgaggc c 21 1191 21 DNA Homo
sapiens 1191 tctcacggat rgcaccatca c 21 1192 21 DNA Homo sapiens
1192 atctaatgac maaaagtgac a 21 1193 21 DNA Homo sapiens 1193
gatgatgaac rgtttgtccc a 21 1194 21 DNA Homo sapiens 1194 tcagcaagtc
ycttttatgg t 21 1195 21 DNA Homo sapiens 1195 gactggaagg saaagtcaaa
c 21 1196 21 DNA Homo sapiens 1196 ttacctcctg racatggacc g 21 1197
21 DNA Homo sapiens 1197 tcccagattt ycagtctgat a 21 1198 21 DNA
Homo sapiens 1198 ctggaaggca ragtcaaaca g 21 1199 21 DNA Homo
sapiens 1199 agagcatgtc maatgttcca t 21 1200 21 DNA Homo sapiens
1200 atctcaatcg rcacaagctc t 21 1201 21 DNA Homo sapiens 1201
aaaggagaca kgacggcagg a 21 1202 21 DNA Homo sapiens 1202 tgaagctcac
wctttataat c 21 1203 21 DNA Homo sapiens 1203 ctcaacagac rgcttccttg
a 21 1204 21 DNA Homo sapiens 1204 agagccagag ytctacctcg a 21 1205
21 DNA Homo sapiens 1205 gctcagacag rgaaccctga g 21 1206 21 DNA
Homo sapiens 1206 aaaagcctta ygtgtgccgg g 21 1207 21 DNA Homo
sapiens 1207 ctggggatcc rggcccaggg g 21 1208 21 DNA Homo sapiens
1208 gggaaaagcc ktatgtgtgc c 21 1209 21 DNA Homo sapiens 1209
cagctctaat yacacacaag c 21 1210 21 DNA Homo sapiens 1210 agcattgtat
rtggagaagt c 21 1211 21 DNA Homo sapiens 1211 cacagctcct ygctcagcca
g 21 1212 21 DNA Homo sapiens 1212 tcagccagca ygaaaggacg c 21 1213
21 DNA Homo sapiens 1213 agtcacagct ygtccctcac c 21 1214 21 DNA
Homo sapiens 1214 gcgaatccac rctggggaga a 21 1215 21 DNA Homo
sapiens 1215 caggagagaa rccctatgaa t 21 1216 21 DNA Homo sapiens
1216 aaagccgtat sggtgcaatg a 21 1217 21 DNA Homo sapiens 1217
caccaaacat yagcgaatcc a 21 1218 21 DNA Homo sapiens 1218 cctatgggcc
rttcaccacg g 21 1219 21 DNA Homo sapiens 1219 tccccaagtg ractcgcccc
g 21 1220 21 DNA Homo sapiens 1220 gagctggcct rtactttagc a 21 1221
21 DNA Homo sapiens 1221 tgctgtgggc rtaagcaccc t 21 1222 21 DNA
Homo sapiens 1222 tgagtcctct ktttcatcag c 21 1223 21 DNA Homo
sapiens 1223 aaacatcatt ygattgaaca c 21 1224 21 DNA Homo sapiens
1224 agatattcca waagagtagt t 21 1225 21 DNA Homo sapiens 1225
agagaaggga mtgctaagaa c 21 1226 21 DNA Homo sapiens 1226 tgccaacaga
ycagacagtg t 21 1227 21 DNA Homo sapiens 1227 ataactttag ytgctccctg
t 21 1228 21 DNA Homo sapiens 1228 cagttttacc rgtgggatca a 21 1229
21 DNA Homo sapiens 1229 cttgccaaca rtccaaaata g 21 1230 21 DNA
Homo sapiens 1230 acaagtatct statgccatg c 21 1231 21 DNA Homo
sapiens 1231 tgacgatgtc rgaaaccatg c 21 1232 21 DNA Homo sapiens
1232 gccattccca ygccaaaatg t 21 1233 21 DNA Homo sapiens 1233
agagtaccag stgttggtgg a 21 1234 10 DNA Homo sapiens 1234 attgttcccs
10 1235 21 DNA Homo sapiens 1235 tgctggcaga rtcagatgaa t 21 1236 21
DNA Homo sapiens 1236 tggccaaggc maaagctgtg a 21 1237 21 DNA Homo
sapiens 1237 aactgcctga rtgtcttaaa t 21 1238 21 DNA Homo sapiens
1238 tcgaaatgga scgtgcgttc c 21 1239 21 DNA Homo sapiens 1239
actgccccac sgtcattaac a 21 1240 21 DNA Homo sapiens 1240 ctgccccacc
rtcattaaca g 21 1241 21 DNA Homo sapiens 1241 aagagactat yacagccctc
t 21 1242 21 DNA Homo sapiens 1242 ccgccaccag yagtaccggg t 21 1243
21 DNA Homo sapiens 1243 ggagcgcaga stcggcaggc a 21 1244 21 DNA
Homo sapiens 1244 gccctcaagg rctgaaaata a 21 1245 21 DNA Homo
sapiens 1245 atgagtacga ygagcttcca g 21 1246 21 DNA Homo sapiens
1246 tcatgggtct rgatggggcc a 21 1247 21 DNA Homo sapiens 1247
ctcagatcca ytggacactt t 21 1248 21 DNA Homo sapiens 1248 cgcaggctga
rgtgggagta c 21 1249 21 DNA Homo sapiens 1249 aggccttgtc ycctttctat
t 21 1250 21 DNA Homo sapiens 1250 cttctaacga raccactttt g 21 1251
21 DNA Homo sapiens 1251 gcttacattc kgaattactt a 21 1252 21 DNA
Homo sapiens 1252 tggctcacta ygacaccacc g 21 1253 21 DNA Homo
sapiens 1253 tcatccccac rgtgctggac a 21 1254 21 DNA Homo sapiens
1254 ggcacccaat rgaagccatg c 21 1255 21 DNA Homo sapiens 1255
tcatgggcct rgcagtggtg c 21 1256 21 DNA Homo sapiens 1256 cgtcacgcag
saaagggacg a 21 1257 21 DNA Homo sapiens 1257 aggcctatgg saatggctac
t 21 1258 21 DNA Homo sapiens 1258 cactctctgg rtatgaagag c 21 1259
21 DNA Homo sapiens 1259 gcagaaacta ycagaggccg t 21 1260 21 DNA
Homo sapiens 1260 gcctccttca yggcctacag c 21 1261 21 DNA Homo
sapiens 1261 agatccagac rgagaggagg g 21 1262 21 DNA Homo sapiens
1262 gcatcatcga ygtaatcaca c 21 1263 21 DNA Homo sapiens 1263
atcatccata ygacgcagca c 21 1264 21 DNA Homo sapiens 1264 aaaattctcc
rttgaaggat t 21 1265 21 DNA Homo sapiens 1265 tcaccaagtg yttctctagc
a 21 1266 21 DNA Homo sapiens 1266 caatatcaag ygaaatattc a 21 1267
21 DNA Homo sapiens 1267 cagagaataa ycttcaattc c 21 1268 21 DNA
Homo sapiens 1268 ttctgacaag ygttgggtct a 21 1269 21 DNA Homo
sapiens 1269 ctatgaaaaa sgagaaaaat g 21 1270 21 DNA Homo sapiens
1270 tcatctactc sagcccaggc g 21 1271 21 DNA Homo sapiens 1271
ggagaactgg ytgtctgagt g 21 1272 21 DNA Homo sapiens 1272 tggagctcca
magaaggatg t 21 1273 21 DNA Homo sapiens 1273 cacctcccac rtcccggagg
t 21 1274 21 DNA Homo sapiens 1274 ctggacaggg ygacccgaga g 21 1275
21 DNA Homo sapiens 1275 caagagctac rtcatcgctg g 21 1276 21 DNA
Homo sapiens 1276 tggcacacat yctgggcatc c 21 1277 21 DNA Homo
sapiens 1277 ggggcatcaa ygtcctgctg a 21 1278 21 DNA Homo sapiens
1278 acatggccca rgggaagcac a 21 1279 21 DNA Homo sapiens 1279
ggacccggct yccgtccgtg a 21 1280 21 DNA Homo sapiens 1280 cacctttgtg
rtgataccaa c 21 1281 21 DNA Homo sapiens 1281 tctacctgga yggcaggtgt
g 21 1282 21 DNA Homo sapiens 1282 ggcaggatgc rtgtggttcc a 21 1283
21 DNA Homo sapiens 1283 gcgtgcccac ragtccggag g 21 1284 21 DNA
Homo sapiens 1284 agcagcgggc raggctcccc c 21 1285 21 DNA Homo
sapiens 1285 atgacagtgc rggaaagcag c 21 1286 21 DNA Homo sapiens
1286 atcacagaca stctggttgc a 21 1287 21 DNA Homo sapiens 1287
cactctccag sagctccgtg c 21 1288 21 DNA Homo sapiens 1288 gctgctgccg
scaacctaca a 21 1289 21 DNA Homo sapiens 1289 ctccagaaat rctgaggaac
a 21 1290 21 DNA Homo sapiens 1290 ttgctcgtgc sgtggacaca c 21 1291
21 DNA Homo sapiens 1291 aggacctgga sgtgattctc c 21 1292 21 DNA
Homo sapiens 1292 gcccctgaga rcaaggcctt c 21 1293 21 DNA Homo
sapiens 1293 tggcctcaac ygccaccaat g 21 1294 21 DNA Homo sapiens
1294 actgtaccat ragtggagtc c 21 1295 21 DNA Homo sapiens 1295
gctcgagtgt rccaaaacgt g 21 1296 21 DNA Homo sapiens 1296 gccagaacta
ygacctggag t 21 1297 21 DNA Homo sapiens 1297 tctcggaacc rccgttgcac
g 21 1298 21 DNA Homo sapiens 1298 aactttgtcc rctacgtcca g 21 1299
21 DNA Homo sapiens 1299 gccctaatgc yaacgtgcag g 21 1300 21 DNA
Homo sapiens 1300 ttaccagtga ygtcttccag g 21 1301 21 DNA Homo
sapiens 1301 acatggtgac ygtggagtac c 21 1302 21 DNA Homo sapiens
1302 caggagcaag ragttcatgg a 21 1303 21 DNA Homo sapiens 1303
cctgcagcgg ktgcgagaga t 21 1304 21 DNA Homo sapiens 1304 tcagcgaggc
mcagtccaaa g 21 1305 21 DNA Homo sapiens 1305 aaacaaggag yaggacctgg
a 21 1306 21 DNA Homo sapiens 1306 tcaccttggt yacatcttca c 21 1307
21 DNA Homo sapiens 1307 caggtgtgca rccagctgga g 21 1308 21 DNA
Homo sapiens 1308 accaaccaca ytgtgatgac c 21 1309 21 DNA Homo
sapiens 1309 tcactgccga ycagctcagg a 21 1310 21 DNA Homo sapiens
1310 catctacaac wtgataggat a 21 1311 21 DNA Homo sapiens 1311
tgaagaagct rgtatacctc t 21 1312 21 DNA Homo sapiens 1312 ttcttggcgg
yggccttgac a 21 1313 21 DNA Homo sapiens 1313 aggtccacgc rccactcagc
c 21 1314 21 DNA Homo sapiens 1314 gaggcaccac yatgtaccct g 21 1315
21 DNA Homo sapiens 1315 cgaggctgac ygagagcgag g 21 1316 21 DNA
Homo sapiens 1316 ggtgcccagc ygtgaccaga c 21 1317 21 DNA Homo
sapiens 1317 acaccgtcta yagcatggag c 21 1318 21 DNA Homo sapiens
1318 gatcttggca rgagacaaga a 21 1319 21 DNA Homo sapiens 1319
ggctgctctc rgagatccgg c 21 1320 21 DNA Homo sapiens 1320 tgctgctgcc
kgatgactac c 21 1321 21 DNA Homo sapiens 1321 tgtactaccg yggtgccaac
c 21 1322 21 DNA Homo sapiens 1322 agctggtctc ygaagccaag g 21 1323
21 DNA Homo sapiens 1323 agagtgtcat yggcagcgtg c 21 1324 21 DNA
Homo sapiens 1324 acgccagtga ygacggcagc g 21 1325 21 DNA Homo
sapiens 1325 cttgccaacc wggccgacct g 21 1326 21 DNA Homo sapiens
1326 tcatgggtga yggcctggcc a 21 1327 21 DNA Homo sapiens 1327
gacctctgcg sccggaaggt c 21 1328 21 DNA Homo sapiens 1328 gtgacgacgg
yagcggctcg g 21 1329 21 DNA Homo sapiens 1329 tgacctctgc rgccggaagg
t 21 1330 21 DNA Homo sapiens 1330 tctggcactt ygccgacaac c 21 1331
21 DNA Homo sapiens 1331 gctccgtggc ycaggttgtg c 21 1332 21 DNA
Homo sapiens 1332 ccctcatcct sgtgatgttt g 21 1333 21 DNA Homo
sapiens 1333 tgtgtgccca ygaggagctc c 21 1334 21 DNA Homo sapiens
1334 ccatacacag kccttgcaaa c 21 1335 21 DNA Homo sapiens 1335
ggagatctgt kttcgtacag t 21 1336 21 DNA Homo sapiens 1336 tggctgctgt
ycatgccgaa a 21 1337 21 DNA Homo sapiens 1337 cccggggcag yggtgtcaat
g 21 1338 21 DNA Homo sapiens 1338 acgagctgat rgtgcgccgc g 21 1339
21 DNA Homo sapiens 1339 gctggaggtg wcagtcactt a 21 1340 21 DNA
Homo sapiens 1340 ggtggcagtc mcagaatgat g 21 1341 21 DNA Homo
sapiens 1341 cttcatctac ytgtggactg a 21 1342 21 DNA Homo sapiens
1342 gaggctactg yaatcgctac c 21 1343 21 DNA Homo sapiens 1343
gaccaggcag wtgattaggg c 21 1344 21 DNA Homo sapiens 1344 tttctccgag
yttcatctac c 21 1345 21 DNA Homo sapiens 1345 cacggccatg ytgatcgctg
c 21 1346 21 DNA Homo sapiens 1346 agtgtgatcc rgatggggca g 21 1347
21 DNA Homo sapiens 1347 ctatggagac rtggccacag g 21 1348 21 DNA
Homo sapiens 1348 ggctgtgaac ygtgtgcctg c
21 1349 21 DNA Homo sapiens 1349 cctgacagga ytggagaagc g 21 1350 21
DNA Homo sapiens 1350 tgctgcgctc rgcggacctg a 21 1351 21 DNA Homo
sapiens 1351 tggagcagga kaagcaccgg c 21 1352 21 DNA Homo sapiens
1352 cgtttggcag rgcagccagg c 21 1353 21 DNA Homo sapiens 1353
ggtcccaatg rgcaaggagc c 21 1354 21 DNA Homo sapiens 1354 ccacagagat
ycctgacttc a 21 1355 21 DNA Homo sapiens 1355 tttgggatga ytccagctgc
c 21 1356 21 DNA Homo sapiens 1356 ttcaggctta yggtatgaag c 21 1357
21 DNA Homo sapiens 1357 agattgacaa rttcgagttt g 21 1358 21 DNA
Homo sapiens 1358 gcaaagtcgg ygggcgctgg a 21 1359 21 DNA Homo
sapiens 1359 ggagctctgg sagaccctgc a 21 1360 21 DNA Homo sapiens
1360 gattctcctc rggcatcaca g 21 1361 21 DNA Homo sapiens 1361
ttgagttcca ytgtgctgtg c 21 1362 21 DNA Homo sapiens 1362 aatgctatga
yagctcccca t 21 1363 21 DNA Homo sapiens 1363 tggctgtgcc ygaggaaacc
g 21 1364 21 DNA Homo sapiens 1364 gtgccgctgg yggccagcat c 21 1365
21 DNA Homo sapiens 1365 ggacagccac rcggtgctgc a 21 1366 21 DNA
Homo sapiens 1366 caaagaaatc rattcagtcg g 21 1367 21 DNA Homo
sapiens 1367 atctaaacag yctgcctcac a 21 1368 21 DNA Homo sapiens
1368 ctaaggttgt rtctcagtat c 21 1369 21 DNA Homo sapiens 1369
tacagcgtgg ygaagacgga t 21 1370 21 DNA Homo sapiens 1370 attattgctg
mccggaagca g 21 1371 21 DNA Homo sapiens 1371 agatgtcctt rctggctaca
a 21 1372 21 DNA Homo sapiens 1372 agagagttaa kgccctggag g 21 1373
21 DNA Homo sapiens 1373 aacttcacca raacatggca a 21 1374 21 DNA
Homo sapiens 1374 tcgatgtggc rggcaacctg g 21 1375 21 DNA Homo
sapiens 1375 ttcaccatgt ytctgaacct g 21 1376 21 DNA Homo sapiens
1376 gaggtggacc rgatgttcca g 21 1377 21 DNA Homo sapiens 1377
tcgagaacct rcggcggcga t 21 1378 21 DNA Homo sapiens 1378 tcgctggcat
rctggcagta g 21 1379 21 DNA Homo sapiens 1379 aacccaacac rccatttgcc
g 21 1380 21 DNA Homo sapiens 1380 actcgtactc sttccgggtc t 21 1381
21 DNA Homo sapiens 1381 agagagggag sctcggagtg g 21 1382 21 DNA
Homo sapiens 1382 ctgtcgacga yccctacgcc a 21 1383 21 DNA Homo
sapiens 1383 gaaagatgag ytttgccgtc a 21 1384 21 DNA Homo sapiens
1384 atgacttggc ytccctcagt g 21 1385 21 DNA Homo sapiens 1385
aagatcctaa yctggtgaat g 21 1386 21 DNA Homo sapiens 1386 gctgctactt
ygacatcgag t 21 1387 21 DNA Homo sapiens 1387 gaaatatacc rtaagtatgg
a 21 1388 21 DNA Homo sapiens 1388 gtataataaa ytcctggagt t 21 1389
21 DNA Homo sapiens 1389 agcagcctta rgcatcttgg a 21 1390 21 DNA
Homo sapiens 1390 tcaaccagct ktctgtgcct t 21 1391 21 DNA Homo
sapiens 1391 aaaaaggcaa wactgttcct g 21 1392 21 DNA Homo sapiens
1392 tttttaatta yatttactcc a 21 1393 21 DNA Homo sapiens 1393
ttagtaaaac yggagctgaa g 21 1394 21 DNA Homo sapiens 1394 gctcattggc
rtcaacctga t 21 1395 21 DNA Homo sapiens 1395 ctgtccatgt kccagttcag
c 21 1396 21 DNA Homo sapiens 1396 actacaacac rtccagcaaa g 21 1397
21 DNA Homo sapiens 1397 ctggtcccca rgggcattgg t 21 1398 21 DNA
Homo sapiens 1398 cagcctcctc rgagacctcc a 21 1399 21 DNA Homo
sapiens 1399 aatccaccga yggaagccgc a 21 1400 21 DNA Homo sapiens
1400 ccggcaaacc ygacagccag t 21 1401 21 DNA Homo sapiens 1401
tctcggacac ygtggctttt g 21 1402 21 DNA Homo sapiens 1402 gctgcgttct
yttccgcact c 21 1403 21 DNA Homo sapiens 1403 ctggattacg ytgcgttctc
t 21 1404 21 DNA Homo sapiens 1404 gagtgcactt ycctatcccg c 21 1405
21 DNA Homo sapiens 1405 agaagacgtt yaccaagccc c 21 1406 21 DNA
Homo sapiens 1406 aatttctcca ycaattttcc a 21 1407 21 DNA Homo
sapiens 1407 tgtgtgaact ktcacctgtc a 21 1408 21 DNA Homo sapiens
1408 ctgatgagct yctgtttagc c 21 1409 21 DNA Homo sapiens 1409
agctacggat yctgctggac c 21 1410 21 DNA Homo sapiens 1410 tcttgaagtg
maaaaagtct g 21 1411 21 DNA Homo sapiens 1411 cctcctgagc yacggatcct
g 21 1412 21 DNA Homo sapiens 1412 atgttgaggt rtctgttact a 21 1413
21 DNA Homo sapiens 1413 ctctgcgcgg ytttttgagc g 21 1414 21 DNA
Homo sapiens 1414 agacagcgat ygcctcggag g 21 1415 21 DNA Homo
sapiens 1415 accttctgga rtggattgaa c 21 1416 21 DNA Homo sapiens
1416 agctcgaggc ygagaattac c 21 1417 21 DNA Homo sapiens 1417
acatcaagaa ygagatcgac a 21 1418 21 DNA Homo sapiens 1418 ccaagcacat
ygcggaagag g 21 1419 21 DNA Homo sapiens 1419 aaggccagac katgccccta
t 21 1420 21 DNA Homo sapiens 1420 ccaacaaagc kgttaagggc a 21 1421
21 DNA Homo sapiens 1421 ctatggagtc ytcagatgag g 21 1422 21 DNA
Homo sapiens 1422 gggtccattg mccatgcatc t 21 1423 21 DNA Homo
sapiens 1423 atgaccacac rtcagaaaag t 21 1424 21 DNA Homo sapiens
1424 tccatccagc rtctcctccc c 21 1425 21 DNA Homo sapiens 1425
agggtgaaca yataagggaa a 21 1426 21 DNA Homo sapiens 1426 ccatcctgaa
rgaggagggt g 21 1427 21 DNA Homo sapiens 1427 tgatcctaaa saaagagatg
a 21 1428 21 DNA Homo sapiens 1428 ccatctcccc ratggtgatg g 21 1429
21 DNA Homo sapiens 1429 gggatgaaga ygcctgggcc a 21 1430 21 DNA
Homo sapiens 1430 aagcacagcg rtggattgat a 21 1431 21 DNA Homo
sapiens 1431 gccagggtgg ytacaaagat a 21 1432 21 DNA Homo sapiens
1432 gaattcttca rtccttaaaa c 21 1433 21 DNA Homo sapiens 1433
ttagacctgc mgaaatcctg a 21 1434 21 DNA Homo sapiens 1434 agtgttctag
mtattctgaa a 21 1435 21 DNA Homo sapiens 1435 cttttggcaa ygtggagcct
g 21 1436 21 DNA Homo sapiens 1436 ctctggaaca rctcctaatt c 21 1437
21 DNA Homo sapiens 1437 aaccttatta ytttatgtga g 21 1438 21 DNA
Homo sapiens 1438 attagatgac yttgttgaaa c 21 1439 21 DNA Homo
sapiens 1439 gtggtcccag rtgcacttcc t 21 1440 21 DNA Homo sapiens
1440 cagacaagtg yaatatgatt a 21 1441 21 DNA Homo sapiens 1441
agatgacttt rttgaaacgg g 21 1442 21 DNA Homo sapiens 1442 atgcctccaa
raaagatggg g 21 1443 21 DNA Homo sapiens 1443 ggaactttgc rtactgggct
g 21 1444 21 DNA Homo sapiens 1444 ccgaggaggc yactggcgtc g 21 1445
21 DNA Homo sapiens 1445 gctgctgctg ytcttcgtag g 21 1446 21 DNA
Homo sapiens 1446 ccataacctg mtgacatttc a 21 1447 21 DNA Homo
sapiens 1447 agctggaggt raagatccgt g 21 1448 21 DNA Homo sapiens
1448 acaggacaat ygaggagctg c 21 1449 21 DNA Homo sapiens 1449
ggaggaggcc racactgagc t 21 1450 21 DNA Homo sapiens 1450 ctggctgctg
mtgacttccg c 21 1451 21 DNA Homo sapiens 1451 atcgattgca stcagagcct
g 21 1452 21 DNA Homo sapiens 1452 gtcctatcag yactgagagg c 21 1453
21 DNA Homo sapiens 1453 acacccggga rctgtttctc a 21 1454 21 DNA
Homo sapiens 1454 acctgaagag ygtgatgctg c 21 1455 21 DNA Homo
sapiens 1455 tcgaggagaa stctggcatg g 21 1456 21 DNA Homo sapiens
1456 agttccacag raaataccgg a 21 1457 21 DNA Homo sapiens 1457
cctccttcct rcgggcaccc a 21 1458 21 DNA Homo sapiens 1458 ccagccgcct
ytttgaccag t 21 1459 21 DNA Homo sapiens 1459 ggatcccagc ygatgtagac
c 21 1460 21 DNA Homo sapiens 1460 tagagttggc rttggaaaca t 21 1461
21 DNA Homo sapiens 1461 tatttagtag ygaaaccaaa t 21 1462 21 DNA
Homo sapiens 1462 tcattatcac rcaaggtaac t 21 1463 21 DNA Homo
sapiens 1463 cggtcagtgg yttccagcca g 21 1464 21 DNA Homo sapiens
1464 catgctgatg rtcacacacc t 21 1465 21 DNA Homo sapiens 1465
agcctcctga wgctgatggt g 21 1466 21 DNA Homo sapiens 1466 tacatcaact
ytttggagat g 21 1467 21 DNA Homo sapiens 1467 gctttgccta yattgcccgc
c 21 1468 21 DNA Homo sapiens 1468 gtcactggga ytgctgtagc g 21 1469
21 DNA Homo sapiens 1469 gggagtacac rtgccagact g 21 1470 21 DNA
Homo sapiens 1470 tacacgctgt wctcatccaa g 21 1471 21 DNA Homo
sapiens 1471 ttacgtccat rctttatcat c 21 1472 21 DNA Homo sapiens
1472 gagtgtcctg rctcctttta c 21 1473 21 DNA Homo sapiens 1473
gccagcaagg wcttctctcc g 21 1474 21 DNA Homo sapiens 1474 ccagggaaag
rcgcttactt g 21 1475 21 DNA Homo sapiens 1475 accgtgtgtg rctgcaggaa
g 21 1476 21 DNA Homo sapiens 1476 ttattggagt raaaaccttt t 21 1477
21 DNA Homo sapiens 1477 tgctaaagct ragagggctg c 21 1478 21 DNA
Homo sapiens 1478 caggctgcag rcagttcagc g 21 1479 21 DNA Homo
sapiens 1479 tgcccagctc yaggagggac a 21 1480 21 DNA Homo sapiens
1480 gaacaacatt rcttatgggc t 21 1481 21 DNA Homo sapiens 1481
aaggggctga ygtttaccct a 21 1482 21 DNA Homo sapiens 1482 tgcacttggg
kgtgcagatg c 21 1483 21 DNA Homo sapiens 1483 gtacctgctc rtaaggaggg
t 21 1484 21 DNA Homo sapiens 1484 tgctcagcaa ygtgggagct g 21 1485
21 DNA Homo sapiens 1485 cccgcctggt kcagcagcgg c 21 1486 21 DNA
Homo sapiens 1486 tgataaggtg rtggcggctg c 21 1487 21 DNA Homo
sapiens 1487 gccaatcaaa kgagggctca c 21 1488 21 DNA Homo sapiens
1488 ccgcccaccc rggcccggag t 21 1489 21 DNA Homo sapiens 1489
accgccacgt ygcagatggg g 21 1490 21 DNA Homo sapiens 1490 acaaaaaact
yatcatgtat t 21 1491 21 DNA Homo sapiens 1491 atcacatgaa ragagcaact
c 21 1492 21 DNA Homo sapiens 1492 agaattgtca kaattgtccc t 21 1493
21 DNA Homo sapiens 1493 gtgcccggct sctgaaagcc g 21 1494 21 DNA
Homo sapiens 1494 ggctgtctgt rgagaccctg g 21 1495 21 DNA Homo
sapiens 1495 acacagtctt ygctcccaca a 21 1496 21 DNA Homo sapiens
1496 gtaatagcct ytgcattgag a 21 1497 21 DNA Homo sapiens 1497
gctgaccaat raggccaccc t 21 1498 21 DNA Homo sapiens 1498 tgcccgagac
ygaggacgag a 21 1499 21 DNA Homo sapiens 1499 gcaaaacaag rgcatcagtg
c 21 1500 21 DNA Homo sapiens 1500 tgacctggcg ygctgccatg c 21 1501
21 DNA Homo sapiens 1501 tcattatatt ygagcagatt c 21 1502 21 DNA
Homo sapiens 1502 tttcagttcc ytattttctg t 21 1503 21 DNA Homo
sapiens 1503 ttttctgttt saacattggc g 21 1504 21 DNA Homo sapiens
1504 ggggttatgt ygctatgaag t 21 1505 21 DNA Homo sapiens 1505
tccagccaac ratgaccagt c 21 1506 21 DNA Homo sapiens 1506 ttcagtcctc
rgcctctcca g 21 1507 21 DNA Homo sapiens 1507 gctaaataaa racatgacct
a 21 1508 21 DNA Homo sapiens 1508 ccagcctctc raatgggcac a 21 1509
21 DNA Homo sapiens 1509 caactcgacg rtccaggcct c 21 1510 21 DNA
Homo sapiens 1510 gatttctgga ytccactgtt g 21 1511 21 DNA Homo
sapiens 1511 acctgaagaa rtttatagaa a 21 1512 21 DNA Homo sapiens
1512 gatgtctgca rtgggaagag t 21 1513 21 DNA Homo sapiens 1513
aatttacaaa yttcaatctt t 21 1514 21 DNA Homo sapiens 1514 ctccaggtca
rcccctgcca c 21 1515 21 DNA Homo sapiens 1515 cacatcgacc rggctctgga
t 21 1516 21 DNA Homo sapiens 1516 tcatcgtgcc rctgctgatc a 21 1517
21 DNA Homo sapiens 1517 gccatggact yctcaagatt c 21 1518 21 DNA
Homo sapiens 1518 atggagagtg rcagctttga a 21 1519 21 DNA Homo
sapiens 1519 gctatgccag yccggagatg t 21 1520 21 DNA Homo sapiens
1520 atggcggcag ytgtggctgt g 21 1521 21 DNA Homo sapiens 1521
agcttgacaa ratggtgaca g 21 1522 21 DNA Homo sapiens 1522 tggtcaacct
rcccttggtg a 21 1523 21 DNA Homo sapiens 1523 tctggagaca ytacttccag
a 21 1524 21 DNA Homo sapiens 1524
cgagatcttt ktcataatcc t 21 1525 21 DNA Homo sapiens 1525 tcctcataaa
rtacaggagg c 21 1526 21 DNA Homo sapiens 1526 gcaagaagat mctgctgccc
g 21 1527 21 DNA Homo sapiens 1527 tagaagggca ygtggtgatt c 21 1528
21 DNA Homo sapiens 1528 ccctgctcaa rcccaacatg g 21 1529 21 DNA
Homo sapiens 1529 tgaagccttc scatgtaatt t 21 1530 21 DNA Homo
sapiens 1530 ttttctcaac rcattacttc c 21 1531 21 DNA Homo sapiens
1531 tgcaaggtaa rgccaattgg a 21 1532 21 DNA Homo sapiens 1532
ctcctcgcca sgtctctgca a 21 1533 21 DNA Homo sapiens 1533 gtggagcaga
ratcttcgtt g 21 1534 21 DNA Homo sapiens 1534 agttcccacg saaatgagag
g 21 1535 21 DNA Homo sapiens 1535 ggtgacttgg sagcctccca g 21 1536
21 DNA Homo sapiens 1536 tctaaactgg stacggagtc g 21 1537 21 DNA
Homo sapiens 1537 ccagtgtccc ygagctggtc g 21 1538 21 DNA Homo
sapiens 1538 acaacaacac yaagctcgca a 21 1539 21 DNA Homo sapiens
1539 gctgaaagtg magaaagtca t 21 1540 21 DNA Homo sapiens 1540
gaagaaatat rtccgcaggg a 21 1541 21 DNA Homo sapiens 1541 ttcaagccac
rgagcttgcc a 21 1542 21 DNA Homo sapiens 1542 acaaactggc ygagtcctgt
g 21 1543 21 DNA Homo sapiens 1543 gcctcaatga kcctggtcca t 21 1544
21 DNA Homo sapiens 1544 tggatgtgca ygcggacagg a 21 1545 21 DNA
Homo sapiens 1545 cactttccat ygctttgaca a 21 1546 21 DNA Homo
sapiens 1546 tgcgggaggt ytttgagagc a 21 1547 21 DNA Homo sapiens
1547 gtaccaaggg ycagctggcc a 21 1548 21 DNA Homo sapiens 1548
cctggggagt ygctccaaca a 21 1549 21 DNA Homo sapiens 1549 aggccatcat
ygactgcctg g 21 1550 21 DNA Homo sapiens 1550 tccaaattta ytctgctgac
a 21 1551 21 DNA Homo sapiens 1551 aaggctatga ygtcattgcc t 21 1552
21 DNA Homo sapiens 1552 ggccctgcat ygcccgcaaa c 21 1553 21 DNA
Homo sapiens 1553 aatcccagac rctatgtcca g 21 1554 21 DNA Homo
sapiens 1554 tggacacctc stgcatcctc g 21 1555 21 DNA Homo sapiens
1555 agtttgtgga rgagttcatc t 21 1556 21 DNA Homo sapiens 1556
aggcactgaa rcttggggcc a 21 1557 21 DNA Homo sapiens 1557 ccagtccagc
rcactgtatg a 21 1558 21 DNA Homo sapiens 1558 tgtcccacgg ygccacagga
a 21 1559 21 DNA Homo sapiens 1559 gaattctaca rccggttcaa g 21 1560
21 DNA Homo sapiens 1560 ttctcgagat ygagttcaaa a 21 1561 21 DNA
Homo sapiens 1561 atgctcattt rgacatcgag g 21 1562 21 DNA Homo
sapiens 1562 cagttttcca ygagcaacat c 21 1563 21 DNA Homo sapiens
1563 ttcagtggaa ygcaggctca g 21 1564 21 DNA Homo sapiens 1564
ggtttcttct stgtctccgc g 21 1565 21 DNA Homo sapiens 1565 ccacgagtgc
rttcctgggg a 21 1566 21 DNA Homo sapiens 1566 cgagtgattg ragagcccac
g 21 1567 21 DNA Homo sapiens 1567 gggtgctccc rgccggccga g 21 1568
21 DNA Homo sapiens 1568 agccgtgctg yggacatttc c 21 1569 21 DNA
Homo sapiens 1569 gcaagaatct ygcagcagca t 21 1570 21 DNA Homo
sapiens 1570 acaacaccac ytctaacatg g 21 1571 21 DNA Homo sapiens
1571 aagttgatta yccccgggat g 21 1572 21 DNA Homo sapiens 1572
catcatttca rtgaaggaaa a 21 1573 21 DNA Homo sapiens 1573 accctgctac
rtttatctga t 21 1574 21 DNA Homo sapiens 1574 acccaggtca rcacgcaggc
c 21 1575 21 DNA Homo sapiens 1575 acacgcaggc ygagcagctg c 21 1576
21 DNA Homo sapiens 1576 ctcaattgct rttgacacaa t 21 1577 21 DNA
Homo sapiens 1577 atctttcatt kctgcaagga a 21 1578 21 DNA Homo
sapiens 1578 tccatcgcag ygaacgccga c 21 1579 21 DNA Homo sapiens
1579 ctgccgccca ygctgctggg g 21 1580 21 DNA Homo sapiens 1580
ttttgccttt raagtggatg g 21 1581 21 DNA Homo sapiens 1581 agccggagcc
rgagctggaa c 21 1582 21 DNA Homo sapiens 1582 cagggcctgg kcgtcacacc
c 21 1583 21 DNA Homo sapiens 1583 agctgacact sgttcgcgtg a 21 1584
21 DNA Homo sapiens 1584 accccaaacc ygaggttgct g 21 1585 21 DNA
Homo sapiens 1585 tttggcagaa raagccacgt t 21 1586 21 DNA Homo
sapiens 1586 gttacatgat ygacaacgtg a 21 1587 21 DNA Homo sapiens
1587 taaaggtttc yaacaccctg g 21 1588 21 DNA Homo sapiens 1588
tcactaccaa yctgatcaat t 21 1589 21 DNA Homo sapiens 1589 aggtatacgg
yattgaaggt c 21 1590 21 DNA Homo sapiens 1590 atcacagcaa ragagaggtt
c 21 1591 21 DNA Homo sapiens 1591 tgccctggac rcccaccagc a 21 1592
21 DNA Homo sapiens 1592 cgcaatgtct ytgacggcat c 21 1593 21 DNA
Homo sapiens 1593 gcactatctg ygtggcctac c 21 1594 21 DNA Homo
sapiens 1594 caggaccatg wtgaagaaca t 21 1595 21 DNA Homo sapiens
1595 tgcactgacc yagattaatg t 21 1596 21 DNA Homo sapiens 1596
atgtcacgct yatcatcctg g 21 1597 21 DNA Homo sapiens 1597 agctgcgttc
ragggatgca c 21 1598 21 DNA Homo sapiens 1598 tgatccaagg raatgatctg
a 21 1599 21 DNA Homo sapiens 1599 tactagcact rttgaaggaa a 21 1600
21 DNA Homo sapiens 1600 cctggcggct kcgccggtcc a 21 1601 21 DNA
Homo sapiens 1601 cagaccgtga raatagatgc c 21 1602 21 DNA Homo
sapiens 1602 tgaaaggcaa kccctccaga g 21 1603 21 DNA Homo sapiens
1603 cgaggctgct rttacggctc a 21 1604 21 DNA Homo sapiens 1604
cagtgacggg racaaaggtc t 21 1605 21 DNA Homo sapiens 1605 accgccgagg
mtgctgttac g 21 1606 21 DNA Homo sapiens 1606 tttccccagg ygaatgggct
g 21 1607 21 DNA Homo sapiens 1607 tgcctcatgc rtacgtccca c 21 1608
21 DNA Homo sapiens 1608 acaaatctct yactgaagaa g 21 1609 21 DNA
Homo sapiens 1609 ccagtgtcag yttgtgattc a 21 1610 21 DNA Homo
sapiens 1610 tgagcctttg saggccccag a 21 1611 21 DNA Homo sapiens
1611 ctgtactcac yctttgggaa a 21 1612 21 DNA Homo sapiens 1612
cggacaacct kacgctgcgg t 21 1613 21 DNA Homo sapiens 1613 cggcctccgg
stacctcttg c 21 1614 21 DNA Homo sapiens 1614 tgccacaaga ragcaggagt
t 21 1615 21 DNA Homo sapiens 1615 aactacaact kgtcacttac a 21 1616
21 DNA Homo sapiens 1616 agggctgagc mttcaggcag c 21 1617 21 DNA
Homo sapiens 1617 agtatgatct rtctgacatg c 21 1618 21 DNA Homo
sapiens 1618 atttctttaa yaactacaag a 21 1619 21 DNA Homo sapiens
1619 gtgcagaaga mtatctatcc g 21 1620 21 DNA Homo sapiens 1620
aagactatct mtccgtggtc c 21 1621 21 DNA Homo sapiens 1621 ttgttgagct
ygtgaaacac a 21 1622 21 DNA Homo sapiens 1622 cagggcggac yttgccaagt
a 21 1623 21 DNA Homo sapiens 1623 tatctatccg wggtcctgaa c 21 1624
21 DNA Homo sapiens 1624 ccagaatgcg ytattagttc g 21 1625 21 DNA
Homo sapiens 1625 cctaggaaaa rtgggcagca a 21 1626 21 DNA Homo
sapiens 1626 accagccctt yctcatcgag g 21 1627 21 DNA Homo sapiens
1627 gctagccact sctcagtaat g 21 1628 21 DNA Homo sapiens 1628
tgttcttcac yaccttcatg c 21 1629 21 DNA Homo sapiens 1629 agaatgggca
ygtggatata g 21 1630 21 DNA Homo sapiens 1630 aaagtatgaa rttcctgaag
g 21 1631 21 DNA Homo sapiens 1631 aagaaaagta ygtgaacagg a 21 1632
21 DNA Homo sapiens 1632 tcgtacccga ygtctcctac g 21 1633 21 DNA
Homo sapiens 1633 aggatggcca rgcctctgga g 21 1634 21 DNA Homo
sapiens 1634 tgctgcagaa rgagctggcc a 21 1635 21 DNA Homo sapiens
1635 tctactgcca ygagtacttc a 21 1636 21 DNA Homo sapiens 1636
acggggtcca ygccactaag c 21 1637 21 DNA Homo sapiens 1637 ggaggccata
ytggacataa t 21 1638 21 DNA Homo sapiens 1638 cagacacacc yagtggagac
a 21 1639 21 DNA Homo sapiens 1639 aaggaggact rtcacaagtc c 21 1640
21 DNA Homo sapiens 1640 tggtggagaa rtcagtgaca g 21 1641 21 DNA
Homo sapiens 1641 attggctacc yagtgatgat c 21 1642 21 DNA Homo
sapiens 1642 tggagaagtc mgtgacaggt t 21 1643 21 DNA Homo sapiens
1643 gacaccattg rctacccagt g 21 1644 21 DNA Homo sapiens 1644
agcctgtttt kaatatcaca a 21 1645 21 DNA Homo sapiens 1645 cacaaaggcc
yttgctatga c 21 1646 21 DNA Homo sapiens 1646 aaagctacca mcattacatc
a 21 1647 21 DNA Homo sapiens 1647 gtgccaacgt ycctcaaccg t 21 1648
21 DNA Homo sapiens 1648 agcagtgccc rccaggcctg c 21 1649 21 DNA
Homo sapiens 1649 ttttgttccg matgtctgag g 21 1650 21 DNA Homo
sapiens 1650 ggccatcgcc yggactccga g 21 1651 21 DNA Homo sapiens
1651 tcgcctggac wccgagactc c 21 1652 21 DNA Homo sapiens 1652
ttcgtgactt ygctggccgc a 21 1653 21 DNA Homo sapiens 1653 tgcgccgccg
yccgcccggc c 21 1654 21 DNA Homo sapiens 1654 tctgttgatc mgaacctgtg
g 21 1655 21 DNA Homo sapiens 1655 tggtggccac rcagcaggag a 21 1656
21 DNA Homo sapiens 1656 tctggggcca sccccaaaga g 21 1657 21 DNA
Homo sapiens 1657 acgacctcgc ygggctcggc a 21 1658 21 DNA Homo
sapiens 1658 gatggtggcc ytattgacgg g 21 1659 21 DNA Homo sapiens
1659 ataagcggag rcggagcgtg a 21 1660 21 DNA Homo sapiens 1660
agagccccat ygcgccctgt a 21 1661 21 DNA Homo sapiens 1661 aaatccaaac
mgatcggcag a 21 1662 21 DNA Homo sapiens 1662 tatagcctga wttttgtgtt
g 21 1663 21 DNA Homo sapiens 1663 aaggatgcag yggtgtcctt t 21 1664
21 DNA Homo sapiens 1664 tgtgttgggc ytcagcggga a 21 1665 21 DNA
Homo sapiens 1665 aaaatagctg yagccttggt g 21 1666 21 DNA Homo
sapiens 1666 tctgagaact mccctaacaa g 21 1667 21 DNA Homo sapiens
1667 aggctgagga mccgggccaa g 21 1668 21 DNA Homo sapiens 1668
gatggttgag rtctatctgc t 21 1669 21 DNA Homo sapiens 1669 atgagcctgg
rcaagtacct g 21 1670 21 DNA Homo sapiens 1670 cagggccggg ytttaaaaat
a 21 1671 21 DNA Homo sapiens 1671 ttccagatgt kaccagtcaa c 21 1672
21 DNA Homo sapiens 1672 tccaccccag yggggccata g 21 1673 21 DNA
Homo sapiens 1673 ttcctaacac rgtgactgtg g 21 1674 21 DNA Homo
sapiens 1674 cctgccctat yaccgacgcc c 21 1675 21 DNA Homo sapiens
1675 atattgtcca yaagcatgga g 21 1676 21 DNA Homo sapiens 1676
gggacagaag yacatgaccg c 21 1677 21 DNA Homo sapiens 1677 tggtgaagct
sttcgggccc t 21 1678 21 DNA Homo sapiens 1678 tgaagtacta yaccctagag
g 21 1679 21 DNA Homo sapiens 1679 agaatttcgt mgttgggaag t 21 1680
21 DNA Homo sapiens 1680 ctgttgatcc ygatgaacct g 21 1681 21 DNA
Homo sapiens 1681 tggatttcaa kaatatacca t 21 1682 21 DNA Homo
sapiens 1682 acacttactc rgagtggcac a 21 1683 21 DNA Homo sapiens
1683 gggaaagtgc rtgtgagcgg c 21 1684 21 DNA Homo sapiens 1684
ctggcaaaag ktggcctatt g 21 1685 21 DNA Homo sapiens 1685 gttattttct
ycttaccctg g 21 1686 21 DNA Homo sapiens 1686 aatgaaacca matccgtggt
t 21 1687 21 DNA Homo sapiens 1687 ccctgcacca ygccttggaa c 21 1688
21 DNA Homo sapiens 1688 ctgacgtctt yctggaggca t 21 1689 21 DNA
Homo sapiens 1689 ccttcccgac rtgaacaaga t 21 1690 21 DNA Homo
sapiens 1690 cgagctggcc rtgatggtga t 21 1691 21 DNA Homo sapiens
1691 ttaccagcat kccagacacc t 21 1692 21 DNA Homo sapiens 1692
gtttttcatt mtgcctgcca a 21 1693 21 DNA Homo sapiens 1693 gcttgaatgt
kaagaaattt t 21 1694 21 DNA Homo sapiens 1694 catcacagtg rtggtgtttt
t 21 1695 21 DNA Homo sapiens 1695 gaaaagtttg raaaaaaact c 21 1696
21 DNA Homo sapiens 1696 tgagagatac ratgaggaag a 21 1697 21 DNA
Homo sapiens 1697 tacttaggca satattacca g 21 1698 21 DNA Homo
sapiens 1698 cttacggtat ytacatcgtt g 21 1699 21 DNA Homo sapiens
1699 gcgctcacgt sttcaccacg g 21
1700 21 DNA Homo sapiens 1700 tgcaatcagc ygactaagtt t 21 1701 21
DNA Homo sapiens 1701 catcaaagtg rttggcaatg g 21 1702 21 DNA Homo
sapiens 1702 aacccgggaa yaaatccgag a 21 1703 21 DNA Homo sapiens
1703 aagaagtggc rgcacaagtc g 21 1704 21 DNA Homo sapiens 1704
atggcgagcc ytccggagag c 21 1705 21 DNA Homo sapiens 1705 agaaaccatt
rtcatcaccc t 21 1706 21 DNA Homo sapiens 1706 cgcgctggtg ktggccacca
t 21 1707 21 DNA Homo sapiens 1707 gaccctgccg ygggcgcggc a 21 1708
21 DNA Homo sapiens 1708 aggtgctgac rtgctcctgg t 21 1709 21 DNA
Homo sapiens 1709 cgggagcaac ktgctggaga c 21 1710 21 DNA Homo
sapiens 1710 cttataggta ytttcagcca t 21 1711 21 DNA Homo sapiens
1711 tgaaagccat yctcgttaca c 21 1712 21 DNA Homo sapiens 1712
cgattccacg ygaagacatt g 21 1713 21 DNA Homo sapiens 1713 attggtgaga
ragacataaa g 21 1714 21 DNA Homo sapiens 1714 attgcaaagc rccctaatgt
t 21 1715 21 DNA Homo sapiens 1715 tccctgccac rgtctgagag c 21 1716
21 DNA Homo sapiens 1716 cccctgaacc rtccgcagct c 21 1717 21 DNA
Homo sapiens 1717 catgatcagc ygggccaaga a 21 1718 21 DNA Homo
sapiens 1718 ggaagtgtta ygaagtggga a 21 1719 21 DNA Homo sapiens
1719 aggcctgccg rcttcggaag t 21 1720 21 DNA Homo sapiens 1720
gctttgaagg rctatagcat g 21 1721 21 DNA Homo sapiens 1721 gcaacatcaa
rcaagtgcag g 21 1722 21 DNA Homo sapiens 1722 gaggacatac rtcatgatgg
t 21 1723 21 DNA Homo sapiens 1723 cctgtatgaa mttcgattaa a 21 1724
21 DNA Homo sapiens 1724 cactgttggc rtgtacaatg g 21 1725 21 DNA
Homo sapiens 1725 ccaatgtcaa rgagatcaag g 21 1726 21 DNA Homo
sapiens 1726 ccaacatgat ygtggaggag t 21 1727 21 DNA Homo sapiens
1727 cttattttcc rgagatggaa g 21 1728 21 DNA Homo sapiens 1728
cagcttgcat kgctgacttt g 21 1729 21 DNA Homo sapiens 1729 ctgactttgg
sttggcctta a 21 1730 21 DNA Homo sapiens 1730 tctcttggaa ygaactgtgt
c 21 1731 21 DNA Homo sapiens 1731 tgagcgggaa ygcgtgtgtg c 21 1732
21 DNA Homo sapiens 1732 tctggcagaa yttgcggctc a 21 1733 21 DNA
Homo sapiens 1733 tggacagcct rccccaggca g 21 1734 21 DNA Homo
sapiens 1734 aagccactgt sgcttctggc a 21 1735 21 DNA Homo sapiens
1735 ccagcgaccc rgcaggacct a 21 1736 21 DNA Homo sapiens 1736
tatgcagctg ytaccctcca g 21 1737 21 DNA Homo sapiens 1737 gggatcccag
ytttgaggag g 21 1738 21 DNA Homo sapiens 1738 aaccccaacc rcgttcgcat
g 21 1739 21 DNA Homo sapiens 1739 gcttcctcaa yggggaggtg c 21 1740
21 DNA Homo sapiens 1740 agcagagcca rggcacctgc a 21 1741 21 DNA
Homo sapiens 1741 atgctcttcg sgtgcctcca c 21 1742 21 DNA Homo
sapiens 1742 atgaggagga rgaagagcca c 21 1743 21 DNA Homo sapiens
1743 gcctggccaa ygctgctgcc t 21 1744 21 DNA Homo sapiens 1744
gcagcagagt ygccacatca t 21 1745 21 DNA Homo sapiens 1745 gacgcttgtg
yttgccctgg c 21 1746 21 DNA Homo sapiens 1746 acagggaggt rgccgagatc
c 21 1747 21 DNA Homo sapiens 1747 tcatgctggc ygtgggagga g 21 1748
21 DNA Homo sapiens 1748 ccatcgcgct rgcactgctg g 21 1749 21 DNA
Homo sapiens 1749 agtgaagatc magaagacaa g 21 1750 21 DNA Homo
sapiens 1750 atgatcgttt ycttagtcag t 21 1751 21 DNA Homo sapiens
1751 tagtagcagt yttagaatac a 21 1752 21 DNA Homo sapiens 1752
ctcagccccg magtgcttca g 21 1753 21 DNA Homo sapiens 1753 gttgtaatga
rtttataatg g 21 1754 21 DNA Homo sapiens 1754 atttataatg raaggaactc
t 21 1755 21 DNA Homo sapiens 1755 aagcaggaac yggccaagta c 21 1756
21 DNA Homo sapiens 1756 agtattgtcc rtatcagacc t 21 1757 21 DNA
Homo sapiens 1757 ccattgacat sgccacggaa a 21 1758 21 DNA Homo
sapiens 1758 gctacattgc ygagcagaac a 21 1759 21 DNA Homo sapiens
1759 gctgcagcaa rtgctcgccg g 21 1760 21 DNA Homo sapiens 1760
tctgcacctg yaggcccggc t 21 1761 21 DNA Homo sapiens 1761 gatctgtaac
rtggtggcca t 21 1762 21 DNA Homo sapiens 1762 aatgcaagca kggatgcagt
c 21 1763 21 DNA Homo sapiens 1763 ccaagcacct ycttcctgct c 21 1764
21 DNA Homo sapiens 1764 gccgctgccc rctcatgctg a 21 1765 21 DNA
Homo sapiens 1765 cgcgctacag ycagcgccca g 21 1766 21 DNA Homo
sapiens 1766 tcggcctcta ygactccgtc a 21 1767 21 DNA Homo sapiens
1767 tgcaccacag ragccatggc g 21 1768 21 DNA Homo sapiens 1768
tacgggaatc rccgttttga a 21 1769 21 DNA Homo sapiens 1769 atcctgacca
yggtgcggac t 21 1770 21 DNA Homo sapiens 1770 actgtggcat mgagatatac
t 21 1771 21 DNA Homo sapiens 1771 atattaactt satggctgca a 21 1772
21 DNA Homo sapiens 1772 cctgtagtga mtcggccgct g 21 1773 21 DNA
Homo sapiens 1773 cgctgcagcg mctggtggag g 21 1774 21 DNA Homo
sapiens 1774 ggaccgctac stggccgtgg t 21 1775 21 DNA Homo sapiens
1775 tggccgtggt rcatcccatc a 21 1776 21 DNA Homo sapiens 1776
tgcagctggt yaacgtgttt g 21 1777 21 DNA Homo sapiens 1777 gccacggagc
ygcgtccaga c 21 1778 21 DNA Homo sapiens 1778 acgtgtcggc rggcccaagc
c 21 1779 21 DNA Homo sapiens 1779 ccacccgctc rgcccgctgg c 21 1780
21 DNA Homo sapiens 1780 agctgaatga yactcaccct c 21 1781 21 DNA
Homo sapiens 1781 agctgatcac ytcagtggca g 21 1782 21 DNA Homo
sapiens 1782 tgtacaaccg yattaagaaa g 21 1783 21 DNA Homo sapiens
1783 aagcaagttg raagtcatct t 21 1784 21 DNA Homo sapiens 1784
gatgtggacc stctgagaag g 21 1785 21 DNA Homo sapiens 1785 ccggggaagc
kgccgtctaa a 21 1786 21 DNA Homo sapiens 1786 ggacgactcc ragctgccta
c 21 1787 21 DNA Homo sapiens 1787 tgggaggcac rgtgattgga a 21 1788
21 DNA Homo sapiens 1788 tgattggaag ygcccggtgc a 21 1789 21 DNA
Homo sapiens 1789 cgtgggatca scaatctctg t 21 1790 21 DNA Homo
sapiens 1790 cactgtggat rcctggccct t 21 1791 21 DNA Homo sapiens
1791 atggcagcct yacaggtgcc a 21 1792 21 DNA Homo sapiens 1792
cagcgttctt ygtgacgtta g 21 1793 21 DNA Homo sapiens 1793 aatatctcgc
ygtggagtcc c 21 1794 21 DNA Homo sapiens 1794 acttcaaacg katgacagca
c 21 1795 21 DNA Homo sapiens 1795 cctcacatac saggcctcca t 21 1796
21 DNA Homo sapiens 1796 tccgggatct yagtaagcca g 21 1797 21 DNA
Homo sapiens 1797 aagtatatca ktttcaaata t 21 1798 21 DNA Homo
sapiens 1798 gtagccatgc ytacgcaaat c 21 1799 21 DNA Homo sapiens
1799 cacgagcact rtaaaatcca c 21 1800 21 DNA Homo sapiens 1800
ccatgcttac rcaaatcttg g 21 1801 21 DNA Homo sapiens 1801 tgccattcag
sgattgtatg t 21 1802 21 DNA Homo sapiens 1802 attctgcatc rtgggactct
a 21 1803 21 DNA Homo sapiens 1803 ttgtgaaatc wattcgaagt a 21 1804
21 DNA Homo sapiens 1804 cgaagtaatg ytcagcgcca g 21 1805 21 DNA
Homo sapiens 1805 attgcttcaa sgacacctga a 21 1806 21 DNA Homo
sapiens 1806 gagtagtcgc yatggcacag g 21 1807 21 DNA Homo sapiens
1807 gtaatgctca scgccaggaa a 21 1808 21 DNA Homo sapiens 1808
tgcaagatta yaggctgttg c 21 1809 21 DNA Homo sapiens 1809 ccctcagtca
ygattcttta a 21 1810 21 DNA Homo sapiens 1810 gttggcagtt wccagctccc
a 21 1811 21 DNA Homo sapiens 1811 gcagtactca rtctgaaaag c 21 1812
21 DNA Homo sapiens 1812 tcctgaacca kggctttctg g 21 1813 21 DNA
Homo sapiens 1813 actatattac rtgcttcaaa a 21 1814 21 DNA Homo
sapiens 1814 acaatagcca yatgggaaat a 21 1815 21 DNA Homo sapiens
1815 atcaaatgga rttccccacc a 21 1816 21 DNA Homo sapiens 1816
atttgtcccc rcacagaagt a 21 1817 21 DNA Homo sapiens 1817 tgcggtccat
yttggtcaag g 21 1818 21 DNA Homo sapiens 1818 accaacctgc mcttccaggc
c 21 1819 21 DNA Homo sapiens 1819 ccatctcata macgggcgac g 21 1820
21 DNA Homo sapiens 1820 gggacctatg ytgataaact g 21 1821 21 DNA
Homo sapiens 1821 cctgttaata ytaggagtaa g 21 1822 21 DNA Homo
sapiens 1822 ggtaatgaag kcacgtgtgt t 21 1823 21 DNA Homo sapiens
1823 gtacctttgt yatccaggcc a 21 1824 21 DNA Homo sapiens 1824
ccaggcagat sgaggcctta c 21 1825 21 DNA Homo sapiens 1825 gagtaatcat
wgaagatgtg g 21 1826 21 DNA Homo sapiens 1826 tccaataatc wgtcaacttt
a 21 1827 21 DNA Homo sapiens 1827 ttcaaaagca wttcaatcaa a 21 1828
21 DNA Homo sapiens 1828 tattcagctc rtccgtatcc t 21 1829 21 DNA
Homo sapiens 1829 atctttacct yggtgctatg a 21 1830 21 DNA Homo
sapiens 1830 gtggaaatcc rtactacctg t 21 1831 21 DNA Homo sapiens
1831 ttgtggcatt sctagcagac a 21 1832 21 DNA Homo sapiens 1832
atccatctat ygtaaatggc a 21 1833 21 DNA Homo sapiens 1833 ctatggacct
yagataactg t 21 1834 21 DNA Homo sapiens 1834 accatcacag rgatgtgcca
g 21 1835 21 DNA Homo sapiens 1835 ccctttacga rgcagcatta t 21 1836
21 DNA Homo sapiens 1836 tatgtgggag rcacccattg c 21 1837 21 DNA
Homo sapiens 1837 aagagctcct ytgggagaat a 21 1838 21 DNA Homo
sapiens 1838 gtctttgcaa ygatgtcatt c 21 1839 21 DNA Homo sapiens
1839 gctcattgcg rtatcttctt g 21 1840 21 DNA Homo sapiens 1840
tatcttcttg watggataga a 21 1841 21 DNA Homo sapiens 1841 agaagtcagc
rttcacacgg t 21 1842 21 DNA Homo sapiens 1842 cctgtgtgtt wgacatggaa
g 21 1843 21 DNA Homo sapiens 1843 ggggttctct yttcggcaga t 21 1844
21 DNA Homo sapiens 1844 cagctcagca wctcgtgcgc a 21 1845 21 DNA
Homo sapiens 1845 ctttgttgta rcacaggccc t 21 1846 21 DNA Homo
sapiens 1846 agaactgtct scctgaccct g 21 1847 21 DNA Homo sapiens
1847 ttaaaccaca ytttggcagt g 21 1848 21 DNA Homo sapiens 1848
acgtggacaa ygccgagggc t 21 1849 21 DNA Homo sapiens 1849 attccccatt
ygccggggca c 21 1850 21 DNA Homo sapiens 1850 ggcaaggtga rgcagcagca
g 21 1851 21 DNA Homo sapiens 1851 atgctcccat ygtctccgaa a 21 1852
21 DNA Homo sapiens 1852 tccagaggaa yaggacactg c 21 1853 21 DNA
Homo sapiens 1853 cactcctcaa ytggataaat g 21 1854 21 DNA Homo
sapiens 1854 tggagaacca rgtgctggta a 21 1855 21 DNA Homo sapiens
1855 gtaaatggac rgttaataga g 21 1856 21 DNA Homo sapiens 1856
agcatatcat stcccgagtg g 21 1857 21 DNA Homo sapiens 1857 agtcatcagc
yttgtgccac c 21 1858 21 DNA Homo sapiens 1858 ctcagtacca ygatcctgat
g 21 1859 21 DNA Homo sapiens 1859 ccgagccata ygatgagagc g 21 1860
21 DNA Homo sapiens 1860 aaatctcctc rgaacacgcc c 21 1861 21 DNA
Homo sapiens 1861 gccccagaag racctgagca g 21 1862 21 DNA Homo
sapiens 1862 tcctggttta ycagctgctg c 21 1863 21 DNA Homo sapiens
1863 tttgcatgca ragaacatca t 21 1864 21 DNA Homo sapiens 1864
gacagtctaa rgaaagcact g 21 1865 21 DNA Homo sapiens 1865 ccaaacagag
rattttagtc t 21 1866 21 DNA Homo sapiens 1866 aggaagaggc rtccttagca
g 21 1867 21 DNA Homo sapiens 1867 aagaagacaa kaggtttctt c 21 1868
21 DNA Homo sapiens 1868 gcatatacct sgagtatgtg a 21 1869 21 DNA
Homo sapiens 1869 ataacaatta yggctgtgtc c 21 1870 21 DNA Homo
sapiens 1870 tgaaattcag rgaattgacc c 21 1871 21 DNA Homo sapiens
1871 gaagctcaac ytggactcga t 21 1872 21 DNA Homo sapiens 1872
aagacggcta ygagttcttt g 21 1873 21 DNA Homo sapiens 1873 cattgaacca
mcacagttca a 21 1874 21 DNA Homo sapiens 1874 atcagaaatt ygtacaacag
c 21 1875 21 DNA Homo sapiens 1875 aggagtacct stcctttcgt t
21 1876 21 DNA Homo sapiens 1876 aaaactgtct yttgaaagga a 21 1877 21
DNA Homo sapiens 1877 agcacggaca ygcaggcccg g 21 1878 21 DNA Homo
sapiens 1878 tgaccctcac rtgagtagta a 21 1879 21 DNA Homo sapiens
1879 ttctggggaa raagctgaag c 21 1880 21 DNA Homo sapiens 1880
taagcattgc rgagacgcca a 21 1881 21 DNA Homo sapiens 1881 ccctgaaagc
mctgaggctc t 21 1882 21 DNA Homo sapiens 1882 tggtgttccc rcctggactg
g 21 1883 21 DNA Homo sapiens 1883 tgaggctctc ycgtcagcgg t 21 1884
21 DNA Homo sapiens 1884 gacgccaagt ktgaaggaac t 21 1885 21 DNA
Homo sapiens 1885 tctggagatg rtactgacta t 21 1886 21 DNA Homo
sapiens 1886 tgatcttgga ygaaggacac a 21 1887 21 DNA Homo sapiens
1887 ctaacatatc ygtaaatgat g 21 1888 21 DNA Homo sapiens 1888
gggcacctgc rggaagcttc t 21 1889 21 DNA Homo sapiens 1889 tatcatggaa
wtagatgaca c 21 1890 21 DNA Homo sapiens 1890 cctcatgtta sacggcgcac
c 21 1891 21 DNA Homo sapiens 1891 ttttatgatg ratgtctgcg a 21 1892
21 DNA Homo sapiens 1892 ttcatggaca rtatacagat t 21 1893 21 DNA
Homo sapiens 1893 cattctggag rattactagc a 21 1894 21 DNA Homo
sapiens 1894 aggggtatga wcacaaagca a 21 1895 21 DNA Homo sapiens
1895 ccaattattg yggagagttt g 21 1896 21 DNA Homo sapiens 1896
gatcttatat ktagagccca t 21 1897 21 DNA Homo sapiens 1897 aaagatgcag
rtctgaactc t 21 1898 21 DNA Homo sapiens 1898 cgatgggaac kccccatcct
t 21 1899 21 DNA Homo sapiens 1899 cgccccatcc yttggtttac t 21 1900
21 DNA Homo sapiens 1900 acttaaagga yattgcagga g 21 1901 21 DNA
Homo sapiens 1901 taaagatgtg yttggacatc t 21 1902 21 DNA Homo
sapiens 1902 atgttcaggg ytgcaggggg a 21 1903 21 DNA Homo sapiens
1903 attatggcag yaacttacag a 21 1904 21 DNA Homo sapiens 1904
caaagatgca ratctgaact c 21 1905 21 DNA Homo sapiens 1905 acctttgtct
yatagaaact c 21 1906 21 DNA Homo sapiens 1906 tgcaagtggc yaacaccacc
a 21 1907 21 DNA Homo sapiens 1907 gtcatgcaag yggccaacac c 21 1908
21 DNA Homo sapiens 1908 acaaggacgt rgagcccggc a 21 1909 21 DNA
Homo sapiens 1909 tccacgacgg mgagtgcatg c 21 1910 21 DNA Homo
sapiens 1910 cttctgctca satgctccaa g 21 1911 21 DNA Homo sapiens
1911 agaaggagca ratgacattc c 21 1912 21 DNA Homo sapiens 1912
aagtggccgg macctgagaa t 21 1913 21 DNA Homo sapiens 1913 ctccaccacc
wcgtcgaaga a 21 1914 21 DNA Homo sapiens 1914 caccacgtcg ragaatcgca
t 21 1915 21 DNA Homo sapiens 1915 cccctgacta yagggatctc a 21 1916
21 DNA Homo sapiens 1916 tctgcagact yttcaggaga g 21 1917 21 DNA
Homo sapiens 1917 aagcattaga rgccttacag a 21 1918 21 DNA Homo
sapiens 1918 caaatatcca ygtggactaa a 21 1919 21 DNA Homo sapiens
1919 ttctgctgtg kcgctccatc c 21 1920 21 DNA Homo sapiens 1920
cttgcccaga kcatgcaact t 21 1921 21 DNA Homo sapiens 1921 gcaccaagca
rtggacagtt g 21 1922 21 DNA Homo sapiens 1922 tgaagacgtg ratgaatgtg
c 21 1923 21 DNA Homo sapiens 1923 ttactattgc rcttgcaaac a 21 1924
21 DNA Homo sapiens 1924 tcaccagcag sgtctgccct g 21 1925 21 DNA
Homo sapiens 1925 ctcagcaaat rtcactccgg c 21 1926 21 DNA Homo
sapiens 1926 acactggcat ytttttggaa a 21 1927 21 DNA Homo sapiens
1927 gacaacaaga ygggctgcgc c 21 1928 21 DNA Homo sapiens 1928
tgcctcccta ygccttcttc t 21 1929 21 DNA Homo sapiens 1929 aacgtgagcc
rggagcagcg t 21 1930 21 DNA Homo sapiens 1930 attgttttta rggtgagaaa
t 21 1931 21 DNA Homo sapiens 1931 ctcgccgaac raccctgtca c 21 1932
21 DNA Homo sapiens 1932 tcctgccgct ygatttctcc a 21 1933 21 DNA
Homo sapiens 1933 ggccatgggc rtgaagcggg a 21 1934 21 DNA Homo
sapiens 1934 gacaaacagc ytttcaccct g 21 1935 21 DNA Homo sapiens
1935 aggagaaagc yctcaaagca t 21 1936 21 DNA Homo sapiens 1936
ccttcagcaa ygggaggaaa a 21 1937 21 DNA Homo sapiens 1937 cctatcctta
mcctcggtac a 21 1938 21 DNA Homo sapiens 1938 tttctgctgc ygccaacaac
a 21 1939 21 DNA Homo sapiens 1939 tctatgacct yggagatgtg c 21 1940
21 DNA Homo sapiens 1940 ccttcatgac kcagagctcc c 21 1941 21 DNA
Homo sapiens 1941 ttcatgactc rgagctcccc t 21 1942 21 DNA Homo
sapiens 1942 tcacccagga ygcccagctg a 21 1943 21 DNA Homo sapiens
1943 cgccacgcgc rcctgcggcc t 21 1944 21 DNA Homo sapiens 1944
ggccgcgcca scgaggtccc c 21 1945 21 DNA Homo sapiens 1945 tcgatgccta
maaacaggtg a 21 1946 21 DNA Homo sapiens 1946 tgcctacaaa maggtgaaat
t 21 1947 21 DNA Homo sapiens 1947 tgtctccagt rcagaaggag g 21 1948
21 DNA Homo sapiens 1948 cgagcctggg ragccccggg g 21 1949 21 DNA
Homo sapiens 1949 ggctcgccga wttgcccaga t 21 1950 21 DNA Homo
sapiens 1950 actgccaggc rttcagtggc a 21 1951 21 DNA Homo sapiens
1951 ttggaaaaac wctaggagaa g 21 1952 21 DNA Homo sapiens 1952
cgagtgagct kcgagacctg c 21 1953 21 DNA Homo sapiens 1953 tcggctggaa
wgaatggata a 21 1954 21 DNA Homo sapiens 1954 ctgtggagca rtggaaagcc
c 21 1955 21 DNA Homo sapiens 1955 tgtgactgct scatgcactg t 21 1956
21 DNA Homo sapiens 1956 agcacctact ycatgctggg c 21 1957 21 DNA
Homo sapiens 1957 aggaaatgat ygaggaactc c 21 1958 21 DNA Homo
sapiens 1958 aagtgcacac yataccagcc a 21 1959 21 DNA Homo sapiens
1959 gtttatcagg kgctccagga g 21 1960 21 DNA Homo sapiens 1960
aggtgctcca rgagcacttg g 21 1961 21 DNA Homo sapiens 1961 ggctggctgg
kgtttgacat c 21 1962 21 DNA Homo sapiens 1962 ggcctgcagc kctcggtgga
g 21 1963 21 DNA Homo sapiens 1963 atctacaagg rctacatccg g 21 1964
21 DNA Homo sapiens 1964 gccactagct yctccgagaa t 21 1965 21 DNA
Homo sapiens 1965 gttcccttta kgattatctg a 21 1966 21 DNA Homo
sapiens 1966 gctaaatcaa ygctgaagtt a 21 1967 21 DNA Homo sapiens
1967 tatcagacag kgttgatgag g 21 1968 21 DNA Homo sapiens 1968
tccttatcat racctagtgc c 21 1969 21 DNA Homo sapiens 1969 gttacgcccc
kcattcccaa a 21 1970 21 DNA Homo sapiens 1970 tgttggacga ragcttgaac
a 21 1971 21 DNA Homo sapiens 1971 aaatttggca rcaagcacaa a 21 1972
21 DNA Homo sapiens 1972 tggagttgcc wagatgaata c 21 1973 21 DNA
Homo sapiens 1973 atgatcagga yggcaatgga t 21 1974 21 DNA Homo
sapiens 1974 gggcacaatt scagctgatg a 21 1975 21 DNA Homo sapiens
1975 tacctgtgga yacctttctg a 21 1976 21 DNA Homo sapiens 1976
ttacggatat yctacaatgt g 21 1977 21 DNA Homo sapiens 1977 cctacaatgt
ktacttagca g 21 1978 21 DNA Homo sapiens 1978 ggagagggct yttcaccaat
g 21 1979 21 DNA Homo sapiens 1979 tacggatatc ytacaatgtg t 21 1980
21 DNA Homo sapiens 1980 tcgtgctctg yatctcatgc a 21 1981 21 DNA
Homo sapiens 1981 tgtcctcctg rtgtttgagg c 21 1982 21 DNA Homo
sapiens 1982 tctcccgcaa scggtccagc a 21 1983 21 DNA Homo sapiens
1983 tcctattcat wttggagtag c 21 1984 21 DNA Homo sapiens 1984
cattccagcc katgccagca c 21 1985 21 DNA Homo sapiens 1985 agggatatct
rcatcgactt c 21 1986 21 DNA Homo sapiens 1986 gatatttgcc rtagaggaga
t 21 1987 21 DNA Homo sapiens 1987 ttctggtcca rtgagaacca c 21 1988
21 DNA Homo sapiens 1988 agctggagga ygagatcatc t 21 1989 21 DNA
Homo sapiens 1989 tcagcaactc sacggcgcgc a 21 1990 21 DNA Homo
sapiens 1990 cggcgccctg ytagtcaacg c 21 1991 21 DNA Homo sapiens
1991 gcggctccct rctattcatt g 21 1992 21 DNA Homo sapiens 1992
aacgatgttg magcaggaac t 21 1993 21 DNA Homo sapiens 1993 tggacaaatt
wtacccagtg t 21 1994 21 DNA Homo sapiens 1994 aggcattcca rgattccctg
g 21 1995 21 DNA Homo sapiens 1995 tgccaaccag sgggtaacag g 21 1996
21 DNA Homo sapiens 1996 cataccacgt scatgtgaaa g 21 1997 21 DNA
Homo sapiens 1997 agtcatgcct sagggtttta t 21 1998 21 DNA Homo
sapiens 1998 agaagaaaac wgtgacaatg a 21 1999 21 DNA Homo sapiens
1999 tgacaatgat wgttgattgt a 21 2000 21 DNA Homo sapiens 2000
tagtccagac wgtgactctt c 21 2001 21 DNA Homo sapiens 2001 agactgtgac
wcttcagcac c 21 2002 21 DNA Homo sapiens 2002 tgacgggaag wggcatcggg
t 21 2003 21 DNA Homo sapiens 2003 tggcatcggg wagcaatcag c 21 2004
21 DNA Homo sapiens 2004 cgtcctggct yaccaggggc t 21 2005 21 DNA
Homo sapiens 2005 tgggtttcca rgtgccaatg g 21 2006 21 DNA Homo
sapiens 2006 gtccagaagg wcttcggggc a 21 2007 21 DNA Homo sapiens
2007 gaaaaaggtg wccgagggct c 21 2008 21 DNA Homo sapiens 2008
gctaaggggg magcaggtgc a 21 2009 21 DNA Homo sapiens 2009 agacatactg
raggcatgca a 21 2010 21 DNA Homo sapiens 2010 aacaagacat ygagcatatg
a 21 2011 21 DNA Homo sapiens 2011 aagcactaga ktttcacaat t 21 2012
21 DNA Homo sapiens 2012 gggagcctgg scctccaggt c 21 2013 21 DNA
Homo sapiens 2013 aattgatcaa rtacctattg t 21 2014 21 DNA Homo
sapiens 2014 ggagttcaag rtcctgttgg t 21 2015 21 DNA Homo sapiens
2015 gagatgtcct wtgacaataa t 21 2016 21 DNA Homo sapiens 2016
tcccctgaga ytccgtgggg c 21 2017 21 DNA Homo sapiens 2017 caatggcgct
ratggcccac a 21 2018 21 DNA Homo sapiens 2018 gcctggctca racggacccc
c 21 2019 21 DNA Homo sapiens 2019 gcctctcctc ytgcagagac c 21 2020
21 DNA Homo sapiens 2020 tgttggacaa raaatgacaa c 21 2021 21 DNA
Homo sapiens 2021 gcttgttgca wgctgtggca a 21 2022 21 DNA Homo
sapiens 2022 attccaccag mccgggatgt a 21 2023 21 DNA Homo sapiens
2023 aagaagtaaa racattattt t 21 2024 21 DNA Homo sapiens 2024
tggctcctat wgcattggga t 21 2025 21 DNA Homo sapiens 2025 attacttgga
ytcaagctcc a 21 2026 21 DNA Homo sapiens 2026 cagataagat rgagaccatc
t 21 2027 21 DNA Homo sapiens 2027 gagcccatgg wagcctttgt t 21 2028
21 DNA Homo sapiens 2028 ccaggatgag rtcaagaagg c 21 2029 21 DNA
Homo sapiens 2029 acctcggggg stgcctgggc c 21 2030 21 DNA Homo
sapiens 2030 tcgggggctg yctgggcccc c 21 2031 21 DNA Homo sapiens
2031 ccccctggcc rtcctggaaa c 21 2032 21 DNA Homo sapiens 2032
cagtatttgc macttacagc a 21 2033 21 DNA Homo sapiens 2033 tgtgactgta
sttcccgttt a 21 2034 21 DNA Homo sapiens 2034 aggaaacaag kgctccatgg
g 21 2035 21 DNA Homo sapiens 2035 tccagggact ycagggaatg a 21 2036
21 DNA Homo sapiens 2036 tgtgggtcca rgcagtgaag a 21 2037 21 DNA
Homo sapiens 2037 atattccaat rtactccttt g 21 2038 21 DNA Homo
sapiens 2038 ccatttgcaa katctgtcca c 21 2039 21 DNA Homo sapiens
2039 ccagcagcac ycgtggtggc g 21 2040 21 DNA Homo sapiens 2040
aaggcgacca rggagcccag g 21 2041 21 DNA Homo sapiens 2041 ggcgaccagg
ratttcaagg c 21 2042 21 DNA Homo sapiens 2042 ccatgaaaac yatgaagggg
c 21 2043 21 DNA Homo sapiens 2043 ccaaaggtga maaaggggac a 21 2044
21 DNA Homo sapiens 2044 gcccacgcga mgagtattcc c 21 2045 21 DNA
Homo sapiens 2045 ggggtctccc rgaggagttt g 21 2046 21 DNA Homo
sapiens 2046 ctcatgaaga mgtctgccat c 21 2047 21 DNA Homo sapiens
2047 cctggtcctc ygggattgcc a 21 2048 21 DNA Homo sapiens 2048
tcctggctgt kttgggagcc c 21 2049 21 DNA Homo sapiens 2049 acctcatcca
ycgactcagc c 21 2050 21 DNA Homo sapiens 2050 acaggcgaga rgggccagaa
a 21 2051 21 DNA Homo sapiens 2051 gtcaggagct
ytgggaccct c 21 2052 21 DNA Homo sapiens 2052 tcctggtgaa saaggtccct
c 21 2053 21 DNA Homo sapiens 2053 atgaggagac yggcaacctg a 21 2054
21 DNA Homo sapiens 2054 ggtgcaatcg rcagtccagg a 21 2055 21 DNA
Homo sapiens 2055 ggtgtcaagg rtgaaagtgg g 21 2056 21 DNA Homo
sapiens 2056 tcttggtcag ycctatgcgg a 21 2057 21 DNA Homo sapiens
2057 ctggacctca rggaccccca g 21 2058 21 DNA Homo sapiens 2058
tagaggtgga rctggtcccc c 21 2059 21 DNA Homo sapiens 2059 gggattggag
rtgaaaaagc t 21 2060 21 DNA Homo sapiens 2060 gagattggcg ygactggtga
t 21 2061 21 DNA Homo sapiens 2061 ctcgtggaaa raaaggtccc c 21 2062
21 DNA Homo sapiens 2062 gaaaggacca rtgggattcc c 21 2063 21 DNA
Homo sapiens 2063 atgatgtggg rccacctggt c 21 2064 21 DNA Homo
sapiens 2064 accaggaaag matggtgcct c 21 2065 21 DNA Homo sapiens
2065 ctgtttgcca ytgtgttcct g 21 2066 21 DNA Homo sapiens 2066
tccaggggat satgaagatg c 21 2067 21 DNA Homo sapiens 2067 gccttcccgt
rtttagcacg c 21 2068 21 DNA Homo sapiens 2068 ctggaccacc rgggtgccca
g 21 2069 21 DNA Homo sapiens 2069 ggagcatccg sagagcaggg c 21 2070
21 DNA Homo sapiens 2070 ctggtcttcc rggtcccaga g 21 2071 21 DNA
Homo sapiens 2071 gccacttttt mgcaaataag t 21 2072 21 DNA Homo
sapiens 2072 gacttgcctg ygatgtggtc t 21 2073 21 DNA Homo sapiens
2073 ttcaaggttt wctgcaactt c 21 2074 21 DNA Homo sapiens 2074
aacagggtat yactggtcct t 21 2075 21 DNA Homo sapiens 2075 tcggtcctcc
sggtgaacag g 21 2076 21 DNA Homo sapiens 2076 acggcctggc wgggttgcca
g 21 2077 21 DNA Homo sapiens 2077 gtgaccctgg yccttccggc c 21 2078
21 DNA Homo sapiens 2078 cgggcagaaa rgtgatgaag g 21 2079 21 DNA
Homo sapiens 2079 atggactgga rccagatact g 21 2080 21 DNA Homo
sapiens 2080 tatcctggcg rccactcaga g 21 2081 21 DNA Homo sapiens
2081 gactcggtga ytttggcctg g 21 2082 21 DNA Homo sapiens 2082
cggactatga kgtgaccgtg a 21 2083 21 DNA Homo sapiens 2083 ccaagtgact
ktgattgccc t 21 2084 21 DNA Homo sapiens 2084 cgccgggagc yggaaactcc
a 21 2085 21 DNA Homo sapiens 2085 gcttagctac wctgtgcggg t 21 2086
21 DNA Homo sapiens 2086 tgtccgccgg ragccggaaa c 21 2087 21 DNA
Homo sapiens 2087 gggccctgct rcagtcatcg t 21 2088 21 DNA Homo
sapiens 2088 gagccagata ytgagtatac g 21 2089 21 DNA Homo sapiens
2089 tcatctgtca ycattacctg g 21 2090 21 DNA Homo sapiens 2090
accaggagag ygtggtatgg c 21 2091 21 DNA Homo sapiens 2091 gggtgaccga
kgctttgacg g 21 2092 21 DNA Homo sapiens 2092 cgccatccgt ragcttagct
a 21 2093 21 DNA Homo sapiens 2093 aggatccgtg wcatgcccta c 21 2094
21 DNA Homo sapiens 2094 acggagaacc yggggaccct g 21 2095 21 DNA
Homo sapiens 2095 tgccagggcc scgaggcgag a 21 2096 21 DNA Homo
sapiens 2096 gcttggatgg ygacaaagga c 21 2097 21 DNA Homo sapiens
2097 accgtggttc ycactggacc a 21 2098 21 DNA Homo sapiens 2098
tcctagggcc rgctggagaa g 21 2099 21 DNA Homo sapiens 2099 ccagggagat
yctggagagg a 21 2100 21 DNA Homo sapiens 2100 atcttgcaaa rgatccgtga
c 21 2101 21 DNA Homo sapiens 2101 atgggcaagg ragccgttcc c 21 2102
21 DNA Homo sapiens 2102 caggcgggac rgcccggaag t 21 2103 21 DNA
Homo sapiens 2103 aagggagaga ygggccctca t 21 2104 21 DNA Homo
sapiens 2104 aagtgggtga yccaggggtg g 21 2105 21 DNA Homo sapiens
2105 ccaccagggc stagcgggtg t 21 2106 10 DNA Homo sapiens 2106
tgctccctgk 10 2107 21 DNA Homo sapiens 2107 atggagagct raagtccaag a
21 2108 21 DNA Homo sapiens 2108 gcgccgaggg rccaaatgag a 21 2109 21
DNA Homo sapiens 2109 tgctgaagtt rtggaaacat c 21 2110 21 DNA Homo
sapiens 2110 gtatcagaag ytatttttag a 21 2111 21 DNA Homo sapiens
2111 ccctggagac mctcgagacc a 21 2112 21 DNA Homo sapiens 2112
ctcagcaaga rgccctgcct g 21 2113 21 DNA Homo sapiens 2113 ccttcaggga
yggaggcaat g 21 2114 21 DNA Homo sapiens 2114 ccgcgctgat ygaggccatc
c 21 2115 21 DNA Homo sapiens 2115 ttgaccggaa ygtgccccgg a 21 2116
21 DNA Homo sapiens 2116 atcacctcac wcatggaaag c 21 2117 21 DNA
Homo sapiens 2117 aagatgatga rgaccatgtg g 21 2118 21 DNA Homo
sapiens 2118 ccattgactc raacgactct g 21 2119 21 DNA Homo sapiens
2119 taaacaggct rattctggaa g 21 2120 21 DNA Homo sapiens 2120
ccaggacctg macgcgcctt c 21 2121 21 DNA Homo sapiens 2121 catacaaggc
matccccgtt g 21 2122 21 DNA Homo sapiens 2122 gacagcagtc sggatgccgc
c 21 2123 21 DNA Homo sapiens 2123 cggccattga rgcagagctg g 21 2124
21 DNA Homo sapiens 2124 ggacaaccgg racagttcca t 21 2125 21 DNA
Homo sapiens 2125 gtacaatgcc rtgtccaacg c 21 2126 21 DNA Homo
sapiens 2126 cagttcctcc rcctgtcctc t 21 2127 21 DNA Homo sapiens
2127 cctgcaggcc mccaacatct t 21 2128 21 DNA Homo sapiens 2128
gaactgaatt yggcctgaag t 21 2129 21 DNA Homo sapiens 2129 tcatcgactt
ygtgtggatc a 21 2130 21 DNA Homo sapiens 2130 aagcagctca scatcagaaa
a 21 2131 21 DNA Homo sapiens 2131 gatgcttcac sagcagaggt c 21 2132
21 DNA Homo sapiens 2132 acctgcattg kcatgtgcaa g 21 2133 21 DNA
Homo sapiens 2133 cgggaaccca ygtcggccga g 21 2134 21 DNA Homo
sapiens 2134 cctctttgag ygtcactggc a 21 2135 21 DNA Homo sapiens
2135 atggcgtctg racagctcag c 21 2136 21 DNA Homo sapiens 2136
cgtggaggtg sagctgctac a 21 2137 21 DNA Homo sapiens 2137 taggagctgg
yttgctaatg g 21 2138 21 DNA Homo sapiens 2138 agaagaaagt raccttggaa
a 21 2139 21 DNA Homo sapiens 2139 caaatcatca kgtggcctag a 21 2140
21 DNA Homo sapiens 2140 gaagattcca ycagatccca t 21 2141 21 DNA
Homo sapiens 2141 ctgggccctt ycctgatgaa c 21 2142 21 DNA Homo
sapiens 2142 tgccatcact yctgctgttg g 21 2143 21 DNA Homo sapiens
2143 tgtttgaact yaaacatatg a 21 2144 21 DNA Homo sapiens 2144
ccccgttact ktctctttgg g 21 2145 21 DNA Homo sapiens 2145 gagcgccaag
ygctcatgct c 21 2146 21 DNA Homo sapiens 2146 gtccccgtgg ragcctgcag
g 21 2147 21 DNA Homo sapiens 2147 gctggcacaa rgctgcgggc a 21 2148
21 DNA Homo sapiens 2148 tgatggccac rtcccggaaa t 21 2149 21 DNA
Homo sapiens 2149 cccactgcac magtgtgaca t 21 2150 21 DNA Homo
sapiens 2150 tccccttcag ytacctcgtc g 21 2151 21 DNA Homo sapiens
2151 tcaggtactt ygtcagcttc a 21 2152 21 DNA Homo sapiens 2152
agcccctcta yctgaacctc c 21 2153 21 DNA Homo sapiens 2153 tcagcagcag
ygtgtcctca g 21 2154 21 DNA Homo sapiens 2154 cctttgtgct rctcatgttg
c 21 2155 21 DNA Homo sapiens 2155 ctagcaagat ygactttgtg c 21 2156
21 DNA Homo sapiens 2156 tcgtcatcct sgcctgggcc a 21 2157 21 DNA
Homo sapiens 2157 tgtttgggag yggcctgcct g 21 2158 21 DNA Homo
sapiens 2158 ccttgttctc yggtatcggc t 21 2159 21 DNA Homo sapiens
2159 tagaagacct yatcaaacct c 21 2160 21 DNA Homo sapiens 2160
gattgttgtg stgggacctc g 21 2161 21 DNA Homo sapiens 2161 ggcttttcct
rgcctgtgct t 21 2162 21 DNA Homo sapiens 2162 atacaatatc rgccagcctg
g 21 2163 21 DNA Homo sapiens 2163 ctgagctggg yaagccgcgg c 21 2164
21 DNA Homo sapiens 2164 agagccccct racctatgag g 21 2165 21 DNA
Homo sapiens 2165 ctcgtgagat ygccaagtcc c 21 2166 21 DNA Homo
sapiens 2166 atctcgtctc ygaagacatc t 21 2167 21 DNA Homo sapiens
2167 atgtgaacga yggtgcgatg c 21 2168 21 DNA Homo sapiens 2168
gtatctcaat ktgttcatcc c 21 2169 21 DNA Homo sapiens 2169 atgggcctcc
ygagcaggtc t 21 2170 21 DNA Homo sapiens 2170 aggatgtcca rtgcttttcc
g 21 2171 21 DNA Homo sapiens 2171 ctagtggtat sccagcaact a 21 2172
21 DNA Homo sapiens 2172 gcctggcagt ragctggaca a 21 2173 21 DNA
Homo sapiens 2173 ctctgaggcc yggagtacca a 21 2174 21 DNA Homo
sapiens 2174 ccaacgactc yggcccccgc c 21 2175 21 DNA Homo sapiens
2175 gaaaattata yttagaacga g 21 2176 21 DNA Homo sapiens 2176
cagctggaac rtgaagaggg c 21 2177 21 DNA Homo sapiens 2177 ggaagctttt
saaagaatgt t 21 2178 21 DNA Homo sapiens 2178 gcgtgtgcac rgaagctggc
a 21 2179 21 DNA Homo sapiens 2179 ctcacggagg rttccccaac a 21 2180
21 DNA Homo sapiens 2180 ggttgtgatc ytagggaaac a 21 2181 21 DNA
Homo sapiens 2181 gctactggaa ygagtatgaa a 21 2182 21 DNA Homo
sapiens 2182 tcttttccta rtcagcaggt t 21 2183 21 DNA Homo sapiens
2183 gctacaacgt rtatggaaca g 21 2184 21 DNA Homo sapiens 2184
ctcagcatta rgaacgcctg t 21 2185 21 DNA Homo sapiens 2185 tgcagacgac
raccatgtgc a 21 2186 21 DNA Homo sapiens 2186 cacagactgc rcctcaacag
g 21 2187 21 DNA Homo sapiens 2187 gtggtcttgg sctgtttgtt t 21 2188
21 DNA Homo sapiens 2188 atcctgtttc raccccagaa g 21 2189 21 DNA
Homo sapiens 2189 acacccttgg ycaaagcatc g 21 2190 21 DNA Homo
sapiens 2190 ccctgctgac yaagacaaac t 21 2191 21 DNA Homo sapiens
2191 gcgccaatgc ytccttcacc t 21 2192 21 DNA Homo sapiens 2192
caacaaatgc ytggaactgg c 21 2193 21 DNA Homo sapiens 2193 agggtatact
ycaaggatgc a 21 2194 21 DNA Homo sapiens 2194 gcgtggccca yggatgcacc
a 21 2195 21 DNA Homo sapiens 2195 agctgatggc rtcttcgacc c 21 2196
21 DNA Homo sapiens 2196 cctcatggaa yaaataacac t 21 2197 21 DNA
Homo sapiens 2197 tttacctgct rgcggtgctg g 21 2198 21 DNA Homo
sapiens 2198 ctgggcctgg rgggtggagg t 21 2199 21 DNA Homo sapiens
2199 tcactgatgg kcacataaaa g 21 2200 21 DNA Homo sapiens 2200
gcaagccact sgaggttaat t 21 2201 21 DNA Homo sapiens 2201 acactacccg
ragaattggt c 21 2202 21 DNA Homo sapiens 2202 accaaaatca rtgatggcca
g 21 2203 21 DNA Homo sapiens 2203 ctctgtgact rcttcctccc t 21 2204
21 DNA Homo sapiens 2204 gtcagtcctc rggtggaaga t 21 2205 21 DNA
Homo sapiens 2205 tgtgagagcc ytggatggac c 21 2206 21 DNA Homo
sapiens 2206 aagtaacagc rgtgttgcca a 21 2207 21 DNA Homo sapiens
2207 ggcgaggaac yctacatcat c 21 2208 21 DNA Homo sapiens 2208
gccgtcaggg matctcccct a 21 2209 21 DNA Homo sapiens 2209 ttggagttcc
rgccatgtct a 21 2210 21 DNA Homo sapiens 2210 tgaccttcgc ygaggcccag
g 21 2211 21 DNA Homo sapiens 2211 gaggtgacag rtgttgtgtt c 21 2212
21 DNA Homo sapiens 2212 acaggatatc rccgatgcca g 21 2213 21 DNA
Homo sapiens 2213 agcgcagccc sagatgcccc t 21 2214 21 DNA Homo
sapiens 2214 gctttgcccg rgagctgggg g 21 2215 21 DNA Homo sapiens
2215 acattgatga ytgcctctgc a 21 2216 21 DNA Homo sapiens 2216
gccaagcgca rcccgagatg c 21 2217 21 DNA Homo sapiens 2217 atgaaaacac
rtggatcggc c 21 2218 21 DNA Homo sapiens 2218 ccagggcaga sttcagagaa
a 21 2219 21 DNA Homo sapiens 2219 atatcaccga kgccagcgaa a 21 2220
21 DNA Homo sapiens 2220 acaggacttg yccatcctgg t 21 2221 21 DNA
Homo sapiens 2221 gcatgagcaa rccagccgga t 21 2222 21 DNA Homo
sapiens 2222 ataaggatac macaagaagg a 21 2223 21 DNA Homo sapiens
2223 ggcagcaaat katgacatgg t 21 2224 21 DNA Homo sapiens 2224
cagacgaagg kcaatgctgg c 21 2225 21 DNA Homo sapiens 2225 atctcccaga
mactgaatgt t 21 2226 21 DNA Homo sapiens 2226 gaagcctgaa racagtgaat
g 21 2227 21 DNA
Homo sapiens 2227 taccggaaaa wtccagggga c 21 2228 21 DNA Homo
sapiens 2228 aactttttga rtccggaaaa a 21 2229 21 DNA Homo sapiens
2229 tcgagactat rttgtgacca a 21 2230 21 DNA Homo sapiens 2230
gaggaagcct saaaacagtg a 21 2231 21 DNA Homo sapiens 2231 aagtaaaaga
yttgaaaaag a 21 2232 21 DNA Homo sapiens 2232 tccatgaata wcagcatttg
g 21 2233 21 DNA Homo sapiens 2233 cctggagcta rgtccatgaa t 21 2234
21 DNA Homo sapiens 2234 tgaccaagac rtatgccact g 21 2235 21 DNA
Homo sapiens 2235 accttctacc ycaatcacaa a 21 2236 21 DNA Homo
sapiens 2236 cgtcagtgtc wgggaactgg a 21 2237 21 DNA Homo sapiens
2237 catgtctgac rgatacaagc t 21 2238 21 DNA Homo sapiens 2238
tgtccaacgc rgtcaagcag a 21 2239 21 DNA Homo sapiens 2239 ttaaagtaga
rcaggccgaa t 21 2240 21 DNA Homo sapiens 2240 ccaaccccga ygagaagacg
a 21 2241 21 DNA Homo sapiens 2241 tacacgacat kttcatggac a 21 2242
21 DNA Homo sapiens 2242 tatgacagag racagaggat g 21 2243 21 DNA
Homo sapiens 2243 gcatccacat sgtgacaggt c 21 2244 21 DNA Homo
sapiens 2244 ctaactggtc kggattacag a 21 2245 21 DNA Homo sapiens
2245 gaaatgaaac rgattgttga g 21 2246 21 DNA Homo sapiens 2246
gagtttttca ytgcactcaa t 21 2247 21 DNA Homo sapiens 2247 tgtgagacac
rgttcagatc c 21 2248 21 DNA Homo sapiens 2248 tataatccat mtacacggag
t 21 2249 21 DNA Homo sapiens 2249 gattacctgc maacaggaat g 21 2250
21 DNA Homo sapiens 2250 ccttctatac yccagagcca g 21 2251 21 DNA
Homo sapiens 2251 tcctgaaaga yaccaagagc a 21 2252 21 DNA Homo
sapiens 2252 cagacggaaa ktgctcacac c 21 2253 21 DNA Homo sapiens
2253 tggtgggaca yggataaagc t 21 2254 21 DNA Homo sapiens 2254
gaaaagcttt ytatcgaaac a 21 2255 21 DNA Homo sapiens 2255 aatgactacg
ycaacggctt c 21 2256 21 DNA Homo sapiens 2256 actgggcaga yggaaagtgc
t 21 2257 21 DNA Homo sapiens 2257 actacgccaa mggcttcatg g 21 2258
21 DNA Homo sapiens 2258 gctcagatac yagcagcctg g 21 2259 21 DNA
Homo sapiens 2259 tctttgacaa rtcctgcagc g 21 2260 21 DNA Homo
sapiens 2260 cttgattggg sagaacgaga a 21 2261 21 DNA Homo sapiens
2261 gatggctatg rcctggagat c 21 2262 21 DNA Homo sapiens 2262
cctgagacca raagaaacgc a 21 2263 21 DNA Homo sapiens 2263 ccgcagggat
ytactgagac t 21 2264 21 DNA Homo sapiens 2264 agattaccaa rcccaacgtg
t 21 2265 21 DNA Homo sapiens 2265 tgtcctgcag kgacaagatt g 21 2266
21 DNA Homo sapiens 2266 gggttggagg yccgtgactg c 21 2267 21 DNA
Homo sapiens 2267 atgatgaccc rtctcttgaa g 21 2268 21 DNA Homo
sapiens 2268 aagctggtct rccagatctt c 21 2269 21 DNA Homo sapiens
2269 aaatccacag rtttctgatg a 21 2270 21 DNA Homo sapiens 2270
aattccgact ygacctatga g 21 2271 21 DNA Homo sapiens 2271 gggccacgtc
rgaccctctg g 21 2272 21 DNA Homo sapiens 2272 gttcttcctc ytggagaatg
t 21 2273 21 DNA Homo sapiens 2273 aggacctgat maacaagatc g 21 2274
21 DNA Homo sapiens 2274 agacattcac wggacacaga g 21 2275 21 DNA
Homo sapiens 2275 cctctggctc mgtgttccga g 21 2276 21 DNA Homo
sapiens 2276 actcactttg wtgagctcca g 21 2277 21 DNA Homo sapiens
2277 gaaccttcac rccatctatg a 21 2278 21 DNA Homo sapiens 2278
tgaccaggag wtggaggagc t 21 2279 21 DNA Homo sapiens 2279 aacgacgtgg
rcggccagcg c 21 2280 21 DNA Homo sapiens 2280 gtcctgccca ytggggggcg
c 21 2281 21 DNA Homo sapiens 2281 cgcagctggg rcccaagctc t 21 2282
21 DNA Homo sapiens 2282 caggcagctg rtctgcaacg t 21 2283 21 DNA
Homo sapiens 2283 ctcaggcaaa yggagtaagc c 21 2284 21 DNA Homo
sapiens 2284 accgtctgaa sttgtaggga g 21 2285 21 DNA Homo sapiens
2285 caagggtacc rcgtcgatgc t 21 2286 21 DNA Homo sapiens 2286
ttttggcttc stggcctttg g 21 2287 21 DNA Homo sapiens 2287 cccagttcat
kgatggtgcc c 21 2288 21 DNA Homo sapiens 2288 ctgtgagtgg satttgtttt
g 21 2289 21 DNA Homo sapiens 2289 ggtctgcagt kgccacctga a 21 2290
21 DNA Homo sapiens 2290 gtgtaacaga mgacgggggt t 21 2291 21 DNA
Homo sapiens 2291 aggccatcaa satggggcag t 21 2292 21 DNA Homo
sapiens 2292 gtcaacagta rcctggtgtg c 21 2293 21 DNA Homo sapiens
2293 ccttcactta ygaggatccc a 21 2294 21 DNA Homo sapiens 2294
acctgtgtgg ytcatgcaga g 21 2295 21 DNA Homo sapiens 2295 ctttgggata
ytcatgtggg a 21 2296 21 DNA Homo sapiens 2296 gagaccttca ycctttacta
c 21 2297 21 DNA Homo sapiens 2297 tttgaggtgc maggctcagc a 21 2298
21 DNA Homo sapiens 2298 ctatgaccag rcagaagacg a 21 2299 21 DNA
Homo sapiens 2299 ggggctttgg scttcctcct g 21 2300 21 DNA Homo
sapiens 2300 ggccatccag rccctgtggg c 21 2301 21 DNA Homo sapiens
2301 ggaggtcatt sggacaggct c 21 2302 21 DNA Homo sapiens 2302
ttcctcaggc rgcgggaggg c 21 2303 21 DNA Homo sapiens 2303 agccattgga
ytggagtgct a 21 2304 21 DNA Homo sapiens 2304 agctgaacct sctgacagag
t 21 2305 21 DNA Homo sapiens 2305 tttggtgttc ratagcatat t 21 2306
21 DNA Homo sapiens 2306 tgaagcaaat scagatactt c 21 2307 21 DNA
Homo sapiens 2307 gcatcagcca ygatggtaga a 21 2308 21 DNA Homo
sapiens 2308 tacagaacag rctactcggg t 21 2309 21 DNA Homo sapiens
2309 cagcaatggg yatcccctcg g 21 2310 21 DNA Homo sapiens 2310
aaatcccgta rtgaatccaa g 21 2311 21 DNA Homo sapiens 2311 taacaggaaa
ygtgcagttt a 21 2312 21 DNA Homo sapiens 2312 agatcagcag kgtagcccgt
g 21 2313 21 DNA Homo sapiens 2313 cagaagagtc sttcacagct g 21 2314
21 DNA Homo sapiens 2314 ctagagaaat wctactttgc t 21 2315 21 DNA
Homo sapiens 2315 aagtcagtac rgtggatgcc a 21 2316 21 DNA Homo
sapiens 2316 gaacatgaca raagagtcct t 21 2317 21 DNA Homo sapiens
2317 ggaagatcat rgaagttgaa g 21 2318 21 DNA Homo sapiens 2318
ttctcttaac saagccatca t 21 2319 21 DNA Homo sapiens 2319 tgttggctta
ytcattcacg c 21 2320 21 DNA Homo sapiens 2320 ggctgccatt ktcattgctc
a 21 2321 21 DNA Homo sapiens 2321 aaacccttgg rtttttattg g 21 2322
21 DNA Homo sapiens 2322 ctgttggagc maccattaac a 21 2323 21 DNA
Homo sapiens 2323 gactttgtgc ycaacgtcaa g 21 2324 21 DNA Homo
sapiens 2324 cttctatgtc rcctccagtg a 21 2325 21 DNA Homo sapiens
2325 atgcaagtat kttgggctcg c 21 2326 21 DNA Homo sapiens 2326
cccagtttgt ycccactgtt t 21 2327 21 DNA Homo sapiens 2327 acaggtggcc
rtctgcctgg c 21 2328 21 DNA Homo sapiens 2328 gtgcttggct kcctctttgc
g 21 2329 21 DNA Homo sapiens 2329 cctcttccag ycgcagaaga a 21 2330
21 DNA Homo sapiens 2330 agcccgacct kggcacctgc t 21 2331 21 DNA
Homo sapiens 2331 ggacctgtcg ytcatctgcc t 21 2332 21 DNA Homo
sapiens 2332 accagcggac rctcgacccc c 21 2333 21 DNA Homo sapiens
2333 atcgcaaatg macaggacag g 21 2334 21 DNA Homo sapiens 2334
tcctgtcttc ytggcaatgt t 21 2335 21 DNA Homo sapiens 2335 tgtgcacact
rccatgtaag c 21 2336 21 DNA Homo sapiens 2336 tgtgctgact wccggggtgt
c 21 2337 21 DNA Homo sapiens 2337 aagccagagg rgttctcaag t 21 2338
21 DNA Homo sapiens 2338 tcatagacta ygatgaacac a 21 2339 21 DNA
Homo sapiens 2339 cgaactcttg mcaataatcg a 21 2340 21 DNA Homo
sapiens 2340 aaacaaaccg yatccaccga a 21 2341 21 DNA Homo sapiens
2341 gagggcttca rgacgcgaac t 21 2342 21 DNA Homo sapiens 2342
attagtccag satctcagct g 21 2343 21 DNA Homo sapiens 2343 ttttctctgt
kattcaatca c 21 2344 21 DNA Homo sapiens 2344 ttaccatgta yaccacctgc
a 21 2345 21 DNA Homo sapiens 2345 aactcaggcc mcagcagagc c 21 2346
21 DNA Homo sapiens 2346 gaagtcgctc wacaactgcc g 21 2347 21 DNA
Homo sapiens 2347 gtctgagaat raaattccca c 21 2348 21 DNA Homo
sapiens 2348 gcgtgtccaa ygatgtctgc a 21 2349 21 DNA Homo sapiens
2349 tgggcaatcc rtttacatgc t 21 2350 21 DNA Homo sapiens 2350
ggatcaagac wctccaagag g 21 2351 21 DNA Homo sapiens 2351 gcaaatctgg
ycgcacctaa c 21 2352 21 DNA Homo sapiens 2352 ctccaagttt rgcatgaaag
g 21 2353 21 DNA Homo sapiens 2353 gtcggtggcc rcacaatgct g 21 2354
21 DNA Homo sapiens 2354 tccttaagga yaactaacat t 21 2355 21 DNA
Homo sapiens 2355 aggatgccag ygacaatgca c 21 2356 21 DNA Homo
sapiens 2356 ggacctcaac magttcctca g 21 2357 21 DNA Homo sapiens
2357 agcatgggga yctcaacaag t 21 2358 21 DNA Homo sapiens 2358
gtaatgaaat yccttccaca g 21 2359 21 DNA Homo sapiens 2359 tactaaaata
yatgttacca a 21 2360 21 DNA Homo sapiens 2360 catttgttca scacatcaag
c 21 2361 21 DNA Homo sapiens 2361 cacgcaagga yttccaccgt g 21 2362
21 DNA Homo sapiens 2362 ctgtcattat yggaatgacc a 21 2363 21 DNA
Homo sapiens 2363 attggaatga scaagatccc t 21 2364 21 DNA Homo
sapiens 2364 ccagtacttt kgcatcacca a 21 2365 21 DNA Homo sapiens
2365 gacataacat kgttctgaaa a 21 2366 21 DNA Homo sapiens 2366
aaatctggcc kcacctaacc t 21 2367 21 DNA Homo sapiens 2367 tgctgcccat
ycgctggatg c 21 2368 21 DNA Homo sapiens 2368 gatgctgcat wtagcccagc
a 21 2369 21 DNA Homo sapiens 2369 cgtcccagca mttcgtgcac c 21 2370
21 DNA Homo sapiens 2370 cccattcgct rgatgcctcc a 21 2371 21 DNA
Homo sapiens 2371 tttggccacc mggaactgcc t 21 2372 21 DNA Homo
sapiens 2372 ggagaacttg ytggtgaaaa t 21 2373 21 DNA Homo sapiens
2373 gggatgtcgt yctggataag g 21 2374 21 DNA Homo sapiens 2374
tgtattggga ygttggtaac c 21 2375 21 DNA Homo sapiens 2375 ggtataagag
ycgccctgtc g 21 2376 21 DNA Homo sapiens 2376 ccggagctgc rggaggccta
c 21 2377 21 DNA Homo sapiens 2377 tgcaattcaa ygcagtccga a 21 2378
21 DNA Homo sapiens 2378 tgcacacagt rgaccacgtg g 21 2379 21 DNA
Homo sapiens 2379 acgtccggaa maaactgaag a 21 2380 21 DNA Homo
sapiens 2380 agcaagccct yagtgagatt g 21 2381 21 DNA Homo sapiens
2381 gctgaattaa ragtggccta a 21 2382 21 DNA Homo sapiens 2382
attgaggaaa ytcggcttaa c 21 2383 21 DNA Homo sapiens 2383 cagctgacac
rggatgatga t 21 2384 21 DNA Homo sapiens 2384 ccggaagaaa ytgataatta
t 21 2385 21 DNA Homo sapiens 2385 tacagtatca ytctctctgc a 21 2386
21 DNA Homo sapiens 2386 acttccagtc wgtcacctcc a 21 2387 21 DNA
Homo sapiens 2387 atttcgtgag rgccaagggc a 21 2388 21 DNA Homo
sapiens 2388 tccagatcaa ygttatcccc a 21 2389 21 DNA Homo sapiens
2389 attctggcct wgatgaagtg g 21 2390 21 DNA Homo sapiens 2390
agtccctgtc sccttcagga t 21 2391 21 DNA Homo sapiens 2391 aagggaagaa
rgtctggata g 21 2392 21 DNA Homo sapiens 2392 gggagagcct rcgacaggga
a 21 2393 21 DNA Homo sapiens 2393 gcccaaatac kggaaataaa a 21 2394
21 DNA Homo sapiens 2394 tcgtgcgcaa ygtgccctgg g 21 2395 21 DNA
Homo sapiens 2395 ctggggccac rtgccccaca g 21 2396 21 DNA Homo
sapiens 2396 gcagtgctgc maagctaaag a 21 2397 21 DNA Homo sapiens
2397 ttaccttggt rttcccattg t 21 2398 21 DNA Homo sapiens 2398
acagcttgtt raaaaaaagc t 21 2399 21 DNA Homo sapiens 2399 gagcagtttt
yggaggccag c 21 2400 21 DNA Homo sapiens 2400 cggaggagtt sgtgccccag
g 21 2401 21 DNA Homo sapiens 2401 gagctcagaa ygtctctaag g 21 2402
21 DNA Homo sapiens 2402 agagccagcg rgttgtgctg c
21 2403 21 DNA Homo sapiens 2403 gaccacttaa ytgagcgact a 21 2404 21
DNA Homo sapiens 2404 ctgcaaggca rcctggaaac t 21 2405 21 DNA Homo
sapiens 2405 tggtggtgat ycctgcagag g 21 2406 21 DNA Homo sapiens
2406 gctggagcca statctggcc t 21 2407 21 DNA Homo sapiens 2407
aaggatgaga rggaccactt a 21 2408 21 DNA Homo sapiens 2408 actgcgcacc
ygaaattctt a 21 2409 21 DNA Homo sapiens 2409 agagccacaa rgctagccga
g 21 2410 21 DNA Homo sapiens 2410 catgttcagg wgaattctga a 21 2411
21 DNA Homo sapiens 2411 tggcctcttc scgcctggga a 21 2412 21 DNA
Homo sapiens 2412 atgacattcc ygatcgtcca g 21 2413 21 DNA Homo
sapiens 2413 atagccttcc ytaatccata c 21 2414 21 DNA Homo sapiens
2414 cattggagcg rtcgcaggaa g 21 2415 21 DNA Homo sapiens 2415
atattttccg raagctggga c 21 2416 21 DNA Homo sapiens 2416 gccattgaag
yttcgaagca t 21 2417 21 DNA Homo sapiens 2417 tcccttagct ktcctgacac
a 21 2418 21 DNA Homo sapiens 2418 catcatcaga rgttacttgg g 21 2419
21 DNA Homo sapiens 2419 agtagtaaca ytaacaggat t 21 2420 21 DNA
Homo sapiens 2420 caatggagat ygtggtggat a 21 2421 21 DNA Homo
sapiens 2421 gagaggttga ycaggaaata c 21 2422 21 DNA Homo sapiens
2422 ccctcccagg ytaagctgcg g 21 2423 21 DNA Homo sapiens 2423
ctcacgcaag scgaagacca g 21 2424 21 DNA Homo sapiens 2424 tcaacacctc
ytccttgctg g 21 2425 21 DNA Homo sapiens 2425 gagctaagcc rgggcaagct
c 21 2426 21 DNA Homo sapiens 2426 ctaagccggg kcaagctcta t 21 2427
21 DNA Homo sapiens 2427 tcttcacggg rtactacggg a 21 2428 21 DNA
Homo sapiens 2428 gggtcatgag ygtctgtctg c 21 2429 21 DNA Homo
sapiens 2429 tgctgcccat ycgctggatg g 21 2430 21 DNA Homo sapiens
2430 aagatctggt yagtcttgat t 21 2431 21 DNA Homo sapiens 2431
taccaggagc yccggcctcg t 21 2432 21 DNA Homo sapiens 2432 cgccccactc
ygctccctgt g 21 2433 21 DNA Homo sapiens 2433 tggagaacgg ygacctcaac
c 21 2434 21 DNA Homo sapiens 2434 tgaaagcttt kacctggagc c 21 2435
21 DNA Homo sapiens 2435 ccacgcgatt satcaggatc t 21 2436 21 DNA
Homo sapiens 2436 gaccttctgg yatcacatgt c 21 2437 21 DNA Homo
sapiens 2437 ttcccaagct kacgaaaatc a 21 2438 21 DNA Homo sapiens
2438 ttttttacac ygacagcgcg a 21 2439 21 DNA Homo sapiens 2439
acttgggcct yctgcgcttt g 21 2440 21 DNA Homo sapiens 2440 gaaatctggg
mtggattccc t 21 2441 21 DNA Homo sapiens 2441 cagaatggag stgctgggct
g 21 2442 21 DNA Homo sapiens 2442 ttgtctttgc rccaaagatg t 21 2443
21 DNA Homo sapiens 2443 tgggtcccac rtcggcacac t 21 2444 21 DNA
Homo sapiens 2444 ggattgctaa ygaacagatc a 21 2445 21 DNA Homo
sapiens 2445 atgacacccc kgacatccga a 21 2446 21 DNA Homo sapiens
2446 tggcactcag rtatcgccct c 21 2447 21 DNA Homo sapiens 2447
atggctacta ygtcaaatcc t 21 2448 21 DNA Homo sapiens 2448 gttcatcgac
rgggatcctc t 21 2449 21 DNA Homo sapiens 2449 gcaacctcag kgtctggcgc
c 21 2450 21 DNA Homo sapiens 2450 gctatatcac ytctcccggt t 21 2451
21 DNA Homo sapiens 2451 cttttgcagt kgacatccca g 21 2452 21 DNA
Homo sapiens 2452 ttgcagtgga satcccagaa a 21 2453 21 DNA Homo
sapiens 2453 aaggatatga rgatgaaatt g 21 2454 21 DNA Homo sapiens
2454 agatgaaatt katgatgaat a 21 2455 21 DNA Homo sapiens 2455
tcgttcatcg wcggggatcc t 21 2456 21 DNA Homo sapiens 2456 atggcggtgg
ycaaggatgg c 21 2457 21 DNA Homo sapiens 2457 acaatgggaa raaatcagta
g 21 2458 21 DNA Homo sapiens 2458 actggttcat rgccgtctgt t 21 2459
21 DNA Homo sapiens 2459 tgtcagcaag rttgacaaaa t 21 2460 21 DNA
Homo sapiens 2460 caaaagaaag rcatcaaagc c 21 2461 21 DNA Homo
sapiens 2461 agaacaaatg mtttggttca c 21 2462 21 DNA Homo sapiens
2462 aattacgatg yttcagctgc a 21 2463 21 DNA Homo sapiens 2463
aaggctatga yattcgtctg a 21 2464 21 DNA Homo sapiens 2464 ctctgggtgc
ytgataccta t 21 2465 21 DNA Homo sapiens 2465 ctggatggaa sctacagtga
g 21 2466 21 DNA Homo sapiens 2466 accaccatca ycacgggcgt g 21 2467
21 DNA Homo sapiens 2467 cgtctcctac rtcaaggccg t 21 2468 21 DNA
Homo sapiens 2468 gtcctgctcc mgttcaccac t 21 2469 21 DNA Homo
sapiens 2469 gataacagca mgccacattt g 21 2470 21 DNA Homo sapiens
2470 ctgggtagtg yaacgtgcaa g 21 2471 21 DNA Homo sapiens 2471
ctggcctctt yaccgtggag a 21 2472 21 DNA Homo sapiens 2472 ctaccccaac
mcagaaacta c 21 2473 21 DNA Homo sapiens 2473 gtgtgcccca ragtccgagc
c 21 2474 21 DNA Homo sapiens 2474 atcagcttct rcatgctctg t 21 2475
21 DNA Homo sapiens 2475 accacctgga ygagtttaaa a 21 2476 21 DNA
Homo sapiens 2476 ccggctccaa ygccaacatc a 21 2477 21 DNA Homo
sapiens 2477 cttcacatag yccttttggt a 21 2478 21 DNA Homo sapiens
2478 aagaggaccc wgctccatgt g 21 2479 21 DNA Homo sapiens 2479
gctggacaga ygtgctctac t 21 2480 21 DNA Homo sapiens 2480 ggcaagttta
wttttgatga a 21 2481 21 DNA Homo sapiens 2481 tgctgagcag ygctgccctg
g 21 2482 21 DNA Homo sapiens 2482 ttgaagatga yaacttttgg a 21 2483
21 DNA Homo sapiens 2483 actgggttac yttgactatg c 21 2484 21 DNA
Homo sapiens 2484 tgcctctcaa yagtgacggg a 21 2485 21 DNA Homo
sapiens 2485 tgctttggtt ygaacggctc t 21 2486 21 DNA Homo sapiens
2486 cagatatcgt rgctgaagag g 21 2487 21 DNA Homo sapiens 2487
accaagcgga kcacctttga c 21 2488 21 DNA Homo sapiens 2488 tcaccttttt
ycgtcttttc c 21 2489 21 DNA Homo sapiens 2489 gctacagcga ygaagagcca
g 21 2490 21 DNA Homo sapiens 2490 cccgagccaa yggggatgtg g 21 2491
21 DNA Homo sapiens 2491 tacatcgagc rtgcttcatg a 21 2492 21 DNA
Homo sapiens 2492 gccactacat ygtgaacctg c 21 2493 21 DNA Homo
sapiens 2493 atgtagatca ygagaaaaac a 21 2494 21 DNA Homo sapiens
2494 agaacgagaa ygaacgctgc g 21 2495 21 DNA Homo sapiens 2495
tatggacccc rccgatgacg g 21 2496 21 DNA Homo sapiens 2496 atgacggaca
kttccaagaa c 21 2497 21 DNA Homo sapiens 2497 gctggcagga rgccttgatg
a 21 2498 21 DNA Homo sapiens 2498 ccctcctttc ytacagctcc c 21 2499
21 DNA Homo sapiens 2499 aacgctttgg saaccaacaa a 21 2500 21 DNA
Homo sapiens 2500 tgacttcatc rccgtgattg g 21 2501 21 DNA Homo
sapiens 2501 ttgatgccct ytgatgaggc c 21 2502 21 DNA Homo sapiens
2502 tggacaggat yttcacagcg t 21 2503 21 DNA Homo sapiens 2503
aggctctctt ygacttcctc a 21 2504 21 DNA Homo sapiens 2504 catgcggcct
rtggtgctgg t 21 2505 21 DNA Homo sapiens 2505 actctgccta ygtagagcca
a 21 2506 21 DNA Homo sapiens 2506 catttgactc rgaaacccag g 21 2507
21 DNA Homo sapiens 2507 ccaattgaaa racgaagtct a 21 2508 21 DNA
Homo sapiens 2508 ggagcaggtt kaaaagatcc g 21 2509 21 DNA Homo
sapiens 2509 acacttacaa rccccatagg a 21 2510 21 DNA Homo sapiens
2510 tcctgcacgg ygggcaaccc c 21 2511 21 DNA Homo sapiens 2511
acacacacca ycgctcaccc a 21 2512 21 DNA Homo sapiens 2512 aagattttta
yagaagacat t 21 2513 21 DNA Homo sapiens 2513 acacttcaga ygtggtgatt
g 21 2514 21 DNA Homo sapiens 2514 ctggaacccc rctgattttg g 21 2515
21 DNA Homo sapiens 2515 aagttatacg ygttccttca g 21 2516 21 DNA
Homo sapiens 2516 ccattagata matttcgaga c 21 2517 21 DNA Homo
sapiens 2517 gatactactc rgcgctgcga c 21 2518 21 DNA Homo sapiens
2518 gaaaacgatc yagcccagag a 21 2519 21 DNA Homo sapiens 2519
gcgactgggg ytgtccggac t 21 2520 21 DNA Homo sapiens 2520 tggtcttcat
ygtcacttcc t 21 2521 21 DNA Homo sapiens 2521 tgatgtgtgt ractgtgagg
c 21 2522 21 DNA Homo sapiens 2522 gccgctgacc kccgtctaca c 21 2523
21 DNA Homo sapiens 2523 tggaggagtc rgagcatctg c 21 2524 21 DNA
Homo sapiens 2524 cctccacctg ygtcaaccca t 21 2525 21 DNA Homo
sapiens 2525 agttcctggc rgataaggtg g 21 2526 21 DNA Homo sapiens
2526 gggcttcatc ytggtctgtt a 21 2527 21 DNA Homo sapiens 2527
catctaccgg ygcctgcaga g 21 2528 21 DNA Homo sapiens 2528 gtgatggtgg
wggcctttgc c 21 2529 21 DNA Homo sapiens 2529 tggcctttgc ygtgctctgg
c 21 2530 21 DNA Homo sapiens 2530 caacagcctg raagactggc a 21 2531
21 DNA Homo sapiens 2531 ccatctgcca ygggaacctc a 21 2532 21 DNA
Homo sapiens 2532 tgactcatgc ytactggggc a 21 2533 21 DNA Homo
sapiens 2533 accacccagc rtctaataca a 21 2534 21 DNA Homo sapiens
2534 gagcccttcc rcaacctctc t 21 2535 21 DNA Homo sapiens 2535
aaggtacttg ygttcagaaa a 21 2536 21 DNA Homo sapiens 2536 tccacactct
kcctgtgtca g 21 2537 21 DNA Homo sapiens 2537 taaggaccag raagacaagg
c 21 2538 21 DNA Homo sapiens 2538 gggcctattc kcattgccgg a 21 2539
21 DNA Homo sapiens 2539 cttagatggc racctgtccg a 21 2540 21 DNA
Homo sapiens 2540 atgtatgaga kttgggtgcc a 21 2541 21 DNA Homo
sapiens 2541 gacaggatgt rgcccggttt a 21 2542 21 DNA Homo sapiens
2542 tggaggagga rtttaactac c 21 2543 21 DNA Homo sapiens 2543
caaataagac mtactccttc c 21 2544 21 DNA Homo sapiens 2544 caatctgggc
katgagatca a 21 2545 21 DNA Homo sapiens 2545 cagaattact rgcctcgatc
c 21 2546 21 DNA Homo sapiens 2546 ctggtcgaag mattggaatc c 21 2547
21 DNA Homo sapiens 2547 gacttggaga wgtggaccag c 21 2548 21 DNA
Homo sapiens 2548 aataagaagt saggctgaaa c 21 2549 21 DNA Homo
sapiens 2549 taagaagtca rgctgaaact g 21 2550 21 DNA Homo sapiens
2550 aggctgaaac ygggcgaatc t 21 2551 21 DNA Homo sapiens 2551
gaaactgggc raatctacag a 21
* * * * *